<?xml version='1.0' encoding='utf-8'?>
<PubmedArticleSet>
  <PubmedArticle>
    <ArticleTitle>An improved in vitro model simulating the feto-maternal interface to study developmental effects of potentially toxic compounds: The example of titanium dioxide nanoparticles.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35537546</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00201-0</DOI>
    <KeywordList>
      <Keywords>Embryoid Bodies</Keywords>
      <Keywords>Embryotoxicity</Keywords>
      <Keywords>In Vitro Translocation Study</Keywords>
      <Keywords>Placenta</Keywords>
      <Keywords>Syncytiotrophoblast</Keywords>
      <Keywords>Titanium-Dioxide Nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Valentina Lacconi</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy; Saint Camillus International University of Health Sciences, Via di Sant'Alessandro, 8, 00131 Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Micol Massimiani</Name>
        <Affiliation>Saint Camillus International University of Health Sciences, Via di Sant'Alessandro, 8, 00131 Rome, Italy; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy. Electronic address: micol.massimiani@unicamillus.org.</Affiliation>
      </Author>
      <Author>
        <Name>Lorenzo Paglione</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandra Messina</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy. Electronic address: alessandra.messina@uniroma2.it.</Affiliation>
      </Author>
      <Author>
        <Name>Beatrice Battistini</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Patrizia De Filippis</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy. Electronic address: patrizia.de.filippis@uniroma2.it.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Magrini</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy. Electronic address: andrea.magrini@uniroma2.it.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio Pietroiusti</Name>
        <Affiliation>Saint Camillus International University of Health Sciences, Via di Sant'Alessandro, 8, 00131 Rome, Italy; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy. Electronic address: antonio.pietroiusti@unicamillus.org.</Affiliation>
      </Author>
      <Author>
        <Name>Luisa Campagnolo</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy. Electronic address: campagnolo@med.uniroma2.it.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of inhalation toxicology after a 90-day xylitol aerosol exposure in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35526792</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00190-9</DOI>
    <KeywordList>
      <Keywords>Aerosol</Keywords>
      <Keywords>Inhalation exposure</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>Xylitol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yushan Tian</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongjuan Wang</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingxia Wang</Name>
        <Affiliation>Qingdao ETSONG Technology Co., Ltd, Qingdao 266000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xianmei Li</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengjun Lu</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuhao Ma</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenming Wang</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jili Wang</Name>
        <Affiliation>Qingdao ETSONG Technology Co., Ltd, Qingdao 266000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiayou Tang</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Wu</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengxia Feng</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaning Fu</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shulei Han</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Tong Liu</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Huan Chen</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongwei Hou</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China. Electronic address: qsfctc@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Qingyuan Hu</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, Zhengzhou 450001, PR China; Key Laboratory of Tobacco Biological Effects, Zhengzhou 450001, PR China. Electronic address: huqy@ztri.com.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Resveratrol attenuates atherosclerotic endothelial injury through the Pin1/Notch1 pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35526791</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00192-2</DOI>
    <KeywordList>
      <Keywords>Atherosclerosis</Keywords>
      <Keywords>Endothelial cell injury</Keywords>
      <Keywords>Notch1</Keywords>
      <Keywords>Pin1</Keywords>
      <Keywords>Resveratrol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guo Hui Yu</Name>
        <Affiliation>Department of Traditional Chinese Medicine, The Affiliated Hanyang Hospital of Wuhan University of Science and Technology, Wuhan Hanyang Hospital, Wuhan 430050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Fang</Name>
        <Affiliation>Department of Traditional Chinese Medicine, The Affiliated Hanyang Hospital of Wuhan University of Science and Technology, Wuhan Hanyang Hospital, Wuhan 430050, China. Electronic address: fangyong_whh@126.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>IL-22 regulates inflammatory responses to agricultural dust-induced airway inflammation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35525330</pubmedLink>
    <GrantList>
      <Grant>R00 ES025819</Grant>
      <Grant>R01 HL158926</Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00189-2</DOI>
    <KeywordList>
      <Keywords>Agricultural dust</Keywords>
      <Keywords>IL-22</Keywords>
      <Keywords>IL-22R1</Keywords>
      <Keywords>Macrophage</Keywords>
      <Keywords>Resolution of inflammation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Arzu Ulu</Name>
        <Affiliation>Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stefanie Sveiven</Name>
        <Affiliation>Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amanpreet Bilg</Name>
        <Affiliation>Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jalene V. Velazquez</Name>
        <Affiliation>Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marissa Diaz</Name>
        <Affiliation>Riverside Community College, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maheswari Mukherjee</Name>
        <Affiliation>Department of Medical Sciences, College of Allied Health Professions, University of Nebraska Medical Center, Omaha, NE 68198, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ana G. Yuil-Valdes</Name>
        <Affiliation>Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Santosh Kota</Name>
        <Affiliation>Department of Preprofessional Biology, University of Florida, Gainesville, FL 32603, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Abigail Burr</Name>
        <Affiliation>Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Aileen Najera</Name>
        <Affiliation>Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tara M. Nordgren</Name>
        <Affiliation>Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521, USA; Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA. Electronic address: tmnordgren@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The role of Iron in lipid peroxidation and protein nitration during acetaminophen-induced liver injury in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35513057</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00188-0</DOI>
    <KeywordList>
      <Keywords>Acetaminophen Hepatotoxicity</Keywords>
      <Keywords>Deferoxamine</Keywords>
      <Keywords>Ferrous iron</Keywords>
      <Keywords>Lipid Peroxidation</Keywords>
      <Keywords>Minocycline</Keywords>
      <Keywords>Peroxynitrite</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Olamide B. Adelusi</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anup Ramachandran</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John J. Lemasters</Name>
        <Affiliation>Center for Cell Death, Injury &amp; Regeneration, Departments of Drug Discovery &amp; Biomedical Sciences and Biochemistry &amp; Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hartmut Jaeschke</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA. Electronic address: hjaeschke@kumc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic arsenic exposure suppresses ATM pathway activation in human keratinocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35513056</pubmedLink>
    <GrantList>
      <Grant>P30 ES030283</Grant>
      <Grant>R01 ES027778</Grant>
      <Grant>R25 CA134283</Grant>
      <Grant>T32 ES011564</Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00187-9</DOI>
    <KeywordList>
      <Keywords>ATM</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>DNA damage response</Keywords>
      <Keywords>Keratinocytes</Keywords>
      <Keywords>MRN</Keywords>
      <Keywords>Phosphatases</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alexandra N. Nail</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Center for Integrated Environmental Health Science, University of Louisville, Louisville, KY 40209, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Lakynkalina M. McCaffrey</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Center for Integrated Environmental Health Science, University of Louisville, Louisville, KY 40209, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Mayukh Banerjee</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Center for Integrated Environmental Health Science, University of Louisville, Louisville, KY 40209, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Ana P. Ferragut Cardoso</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Center for Integrated Environmental Health Science, University of Louisville, Louisville, KY 40209, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>J. Christopher States</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Center for Integrated Environmental Health Science, University of Louisville, Louisville, KY 40209, United States of America. Electronic address: jcstates@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Vulnerability of HIF1α and HIF2α to damage by proteotoxic stressors.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35504338</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00186-7</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>HIF1A</Keywords>
      <Keywords>HIF2A</Keywords>
      <Keywords>Heat shock</Keywords>
      <Keywords>Proteotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lauren M. Meyers</Name>
        <Affiliation>Brown University, Legoretta Cancer Center, Department of Pathology and Laboratory Medicine, Providence, RI 02912, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Casey Krawic</Name>
        <Affiliation>Brown University, Legoretta Cancer Center, Department of Pathology and Laboratory Medicine, Providence, RI 02912, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michal W. Luczak</Name>
        <Affiliation>Brown University, Legoretta Cancer Center, Department of Pathology and Laboratory Medicine, Providence, RI 02912, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anatoly Zhitkovich</Name>
        <Affiliation>Brown University, Legoretta Cancer Center, Department of Pathology and Laboratory Medicine, Providence, RI 02912, USA. Electronic address: anatoly_zhitkovich@brown.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mogrol suppresses lung cancer cell growth by activating AMPK-dependent autophagic death and inducing p53-dependent cell cycle arrest and apoptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35489526</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00182-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Cell cycle arrest</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Mogrol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>He Li</Name>
        <Affiliation>School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, PR China; Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Linling Liu</Name>
        <Affiliation>School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, PR China; Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Ying Chen</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Yan</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ru Li Li</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Lan</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Kun Yue Xue</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Li</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Cai Li Zhuo</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Lin</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Yu Li</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuang Wu</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Die Zhang</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Mei Wang</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Jing Huang</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingling Wang</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Jiang</Name>
        <Affiliation>Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, PR China. Electronic address: wcumsjw@scu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Liming Zhou</Name>
        <Affiliation>School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, PR China. Electronic address: zhou108@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Autophagy contributes to 4-Amino-2-Trifluoromethyl-Phenyl Retinate-induced differentiation in human acute promyelocytic leukemia NB4 cells" [Toxicology and Applied Pharmacology 319 (2017) 1-11].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35489525</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00185-5</DOI>
    <AuthorList>
      <Author>
        <Name>Yue Li</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ge Li</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Wang</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Ya Xie</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ren Peng Zhou</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yao Meng</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ran Ding</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Fang Ge</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Hu Chen</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China. Electronic address: chenfeihu@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sex-divergent expression of cytochrome P450 and SIRTUIN 1-7 proteins in toxicity evaluation of a benzimidazole-derived epigenetic modulator in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35489524</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00184-3</DOI>
    <KeywordList>
      <Keywords>Acute and repeated dose toxicity</Keywords>
      <Keywords>BZD9L1</Keywords>
      <Keywords>Benzimidazole derivative</Keywords>
      <Keywords>CYPs</Keywords>
      <Keywords>Sex-divergent</Keywords>
      <Keywords>Sirtuin inhibitor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yeuan Ting Lee</Name>
        <Affiliation>Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Penang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Jer Tan</Name>
        <Affiliation>Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Penang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Pei Yi Mok</Name>
        <Affiliation>Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Penang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Gurjeet Kaur</Name>
        <Affiliation>Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Penang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Sasidharan Sreenivasan</Name>
        <Affiliation>Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Penang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Falasca</Name>
        <Affiliation>Curtin Medical School, Curtin Health Innovation Research Institute (CHIRI), Curtin University, GPO Box U1987, Perth, WA 6845, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Chern Ein Oon</Name>
        <Affiliation>Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Penang, Malaysia. Electronic address: chern.oon@usm.my.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Targeted delivery of doxorubicin by Thermo/pH-responsive magnetic nanoparticles in a rat model of breast cancer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35487267</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00181-8</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Folate targeting</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Tumor-targeted drug delivery systems</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nasibeh Mohammad Ali Pourradi</Name>
        <Affiliation>Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmacology and Toxicology, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Hossein Babaei</Name>
        <Affiliation>Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmacology and Toxicology, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Hamed Hamishehkar</Name>
        <Affiliation>Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Behzad Baradaran</Name>
        <Affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Behrooz Shokouhi-Gogani</Name>
        <Affiliation>Department of Pathology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Dariush Shanehbandi</Name>
        <Affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Marjan Ghorbani</Name>
        <Affiliation>Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Yadollah Azarmi</Name>
        <Affiliation>Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmacology and Toxicology, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: azarmiy@tbzmed.ac.ir.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Combining phenotypic profiling and targeted RNA-Seq reveals linkages between transcriptional perturbations and chemical effects on cell morphology: Retinoic acid as an example.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35483669</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00177-6</DOI>
    <KeywordList>
      <Keywords>Cell Painting</Keywords>
      <Keywords>Computational Toxicology</Keywords>
      <Keywords>Concentration-Response</Keywords>
      <Keywords>High-Throughput Phenotypic Profiling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Johanna Nyffeler</Name>
        <Affiliation>Center for Computational Toxicology &amp; Exposure, Office of Research and Development, US Environmental Protection Agency, Durham, NC 27711, United States of America; Oak Ridge Institute for Science and Education (ORISE) Postdoctoral Fellow, Oak Ridge, TN 37831, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Clinton Willis</Name>
        <Affiliation>Center for Computational Toxicology &amp; Exposure, Office of Research and Development, US Environmental Protection Agency, Durham, NC 27711, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Felix R. Harris</Name>
        <Affiliation>Center for Computational Toxicology &amp; Exposure, Office of Research and Development, US Environmental Protection Agency, Durham, NC 27711, United States of America; Oak Ridge Associated Universities (ORAU) National Student Services Contractor, Oak Ridge, TN 37831, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Laura W. Taylor</Name>
        <Affiliation>Center for Computational Toxicology &amp; Exposure, Office of Research and Development, US Environmental Protection Agency, Durham, NC 27711, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Judson</Name>
        <Affiliation>Center for Computational Toxicology &amp; Exposure, Office of Research and Development, US Environmental Protection Agency, Durham, NC 27711, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Logan J. Everett</Name>
        <Affiliation>Center for Computational Toxicology &amp; Exposure, Office of Research and Development, US Environmental Protection Agency, Durham, NC 27711, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua A. Harrill</Name>
        <Affiliation>Center for Computational Toxicology &amp; Exposure, Office of Research and Development, US Environmental Protection Agency, Durham, NC 27711, United States of America. Electronic address: harrill.joshua@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Carbon tetrachloride induced mitochondrial division, respiratory chain damage, abnormal intracellular [H</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35483668</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00183-1</DOI>
    <AuthorList>
      <Author>
        <Name>Yuxin Zhang</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiurui Liang</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Guan</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiaqi Jin</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Zhang</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Xu</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jihua Fu</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China. Electronic address: jihua_fu@cpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TRIM62 silencing represses the proliferation and invasion and increases the chemosensitivity of hepatocellular carcinoma cells by affecting the NF-κB pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35469851</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00180-6</DOI>
    <KeywordList>
      <Keywords>Hepatocellular carcinoma</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>TRIM62</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wanhu Fan</Name>
        <Affiliation>Department of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an 710061, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojing Liu</Name>
        <Affiliation>Department of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an 710061, People's Republic of China. Electronic address: liu_xiaojing518@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Danfeng Ren</Name>
        <Affiliation>Department of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an 710061, People's Republic of China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Foodborne compounds that alter plasma membrane architecture can modify the response of intestinal cells to shear stress in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35461954</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00179-X</DOI>
    <KeywordList>
      <Keywords>Actin cytoskeletal network</Keywords>
      <Keywords>Alternariol</Keywords>
      <Keywords>Cholesterol</Keywords>
      <Keywords>Intestinal mechanotransduction</Keywords>
      <Keywords>Lovastatin</Keywords>
      <Keywords>PIEZO1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Valerie Isabella Charlotte Rebhahn</Name>
        <Affiliation>Department of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Währingerstraße, 38-40-1090 Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Endre Kiss</Name>
        <Affiliation>Core Facility Multimodal Imaging, Faculty of Chemistry, University of Vienna, Währingerstraße, 38-40-1090 Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Doris Marko</Name>
        <Affiliation>Department of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Währingerstraße, 38-40-1090 Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Giorgia Del Favero</Name>
        <Affiliation>Department of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Währingerstraße, 38-40-1090 Vienna, Austria; Core Facility Multimodal Imaging, Faculty of Chemistry, University of Vienna, Währingerstraße, 38-40-1090 Vienna, Austria. Electronic address: giorgia.del.favero@univie.ac.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integrative description of changes occurring on zebrafish embryos exposed to water-soluble crude oil components and its mixture with a chemical surfactant.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35452689</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00178-8</DOI>
    <KeywordList>
      <Keywords>Gene expression</Keywords>
      <Keywords>Histology</Keywords>
      <Keywords>Malformations</Keywords>
      <Keywords>Proteomics</Keywords>
      <Keywords>WAF/CEWAF</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carlos Eduardo González-Penagos</Name>
        <Affiliation>Departamento de Recursos del Mar, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN) Unidad Mérida, Antigua carretera a Progreso Km. 6, CP 97310 Mérida, Yucatán, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Jesús Alejandro Zamora-Briseño</Name>
        <Affiliation>Laboratorio de Entomología Molecular, Red de Estudios Moleculares Avanzados, Clúster Científico y Tecnológico BioMimic®, El Instituto de Ecología, Carretera antigua a Coatepec 351, El Haya, Xalapa, Veracruz, CP 91070, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Monica Améndola-Pimenta</Name>
        <Affiliation>Departamento de Recursos del Mar, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN) Unidad Mérida, Antigua carretera a Progreso Km. 6, CP 97310 Mérida, Yucatán, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>José Miguel Elizalde-Contreras</Name>
        <Affiliation>Laboratorio de Entomología Molecular, Red de Estudios Moleculares Avanzados, Clúster Científico y Tecnológico BioMimic®, El Instituto de Ecología, Carretera antigua a Coatepec 351, El Haya, Xalapa, Veracruz, CP 91070, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Flor Árcega-Cabrera</Name>
        <Affiliation>Unidad de Química Sisal, Facultad de Química, Universidad Nacional Autónoma de México, Puerto de Abrigo S/N, Sisal, Yucatán 97356, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Yanis Cruz-Quintana</Name>
        <Affiliation>Grupo de Investigación en Sanidad Acuícola, Inocuidad y Salud Ambiental, Facultad de Ciencias Veterinarias, Departamento de Acuicultura, Pesca y Recursos Naturales Renovables. Universidad Técnica de Manabí, Ciudadela Universitaria, Bahía de Caráquez, Manabí 130104, Ecuador.</Affiliation>
      </Author>
      <Author>
        <Name>Ana María Santana-Piñeros</Name>
        <Affiliation>Grupo de Investigación en Sanidad Acuícola, Inocuidad y Salud Ambiental, Facultad de Ciencias Veterinarias, Departamento de Acuicultura, Pesca y Recursos Naturales Renovables. Universidad Técnica de Manabí, Ciudadela Universitaria, Bahía de Caráquez, Manabí 130104, Ecuador.</Affiliation>
      </Author>
      <Author>
        <Name>Mayra Alejandra Cañizárez-Martínez</Name>
        <Affiliation>Departamento de Recursos del Mar, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN) Unidad Mérida, Antigua carretera a Progreso Km. 6, CP 97310 Mérida, Yucatán, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Antonio Pérez-Vega</Name>
        <Affiliation>Departamento de Recursos del Mar, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN) Unidad Mérida, Antigua carretera a Progreso Km. 6, CP 97310 Mérida, Yucatán, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Eliel Ruiz-May</Name>
        <Affiliation>Laboratorio de Entomología Molecular, Red de Estudios Moleculares Avanzados, Clúster Científico y Tecnológico BioMimic®, El Instituto de Ecología, Carretera antigua a Coatepec 351, El Haya, Xalapa, Veracruz, CP 91070, Mexico. Electronic address: eliel.ruiz@inecol.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Rossanna Rodríguez-Canul</Name>
        <Affiliation>Departamento de Recursos del Mar, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN) Unidad Mérida, Antigua carretera a Progreso Km. 6, CP 97310 Mérida, Yucatán, Mexico. Electronic address: rossana.rodriguez@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacological PDGFRβ inhibitors imatinib and sunitinib cause human brain pericyte death in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35443205</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00170-3</DOI>
    <KeywordList>
      <Keywords>Imatinib</Keywords>
      <Keywords>Pericytes</Keywords>
      <Keywords>Platelet derived growth factor receptor beta</Keywords>
      <Keywords>Sunitinib</Keywords>
      <Keywords>Tyrosine kinase inhibitors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Natalie E. King</Name>
        <Affiliation>Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Jo Maree Courtney</Name>
        <Affiliation>Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Lachlan S. Brown</Name>
        <Affiliation>Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine G. Foster</Name>
        <Affiliation>Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Jake M. Cashion</Name>
        <Affiliation>Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Emily Attrill</Name>
        <Affiliation>Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Dino Premilovac</Name>
        <Affiliation>Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>David W. Howells</Name>
        <Affiliation>Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Brad A. Sutherland</Name>
        <Affiliation>Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia. Electronic address: brad.sutherland@utas.edu.au.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35439480</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00169-7</DOI>
    <KeywordList>
      <Keywords>Adverse reaction</Keywords>
      <Keywords>Bulleyaconitine A</Keywords>
      <Keywords>Cytochrome P450 enzymes</Keywords>
      <Keywords>Drug-drug interactions</Keywords>
      <Keywords>Human liver microsomes</Keywords>
      <Keywords>Metabolism</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaocui Li</Name>
        <Affiliation>Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowen Ou</Name>
        <Affiliation>Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiadong Ni</Name>
        <Affiliation>Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yihong Xu</Name>
        <Affiliation>Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huilin Zuo</Name>
        <Affiliation>Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Fu</Name>
        <Affiliation>Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Caihua Yang</Name>
        <Affiliation>Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongxiang Zhao</Name>
        <Affiliation>School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Li</Name>
        <Affiliation>Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau 999078, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Zhou</Name>
        <Affiliation>Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau 999078, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Zhang</Name>
        <Affiliation>Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongqiu Liu</Name>
        <Affiliation>Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Fu</Name>
        <Affiliation>Huizhou Hospital of Guangzhou University of Chinese Medicine, Huizhou 516000, China. Electronic address: fuling9@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lijun Zhu</Name>
        <Affiliation>Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China. Electronic address: zhulijun@gzucm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hepatoprotective effects of flexirubin, a novel pigment from Chryseobacterium artocarpi, against carbon tetrachloride-induced liver injury: An in vivo study and molecular modeling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35436475</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00167-3</DOI>
    <KeywordList>
      <Keywords>Anti-apoptosis</Keywords>
      <Keywords>Anti-inflammation</Keywords>
      <Keywords>Antioxidant</Keywords>
      <Keywords>Carbon tetrachloride</Keywords>
      <Keywords>Flexirubin pigment</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Molecular docking</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Abeer Mogadem</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, Universiti Teknologi Malaysia, 81310 Skudai, Johor Bahru, Malaysia; Department of Chemistry, College of Science, Taibah University, Almadinah Almunawarah, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Arshi Naqvi</Name>
        <Affiliation>Department of Chemistry, College of Science, Taibah University, Almadinah Almunawarah, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed Ali Almamary</Name>
        <Affiliation>Department of Chemistry, College of Science, Taibah University, Almadinah Almunawarah, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Wan Azlina Ahmad</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, Universiti Teknologi Malaysia, 81310 Skudai, Johor Bahru, Malaysia. Electronic address: azlina@kimia.fs.utm.my.</Affiliation>
      </Author>
      <Author>
        <Name>Khairunadwa Jemon</Name>
        <Affiliation>Department of Bioscience, Faculty of Science, Universiti Teknologi Malaysia, 81310 Skudai, Johor Bahru, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Sherif Helmy El-Alfy</Name>
        <Affiliation>Department of Zoology, Faculty of Science, Ain Shams University, Cairo, Egypt; Department of Biology, College of Science, Taibah University, Almadinah Almunawarah, Saudi Arabia. Electronic address: s.helmy23@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Titanium dioxide nanoparticles induced reactive oxygen species (ROS) related changes of metabolomics signatures in human normal bronchial epithelial (BEAS-2B) cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35430233</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00165-X</DOI>
    <KeywordList>
      <Keywords>Lipid metabolism</Keywords>
      <Keywords>Liquid chromatography</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Reactive oxygen pecies</Keywords>
      <Keywords>Titanium dioxide nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiahe Zhang</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiaqi Shi</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuo Han</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pai Zheng</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhangjian Chen</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, PR China. Electronic address: zhangjianchen@pku.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Guang Jia</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of carbon tetrafluoride as an inert hyperbaric breathing gas in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35429552</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00168-5</DOI>
    <KeywordList>
      <Keywords>Carbon tetrafluoride</Keywords>
      <Keywords>Hyperbaric</Keywords>
      <Keywords>Inert breathing gas</Keywords>
      <Keywords>Tetrafluoromethane</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Matthew S. Makowski</Name>
        <Affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University School of Medicine, 2301 Erwin Road, Durham, NC 27710, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Sproul</Name>
        <Affiliation>Integrated Laboratory Systems, LLC, 601 Keystone Park Drive, Morrisville, NC 27560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carol Swartz</Name>
        <Affiliation>Integrated Laboratory Systems, LLC, 601 Keystone Park Drive, Morrisville, NC 27560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey I. Everitt</Name>
        <Affiliation>Department of Pathology, Duke University School of Medicine, 6 Circuit Drive, Durham, NC 27710, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Darin A. Knaus</Name>
        <Affiliation>Creare LLC, 16 Great Hollow Road, Hanover, NH 03755, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jed C. Wilbur</Name>
        <Affiliation>Creare LLC, 16 Great Hollow Road, Hanover, NH 03755, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard E. Moon</Name>
        <Affiliation>Departments of Anesthesiology and Medicine, Duke University School of Medicine, 2301 Erwin Road, Durham, NC 27710, USA. Electronic address: richard.moon@duke.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tanshinone IIA improves sepsis-induced acute lung injury through the ROCK2/NF-κB axis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35421429</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00166-1</DOI>
    <KeywordList>
      <Keywords>Lung injury</Keywords>
      <Keywords>NF-κB signaling pathway</Keywords>
      <Keywords>ROCK2</Keywords>
      <Keywords>Tanshinone IIA</Keywords>
      <Keywords>sepsis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jie Liu</Name>
        <Affiliation>Department of Emergency, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Hong Wu</Name>
        <Affiliation>Department of Clinical Immunology and Pathogen Examination, Xi'an Medical College, Xi'an 710068, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Liang Zhang</Name>
        <Affiliation>Department of Emergency, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China. Electronic address: zhengliangzhang@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Li</Name>
        <Affiliation>Department of Emergency, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China. Electronic address: lipingjun@163.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no financial conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The surfactant Dioctyl Sodium Sulfosuccinate (DOSS) exposure causes adverse effects in embryos and adults of zebrafish (Danio rerio).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35398465</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00164-8</DOI>
    <KeywordList>
      <Keywords>Biological Response</Keywords>
      <Keywords>DOSS</Keywords>
      <Keywords>Gene Expression</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carlos Eduardo González-Penagos</Name>
        <Affiliation>Departamento de Recursos del Mar, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN) Unidad Mérida, Antigua carretera a Progreso Km. 6, CP 97310 Mérida, Yucatán, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Jesús Alejandro Zamora-Briseño</Name>
        <Affiliation>Departamento de Recursos del Mar, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN) Unidad Mérida, Antigua carretera a Progreso Km. 6, CP 97310 Mérida, Yucatán, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Monica Améndola-Pimenta</Name>
        <Affiliation>Departamento de Recursos del Mar, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN) Unidad Mérida, Antigua carretera a Progreso Km. 6, CP 97310 Mérida, Yucatán, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Antonio Pérez-Vega</Name>
        <Affiliation>Departamento de Recursos del Mar, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN) Unidad Mérida, Antigua carretera a Progreso Km. 6, CP 97310 Mérida, Yucatán, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Montero-Muñoz</Name>
        <Affiliation>Departamento de Recursos del Mar, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN) Unidad Mérida, Antigua carretera a Progreso Km. 6, CP 97310 Mérida, Yucatán, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Mayra Alejandra Cañizares-Martínez</Name>
        <Affiliation>Departamento de Recursos del Mar, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN) Unidad Mérida, Antigua carretera a Progreso Km. 6, CP 97310 Mérida, Yucatán, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Rossanna Rodríguez-Canul</Name>
        <Affiliation>Departamento de Recursos del Mar, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN) Unidad Mérida, Antigua carretera a Progreso Km. 6, CP 97310 Mérida, Yucatán, Mexico. Electronic address: rossana.rodriguez@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Methamphetamine induces intestinal injury by altering gut microbiota and promoting inflammation in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35390362</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00156-9</DOI>
    <KeywordList>
      <Keywords>Gut microbiota</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Intestinal injury</Keywords>
      <Keywords>Methamphetamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Li Bin Wang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), No. 1838 North Guangzhou Road, 510515 Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Ling Xu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), No. 1838 North Guangzhou Road, 510515 Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Jian Chen</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, Southern Medical University, No. 1838 North Guangzhou Road, 510515 Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Kai Zhang</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, Southern Medical University, No. 1838 North Guangzhou Road, 510515 Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Yao Zhang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), No. 1838 North Guangzhou Road, 510515 Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Kui Chen</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), No. 1838 North Guangzhou Road, 510515 Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Hao Li</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, Southern Medical University, No. 1838 North Guangzhou Road, 510515 Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Li Liu</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, Southern Medical University, No. 1838 North Guangzhou Road, 510515 Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Wang</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, Southern Medical University, No. 1838 North Guangzhou Road, 510515 Guangzhou, China. Electronic address: wangqi1980@smu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Li Xie</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), No. 1838 North Guangzhou Road, 510515 Guangzhou, China. Electronic address: xiexiaoli1999@smu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Epidermal Growth Factor-labeled liposomes as a way to target the toxicity of silver nanoparticles into EGFR-overexpressing cancer cells in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35385781</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00154-5</DOI>
    <KeywordList>
      <Keywords>Anticancer treatment</Keywords>
      <Keywords>Drug delivery system</Keywords>
      <Keywords>EGFR</Keywords>
      <Keywords>Epidermal growth factor</Keywords>
      <Keywords>Liposomes</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Silver nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bartosz Skóra</Name>
        <Affiliation>Department of Biotechnology and Cell Biology, Medical College, University of Information Technology and Management, St. Sucharskiego 2, 35-225 Rzeszow, Poland. Electronic address: bskora@wsiz.edu.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Tomasz Piechowiak</Name>
        <Affiliation>Department of Chemistry and Food Toxicology, Institute of Food Technology and Nutrition, University of Rzeszow, St. Cwiklinskiej 1A, 35-601 Rzeszow, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Konrad A. Szychowski</Name>
        <Affiliation>Department of Biotechnology and Cell Biology, Medical College, University of Information Technology and Management, St. Sucharskiego 2, 35-225 Rzeszow, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Establishment of baseline profiles of 50 bile acids in preclinical toxicity species: A comprehensive assessment of translational differences and study design considerations for biomarker development.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35378153</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00153-3</DOI>
    <KeywordList>
      <Keywords>Bile acids</Keywords>
      <Keywords>Biomarker</Keywords>
      <Keywords>Drug induced liver injury</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Liver disease</Keywords>
      <Keywords>Preclinical species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dewakar Sangaraju</Name>
        <Affiliation>Drug Metabolism &amp; Pharmacokinetics, Genentech, Inc., South San Francisco, CA, United States of America. Electronic address: sangaraju.dewakar@gene.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paula Katavolos</Name>
        <Affiliation>Nonclinical Safety, Bristol Myers Squibb, New Brunswick, NJ, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaorong Liang</Name>
        <Affiliation>Drug Metabolism &amp; Pharmacokinetics, Genentech, Inc., South San Francisco, CA, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina Chou</Name>
        <Affiliation>Safety Assessment, Genentech, Inc., Translational Safety Sciences, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Tanja S. Zabka</Name>
        <Affiliation>Safety Assessment, Genentech, Inc., Translational Safety Sciences, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Dean</Name>
        <Affiliation>Drug Metabolism &amp; Pharmacokinetics, Genentech, Inc., South San Francisco, CA, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Maher</Name>
        <Affiliation>Theravance, South San Francisco, CA, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Carbon tetrachloride induced mitochondrial division, respiratory chain damage, abnormal intracellular [H</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35378152</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00155-7</DOI>
    <AuthorList>
      <Author>
        <Name>Yuxin Zhang</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiurui Liang</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Guan</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiaqi Jin</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Zhang</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Xu</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jihua Fu</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China. Electronic address: jihua_fu@cpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>DNA damage by reactive oxygen species resulting from metabolic activation of 8-epidiosbulbin E acetate in vitro and in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35367474</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00152-1</DOI>
    <KeywordList>
      <Keywords>8-epidiosbulbin E acetate</Keywords>
      <Keywords>CYP3A</Keywords>
      <Keywords>DNA damage</Keywords>
      <Keywords>Metabolic activation</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shiyu Zhang</Name>
        <Affiliation>State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Liu</Name>
        <Affiliation>State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou 550004, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Liu</Name>
        <Affiliation>State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; School of Pharmacy, Guizhou Medical University, Guiyang, Guizhou 550004, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Pan</Name>
        <Affiliation>State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; School of Pharmacy, Guizhou Medical University, Guiyang, Guizhou 550004, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Tan</Name>
        <Affiliation>State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou 550004, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zixia Hu</Name>
        <Affiliation>Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bowen Gong</Name>
        <Affiliation>State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou 550004, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufen Liao</Name>
        <Affiliation>State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; School of Pharmacy, Guizhou Medical University, Guiyang, Guizhou 550004, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Luo</Name>
        <Affiliation>State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; Key Laboratory of Environmental Pollution, Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, Guizhou 550004, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qibing Zeng</Name>
        <Affiliation>State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; Key Laboratory of Environmental Pollution, Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, Guizhou 550004, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiwei Li</Name>
        <Affiliation>State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; School of Pharmacy, Guizhou Medical University, Guiyang, Guizhou 550004, PR China. Electronic address: weiweili0615@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jiang Zheng</Name>
        <Affiliation>State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; Key Laboratory of Environmental Pollution, Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; School of Pharmacy, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China. Electronic address: zhengneu@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An innovative study design with intermittent dosing to generate a GLP-regulatory package in preclinical species for long lasting molecule M5717, inhibitor of Plasmodium eukaryotic translation elongation factor 2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35367236</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00151-X</DOI>
    <KeywordList>
      <Keywords>Antimalarial treatment</Keywords>
      <Keywords>DDD498</Keywords>
      <Keywords>GLP-regulatory package</Keywords>
      <Keywords>Innovative study design</Keywords>
      <Keywords>Intermittent dosing</Keywords>
      <Keywords>M5717</Keywords>
      <Keywords>Malaria</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Philip Hewitt</Name>
        <Affiliation>The healthcare business of Merck KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany. Electronic address: philip.hewitt@emdgroup.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nada Abla</Name>
        <Affiliation>Ares Trading S.A., Route de Crassier 1, 1262 Eysins, Switzerland (an affiliate of Merck KGaA, Darmstadt, Germany); Medicines for Malaria Venture (MMV), Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Floriane Lignet</Name>
        <Affiliation>The healthcare business of Merck KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Claude Oeuvray</Name>
        <Affiliation>Ares Trading S.A., Route de Crassier 1, 1262 Eysins, Switzerland (an affiliate of Merck KGaA, Darmstadt, Germany).</Affiliation>
      </Author>
      <Author>
        <Name>Wilhelmina Bagchus</Name>
        <Affiliation>The healthcare business of Merck KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lidiya Bebrevska</Name>
        <Affiliation>Medicines for Malaria Venture (MMV), Geneva, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prenatal exposure to arsenic promotes sterile inflammation through the Polycomb repressive element EZH2 and accelerates skin tumorigenesis in mouse.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35364107</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00149-1</DOI>
    <KeywordList>
      <Keywords>Developmental origin of health and disease (DoHAD)</Keywords>
      <Keywords>Histone marks (H3K27me3 and H3K4me3)</Keywords>
      <Keywords>Histone methyl transferase (EZH2)</Keywords>
      <Keywords>Interleukin-1α (IL-1α)</Keywords>
      <Keywords>Prenatal arsenic exposure</Keywords>
      <Keywords>Skin tumorigenesis</Keywords>
      <Keywords>Tumor necrosis factor-α (TNF-α)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vineeta Sharma</Name>
        <Affiliation>Developmental Toxicology Laboratory, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India. Electronic address: vineeta.palwal@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Siddhartha Gangopadhyay</Name>
        <Affiliation>Developmental Toxicology Laboratory, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; Academy of Scientific and Innovation Research (AcSIR), Ghaziabad 201002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Shagun Shukla</Name>
        <Affiliation>Developmental Toxicology Laboratory, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; Department of Microbiology, Dr Shakuntala Mishra National Rehabilitation University, Lucknow, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anchal Chauhan</Name>
        <Affiliation>Developmental Toxicology Laboratory, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; Academy of Scientific and Innovation Research (AcSIR), Ghaziabad 201002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sukhveer Singh</Name>
        <Affiliation>Developmental Toxicology Laboratory, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; Academy of Scientific and Innovation Research (AcSIR), Ghaziabad 201002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Radha Dutt Singh</Name>
        <Affiliation>Developmental Toxicology Laboratory, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ratnakar Tiwari</Name>
        <Affiliation>Developmental Toxicology Laboratory, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Dhirendra Singh</Name>
        <Affiliation>Animal Facility, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vikas Srivastava</Name>
        <Affiliation>Developmental Toxicology Laboratory, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; Academy of Scientific and Innovation Research (AcSIR), Ghaziabad 201002, India. Electronic address: vikas@iitr.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Molnupiravir; molecular and functional descriptors of mitochondrial safety.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35358570</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00148-X</DOI>
    <KeywordList>
      <Keywords>Covid-19</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Molnupiravir</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>K. B. Wallace</Name>
        <Affiliation>Department of Biomedical Sciences, University of Minnesota Medical School Duluth, MN 55812, USA. Electronic address: kwallace@d.umn.edu.</Affiliation>
      </Author>
      <Author>
        <Name>J. A. Bjork</Name>
        <Affiliation>Department of Biomedical Sciences, University of Minnesota Medical School Duluth, MN 55812, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35353990</pubmedLink>
    <GrantList>
      <Grant>P30 ES030283</Grant>
      <Grant>P42 ES023716</Grant>
      <Grant>T32 ES011564</Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00138-7</DOI>
    <KeywordList>
      <Keywords>4-aminobiphenyl</Keywords>
      <Keywords>Arylamine N-acetyltransferase 2</Keywords>
      <Keywords>Immortalized human lung epithelial cells</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>N-hydroxy-4-aminobiphenyl</Keywords>
      <Keywords>β-naphthylamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James T. F. Wise</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology and Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Raúl A. Salazar-González</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology and Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mariam R. Habil</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology and Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark A. Doll</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology and Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David W. Hein</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology and Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA. Electronic address: david.hein@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Alteration in glucose metabolism in the brain associated with tamoxifen treatment: Study in postmenopausal animal model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35353989</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00147-8</DOI>
    <KeywordList>
      <Keywords>Flavonoids</Keywords>
      <Keywords>Hyperglycemia</Keywords>
      <Keywords>Neurodegeneration</Keywords>
      <Keywords>Postmenopausal women</Keywords>
      <Keywords>Quercetin</Keywords>
      <Keywords>Tamoxifen</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suélyn Koerich</Name>
        <Affiliation>Laboratory of Cellular Toxicology, Western Paraná State University, Brazil.. Electronic address: suelyn_npi@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fernanda Coleraus Silva</Name>
        <Affiliation>Laboratory of Cellular Toxicology, Western Paraná State University, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Maria Itinose</Name>
        <Affiliation>Assistance Center in Toxicology, Western Paraná University Hospital, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Paula Maria Quaglio Bellozi</Name>
        <Affiliation>Laboratory of Bioenergetics and Metabolism, University of Brasilia, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Fabiano Sandrini</Name>
        <Affiliation>Endocrinology Clinic, Center of Medical and Pharmaceutical Sciences, Western Paraná University Hospital, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sara Cristina Sagae Schneider</Name>
        <Affiliation>Laboratory of Endocrine Physiology and Metabolism, Center of Biological and Health Sciences, Western Parana State University, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carla Brugin Marek</Name>
        <Affiliation>Laboratory of Cellular Toxicology, Western Paraná State University, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PBK modelling of topical application and characterisation of the uncertainty of C</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35346730</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00137-5</DOI>
    <AuthorList>
      <Author>
        <Name>Hequn Li</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK. Electronic address: Hequn.Li@unilever.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joe Reynolds</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Sorrell</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Sheffield</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Pendlington</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Cubberley</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Beate Nicol</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35337807</pubmedLink>
    <GrantList>
      <Grant>P20 GM103430</Grant>
      <Grant>P42 ES027706</Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00136-3</DOI>
    <KeywordList>
      <Keywords>Human hepatocytes</Keywords>
      <Keywords>Lipids</Keywords>
      <Keywords>PFAS</Keywords>
      <Keywords>Perfluorinated compounds</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Emily Marques</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marisa Pfohl</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Wei</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Giuseppe Tarantola</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lucie Ford</Name>
        <Affiliation>Department of Biology and Biomedical Sciences, Salve Regina University, Newport, RI 02840, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ogochukwu Amaeze</Name>
        <Affiliation>Department of Clinical Pharmacy &amp; Biopharmacy, Faculty of Pharmacy, University of Lagos, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica Alesio</Name>
        <Affiliation>Department of Chemical Engineering, University of Rhode Island, Kingston, RI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sangwoo Ryu</Name>
        <Affiliation>Department of Chemical Engineering, University of Rhode Island, Kingston, RI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xuelian Jia</Name>
        <Affiliation>The Rutgers Center for Computational and Integrative Biology, Camden, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Zhu</Name>
        <Affiliation>The Rutgers Center for Computational and Integrative Biology, Camden, NJ, USA; Department of Chemistry, Rutgers University, Camden, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Geoffrey D. Bothun</Name>
        <Affiliation>Department of Chemical Engineering, University of Rhode Island, Kingston, RI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angela Slitt</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA. Electronic address: aslitt@uri.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rac GTPases in acute myeloid leukemia cells: Expression profile and biological effects of pharmacological inhibition.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35331739</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00135-1</DOI>
    <KeywordList>
      <Keywords>Acute myeloid leukemia</Keywords>
      <Keywords>EHT-1864</Keywords>
      <Keywords>RAC Subfamily</Keywords>
      <Keywords>Rac1</Keywords>
      <Keywords>Rac2</Keywords>
      <Keywords>Rac3</Keywords>
      <Keywords>Rho GTPases</Keywords>
      <Keywords>leukemia</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Débora Felícia Vieira Ramos</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Federal University of São Paulo, Diadema, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rubia Isler Mancuso</Name>
        <Affiliation>Hematology and Bloood Transfusion Center, University of Campinas, Campinas, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bruna Contieri</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Federal University of São Paulo, Diadema, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Adriana Duarte</Name>
        <Affiliation>Hematology and Bloood Transfusion Center, University of Campinas, Campinas, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luciana Paiva</Name>
        <Affiliation>Hematology and Bloood Transfusion Center, University of Campinas, Campinas, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jeferson de Melo Carrilho</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Federal University of São Paulo, Diadema, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sara Teresinha Olalla Saad</Name>
        <Affiliation>Hematology and Bloood Transfusion Center, University of Campinas, Campinas, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mariana Lazarini</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Federal University of São Paulo, Diadema, São Paulo, Brazil; Hematology and Bloood Transfusion Center, University of Campinas, Campinas, São Paulo, Brazil. Electronic address: lazarini@unifesp.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Enzyme-sensitive nanoparticles, smart TAT and cetuximab conjugated immunoliposomes to overcome multidrug resistance in breast cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35314202</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00134-X</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>EGFR</Keywords>
      <Keywords>Gene therapy</Keywords>
      <Keywords>Immunoliposome</Keywords>
      <Keywords>Tumor targeting</Keywords>
      <Keywords>siRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohsen Safaei</Name>
        <Affiliation>Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Pegah Khosravian</Name>
        <Affiliation>Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Sedighe Kazemi Sheykhshabani</Name>
        <Affiliation>Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Gashtasb Mardani</Name>
        <Affiliation>Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Fatemeh Elahian</Name>
        <Affiliation>Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Seyed Abbas Mirzaei</Name>
        <Affiliation>Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran; Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran. Electronic address: mirzaei.a@skums.ac.ir.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The rapid transformation of triclosan in the liver reduces its effectiveness as inhibitor of hepatic energy metabolism.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35307377</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00132-6</DOI>
    <KeywordList>
      <Keywords>Energy metabolism</Keywords>
      <Keywords>Gluconeogenesis</Keywords>
      <Keywords>Glycolysis</Keywords>
      <Keywords>Liver zonation</Keywords>
      <Keywords>Triclosan metabolic effects</Keywords>
      <Keywords>Triclosan single-pass transformation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heloisa V. Pereira-Maróstica</Name>
        <Affiliation>Department of Biochemistry, State University of Maringá, Maringá, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lívia Bracht</Name>
        <Affiliation>Department of Biochemistry, State University of Maringá, Maringá, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jurandir F. Comar</Name>
        <Affiliation>Department of Biochemistry, State University of Maringá, Maringá, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rosane M. Peralta</Name>
        <Affiliation>Department of Biochemistry, State University of Maringá, Maringá, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Adelar Bracht</Name>
        <Affiliation>Department of Biochemistry, State University of Maringá, Maringá, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Anacharis B. Sá-Nakanishi</Name>
        <Affiliation>Department of Biochemistry, State University of Maringá, Maringá, PR, Brazil. Electronic address: absnakanishi@uem.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Octreotide ameliorates hepatic ischemia-reperfusion injury through SNHG12/TAF15-mediated Sirt1 stabilization and YAP1 transcription.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35307376</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00120-X</DOI>
    <KeywordList>
      <Keywords>Hepatic ischemia-reperfusion Injury</Keywords>
      <Keywords>Octreotide</Keywords>
      <Keywords>Sirt1</Keywords>
      <Keywords>TAF15</Keywords>
      <Keywords>YAP1</Keywords>
      <Keywords>lncRNA SNHG12</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shuang Fa Zou</Name>
        <Affiliation>Department of Anesthesiology, Hunan Cancer Hospital, Changsha 410013, Hunan Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Hua Peng</Name>
        <Affiliation>Department of Anesthesiology, Hunan Cancer Hospital, Changsha 410013, Hunan Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chu Mei Zheng</Name>
        <Affiliation>Department of Anesthesiology, Hunan Cancer Hospital, Changsha 410013, Hunan Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Xia Fei</Name>
        <Affiliation>Department of Anesthesiology, Hunan Cancer Hospital, Changsha 410013, Hunan Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Wu Zhao</Name>
        <Affiliation>Department of Anesthesiology, Hunan Cancer Hospital, Changsha 410013, Hunan Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Ping Sun</Name>
        <Affiliation>Department of Anesthesiology, Hunan Cancer Hospital, Changsha 410013, Hunan Province, PR China. Electronic address: hhuuppnggssun789@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Feng Yang</Name>
        <Affiliation>Department of Anesthesiology, Hunan Cancer Hospital, Changsha 410013, Hunan Province, PR China. Electronic address: jjnnffengyyaa456@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hexachlorophene, a selective SHP2 inhibitor, suppresses proliferation and metastasis of KRAS-mutant NSCLC cells by inhibiting RAS/MEK/ERK and PI3K/AKT signaling pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35307375</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00133-8</DOI>
    <KeywordList>
      <Keywords>Hexachlorophene</Keywords>
      <Keywords>Inhibitor</Keywords>
      <Keywords>Non-small cell lung cancer</Keywords>
      <Keywords>RAS</Keywords>
      <Keywords>SHP2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nai Jie Fu</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; University of Chinese Academy of Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Ying Xi</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; University of Chinese Academy of Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Ke Shi</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; University of Chinese Academy of Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Run Ze Li</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; University of Chinese Academy of Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhong Hui Zhang</Name>
        <Affiliation>College of Chemical Engineering, Sichuan University, Chengdu 610064, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Yu Li</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; University of Chinese Academy of Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Lin Zhang</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China. Electronic address: zhanggl@cib.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Wang</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China. Electronic address: wangfei@cib.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Priming treatment with T-cell redirecting bispecific antibody ERY974 reduced cytokine induction without losing cytotoxic activity in vitro by changing the chromatin state in T cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35304238</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00131-4</DOI>
    <KeywordList>
      <Keywords>ATAC-seq</Keywords>
      <Keywords>CD3 bispecific construct</Keywords>
      <Keywords>Cytokine release syndrome (CRS)</Keywords>
      <Keywords>Glypican 3 (GPC3)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yoshika Iwata</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan. Electronic address: iwataysk@chugai-pharm.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yuta Narushima</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Asako Harada</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masayuki Mishima</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the distribution and excretion of [</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35288146</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00123-5</DOI>
    <KeywordList>
      <Keywords>Cynomolgus monkeys</Keywords>
      <Keywords>Inclisiran</Keywords>
      <Keywords>PCSK9</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>siRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dario Lehoux</Name>
        <Affiliation>Targanta Therapeutics Inc., a wholly owned subsidiary of The Medicines Company, Saint Laurent, Quebec H4S 2A1, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Adel Rafai Far</Name>
        <Affiliation>Targanta Therapeutics Inc., a wholly owned subsidiary of The Medicines Company, Saint Laurent, Quebec H4S 2A1, Canada. Electronic address: adel.rafai_far@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>David Kallend</Name>
        <Affiliation>The Medicines Company (Schweiz) GmbH, Zurich 8001, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Peter L. J. Wijngaard</Name>
        <Affiliation>The Medicines Company Inc., Parsippany, NJ 07054, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brad Zerler</Name>
        <Affiliation>The Medicines Company Inc., Parsippany, NJ 07054, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>LncRNA UCA1 regulates silicosis-related lung epithelial cell-to-mesenchymal transition through competitive adsorption of miR-204-5p.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35288145</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00122-3</DOI>
    <KeywordList>
      <Keywords>Epithelial-Mesenchymal Transition</Keywords>
      <Keywords>LncRNA UCA1</Keywords>
      <Keywords>Silicosis</Keywords>
      <Keywords>miR-204-5p</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guo Yang</Name>
        <Affiliation>School of public health, Zhengzhou University, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yangyang Tian</Name>
        <Affiliation>School of public health, Zhengzhou University, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Li</Name>
        <Affiliation>School of public health, Zhengzhou University, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiarui Xia</Name>
        <Affiliation>School of public health, Zhengzhou University, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanmeng Qi</Name>
        <Affiliation>School of public health, Zhengzhou University, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wu Yao</Name>
        <Affiliation>School of public health, Zhengzhou University, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changfu Hao</Name>
        <Affiliation>School of public health, Zhengzhou University, Henan, China. Electronic address: haochangfu@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>F-box protein FBXO41 plays vital role in arsenic trioxide-mediated autophagic death of cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35278439</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00118-1</DOI>
    <KeywordList>
      <Keywords>ATG7</Keywords>
      <Keywords>Apoptosis independent autophagy</Keywords>
      <Keywords>Autophagic cell death</Keywords>
      <Keywords>FBXO41</Keywords>
      <Keywords>Tumor suppressor</Keywords>
      <Keywords>mTOR independent autophagy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yashika Agrawal</Name>
        <Affiliation>Molecular Oncology Laboratory, National Centre for Cell Science, Ganeshkhind Road, Pune, Maharashtra 411007, India; Department of Biotechnology, S.P. Pune University, Ganeshkhind Road, Pune, Maharashtra 411007, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kaustubh S. Nadkarni</Name>
        <Affiliation>Molecular Oncology Laboratory, National Centre for Cell Science, Ganeshkhind Road, Pune, Maharashtra 411007, India; Department of Biotechnology, S.P. Pune University, Ganeshkhind Road, Pune, Maharashtra 411007, India.</Affiliation>
      </Author>
      <Author>
        <Name>Neha A. Gupta</Name>
        <Affiliation>Molecular Oncology Laboratory, National Centre for Cell Science, Ganeshkhind Road, Pune, Maharashtra 411007, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rajesh Kumar Manne</Name>
        <Affiliation>Molecular Oncology Laboratory, National Centre for Cell Science, Ganeshkhind Road, Pune, Maharashtra 411007, India.</Affiliation>
      </Author>
      <Author>
        <Name>Manas Kumar Santra</Name>
        <Affiliation>Molecular Oncology Laboratory, National Centre for Cell Science, Ganeshkhind Road, Pune, Maharashtra 411007, India. Electronic address: manas@nccs.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35276128</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00117-X</DOI>
    <KeywordList>
      <Keywords>Differentiation</Keywords>
      <Keywords>Interstitial lung diseases</Keywords>
      <Keywords>Metalloid</Keywords>
      <Keywords>Migration</Keywords>
      <Keywords>Primary human lung fibroblasts</Keywords>
      <Keywords>Proliferation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Audrey Joannes</Name>
        <Affiliation>Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, F-35000 Rennes, France. Electronic address: audrey.joannes@univ-rennes1.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Claudie Morzadec</Name>
        <Affiliation>Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, F-35000 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Maëla Duclos</Name>
        <Affiliation>Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, F-35000 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Francisco Llamas Gutierrez</Name>
        <Affiliation>Department of Pathology and Cytology, Rennes University Hospital, 35033 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Cristian Chiforeanu</Name>
        <Affiliation>Department of Pathology and Cytology, Rennes University Hospital, 35033 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Cécile Le Naoures</Name>
        <Affiliation>Department of Pathology and Cytology, Rennes University Hospital, 35033 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Bertrand De Latour</Name>
        <Affiliation>Department of Thoracic, Cardiac and Vascular Surgery, Rennes University Hospital, 35033 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Rouzé</Name>
        <Affiliation>Department of Thoracic, Cardiac and Vascular Surgery, Rennes University Hospital, 35033 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Lutz Wollin</Name>
        <Affiliation>Boehringer Ingelheim Pharma GmbH &amp; Co, KG, Biberach an der Riss, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stéphane Jouneau</Name>
        <Affiliation>Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, F-35000 Rennes, France; Department of Respiratory Diseases, Competence Center for Rare Pulmonary Disease, Rennes University Hospital, 35033, Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Laurent Vernhet</Name>
        <Affiliation>Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, F-35000 Rennes, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The position of the nitro group affects the mutagenicity of nitroarenes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35276127</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00119-3</DOI>
    <KeywordList>
      <Keywords>Benzo[a]pyrene</Keywords>
      <Keywords>LUMO</Keywords>
      <Keywords>Molecular Docking</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Nitroarene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Akiko Ohno</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety &amp; Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan. Electronic address: ako-ohno@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshio Okiyama</Name>
        <Affiliation>Division of Medicinal Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan. Electronic address: okiyama@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Akihiko Hirose</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety &amp; Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan. Electronic address: hirose@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kiyoshi Fukuhara</Name>
        <Affiliation>Division of Organic and Medicinal Chemistry, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan. Electronic address: fukuhara@pharm.showa-u.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p" [Toxicology and Applied Pharmacology 396 (2020) 114998].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35276126</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00121-1</DOI>
    <AuthorList>
      <Author>
        <Name>Xiang Li</Name>
        <Affiliation>Department of Preclinical Medicine, Medical College, Hunan Normal University, Changsha 410013, China. Electronic address: lx58616@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lianghou Wang</Name>
        <Affiliation>Department of Preclinical Medicine, Medical College, Hunan Normal University, Changsha 410013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaocheng Cao</Name>
        <Affiliation>Department of Pharmaceutical Science, Medical College, Hunan Normal University, Changsha 410013, China; Key Laboratory of Study and Discover of Small Targeted Molecules of Hunan Province, Medical College, Hunan Normal University, Changsha 410013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingli Zhou</Name>
        <Affiliation>Department of Preclinical Medicine, Medical College, Hunan Normal University, Changsha 410013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Xu</Name>
        <Affiliation>Department of Pharmaceutical Science, Medical College, Hunan Normal University, Changsha 410013, China; Key Laboratory of Study and Discover of Small Targeted Molecules of Hunan Province, Medical College, Hunan Normal University, Changsha 410013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yinghong Cui</Name>
        <Affiliation>Department of Preclinical Medicine, Medical College, Hunan Normal University, Changsha 410013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yebei Qiu</Name>
        <Affiliation>Department of Pharmaceutical Science, Medical College, Hunan Normal University, Changsha 410013, China; Key Laboratory of Study and Discover of Small Targeted Molecules of Hunan Province, Medical College, Hunan Normal University, Changsha 410013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Cao</Name>
        <Affiliation>Department of Pharmaceutical Science, Medical College, Hunan Normal University, Changsha 410013, China; Key Laboratory of Study and Discover of Small Targeted Molecules of Hunan Province, Medical College, Hunan Normal University, Changsha 410013, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cytochalasin Q exerts anti-melanoma effect by inhibiting creatine kinase B.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35276125</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00116-8</DOI>
    <KeywordList>
      <Keywords>Creatine kinase B</Keywords>
      <Keywords>Creatine metabolism</Keywords>
      <Keywords>Cytochalasin Q</Keywords>
      <Keywords>Melanoma</Keywords>
      <Keywords>Microfilament</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yi Lu</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Zhang</Name>
        <Affiliation>Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongdan Chen</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Breast and Thyroid Surgical Department, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing 400014, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingyi Tong</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Wang</Name>
        <Affiliation>Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Li</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Tian</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Yang</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Senlin Li</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zijun Zhang</Name>
        <Affiliation>Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huimin Yuan</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Xiang</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: xiangming@tjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effects of oil sands process-affected water naphthenic acid fraction components on GDF15 secretion in extravillous trophoblast cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35259347</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00115-6</DOI>
    <KeywordList>
      <Keywords>Growth differentiation factor 15</Keywords>
      <Keywords>Naphthenic acids</Keywords>
      <Keywords>Oil sands process affected water</Keywords>
      <Keywords>Placental dysfunction</Keywords>
      <Keywords>Prostaglandins</Keywords>
      <Keywords>Trophoblasts</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laiba Jamshed</Name>
        <Affiliation>Department of Obstetrics and Gynecology, McMaster University, Hamilton, ON L8S 4K1, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Genevieve A. Perono</Name>
        <Affiliation>Department of Obstetrics and Gynecology, McMaster University, Hamilton, ON L8S 4K1, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Lina R. Yacoub</Name>
        <Affiliation>Department of Obstetrics and Gynecology, McMaster University, Hamilton, ON L8S 4K1, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Robert M. Gutgesell</Name>
        <Affiliation>Department of Obstetrics and Gynecology, McMaster University, Hamilton, ON L8S 4K1, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Frank</Name>
        <Affiliation>Water Science, and Technology Directorate, Environment and Climate Change Canada, Burlington, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>L. Mark Hewitt</Name>
        <Affiliation>Water Science, and Technology Directorate, Environment and Climate Change Canada, Burlington, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Philippe J. Thomas</Name>
        <Affiliation>Environment and Climate Change Canada, National Wildlife Research Centre, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Alison C. Holloway</Name>
        <Affiliation>Department of Obstetrics and Gynecology, McMaster University, Hamilton, ON L8S 4K1, Canada. Electronic address: hollow@mcmaster.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Icariin promotes mouse Leydig cell testosterone synthesis via the Esr1/Src/Akt/Creb/Sf-1 pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35259346</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00114-4</DOI>
    <KeywordList>
      <Keywords>Akt</Keywords>
      <Keywords>Icariin</Keywords>
      <Keywords>Leydig cells</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Steroidogenic enzymes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiandong Sun</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fujian Medical University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiwei Xu</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fujian Medical University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuyuan Zheng</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fujian Medical University, Fuzhou 350122, PR China; Undergraduate Class, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chengyu Lv</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fujian Medical University, Fuzhou 350122, PR China; Department of Obstetrics and Gynecology, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou 350001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianmin Lin</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fujian Medical University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Siqi Chen</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fujian Medical University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonghong Qiu</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fujian Medical University, Fuzhou 350122, PR China; Undergraduate Class, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xia Jiang</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fujian Medical University, Fuzhou 350122, PR China; Undergraduate Class, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Eman Draz</Name>
        <Affiliation>Department of Histology, and Embryology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, PR China; Human Anatomy and Embryology department, Suez Canal University, 12411, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Shie Wang</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fujian Medical University, Fuzhou 350122, PR China; Department of Histology, and Embryology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, PR China. Electronic address: shiewang@fjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Silencing of Nudix type 5 represses proliferation and invasion and enhances chemosensitivity of gastric carcinoma cells by affecting the AKT/GSK-3β/β-catenin pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35247377</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00113-2</DOI>
    <KeywordList>
      <Keywords>AKT</Keywords>
      <Keywords>Gastric carcinoma</Keywords>
      <Keywords>NUDT5</Keywords>
      <Keywords>β-catenin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dong Tan</Name>
        <Affiliation>Department of General Surgery, No. 215 Hospital of Shaanxi Nuclear Industry, No. 52 Weiyang West Road, Xianyang, Shaanxi 712000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yafei Zhang</Name>
        <Affiliation>Department of Endoscopy, No. 215 Hospital of Shaanxi Nuclear Industry, No. 52 Weiyang West Road, Xianyang, Shaanxi 712000, China. Electronic address: zhangyafei215@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute exposure to phthalates during recovery from a myocardial infarction induces greater inflammasome activation in male C57bl/6N mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35245615</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00099-0</DOI>
    <KeywordList>
      <Keywords>Macrophage</Keywords>
      <Keywords>Myocardial infarction</Keywords>
      <Keywords>NLPR3 inflammasome</Keywords>
      <Keywords>Phthalates</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Adam Schwendt</Name>
        <Affiliation>Lady Davis Institute for Medical Research, 3755 chemin Cote Ste Catherine, Montréal, Québec H3T 1E2, Canada. Electronic address: adam.schwendt@mail.mcgill.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Joey Bahige Chammas</Name>
        <Affiliation>Lady Davis Institute for Medical Research, 3755 chemin Cote Ste Catherine, Montréal, Québec H3T 1E2, Canada. Electronic address: joey-bahige.chammas@mail.mcgill.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Lorraine E. Chalifour</Name>
        <Affiliation>Lady Davis Institute for Medical Research, 3755 chemin Cote Ste Catherine, Montréal, Québec H3T 1E2, Canada; Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montréal, Québec H3T 1E, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, 850 Sherbrooke Street, Montréal, Québec H3A 1A2, Canada. Electronic address: lorraine.chalifour@mcgill.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An insight about the mechanism of action (MoA) of R-bicalutamide on the androgen receptor homodimer using molecular dynamic.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35245614</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00098-9</DOI>
    <KeywordList>
      <Keywords>Androgen receptor</Keywords>
      <Keywords>Androgen receptor insensitivity</Keywords>
      <Keywords>Molecular dynamic</Keywords>
      <Keywords>Prostate cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Francesca Cavaliere</Name>
        <Affiliation>Molecular Modeling Lab, Department of Food and Drug, University of Parma, Parco Area Delle Scienze 17/A, 43124 Parma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Pietro Cozzini</Name>
        <Affiliation>Molecular Modeling Lab, Department of Food and Drug, University of Parma, Parco Area Delle Scienze 17/A, 43124 Parma, Italy. Electronic address: pietro.cozzini@unipr.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of angiotensin pathway via valsartan reduces tumor growth in models of colorectal cancer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35235860</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00096-5</DOI>
    <KeywordList>
      <Keywords>Angiotensin receptor blocker</Keywords>
      <Keywords>Colorectal cancer</Keywords>
      <Keywords>Combination therapy</Keywords>
      <Keywords>Valsartan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fereshteh Asgharzadeh</Name>
        <Affiliation>Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Asma Mostafapour</Name>
        <Affiliation>Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Safieh Ebrahimi</Name>
        <Affiliation>Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Forouzan Amerizadeh</Name>
        <Affiliation>Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Basic Medical Sciences Institute, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Reihaneh Sabbaghzadeh</Name>
        <Affiliation>Department of Biology, Faculty of Science, Hakim Sabzevari University, Sabzevar 96179-76487, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Seyed Mahdi Hassanian</Name>
        <Affiliation>Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Maryam Fakhraei</Name>
        <Affiliation>Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Alieh Farshbaf</Name>
        <Affiliation>Dental Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Gordon A. Ferns</Name>
        <Affiliation>Brighton &amp; Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex BN1 9PH, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Elisa Giovannetti</Name>
        <Affiliation>Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Amir Avan</Name>
        <Affiliation>Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Basic Medical Sciences Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Medical Genetics Research center, Mashhad University of Medical Sciences, Mashhad, Iran.. Electronic address: avana@mums.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Majid Khazaei</Name>
        <Affiliation>Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: Khazaeimaj@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Resveratrol attenuates methylmercury-induced neurotoxicity by modulating synaptic homeostasis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35231462</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00097-7</DOI>
    <KeywordList>
      <Keywords>Hippocampal</Keywords>
      <Keywords>Memory</Keywords>
      <Keywords>Methylmercury</Keywords>
      <Keywords>Offspring</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Resveratrol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wenjuan Wang</Name>
        <Affiliation>The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang 550025, Guizhou, PR China. Electronic address: reality0337@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Caiyun Deng</Name>
        <Affiliation>The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang 550025, Guizhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Chen</Name>
        <Affiliation>The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang 550025, Guizhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Zhang</Name>
        <Affiliation>The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang 550025, Guizhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Hu</Name>
        <Affiliation>The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang 550025, Guizhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Lu</Name>
        <Affiliation>The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang 550025, Guizhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Aihua Zhang</Name>
        <Affiliation>The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang 550025, Guizhou, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metabolomics of oxidative stress: Nrf2 independent depletion of NAD or increases of sugar alcohols.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35227738</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00094-1</DOI>
    <KeywordList>
      <Keywords>Cardiomyocytes</Keywords>
      <Keywords>NAD</Keywords>
      <Keywords>Nrf2 knockout</Keywords>
      <Keywords>Pentose phosphate pathway</Keywords>
      <Keywords>Sugar alcohols</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chao Zhu</Name>
        <Affiliation>Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ 85721, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Haiwei Gu</Name>
        <Affiliation>College of Health Solutions, Arizona State University, Phoenix, AZ 85004, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Jin</Name>
        <Affiliation>College of Health Solutions, Arizona State University, Phoenix, AZ 85004, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Wurm</Name>
        <Affiliation>Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ 85721, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Freidhof</Name>
        <Affiliation>Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ 85721, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Yingying Lu</Name>
        <Affiliation>Interdisciplinary Program in Statistics and Data Science, University of Arizona, 617 N. Santa Rita Ave, Tucson, AZ 85721, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Qin M. Chen</Name>
        <Affiliation>Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ 85721, United States of America. Electronic address: qchen@email.arizona.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>CDK5RAP3 acts as a putative tumor inhibitor in papillary thyroid carcinoma via modulation of Akt/GSK-3β/Wnt/β-catenin signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35219640</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00085-0</DOI>
    <KeywordList>
      <Keywords>Akt</Keywords>
      <Keywords>CDK5RAP3</Keywords>
      <Keywords>Papillary thyroid carcinoma</Keywords>
      <Keywords>Wnt</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaolei Feng</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jue Jiang</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Sun</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Zhou</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China. Electronic address: zhou_qizq@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cadmium induces placental glucocorticoid barrier damage by suppressing the cAMP/PKA/Sp1 pathway and the protective role of taurine.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35219639</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00083-7</DOI>
    <KeywordList>
      <Keywords>11β-HSD2</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Glucocorticoids</Keywords>
      <Keywords>Sp1</Keywords>
      <Keywords>Taurine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Na Chen</Name>
        <Affiliation>Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China; The Second Clinical Medical College of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xia Tong</Name>
        <Affiliation>Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China; The Second Clinical Medical College of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sisi Wu</Name>
        <Affiliation>Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China; The Second Clinical Medical College of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Xu</Name>
        <Affiliation>Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China; The Second Clinical Medical College of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qihui Chen</Name>
        <Affiliation>Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China; The Second Clinical Medical College of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Wang</Name>
        <Affiliation>Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China; The Second Clinical Medical College of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China. Electronic address: wf@wzhealth.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The protective effect of safranal against intestinal tissue damage in Drosophila.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35217026</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00084-9</DOI>
    <KeywordList>
      <Keywords>Damage</Keywords>
      <Keywords>Drosophila</Keywords>
      <Keywords>Intestinal stem cells</Keywords>
      <Keywords>Safranal</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xue Lei</Name>
        <Affiliation>Department of Genetics, College of Life Sciences, Northeast Forestry University, Harbin, Heilongjiang Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ziqian Zhou</Name>
        <Affiliation>Department of Genetics, College of Life Sciences, Northeast Forestry University, Harbin, Heilongjiang Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sihong Wang</Name>
        <Affiliation>Key Laboratory of Natural Resource of the Changbai Mountain and Functional Molecules, Ministry of Education, Yanbian Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Hua Jin</Name>
        <Affiliation>Department of Genetics, College of Life Sciences, Northeast Forestry University, Harbin, Heilongjiang Province, China. Electronic address: lhjin2000@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pulmonary inflammation and cellular responses following exposure to benzalkonium chloride: Potential impact of disrupted pulmonary surfactant homeostasis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35202710</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00075-8</DOI>
    <KeywordList>
      <Keywords>Autophagosome</Keywords>
      <Keywords>Benzalkonium chloride</Keywords>
      <Keywords>Disinfectants</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Lamellar body-like structures</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eun Jung Park</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea; Human Health and Environmental Toxins Research Center, Kyung Hee University, 02447, Republic of Korea. Electronic address: pejtoxic@khu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Woo Jin</Name>
        <Affiliation>Department of Biomedical Science and Technology, Graduate School, Kyung Hee University, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Min Sung Kang</Name>
        <Affiliation>Department of Biomedical Science and Technology, Graduate School, Kyung Hee University, Republic of Korea; Jeonbuk Branch Institute, Korea Institute of Toxicology, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Jin Yang</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Hwan Kim</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyoung Yun Han</Name>
        <Affiliation>Department of Predictive Toxicology, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Won Kang</Name>
        <Affiliation>Department of Chemical and Biological Engineering, Korea University, 0284, Republic of Korea; Graduate School of Energy and Environment, Korea University, 0284, Republic of Korea.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protocatechuic acid protects against thioacetamide-induced chronic liver injury and encephalopathy in mice via modulating mTOR, p53 and the IL-6/ IL-17/ IL-23 immunoinflammatory pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35202709</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00076-X</DOI>
    <KeywordList>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Protocatechuic acid</Keywords>
      <Keywords>Thioacetamide</Keywords>
      <Keywords>mTOR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rehab S. Abdelrahman</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al-Madina Al-Munawwarah 30001, Saudi Arabia; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, 35516 Mansoura, Egypt. Electronic address: Dr_rehabsabri@mans.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Ghada S. El-Tanbouly</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 11152, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carbon tetrachloride induced mitochondrial division, respiratory chain damage, abnormal intracellular [H</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35202708</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00074-6</DOI>
    <KeywordList>
      <Keywords>5-HT degradation system</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Intracellular pH value</Keywords>
      <Keywords>Mitochondrial division</Keywords>
      <Keywords>Mitochondrial respiratory chain</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuxin Zhang</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiurui Liang</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Guan</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiaqi Jin</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Zhang</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Xu</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jihua Fu</Name>
        <Affiliation>Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China. Electronic address: jihua_fu@cpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Breast cancer cells-derived Von Willebrand Factor promotes VEGF-A-related angiogenesis through PI3K/Akt-miR-205-5p signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35192807</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00072-2</DOI>
    <KeywordList>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Metastasis</Keywords>
      <Keywords>PI3K/Akt</Keywords>
      <Keywords>vWF</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qianying Tao</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingxue Qi</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiayi Gu</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Die Yu</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China; Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuxin Lu</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianwen Liu</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Liang</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China. Electronic address: xin.liang@ecust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Delineation of the molecular mechanisms underlying Colistin-mediated toxicity using metabolomic and transcriptomic analyses.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35189178</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00073-4</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Colistin</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Nephrotoxicity</Keywords>
      <Keywords>Transcriptomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nguyen Phuoc Long</Name>
        <Affiliation>Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan 614-735, Republic of Korea; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan 614-735, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Hwa Oh</Name>
        <Affiliation>Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Se Myo Park</Name>
        <Affiliation>Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Nguyen Thi Hai Yen</Name>
        <Affiliation>Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan 614-735, Republic of Korea; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan 614-735, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Nguyen Ky Phat</Name>
        <Affiliation>Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan 614-735, Republic of Korea; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan 614-735, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Soon Cho</Name>
        <Affiliation>Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan 614-735, Republic of Korea; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan 614-735, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Min Kim</Name>
        <Affiliation>College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seokjoo Yoon</Name>
        <Affiliation>Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Gook Shin</Name>
        <Affiliation>Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan 614-735, Republic of Korea; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan 614-735, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Hyun Kim</Name>
        <Affiliation>Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan 614-735, Republic of Korea. Electronic address: dhkim@inje.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Benzo[ghi]perylene induces cellular dormancy signaling and endoplasmic reticulum stress in NL-20 human bronchial epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35182551</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00070-9</DOI>
    <KeywordList>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Benzo[ghi]perylene</Keywords>
      <Keywords>Cellular dormancy</Keywords>
      <Keywords>Endoplasmic reticulum stress</Keywords>
      <Keywords>Polycyclic aromatic hydrocarbons</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Montserrat Zaragoza-Ojeda</Name>
        <Affiliation>Laboratorio de Investigación en Patología Experimental, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico; Posgrado en Ciencias Biológicas, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Ulises Torres-Flores</Name>
        <Affiliation>Laboratorio de Investigación en Patología Experimental, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandra Rodríguez-Leviz</Name>
        <Affiliation>Laboratorio de Microscopía Electrónica, Patología Clínica y Experimental, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Francisco Arenas-Huertero</Name>
        <Affiliation>Laboratorio de Investigación en Patología Experimental, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico. Electronic address: farenashuertero@yahoo.com.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Restraint of chaperonin containing T-complex protein-1 subunit 3 has antitumor roles in non-small cell lung cancer via affection of YAP1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35182550</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00071-0</DOI>
    <KeywordList>
      <Keywords>CCT3</Keywords>
      <Keywords>Non-small cell lung cancer</Keywords>
      <Keywords>YAP1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hongyang Shi</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157 Xiwu Road, Xi'an, Shaanxi 71004, China. Electronic address: shihongyanghy@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yonghong Zhang</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157 Xiwu Road, Xi'an, Shaanxi 71004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Wang</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157 Xiwu Road, Xi'an, Shaanxi 71004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Fang</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157 Xiwu Road, Xi'an, Shaanxi 71004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Liu</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157 Xiwu Road, Xi'an, Shaanxi 71004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Li</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157 Xiwu Road, Xi'an, Shaanxi 71004, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>AMPAkine CX516 alleviated chronic ethanol exposure-induced neurodegeneration and depressive-like behavior in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35181401</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00069-2</DOI>
    <KeywordList>
      <Keywords>AMPA receptor</Keywords>
      <Keywords>CX516</Keywords>
      <Keywords>Depression</Keywords>
      <Keywords>Ethanol</Keywords>
      <Keywords>Neurodegeneration</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hui Yao</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Dalin Zhang</Name>
        <Affiliation>Department of Thyroid Surgery, the 1st Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Yu</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Shen</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinze Lan</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Liu</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohuan Chen</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Wu</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guohua Zhang</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang, Liaoning 110122, PR China. Electronic address: ghzhang@cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaolong Wang</Name>
        <Affiliation>Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang, Liaoning 110122, PR China. Electronic address: wangxiaolong@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Predicting nonlinear relationships between external and internal concentrations with physiologically based pharmacokinetic modeling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35176293</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00067-9</DOI>
    <KeywordList>
      <Keywords>Animal Study Design</Keywords>
      <Keywords>Internal Concentrations</Keywords>
      <Keywords>Nonlinear Pharmacokinetics</Keywords>
      <Keywords>Physiologically Based Pharmacokinetic (PBPK)</Keywords>
      <Keywords>Saturation of Absorption</Keywords>
      <Keywords>Saturation of Clearance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniel Hoer</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hugh A. Barton</Name>
        <Affiliation>Consultant, Mystic, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alicia Paini</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Italy. Electronic address: alicia.paini@esqlabs.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Bartels</Name>
        <Affiliation>ToxMetrics.com, LLC, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brandall Ingle</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeanne Domoradzki</Name>
        <Affiliation>Corteva Agriscience, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Fisher</Name>
        <Affiliation>ScitoVation, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Embry</Name>
        <Affiliation>Health and Environmental Sciences Institute, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Villanueva</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Miller</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Nguyen</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Zhang</Name>
        <Affiliation>Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen W. Edwards</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Mei Tan</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Durham, NC, USA. Electronic address: tan.cecilia@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lactobacillus rhamnosus GG combined with inosine ameliorates alcohol-induced liver injury through regulation of intestinal barrier and Treg/Th1 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35176292</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00068-0</DOI>
    <KeywordList>
      <Keywords>Alcoholic liver disease</Keywords>
      <Keywords>Gut microbiota</Keywords>
      <Keywords>IFN-γ–producing CD4(+) T cells</Keywords>
      <Keywords>Inosine</Keywords>
      <Keywords>Lactobacillus rhamnosus GG</Keywords>
      <Keywords>Regulatory T cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yin Zhu</Name>
        <Affiliation>Department of Infectious Diseases and liver Diseases, Ningbo Medical Centre Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, Ningbo Institute of Innovation for Combined Medicine and Engineering, Ningbo 315040, China; Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Hepatology Institute of Wenzhou Medical University, Wenzhou 325025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaozhi Wang</Name>
        <Affiliation>Department of General and Gastrointestinal Surgery, The Affiliated Mindong Hospital of Fujian Medical University, Fujian 355000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lujian Zhu</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Hepatology Institute of Wenzhou Medical University, Wenzhou 325025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yulu Tu</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Hepatology Institute of Wenzhou Medical University, Wenzhou 325025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanting Chen</Name>
        <Affiliation>Department of Infectious Diseases and liver Diseases, Ningbo Medical Centre Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, Ningbo Institute of Innovation for Combined Medicine and Engineering, Ningbo 315040, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingwen Gong</Name>
        <Affiliation>Department of Infectious Diseases and liver Diseases, Ningbo Medical Centre Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, Ningbo Institute of Innovation for Combined Medicine and Engineering, Ningbo 315040, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tongtong Pan</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Hepatology Institute of Wenzhou Medical University, Wenzhou 325025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongwei Lin</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Hepatology Institute of Wenzhou Medical University, Wenzhou 325025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Lin</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Hepatology Institute of Wenzhou Medical University, Wenzhou 325025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huiling Sun</Name>
        <Affiliation>Department of Infectious Diseases and Liver Diseases, Lishui City People's Hospital, Lishui 323020, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuli Ge</Name>
        <Affiliation>Department of Infectious Diseases and Liver Diseases, Lishui City People's Hospital, Lishui 323020, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Wei</Name>
        <Affiliation>Department of Infectious Diseases and liver Diseases, Ningbo Medical Centre Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, Ningbo Institute of Innovation for Combined Medicine and Engineering, Ningbo 315040, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Guo</Name>
        <Affiliation>Department of Infectious Diseases and liver Diseases, Ningbo Medical Centre Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, Ningbo Institute of Innovation for Combined Medicine and Engineering, Ningbo 315040, China.</Affiliation>
      </Author>
      <Author>
        <Name>Caide Lu</Name>
        <Affiliation>Department of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Centre Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, Ningbo 315040, China. Electronic address: lucaide@nbu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yongping Chen</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Hepatology Institute of Wenzhou Medical University, Wenzhou 325025, China. Electronic address: cyp@wmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Lanman Xu</Name>
        <Affiliation>Department of Infectious Diseases and liver Diseases, Ningbo Medical Centre Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, Ningbo Institute of Innovation for Combined Medicine and Engineering, Ningbo 315040, China; Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Hepatology Institute of Wenzhou Medical University, Wenzhou 325025, China. Electronic address: 13587646315@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Indoleamine 2,3-dioxygenase 1 regulates breast cancer tamoxifen resistance through interleukin-6/signal transducer and activator of transcription.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35157906</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00066-7</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>IDO1</Keywords>
      <Keywords>IL-6</Keywords>
      <Keywords>STAT3</Keywords>
      <Keywords>Tamoxifen</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xinchun Zhao</Name>
        <Affiliation>Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of General Surgery, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yujia Jiang</Name>
        <Affiliation>Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Xu</Name>
        <Affiliation>Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Hu</Name>
        <Affiliation>Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Nan Feng</Name>
        <Affiliation>Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huifang Deng</Name>
        <Affiliation>Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chong Lu</Name>
        <Affiliation>Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Huang</Name>
        <Affiliation>Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: huangtaowh@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Occurrence of early afterdepolarization under healthy or hypertrophic cardiomyopathy conditions in the human ventricular endocardial myocyte: In silico study using 109 torsadogenic or non-torsadogenic compounds.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35150662</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00059-X</DOI>
    <KeywordList>
      <Keywords>Comprehensive in vitro pro-arrhythmia assay (CiPA) initiative</Keywords>
      <Keywords>Early afterdepolarization</Keywords>
      <Keywords>Human ventricular cardiomyocyte</Keywords>
      <Keywords>Hypertrophic cardiomyopathy</Keywords>
      <Keywords>In silico cardiac action potential modelling</Keywords>
      <Keywords>Torsades de pointes risk prediction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bernard Christophe</Name>
        <Affiliation>Scaptest, rue d'albroux 10, B-1367 Grand Rosière Hottomont, Belgium. Electronic address: bchristophe@scaptest.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cetylpyridinium chloride (CPC) reduces zebrafish mortality from influenza infection: Super-resolution microscopy reveals CPC interference with multiple protein interactions with phosphatidylinositol 4,5-bisphosphate in immune function.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35149080</pubmedLink>
    <GrantList>
      <Grant>R15 AI131202</Grant>
      <Grant>P20 GM103423</Grant>
      <Grant>1R15 GM139070</Grant>
      <Grant>R15 GM116002</Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00058-8</DOI>
    <KeywordList>
      <Keywords>Cetylpyridinium chloride</Keywords>
      <Keywords>Influenza</Keywords>
      <Keywords>Phosphatidylinositol 4,5-bisphosphate</Keywords>
      <Keywords>Quaternary ammonium compound</Keywords>
      <Keywords>Super-resolution microscopy</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Prakash Raut</Name>
        <Affiliation>Department of Physics and Astronomy, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sasha R. Weller</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bright Obeng</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brandy L. Soos</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bailey E. West</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christian M. Potts</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suraj Sangroula</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marissa S. Kinney</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John E. Burnell</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Benjamin L. King</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julie A. Gosse</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA. Electronic address: julie.gosse@maine.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel T. Hess</Name>
        <Affiliation>Department of Physics and Astronomy, University of Maine, Orono, ME, USA. Electronic address: samuel.hess@maine.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of perfluoroundecanoic acid on the function of Leydig cells in adult male rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35143807</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00048-5</DOI>
    <KeywordList>
      <Keywords>AKT</Keywords>
      <Keywords>Cell number</Keywords>
      <Keywords>Leydig cells</Keywords>
      <Keywords>PFUnA</Keywords>
      <Keywords>Testosterone</Keywords>
      <Keywords>mTOR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiu Xin</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haiqiong Chen</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fuhong Tian</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingjing Li</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haoni Yan</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yige Yu</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feifei Ma</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huitao Li</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiyan Wang</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoheng Li</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Zhu</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ren Shan Ge</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: r_ge@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ethoxy-erianin phosphate and afatinib synergistically inhibit liver tumor growth and angiogenesis via regulating VEGF and EGFR signaling pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35143806</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00056-4</DOI>
    <KeywordList>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>EGFR</Keywords>
      <Keywords>Ethoxy-Erianin phosphate</Keywords>
      <Keywords>Hepatocellular carcinoma</Keywords>
      <Keywords>Tyrosine kinase inhibitors</Keywords>
      <Keywords>VEGF</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jingyun Chen</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiajun Liu</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Baixue Xu</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiou Cao</Name>
        <Affiliation>Department of Surgery, Minhang Hospital, Fudan University, China; Key Laboratory of Whole-period Monitoring and Precise Intervention of Digestive Cancer (SMHC), Minhang Hospital &amp; AHS, Fudan University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Liang</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Fanhong Wu</Name>
        <Affiliation>School of Chemical and Environmental Engineering, Shanghai Institute of Technology, Shanghai Engineering Research Center of Green Fluoropharmaceutical Technology, Shanghai 201418, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodong Shen</Name>
        <Affiliation>Department of Surgery, Minhang Hospital, Fudan University, China; Key Laboratory of Whole-period Monitoring and Precise Intervention of Digestive Cancer (SMHC), Minhang Hospital &amp; AHS, Fudan University, Shanghai, China. Electronic address: xds187@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoying Ma</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, People's Republic of China. Electronic address: y20150160@mail.ecust.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jianwen Liu</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, People's Republic of China. Electronic address: liujian@ecust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prediction of the human pharmacokinetics of epyrifenacil and its major metabolite, S-3100-CA, by a physiologically based pharmacokinetic modeling using chimeric mice with humanized liver.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35143805</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00057-6</DOI>
    <KeywordList>
      <Keywords>Chimeric Mice with Humanized Liver</Keywords>
      <Keywords>Epyrifenacil</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Interspecies Difference</Keywords>
      <Keywords>PBPK Model</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kota Hirasawa</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., 1-98, 3-Chome, Kasugade-Naka, Konohana-Ku, Osaka 554-8558, Japan. Electronic address: hirasawak@sc.sumitomo-chem.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Abe</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., 1-98, 3-Chome, Kasugade-Naka, Konohana-Ku, Osaka 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hirohisa Nagahori</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., 1-98, 3-Chome, Kasugade-Naka, Konohana-Ku, Osaka 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Sachiko Kitamoto</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., 1-98, 3-Chome, Kasugade-Naka, Konohana-Ku, Osaka 554-8558, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Emodin-8-O-β-D-glucopyranoside, a natural hydroxyanthraquinone glycoside from plant, suppresses cancer cell proliferation via p21-CDKs-Rb axis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35134436</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00054-0</DOI>
    <KeywordList>
      <Keywords>CDK1/2</Keywords>
      <Keywords>Emodin-8-O-β-D-glucopyranoside</Keywords>
      <Keywords>Rb phosphorylation</Keywords>
      <Keywords>Tumor growth inhibition</Keywords>
      <Keywords>p21</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yiqun Li</Name>
        <Affiliation>School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kaiming Li</Name>
        <Affiliation>School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhao</Name>
        <Affiliation>School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Li</Name>
        <Affiliation>School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dengke Li</Name>
        <Affiliation>School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liangliang Shen</Name>
        <Affiliation>School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Wang</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hsin Sheng Yang</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY, USA. Electronic address: hyang3@uky.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenxiao Sun</Name>
        <Affiliation>School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China. Electronic address: sunzxcn@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Methylglyoxal produced by tumor cells through formaldehyde-enhanced Warburg effect potentiated polarization of tumor-associated macrophages.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35134435</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00055-2</DOI>
    <KeywordList>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>HIF-1α</Keywords>
      <Keywords>Methylglyoxal</Keywords>
      <Keywords>Polarization</Keywords>
      <Keywords>Tumor-associated macrophages</Keywords>
      <Keywords>Warburg effect</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Huijuan Ma</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China 200237.</Affiliation>
      </Author>
      <Author>
        <Name>Zhaoqian Ding</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China 200237.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Xie</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China 200237.</Affiliation>
      </Author>
      <Author>
        <Name>Linyi Li</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China 200237.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Li</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China 200237.</Affiliation>
      </Author>
      <Author>
        <Name>Kaiyan Lou</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China 200237. Electronic address: kylou@ecust.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Wang</Name>
        <Affiliation>Department of Pharmacology and Toxicology and BIO5 Institute, University of Arizona, Tucson, AZ 85721-0207, USA. Electronic address: wwang@pharmacy.arizona.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Huan Xu</Name>
        <Affiliation>Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China 200237. Electronic address: xuhuan@ecust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Suppression of JNK/ERK dependent autophagy enhances Jaspine B derivative-induced gastric cancer cell death via attenuation of p62/Keap1/Nrf2 pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35123989</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00053-9</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Gastric cancer cells</Keywords>
      <Keywords>JNK/ERK</Keywords>
      <Keywords>Jaspine B derivative</Keywords>
      <Keywords>p62/Keap1/Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Feng Xu</Name>
        <Affiliation>Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Xie</Name>
        <Affiliation>Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Wei Li</Name>
        <Affiliation>Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Qing Jing</Name>
        <Affiliation>Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Jie Liu</Name>
        <Affiliation>Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Chao Xu</Name>
        <Affiliation>Key Laboratory of Advanced Technology for Drug Preparation, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Wang</Name>
        <Affiliation>Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Liu</Name>
        <Affiliation>Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>GiYoung Kim</Name>
        <Affiliation>Department of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>YungHyun Choi</Name>
        <Affiliation>Department of Biochemistry, College of Oriental Medicine, Dong-Eui University, Busan 47227, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Guo</Name>
        <Affiliation>Key Laboratory of Advanced Technology for Drug Preparation, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China. Electronic address: guoyong-122@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>En Zhang</Name>
        <Affiliation>Key Laboratory of Advanced Technology for Drug Preparation, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China. Electronic address: zhangen@zzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Yun Jin</Name>
        <Affiliation>Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China; Key Laboratory of Advanced Technology for Drug Preparation, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China; State Key Laboratory of Esophageal Cancer Prevention &amp; Treatment, Zhengzhou University, Zhengzhou, Henan Province 450052, China. Electronic address: cyjin@zzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Kynurenic acid ameliorates lipopolysaccharide-induced endometritis by regulating the GRP35/NF-κB signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35123988</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00052-7</DOI>
    <KeywordList>
      <Keywords>Endometritis</Keywords>
      <Keywords>Inflammatory response</Keywords>
      <Keywords>Kynurenic acid</Keywords>
      <Keywords>LPS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ying Wang</Name>
        <Affiliation>Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province 130062, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuoyu Liu</Name>
        <Affiliation>Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province 130062, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Shen</Name>
        <Affiliation>Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province 130062, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Caijun Zhao</Name>
        <Affiliation>Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province 130062, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Liu</Name>
        <Affiliation>Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province 130062, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Shu</Name>
        <Affiliation>Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province 130062, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyu Hu</Name>
        <Affiliation>Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province 130062, People's Republic of China. Electronic address: huxiaoyu@jlu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yunhe Fu</Name>
        <Affiliation>Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin Province 130062, People's Republic of China. Electronic address: fuyunhesky@sina.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Linagliptin ameliorates acetic acid-induced colitis via modulating AMPK/SIRT1/PGC-1α and JAK2/STAT3 signaling pathway in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35122774</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00051-5</DOI>
    <KeywordList>
      <Keywords>AMPK</Keywords>
      <Keywords>Acetic acid</Keywords>
      <Keywords>Linagliptin</Keywords>
      <Keywords>STAT3</Keywords>
      <Keywords>Ulcerative colitis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohamed S. El-Ghannam</Name>
        <Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmacy, Heliopolis University for Sustainable Development, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Muhammed A. Saad</Name>
        <Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Giza, Egypt; School of Pharmacy, Newgiza University, Giza, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Noha N. Nassar</Name>
        <Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Giza, Egypt. Electronic address: noha.nassar@pharma.cu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Muhammad Farag El-Yamany</Name>
        <Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Giza, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Alshaymaa A. Z. El-Bahy</Name>
        <Affiliation>Pharmacology and Toxicology Department, School of Pharmaceutical Science (Life and Medical Sciences-LMS), University of Hertfordshire (United Kingdom) hosted by Global academic foundation, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lung-restricted ALK5 inhibition avoids systemic toxicities associated with TGFβ pathway inhibition.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35122773</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00050-3</DOI>
    <KeywordList>
      <Keywords>Aerosols</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Inhalation toxicity</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Pharmaceuticals</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jonathan M. Maher</Name>
        <Affiliation>Theravance Biopharma US, Inc., South San Francisco, CA, USA. Electronic address: JMaher@theravance.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Zhang</Name>
        <Affiliation>Theravance Biopharma US, Inc., South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gopinath Palanisamy</Name>
        <Affiliation>Olema Oncology, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kimberly Perkins</Name>
        <Affiliation>Theravance Biopharma US, Inc., South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lynda Liu</Name>
        <Affiliation>Theravance Biopharma US, Inc., South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Brassil</Name>
        <Affiliation>Theravance Biopharma US, Inc., South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander McNamara</Name>
        <Affiliation>Theravance Biopharma US, Inc., South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Arthur Lo</Name>
        <Affiliation>Theravance Biopharma US, Inc., South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Adam D. Hughes</Name>
        <Affiliation>Theravance Biopharma US, Inc., South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jitendra Kanodia</Name>
        <Affiliation>Theravance Biopharma US, Inc., South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Svitlana Kulyk</Name>
        <Affiliation>Mirati Therapeutics, San Diego, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kristen J. Nikula</Name>
        <Affiliation>Inotiv, Maryland Heights, MO, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hart S. Dengler</Name>
        <Affiliation>Interline Therapeutics, South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amy Scandurra</Name>
        <Affiliation>Theravance Biopharma US, Inc., South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ingrid Lua</Name>
        <Affiliation>Theravance Biopharma US, Inc., South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Harstad</Name>
        <Affiliation>Theravance Biopharma US, Inc., South San Francisco, CA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of dexamethasone treatment at variable therapeutic windows in reversing nitrogen mustard-induced corneal injuries in rabbit ocular in vivo model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35108561</pubmedLink>
    <GrantList>
      <Grant>U01 EY023143</Grant>
      <Grant>U01 EY030405</Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00049-7</DOI>
    <KeywordList>
      <Keywords>Corneal inflammation</Keywords>
      <Keywords>Corneal injury</Keywords>
      <Keywords>Corneal neovascularization</Keywords>
      <Keywords>Dexamethasone</Keywords>
      <Keywords>Epithelial degradation</Keywords>
      <Keywords>Nitrogen mustard</Keywords>
      <Keywords>Vesicant</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dinesh G. Goswami</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Neha Mishra</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rama Kant</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Chapla Agarwal</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David A. Ammar</Name>
        <Affiliation>Department of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>J. Mark Petrash</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States; Department of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Neera Tewari-Singh</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rajesh Agarwal</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States. Electronic address: rajesh.agarwal@cuanschutz.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Particulate hexavalent chromium alters microRNAs in human lung cells that target key carcinogenic pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35101437</pubmedLink>
    <GrantList>
      <Grant>P30 ES030283</Grant>
      <Grant>R35ES032876</Grant>
      <Grant>T32 ES011564</Grant>
      <Grant>R01ES016893</Grant>
      <Grant>R35 ES032876</Grant>
      <Grant>R01 ES016893</Grant>
      <Grant>P30ES030283 </Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00035-7</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Hexavalent chromium</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>RNA sequencing</Keywords>
      <Keywords>microRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rachel M. Speer</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Idoia Meaza</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer H. Toyoda</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Lu</Name>
        <Affiliation>Xiphophorus Genetic Stock Center, Texas State University, 601 University Dr. San Marcos, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Xu</Name>
        <Affiliation>Department of Bioinformatics and Biostatistics, University of Louisville, 485 E. Gray St., Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald B. Walter</Name>
        <Affiliation>Xiphophorus Genetic Stock Center, Texas State University, 601 University Dr. San Marcos, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maiying Kong</Name>
        <Affiliation>Department of Bioinformatics and Biostatistics, University of Louisville, 485 E. Gray St., Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyan Lu</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Calvin Kouokam</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Pierce Wise</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY, USA. Electronic address: john.wise@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Melatonin alleviates doxorubicin-induced mitochondrial oxidative damage and ferroptosis in cardiomyocytes by regulating YAP expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35093381</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00047-3</DOI>
    <KeywordList>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Ferroptosis</Keywords>
      <Keywords>Lipid peroxidation</Keywords>
      <Keywords>Melatonin</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>YAP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiao Sun</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China; Department of Ultrasound, Tongliao Municipal Hospital, Tongliao, Inner Mongolia 028000, China; Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, Inner Mongolia 028000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Sun</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Zhen</Name>
        <Affiliation>Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, Inner Mongolia 028000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangli Xu</Name>
        <Affiliation>Department of Ultrasound, The Second Hospital of Harbin, Harbin, Heilongjiang 150056, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Yang</Name>
        <Affiliation>Department of Ultrasound, Tongliao Municipal Hospital, Tongliao, Inner Mongolia 028000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Danni Fu</Name>
        <Affiliation>Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, Inner Mongolia 028000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chengxi Wei</Name>
        <Affiliation>Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, Inner Mongolia 028000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofeng Niu</Name>
        <Affiliation>Medical Imaging Department, The First People' s Hospital of Keerqin District, Tongliao, Inner Mongolia, 028000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiawei Tian</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China. Electronic address: jwtian2004@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hairu Li</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China. Electronic address: lihairu0419@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mechanism of hepatobiliary toxicity of the LPA</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35090952</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00030-8</DOI>
    <KeywordList>
      <Keywords>Bile acids</Keywords>
      <Keywords>Hepatobiliary toxicity</Keywords>
      <Keywords>LPAR1</Keywords>
      <Keywords>Lysophosphatidic acid receptor-1 antagonists</Keywords>
      <Keywords>Mitochondrial function</Keywords>
      <Keywords>Phospholipids</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael W. Gill</Name>
        <Affiliation>Discovery Toxicology, Pharmaceutical Candidate Optimization, Bristol Myers Squibb, Princeton, NJ, USA. Electronic address: mg3307669@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Brian J. Murphy</Name>
        <Affiliation>Discovery Biology, Bristol Myers Squibb, Princeton, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Peter T. W. Cheng</Name>
        <Affiliation>Discovery Chemistry, Bristol Myers Squibb, Princeton, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lakshmi Sivaraman</Name>
        <Affiliation>Nonclinical Safety, Bristol Myers Squibb, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Myrtle Davis</Name>
        <Affiliation>Discovery Toxicology, Pharmaceutical Candidate Optimization, Bristol Myers Squibb, Princeton, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lois Lehman-McKeeman</Name>
        <Affiliation>Pharmaceutical Candidate Optimization, Bristol Myers Squibb, Princeton, NJ, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A rational approach to assess off-target reactivity of a dual-signal integrator for T cell therapy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35085592</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00039-4</DOI>
    <KeywordList>
      <Keywords>Cell-based</Keywords>
      <Keywords>Cross-reactivity</Keywords>
      <Keywords>Functional assay</Keywords>
      <Keywords>Genome</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>T cell therapy</Keywords>
      <Keywords>Tmod</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xueyin Wang</Name>
        <Affiliation>A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Min Wong</Name>
        <Affiliation>A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michele E. McElvain</Name>
        <Affiliation>A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sara Martire</Name>
        <Affiliation>A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Hua Lee</Name>
        <Affiliation>A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chuck Z. Li</Name>
        <Affiliation>A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando A. Fisher</Name>
        <Affiliation>A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ruchika L. Maheshwari</Name>
        <Affiliation>A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Lun Wu</Name>
        <Affiliation>A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maria C. Imun</Name>
        <Affiliation>A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rabi Murad</Name>
        <Affiliation>Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dora Toledo Warshaviak</Name>
        <Affiliation>A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Yin</Name>
        <Affiliation>Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander Kamb</Name>
        <Affiliation>A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA. Electronic address: akamb@a2bio.com.</Affiliation>
      </Author>
      <Author>
        <Name>Han Xu</Name>
        <Affiliation>A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA. Electronic address: hxu@a2bio.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Beneficial effects of metformin supplementation in hypothalamic paraventricular nucleus and arcuate nucleus of type 2 diabetic rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35085591</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00038-2</DOI>
    <KeywordList>
      <Keywords>Hypothalamic arcuate nucleus</Keywords>
      <Keywords>Hypothalamic paraventricular nucleus</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Metformin</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Type 2 diabetes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiao Jing Yu</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Shaanxi Engineering and Research Center of Vaccine, Key Laboratory of Environment and Genes Related to Diseases of Education Ministry of China, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Mei Chen</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Shaanxi Engineering and Research Center of Vaccine, Key Laboratory of Environment and Genes Related to Diseases of Education Ministry of China, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Jing Liu</Name>
        <Affiliation>Department of Cardiology, The Second Clinical Medical College, Shanxi Medical University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Jie Bai</Name>
        <Affiliation>Key Laboratory of Cellular Physiology of Ministry of Education, Department of Physiology, Shanxi Medical University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Li Liu</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Shaanxi Engineering and Research Center of Vaccine, Key Laboratory of Environment and Genes Related to Diseases of Education Ministry of China, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Yan Fu</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Shaanxi Engineering and Research Center of Vaccine, Key Laboratory of Environment and Genes Related to Diseases of Education Ministry of China, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Li Gao</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Shaanxi Engineering and Research Center of Vaccine, Key Laboratory of Environment and Genes Related to Diseases of Education Ministry of China, Xi'an 710061, China. Electronic address: hongli1989214@mail.xjtu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Tian Ze Sun</Name>
        <Affiliation>Department of Human Anatomy and Histology and Embryology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Lian Shi</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Qi</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Shaanxi Engineering and Research Center of Vaccine, Key Laboratory of Environment and Genes Related to Diseases of Education Ministry of China, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Li</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Shaanxi Engineering and Research Center of Vaccine, Key Laboratory of Environment and Genes Related to Diseases of Education Ministry of China, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Ming Kang</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Shaanxi Engineering and Research Center of Vaccine, Key Laboratory of Environment and Genes Related to Diseases of Education Ministry of China, Xi'an 710061, China. Electronic address: ykang@mail.xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Crocin induces ROS-mediated papillary thyroid cancer cell apoptosis by modulating the miR-34a-5p/PTPN4 axis in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35085590</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00037-0</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Crocin</Keywords>
      <Keywords>PTPN4</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>miR-34a-5p</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Tang</Name>
        <Affiliation>Department of General Surgery, Nanyang First People's Hospital Affiliated to Henan University, Nanyang, Henan 473004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Han Yang</Name>
        <Affiliation>Department of Endocrinology, Nanshi Hospital Affiliated to Henan University, Nanyang, Henan 473065, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinsong Yu</Name>
        <Affiliation>Department of Thyroid and Breast Surgery, Nanyang First People's Hospital Affiliated to Henan University, Nanyang, Henan 473004, China; Key Laboratory of Thyroid Tumor Prevention and Treatment of Nanyang, Nanyang First People's Hospital Affiliated to Henan University, Nanyang, Henan 473004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhong Li</Name>
        <Affiliation>Department of General Surgery, Nanyang First People's Hospital Affiliated to Henan University, Nanyang, Henan 473004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Quanxiao Xu</Name>
        <Affiliation>Department of Oncology, Nanyang First People's Hospital Affiliated to Henan University, Nanyang, Henan 473004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Ding</Name>
        <Affiliation>Department of General Surgery, Nanyang First People's Hospital Affiliated to Henan University, Nanyang, Henan 473004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangwei Jia</Name>
        <Affiliation>Department of Thyroid and Breast Surgery, Nanyang First People's Hospital Affiliated to Henan University, Nanyang, Henan 473004, China; Key Laboratory of Thyroid Tumor Prevention and Treatment of Nanyang, Nanyang First People's Hospital Affiliated to Henan University, Nanyang, Henan 473004, China. Electronic address: jiaguangwei2022@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oleanolic acid-loaded nanoparticles attenuate activation of hepatic stellate cells via suppressing TGF-β1 and oxidative stress in PM2.5-exposed hepatocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35077758</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00036-9</DOI>
    <KeywordList>
      <Keywords>Liver fibrosis</Keywords>
      <Keywords>Oleanolic acid-loaded nanoparticles</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>PM2.5</Keywords>
      <Keywords>Transforming growth factor-β1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lin Leilei</Name>
        <Affiliation>School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiu Wenke</Name>
        <Affiliation>School of Pharmacy, Guangdong Pharmaceutical University, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Luo Yuyuan</Name>
        <Affiliation>School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangdong, China; First Affiliated Hospital, Guangzhou Medical University, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Sihang</Name>
        <Affiliation>School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Xue</Name>
        <Affiliation>School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Weiqiang</Name>
        <Affiliation>School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ye Lianbao</Name>
        <Affiliation>School of Pharmacy, Guangdong Pharmaceutical University, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wang Ying</Name>
        <Affiliation>School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Yan</Name>
        <Affiliation>School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangdong, China. Electronic address: liy506@gzucm.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Li Ming</Name>
        <Affiliation>School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangdong, China. Electronic address: lim99011@gdpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effect of nutritional status on the pharmacokinetic profile of acetaminophen.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35065993</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00033-3</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Balb/C mice</Keywords>
      <Keywords>High fat diet</Keywords>
      <Keywords>Low protein diet</Keywords>
      <Keywords>Nutrition</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vinitha D. Souza</Name>
        <Affiliation>Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Nitte University Centre for Animal Research and Experimentation (NUCARE), Paneer campus, Deralakatte, Mangalore 575 018, India.</Affiliation>
      </Author>
      <Author>
        <Name>Meghashree Shetty</Name>
        <Affiliation>Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Nitte University Centre for Animal Research and Experimentation (NUCARE), Paneer campus, Deralakatte, Mangalore 575 018, India.</Affiliation>
      </Author>
      <Author>
        <Name>Murali Badanthadka</Name>
        <Affiliation>Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Nitte University Centre for Animal Research and Experimentation (NUCARE), Paneer campus, Deralakatte, Mangalore 575 018, India.. Electronic address: murali@nitte.edu.in.</Affiliation>
      </Author>
      <Author>
        <Name>B. S. Mamatha</Name>
        <Affiliation>NUCSER, Nittte (Deemed to be University), Paneer Campus, Deralakatte, Mangalore 575 018., India.</Affiliation>
      </Author>
      <Author>
        <Name>K. Vijayanarayana</Name>
        <Affiliation>Dept. Of Pharmacy Practice, Manipal college of Pharmaceutical Sciences, Manipal Academy of Higher Education. Madhav Nagar, Manipal 576104, Karnataka, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of quercetin-loaded PVCL-PVA-PEG micelles and application in inhibiting tumor angiogenesis through the PI3K/Akt/VEGF pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35065992</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00034-5</DOI>
    <KeywordList>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>Micelles</Keywords>
      <Keywords>Quercetin</Keywords>
      <Keywords>Soluplus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xueju Qi</Name>
        <Affiliation>Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cong Gao</Name>
        <Affiliation>The Third Affiliated Hospital of Shandong First Medical University, Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan 250031, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chuanjin Yin</Name>
        <Affiliation>Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junting Fan</Name>
        <Affiliation>Department of Pharmaceutical Analysis, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaochen Wu</Name>
        <Affiliation>Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guohu Di</Name>
        <Affiliation>School of Basic Medicine, Qingdao University, Qingdao 266071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Wang</Name>
        <Affiliation>Department of Biology Science and Technology, Baotou Teacher's College, Baotou 014030, China. Electronic address: vicwj@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chuanlong Guo</Name>
        <Affiliation>Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China; State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266273, Shandong, China. Electronic address: guochuanlong@qust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35063459</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00032-1</DOI>
    <KeywordList>
      <Keywords>Anti-cancer</Keywords>
      <Keywords>Breast cancer stem cells</Keywords>
      <Keywords>Induced pluripotent stem cell</Keywords>
      <Keywords>Kaempferol</Keywords>
      <Keywords>Multidrug resistance</Keywords>
      <Keywords>Neoadjuvant therapy</Keywords>
      <Keywords>Synergism</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sourav Kumar Nandi</Name>
        <Affiliation>Department of Molecular Biology, Netaji Subhas Chandra Bose Cancer Research Institute, 3081 Nayabad, Kolkata 700094, India.</Affiliation>
      </Author>
      <Author>
        <Name>Tanaya Roychowdhury</Name>
        <Affiliation>Cancer Biology and Inflammatory Disorder Division, Indian Institute of Chemical Biology, 4, Raja S. C. Mullick Road, Kolkata 700032, India.</Affiliation>
      </Author>
      <Author>
        <Name>Samit Chattopadhyay</Name>
        <Affiliation>Cancer Biology and Inflammatory Disorder Division, Indian Institute of Chemical Biology, 4, Raja S. C. Mullick Road, Kolkata 700032, India; Department of Biological Sciences, BITS Pilani, K K Birla Goa Campus, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sudarshana Basu</Name>
        <Affiliation>Department of Molecular Biology, Netaji Subhas Chandra Bose Cancer Research Institute, 3081 Nayabad, Kolkata 700094, India.</Affiliation>
      </Author>
      <Author>
        <Name>Krishti Chatterjee</Name>
        <Affiliation>Department of Pathology, Netaji Subhas Chandra Bose Cancer Research Institute, 3081 Nayabad, Kolkata 700094, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pritha Choudhury</Name>
        <Affiliation>Department of Cancer Chemoprevention, Chittaranjan National Cancer Institute, 37, Shyamaprasad Mukherjee Rd, Kolkata, West Bengal 700026, India.</Affiliation>
      </Author>
      <Author>
        <Name>Nirmalya Banerjee</Name>
        <Affiliation>Department of Pathology, Netaji Subhas Chandra Bose Cancer Research Institute, 3081 Nayabad, Kolkata 700094, India.</Affiliation>
      </Author>
      <Author>
        <Name>Prosenjit Saha</Name>
        <Affiliation>Department of Cancer Chemoprevention, Chittaranjan National Cancer Institute, 37, Shyamaprasad Mukherjee Rd, Kolkata, West Bengal 700026, India.</Affiliation>
      </Author>
      <Author>
        <Name>Soma Mukhopadhyay</Name>
        <Affiliation>Department of Molecular Biology, Netaji Subhas Chandra Bose Cancer Research Institute, 3081 Nayabad, Kolkata 700094, India. Electronic address: admin@nscri.in.</Affiliation>
      </Author>
      <Author>
        <Name>Ashis Mukhopadhyay</Name>
        <Affiliation>Department of Haematooncology, Netaji Subhas Chandra Bose Cancer Research Institute, 3081 Nayabad, Kolkata 700094, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rittwika Bhattacharya</Name>
        <Affiliation>Department of Molecular Biology, Netaji Subhas Chandra Bose Cancer Research Institute, 3081 Nayabad, Kolkata 700094, India. Electronic address: rittwika@nscri.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Environmental exposure to volatile organic compounds is associated with endothelial injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35045333</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00022-9</DOI>
    <KeywordList>
      <Keywords>Benzene</Keywords>
      <Keywords>Circulating angiogenic cells</Keywords>
      <Keywords>Endothelial injury</Keywords>
      <Keywords>Ethylbenzene</Keywords>
      <Keywords>VOCs</Keywords>
      <Keywords>Volatile organic compounds</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniel W. Riggs</Name>
        <Affiliation>Superfund Research Center, University of Louisville, United States of America; Diabetes and Obesity Center, University of Louisville, United States of America; Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Division of Environmental Medicine, Department of Medicine, University of Louisville, United States of America; Department of Epidemiology and Population Health, University of Louisville, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Marina V. Malovichko</Name>
        <Affiliation>Superfund Research Center, University of Louisville, United States of America; Diabetes and Obesity Center, University of Louisville, United States of America; Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Division of Environmental Medicine, Department of Medicine, University of Louisville, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Gao</Name>
        <Affiliation>Superfund Research Center, University of Louisville, United States of America; Diabetes and Obesity Center, University of Louisville, United States of America; Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Division of Environmental Medicine, Department of Medicine, University of Louisville, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Katlyn E. McGraw</Name>
        <Affiliation>Superfund Research Center, University of Louisville, United States of America; Diabetes and Obesity Center, University of Louisville, United States of America; Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Division of Environmental Medicine, Department of Medicine, University of Louisville, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Breandon S. Taylor</Name>
        <Affiliation>Superfund Research Center, University of Louisville, United States of America; Diabetes and Obesity Center, University of Louisville, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Tatiana Krivokhizhina</Name>
        <Affiliation>Superfund Research Center, University of Louisville, United States of America; Diabetes and Obesity Center, University of Louisville, United States of America; Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Division of Environmental Medicine, Department of Medicine, University of Louisville, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Shesh N. Rai</Name>
        <Affiliation>Superfund Research Center, University of Louisville, United States of America; Diabetes and Obesity Center, University of Louisville, United States of America; Department of Bioinformatics and Biostatistics, University of Louisville, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel J. Keith</Name>
        <Affiliation>Superfund Research Center, University of Louisville, United States of America; Diabetes and Obesity Center, University of Louisville, United States of America; Division of Environmental Medicine, Department of Medicine, University of Louisville, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Aruni Bhatnagar</Name>
        <Affiliation>Superfund Research Center, University of Louisville, United States of America; Diabetes and Obesity Center, University of Louisville, United States of America; Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Division of Environmental Medicine, Department of Medicine, University of Louisville, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Sanjay Srivastava</Name>
        <Affiliation>Superfund Research Center, University of Louisville, United States of America; Diabetes and Obesity Center, University of Louisville, United States of America; Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Division of Environmental Medicine, Department of Medicine, University of Louisville, United States of America. Electronic address: sanjay.srivastava@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Kinase inhibitor-induced cardiotoxicity assessed in vitro with human pluripotent stem cell derived cardiomyocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35041852</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00031-X</DOI>
    <KeywordList>
      <Keywords>Cardiomyocytes</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Human pluripotent stem cells</Keywords>
      <Keywords>Kinase inhibitors</Keywords>
      <Keywords>MEA</Keywords>
      <Keywords>hPSC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hai Qing Xian</Name>
        <Affiliation>VistaGen Therapeutics, Inc., 343 Allerton Ave., South San Francisco, CA, 94080, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Carmina Blanco</Name>
        <Affiliation>Senti Biosciences, 2 Corporate Drive, South San Francisco, CA 94080, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Kristina Bonham</Name>
        <Affiliation>VistaGen Therapeutics, Inc., 343 Allerton Ave., South San Francisco, CA, 94080, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>H. Ralph Snodgrass</Name>
        <Affiliation>VistaGen Therapeutics, Inc., 343 Allerton Ave., South San Francisco, CA, 94080, United States of America. Electronic address: rsnodgrass@vistagen.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Prenatal nicotine exposure intergenerationally programs imperfect articular cartilage via histone deacetylation through maternal lineage" [Toxicology and Applied Pharmacology 1(2018) 107-118/352].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35032483</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00010-2</DOI>
    <AuthorList>
      <Author>
        <Name>Zhe Xie</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Zhao</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Yang</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Linguo Pei</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hanwen Luo</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qubo Ni</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Li</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongjian Qi</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Tie</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jacques Magdalou</Name>
        <Affiliation>UMR 7561CNRS, Université de Lorraine, Faculté de Médicine, Vandoeuvre-lès-Nancy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Liaobin Chen</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China. Electronic address: lbchen@whu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ADR cells by inhibiting BCRP function and mediating apoptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35031325</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00028-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>BCRP</Keywords>
      <Keywords>Breast cancer</Keywords>
      <Keywords>G2/M arrest</Keywords>
      <Keywords>MDM2</Keywords>
      <Keywords>Multidrug resistance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xing Chang</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zi Liu</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Simeng Cao</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiang Bian</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dayong Zheng</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China; School of Pharmacy, North China University of Science and Technology, 21 Bohai Road, Caofeidian District, Tangshan 063210, China.</Affiliation>
      </Author>
      <Author>
        <Name>Nuo Wang</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Guan</Name>
        <Affiliation>Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingliang Wu</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weige Zhang</Name>
        <Affiliation>Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China. Electronic address: zhangweige2000@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zengqiang Li</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China. Electronic address: q8v@foxmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Daiying Zuo</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China. Electronic address: zuodaiying@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic activates STAT3 signaling during the transformation of the human bronchial epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35031324</pubmedLink>
    <GrantList>
      <Grant>R01 ES028263</Grant>
      <Grant>R01 ES028335</Grant>
      <Grant>R01 ES031822</Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00029-1</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>PDCD4</Keywords>
      <Keywords>STAT3</Keywords>
      <Keywords>Transformation</Keywords>
      <Keywords>miR-21</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bandar Almutairy</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI 48201, USA; College of Pharmacy, Al-Dawadmi Campus, Shaqra University, P.O.Box 11961, Riyadh, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Yao Fu</Name>
        <Affiliation>Stony Brook Cancer Center, Renaissance School of Medicine, Stony Brook University, Lauterbur Drive, Stony Brook, NY 11794, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuoyue Bi</Name>
        <Affiliation>Stony Brook Cancer Center, Renaissance School of Medicine, Stony Brook University, Lauterbur Drive, Stony Brook, NY 11794, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wenxuan Zhang</Name>
        <Affiliation>Stony Brook Cancer Center, Renaissance School of Medicine, Stony Brook University, Lauterbur Drive, Stony Brook, NY 11794, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Priya Wadgaonkar</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI 48201, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yiran Qiu</Name>
        <Affiliation>Stony Brook Cancer Center, Renaissance School of Medicine, Stony Brook University, Lauterbur Drive, Stony Brook, NY 11794, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chitra Thakur</Name>
        <Affiliation>Stony Brook Cancer Center, Renaissance School of Medicine, Stony Brook University, Lauterbur Drive, Stony Brook, NY 11794, USA; Department of Pathology, Renaissance School of Medicine, Stony Brook University, 101 Nicolls Road, Stony Brook, NY 11794, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Chen</Name>
        <Affiliation>Stony Brook Cancer Center, Renaissance School of Medicine, Stony Brook University, Lauterbur Drive, Stony Brook, NY 11794, USA; Department of Pathology, Renaissance School of Medicine, Stony Brook University, 101 Nicolls Road, Stony Brook, NY 11794, USA. Electronic address: Fei.Chen.1@stonybrook.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Geraniin inhibits whole blood IFN-γ and IL-6 and promotes IL-1β and IL-8, and stimulates calcium-dependent and sucrose-sensitive erythrocyte death.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35026210</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00026-6</DOI>
    <KeywordList>
      <Keywords>Calcium</Keywords>
      <Keywords>Cytokine</Keywords>
      <Keywords>Eryptosis</Keywords>
      <Keywords>Geraniin</Keywords>
      <Keywords>Hemolysis</Keywords>
      <Keywords>Whole blood</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jawaher Alsughayyir</Name>
        <Affiliation>Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Wafa Alshaiddi</Name>
        <Affiliation>Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Roua Alsubki</Name>
        <Affiliation>Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Amal Alshammary</Name>
        <Affiliation>Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmed M. Basudan</Name>
        <Affiliation>Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad A. Alfhili</Name>
        <Affiliation>Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia. Electronic address: malfeehily@ksu.edu.sa.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nivalenol affects spindle formation and organelle functions during mouse oocyte maturation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35016910</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00027-8</DOI>
    <KeywordList>
      <Keywords>Meiosis</Keywords>
      <Keywords>Nivalenol</Keywords>
      <Keywords>Oocyte</Keywords>
      <Keywords>Organelle</Keywords>
      <Keywords>Spindle</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yue Wang</Name>
        <Affiliation>College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Nan Pan</Name>
        <Affiliation>College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Hua Xing</Name>
        <Affiliation>College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Lin Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shao Chen Sun</Name>
        <Affiliation>College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China. Electronic address: sunsc@njau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of intestinal injury of hexavalent chromium using a modified in vitro gastrointestinal digestion model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35016909</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00025-4</DOI>
    <KeywordList>
      <Keywords>Hexavalent chromium</Keywords>
      <Keywords>In vitro gastrointestinal digestion model</Keywords>
      <Keywords>Intestinal injury</Keywords>
      <Keywords>Oral exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ziwei Wang</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Peng</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Zhang</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinhang Jiang</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shen Chen</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Guo</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongmei Xiao</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowen Zeng</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Wang</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Aschner</Name>
        <Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer 209, 1300 Morris Park Avenue, Bronx, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Chun Chou</Name>
        <Affiliation>Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA; Center for Environmental and Human Toxicology, University of Florida, Gainesville, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daochuan Li</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Chen</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China. Electronic address: chenwen@mail.sysu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Liping Chen</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China. Electronic address: chliping@mail.sysu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Circadian disruption and cisplatin chronotherapy for mammary carcinoma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34998857</pubmedLink>
    <GrantList>
      <Grant>R01 ES030113</Grant>
      <Grant>R21 CA227381</Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00002-3</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Chronotherapy</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Clock disruption</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bala S. C. Koritala</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA; Sleep and Performance Research Center, Washington State University, Spokane, WA, USA; Division of Pediatric Otolaryngology-Head and Neck Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth I. Porter</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA; Sleep and Performance Research Center, Washington State University, Spokane, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Soumyadeep Sarkar</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA; Sleep and Performance Research Center, Washington State University, Spokane, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shobhan Gaddameedhi</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA; Sleep and Performance Research Center, Washington State University, Spokane, WA, USA. Electronic address: sgaddam4@ncsu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PARP inhibitor BMN-673 induced apoptosis by trapping PARP-1 and inhibiting base excision repair via modulation of pol-β in chromatin of breast cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34998856</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00464-6</DOI>
    <KeywordList>
      <Keywords>BER</Keywords>
      <Keywords>BMN-673</Keywords>
      <Keywords>PARP-1-trapping</Keywords>
      <Keywords>PARylation</Keywords>
      <Keywords>Pol-β</Keywords>
      <Keywords>Quinacrine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chinmayee Sethy</Name>
        <Affiliation>Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology, Campus-11, Patia, Bhubaneswar, Odisha 751024, India.</Affiliation>
      </Author>
      <Author>
        <Name>Chanakya Nath Kundu</Name>
        <Affiliation>Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology, Campus-11, Patia, Bhubaneswar, Odisha 751024, India. Electronic address: cnkundu@kiitbiotech.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Intranasal curcumin and dexamethasone combination ameliorates inflammasome (NLRP3) activation in lipopolysachharide exposed asthma exacerbations.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34998855</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00465-8</DOI>
    <KeywordList>
      <Keywords>Curcumin</Keywords>
      <Keywords>Dexamethasone</Keywords>
      <Keywords>Gasdermin</Keywords>
      <Keywords>LPS</Keywords>
      <Keywords>NLRP3 inflammasome</Keywords>
      <Keywords>Pyroptosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anju Jaiswal</Name>
        <Affiliation>Department of Zoology, MMV, Banaras Hindu University, Varanasi 221005, India.</Affiliation>
      </Author>
      <Author>
        <Name>D. Dash</Name>
        <Affiliation>Department of Biochemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rashmi Singh</Name>
        <Affiliation>Department of Zoology, MMV, Banaras Hindu University, Varanasi 221005, India. Electronic address: singhras@bhu.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "nAChRs-ERK1/2-Egr-1 signaling participates in the developmental toxicity of nicotine by epigenetically down-regulating placental 11β-HSD2" [Toxicol Appl Pharmacol. 2018 Apr 1;344:1-12.].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34998854</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00009-6</DOI>
    <AuthorList>
      <Author>
        <Name>Jin Zhou</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fulin Liu</Name>
        <Affiliation>Department of Gynaecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</Affiliation>
      </Author>
      <Author>
        <Name>Luting Yu</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Xu</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Li</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guohui Zhang</Name>
        <Affiliation>Department of Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Huang</Name>
        <Affiliation>Department of Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Li</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanzhen Zhang</Name>
        <Affiliation>Department of Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhang</Name>
        <Affiliation>Department of Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Patterns of cardio-respiratory motor outputs during acute and subacute exposure to chlorpyrifos in an ex-vivo in situ preparation in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34998853</pubmedLink>
    <GrantList>
      <Grant>R01 AT008632</Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00001-1</DOI>
    <KeywordList>
      <Keywords>Cardiorespiratory</Keywords>
      <Keywords>Chlorpyrifos</Keywords>
      <Keywords>Organophosphate</Keywords>
      <Keywords>Organophosphorus</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Poisoning</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Igor S. A. Felippe</Name>
        <Affiliation>Postgraduate Program in Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil; The Centre for Heart Research - Manaaki Mānawa, Department of Physiology, Faculty of Health &amp; Medical Sciences, University of Auckland, Grafton Campus, Auckland 1023, New Zealand.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia J. T. Müller</Name>
        <Affiliation>Postgraduate Program in Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luciana M. Passamani</Name>
        <Affiliation>Brazilian Hospital Services Company, Federal University of Espírito Santo, Vitória, ES, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana P. Abdala</Name>
        <Affiliation>Department of Physiology, Pharmacology &amp; Neuroscience, Biomedical Sciences, University of Bristol, Bristol BS8 ITD, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Julian F. R. Paton</Name>
        <Affiliation>The Centre for Heart Research - Manaaki Mānawa, Department of Physiology, Faculty of Health &amp; Medical Sciences, University of Auckland, Grafton Campus, Auckland 1023, New Zealand.</Affiliation>
      </Author>
      <Author>
        <Name>Karla N. Sampaio</Name>
        <Affiliation>Postgraduate Program in Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil. Electronic address: karla.sampaio@ufes.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "cAMP/PKA/EGR1 signaling mediates the molecular mechanism of ethanol-induced inhibition of placental 11β-HSD2 expression" [Published in toxicology and applied pharmacology 352 (2018) 77-86, DOI: 10.1016/j.taap.2018.05.029].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34998852</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(22)00011-4</DOI>
    <AuthorList>
      <Author>
        <Name>Luting Yu</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Zhou</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guohui Zhang</Name>
        <Affiliation>Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Huang</Name>
        <Affiliation>Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Linguo Pei</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Lv</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanzhen Zhang</Name>
        <Affiliation>Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhang</Name>
        <Affiliation>Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Whole life exposure to low dose cadmium alters diet-induced NAFLD.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34990729</pubmedLink>
    <GrantList>
      <Grant>P30 ES030283</Grant>
      <Grant>P20 GM113226</Grant>
      <Grant>T32 ES011564</Grant>
      <Grant>R21 ES031510</Grant>
      <Grant>R01 ES032189</Grant>
      <Grant>R35 ES028373</Grant>
      <Grant>P42 ES023716</Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00459-2</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Metallothionein</Keywords>
      <Keywords>NAFLD</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Whole-life exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jamie L. Young</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA; Division of Gastroenterology, Hepatology &amp; Nutrition, Department of Medicine, the University of Louisville School of Medicine, Louisville, KY 40202, USA; Pediatric Research Institute, Departments of Pediatrics, University of Louisville School of Medicine, Louisville, KY 40202, USA. Electronic address: jamie.young.1@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew C. Cave</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA; Division of Gastroenterology, Hepatology &amp; Nutrition, Department of Medicine, the University of Louisville School of Medicine, Louisville, KY 40202, USA; The Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, KY 40202, USA; Department of Biochemistry and Molecular Genetics, the University of Louisville School of Medicine, Louisville, KY 40202, USA; Superfund Research Center, the University of Louisville, Louisville, KY 40202, USA; The Hepatobiology and Toxicology Center, University of Louisville, Louisville, KY 40202, USA. Electronic address: matt.cave@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Xu</Name>
        <Affiliation>Department of Bioinformatics and Biostatistics, University of Louisville School of Public Health and Information Sciences, Louisville, KY, USA. Electronic address: qian.xu@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Maiying Kong</Name>
        <Affiliation>Department of Bioinformatics and Biostatistics, University of Louisville School of Public Health and Information Sciences, Louisville, KY, USA. Electronic address: maiying.kong@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jianxiang Xu</Name>
        <Affiliation>Pediatric Research Institute, Departments of Pediatrics, University of Louisville School of Medicine, Louisville, KY 40202, USA. Electronic address: jianxiang.xu@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Lin</Name>
        <Affiliation>Pediatric Research Institute, Departments of Pediatrics, University of Louisville School of Medicine, Louisville, KY 40202, USA. Electronic address: qian.lin@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Tan</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA; Pediatric Research Institute, Departments of Pediatrics, University of Louisville School of Medicine, Louisville, KY 40202, USA. Electronic address: yi.tan@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Cai</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA; Pediatric Research Institute, Departments of Pediatrics, University of Louisville School of Medicine, Louisville, KY 40202, USA; The Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, KY 40202, USA. Electronic address: lu.cai@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34990728</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00463-4</DOI>
    <KeywordList>
      <Keywords>PDE4</Keywords>
      <Keywords>Parkin</Keywords>
      <Keywords>Parkinson's Disease</Keywords>
      <Keywords>p38 MAPK</Keywords>
      <Keywords>α-Synuclein</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiahong Zhong</Name>
        <Affiliation>School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengfan Li</Name>
        <Affiliation>School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiangping Xu</Name>
        <Affiliation>School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; Center for Brain Science and Brain-Inspired Intelligence, Guangdong-Hong Kong-Macao Greater Bay Area, China; Key Laboratory of Mental Health of the Ministry of Education, Southern Medical University, Guangzhou 510515, China. Electronic address: jpx@smu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Wenli Dong</Name>
        <Affiliation>School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunyun Qin</Name>
        <Affiliation>School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuqing Qiu</Name>
        <Affiliation>School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xing Li</Name>
        <Affiliation>School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haitao Wang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; Center for Brain Science and Brain-Inspired Intelligence, Guangdong-Hong Kong-Macao Greater Bay Area, China; Key Laboratory of Mental Health of the Ministry of Education, Southern Medical University, Guangzhou 510515, China. Electronic address: wht821@smu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel halogenated adenosine analog 5'-BrDA displays potent toxicity against colon cancer cells in vivo and in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34979143</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00461-0</DOI>
    <KeywordList>
      <Keywords>Anti-colon cancer</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Halogenated adenosine analogue</Keywords>
      <Keywords>ROS overproduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Long Ma</Name>
        <Affiliation>State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Microbiology, Ministry of Education, Tianjin Key Laboratory of Industry Microbiology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science &amp; Technology, Tianjin 300457, China. Electronic address: malong@tust.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yingying Lu</Name>
        <Affiliation>State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Microbiology, Ministry of Education, Tianjin Key Laboratory of Industry Microbiology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science &amp; Technology, Tianjin 300457, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaqin Li</Name>
        <Affiliation>State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Microbiology, Ministry of Education, Tianjin Key Laboratory of Industry Microbiology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science &amp; Technology, Tianjin 300457, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhizhen Yang</Name>
        <Affiliation>State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Microbiology, Ministry of Education, Tianjin Key Laboratory of Industry Microbiology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science &amp; Technology, Tianjin 300457, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Mao</Name>
        <Affiliation>State Key Laboratory of Coordination Chemistry, Jiangsu Key Laboratory of Advanced Organic Materials, Collaborative Innovation Center of Advanced Microstructures, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Wang</Name>
        <Affiliation>State Key Laboratory of Coordination Chemistry, Jiangsu Key Laboratory of Advanced Organic Materials, Collaborative Innovation Center of Advanced Microstructures, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China. Electronic address: yiwang@nju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shuli Man</Name>
        <Affiliation>State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Microbiology, Ministry of Education, Tianjin Key Laboratory of Industry Microbiology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science &amp; Technology, Tianjin 300457, China. Electronic address: msl@tust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Scopoletin and umbelliferone protect hepatocytes against palmitate- and bile acid-induced cell death by reducing endoplasmic reticulum stress and oxidative stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34979142</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00462-2</DOI>
    <KeywordList>
      <Keywords>Cell death</Keywords>
      <Keywords>ER stress</Keywords>
      <Keywords>Lipotoxicity</Keywords>
      <Keywords>NAFLD</Keywords>
      <Keywords>Scopoletin</Keywords>
      <Keywords>Umbelliferone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zongmei Wu</Name>
        <Affiliation>Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Yana Geng</Name>
        <Affiliation>Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Manon Buist-Homan</Name>
        <Affiliation>Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Han Moshage</Name>
        <Affiliation>Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: a.j.moshage@umcg.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>ZC3H4 promotes pulmonary fibrosis via an ER stress-related positive feedback loop.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34979141</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00460-9</DOI>
    <KeywordList>
      <Keywords>ER stress</Keywords>
      <Keywords>Positive feedback</Keywords>
      <Keywords>Pulmonary fibroblasts</Keywords>
      <Keywords>Silicosis</Keywords>
      <Keywords>ZC3H4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hammad Ghafoor</Name>
        <Affiliation>Department of Physiology, School of Medicine, Southeast University, Nanjing, Jiangsu 2100096, China; Department of Pharmacology, School of Medicine, Southeast University, Nanjing, Jiangsu 2100096, China; Department of Microbiology and Immunology, School of Medicine, Southeast University, Nanjing, Jiangsu 2100096, China; Jiangsu Provincial Key Laboratory of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Han Chu</Name>
        <Affiliation>Department of Physiology, School of Medicine, Southeast University, Nanjing, Jiangsu 2100096, China; Key Laboratory of Development Genes and Human Disease, Southeast University, Nanjing, Jiangsu 2100096, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Huang</Name>
        <Affiliation>Department of Physiology, School of Medicine, Southeast University, Nanjing, Jiangsu 2100096, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengling Chen</Name>
        <Affiliation>Department of Physiology, School of Medicine, Southeast University, Nanjing, Jiangsu 2100096, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sha Wang</Name>
        <Affiliation>Department of Physiology, School of Medicine, Southeast University, Nanjing, Jiangsu 2100096, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Wang</Name>
        <Affiliation>Department of Physiology, School of Medicine, Southeast University, Nanjing, Jiangsu 2100096, China. Electronic address: wangjing201612@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Chao</Name>
        <Affiliation>Department of Physiology, School of Medicine, Southeast University, Nanjing, Jiangsu 2100096, China; Jiangsu Provincial Key Laboratory of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China; Key Laboratory of Development Genes and Human Disease, Southeast University, Nanjing, Jiangsu 2100096, China; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, Jiangsu 210009, China; School of Medicine, Xizang Minzu University, Xianyang, Shanxi 712082, China. Electronic address: chaojie@seu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Structure dependence and species sensitivity of in vivo hepatobiliary toxicity with lysophosphatidic acid receptor 1 (LPA</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34974053</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00450-6</DOI>
    <KeywordList>
      <Keywords>Bile Acids</Keywords>
      <Keywords>Hepatobiliary Toxicity</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>LPA(1) Antagonists</Keywords>
      <Keywords>Liver Function Enzymes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>L. Sivaraman</Name>
        <Affiliation>Nonclinical Safety, Bristol-Myers Squibb, New Brunswick, NJ, USA. Electronic address: lakshmi.sivaraman@bms.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Gill</Name>
        <Affiliation>Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. M. Nelson</Name>
        <Affiliation>Translational Medicine, Bristol-Myers Squibb, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. D. Chadwick</Name>
        <Affiliation>Global Regulatory Strategy and Policy, Bristol-Myers Squibb, Princeton, NJ, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Involvement of m6A regulatory factor IGF2BP1 in malignant transformation of human bronchial epithelial Beas-2B cells induced by tobacco carcinogen NNK.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34974052</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00453-1</DOI>
    <KeywordList>
      <Keywords>Beas-2B Cells</Keywords>
      <Keywords>IGF2BP1</Keywords>
      <Keywords>Malignant Transformation</Keywords>
      <Keywords>N6-Methyladenosine</Keywords>
      <Keywords>NNK</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiaxin Zhou</Name>
        <Affiliation>The Institute for Chemical Carcinogenesis, Guangzhou Medical University, Xinzao, Panyu District, Guangzhou 511436, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Xiong</Name>
        <Affiliation>The Institute for Chemical Carcinogenesis, Guangzhou Medical University, Xinzao, Panyu District, Guangzhou 511436, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiazhen Zhou</Name>
        <Affiliation>The Institute for Chemical Carcinogenesis, Guangzhou Medical University, Xinzao, Panyu District, Guangzhou 511436, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinchao Guan</Name>
        <Affiliation>The Institute for Chemical Carcinogenesis, Guangzhou Medical University, Xinzao, Panyu District, Guangzhou 511436, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guanqing Jiang</Name>
        <Affiliation>The Institute for Chemical Carcinogenesis, Guangzhou Medical University, Xinzao, Panyu District, Guangzhou 511436, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuyang Chen</Name>
        <Affiliation>School of Anesthesiology, Southern Medical University, 1023-1063 Shatai Nan Road, Baiyun District, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiaoyuan Yang</Name>
        <Affiliation>The Institute for Chemical Carcinogenesis, Guangzhou Medical University, Xinzao, Panyu District, Guangzhou 511436, China; State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, No. 151 Yanjiang Road, Yuexiu District, Guangzhou 510120, China. Electronic address: qiaoyuan_yang@gzhmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonylphenol regulates TL1A through the AhR/HDAC2/HNF4α pathway in endothelial cells to promote the angiogenesis of colorectal cancer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34974051</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00458-0</DOI>
    <KeywordList>
      <Keywords>AhR</Keywords>
      <Keywords>Colorectal cancer</Keywords>
      <Keywords>HDAC2</Keywords>
      <Keywords>HNF4α</Keywords>
      <Keywords>Nonylphenol</Keywords>
      <Keywords>TL1A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tao Zhang</Name>
        <Affiliation>Department of Gastrointestinal Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Wei Ning</Name>
        <Affiliation>Department of Gastrointestinal Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Zhang</Name>
        <Affiliation>Department of Gastrointestinal Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fu Jian Xu</Name>
        <Affiliation>Department of Gastrointestinal Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xing Qin Wang</Name>
        <Affiliation>Department of Gastrointestinal Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Biao Li</Name>
        <Affiliation>Department of Gastrointestinal Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Xie</Name>
        <Affiliation>Department of Gastrointestinal Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China. Electronic address: xiemingxm852@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of ferroptosis in promoting cardiotoxicity induced by Imatinib Mesylate via down-regulating Nrf2 pathways in vitro and in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34973290</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00456-7</DOI>
    <KeywordList>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Ferroptosis</Keywords>
      <Keywords>Imatinib Mesylate</Keywords>
      <Keywords>Mechanism</Keywords>
      <Keywords>Nrf2 Pathways</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chengzhu Song</Name>
        <Affiliation>Institute of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongning Li</Name>
        <Affiliation>Institute of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Zhang</Name>
        <Affiliation>Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400000, China. Electronic address: zhjzhj121@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyan Zhao</Name>
        <Affiliation>Institute of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China. Electronic address: zhaoxiaoyan67@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neuroprotective effects of indole-3-carbinol on the rotenone rat model of Parkinson's disease: Impact of the SIRT1-AMPK signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34973289</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00457-9</DOI>
    <KeywordList>
      <Keywords>AMPK</Keywords>
      <Keywords>Indole-3-carbinol</Keywords>
      <Keywords>Parkinson's disease</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Rotenone</Keywords>
      <Keywords>Sirtuin 1 (SIRT1)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Khalid A. Mohamad</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. Electronic address: khaled.mohamed1@pharma.asu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Reem N. El-Naga</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. Electronic address: reemelnaga@pharma.asu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Sara A. Wahdan</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. Electronic address: sara_wahdan@pharma.asu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Resveratrol and its nanocrystals: A promising approach for cancer therapy?</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34971666</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00455-5</DOI>
    <KeywordList>
      <Keywords>Antitumor effect</Keywords>
      <Keywords>EAT tumour</Keywords>
      <Keywords>Nanocrystals</Keywords>
      <Keywords>Resveratrol</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniela Ančić</Name>
        <Affiliation>Agency for Medicinal Products and Medical Devices, Ksaverska cesta 4, HR-10000 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Nada Oršolić</Name>
        <Affiliation>Division of Animal Physiology, Faculty of Science, University of Zagreb, Rooseveltov trg 6, HR-10000 Zagreb, Croatia. Electronic address: nada.orsolic@biol.pmf.hr.</Affiliation>
      </Author>
      <Author>
        <Name>Dyana Odeh</Name>
        <Affiliation>Division of Animal Physiology, Faculty of Science, University of Zagreb, Rooseveltov trg 6, HR-10000 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Matea Tomašević</Name>
        <Affiliation>Division of Animal Physiology, Faculty of Science, University of Zagreb, Rooseveltov trg 6, HR-10000 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Ivan Pepić</Name>
        <Affiliation>Department of Pharmaceutical Technology, Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, HR-10000, Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Snježana Ramić</Name>
        <Affiliation>Department of Pathology, University Cancer Hospital, Sestre Milosrdnice University Hospital Centre, Ilica 197, HR-10000 Zagreb, Croatia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The exosome-circ_0001359 derived from cigarette smoke exposed-prostate stromal cells promotes epithelial cells collagen deposition and primary ciliogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34968637</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00454-3</DOI>
    <KeywordList>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>Circ_0001359</Keywords>
      <Keywords>Collagen deposition</Keywords>
      <Keywords>Epithelial-mesenchymal transition</Keywords>
      <Keywords>Exosomes</Keywords>
      <Keywords>Prostate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jinglou Chen</Name>
        <Affiliation>School of Medical, Jianghan University, Wuhan, China; The Gerontology Research Center of Jianghan University, The Sixth Hospital of Wuhan (Affiliated Hospital of Jianghan University), Jianghan University, Wuhan, China. Electronic address: jinglouchen@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nan Rong</Name>
        <Affiliation>The Gerontology Research Center of Jianghan University, The Sixth Hospital of Wuhan (Affiliated Hospital of Jianghan University), Jianghan University, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Liu</Name>
        <Affiliation>The Gerontology Research Center of Jianghan University, The Sixth Hospital of Wuhan (Affiliated Hospital of Jianghan University), Jianghan University, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Congyue Xu</Name>
        <Affiliation>School of Medical, Jianghan University, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Guo</Name>
        <Affiliation>School of Medical, Jianghan University, Wuhan, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34963561</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00451-8</DOI>
    <KeywordList>
      <Keywords>CREB/Sp1-mediated MCL1 expression</Keywords>
      <Keywords>Daunorubicin</Keywords>
      <Keywords>Leukemia</Keywords>
      <Keywords>NFκB-mediated ABCB1 expression</Keywords>
      <Keywords>p38 MAPK/PP2A axis: Akt/ERK/β-TrCP axis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Ting Chiou</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Hui Huang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ti Hsiao Wu</Name>
        <Affiliation>Department of Cardiovascular Surgery, Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung 813, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Jun Wang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Chin Lee</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Po Wei Huang</Name>
        <Affiliation>Department of Surgery, Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung 813, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Long Sen Chang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan; Department of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan. Electronic address: lschang@mail.nsysu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of major components of Tripterygium wilfordii Hook. f on the uptake function of organic anion transporting polypeptide 1B1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34958783</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00452-X</DOI>
    <KeywordList>
      <Keywords>Herb-drug interaction</Keywords>
      <Keywords>Organic anion transporting polypeptide 1B1</Keywords>
      <Keywords>Post- translational modification</Keywords>
      <Keywords>Triptergium wilfordii Hook. f</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jieru Chen</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanping Xue</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyu Shuai</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunxu Ni</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zihui Fang</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Ye</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of New Drug Screening and School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Hong</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China; Guangdong Provincial Key Laboratory of Protein Function and Regulation in Agricultural Organisms, South China Agricultural University, Guangzhou, China. Electronic address: mh2788@scau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The mechanism underlying arsenic-induced PD-L1 upregulation in transformed BEAS-2B cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34953898</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00449-X</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Lnc-DC</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>PD-L1</Keywords>
      <Keywords>STAT3</Keywords>
      <Keywords>Tumorigenesis</Keywords>
      <Keywords>lnRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hongsen Wang</Name>
        <Affiliation>Department of Biochemistry, College of Medicine, Yichun University, Yichun, Jiangxi 336000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiaqi Li</Name>
        <Affiliation>Department of Clinical Medicine, Dali University, Dali, Yunnan 671003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenhua Xu</Name>
        <Affiliation>Department Pharmacology &amp; Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, USA; Department of Neurology, the First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui 230001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunming Li</Name>
        <Affiliation>Department of Biochemistry, College of Medicine, Yichun University, Yichun, Jiangxi 336000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kuaiying Wu</Name>
        <Affiliation>Department of Biochemistry, College of Medicine, Yichun University, Yichun, Jiangxi 336000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gang Chen</Name>
        <Affiliation>Department Pharmacology &amp; Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, USA. Electronic address: gangchen6@uky.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jiajun Cui</Name>
        <Affiliation>Department of Biochemistry, College of Medicine, Yichun University, Yichun, Jiangxi 336000, China. Electronic address: cui_jj@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The therapeutic effect of hesperetin on doxorubicin-induced testicular toxicity: Potential roles of the mechanistic target of rapamycin kinase (mTOR) and dynamin-related protein 1 (DRP1).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34933056</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00437-3</DOI>
    <KeywordList>
      <Keywords>DRP1</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Hesperetin</Keywords>
      <Keywords>Testis</Keywords>
      <Keywords>mTOR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ahmet Tektemur</Name>
        <Affiliation>Department of Medical Biology, Faculty of Medicine, Firat University, Elazig, Turkey. Electronic address: atektemur@firat.edu.tr.</Affiliation>
      </Author>
      <Author>
        <Name>Nalan Kaya Tektemur</Name>
        <Affiliation>Department of Histology and Embryology, Faculty of Medicine, Firat University, Elazig, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Elif Erdem Güzel</Name>
        <Affiliation>Mardin Artuklu University, Faculty of Health Sciences, Department of Midwifery, Mardin, Turkey.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A synergism of in silico and statistical approaches to discover new potential endocrine disruptor mycotoxins.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34933055</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00436-1</DOI>
    <KeywordList>
      <Keywords>Dimension reduction</Keywords>
      <Keywords>Endocrine disruptors</Keywords>
      <Keywords>Molecular docking</Keywords>
      <Keywords>Mycotoxins</Keywords>
      <Keywords>Nuclear receptors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Giulia Spaggiari</Name>
        <Affiliation>Molecular Modeling Lab, Department of Food and Drug, Parco Area Delle Scienze 17/A, University of Parma, 43124 Parma, Italy. Electronic address: giulia.spaggiari@unipr.it.</Affiliation>
      </Author>
      <Author>
        <Name>Gianluca Morelli</Name>
        <Affiliation>Department of Economics and Management and Interdepartmental Center of Robust Statistics, Via J. F. Kennedy 6, University of Parma, 43100 Parma, Italy. Electronic address: gianluca.morelli@unipr.it.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Riani</Name>
        <Affiliation>Department of Economics and Management and Interdepartmental Center of Robust Statistics, Via J. F. Kennedy 6, University of Parma, 43100 Parma, Italy. Electronic address: marco.riani@unipr.it.</Affiliation>
      </Author>
      <Author>
        <Name>Pietro Cozzini</Name>
        <Affiliation>Molecular Modeling Lab, Department of Food and Drug, Parco Area Delle Scienze 17/A, University of Parma, 43124 Parma, Italy. Electronic address: pietro.cozzini@unipr.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Kinesin family member 23 exerts a protumor function in breast cancer via stimulation of the Wnt/β-catenin pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34933054</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00438-5</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>KIF23</Keywords>
      <Keywords>Wnt</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xin He</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xi'an, Shaanxi 710004, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Wang</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xi'an, Shaanxi 710004, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ru Zhou</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xi'an, Shaanxi 710004, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shanshan Yu</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xi'an, Shaanxi 710004, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jue Jiang</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xi'an, Shaanxi 710004, PR China. Electronic address: jiangjuejj0414@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Zhou</Name>
        <Affiliation>Department of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xi'an, Shaanxi 710004, PR China. Electronic address: zhou_qizq@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Translating dosimetry of Dibenzo[def,p]chrysene (DBC) and metabolites across dose and species using physiologically based pharmacokinetic (PBPK) modeling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34933053</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00434-8</DOI>
    <KeywordList>
      <Keywords>Dibenzo[def,p]chrysene (DBC)</Keywords>
      <Keywords>Internal dose-metrics</Keywords>
      <Keywords>Interspecies extrapolation</Keywords>
      <Keywords>Physiologically based pharmacokinetic (PBPK) modeling</Keywords>
      <Keywords>Polycyclic aromatic hydrocarbon (PAH)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paritosh Pande</Name>
        <Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Erin P. Madeen</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David E. Williams</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susan R. Crowell</Name>
        <Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ted J. Ognibene</Name>
        <Affiliation>Lawrence Livermore National Laboratory, Livermore, CA 94550, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ken W. Turteltaub</Name>
        <Affiliation>Lawrence Livermore National Laboratory, Livermore, CA 94550, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Corley</Name>
        <Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jordan N. Smith</Name>
        <Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA; Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA. Electronic address: jordan.smith@pnnl.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of human relevance of Nicofluprole-induced rat thyroid disruption.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34922950</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00435-X</DOI>
    <KeywordList>
      <Keywords>CAR/PXR nuclear receptor activators</Keywords>
      <Keywords>Rat thyroid and liver effects</Keywords>
      <Keywords>Sandwich cultures</Keywords>
      <Keywords>Thyroxine-glucuronoconjugation</Keywords>
      <Keywords>Wistar rat and human hepatocytes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Céline Parmentier</Name>
        <Affiliation>KaLy-Cell S.A.S, 20A rue du Général Leclerc, 67115 Plobsheim, France. Electronic address: c.parmentier@kaly-cell.com.</Affiliation>
      </Author>
      <Author>
        <Name>Audrey Baze</Name>
        <Affiliation>KaLy-Cell S.A.S, 20A rue du Général Leclerc, 67115 Plobsheim, France. Electronic address: a.baze@kaly-cell.com.</Affiliation>
      </Author>
      <Author>
        <Name>Meiggie Untrau</Name>
        <Affiliation>KaLy-Cell S.A.S, 20A rue du Général Leclerc, 67115 Plobsheim, France.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Kampkoetter</Name>
        <Affiliation>Bayer Animal Health GmbH, An Elanco Animal Health Company, 50 Alfred-Nobel-Strasse, 40789 Monheim, Germany. Electronic address: ANDREAS.KAMPKOETTER@elancoah.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dominique Lasserre</Name>
        <Affiliation>Bayer S.A.S. Bayer CropScience, 355 rue Dostoïevski, F-06560 Sophia Antipolis, France. Electronic address: dominique.lasserre-bigot@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lysiane Richert</Name>
        <Affiliation>KaLy-Cell S.A.S, 20A rue du Général Leclerc, 67115 Plobsheim, France. Electronic address: l.richert@kaly-cell.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Biatriosporin D displays anti-virulence activity through decreasing the intracellular cAMP levels" [Toxicology and Applied Pharmacology 322 (2017) 104-112].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34919947</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00432-4</DOI>
    <AuthorList>
      <Author>
        <Name>Ming Zhang</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenqiang Chang</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongzhuo Shi</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanhui Zhou</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sha Zheng</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Li</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Li</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongxiang Lou</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China. Electronic address: louhongxiang@sdu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34919946</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00433-6</DOI>
    <KeywordList>
      <Keywords>CARM1</Keywords>
      <Keywords>HCC</Keywords>
      <Keywords>PRMT5</Keywords>
      <Keywords>Ribavirin</Keywords>
      <Keywords>VEGF</Keywords>
      <Keywords>eIF4E</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yizhen Tian</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University; Lanzhou 730000, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Weihu Yang</Name>
        <Affiliation>Gansu Provincial Maternity and Child-Care Hospital, Lanzhou 730050, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruiying Yang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University; Lanzhou 730000, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingqing Zhang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University; Lanzhou 730000, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Luyang Hao</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University; Lanzhou 730000, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Enze Bian</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University; Lanzhou 730000, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuquan Yang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University; Lanzhou 730000, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuewei Huang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University; Lanzhou 730000, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongjie Wu</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University; Lanzhou 730000, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Baolai Zhang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University; Lanzhou 730000, People's Republic of China. Electronic address: zhangbl@lzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Candesartan protects against d-galactose induced - Neurotoxicity and memory deficit via modulation of autophagy and oxidative stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34906534</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00431-2</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Beclin 1</Keywords>
      <Keywords>Candesartan</Keywords>
      <Keywords>GDNF-1</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>d-galactose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Naglaa F. Khedr</Name>
        <Affiliation>Faculty of Pharmacy, Department of Biochemistry, Tanta University, Tanta, Egypt. Electronic address: naglaa.khedr@pharm.tanta.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Rehab H. Werida</Name>
        <Affiliation>Faculty of Pharmacy, Department of Clinical Pharmacy &amp; Pharmacy Practice, Damanhur University, El- Bahiara, Egypt. Electronic address: rehabwrieda@pharm.dmu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Mariam A. Abo-Saif</Name>
        <Affiliation>Faculty of Pharmacy, Department of Biochemistry, Tanta University, Tanta, Egypt. Electronic address: maryem_abosaif@pharm.tanta.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Microsomal triglyceride transfer protein inhibitor lomitapide-induced liver toxicity is ameliorated by Triiodothyronine treatment following improved bile homeostasis and β-oxidation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34902352</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00429-4</DOI>
    <KeywordList>
      <Keywords>Familial Hyperlipidemia</Keywords>
      <Keywords>Liver Toxicity</Keywords>
      <Keywords>Lomitapide</Keywords>
      <Keywords>Triiodothyronine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vishal Patel</Name>
        <Affiliation>Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H.No.8A, Moraiya, Ahmedabad 382210, India.</Affiliation>
      </Author>
      <Author>
        <Name>Amit Joharapurkar</Name>
        <Affiliation>Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H.No.8A, Moraiya, Ahmedabad 382210, India. Electronic address: amitjoharapurkar@zyduscadila.com.</Affiliation>
      </Author>
      <Author>
        <Name>Samadhan Kshirsagar</Name>
        <Affiliation>Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H.No.8A, Moraiya, Ahmedabad 382210, India.</Affiliation>
      </Author>
      <Author>
        <Name>Maulik Patel</Name>
        <Affiliation>Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H.No.8A, Moraiya, Ahmedabad 382210, India.</Affiliation>
      </Author>
      <Author>
        <Name>Hiren Patel</Name>
        <Affiliation>Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H.No.8A, Moraiya, Ahmedabad 382210, India.</Affiliation>
      </Author>
      <Author>
        <Name>Hardikkumar Savsani</Name>
        <Affiliation>Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H.No.8A, Moraiya, Ahmedabad 382210, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mukul Jain</Name>
        <Affiliation>Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H.No.8A, Moraiya, Ahmedabad 382210, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of KVO treatment strategies for chronic pain in a rat model of Gulf War Illness.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34896435</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00425-7</DOI>
    <KeywordList>
      <Keywords>Chronic pain</Keywords>
      <Keywords>Diclofenac</Keywords>
      <Keywords>Gulf war illness</Keywords>
      <Keywords>K(v)7</Keywords>
      <Keywords>Retigabine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>L. K. Flunker</Name>
        <Affiliation>Division of Neuroscience, Dept. of Oral and Maxillofacial Surgery, Box 100416, JHMHC, University of Florida College of Dentistry, Gainesville, FL 32610, USA. Electronic address: lflunker@dental.ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>T. J. Nutter</Name>
        <Affiliation>Division of Neuroscience, Dept. of Oral and Maxillofacial Surgery, Box 100416, JHMHC, University of Florida College of Dentistry, Gainesville, FL 32610, USA. Electronic address: tnutter@dental.ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>C. M. Bowers</Name>
        <Affiliation>Division of Neuroscience, Dept. of Oral and Maxillofacial Surgery, Box 100416, JHMHC, University of Florida College of Dentistry, Gainesville, FL 32610, USA. Electronic address: clarissa.m.bowers@vanderbilt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>B. Y. Cooper</Name>
        <Affiliation>Division of Neuroscience, Dept. of Oral and Maxillofacial Surgery, Box 100416, JHMHC, University of Florida College of Dentistry, Gainesville, FL 32610, USA. Electronic address: bcooper@dental.ufl.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Apple polyphenol phloretin complexed with ruthenium is capable of reprogramming the breast cancer microenvironment through modulation of PI3K/Akt/mTOR/VEGF pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34896434</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00426-9</DOI>
    <KeywordList>
      <Keywords>Antioxidant</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Breast carcinoma</Keywords>
      <Keywords>Chemotherapeutics</Keywords>
      <Keywords>DMBA</Keywords>
      <Keywords>Ruthenium-phloretin complex</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Souvik Roy</Name>
        <Affiliation>Department of Pharmacy, NSHM Knowledge Campus- Kolkata, 124 B.L. Saha Road, Kolkata 700053, West Bengal, India. Electronic address: souvik.roy@nshm.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anil Kumar Mondru</Name>
        <Affiliation>Department of molecular and clinical cancer medicine, University of Liverpool, 1(st) Floor Sherrington building, Ashton Street, Liverpool, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Tania Chakraborty</Name>
        <Affiliation>Department of Pharmacy, NSHM Knowledge Campus- Kolkata, 124 B.L. Saha Road, Kolkata 700053, West Bengal, India.</Affiliation>
      </Author>
      <Author>
        <Name>Abhijit Das</Name>
        <Affiliation>Department of Pharmacy, NSHM Knowledge Campus- Kolkata, 124 B.L. Saha Road, Kolkata 700053, West Bengal, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sandipan Dasgupta</Name>
        <Affiliation>Department of Pharmacology, Maulana Abul Kalam Azad University of Technology, Simhat Haringhata, Nadia 741249, West Bengal, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporter.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34896433</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00427-0</DOI>
    <KeywordList>
      <Keywords>ABC transporter</Keywords>
      <Keywords>Alisertib</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Multidrug resistance</Keywords>
      <Keywords>Pharmacokinetic drug-drug interaction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dimitrios Vagiannis</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovskeho 1203, 500 05 Hradec Králové, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Zhang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovskeho 1203, 500 05 Hradec Králové, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Youssif Budagaga</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovskeho 1203, 500 05 Hradec Králové, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Eva Novotna</Name>
        <Affiliation>Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovskeho 1203, 500 05 Hradec Králové, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Adam Skarka</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, University of Hradec Králové, Hradecká 1285, Hradec Králové 500 03, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Kammerer</Name>
        <Affiliation>Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Universitätsplatz 1, 01968 Senftenberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Heiner Küpper</Name>
        <Affiliation>Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Universitätsplatz 1, 01968 Senftenberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jakub Hofman</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovskeho 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: jakub.hofman@faf.cuni.cz.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Curcumin alleviates arsenic-induced injury in duck skeletal muscle via regulating the PINK1/Parkin pathway and protecting mitochondrial function.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34896432</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00424-5</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Arsenic trioxide</Keywords>
      <Keywords>Curcumin</Keywords>
      <Keywords>Mitochondrial biogenesis</Keywords>
      <Keywords>Mitochondrial dynamics</Keywords>
      <Keywords>Skeletal muscle</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juan Lan</Name>
        <Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China. Electronic address: 20202029004@stu.scau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Lixuan Tang</Name>
        <Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaofeng Wu</Name>
        <Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China. Electronic address: 20192029013@stu.scau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Riming Huang</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food Quality and Safety, College of Food Science, South China Agricultural University, Guangzhou 510642, China. Electronic address: huangriming@scau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Gaolong Zhong</Name>
        <Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China. Electronic address: zgl1216@stu.scau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xuanxuan Jiang</Name>
        <Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China. Electronic address: xuan@stu.scau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhaoxin Tang</Name>
        <Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China. Electronic address: tangzx@scau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Lianmei Hu</Name>
        <Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China. Electronic address: hulianmei@scau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TGF-β/Smad signaling pathway plays a crucial role in patulin-induced pro-fibrotic changes in rat kidney via modulation of slug and snail expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34896196</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00423-3</DOI>
    <KeywordList>
      <Keywords>EMT</Keywords>
      <Keywords>Kidney</Keywords>
      <Keywords>Mycotoxin</Keywords>
      <Keywords>Patulin</Keywords>
      <Keywords>Pro-Fibrotic Changes</Keywords>
      <Keywords>TGF-β(1)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Saurabh Pal</Name>
        <Affiliation>Food Toxicology Laboratory, Food, Drug, and Chemical Toxicology Group, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; Academy of Scientific and Innovative Research, CSIR-Indian Institute of Toxicology Research, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Neha Singh</Name>
        <Affiliation>Food Toxicology Laboratory, Food, Drug, and Chemical Toxicology Group, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; Academy of Scientific and Innovative Research, CSIR-Indian Institute of Toxicology Research, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Indra Dev</Name>
        <Affiliation>Food Toxicology Laboratory, Food, Drug, and Chemical Toxicology Group, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; Academy of Scientific and Innovative Research, CSIR-Indian Institute of Toxicology Research, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vineeta Sharma</Name>
        <Affiliation>Developmental Toxicology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pankaj Ramji Jagdale</Name>
        <Affiliation>Pathology Laboratory, Regulatory Toxicology Group, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31 M. G. Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anjaneya Ayanur</Name>
        <Affiliation>Academy of Scientific and Innovative Research, CSIR-Indian Institute of Toxicology Research, Lucknow 226001, Uttar Pradesh, India; Pathology Laboratory, Regulatory Toxicology Group, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31 M. G. Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kausar Mahmood Ansari</Name>
        <Affiliation>Food Toxicology Laboratory, Food, Drug, and Chemical Toxicology Group, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; Academy of Scientific and Innovative Research, CSIR-Indian Institute of Toxicology Research, Lucknow 226001, Uttar Pradesh, India. Electronic address: kmansari@iitr.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Ochratoxin A exposure decreased sperm motility via the AMPK and PTEN signaling pathways" [Toxicology and Applied Pharmacology 271 (2018) 49-57].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34896195</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00430-0</DOI>
    <AuthorList>
      <Author>
        <Name>Tian Yu Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Ying Wu</Name>
        <Affiliation>Center for Reproductive Medicine, Qingdao Women's and Children's Hospital, Qingdao University, Qingdao 266034, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Zhao</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Shuang Xu</Name>
        <Affiliation>Center for Reproductive Medicine, Qingdao Women's and Children's Hospital, Qingdao University, Qingdao 266034, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Dong Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Ge</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Liu</Name>
        <Affiliation>Core Laboratories of Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhong Yi Sun</Name>
        <Affiliation>Department of Urology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Hua Zou</Name>
        <Affiliation>Center for Reproductive Medicine, Qingdao Women's and Children's Hospital, Qingdao University, Qingdao 266034, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Shen</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China; College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China. Electronic address: wshen@qau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical toxicology development of a novel antibody antibiotic conjugate for treating invasive Staphylococcus Aureus infections.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34896194</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00415-4</DOI>
    <KeywordList>
      <Keywords>Antibiotics</Keywords>
      <Keywords>Antibody-mediated delivery</Keywords>
      <Keywords>Infectious disease</Keywords>
      <Keywords>Nonclinical toxicology</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Staphylococcus aureus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicola J. Stagg</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address: Nicola.Stagg@lifesciadv.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paula Katavolos</Name>
        <Affiliation>Nonclinical Safety, Bristol Myers Squibb, New Brunswick, NJ 08901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kirsten Achilles Poon</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ultragenyx Pharmaceutical, Inc., Novato, CA 94949, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shelly Zhong</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nina Ljumanovic</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amrita Kamath</Name>
        <Affiliation>Department of Preclinical &amp; Translational Pharmacokinetics &amp; Pharmacodynamics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Cai</Name>
        <Affiliation>Department of Preclinical &amp; Translational Pharmacokinetics &amp; Pharmacodynamics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Montserrat Carrasco-Triguero</Name>
        <Affiliation>Bioanalytical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wendy Halpern</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address: Halpern.Wendy@gene.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pirfenidone attenuates acetaminophen-induced liver injury via suppressing c-Jun N-terminal kinase phosphorylation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34890640</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00421-X</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Acute Liver Failure</Keywords>
      <Keywords>Cell Death</Keywords>
      <Keywords>JNK</Keywords>
      <Keywords>Pirfenidone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shigeki Tashiro</Name>
        <Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masatake Tanaka</Name>
        <Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeshi Goya</Name>
        <Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomomi Aoyagi</Name>
        <Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Miho Kurokawa</Name>
        <Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Koji Imoto</Name>
        <Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akifumi Kuwano</Name>
        <Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Motoi Takahashi</Name>
        <Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hideo Suzuki</Name>
        <Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Motoyuki Kohjima</Name>
        <Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. Electronic address: kohjima@med.kyushu-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Masaki Kato</Name>
        <Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; Graduate School of Nutritional Sciences, Nakamura Gakuen University, 5-7-1 Befu, Jounan-ku, Fukuoka 814-0198, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshihiro Ogawa</Name>
        <Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition" [Toxicol Appl Pharmacol 360 (2018) 1-8].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34890639</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00428-2</DOI>
    <AuthorList>
      <Author>
        <Name>Yan Rong Liu</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; Drug Safety Evaluation Center, Tianjin International Joint Academy of Biomedicine, Tianjin, China. Electronic address: liuyanrong1984@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Sun</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Hong Zhu</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Wei Li</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Xuan Tian</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Meng Wang</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Min Zong</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Zhen Sheng</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Li</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuang Chen</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Qin</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Juan Liu</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Gang Zhou</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Sun</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China. Electronic address: sunrockmia@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Yang</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China. Electronic address: cyang66_2001@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of tyrosine kinase inhibitors on androgen, estrogen α, glucocorticoid and thyroid receptors.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34890638</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00422-1</DOI>
    <KeywordList>
      <Keywords>Cell adhesion</Keywords>
      <Keywords>Cell proliferation</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Hormonal effects</Keywords>
      <Keywords>Nuclear receptors</Keywords>
      <Keywords>Tyrosine kinase inhibitors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maša Kenda</Name>
        <Affiliation>University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. Electronic address: masa.kenda@ffa.uni-lj.si.</Affiliation>
      </Author>
      <Author>
        <Name>Damjan Avsec</Name>
        <Affiliation>University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. Electronic address: damjan.avsec@ffa.uni-lj.si.</Affiliation>
      </Author>
      <Author>
        <Name>Taja Zore</Name>
        <Affiliation>University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. Electronic address: taja.zore@ffa.uni-lj.si.</Affiliation>
      </Author>
      <Author>
        <Name>Eva Kogovšek</Name>
        <Affiliation>University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, SI-1000 Ljubljana, Slovenia.</Affiliation>
      </Author>
      <Author>
        <Name>Urša Pečar Fonović</Name>
        <Affiliation>University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. Electronic address: ursa.pecarfonovic@ffa.uni-lj.si.</Affiliation>
      </Author>
      <Author>
        <Name>Janko Kos</Name>
        <Affiliation>University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. Electronic address: janko.kos@ffa.uni-lj.si.</Affiliation>
      </Author>
      <Author>
        <Name>Krištof Bozovičar</Name>
        <Affiliation>University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. Electronic address: kristof.bozovicar@ffa.uni-lj.si.</Affiliation>
      </Author>
      <Author>
        <Name>Tomaž Bratkovič</Name>
        <Affiliation>University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. Electronic address: tomaz.bratkovic@ffa.uni-lj.si.</Affiliation>
      </Author>
      <Author>
        <Name>Nataša Karas Kuželički</Name>
        <Affiliation>University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. Electronic address: natasa.karaskuzelicki@ffa.uni-lj.si.</Affiliation>
      </Author>
      <Author>
        <Name>Bojana Žegura</Name>
        <Affiliation>National Institute of Biology, Department of Genetic Toxicology and Cancer Biology, Večna pot 111, SI-1000 Ljubljana, Slovenia. Electronic address: bojana.zegura@nib.si.</Affiliation>
      </Author>
      <Author>
        <Name>Metka Filipič</Name>
        <Affiliation>National Institute of Biology, Department of Genetic Toxicology and Cancer Biology, Večna pot 111, SI-1000 Ljubljana, Slovenia. Electronic address: metka.filipic@nib.si.</Affiliation>
      </Author>
      <Author>
        <Name>Marija Sollner Dolenc</Name>
        <Affiliation>University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. Electronic address: marija.sollner@ffa.uni-lj.si.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34856211</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00420-8</DOI>
    <KeywordList>
      <Keywords>Multidrug resistance</Keywords>
      <Keywords>Ovarian cancer cells</Keywords>
      <Keywords>P-gp substrate drugs</Keywords>
      <Keywords>Paclitaxel</Keywords>
      <Keywords>Voacamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Evelin Pellegrini</Name>
        <Affiliation>National Center for Drug Research and Evaluation, National Institute of Health, 00161 Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Giuseppina Multari</Name>
        <Affiliation>National Center for Drug Research and Evaluation, National Institute of Health, 00161 Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Francesca Romana Gallo</Name>
        <Affiliation>National Center for Drug Research and Evaluation, National Institute of Health, 00161 Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Davide Vecchiotti</Name>
        <Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Francesca Zazzeroni</Name>
        <Affiliation>Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Condello</Name>
        <Affiliation>National Center for Drug Research and Evaluation, National Institute of Health, 00161 Rome, Italy.. Electronic address: maria.condello@iss.it.</Affiliation>
      </Author>
      <Author>
        <Name>Stefania Meschini</Name>
        <Affiliation>National Center for Drug Research and Evaluation, National Institute of Health, 00161 Rome, Italy.. Electronic address: stefania.meschini@iss.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative study of estrogenic activities of phytoestrogens using OECD in vitro and in vivo testing methods.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34848279</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00419-1</DOI>
    <KeywordList>
      <Keywords>ER-α dimerization</Keywords>
      <Keywords>Estrogen receptors</Keywords>
      <Keywords>OECD test methods</Keywords>
      <Keywords>Phytoestrogens</Keywords>
      <Keywords>Transcriptional activation</Keywords>
      <Keywords>Uterotrophic effect</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kyu Sang Sim</Name>
        <Affiliation>Department of Food Science and Biotechnology, Andong National University, Andong 36729, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Song Park</Name>
        <Affiliation>Department of Food Science and Biotechnology, Andong National University, Andong 36729, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Huiwon Seo</Name>
        <Affiliation>Department of Food Science and Biotechnology, Dongguk University, Gyeonggi-do 10326, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seok Hee Lee</Name>
        <Affiliation>Department of Food Science and Biotechnology, Dongguk University, Gyeonggi-do 10326, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hee Seok Lee</Name>
        <Affiliation>Department of Food Science and Technology, Chung-Ang University, Anseong 17546, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yooheon Park</Name>
        <Affiliation>Department of Food Science and Biotechnology, Dongguk University, Gyeonggi-do 10326, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Ho Kim</Name>
        <Affiliation>Department of Food Science and Biotechnology, Andong National University, Andong 36729, Republic of Korea. Electronic address: jhkim@anu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicokinetics of mono-(2-ethylhexyl) phthalate with low-dose exposure applying fluorescence tracing technique.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34843800</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00418-X</DOI>
    <KeywordList>
      <Keywords>Absorption</Keywords>
      <Keywords>Distribution</Keywords>
      <Keywords>Fluorescent probe</Keywords>
      <Keywords>Low-dose exposure</Keywords>
      <Keywords>Phthalates</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yi Zhen Yuan</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210046, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Chong Ye</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210046, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Hui Sun</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210046, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Yuan Hu</Name>
        <Affiliation>College of Food and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210046, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Shao Jie Huo</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210046, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Ting Zhu</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210046, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Su Yun Xiang</Name>
        <Affiliation>College of Food and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210046, People's Republic of China. Electronic address: xiangsy@njnu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Qin Yu</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210046, People's Republic of China. Electronic address: yushuqin@njnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of β-adrenergic ligands for development of pharmacological heart failure and transparency models in zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34838787</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00416-6</DOI>
    <KeywordList>
      <Keywords>Animal Model</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Catecholamine</Keywords>
      <Keywords>Lipophilicity</Keywords>
      <Keywords>Salmeterol Xinafoate</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Monika Maciag</Name>
        <Affiliation>Department of Biopharmacy, Medical University of Lublin, 4a Chodzki Street, 20-093 Lublin, Poland; Independent Laboratory of Behavioral Studies, Medical University of Lublin, 4a Chodzki Street, 20-093 Lublin, Poland. Electronic address: monika.maciag@umlub.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Artur Wnorowski</Name>
        <Affiliation>Department of Biopharmacy, Medical University of Lublin, 4a Chodzki Street, 20-093 Lublin, Poland. Electronic address: artur.wnorowski@umlub.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Kinga Bednarz</Name>
        <Affiliation>Department of Biopharmacy, Medical University of Lublin, 4a Chodzki Street, 20-093 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Anita Plazinska</Name>
        <Affiliation>Department of Biopharmacy, Medical University of Lublin, 4a Chodzki Street, 20-093 Lublin, Poland. Electronic address: anitaplazinska@umlub.pl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exploring the potential neurotoxicity of vaping vitamin E or vitamin E acetate.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34838608</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00417-8</DOI>
    <KeywordList>
      <Keywords>Computational model</Keywords>
      <Keywords>E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI)</Keywords>
      <Keywords>Electronic Nicotine Delivery Systems (ENDS)</Keywords>
      <Keywords>Electronic cigarettes</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Pulmonary injury</Keywords>
      <Keywords>Tobacco products</Keywords>
      <Keywords>Vaping</Keywords>
      <Keywords>Vitamin E</Keywords>
      <Keywords>Vitamin E acetate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kimberly Stratford</Name>
        <Affiliation>United States Food and Drug Administration, Center for Tobacco Products, Office of Science, Division of Nonclinical Science, 11785 Beltsville Drive, Beltsville, MD 20705, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Prabha Kc</Name>
        <Affiliation>United States Food and Drug Administration, Center for Tobacco Products, Office of Science, Division of Nonclinical Science, 11785 Beltsville Drive, Beltsville, MD 20705, USA; United States Food and Drug Administration, Center for Tobacco Products, Tobacco Product Surveillance Team, 11785 Beltsville Drive, Beltsville, MD 20705, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Rudy</Name>
        <Affiliation>United States Food and Drug Administration, Center for Tobacco Products, Office of Science, Division of Individual Health Science/Medical Branch, 11785 Beltsville Drive, Beltsville, MD 20705, USA; United States Food and Drug Administration, Center for Tobacco Products, Tobacco Product Surveillance Team, 11785 Beltsville Drive, Beltsville, MD 20705, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Sophie Weidner</Name>
        <Affiliation>United States Food and Drug Administration, Center for Tobacco Products, Office of Science, Division of Individual Health Science/Medical Branch, 11785 Beltsville Drive, Beltsville, MD 20705, USA; United States Food and Drug Administration, Center for Tobacco Products, Tobacco Product Surveillance Team, 11785 Beltsville Drive, Beltsville, MD 20705, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Priscilla Callahan-Lyon</Name>
        <Affiliation>United States Food and Drug Administration, Center for Tobacco Products, Office of Science, Division of Individual Health Science/Medical Branch, 11785 Beltsville Drive, Beltsville, MD 20705, USA; United States Food and Drug Administration, Center for Tobacco Products, Tobacco Product Surveillance Team, 11785 Beltsville Drive, Beltsville, MD 20705, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Luis G. Valerio</Name>
        <Affiliation>United States Food and Drug Administration, Center for Tobacco Products, Office of Science, Division of Nonclinical Science, 11785 Beltsville Drive, Beltsville, MD 20705, USA. Electronic address: luis.valerio@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Induction of ZIP8, a ZIP transporter, via NF-κB signaling by the activation of IκBα and JNK signaling in cultured vascular endothelial cells exposed to cadmium.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34822840</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00406-3</DOI>
    <KeywordList>
      <Keywords>C-jun N-terminal kinase</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Endothelial cell</Keywords>
      <Keywords>Nuclear factor-κB</Keywords>
      <Keywords>Zrt- and Irt-like protein transporter</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tomoya Fujie</Name>
        <Affiliation>Department of Environmental Health, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi 274-8510, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Keisuke Ito</Name>
        <Affiliation>Department of Environmental Health, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda 278-8510, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yusuke Ozaki</Name>
        <Affiliation>Department of Environmental Health, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda 278-8510, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Suzuka Takahashi</Name>
        <Affiliation>Department of Environmental Health, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda 278-8510, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Chika Yamamoto</Name>
        <Affiliation>Department of Environmental Health, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi 274-8510, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshiyuki Kaji</Name>
        <Affiliation>Department of Environmental Health, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda 278-8510, Japan. Electronic address: t-kaji@rs.tus.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tetracaine hydrochloride induces cell cycle arrest in melanoma by downregulating hnRNPA1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34822839</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00414-2</DOI>
    <KeywordList>
      <Keywords>Cell cycle</Keywords>
      <Keywords>Skin cancer</Keywords>
      <Keywords>Tetracaine</Keywords>
      <Keywords>hnRNPA1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiang Huang</Name>
        <Affiliation>Department of Anesthesiology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yirong Chen</Name>
        <Affiliation>Department of Anesthesiology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junxiu Yi</Name>
        <Affiliation>Department of Ultrasound Diagnosis, Southwest Hospital, Army Medical University, Chongqing 400038, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Yi</Name>
        <Affiliation>Department of Anesthesiology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Jia</Name>
        <Affiliation>Department of Anesthesiology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonghong Liao</Name>
        <Affiliation>Department of Anesthesiology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Feng</Name>
        <Affiliation>Department of Anesthesiology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China. Electronic address: fengjianguo@swmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xian Jiang</Name>
        <Affiliation>Department of Anesthesiology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China; Department of Anesthesiology, Luzhou People's Hospital, Luzhou, Sichuan Province, China. Electronic address: jiangxian@swmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Up-regulation of PUMA caused the activation of p53 phosphorylation and acetylation, enhancing the interaction between PUMA and Bcl-X and mediating arsenic-induced apoptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34798143</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00404-X</DOI>
    <KeywordList>
      <Keywords>Acetylation</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Metabolites</Keywords>
      <Keywords>PUMA</Keywords>
      <Keywords>p53 Phosphorylation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qian Zhou</Name>
        <Affiliation>School of Public Health, Kunming Medical University, No.1168 Chunrongxi Road, Chenggong District, Kunming, Yunnan Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinyao Yin</Name>
        <Affiliation>School of Public Health, Kunming Medical University, No.1168 Chunrongxi Road, Chenggong District, Kunming, Yunnan Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwen Tan</Name>
        <Affiliation>School of Public Health, Kunming Medical University, No.1168 Chunrongxi Road, Chenggong District, Kunming, Yunnan Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuting Li</Name>
        <Affiliation>School of Public Health, Kunming Medical University, No.1168 Chunrongxi Road, Chenggong District, Kunming, Yunnan Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenglan Jiang</Name>
        <Affiliation>School of Public Health, Kunming Medical University, No.1168 Chunrongxi Road, Chenggong District, Kunming, Yunnan Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuefeng He</Name>
        <Affiliation>School of Public Health, Kunming Medical University, No.1168 Chunrongxi Road, Chenggong District, Kunming, Yunnan Province, China. Electronic address: heyuefeng@kmmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Contribution of NADPH oxidase to the retention of UVR-induced DNA damage by arsenic.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34798142</pubmedLink>
    <GrantList>
      <Grant>R01 ES021100</Grant>
      <Grant>R01 ES030993</Grant>
      <Grant>R25 GM060201</Grant>
      <Grant>P42 ES025589</Grant>
      <Grant>P20 GM130422</Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00403-8</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Co-carcinogenesis</Keywords>
      <Keywords>DNA repair</Keywords>
      <Keywords>NADPH oxidase</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>PARP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Karen L. Cooper</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, 1 University of New Mexico, Albuquerque, NM 87131, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Lindsay B. Volk</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, 1 University of New Mexico, Albuquerque, NM 87131, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Dayna R. Dominguez</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, 1 University of New Mexico, Albuquerque, NM 87131, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Antonia D. Duran</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, 1 University of New Mexico, Albuquerque, NM 87131, United States of America; Department of Chemistry and Biochemistry, Ohio State University, Columbus, OH 43210, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>K. J. Ke Jian Liu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, 1 University of New Mexico, Albuquerque, NM 87131, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Laurie G. Hudson</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, 1 University of New Mexico, Albuquerque, NM 87131, United States of America. Electronic address: lhudson@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic" [Toxicology and applied pharmacology 367 (2019) 62-70].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34798141</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00405-1</DOI>
    <AuthorList>
      <Author>
        <Name>Zhiyuan Liu</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongyong Hou</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Li</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yang</Name>
        <Affiliation>Department of Rehabilitation, The First Affiliated Hospital of China Medical University, No. 155 Nanjing North Road, Heping Area, Shenyang 110001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingkun Jia</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhixuan Hong</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tingfeng Li</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyuan Xu</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingqi Fu</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongxin Sun</Name>
        <Affiliation>Department of Rehabilitation, The First Affiliated Hospital of China Medical University, No. 155 Nanjing North Road, Heping Area, Shenyang 110001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Masayuki Yamamoto</Name>
        <Affiliation>Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Huihui Wang</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China. Electronic address: hhwang@cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China. Electronic address: jbpi@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Downregulation of HSPA12A underlies myotoxicity of local anesthetic agent bupivacaine through inhibiting PGC1α-mediated mitochondrial integrity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34793778</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00402-6</DOI>
    <KeywordList>
      <Keywords>HSPA12A</Keywords>
      <Keywords>Local anesthetics</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Myotoxicity</Keywords>
      <Keywords>PGC1α</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qian Mao</Name>
        <Affiliation>Department of Anesthesiology, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wansu Yu</Name>
        <Affiliation>Department of Geriatrics, Jiangsu Provincial Key Laboratory of Geriatrics, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shijiang Liu</Name>
        <Affiliation>Department of Anesthesiology, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofei Cao</Name>
        <Affiliation>Department of Anesthesiology, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Dai</Name>
        <Affiliation>Department of Anesthesiology, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojin Zhang</Name>
        <Affiliation>Department of Geriatrics, Jiangsu Provincial Key Laboratory of Geriatrics, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinxu Min</Name>
        <Affiliation>Department of Anesthesiology, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Liu</Name>
        <Affiliation>Department of Geriatrics, Jiangsu Provincial Key Laboratory of Geriatrics, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengnian Ding</Name>
        <Affiliation>Department of Anesthesiology, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. Electronic address: zhengnianding@njmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-clinical safety assessment and in vivo biodistribution of CoviFab, an RBD-specific F(ab')2 fragment derived from equine polyclonal antibodies.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34785274</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00400-2</DOI>
    <KeywordList>
      <Keywords>Biodistribution</Keywords>
      <Keywords>COVID-19</Keywords>
      <Keywords>CoviFab</Keywords>
      <Keywords>Good laboratory practices</Keywords>
      <Keywords>Preclinical studies</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Facundo Salinas</Name>
        <Affiliation>Centro de Medicina Comparada, Instituto de Ciencias Veterinarias del Litoral (ICiVet-Litoral), Universidad Nacional del Litoral (UNL) / Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Esperanza, Santa Fe, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Belkis E. Marelli</Name>
        <Affiliation>Centro de Medicina Comparada, Instituto de Ciencias Veterinarias del Litoral (ICiVet-Litoral), Universidad Nacional del Litoral (UNL) / Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Esperanza, Santa Fe, Argentina; Facultad de Ciencias Veterinarias del Litoral, Universidad Nacional del Litoral (UNL), Esperanza, Santa Fe, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Santiago Sanguineti</Name>
        <Affiliation>INMUNOVA S.A., Av. Patricias Argentinas 435, Ciudad de Buenos Aires C1405BWE, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Goldbaum</Name>
        <Affiliation>INMUNOVA S.A., Av. Patricias Argentinas 435, Ciudad de Buenos Aires C1405BWE, Argentina; CRIP-Centro de Rediseño e Ingeniería de Proteínas UNSAM, Campus Miguelete, San Martín, Provincia de Buenos Aires, Argentina; Laboratorio de Inmunología y Microbiología Molecular, Fundación Instituto Leloir, IIBBA-CONICET, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Luciana Muñoz</Name>
        <Affiliation>INMUNOVA S.A., Av. Patricias Argentinas 435, Ciudad de Buenos Aires C1405BWE, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Lucas Etchevers</Name>
        <Affiliation>Centro de Medicina Comparada, Instituto de Ciencias Veterinarias del Litoral (ICiVet-Litoral), Universidad Nacional del Litoral (UNL) / Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Esperanza, Santa Fe, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Paula Silvestrini</Name>
        <Affiliation>Centro de Medicina Comparada, Instituto de Ciencias Veterinarias del Litoral (ICiVet-Litoral), Universidad Nacional del Litoral (UNL) / Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Esperanza, Santa Fe, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Ulises S. Notaro</Name>
        <Affiliation>Centro de Medicina Comparada, Instituto de Ciencias Veterinarias del Litoral (ICiVet-Litoral), Universidad Nacional del Litoral (UNL) / Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Esperanza, Santa Fe, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Natalia R. Salvetti</Name>
        <Affiliation>Centro de Medicina Comparada, Instituto de Ciencias Veterinarias del Litoral (ICiVet-Litoral), Universidad Nacional del Litoral (UNL) / Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Esperanza, Santa Fe, Argentina; Facultad de Ciencias Veterinarias del Litoral, Universidad Nacional del Litoral (UNL), Esperanza, Santa Fe, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Vanesa Zylberman</Name>
        <Affiliation>INMUNOVA S.A., Av. Patricias Argentinas 435, Ciudad de Buenos Aires C1405BWE, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas, (CONICET), Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Hugo H. Ortega</Name>
        <Affiliation>Centro de Medicina Comparada, Instituto de Ciencias Veterinarias del Litoral (ICiVet-Litoral), Universidad Nacional del Litoral (UNL) / Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Esperanza, Santa Fe, Argentina; Facultad de Ciencias Veterinarias del Litoral, Universidad Nacional del Litoral (UNL), Esperanza, Santa Fe, Argentina. Electronic address: hhortega@fcv.unl.edu.ar.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34780725</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00401-4</DOI>
    <KeywordList>
      <Keywords>ABC transporters</Keywords>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Dabrafenib</Keywords>
      <Keywords>Drug resistance</Keywords>
      <Keywords>Drug–drug interactions</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ales Sorf</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Dimitrios Vagiannis</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Fahda Ahmed</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Jakub Hofman</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Ceckova</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic. Electronic address: martina.ceckova@faf.cuni.cz.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nimbolide attenuated the inflammation in the liver of autoimmune hepatitis's mice through regulation of HDAC3.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34780724</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00399-9</DOI>
    <KeywordList>
      <Keywords>Autoimmune Hepatitis</Keywords>
      <Keywords>HDAC3</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>Nimbolide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dingchao Xia</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou 325006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dazhi Chen</Name>
        <Affiliation>Department of Gastroenterology, The First Hospital of Peking University, BeiJing 100032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tingchen Cai</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou 325006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lujian Zhu</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou 325006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanhan Lin</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou 325006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sijie Yu</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou 325006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kailu Zhu</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou 325006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodong Wang</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou 325006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lanman Xu</Name>
        <Affiliation>Department of Infectious Diseases and Liver Diseases, Ningbo Medical Center Lihuili Hospital, Affiliated Hospital of Ningbo University, Ningbo, 315040, Zhejiang, China. Electronic address: 13587646315@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yongping Chen</Name>
        <Affiliation>Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou 325006, China. Electronic address: did@wzhospital.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of environmental and occupational lead toxicity and its association with iron metabolism.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34780723</pubmedLink>
    <Year>2022</Year>
    <DOI>S0041-008X(21)00398-7</DOI>
    <KeywordList>
      <Keywords>Iron metabolism</Keywords>
      <Keywords>Lead</Keywords>
      <Keywords>iron</Keywords>
      <Keywords>lead poisoning</Keywords>
      <Keywords>lead toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michał Słota</Name>
        <Affiliation>ARKOP Sp. z o.o., Kolejowa 34a, 32-332 Bukowno, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Marta Wąsik</Name>
        <Affiliation>Department of Clinical Biochemistry and Laboratory Diagnostics, Institute of Medicine, University of Opole, Oleska 48, 45-052 Opole, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Tomasz Stołtny</Name>
        <Affiliation>District Hospital of Orthopaedics and Trauma Surgery in Piekary Śląskie, Bytomska 62, 41-940 Piekary Śląskie, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Machoń-Grecka</Name>
        <Affiliation>Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Jordana 19, 41-808 Zabrze, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Sławomir Kasperczyk</Name>
        <Affiliation>Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Jordana 19, 41-808 Zabrze, Poland. Electronic address: skasperczyk@sum.edu.pl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TMED3 exerts a protumor function in non-small cell lung cancer by enhancing the Wnt/β-catenin pathway via regulation of AKT.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34758370</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00397-5</DOI>
    <KeywordList>
      <Keywords>AKT</Keywords>
      <Keywords>NSCLC</Keywords>
      <Keywords>Wnt</Keywords>
      <Keywords>β-Catenin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Danjie Zhang</Name>
        <Affiliation>Department of Thoracic Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xi'an 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liangzhang Sun</Name>
        <Affiliation>Department of Thoracic Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xi'an 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Zhang</Name>
        <Affiliation>Department of Thoracic Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xi'an 710004, China. Electronic address: zhangjin9605@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation of the effect of isolated mitochondria transplantation on renal ischemia-reperfusion injury in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34756876</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00384-7</DOI>
    <KeywordList>
      <Keywords>Ischemia-reperfusion</Keywords>
      <Keywords>Kidney</Keywords>
      <Keywords>Mesenchymal stem cell</Keywords>
      <Keywords>Mitochondrial bioenergetic</Keywords>
      <Keywords>Mitochondrial transplantation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gokhan Burcin Kubat</Name>
        <Affiliation>Department of Exercise and Sports Physiology, Hacettepe University, Ankara, Turkey; Department of Pathology, Gulhane Training and Research Hospital, Health Sciences University, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Yasemin Kartal</Name>
        <Affiliation>Department of Physiology, Hacettepe University, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ozbeyen Atalay</Name>
        <Affiliation>Department of Physiology, Hacettepe University, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Oner Ulger</Name>
        <Affiliation>Department of Physiology, Health Sciences University, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ozgur Ekinci</Name>
        <Affiliation>Department of Pathology, Gazi University, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ertugrul Celik</Name>
        <Affiliation>Department of Pathology, Gulhane Training and Research Hospital, Health Sciences University, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Mukerrem Safali</Name>
        <Affiliation>Department of Pathology, Gulhane Training and Research Hospital, Health Sciences University, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Murat Urkan</Name>
        <Affiliation>Department of General Surgery Service, Training and Research Hospital, Mugla Sıtkı Kocman University, Mugla, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Sevilay Karahan</Name>
        <Affiliation>Department of Biostatistics, Hacettepe University, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Mehmet Ozler</Name>
        <Affiliation>Department of Physiology, Health Sciences University, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Zehra Cicek</Name>
        <Affiliation>Department of Physiology, Health Sciences University, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Murat Timur Budak</Name>
        <Affiliation>Department of Physiology, Hacettepe University, Ankara, Turkey. Electronic address: mtbudak@hacettepe.edu.tr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Indoprofen exerts a potent therapeutic effect against sepsis by alleviating high mobility group box 1-mediated inflammatory responses.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34755645</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00382-3</DOI>
    <KeywordList>
      <Keywords>HMGB1</Keywords>
      <Keywords>Indoprofen</Keywords>
      <Keywords>Inflammatory response</Keywords>
      <Keywords>LPS</Keywords>
      <Keywords>Poly I:C</Keywords>
      <Keywords>Sepsis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaowen Bi</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xintong Yan</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Baolin Jiang</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Juanjuan Liang</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinyi Zhou</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuai Lu</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Liu</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Luo</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China. Electronic address: lanluo@nju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhimin Yin</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, China. Electronic address: yinzhimin@njnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neuronal and cardiac toxicity of pharmacological compounds identified through transcriptomic analysis of human pluripotent stem cell-derived embryoid bodies.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34742744</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00396-3</DOI>
    <KeywordList>
      <Keywords>Chick Embryo</Keywords>
      <Keywords>Developmental Toxicity</Keywords>
      <Keywords>Embryoid Bodies</Keywords>
      <Keywords>Induced Pluripotent Stem Cells</Keywords>
      <Keywords>Pharmacological Compounds</Keywords>
      <Keywords>Transcriptomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vijay Bhaskar Reddy Konala</Name>
        <Affiliation>The University of Trans-Disciplinary Health Sciences and Technology (TDU), Bengaluru 560064, Karnataka, India; Eyestem Research, Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru 560065, Karnataka, India.</Affiliation>
      </Author>
      <Author>
        <Name>Swapna Nandakumar</Name>
        <Affiliation>Eyestem Research, Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru 560065, Karnataka, India.</Affiliation>
      </Author>
      <Author>
        <Name>Harshini Surendran</Name>
        <Affiliation>The University of Trans-Disciplinary Health Sciences and Technology (TDU), Bengaluru 560064, Karnataka, India; Eyestem Research, Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru 560065, Karnataka, India.</Affiliation>
      </Author>
      <Author>
        <Name>Savita Datar</Name>
        <Affiliation>Department of Zoology, S. P. College, Pune 411030, Maharashtra, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ramesh Bhonde</Name>
        <Affiliation>Dr. D. Y. Patil Vidyapeeth, Pune 411018, Maharashtra, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rajarshi Pal</Name>
        <Affiliation>The University of Trans-Disciplinary Health Sciences and Technology (TDU), Bengaluru 560064, Karnataka, India; Eyestem Research, Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru 560065, Karnataka, India. Electronic address: palrajarshi12@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>EGCG protects against myocardial I/RI by regulating lncRNA Gm4419-mediated epigenetic silencing of the DUSP5/ERK1/2 axis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34740634</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00386-0</DOI>
    <KeywordList>
      <Keywords>DUSP5</Keywords>
      <Keywords>EGCG</Keywords>
      <Keywords>ERK1/2</Keywords>
      <Keywords>Myocardial I/RI</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Min Zeng</Name>
        <Affiliation>Medical Center, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou 570311, Hainan Province, P.R. China. Electronic address: hndzm6@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Wei</Name>
        <Affiliation>Department of Otorhinolaryngology Head and Neck Surgery, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou 570311, Hainan Province, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Li He</Name>
        <Affiliation>Medical Center, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou 570311, Hainan Province, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Xiong Chen</Name>
        <Affiliation>Medical Center, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou 570311, Hainan Province, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Ting Lin</Name>
        <Affiliation>Medical Center, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou 570311, Hainan Province, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Xing Xu</Name>
        <Affiliation>Medical Center, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou 570311, Hainan Province, P.R. China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Remdesivir; molecular and functional measures of mitochondrial safety.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34740633</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00387-2</DOI>
    <KeywordList>
      <Keywords>COVID</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Off-Target</Keywords>
      <Keywords>Remdesivir</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. A. Bjork</Name>
        <Affiliation>Dept. Biomedical Sciences, University of Minnesota Medical School, Duluth, MN 55812, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>K. B. Wallace</Name>
        <Affiliation>Dept. Biomedical Sciences, University of Minnesota Medical School, Duluth, MN 55812, United States of America. Electronic address: kwallace@d.umn.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gene regulation by morpholines and piperidines in the cardiac embryonic stem cell test.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34737147</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00385-9</DOI>
    <KeywordList>
      <Keywords>Embryonic stem cell test</Keywords>
      <Keywords>Gene transcript biomarkers</Keywords>
      <Keywords>Morpholines</Keywords>
      <Keywords>Piperidines</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>R. H. Mennen</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Electronic address: gina.mennen@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>N. Hallmark</Name>
        <Affiliation>Bayer AG Crop Science Division, Monheim, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>M. Pallardy</Name>
        <Affiliation>Inflammation, Microbiome and Immunosurveillance, Université Paris-Saclay, INSERM UMR996, Châtenay-Malabry 92296, France.</Affiliation>
      </Author>
      <Author>
        <Name>R. Bars</Name>
        <Affiliation>Bayer Crop Science, Sophia-Antipolis, France.</Affiliation>
      </Author>
      <Author>
        <Name>H. Tinwell</Name>
        <Affiliation>Bayer Crop Science, Sophia-Antipolis, France.</Affiliation>
      </Author>
      <Author>
        <Name>A. H. Piersma</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (IRAS), Utrecht University, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A regulatory relic: After 60 years of research on cancer risk, the Delaney Clause continues to keep us in the past.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34737146</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00383-5</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Delaney Clause</Keywords>
      <Keywords>Food additives</Keywords>
      <Keywords>Food regulations</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mansi Krishan</Name>
        <Affiliation>Danone North America, Broomfield, CO, USA. Electronic address: mansi.krishan@outlook.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Navarro</Name>
        <Affiliation>Flavor Producers, LLC, Sharonville, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Beck</Name>
        <Affiliation>Gradient, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ricardo Carvajal</Name>
        <Affiliation>Hyman, Phelps &amp; McNamara, P.C., Washington, D.C., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Dourson</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA), OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Short-term exposure to perfluorotetradecanoic acid affects the late-stage regeneration of Leydig cells in adult male rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34736952</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00381-1</DOI>
    <KeywordList>
      <Keywords>Leydig cell</Keywords>
      <Keywords>Perfluorotetradecanoic acid</Keywords>
      <Keywords>Regeneration</Keywords>
      <Keywords>Sperm</Keywords>
      <Keywords>Testosterone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Song Zhang</Name>
        <Affiliation>Department of Gynecology and Obstetrics, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China; Department of Reproductive Medicine, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, 123 Tianfeixiang, Mochou Road, Nanjing 210004, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zina Wen</Name>
        <Affiliation>Department of Gynecology and Obstetrics, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoheng Li</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liben Lin</Name>
        <Affiliation>Department of Pathology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Zou</Name>
        <Affiliation>Department of Gynecology and Obstetrics, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Li</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiyan Wang</Name>
        <Affiliation>Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ren Shan Ge</Name>
        <Affiliation>Department of Gynecology and Obstetrics, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China; Department of Anesthesiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: r_ge@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel protoapigenone analog RY10-4 induces apoptosis of breast cancer cells by exacerbating mitochondrial Ca</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34717963</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00380-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Breast cancer</Keywords>
      <Keywords>MCU</Keywords>
      <Keywords>Mitochondrial calcium</Keywords>
      <Keywords>RY10-4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pingping Xue</Name>
        <Affiliation>Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Chen</Name>
        <Affiliation>Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuhua Ren</Name>
        <Affiliation>Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Liu</Name>
        <Affiliation>Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: ld2069@outlook.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofan Yang</Name>
        <Affiliation>Department of Hand Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Electronic address: 2017xh0119@hust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>RNA-Seq unveiled section-specific host response to lack of gut microbiota in mouse intestine.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34715074</pubmedLink>
    <GrantList>
      <Grant>R01 ES031098</Grant>
      <Grant>P30 ES007033</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00379-3</DOI>
    <KeywordList>
      <Keywords>Germ-Free</Keywords>
      <Keywords>Intestine</Keywords>
      <Keywords>Microbiome</Keywords>
      <Keywords>Transcriptomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zidong Donna Fu</Name>
        <Affiliation>Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Felcy Pavithra Selwyn</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Julia Yue Cui</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Curtis D. Klaassen</Name>
        <Affiliation>Department of Pharmacology, Toxicology, and Therapeutics, School of Medicine, University of Kansas, Kansas City, KS, United States of America. Electronic address: curtisklaassenphd@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Curcumin nanocrystals attenuate cyclophosphamide-induced testicular toxicity in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34715073</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00376-8</DOI>
    <KeywordList>
      <Keywords>Chemoprotection</Keywords>
      <Keywords>Chemotherapy</Keywords>
      <Keywords>Curcumin nanocrystals</Keywords>
      <Keywords>Germ cells</Keywords>
      <Keywords>Spermatozoa</Keywords>
      <Keywords>Testicular dysfunction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Keerthana Karunakar Poojary</Name>
        <Affiliation>Division of Clinical Embryology, Department of Reproductive Science, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, India.</Affiliation>
      </Author>
      <Author>
        <Name>Guruprasad Nayak</Name>
        <Affiliation>Division of Reproductive Biology, Department of Reproductive Science, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ashna Vasani</Name>
        <Affiliation>Division of Reproductive Biology, Department of Reproductive Science, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sandhya Kumari</Name>
        <Affiliation>Division of Reproductive Biology, Department of Reproductive Science, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, India.</Affiliation>
      </Author>
      <Author>
        <Name>Reyon Dcunha</Name>
        <Affiliation>Division of Reproductive Biology, Department of Reproductive Science, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, India.</Affiliation>
      </Author>
      <Author>
        <Name>Jyolsna Ponnaratta Kunhiraman</Name>
        <Affiliation>Division of Reproductive Biology, Department of Reproductive Science, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, India.</Affiliation>
      </Author>
      <Author>
        <Name>Divya Gopalan</Name>
        <Affiliation>Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rajat Radhakrishna Rao</Name>
        <Affiliation>Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, India.</Affiliation>
      </Author>
      <Author>
        <Name>Srinivas Mutalik</Name>
        <Affiliation>Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sneha Guruprasad Kalthur</Name>
        <Affiliation>Department of Anatomy, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, India.</Affiliation>
      </Author>
      <Author>
        <Name>M. S. Murari</Name>
        <Affiliation>DST PURSE Program, Mangalore University, Mangalagangotri 574199, Karnataka, India.</Affiliation>
      </Author>
      <Author>
        <Name>Shamprasad Varija Raghu</Name>
        <Affiliation>Neurogenetics Lab, Department of Applied Zoology, Mangalore University, Mangalagangotri 574199, Karnataka, India.</Affiliation>
      </Author>
      <Author>
        <Name>Satish Kumar Adiga</Name>
        <Affiliation>Division of Clinical Embryology, Department of Reproductive Science, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, India.</Affiliation>
      </Author>
      <Author>
        <Name>Guruprasad Kalthur</Name>
        <Affiliation>Division of Reproductive Biology, Department of Reproductive Science, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, India. Electronic address: guru.kalthur@manipal.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dietary biotin supplementation increases proliferation pathways in mice testes without affecting serum follicle-stimulating hormone levels and stem cell factor expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34699867</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00378-1</DOI>
    <KeywordList>
      <Keywords>AKT</Keywords>
      <Keywords>Biotin</Keywords>
      <Keywords>C-Kit</Keywords>
      <Keywords>Cyclins</Keywords>
      <Keywords>ERK</Keywords>
      <Keywords>Proliferation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tonatiuh Salazar-Anzures</Name>
        <Affiliation>Unidad de Genética de la Nutrición, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México/Instituto Nacional de Pediatría, Avenida del Iman#1, 4th floor, Mexico City 04500, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Karina Pastén-Hidalgo</Name>
        <Affiliation>Cátedra CONACYT, Instituto Nacional de Pediatría, Avenida del Iman#1, 4th floor, Mexico City 04500, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Gloria Sicilia-Argumedo</Name>
        <Affiliation>Unidad de Genética de la Nutrición, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México/Instituto Nacional de Pediatría, Avenida del Iman#1, 4th floor, Mexico City 04500, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Leticia Riverón-Negrete</Name>
        <Affiliation>Unidad de Genética de la Nutrición, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México/Instituto Nacional de Pediatría, Avenida del Iman#1, 4th floor, Mexico City 04500, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Alain de Jesús Hernández-Vázquez</Name>
        <Affiliation>Unidad de Genética de la Nutrición, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México/Instituto Nacional de Pediatría, Avenida del Iman#1, 4th floor, Mexico City 04500, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Cristina Fernanadez-Mejia</Name>
        <Affiliation>Unidad de Genética de la Nutrición, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México/Instituto Nacional de Pediatría, Avenida del Iman#1, 4th floor, Mexico City 04500, Mexico. Electronic address: crisfern@biomedicas.unam.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The ponatinib/gossypol novel combination provides enhanced anticancer activity against murine solid Ehrlich carcinoma via triggering apoptosis and inhibiting proliferation/angiogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34699866</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00371-9</DOI>
    <KeywordList>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>FGFR4</Keywords>
      <Keywords>Gossypol</Keywords>
      <Keywords>Ponatinib</Keywords>
      <Keywords>Solid Ehrlich tumor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Naglaa M. El-Lakkany</Name>
        <Affiliation>Department of Pharmacology, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba, Giza 12411, Egypt. Electronic address: n.ellakkany@tbri.gov.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Hadeel H. Elkattan</Name>
        <Affiliation>Department of Pharmacology, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba, Giza 12411, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Alaa E. Elsisi</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inferred inactivation of the Cftr gene in the duodena of mice exposed to hexavalent chromium (Cr(VI)) in drinking water supports its tumor-suppressor status and implies its potential role in Cr(VI)-induced carcinogenesis of the small intestines.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34688701</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00377-X</DOI>
    <KeywordList>
      <Keywords>CFTR</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Chromium</Keywords>
      <Keywords>Duodenal cancer</Keywords>
      <Keywords>Toxicogenomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Roman Mezencev</Name>
        <Affiliation>Center for Public Health and Environmental Assessment, Office of Research and Development, US EPA, Washington, DC, United States. Electronic address: Mezencev.Roman@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Scott S. Auerbach</Name>
        <Affiliation>National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carnosol alleviates nonalcoholic fatty liver disease by inhibiting mitochondrial dysfunction and apoptosis through targeting of PRDX3.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34678374</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00362-8</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Carnosol</Keywords>
      <Keywords>Mitochondrial dysfunction</Keywords>
      <Keywords>Nonalcoholic fatty liver disease</Keywords>
      <Keywords>PRDX3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yunfei Geng</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Wang</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruimin Sun</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohui Kang</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huanyu Zhao</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meiyang Zhu</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Sun</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Hu</Name>
        <Affiliation>Department of Pharmacy, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhecheng Wang</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofeng Tian</Name>
        <Affiliation>Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhao</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China. Electronic address: 474666527@qq.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jihong Yao</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China. Electronic address: yaojihong65@dmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Anemoside A3 activates TLR4-dependent M1-phenotype macrophage polarization to represses breast tumor growth and angiogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34673087</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00359-8</DOI>
    <KeywordList>
      <Keywords>Anemoside A3</Keywords>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Macrophage polarization</Keywords>
      <Keywords>Toll-like receptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Li Yin</Name>
        <Affiliation>National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China; Key Laboratory for Evaluation on Anti-tumor Effect of Chinese Medicine by Strengthening Body Resistance to Eliminate Pathogenic Factors, Nanchang 330006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zeping Fan</Name>
        <Affiliation>National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China; Key Laboratory for Evaluation on Anti-tumor Effect of Chinese Medicine by Strengthening Body Resistance to Eliminate Pathogenic Factors, Nanchang 330006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Liu</Name>
        <Affiliation>National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China; Key Laboratory for Evaluation on Anti-tumor Effect of Chinese Medicine by Strengthening Body Resistance to Eliminate Pathogenic Factors, Nanchang 330006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lanying Chen</Name>
        <Affiliation>National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China; Key Laboratory for Evaluation on Anti-tumor Effect of Chinese Medicine by Strengthening Body Resistance to Eliminate Pathogenic Factors, Nanchang 330006, China. Electronic address: cly5831@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ziyi Guan</Name>
        <Affiliation>National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China; Key Laboratory for Evaluation on Anti-tumor Effect of Chinese Medicine by Strengthening Body Resistance to Eliminate Pathogenic Factors, Nanchang 330006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yahui Liu</Name>
        <Affiliation>National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China; Key Laboratory for Evaluation on Anti-tumor Effect of Chinese Medicine by Strengthening Body Resistance to Eliminate Pathogenic Factors, Nanchang 330006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingying Luo</Name>
        <Affiliation>National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China; Key Laboratory for Evaluation on Anti-tumor Effect of Chinese Medicine by Strengthening Body Resistance to Eliminate Pathogenic Factors, Nanchang 330006, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic-induced lung inflammation and fibrosis in a rat model: Contribution of the HMGB1/RAGE, PI3K/AKT, and TGF-β1/SMAD pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34673086</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00361-6</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>HMGB1</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Lung</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wenjuan Wang</Name>
        <Affiliation>The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang 550025, Guizhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fanyan Zheng</Name>
        <Affiliation>The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang 550025, Guizhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Aihua Zhang</Name>
        <Affiliation>The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang 550025, Guizhou, PR China. Electronic address: 97349238@qq.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cadmium-mediated pancreatic islet transcriptome changes in mice and cultured mouse islets.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34666113</pubmedLink>
    <GrantList>
      <Grant>R01 ES027011</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00360-4</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Insulin-producing β-cells</Keywords>
      <Keywords>Islet transcriptome</Keywords>
      <Keywords>Pancreatic islets</Keywords>
      <Keywords>Type II diabetes mellitus</Keywords>
      <Keywords>mRNA-sequencing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Winifred P. S. Wong</Name>
        <Affiliation>Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Janice C. Wang</Name>
        <Affiliation>Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew J. Schipma</Name>
        <Affiliation>NU Seq Core, Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaomin Zhang</Name>
        <Affiliation>Division of Transplant Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua R. Edwards</Name>
        <Affiliation>College of Graduate Studies, Midwestern University, Downers Grove, IL 60515, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Malek El Muayed</Name>
        <Affiliation>Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address: m-muayed@northwestern.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The role of microRNAs in regulating cadmium-induced apoptosis by targeting Bcl-2 in IEC-6 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34662668</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00341-0</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Bcl-2</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>IEC-6 cells</Keywords>
      <Keywords>microRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jinsong Yang</Name>
        <Affiliation>Department of Infectious Disease Prevention and Control, Fujian Center for Disease Control and Prevention, Fujian Provincial Key Laboratory of Zoonosis Research, Jintai Road No.76, 350001, China. Electronic address: 15258223@qq.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Chen</Name>
        <Affiliation>Department of Infectious Disease Prevention and Control, Fujian Center for Disease Control and Prevention, Fujian Provincial Key Laboratory of Zoonosis Research, Jintai Road No.76, 350001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Sun</Name>
        <Affiliation>Department of Preventive Medicine, Fujian Provincial Key Laboratory of Environmental Factors and Cancer, Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Xueyuan Road No. 1, Minhou Coudslanty, Fuzhou 350108, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pincang Xia</Name>
        <Affiliation>Department of Infectious Disease Prevention and Control, Fujian Center for Disease Control and Prevention, Fujian Provincial Key Laboratory of Zoonosis Research, Jintai Road No.76, 350001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Liu</Name>
        <Affiliation>Department of Preventive Medicine, Fujian Provincial Key Laboratory of Environmental Factors and Cancer, Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Xueyuan Road No. 1, Minhou Coudslanty, Fuzhou 350108, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenchang Zhang</Name>
        <Affiliation>Department of Preventive Medicine, Fujian Provincial Key Laboratory of Environmental Factors and Cancer, Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Xueyuan Road No. 1, Minhou Coudslanty, Fuzhou 350108, China. Electronic address: wenchang2008@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Involvement of endoplasmic reticulum stress-activated PERK-eIF2α-ATF4 signaling pathway in T-2 toxin-induced apoptosis of porcine renal epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34637808</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00357-4</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Endoplasmic reticulum stress</Keywords>
      <Keywords>PK-15 cells</Keywords>
      <Keywords>T-2 Toxin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiangyan Liu</Name>
        <Affiliation>College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ze Wang</Name>
        <Affiliation>College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xianglin Wang</Name>
        <Affiliation>College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaona Yan</Name>
        <Affiliation>College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing He</Name>
        <Affiliation>College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Sha Liu</Name>
        <Affiliation>College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengke Ye</Name>
        <Affiliation>College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowen Li</Name>
        <Affiliation>College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihang Yuan</Name>
        <Affiliation>College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, PR China; Hunan Engineering Research Center of Livestock and Poultry Health Care, Colleges of Veterinary Medicine, Hunan Agricultural University, Changsha City, 410128, China; Hunan Co-innovation Center of Animal Production Safety, Changsha City 410128, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Wu</Name>
        <Affiliation>College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, PR China; Hunan Engineering Research Center of Livestock and Poultry Health Care, Colleges of Veterinary Medicine, Hunan Agricultural University, Changsha City, 410128, China; Hunan Co-innovation Center of Animal Production Safety, Changsha City 410128, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jine Yi</Name>
        <Affiliation>College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, PR China; Hunan Engineering Research Center of Livestock and Poultry Health Care, Colleges of Veterinary Medicine, Hunan Agricultural University, Changsha City, 410128, China; Hunan Co-innovation Center of Animal Production Safety, Changsha City 410128, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lixin Wen</Name>
        <Affiliation>College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, PR China; Hunan Engineering Research Center of Livestock and Poultry Health Care, Colleges of Veterinary Medicine, Hunan Agricultural University, Changsha City, 410128, China; Hunan Co-innovation Center of Animal Production Safety, Changsha City 410128, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rongfang Li</Name>
        <Affiliation>College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, PR China; Hunan Engineering Research Center of Livestock and Poultry Health Care, Colleges of Veterinary Medicine, Hunan Agricultural University, Changsha City, 410128, China; Hunan Co-innovation Center of Animal Production Safety, Changsha City 410128, China. Electronic address: lrf0408@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lung developmental is altered after inhalation exposure to various concentrations of calcium arsenate.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34634286</pubmedLink>
    <GrantList>
      <Grant>P30 ES006694</Grant>
      <Grant>P42 ES004940</Grant>
      <Grant>R01 AI149754</Grant>
      <Grant>R01 ES027013</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00358-6</DOI>
    <KeywordList>
      <Keywords>Lung development</Keywords>
      <Keywords>Lung disease</Keywords>
      <Keywords>Simulated mine tailings dust</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Binh Chau</Name>
        <Affiliation>Department of Cellular &amp; Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85719, United States of America. Electronic address: bchau@email.arizona.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Mark L. Witten</Name>
        <Affiliation>Phoenix Biometrics, Inc., Tucson, AZ 85710, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Doug Cromey</Name>
        <Affiliation>Department of Cellular &amp; Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85719, United States of America. Electronic address: dcromey@arizona.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Yin Chen</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Arizona College of Pharmacy, United States of America. Electronic address: ychen@pharmacy.arizona.edu.</Affiliation>
      </Author>
      <Author>
        <Name>R. Clark Lantz</Name>
        <Affiliation>Department of Cellular &amp; Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85719, United States of America. Electronic address: lantz@email.arizona.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subclinical markers of cardiovascular toxicity of benzene inhalation in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34624356</pubmedLink>
    <GrantList>
      <Grant>R01 HL146134</Grant>
      <Grant>R01 ES029846</Grant>
      <Grant>P42 ES023716</Grant>
      <Grant>R21 ES033323</Grant>
      <Grant>R01 HL137229</Grant>
      <Grant>U54 HL120163</Grant>
      <Grant>R01 HL149351</Grant>
      <Grant>R01 HL156362</Grant>
      <Grant>R01 HL138992</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00346-X</DOI>
    <KeywordList>
      <Keywords>Benzene</Keywords>
      <Keywords>Endothelial cells</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Microparticles</Keywords>
      <Keywords>Platelets</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marina V. Malovichko</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; American Heart Association-Tobacco Center of Regulatory Science, University of Louisville, Louisville, KY 40202, United States of America; Envirome Institute, University of Louisville, Louisville, KY 40202, United States of America; Department of Medicine, Division of Environmental Medicine, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Wesley T. Abplanalp</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; Department of Medicine, Division of Environmental Medicine, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Samantha A. McFall</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; Envirome Institute, University of Louisville, Louisville, KY 40202, United States of America; Department of Medicine, Division of Environmental Medicine, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Breandon S. Taylor</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; Envirome Institute, University of Louisville, Louisville, KY 40202, United States of America; Department of Medicine, Division of Environmental Medicine, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Nalinie S. Wickramasinghe</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; American Heart Association-Tobacco Center of Regulatory Science, University of Louisville, Louisville, KY 40202, United States of America; Envirome Institute, University of Louisville, Louisville, KY 40202, United States of America; Department of Medicine, Division of Environmental Medicine, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Israel D. Sithu</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; American Heart Association-Tobacco Center of Regulatory Science, University of Louisville, Louisville, KY 40202, United States of America; Envirome Institute, University of Louisville, Louisville, KY 40202, United States of America; Department of Medicine, Division of Environmental Medicine, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Igor N. Zelko</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; American Heart Association-Tobacco Center of Regulatory Science, University of Louisville, Louisville, KY 40202, United States of America; Envirome Institute, University of Louisville, Louisville, KY 40202, United States of America; Department of Medicine, Division of Environmental Medicine, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Shizuka Uchida</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; Envirome Institute, University of Louisville, Louisville, KY 40202, United States of America; Department of Medicine, Division of Environmental Medicine, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Bradford G. Hill</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; Envirome Institute, University of Louisville, Louisville, KY 40202, United States of America; Department of Medicine, Division of Environmental Medicine, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Saurin R. Sutaria</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; Department of Chemistry, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Michael H. Nantz</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; Department of Chemistry, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Aruni Bhatnagar</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; American Heart Association-Tobacco Center of Regulatory Science, University of Louisville, Louisville, KY 40202, United States of America; Envirome Institute, University of Louisville, Louisville, KY 40202, United States of America; Department of Medicine, Division of Environmental Medicine, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel J. Conklin</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; American Heart Association-Tobacco Center of Regulatory Science, University of Louisville, Louisville, KY 40202, United States of America; Envirome Institute, University of Louisville, Louisville, KY 40202, United States of America; Department of Medicine, Division of Environmental Medicine, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy E. O'Toole</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; American Heart Association-Tobacco Center of Regulatory Science, University of Louisville, Louisville, KY 40202, United States of America; Envirome Institute, University of Louisville, Louisville, KY 40202, United States of America; Department of Medicine, Division of Environmental Medicine, University of Louisville, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Sanjay Srivastava</Name>
        <Affiliation>University of Louisville Superfund Research Center, University of Louisville, Louisville, KY 40202, United States of America; American Heart Association-Tobacco Center of Regulatory Science, University of Louisville, Louisville, KY 40202, United States of America; Envirome Institute, University of Louisville, Louisville, KY 40202, United States of America; Department of Medicine, Division of Environmental Medicine, University of Louisville, Louisville, KY 40202, United States of America. Electronic address: sanjay@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cardiac toxicity from bisphenol A: Are electrophysiology and calcium handling perturbations dose-dependent?</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34619161</pubmedLink>
    <GrantList>
      <Grant>R01 HL139472</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00344-6</DOI>
    <AuthorList>
      <Author>
        <Name>Nikki Gillum Posnack</Name>
        <Affiliation>Children's National Hospital, Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Heart Institute, Washington, DC, United States; George Washington University, Department of Pharmacology &amp; Physiology, Department of Pediatrics, Washington, DC, United States. Electronic address: nposnack@childrensnational.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A network pharmacology approach to investigate the anticancer mechanism of cinobufagin against hepatocellular carcinoma via downregulation of EGFR-CDK2 signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34619160</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00343-4</DOI>
    <KeywordList>
      <Keywords>CDK2</Keywords>
      <Keywords>Cinobufagin</Keywords>
      <Keywords>EGFR</Keywords>
      <Keywords>Hepatocellular carcinoma</Keywords>
      <Keywords>Proliferation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ai Lin Yang</Name>
        <Affiliation>School of Pharmacy, Binzhou Medical University, Yantai 264003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Wu</Name>
        <Affiliation>School of Pharmacy, Binzhou Medical University, Yantai 264003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhong Dong Hu</Name>
        <Affiliation>Modern Research Center for Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shao Ping Wang</Name>
        <Affiliation>School of Pharmacy, Binzhou Medical University, Yantai 264003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Fan Tao</Name>
        <Affiliation>School of Pharmacy, Binzhou Medical University, Yantai 264003, China.</Affiliation>
      </Author>
      <Author>
        <Name>An Mei Wang</Name>
        <Affiliation>School of Pharmacy, Binzhou Medical University, Yantai 264003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Xuan Sun</Name>
        <Affiliation>School of Pharmacy, Binzhou Medical University, Yantai 264003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiu Lian Li</Name>
        <Affiliation>School of Pharmacy, Binzhou Medical University, Yantai 264003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Long Dai</Name>
        <Affiliation>School of Pharmacy, Binzhou Medical University, Yantai 264003, China. Electronic address: dailong@bzmc.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jiayu Zhang</Name>
        <Affiliation>School of Pharmacy, Binzhou Medical University, Yantai 264003, China. Electronic address: zhangjiayu0615@bzmc.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic-protein interactions as a mechanism of arsenic toxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34619159</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00342-2</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Cysteine</Keywords>
      <Keywords>Interaction</Keywords>
      <Keywords>Protein</Keywords>
      <Keywords>Zinc finger</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cristian A. Vergara-Gerónimo</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Apartado Postal 70228, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Alfonso León Del Río</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Apartado Postal 70228, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Mauricio Rodríguez-Dorantes</Name>
        <Affiliation>Instituto Nacional de Medicina Genómica, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Ostrosky-Wegman</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Apartado Postal 70228, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Ana María Salazar</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Apartado Postal 70228, Ciudad de México, Mexico. Electronic address: anamsm@biomedicas.unam.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Yersinia enterocolitica and Lactobacillus fermentum induces differential cellular and behavioral responses during diclofenac biotransformation in rat gut.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34619158</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00345-8</DOI>
    <KeywordList>
      <Keywords>Diclofenac</Keywords>
      <Keywords>Elevated plus maze</Keywords>
      <Keywords>Lactobacillus fermentum</Keywords>
      <Keywords>Proteomics</Keywords>
      <Keywords>Serotonin</Keywords>
      <Keywords>Yersinia enterocolitica</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shruti Ahlawat</Name>
        <Affiliation>Laboratory of Enzymology and Recombinant DNA Technology, Department of Microbiology, Maharshi Dayanand University, Rohtak 124001, Haryana, India; Presently at SGT University, Gurgaon-Badli Road Chandu, Budhera, Gurugram 122505, Haryana, India.</Affiliation>
      </Author>
      <Author>
        <Name>Akshay Shankar</Name>
        <Affiliation>Laboratory of Enzymology and Recombinant DNA Technology, Department of Microbiology, Maharshi Dayanand University, Rohtak 124001, Haryana, India.</Affiliation>
      </Author>
      <Author>
        <Name> Vandna</Name>
        <Affiliation>Department of Medical Biotechnology, Maharshi Dayanand University, Rohtak 124001, Haryana, India.</Affiliation>
      </Author>
      <Author>
        <Name>Hari Mohan</Name>
        <Affiliation>Department of Medical Biotechnology, Maharshi Dayanand University, Rohtak 124001, Haryana, India.</Affiliation>
      </Author>
      <Author>
        <Name>Krishna Kant Sharma</Name>
        <Affiliation>Laboratory of Enzymology and Recombinant DNA Technology, Department of Microbiology, Maharshi Dayanand University, Rohtak 124001, Haryana, India. Electronic address: kksharma.microbiology@mdurohtak.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tributyltin protects against ovariectomy-induced trabecular bone loss in C57BL/6J mice with an attenuated effect in high fat fed mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34619157</pubmedLink>
    <GrantList>
      <Grant>R21 ES021136</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00340-9</DOI>
    <KeywordList>
      <Keywords>Cortical bone</Keywords>
      <Keywords>Osteoblast</Keywords>
      <Keywords>Osteoclast</Keywords>
      <Keywords>Retinoid X receptor</Keywords>
      <Keywords>Trabecular bone</Keywords>
      <Keywords>Tributyltin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rachel Freid</Name>
        <Affiliation>Environmental Health, Boston University School of Public Health, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amira I. Hussein</Name>
        <Affiliation>Orthopaedic Surgery, Boston University School of Medicine, Boston, MA 02118, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer J. Schlezinger</Name>
        <Affiliation>Environmental Health, Boston University School of Public Health, USA. Electronic address: jschlezi@bu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>P-glycoprotein mediates the pharmacokinetic interaction of olanzapine with fluoxetine in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34610281</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00339-2</DOI>
    <KeywordList>
      <Keywords>Fluoxetine</Keywords>
      <Keywords>Gene knockout rats</Keywords>
      <Keywords>Olanzapine</Keywords>
      <Keywords>P-glycoprotein</Keywords>
      <Keywords>Pharmacokinetic interaction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuan Xu</Name>
        <Affiliation>Changning Maternity and Infant Health Hospital and School of Life Sciences, Shanghai Key Laboratory of Regulatory Biology, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Lu</Name>
        <Affiliation>Changning Maternity and Infant Health Hospital and School of Life Sciences, Shanghai Key Laboratory of Regulatory Biology, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bingyi Yao</Name>
        <Affiliation>Changning Maternity and Infant Health Hospital and School of Life Sciences, Shanghai Key Laboratory of Regulatory Biology, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanjin Zhang</Name>
        <Affiliation>Changning Maternity and Infant Health Hospital and School of Life Sciences, Shanghai Key Laboratory of Regulatory Biology, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengbo Huang</Name>
        <Affiliation>Changning Maternity and Infant Health Hospital and School of Life Sciences, Shanghai Key Laboratory of Regulatory Biology, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Liu</Name>
        <Affiliation>Changning Maternity and Infant Health Hospital and School of Life Sciences, Shanghai Key Laboratory of Regulatory Biology, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanfang Zhang</Name>
        <Affiliation>Changning Maternity and Infant Health Hospital and School of Life Sciences, Shanghai Key Laboratory of Regulatory Biology, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanqing Guo</Name>
        <Affiliation>Changning Maternity and Infant Health Hospital and School of Life Sciences, Shanghai Key Laboratory of Regulatory Biology, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Wang</Name>
        <Affiliation>Changning Maternity and Infant Health Hospital and School of Life Sciences, Shanghai Key Laboratory of Regulatory Biology, East China Normal University, Shanghai, China. Electronic address: xwang@bio.ecnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Benchmark dose-response analyses for multiple endpoints in drug safety evaluation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34606779</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00336-7</DOI>
    <KeywordList>
      <Keywords>Benchmark dose modeling</Keywords>
      <Keywords>Hazard characterization</Keywords>
      <Keywords>Pharmaceutical development</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Toxicity testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Antero Vieira Silva</Name>
        <Affiliation>Unit of Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: antero.silva@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>Joakim Ringblom</Name>
        <Affiliation>Unit of Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Moldeus</Name>
        <Affiliation>Unit of Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Elin Törnqvist</Name>
        <Affiliation>Unit of Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Mattias Öberg</Name>
        <Affiliation>Unit of Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hepatotoxicity or hepatoprotection of emodin? Two sides of the same coin by </ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34606778</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00338-0</DOI>
    <KeywordList>
      <Keywords>Carbon tetrachloride</Keywords>
      <Keywords>Emodin</Keywords>
      <Keywords>Energy metabolism</Keywords>
      <Keywords>Liver injury</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Molecular docking</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lingyu Ruan</Name>
        <Affiliation>Center for Molecular Metabolism, Nanjing University of Science and Technology, 200 Xiao Ling Wei Street, Nanjing 210094, PR China. Electronic address: ruanlingyuamy@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Jiang</Name>
        <Affiliation>Center for Molecular Metabolism, Nanjing University of Science and Technology, 200 Xiao Ling Wei Street, Nanjing 210094, PR China. Electronic address: lguanghui12@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wenlong Zhao</Name>
        <Affiliation>Center for Molecular Metabolism, Nanjing University of Science and Technology, 200 Xiao Ling Wei Street, Nanjing 210094, PR China. Electronic address: jilvguren@live.com.</Affiliation>
      </Author>
      <Author>
        <Name>Huihui Meng</Name>
        <Affiliation>Center for Molecular Metabolism, Nanjing University of Science and Technology, 200 Xiao Ling Wei Street, Nanjing 210094, PR China. Electronic address: menghuihui2014@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Zheng</Name>
        <Affiliation>Center for Molecular Metabolism, Nanjing University of Science and Technology, 200 Xiao Ling Wei Street, Nanjing 210094, PR China. Electronic address: 118102021661@njust.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Junsong Wang</Name>
        <Affiliation>Center for Molecular Metabolism, Nanjing University of Science and Technology, 200 Xiao Ling Wei Street, Nanjing 210094, PR China. Electronic address: wang.junsong@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Disruption of pulmonary resolution mediators contribute to exacerbated silver nanoparticle-induced acute inflammation in a metabolic syndrome mouse model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34601004</pubmedLink>
    <GrantList>
      <Grant>R00 ES024392</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00334-3</DOI>
    <KeywordList>
      <Keywords>Inflammatory resolution</Keywords>
      <Keywords>Lipid supplementation</Keywords>
      <Keywords>Metabolic syndrome</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Nanotoxicity</Keywords>
      <Keywords>Omega-3 polyunsaturated fatty acids</Keywords>
      <Keywords>Specialized pro-resolving mediators</Keywords>
      <Keywords>Susceptibility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Saeed Alqahtani</Name>
        <Affiliation>School of Health Sciences, College of Health and Human Sciences, Purdue University, West Lafayette, IN, United States; National Center for Pharmaceuticals, Life Science and Environment Research Institute, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Li Xia</Name>
        <Affiliation>School of Health Sciences, College of Health and Human Sciences, Purdue University, West Lafayette, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Amber Jannasch</Name>
        <Affiliation>Purdue Metabolite Profiling Facility, Purdue University, West Lafayette, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Christina Ferreira</Name>
        <Affiliation>Purdue Metabolite Profiling Facility, Purdue University, West Lafayette, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jackeline Franco</Name>
        <Affiliation>Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan H. Shannahan</Name>
        <Affiliation>School of Health Sciences, College of Health and Human Sciences, Purdue University, West Lafayette, IN, United States. Electronic address: jshannah@purdue.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Amentoflavone prevents ox-LDL-induced lipid accumulation by suppressing the PPARγ/CD36 signal pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34599948</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00337-9</DOI>
    <KeywordList>
      <Keywords>Amentoflavone</Keywords>
      <Keywords>Atherosclerosis</Keywords>
      <Keywords>CD36</Keywords>
      <Keywords>Ox-LDL</Keywords>
      <Keywords>PPARγ</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jia Ling Zhuang</Name>
        <Affiliation>Department of Laboratory Medicine, Guangdong Provincial Hospital of Chinese Medicine, Zhuhai 519015, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Yi Liu</Name>
        <Affiliation>Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510120, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Zhen Li</Name>
        <Affiliation>Panyu Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Zhen Zhuang</Name>
        <Affiliation>Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510120, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Zhi Tang</Name>
        <Affiliation>Department of Laboratory Medicine, Guangdong Provincial Hospital of Chinese Medicine, Zhuhai 519015, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yujuan Xiong</Name>
        <Affiliation>Panyu Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China. Electronic address: yujuanxiong@gzucm.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xian Zhang Huang</Name>
        <Affiliation>Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China. Electronic address: huangxz020@gzucm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetic characterization of carnosol from rosemary (Salvia Rosmarinus) in male C57BL/6 mice and inhibition profile in human cytochrome P450 enzymes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34592323</pubmedLink>
    <GrantList>
      <Grant>R37 CA227101</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00333-1</DOI>
    <KeywordList>
      <Keywords>Carnosol</Keywords>
      <Keywords>Diterpene</Keywords>
      <Keywords>Food Preservative</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Rosemary</Keywords>
      <Keywords>Salvia Rosmarinus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bhaskar Vemu</Name>
        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice, Chicago, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Restituo Tocmo</Name>
        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice, Chicago, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Mirielle C. Nauman</Name>
        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice, Chicago, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie A. Flowers</Name>
        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice, Chicago, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jacob P. Veenstra</Name>
        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice, Chicago, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jeremy J. Johnson</Name>
        <Affiliation>University of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice, Chicago, IL, United States of America. Electronic address: jjjohn@uic.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Proarrhythmic effects induced by benzethonium chloride and domiphen bromide in vitro and in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34592322</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00335-5</DOI>
    <KeywordList>
      <Keywords>Anaesthetized rabbits</Keywords>
      <Keywords>Benzethonium chloride</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Domiphen bromide</Keywords>
      <Keywords>hiPSC-CMs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Long</Name>
        <Affiliation>Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China; Central Laboratory, Shenzhen Samii Medical Center, Shenzhen, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Hou</Name>
        <Affiliation>Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Tang</Name>
        <Affiliation>Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zuoxian Lin</Name>
        <Affiliation>Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaolin Huang</Name>
        <Affiliation>Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Li</Name>
        <Affiliation>Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yili Chen</Name>
        <Affiliation>Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiyuan Li</Name>
        <Affiliation>Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China. Electronic address: li_zhiyuan@gibh.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongkai Wu</Name>
        <Affiliation>Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Electronic address: wuzhk@mail.sysu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>1,2-Dichloroethane induces apoptosis in the cerebral cortexes of NIH Swiss mice through microRNA-182-5p targeting phospholipase D1 via a mitochondria-dependent pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34560092</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00332-X</DOI>
    <KeywordList>
      <Keywords>1,2-Dichloroethane</Keywords>
      <Keywords>MiR-182-5p</Keywords>
      <Keywords>Mitochondrial apoptosis</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Phospholipase D1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Boxuan Liang</Name>
        <Affiliation>NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Toxicology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yizhou Zhong</Name>
        <Affiliation>NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Toxicology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Wang</Name>
        <Affiliation>NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Toxicology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Lin</Name>
        <Affiliation>NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Toxicology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Liu</Name>
        <Affiliation>NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Toxicology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xi Lin</Name>
        <Affiliation>NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Toxicology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuji Huang</Name>
        <Affiliation>NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Toxicology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Manjiang Hu</Name>
        <Affiliation>NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Toxicology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bingli Zhang</Name>
        <Affiliation>NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Toxicology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Meng</Name>
        <Affiliation>NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Toxicology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Jiang</Name>
        <Affiliation>Department of Toxicology, Guangdong Provincial Hospital for Occupational Disease Prevention and Treatment, Guangzhou 510300, China; Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junying Jiang</Name>
        <Affiliation>Faculty of Preventive Medicine, School of Public Health, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiejiao Wu</Name>
        <Affiliation>Department of Toxicology, Guangdong Provincial Hospital for Occupational Disease Prevention and Treatment, Guangzhou 510300, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yating Zhang</Name>
        <Affiliation>Faculty of Preventive Medicine, School of Public Health, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weifeng Rong</Name>
        <Affiliation>Department of Toxicology, Guangdong Provincial Hospital for Occupational Disease Prevention and Treatment, Guangzhou 510300, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xingfen Yang</Name>
        <Affiliation>Food Safety and Health Research Center, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenlie Huang</Name>
        <Affiliation>NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Toxicology, School of Public Health, Southern Medical University, Guangzhou 510515, China. Electronic address: huangzhenlie858252@smu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quantification and cytotoxicity of degradation products (chloropropanols) in sucralose containing e-liquids with propylene glycol and glycerol as base.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34543670</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00331-8</DOI>
    <KeywordList>
      <Keywords>Chloropropanols</Keywords>
      <Keywords>E-Cigarette</Keywords>
      <Keywords>E-Liquid</Keywords>
      <Keywords>Sucralose</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniel Moser</Name>
        <Affiliation>ADSI-Austrian Drug Screening Institute GmbH, Innrain 66a, 6020 Innsbruck, Austria; Institute of Analytical Chemistry and Radiochemistry, CCB-Centre for Chemistry and Biomedicine, Leopold-Franzens University, Innrain 80/82, 6020 Innsbruck, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Leitner</Name>
        <Affiliation>ADSI-Austrian Drug Screening Institute GmbH, Innrain 66a, 6020 Innsbruck, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Przemyslaw A. Filipek</Name>
        <Affiliation>ADSI-Austrian Drug Screening Institute GmbH, Innrain 66a, 6020 Innsbruck, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Shah Hussain</Name>
        <Affiliation>ADSI-Austrian Drug Screening Institute GmbH, Innrain 66a, 6020 Innsbruck, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Matthias Rainer</Name>
        <Affiliation>Institute of Analytical Chemistry and Radiochemistry, CCB-Centre for Chemistry and Biomedicine, Leopold-Franzens University, Innrain 80/82, 6020 Innsbruck, Austria. Electronic address: m.rainer@uibk.ac.at.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Jakschitz</Name>
        <Affiliation>ADSI-Austrian Drug Screening Institute GmbH, Innrain 66a, 6020 Innsbruck, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Bernd M. Rode</Name>
        <Affiliation>Institute of Analytical Chemistry and Radiochemistry, CCB-Centre for Chemistry and Biomedicine, Leopold-Franzens University, Innrain 80/82, 6020 Innsbruck, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Günther K. Bonn</Name>
        <Affiliation>ADSI-Austrian Drug Screening Institute GmbH, Innrain 66a, 6020 Innsbruck, Austria; Institute of Analytical Chemistry and Radiochemistry, CCB-Centre for Chemistry and Biomedicine, Leopold-Franzens University, Innrain 80/82, 6020 Innsbruck, Austria.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure of silver nanocolloids causes glycosylation disorders and embryonic deformities in medaka.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34543669</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00318-5</DOI>
    <KeywordList>
      <Keywords>Embryogenesis</Keywords>
      <Keywords>Glycan</Keywords>
      <Keywords>Medaka</Keywords>
      <Keywords>Silver Nanocolloid</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kaori Shimizu</Name>
        <Affiliation>Graduate School of Life Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan; Research Center for Life and Environmental Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Daisuke Kotajima</Name>
        <Affiliation>Graduate School of Life Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kensuke Fukao</Name>
        <Affiliation>Department of Life Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Futaba Mogi</Name>
        <Affiliation>Department of Life Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Risa Horiuchi</Name>
        <Affiliation>Graduate School of Life Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan; Department of Food and Nutritional Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Chisato Kataoka</Name>
        <Affiliation>Graduate School of Life Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan; Research Center for Life and Environmental Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan; Japan Society for the Promotion of Science, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshihiro Kagami</Name>
        <Affiliation>Mizuki Biotech Co. Ltd, 1-1 Hyakunenkouen, Kurume, Fukuoka 839-0864, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Misato Fujita</Name>
        <Affiliation>Department of Life Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan; Department of Biological Sciences, Kanagawa University, 2946 Tsuchiya, Hiratsuka, Kanagawa 259-1293, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nobumitsu Miyanishi</Name>
        <Affiliation>Graduate School of Life Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan; Research Center for Life and Environmental Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan; Graduate School of Food and Nutritional Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shosaku Kashiwada</Name>
        <Affiliation>Graduate School of Life Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan; Research Center for Life and Environmental Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan; Department of Life Sciences, Toyo University, 1-1-1 Izumino, Itakura, Gunma 374-0193, Japan. Electronic address: shokashiwada@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sodium cantharidate induces Apoptosis in breast cancer cells by regulating energy metabolism via the protein phosphatase 5-p53 axis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34537213</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00330-6</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Energy metabolism</Keywords>
      <Keywords>Protein phosphatase 5</Keywords>
      <Keywords>Sodium cantharidate</Keywords>
      <Keywords>p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jin Long Pang</Name>
        <Affiliation>School of Pharmacy, Bengbu Medical College, Bengbu City 236425, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fu Hao Huang</Name>
        <Affiliation>School of Pharmacy, Bengbu Medical College, Bengbu City 236425, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Han Zhang</Name>
        <Affiliation>School of Pharmacy, Bengbu Medical College, Bengbu City 236425, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Wu</Name>
        <Affiliation>School of Pharmacy, Bengbu Medical College, Bengbu City 236425, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xian Ming Ge</Name>
        <Affiliation>School of Pharmacy, Bengbu Medical College, Bengbu City 236425, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shanshan Li</Name>
        <Affiliation>School of Pharmacy, Bengbu Medical College, Bengbu City 236425, China. Electronic address: lishanshan@bbmc.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xian Li</Name>
        <Affiliation>School of Pharmacy, Bengbu Medical College, Bengbu City 236425, China; New Technologies for Chinese Medicine Drinker Manufacturing Anhui Provincial Key Laboratory, Hefei City 230012, China; Postdoctoral workstation of Anhui Xiehecheng Drinker Tablets Co., Ltd, Bozhou City 236800, China. Electronic address: 2017039@bbmc.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sensitivity, specificity and limitation of in vitro hippocampal slice and neuron-based assays for assessment of drug-induced seizure liability.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34536444</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00329-X</DOI>
    <KeywordList>
      <Keywords>Brain slices</Keywords>
      <Keywords>Microelectrode array</Keywords>
      <Keywords>Neurons</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Safety pharmacology</Keywords>
      <Keywords>Seizures</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jin Zhai</Name>
        <Affiliation>Department of Genetic Toxicology and In Vitro Cellular Toxicity, Safety Assessment &amp; Laboratory Animal Resources (SALAR), Merck &amp; Co., Inc., West Point, PA 19486, USA. Electronic address: jin.zhai@merck.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Ying Zhou</Name>
        <Affiliation>Program Discovery and Development, Safety Assessment &amp; Laboratory Animal Resources (SALAR), Merck &amp; Co., Inc., West Point, PA 19486, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Armando Lagrutta</Name>
        <Affiliation>Program Discovery and Development, Safety Assessment &amp; Laboratory Animal Resources (SALAR), Merck &amp; Co., Inc., West Point, PA 19486, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neurotoxicity of a pyrethroid pesticide deltamethrin is associated with the imbalance in proteolytic systems caused by mitophagy activation and proteasome inhibition.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34520793</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00327-6</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Deltamethrin</Keywords>
      <Keywords>Mitochondrial dysfunction</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Pyrethroid</Keywords>
      <Keywords>Ubiquitin-proteasome system</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tetsushi Hirano</Name>
        <Affiliation>Life Science Research Center, University of Toyama, 2630 Sugitani, Toyama, Toyama 930-0194, Japan. Electronic address: thirano@cts.u-toyama.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Nihei Suzuki</Name>
        <Affiliation>Life Science Research Center, University of Toyama, 2630 Sugitani, Toyama, Toyama 930-0194, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshinori Ikenaka</Name>
        <Affiliation>Translational Research Unit, Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo, Hokkaido 060-0818, Japan; Water Research Group, Unit for Environmental Sciences and Management, North-West University, Potchefstroom, South Africa; One Health Research Center, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo, Hokkaido 060-0818, Japan; Laboratory of Toxicology, Department of Environmental Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo, Hokkaido 060-0818, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nobuhiko Hoshi</Name>
        <Affiliation>Department of Animal Science, Graduate School of Agricultural Science, Kobe University, 1-1 Rokkodai, Kobe, Hyogo 657-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshiaki Tabuchi</Name>
        <Affiliation>Life Science Research Center, University of Toyama, 2630 Sugitani, Toyama, Toyama 930-0194, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Down-regulation of lncRNA MEG3 promotes chronic low dose cadmium exposure-induced cell transformation and cancer stem cell-like property.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34520792</pubmedLink>
    <GrantList>
      <Grant>R01 ES026151</Grant>
      <Grant>R01 ES029496</Grant>
      <Grant>R01 ES029942</Grant>
      <Grant>R01 ES032787</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00328-8</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Long Non-coding RNA</Keywords>
      <Keywords>MEG3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hsuan Pei Lin</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40506, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Rea</Name>
        <Affiliation>Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Zhishan Wang</Name>
        <Affiliation>Division of Cancer Biology, Department of Medicine, MetroHealth Medical Center, Case Western University School of Medicine, Cleveland, OH 44109, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Chengfeng Yang</Name>
        <Affiliation>Division of Cancer Biology, Department of Medicine, MetroHealth Medical Center, Case Western University School of Medicine, Cleveland, OH 44109, United States of America. Electronic address: Chengfeng.yang@case.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34492290</pubmedLink>
    <GrantList>
      <Grant>G20 RR030956</Grant>
      <Grant>P30 EY008126</Grant>
      <Grant>P30 CA068485</Grant>
      <Grant>UL1 RR024975</Grant>
      <Grant>27302C0031</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00317-3</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Interspecies translation</Keywords>
      <Keywords>Liver injury</Keywords>
      <Keywords>Metabolomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Patric Schyman</Name>
        <Affiliation>Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Development Command, Fort Detrick, MD, USA; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard L. Printz</Name>
        <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Venkat R. Pannala</Name>
        <Affiliation>Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Development Command, Fort Detrick, MD, USA; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA. Electronic address: vpannala@bhsai.org.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed Diwan M. AbdulHameed</Name>
        <Affiliation>Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Development Command, Fort Detrick, MD, USA; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shanea K. Estes</Name>
        <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chiyo Shiota</Name>
        <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kelli Lynn Boyd</Name>
        <Affiliation>Department of Pathology, Microbiology and Immunology, Division of Comparative Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Masakazu Shiota</Name>
        <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, USA. Electronic address: masakazu.shiota@vanderbilt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Anders Wallqvist</Name>
        <Affiliation>Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Development Command, Fort Detrick, MD, USA. Electronic address: sven.a.wallqvist.civ@mail.mil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neonatal metformin short exposure inhibits male reproductive dysfunction caused by a high-fat diet in adult rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34481828</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00316-1</DOI>
    <KeywordList>
      <Keywords>Developmental origin of health and disease concept</Keywords>
      <Keywords>Metformin programs</Keywords>
      <Keywords>Overfeeding</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Reproductive quality</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Henrique Rodrigues Vieira</Name>
        <Affiliation>Department of Biotechnology, Genetics, and Cell Biology, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil; Department of Anatomy, Institute of Biomedical Science III, University of São Paulo (USP), Av. Prof. Lineu Prestes, 2415, CEP: 05508-000 São Paulo, São Paulo, Brazil. Electronic address: vieira.hrbio@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gessica Dutra Gonçalves</Name>
        <Affiliation>Department of Biotechnology, Genetics, and Cell Biology, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Vander Silva Alves</Name>
        <Affiliation>Department of Biotechnology, Genetics, and Cell Biology, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Milene Aparecida Bobato de Melo</Name>
        <Affiliation>Department of Biotechnology, Genetics, and Cell Biology, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie Carvalho Borges</Name>
        <Affiliation>Department of Morphological Sciences, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Josana Klagenberg</Name>
        <Affiliation>Department of Biotechnology, Genetics, and Cell Biology, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Camila Quaglio Neves</Name>
        <Affiliation>Department of Morphological Sciences, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carina Previate</Name>
        <Affiliation>Department of Biotechnology, Genetics, and Cell Biology, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lucas Paulo Jacinto Saavedra</Name>
        <Affiliation>Department of Biotechnology, Genetics, and Cell Biology, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gláucia Eloisa Munhoz de Lion Siervo</Name>
        <Affiliation>Department of General Biology, Biological Sciences Center, State University of Londrina (UEL), Rodovia Celso Garcia Cid, PR 445, CEP: 86057-970 Londrina, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ananda Malta</Name>
        <Affiliation>Department of Biotechnology, Genetics, and Cell Biology, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marialba Avezum Alves de Castro Prado</Name>
        <Affiliation>Department of Biotechnology, Genetics, and Cell Biology, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Kesia Palma-Rigo</Name>
        <Affiliation>Department of Biotechnology, Genetics, and Cell Biology, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil; Faculdade Adventista Paranaense, PR-317 Km 119 Gleba, R. Paiçandu, Lote 80 - Zona Rural, CEP: 87130-000 Ivatuba - Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Nilza Cristina Buttow</Name>
        <Affiliation>Department of Morphological Sciences, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Glaura Scantamburlo Alves Fernandes</Name>
        <Affiliation>Department of General Biology, Biological Sciences Center, State University of Londrina (UEL), Rodovia Celso Garcia Cid, PR 445, CEP: 86057-970 Londrina, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Paulo Cezar de Freitas Mathias</Name>
        <Affiliation>Department of Biotechnology, Genetics, and Cell Biology, State University of Maringá (UEM), Av. Colombo, 5790, CEP: 87020-900 Maringá, Paraná, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Astrocytic Kir4.1 regulates NMDAR/calpain signaling axis in lipopolysaccharide-induced depression-like behaviors in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34474083</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00315-X</DOI>
    <KeywordList>
      <Keywords>Depression</Keywords>
      <Keywords>Kir4.1</Keywords>
      <Keywords>NLRP3</Keywords>
      <Keywords>NMDAR</Keywords>
      <Keywords>Synaptic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhujin Song</Name>
        <Affiliation>Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230038, China; School of Basic Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhijuan Bian</Name>
        <Affiliation>Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengrong Zhang</Name>
        <Affiliation>Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuncui Wang</Name>
        <Affiliation>Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Aisong Zhu</Name>
        <Affiliation>School of Basic Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address: liaoningzhongyi@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guoqi Zhu</Name>
        <Affiliation>Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230038, China. Electronic address: guoqizhu@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Selective antiproliferative effect of C-2 halogenated 13α-estrones on cells expressing Organic anion-transporting polypeptide 2B1 (OATP2B1).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34474082</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00308-2</DOI>
    <KeywordList>
      <Keywords>13α-estrones</Keywords>
      <Keywords>OATP</Keywords>
      <Keywords>Selective antiproliferative effect</Keywords>
      <Keywords>Steroid uptake</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Réka Laczkó-Rigó</Name>
        <Affiliation>Institute of Enzymology, Research Centre for Natural Sciences, Eötvös Loránd Research Center, Magyar tudósok körútja 2, H-1117 Budapest, Hungary. Electronic address: rigo.reka@ttk.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Éva Bakos</Name>
        <Affiliation>Institute of Enzymology, Research Centre for Natural Sciences, Eötvös Loránd Research Center, Magyar tudósok körútja 2, H-1117 Budapest, Hungary. Electronic address: bakos.eva@ttk.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Rebeka Jójárt</Name>
        <Affiliation>Department of Organic Chemistry, University of Szeged, Dóm tér 8, H-6720 Szeged, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Csaba Tömböly</Name>
        <Affiliation>Laboratory of Chemical Biology, Institute of Biochemistry, Biological Research Centre, Temesvári krt. 62, H-6726 Szeged, Hungary. Electronic address: tomboly.csaba@brc.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Erzsébet Mernyák</Name>
        <Affiliation>Department of Organic Chemistry, University of Szeged, Dóm tér 8, H-6720 Szeged, Hungary. Electronic address: bobe@chem.u-szeged.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Csilla Özvegy-Laczka</Name>
        <Affiliation>Institute of Enzymology, Research Centre for Natural Sciences, Eötvös Loránd Research Center, Magyar tudósok körútja 2, H-1117 Budapest, Hungary. Electronic address: laczka.csilla@ttk.hu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>AKT inhibitor AZD5363 suppresses stemness and promotes anti-cancer activity of 3,3'-diindolylmethane in human breast cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34464674</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00304-5</DOI>
    <KeywordList>
      <Keywords>AKT inhibitor</Keywords>
      <Keywords>CyTOF</Keywords>
      <Keywords>Stemness</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kaiyuan Zhu</Name>
        <Affiliation>Department of breast cancer surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150086, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Liu</Name>
        <Affiliation>Department of breast cancer surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150086, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunxiao Liu</Name>
        <Affiliation>Department of breast cancer surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150086, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuting Xu</Name>
        <Affiliation>Department of breast cancer surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150086, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingqiang Fu</Name>
        <Affiliation>Department of breast cancer surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150086, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Dong</Name>
        <Affiliation>Department of breast cancer surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150086, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yadong Yan</Name>
        <Affiliation>Beijing Institute of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjing Wang</Name>
        <Affiliation>Beijing Institute of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China. Electronic address: wangwenjing85321@ccmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Qian</Name>
        <Affiliation>Department of breast cancer surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150086, China; North China Translational Medicine Research Center of Harbin Medical University, Harbin Medical University, Harbin, Heilongjiang 150086, China. Electronic address: qiancheng@ems.hrbmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety and toxicology assessment of sodium nitrite administered by intramuscular injection.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34464673</pubmedLink>
    <GrantList>
      <Grant>K08 HL136857</Grant>
      <Grant>U01 ES023759</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00306-9</DOI>
    <AuthorList>
      <Author>
        <Name>Lutfiya Miller</Name>
        <Affiliation>Intertek Health Sciences, Inc., Pharmaceuticals &amp; Healthcare, Mississauga, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Charles D. Hébert</Name>
        <Affiliation>Southern Research, Birmingham, AL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Sheila D. Grimes</Name>
        <Affiliation>Southern Research, Birmingham, AL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>James S. Toomey</Name>
        <Affiliation>Southern Research, Birmingham, AL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Joo Yeun Oh</Name>
        <Affiliation>Department of Pathology and Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jason J. Rose</Name>
        <Affiliation>Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rakesh P. Patel</Name>
        <Affiliation>Department of Pathology and Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: rakeshpatel@uabmc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>CYP3A deficiency alters bile acid homeostasis and leads to changes in hepatic susceptibility in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34461081</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00307-0</DOI>
    <KeywordList>
      <Keywords>Bile acids</Keywords>
      <Keywords>Cholesterol</Keywords>
      <Keywords>Cytochrome P450 3A</Keywords>
      <Keywords>Gene knockout rats</Keywords>
      <Keywords>Homeostasis regulator</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xuan Qin</Name>
        <Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China; Center of Drug Discovery, Department of Pathology &amp; Immunology, Baylor College of Medicine, Houston, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanjin Zhang</Name>
        <Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Lu</Name>
        <Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengbo Huang</Name>
        <Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zongjun Liu</Name>
        <Affiliation>Department of Cardiology, Central Hospital of Shanghai Putuo District, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Electronic address: lzj72@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Wang</Name>
        <Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China. Electronic address: xwang@bio.ecnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Curcumin ameliorates hypertension via gut-brain communication in spontaneously hypertensive rat.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34453990</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00305-7</DOI>
    <KeywordList>
      <Keywords>Butyrate</Keywords>
      <Keywords>Curcumin</Keywords>
      <Keywords>Gut microbiota</Keywords>
      <Keywords>Gut–brain axis</Keywords>
      <Keywords>Hypertension</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hong Bao Li</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an 710061, China. Electronic address: hongbaoli1985@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Lu Xu</Name>
        <Affiliation>Department of Nephrology, the First Affiliated Hospital of Xi'an Medical University, Xi'an 710077, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Meng Du</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Jing Yu</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Bai</Name>
        <Affiliation>Department of Anesthesiology, Center for Brian Science, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Jie Xia</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Ming Dai</Name>
        <Affiliation>Department of Anesthesia, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Xing Li</Name>
        <Affiliation>Department of Human Anatomy, Medical College of Qinghai University, 810000 Xining, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Li</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Su</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Min Wang</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Yuan Dong</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Ming Kang</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an 710061, China. Electronic address: ykang@mail.xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Targeting CD166</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34437932</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00303-3</DOI>
    <KeywordList>
      <Keywords>Benzo(a)Pyrene</Keywords>
      <Keywords>Cancer stem cells</Keywords>
      <Keywords>Dendritic cell vaccine</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Tumor microenvironment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>N. E. El-Ashmawy</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>M. L. Salem</Name>
        <Affiliation>Department of Zoology, Faculty of Science, Tanta University, Tanta, Egypt; Center of Excellence in Cancer Research, Tanta University, Tanta, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>E. E. Abd El-Fattah</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.. Electronic address: eslam_620@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>E. G. Khedr</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Multibiomarker approach to assess the magnitude of occupational exposure and effects induced by a mixture of metals.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34437931</pubmedLink>
    <GrantList>
      <Grant>R01 ES007331</Grant>
      <Grant>R01 ES010563</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00288-X</DOI>
    <KeywordList>
      <Keywords>Heme parameters</Keywords>
      <Keywords>Magnitude of exposure/effects</Keywords>
      <Keywords>Mine workers</Keywords>
      <Keywords>Multibiomarker</Keywords>
      <Keywords>Pb, As and Mn-mixture</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>V. Lopes de Andrade</Name>
        <Affiliation>Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal. Electronic address: vanda.andrade@esa.ipsantarem.pt.</Affiliation>
      </Author>
      <Author>
        <Name>D. Serrazina</Name>
        <Affiliation>Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>M. L. Mateus</Name>
        <Affiliation>Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>C. Batoréu</Name>
        <Affiliation>Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>M. Aschner</Name>
        <Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer 209, 1300 Morris Park Avenue, Bronx, NY 10461, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>A. P. Marreilha Dos Santos</Name>
        <Affiliation>Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34428447</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00302-1</DOI>
    <KeywordList>
      <Keywords>Neuropathic pain</Keywords>
      <Keywords>PCC-0105002</Keywords>
      <Keywords>PSD-95</Keywords>
      <Keywords>Synaptic plasticity</Keywords>
      <Keywords>nNOS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhihong Sun</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Meng</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunyu Su</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengmin Ji</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Science, Yantai University, Yantai 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongbo Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwei Tian</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China. Electronic address: tianjingwei@luye.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China. Electronic address: gaoyonglin@luye.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/β-catenin, AMPK/mTOR signaling pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34428446</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00301-X</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Bergapten</Keywords>
      <Keywords>Insulin Resistance</Keywords>
      <Keywords>Neuroinflammation</Keywords>
      <Keywords>Sporadic Alzheimer's Disease</Keywords>
      <Keywords>Tadalafil</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohamed A. Salem</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Biochemistry, Faculty of Pharmacy, Future University in Egypt, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Budzyńska</Name>
        <Affiliation>Independent Laboratory of Behavioral Studies, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Kowalczyk</Name>
        <Affiliation>Independent Laboratory of Behavioral Studies, Medical University of Lublin, Lublin, Poland; Chair and Department of Applied Pharmacy, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Nesrine S. El Sayed</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Suzan M. Mansour</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Biochemistry, Faculty of Pharmacy, Future University in Egypt, Cairo, Egypt; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: suzan.mansour@pharma.cu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the environmental contamination and exposure risk in medical/non-medical staff after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34428445</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00298-2</DOI>
    <KeywordList>
      <Keywords>Occupational hazard</Keywords>
      <Keywords>Occupational safety</Keywords>
      <Keywords>Oxaliplatin</Keywords>
      <Keywords>PIPAC</Keywords>
      <Keywords>Personal protective equipment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marion Larroque</Name>
        <Affiliation>Translational Research Unit, Cancer Institute of Montpellier, Montpellier, France; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier F-34298, France; University of Pau and Pays de l'Adour, E2S UPPA, CNRS, Institut des Sciences Analytiques et de Physico-Chimie Pour l'Environnement et les Matériaux (IPREM), UMR5254, Hélioparc, 64053, Pau, France.</Affiliation>
      </Author>
      <Author>
        <Name>Carine Arnaudguilhem</Name>
        <Affiliation>University of Pau and Pays de l'Adour, E2S UPPA, CNRS, Institut des Sciences Analytiques et de Physico-Chimie Pour l'Environnement et les Matériaux (IPREM), UMR5254, Hélioparc, 64053, Pau, France.</Affiliation>
      </Author>
      <Author>
        <Name>Brice Bouyssiere</Name>
        <Affiliation>University of Pau and Pays de l'Adour, E2S UPPA, CNRS, Institut des Sciences Analytiques et de Physico-Chimie Pour l'Environnement et les Matériaux (IPREM), UMR5254, Hélioparc, 64053, Pau, France.</Affiliation>
      </Author>
      <Author>
        <Name>François Quenet</Name>
        <Affiliation>IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier F-34298, France; Department of Surgical Oncology, Cancer Institute of Montpellier, University of Montpellier, Montpellier, France.</Affiliation>
      </Author>
      <Author>
        <Name>Nabila Bouazza</Name>
        <Affiliation>Scientific Direction, ClinicalResearch Center, Cancer Institute of Montpellier, Montpellier, France.</Affiliation>
      </Author>
      <Author>
        <Name>Marta Jarlier</Name>
        <Affiliation>Biometrics Unit, Cancer Institute of Montpellier, Montpellier, France.</Affiliation>
      </Author>
      <Author>
        <Name>Sonia Boulabas</Name>
        <Affiliation>Scientific Direction, ClinicalResearch Center, Cancer Institute of Montpellier, Montpellier, France.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra Mounicou</Name>
        <Affiliation>University of Pau and Pays de l'Adour, E2S UPPA, CNRS, Institut des Sciences Analytiques et de Physico-Chimie Pour l'Environnement et les Matériaux (IPREM), UMR5254, Hélioparc, 64053, Pau, France.</Affiliation>
      </Author>
      <Author>
        <Name>Olivia Sgarbura</Name>
        <Affiliation>IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier F-34298, France; Department of Surgical Oncology, Cancer Institute of Montpellier, University of Montpellier, Montpellier, France. Electronic address: Olivia.sgarbura@icm.unicancer.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mesoporous silica nanoparticles containing copper or silver synthesized with a new metal source: Determination of their structure parameters and cytotoxic and irritating effects.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34428444</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00289-1</DOI>
    <KeywordList>
      <Keywords>Copper and silver oxalates</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Irritating effects</Keywords>
      <Keywords>Mesoporous silica nanomaterials</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anna Sierosławska</Name>
        <Affiliation>Department of Animal Physiology and Toxicology, Faculty of Science and Health, The John Paul II Catholic University of Lublin, 1I Konstantynów Str., 20-708 Lublin, Poland. Electronic address: anna.sieroslawska@kul.lublin.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Borówka</Name>
        <Affiliation>Department of Animal Physiology and Toxicology, Faculty of Science and Health, The John Paul II Catholic University of Lublin, 1I Konstantynów Str., 20-708 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Rymuszka</Name>
        <Affiliation>Department of Animal Physiology and Toxicology, Faculty of Science and Health, The John Paul II Catholic University of Lublin, 1I Konstantynów Str., 20-708 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Grzegorz Żukociński</Name>
        <Affiliation>Centre for Interdisciplinary Research, The John Paul II Catholic University of Lublin, 1H Konstantynów Str., 20-708 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Kamil Sobczak</Name>
        <Affiliation>Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Zwirki i Wigury 101, 02-089 Warsaw, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cardiac toxicity from bisphenol A exposure in human-induced pluripotent stem cell-derived cardiomyocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34419494</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00300-8</DOI>
    <KeywordList>
      <Keywords>Bisphenol-a (BPA)</Keywords>
      <Keywords>Cardiac contraction</Keywords>
      <Keywords>Cardiac dysfunction</Keywords>
      <Keywords>Cardiac ion channels</Keywords>
      <Keywords>Field potentials</Keywords>
      <Keywords>hiPSC-CMs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sung Ae Hyun</Name>
        <Affiliation>Substance Abuse Pharmacology Group, Korea Institute of Toxicology, KRICT, Daejeon 34114, Republic of Korea; Department of Biochemistry, Chungnam National University, Daejeon 34134, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Youn Lee</Name>
        <Affiliation>Substance Abuse Pharmacology Group, Korea Institute of Toxicology, KRICT, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Moon Yi Ko</Name>
        <Affiliation>Substance Abuse Pharmacology Group, Korea Institute of Toxicology, KRICT, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Hwa Chon</Name>
        <Affiliation>Substance Abuse Pharmacology Group, Korea Institute of Toxicology, KRICT, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ye Ji Kim</Name>
        <Affiliation>Substance Abuse Pharmacology Group, Korea Institute of Toxicology, KRICT, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Wook Seo</Name>
        <Affiliation>Substance Abuse Pharmacology Group, Korea Institute of Toxicology, KRICT, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kee K. Kim</Name>
        <Affiliation>Department of Biochemistry, Chungnam National University, Daejeon 34134, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Minhan Ka</Name>
        <Affiliation>Substance Abuse Pharmacology Group, Korea Institute of Toxicology, KRICT, Daejeon 34114, Republic of Korea. Electronic address: minhan.ka@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Improved nonclinical safety profile of a novel, highly selective inhibitor of the immunoproteasome subunit LMP7 (M3258).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34419493</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00299-4</DOI>
    <KeywordList>
      <Keywords>Constitutive proteasome</Keywords>
      <Keywords>Immunoproteasome</Keywords>
      <Keywords>LMP7 (β5i)</Keywords>
      <Keywords>Multiple Myeloma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Willem Sloot</Name>
        <Affiliation>Merck KGaA, Global Chemical and Preclinical Safety, Darmstadt, Germany. Electronic address: willem.sloot@merckgroup.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nina Glaser</Name>
        <Affiliation>Merck KGaA, Global Chemical and Preclinical Safety, Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Annika Hansen</Name>
        <Affiliation>Merck KGaA, Global Chemical and Preclinical Safety, Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Juergen Hellmann</Name>
        <Affiliation>Merck KGaA, Global Chemical and Preclinical Safety, Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sven Jaeckel</Name>
        <Affiliation>Merck KGaA, Global Chemical and Preclinical Safety, Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sigrid Johannes</Name>
        <Affiliation>Merck KGaA, Global Chemical and Preclinical Safety, Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Anja Knippel</Name>
        <Affiliation>Merck KGaA, Global Chemical and Preclinical Safety, Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Valentina Lai</Name>
        <Affiliation>Istituto di Ricerche Biomediche "Antoine Marxer" - RBM; Colleretto Giacosa, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Manuela Onidi</Name>
        <Affiliation>Istituto di Ricerche Biomediche "Antoine Marxer" - RBM; Colleretto Giacosa, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Glycine/glycine N-methyltransferase/sarcosine axis mediates benzene-induced hematotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34418406</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00286-6</DOI>
    <KeywordList>
      <Keywords>Benzene</Keywords>
      <Keywords>Glycine/GNMT/sarcosine axis</Keywords>
      <Keywords>Hematotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Zhang</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Capital Medical University, Beijing 100069, PR China; Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing 100069, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoli Guo</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Capital Medical University, Beijing 100069, PR China; Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing 100069, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Ren</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Capital Medical University, Beijing 100069, PR China; Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing 100069, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yujiao Chen</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Capital Medical University, Beijing 100069, PR China; Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing 100069, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingyu Wang</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Capital Medical University, Beijing 100069, PR China; Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing 100069, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ai Gao</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Capital Medical University, Beijing 100069, PR China; Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing 100069, PR China. Electronic address: gaoai428@ccmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A systematic review of clinical and laboratory findings of lead poisoning: lessons from case reports.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34416225</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00285-4</DOI>
    <KeywordList>
      <Keywords>Lead</Keywords>
      <Keywords>chelating</Keywords>
      <Keywords>poisoning</Keywords>
      <Keywords>pollutant sources</Keywords>
      <Keywords>systematic review</Keywords>
      <Keywords>toxicities</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Saeed Samarghandian</Name>
        <Affiliation>Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran. Electronic address: samarghandians1@nums.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Farshad M. Shirazi</Name>
        <Affiliation>Arizona Poison &amp; Drug Information Center, The University of Arizona, College of Pharmacy and University of Arizona, Tucson, Arizona, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Farhad Saeedi</Name>
        <Affiliation>Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Babak Roshanravan</Name>
        <Affiliation>Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Ali Mohammad Pourbagher-Shahri</Name>
        <Affiliation>Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Emad Yeganeh Khorasani</Name>
        <Affiliation>Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Tahereh Farkhondeh</Name>
        <Affiliation>Faculty of Pharmacy, Birjand University of Medical Sciences (BUMS), Birjand, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Olav Aaseth</Name>
        <Affiliation>Elverum, and Research Department, Innlandet Hospital, Norway University of Applied Sciences, Brumunddal, Norway. Electronic address: jaol-aas@online.no.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Abdollahi</Name>
        <Affiliation>Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: mohammad@tums.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Omid Mehrpour</Name>
        <Affiliation>Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences (BUMS), Birjand, Iran; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA. Electronic address: omehrpour@email.arizona.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Functional, proteomic and phenotypic in vitro studies evidence podocyte injury after chronic exposure to heparin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34411582</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00287-8</DOI>
    <KeywordList>
      <Keywords>Cytoskeleton</Keywords>
      <Keywords>Glomerular filtration</Keywords>
      <Keywords>Heparin</Keywords>
      <Keywords>Podocyte</Keywords>
      <Keywords>Proteome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Olivier Delézay</Name>
        <Affiliation>INSERM, U1059, Dysfonction Vasculaire et Hémostase, Saint-Etienne, France. Electronic address: delezay@univ-st-etienne.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Sophie Hodin</Name>
        <Affiliation>INSERM, U1059, Dysfonction Vasculaire et Hémostase, Saint-Etienne, France.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiguo Hé</Name>
        <Affiliation>EA 2521, Biologie, Ingénierie et Imagerie de la Greffe de Cornée (BIIGC), Saint-Etienne, France.</Affiliation>
      </Author>
      <Author>
        <Name>Edouard Ollier</Name>
        <Affiliation>INSERM, U1059, Dysfonction Vasculaire et Hémostase, Saint-Etienne, France.</Affiliation>
      </Author>
      <Author>
        <Name>Xavier Delavenne</Name>
        <Affiliation>INSERM, U1059, Dysfonction Vasculaire et Hémostase, Saint-Etienne, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of chronic toxicity of cyclocreatine in beagle dogs after oral gavage administration for up to 23 weeks.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34411581</pubmedLink>
    <GrantList>
      <Grant>HHSN261200800001C</Grant>
      <Grant>HHSN261200800001E</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00284-2</DOI>
    <KeywordList>
      <Keywords>Beagle dog</Keywords>
      <Keywords>Creatine analog</Keywords>
      <Keywords>Creatine transporter deficiency (CTD)</Keywords>
      <Keywords>Cyclocreatine</Keywords>
      <Keywords>LUM-001</Keywords>
      <Keywords>Nonclinical toxicity</Keywords>
      <Keywords>Preclinical safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeffrey J. Wallery</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vijay Pralhad Kale</Name>
        <Affiliation>Battelle, Columbus, OH, USA. Electronic address: vkale02@amgen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph Novak</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Seth Gibbs</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Minh Ha T. Do</Name>
        <Affiliation>Lumos Pharma, Austin, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John C. McKew</Name>
        <Affiliation>Lumos Pharma, Austin, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pramod S. Terse</Name>
        <Affiliation>National Center for Advancing Translational Sciences, National Institute of Health, Bethesda, MD, USA. Electronic address: tersep@mail.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>(-)-Epicatechin ameliorates cigarette smoke-induced lung inflammation via inhibiting ROS/NLRP3 inflammasome pathway in rats with COPD.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34403689</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00278-7</DOI>
    <KeywordList>
      <Keywords>(−)-Epicatechin</Keywords>
      <Keywords>Chronic obstructive pulmonary disease</Keywords>
      <Keywords>NLRP3 inflammasome</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xue Tian</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine,100 Haining Road, Shanghai 200080, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yishu Xue</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine,100 Haining Road, Shanghai 200080, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guogang Xie</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine,100 Haining Road, Shanghai 200080, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhou</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine,100 Haining Road, Shanghai 200080, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Xiao</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine,100 Haining Road, Shanghai 200080, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengming Ding</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine,100 Haining Road, Shanghai 200080, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Zhang</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine,100 Haining Road, Shanghai 200080, PR China.. Electronic address: maggie_zhangmin@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A population approach for the estimation of methylmercury ToxicoKinetics in red mullets.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34400196</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00283-0</DOI>
    <KeywordList>
      <Keywords>Approximate Bayesian Computation</Keywords>
      <Keywords>Mathematical mdelling</Keywords>
      <Keywords>Methyl mercury</Keywords>
      <Keywords>Parameter estimation</Keywords>
      <Keywords>Red mullets</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Francesca Pellicanò</Name>
        <Affiliation>Laboratorio di Biomatematica, Istituto di Analisi dei Sistemi ed Informatica "A. Ruberti" (IASI), Consiglio Nazionale delle Ricerche (CNR), Roma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Laura D'Orsi</Name>
        <Affiliation>Laboratorio di Biomatematica, Istituto di Analisi dei Sistemi ed Informatica "A. Ruberti" (IASI), Consiglio Nazionale delle Ricerche (CNR), Roma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea De Gaetano</Name>
        <Affiliation>Laboratorio di Biomatematica, Istituto di Analisi dei Sistemi ed Informatica "A. Ruberti" (IASI), Consiglio Nazionale delle Ricerche (CNR), Roma, Italy; Istituto per la Ricerca e l'Innovazione Biomedica (IRIB), Consiglio Nazionale delle Ricerche (CNR), Palermo, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Simona Panunzi</Name>
        <Affiliation>Laboratorio di Biomatematica, Istituto di Analisi dei Sistemi ed Informatica "A. Ruberti" (IASI), Consiglio Nazionale delle Ricerche (CNR), Roma, Italy. Electronic address: simona.panunzi@biomatematica.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of NLRP3 inflammasome activation in myeloid-derived suppressor cells by andrographolide sulfonate contributes to 5-FU sensitization in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34391754</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00276-3</DOI>
    <KeywordList>
      <Keywords>5-FU</Keywords>
      <Keywords>Andrographolide sulfonate</Keywords>
      <Keywords>MDSCs</Keywords>
      <Keywords>NLRP3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lingyan Xu</Name>
        <Affiliation>Department of Oncology and Cancer Rehabilitation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 2100029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peifen Cai</Name>
        <Affiliation>The Jiangning Affiliated Hospital with Nanjing Medical University, Nanjing 211100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofei Li</Name>
        <Affiliation>Department of Oncology and Cancer Rehabilitation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 2100029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohan Wu</Name>
        <Affiliation>Department of Oncology and Cancer Rehabilitation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 2100029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Gao</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Liu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiashu Yang</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Xu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China. Electronic address: molpharm@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjie Guo</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China. Electronic address: guowj@nju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yanhong Gu</Name>
        <Affiliation>Department of Oncology and Cancer Rehabilitation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 2100029, China. Electronic address: guyhphd@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Delivery of doxorubicin loaded P18 conjugated-poly(2-ethyl-oxazoline)-DOPE nanoliposomes for targeted therapy of breast cancer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34391753</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00275-1</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Drug Delivery</Keywords>
      <Keywords>Nanoliposomes</Keywords>
      <Keywords>Peptide 18</Keywords>
      <Keywords>Targeted therapy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zeynep Busra Bolat</Name>
        <Affiliation>Yeditepe University, Faculty of Engineering, Department of Genetics and Bioengineering, Atasehir, 34755 Istanbul, Turkey; Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Istanbul Sabahattin Zaim University, Kucukcekmece, 34303 Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ayca Ece Nezir</Name>
        <Affiliation>Yeditepe University, Faculty of Engineering, Department of Genetics and Bioengineering, Atasehir, 34755 Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Burcu Devrim</Name>
        <Affiliation>Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Yeni mahalle, 06560 Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ebru Zemheri</Name>
        <Affiliation>University of Health Sciences, Department of Pathology, Umraniye Training and Research Hospital, Umraniye, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Sevgi Gulyuz</Name>
        <Affiliation>Materials Institute, Marmara Research Center, TUBITAK, Gebze, 41470 Kocaeli, Turkey; Department of Chemistry, Faculty of Science and Letters, Istanbul Technical University, Maslak, 34469 Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Umut Ugur Ozkose</Name>
        <Affiliation>Materials Institute, Marmara Research Center, TUBITAK, Gebze, 41470 Kocaeli, Turkey; Department of Chemistry, Faculty of Science and Letters, Istanbul Technical University, Maslak, 34469 Istanbul, Turkey; Department of Chemistry, Faculty of Science and Letters, Piri Reis University, Tuzla, 34940 Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ozgur Yilmaz</Name>
        <Affiliation>Materials Institute, Marmara Research Center, TUBITAK, Gebze, 41470 Kocaeli, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Asuman Bozkir</Name>
        <Affiliation>Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Yeni mahalle, 06560 Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Dilek Telci</Name>
        <Affiliation>Yeditepe University, Faculty of Engineering, Department of Genetics and Bioengineering, Atasehir, 34755 Istanbul, Turkey. Electronic address: dilek.telci@yeditepe.edu.tr.</Affiliation>
      </Author>
      <Author>
        <Name>Fikrettin Sahin</Name>
        <Affiliation>Yeditepe University, Faculty of Engineering, Department of Genetics and Bioengineering, Atasehir, 34755 Istanbul, Turkey. Electronic address: fsahin@yeditepe.edu.tr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A PBPK model describing the pharmacokinetics of γ-HBCD exposure in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34390738</pubmedLink>
    <GrantList>
      <Grant>ZIA BC011476</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00282-9</DOI>
    <KeywordList>
      <Keywords>Brain</Keywords>
      <Keywords>HBCD</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>γ-HBCD</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Claude Emond</Name>
        <Affiliation>BioSimulation Consulting Inc., Newark, DE, USA; School of Public Health, Department of Environmental and Occupational Health, University of Montreal, Quebec, Canada. Electronic address: claude.emond@biosmc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. DeVito</Name>
        <Affiliation>National Institute of Environmental Health Sciences, National Toxicology Program, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Linda S. Birnbaum</Name>
        <Affiliation>National Cancer Institute, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pulmonary injury and oxidative stress in rats induced by inhaled sulfur mustard is ameliorated by anti-tumor necrosis factor-α antibody.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34390737</pubmedLink>
    <GrantList>
      <Grant>T32 ES007148</Grant>
      <Grant>R25 ES020721</Grant>
      <Grant>P30 ES005022</Grant>
      <Grant>U54 AR055073</Grant>
      <Grant>R01 ES004738</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00281-7</DOI>
    <KeywordList>
      <Keywords>Inflammation</Keywords>
      <Keywords>Lung toxicity</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Sulfur mustard</Keywords>
      <Keywords>Tumor necrosis factor α</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rama Malaviya</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alyssa Bellomo</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elena Abramova</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Claire R. Croutch</Name>
        <Affiliation>MRIGlobal, Kansas City, MO 64110, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julie Roseman</Name>
        <Affiliation>MRIGlobal, Kansas City, MO 64110, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rick Tuttle</Name>
        <Affiliation>MRIGlobal, Kansas City, MO 64110, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Peters</Name>
        <Affiliation>MRIGlobal, Kansas City, MO 64110, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert P. Casillas</Name>
        <Affiliation>Latham BioPharm Group, Cambridge, MA 02142, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vasanthi R. Sunil</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey D. Laskin</Name>
        <Affiliation>Department of Environmental and Occupational Health and Justice, School of Public Health, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Debra L. Laskin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: laskin@eohsi.rutgers.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The insecticide deltamethrin enhances sodium channel slow inactivation of human Nav1.9, Nav1.8 and Nav1.7.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34389319</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00280-5</DOI>
    <KeywordList>
      <Keywords>CsF</Keywords>
      <Keywords>Gulf-war syndrome</Keywords>
      <Keywords>Patch-clamp</Keywords>
      <Keywords>Pyrethroids</Keywords>
      <Keywords>Use-dependence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stefanie Nicole Bothe</Name>
        <Affiliation>Institute of Physiology, Uniklinik RWTH Aachen, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany; Research Training Group 2416 MultiSenses-MultiScales, RWTH Aachen University, Aachen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Angelika Lampert</Name>
        <Affiliation>Institute of Physiology, Uniklinik RWTH Aachen, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany; Research Training Group 2416 MultiSenses-MultiScales, RWTH Aachen University, Aachen, Germany; Research Training Group 2415 ME3T, RWTH Aachen University, Aachen, Germany. Electronic address: alampert@ukaachen.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Immunosuppression, oxidative stress, and apoptosis in pig kidney caused by ammonia: Application of transcriptome analysis in risk assessment of ammonia exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34389318</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00279-9</DOI>
    <KeywordList>
      <Keywords>Ammonia</Keywords>
      <Keywords>Environmental Contaminant</Keywords>
      <Keywords>Pig</Keywords>
      <Keywords>Risk Assessment</Keywords>
      <Keywords>Transcriptome Analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hengyi Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenbo Ji</Name>
        <Affiliation>College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Li</Name>
        <Affiliation>College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanru Feng</Name>
        <Affiliation>College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Wang</Name>
        <Affiliation>College of Life Science, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Honggui Liu</Name>
        <Affiliation>College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, PR China; Key Laboratory of Swine Facilities Engineering, Ministry of Agriculture and Rural Affairs, Harbin, PR China. Electronic address: Hg.Liu@neau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Bao</Name>
        <Affiliation>College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, PR China; College of Life Science, Northeast Agricultural University, Harbin 150030, PR China; Key Laboratory of Swine Facilities Engineering, Ministry of Agriculture and Rural Affairs, Harbin, PR China. Electronic address: jbao@neau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of an environmentally relevant PFAS mixture on dopamine and steroid hormone levels in exposed mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34371090</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00274-X</DOI>
    <KeywordList>
      <Keywords>Dopamine</Keywords>
      <Keywords>PFAS mixture</Keywords>
      <Keywords>Rodents</Keywords>
      <Keywords>Ski products</Keywords>
      <Keywords>Steroids</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Randi Grønnestad</Name>
        <Affiliation>Department of Biology, Norwegian University of Science and Technology, Trondheim, Norway. Electronic address: randi.gronnestad@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Silje Modahl Johanson</Name>
        <Affiliation>Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Mette H. B. Müller</Name>
        <Affiliation>Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, Oslo, Norway; Department of Paraclinical Sciences, Norwegian University of Life Sciences, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Schlenk</Name>
        <Affiliation>Department of Environmental Sciences, University of California, Riverside, California, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Tanabe</Name>
        <Affiliation>Department of Environmental Sciences, University of California, Riverside, California, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Åse Krøkje</Name>
        <Affiliation>Department of Biology, Norwegian University of Science and Technology, Trondheim, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Veerle L. B. Jaspers</Name>
        <Affiliation>Department of Biology, Norwegian University of Science and Technology, Trondheim, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Bjørn Munro Jenssen</Name>
        <Affiliation>Department of Biology, Norwegian University of Science and Technology, Trondheim, Norway; Department of Biosciences, Aarhus University, Roskilde, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Erik M. Ræder</Name>
        <Affiliation>Department of Paraclinical Sciences, Norwegian University of Life Sciences, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Jan L. Lyche</Name>
        <Affiliation>Department of Paraclinical Sciences, Norwegian University of Life Sciences, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Qingyang Shi</Name>
        <Affiliation>Department of Environmental Sciences, University of California, Riverside, California, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Augustine Arukwe</Name>
        <Affiliation>Department of Biology, Norwegian University of Science and Technology, Trondheim, Norway.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pegbelfermin, a PEGylated FGF21 analogue, has pharmacology without bone toxicity after 1-year dosing in skeletally-mature monkeys.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34364948</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00277-5</DOI>
    <KeywordList>
      <Keywords>Bone</Keywords>
      <Keywords>FGF21</Keywords>
      <Keywords>Monkey</Keywords>
      <Keywords>Pegbelfermin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kary E. Thompson</Name>
        <Affiliation>Nonclinical Safety, Bristol-Myers Squibb, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Guillot</Name>
        <Affiliation>Musculoskeletal Research &amp; Imaging, Charles River Laboratories, Senneville, QC, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Graziano</Name>
        <Affiliation>Nonclinical Safety, Bristol-Myers Squibb, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Raja S. Mangipudy</Name>
        <Affiliation>Nonclinical Safety, Bristol-Myers Squibb, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kristina D. Chadwick</Name>
        <Affiliation>Nonclinical Safety, Bristol-Myers Squibb, New Brunswick, NJ, USA. Electronic address: kristina.chadwick@bms.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Selectivity of the collagen-binding integrin inhibitors, TC-I-15 and obtustatin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34363821</pubmedLink>
    <GrantList>
      <Grant>NH/11/1/28922</Grant>
      <Grant> SP/15/7/31561</Grant>
      <Grant>FS/15/20/31335 </Grant>
      <Grant> RG/15/4/31268</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00273-8</DOI>
    <KeywordList>
      <Keywords>C2C12</Keywords>
      <Keywords>Cell adhesion</Keywords>
      <Keywords>Collagen peptides</Keywords>
      <Keywords>Integrin</Keywords>
      <Keywords>Obtustatin</Keywords>
      <Keywords>TC-I-15</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Emma J. Hunter</Name>
        <Affiliation>Department of Biochemistry, University of Cambridge, Downing Site, Cambridge CB2 1QW, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Samir W. Hamaia</Name>
        <Affiliation>Department of Biochemistry, University of Cambridge, Downing Site, Cambridge CB2 1QW, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Donald Gullberg</Name>
        <Affiliation>Department of Biomedicine, University of Bergen, Jonas Lies vei 91, N-5009 Bergen, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Daniel Malcor</Name>
        <Affiliation>Department of Biochemistry, University of Cambridge, Downing Site, Cambridge CB2 1QW, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Richard W. Farndale</Name>
        <Affiliation>Department of Biochemistry, University of Cambridge, Downing Site, Cambridge CB2 1QW, UK. Electronic address: rwf10@cam.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacological postconditioning with sappanone A ameliorates myocardial ischemia reperfusion injury and mitochondrial dysfunction via AMPK-mediated mitochondrial quality control.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34358556</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00272-6</DOI>
    <KeywordList>
      <Keywords>AMP-activated protein kinase</Keywords>
      <Keywords>Mitochondrial quality control</Keywords>
      <Keywords>Myocardial ischemia reperfusion injury</Keywords>
      <Keywords>Pharmacological postconditioning</Keywords>
      <Keywords>Sappanone A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaojing Shi</Name>
        <Affiliation>Department of Cardiology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Li</Name>
        <Affiliation>Department of Cardiology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaguang Wang</Name>
        <Affiliation>Department of Cardiology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Tiejia Ding</Name>
        <Affiliation>Department of Cardiology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowen Zhang</Name>
        <Affiliation>Medical Research Center, Shengjing Hospital of China Medical University, Shenyang, PR China. Electronic address: zhangxiaowen@cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Nan Wu</Name>
        <Affiliation>The Central Laboratory of the First Affiliated Hospital of China Medical University, Shenyang, PR China. Electronic address: nwu87@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chloroorganic (DDT) and organophosphate (malathion) insecticides impair the motor function of the bovine cervix.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34343560</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00271-4</DOI>
    <KeywordList>
      <Keywords>Cervix</Keywords>
      <Keywords>Contractions</Keywords>
      <Keywords>Cow</Keywords>
      <Keywords>Insecticides</Keywords>
      <Keywords>Signalling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. H. Wrobel</Name>
        <Affiliation>Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Tuwima Street 10, 10-748 Olsztyn, Poland. Electronic address: m.wrobel@pan.olsztyn.pl.</Affiliation>
      </Author>
      <Author>
        <Name>J. Mlynarczuk</Name>
        <Affiliation>Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Tuwima Street 10, 10-748 Olsztyn, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genomic methylation variations predict the susceptibility of six chemotherapy related adverse effects and cancer development for Chinese colorectal cancer patients.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34332992</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00261-1</DOI>
    <KeywordList>
      <Keywords>Bone marrow suppression</Keywords>
      <Keywords>Capecitabine</Keywords>
      <Keywords>Chemotherapy-related adverse effects</Keywords>
      <Keywords>Colorectal cancer</Keywords>
      <Keywords>DNA methylation</Keywords>
      <Keywords>Hand-foot syndrome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mingming Li</Name>
        <Affiliation>Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaomeng Sun</Name>
        <Affiliation>Research Institute, GloriousMed Clinical Laboratory Co., Ltd., Shanghai 201318, China.</Affiliation>
      </Author>
      <Author>
        <Name>Houshan Yao</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Chen</Name>
        <Affiliation>Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Zhang</Name>
        <Affiliation>Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shouhong Gao</Name>
        <Affiliation>Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xun Zou</Name>
        <Affiliation>Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiani Chen</Name>
        <Affiliation>Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shi Qiu</Name>
        <Affiliation>Traditional Chinese Medicine Resource and Technology Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Wei</Name>
        <Affiliation>Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China; Department of Pharmacy, 905th Hospital of PLA Navy, Naval Medical University, Shanghai 200052, China. Electronic address: weihua@smmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiqian Hu</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China; Department of Gastrointestinal Surgery, Tongji Hospital, Medical College of Tongji University, Shanghai 200065, China. Electronic address: huzq62@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wansheng Chen</Name>
        <Affiliation>Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China; Traditional Chinese Medicine Resource and Technology Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: chenwansheng@smmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of respiratory uncoupling in drug-induced mitochondrial permeability transition.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34332991</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00263-5</DOI>
    <KeywordList>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Mitochondrial permeability transition</Keywords>
      <Keywords>Respiratory uncoupling</Keywords>
      <Keywords>Structure-activity relationship</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tomoyuki Sato</Name>
        <Affiliation>Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8675, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akinori Takemura</Name>
        <Affiliation>Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8675, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kousei Ito</Name>
        <Affiliation>Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8675, Japan. Electronic address: itokousei@chiba-u.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Benzo(a)pyrene exposure in utero exacerbates Parkinson's Disease (PD)-like α-synucleinopathy in A53T human alpha-synuclein transgenic mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34332006</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00262-3</DOI>
    <KeywordList>
      <Keywords>Alpha-synuclein</Keywords>
      <Keywords>Benzo[a]pyrene</Keywords>
      <Keywords>Dopaminergic neuronal loss</Keywords>
      <Keywords>Microglia</Keywords>
      <Keywords>Parkinson's Disease-like α-synucleinopathy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Weixing Xu</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuze Qi</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanjun Gao</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huihui Quan</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingru Li</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Zhou</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Huang</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing 100191, China. Electronic address: jing_huang@bjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TRAIL produced by SAM-1-activated CD4</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34329641</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00260-X</DOI>
    <KeywordList>
      <Keywords>Antitumor</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Death Receptor</Keywords>
      <Keywords>Superantigen</Keywords>
      <Keywords>TRAIL</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guojun Zhang</Name>
        <Affiliation>College of Basic Medical Science, China Medical University, Shenyang, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingkai Xu</Name>
        <Affiliation>Institute of Applied Ecology, Chinese Academy of Sciences, Shenyang, Liaoning, China; Key Laboratory of Superantigen Research, Shenyang Bureau of Science and Technology, Shenyang, Liaoning, China. Electronic address: mkxu@iae.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqing Zhang</Name>
        <Affiliation>College of Basic Medical Science, China Medical University, Shenyang, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Ma</Name>
        <Affiliation>College of Basic Medical Science, China Medical University, Shenyang, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huiwen Zhang</Name>
        <Affiliation>Institute of Applied Ecology, Chinese Academy of Sciences, Shenyang, Liaoning, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of new antiseizure drugs on seizure activity and anxiety-like behavior in adult zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34329640</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00259-3</DOI>
    <KeywordList>
      <Keywords>Color preference</Keywords>
      <Keywords>New ASDs</Keywords>
      <Keywords>Pentylenetetrazole</Keywords>
      <Keywords>Seizure</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mateusz Pieróg</Name>
        <Affiliation>Department of Animal Physiology and Pharmacology, Institute of Biological Sciences, Maria Curie-Sklodowska University, Akademicka 19, PL 20-033 Lublin, Poland. Electronic address: mateusz.pierog@umcs.lublin.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Katarzyna Socała</Name>
        <Affiliation>Department of Animal Physiology and Pharmacology, Institute of Biological Sciences, Maria Curie-Sklodowska University, Akademicka 19, PL 20-033 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Urszula Doboszewska</Name>
        <Affiliation>Department of Animal Physiology and Pharmacology, Institute of Biological Sciences, Maria Curie-Sklodowska University, Akademicka 19, PL 20-033 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Elżbieta Wyska</Name>
        <Affiliation>Department of Pharmacokinetics and Physical Pharmacy, Jagiellonian University Medical College, Medyczna 9, PL 30-688 Kraków, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Leszek Guz</Name>
        <Affiliation>Department of Fish Diseases and Biology, Institute of Biological Bases of Animal Diseases, University of Life Sciences, Akademicka 12, PL 20-033 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Aleksandra Szopa</Name>
        <Affiliation>Laboratory of Preclinical Testing, Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, Chodźki 1, PL 20-093 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Serefko</Name>
        <Affiliation>Laboratory of Preclinical Testing, Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, Chodźki 1, PL 20-093 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Ewa Poleszak</Name>
        <Affiliation>Laboratory of Preclinical Testing, Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, Chodźki 1, PL 20-093 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Piotr Wlaź</Name>
        <Affiliation>Department of Animal Physiology and Pharmacology, Institute of Biological Sciences, Maria Curie-Sklodowska University, Akademicka 19, PL 20-033 Lublin, Poland. Electronic address: piotr.wlaz@umcs.lublin.pl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>KLF15 negatively regulates cardiac fibrosis by which SDF-1β attenuates cardiac fibrosis in type 2 diabetic mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34310909</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00258-1</DOI>
    <KeywordList>
      <Keywords>Cardiac fibrosis</Keywords>
      <Keywords>Diabetic cardiomyopathy</Keywords>
      <Keywords>KLF15</Keywords>
      <Keywords>SDF-1β</Keywords>
      <Keywords>Type 2 diabetes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuanyuan Tian</Name>
        <Affiliation>Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenyu Wang</Name>
        <Affiliation>Department of Spinal Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangyu Zheng</Name>
        <Affiliation>Department of Neurology, The First Hospital of Jilin University, Changchun, Jilin 130021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjing Song</Name>
        <Affiliation>Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Cai</Name>
        <Affiliation>Pediatric Research Institute, Departments of Pediatrics, Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Madhavi Rane</Name>
        <Affiliation>Division Nephrology, Departments of Medicine, Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuguang Zhao</Name>
        <Affiliation>Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China. Electronic address: zhaoyuguang@jlu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modulation of PPAR signaling disrupts pancreas development in the zebrafish, Danio rerio.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34302850</pubmedLink>
    <GrantList>
      <Grant>F32 ES028085</Grant>
      <Grant>K01 ES031640</Grant>
      <Grant>R01 ES025748</Grant>
      <Grant>R01 ES028201</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00257-X</DOI>
    <KeywordList>
      <Keywords>Development</Keywords>
      <Keywords>Organogenesis</Keywords>
      <Keywords>PPAR</Keywords>
      <Keywords>Pancreas</Keywords>
      <Keywords>Peroxisome proliferator-activated receptor</Keywords>
      <Keywords>Zebrafish</Keywords>
      <Keywords>β Cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Olivia Venezia</Name>
        <Affiliation>Department of Environmental Health Sciences, University of Massachusetts-Amherst, Amherst, MA, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Sadia Islam</Name>
        <Affiliation>Department of Environmental Health Sciences, University of Massachusetts-Amherst, Amherst, MA, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Christine Cho</Name>
        <Affiliation>School of Public Health, San Diego State University, San Diego, CA, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Alicia R. Timme-Laragy</Name>
        <Affiliation>Department of Environmental Health Sciences, University of Massachusetts-Amherst, Amherst, MA, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Karilyn E. Sant</Name>
        <Affiliation>Department of Environmental Health Sciences, University of Massachusetts-Amherst, Amherst, MA, United States of America; School of Public Health, San Diego State University, San Diego, CA, United States of America. Electronic address: ksant@sdsu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cardiopulmonary effects of phosphine poisoning: A preliminary evaluation of milrinone.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34298059</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00256-8</DOI>
    <KeywordList>
      <Keywords>Cardiopulmonary</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Milrinone</Keywords>
      <Keywords>Phosphine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wing Y. Tuet</Name>
        <Affiliation>Pharmaceutical Sciences Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel A. Pierce</Name>
        <Affiliation>Pharmaceutical Sciences Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle C. Racine</Name>
        <Affiliation>Pharmaceutical Sciences Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel Stone</Name>
        <Affiliation>Pharmaceutical Sciences Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Erin Pueblo</Name>
        <Affiliation>Pharmaceutical Sciences Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Aliyah Dukes</Name>
        <Affiliation>Pharmaceutical Sciences Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Justin Tressler</Name>
        <Affiliation>Pharmaceutical Sciences Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Jennings</Name>
        <Affiliation>Pharmaceutical Sciences Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan J. McCranor</Name>
        <Affiliation>Pharmaceutical Sciences Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Benjamin Wong</Name>
        <Affiliation>Pharmaceutical Sciences Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010, USA. Electronic address: benjamin.j.wong.civ@mail.mil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel indazole derivative, compound Cyy-272, attenuates LPS-induced acute lung injury by inhibiting JNK phosphorylation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34280409</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00252-0</DOI>
    <KeywordList>
      <Keywords>ALI</Keywords>
      <Keywords>Indazole compound</Keywords>
      <Keywords>Inflammatory</Keywords>
      <Keywords>JNK</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qian Liu</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China; Department of Pharmacy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Yan</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuyong Zheng</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China; Department of Pharmacy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lili Fu</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuyan Bao</Name>
        <Affiliation>Department of Pharmacy, Sanmen People's Hospital of Zhejiang, Sanmen, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haibo Zheng</Name>
        <Affiliation>Department of Orthopedics, Yongjia People's Hospital, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiguo Liu</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China. Electronic address: lzgcnu@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuhua Zhang</Name>
        <Affiliation>Department of Pharmacy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Electronic address: wzzhangxiuhua@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gaozhi Chen</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China; Institute of Chronic Kidney Disease, Wenzhou Medical University, Wenzhou, China. Electronic address: cgztc@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cisplatin induces autophagy-associated apoptosis in human oral squamous cell carcinoma (OSCC) mediated in part through reactive oxygen species.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34274415</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00250-7</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Chemoresistance</Keywords>
      <Keywords>Oral squamous cell carcinoma</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>c-Jun N-terminal kinase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stefania Magnano</Name>
        <Affiliation>School of Biochemistry &amp; Immunology, Trinity College Dublin, Pearse St, Dublin 2, Ireland. Electronic address: magnanos@tcd.ie.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Hannon Barroeta</Name>
        <Affiliation>School of Biochemistry &amp; Immunology, Trinity College Dublin, Pearse St, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>Ronan Duffy</Name>
        <Affiliation>School of Biochemistry &amp; Immunology, Trinity College Dublin, Pearse St, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>Jeff O'Sullivan</Name>
        <Affiliation>School of Dental Science, Trinity College Dublin, Lincoln Place, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela M. Zisterer</Name>
        <Affiliation>School of Biochemistry &amp; Immunology, Trinity College Dublin, Pearse St, Dublin 2, Ireland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prestin and otolin-1 proteins in the hearing loss of adults chronically exposed to lead.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34273409</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00255-6</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Hearing Loss</Keywords>
      <Keywords>Lead Exposure</Keywords>
      <Keywords>Otolin-1</Keywords>
      <Keywords>Prestin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Soledad Solis-Angeles</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), Mexico City, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Cuauhtémoc A. Juárez-Pérez</Name>
        <Affiliation>Unidad de Investigación de Salud en el Trabajo, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Carmina Jiménez-Ramírez</Name>
        <Affiliation>Laboratorio de Análisis Clínico, Unidad Médica de Alta Especialidad, Hospital de Traumatología "Dr. Victorio De la Fuente Narváez", IMSS, Mexico City, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandro Cabello-López</Name>
        <Affiliation>Unidad de Investigación de Salud en el Trabajo, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Guadalupe Aguilar-Madrid</Name>
        <Affiliation>Departamento de Salud Pública, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Luz M. Del Razo</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), Mexico City, Mexico. Electronic address: Ldelrazo@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A delayed treatment model for the evaluation of scopolamine for VX nerve agent intoxication.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34273408</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00254-4</DOI>
    <KeywordList>
      <Keywords>Behavioral Recovery</Keywords>
      <Keywords>Delayed Treatment</Keywords>
      <Keywords>Nerve Agent Poisoning</Keywords>
      <Keywords>Scopolamine</Keywords>
      <Keywords>VX</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alex S. Cornelissen</Name>
        <Affiliation>TNO Defence, Safety and Security, CBRN Protection, Rijswijk, the Netherlands. Electronic address: Alex.cornelissen@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Efrain E. Garcia</Name>
        <Affiliation>Biomedical Advanced Research and Development Authority (BARDA), Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), United States.</Affiliation>
      </Author>
      <Author>
        <Name>Robert E. Raulli</Name>
        <Affiliation>Biomedical Advanced Research and Development Authority (BARDA), Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), United States.</Affiliation>
      </Author>
      <Author>
        <Name>Judith Laney</Name>
        <Affiliation>Biomedical Advanced Research and Development Authority (BARDA), Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), United States.</Affiliation>
      </Author>
      <Author>
        <Name>Marloes J. A. Joosen</Name>
        <Affiliation>TNO Defence, Safety and Security, CBRN Protection, Rijswijk, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Levamisole, a cocaine cutting agent, induces acute and subchronic systemic alterations in Wistar rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34273407</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00253-2</DOI>
    <KeywordList>
      <Keywords>Adulteration</Keywords>
      <Keywords>Cocaine</Keywords>
      <Keywords>Levamisole</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Systemic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ana Olívia Martins Laurentino</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Biológicas, Farmacologia e Terapêutica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/305, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil; Laboratório de Farmacologia e Toxicologia Neurocomportamental, Departamento de Farmacologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/305, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Janaína Solómon</Name>
        <Affiliation>Laboratório de Farmacologia e Toxicologia Neurocomportamental, Departamento de Farmacologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/305, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bruna Ducatti Tonietto</Name>
        <Affiliation>Laboratório de Toxicologia (LATOX), Departamento de Análises, Faculdade de Farmácia - Anexo I, Universidade Federal do Rio Grande do Sul (UFRGS), Rua São Luis, 150/3° andar, 90620-170 Porto Alegre, Rio Grande do Sul, Brazil; Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/1° andar, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Larissa Vivan Cestonaro</Name>
        <Affiliation>Laboratório de Toxicologia (LATOX), Departamento de Análises, Faculdade de Farmácia - Anexo I, Universidade Federal do Rio Grande do Sul (UFRGS), Rua São Luis, 150/3° andar, 90620-170 Porto Alegre, Rio Grande do Sul, Brazil; Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/1° andar, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Nícolas Guimarães Dos Santos</Name>
        <Affiliation>Laboratório de Toxicologia (LATOX), Departamento de Análises, Faculdade de Farmácia - Anexo I, Universidade Federal do Rio Grande do Sul (UFRGS), Rua São Luis, 150/3° andar, 90620-170 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Yasmin Vendruscolo Piton</Name>
        <Affiliation>Laboratório de Toxicologia (LATOX), Departamento de Análises, Faculdade de Farmácia - Anexo I, Universidade Federal do Rio Grande do Sul (UFRGS), Rua São Luis, 150/3° andar, 90620-170 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lucas Izolan</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Biológicas: Neurociências, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/209, 90046-900 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas Marques</Name>
        <Affiliation>Laboratório de Farmacologia e Toxicologia Neurocomportamental, Departamento de Farmacologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/305, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil; Programa de Pós-Graduação em Ciências Biológicas: Neurociências, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/209, 90046-900 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marina Tuerlinckx Costa-Valle</Name>
        <Affiliation>Departamento de Farmacociências, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Solange Cristina Garcia</Name>
        <Affiliation>Laboratório de Toxicologia (LATOX), Departamento de Análises, Faculdade de Farmácia - Anexo I, Universidade Federal do Rio Grande do Sul (UFRGS), Rua São Luis, 150/3° andar, 90620-170 Porto Alegre, Rio Grande do Sul, Brazil; Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/1° andar, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Viviane Sebben</Name>
        <Affiliation>Centro de Informação Toxicológica, Av. Ipiranga, 5400, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Eliane Dallegrave</Name>
        <Affiliation>Departamento de Farmacociências, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Pedro Guilherme Schaefer</Name>
        <Affiliation>Faculdade de Medicina, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), R. Ramiro Barcelos, 2350, 90035-007 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Elvino José Barros</Name>
        <Affiliation>Faculdade de Medicina, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), R. Ramiro Barcelos, 2350, 90035-007 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marcelo Dutra Arbo</Name>
        <Affiliation>Laboratório de Toxicologia (LATOX), Departamento de Análises, Faculdade de Farmácia - Anexo I, Universidade Federal do Rio Grande do Sul (UFRGS), Rua São Luis, 150/3° andar, 90620-170 Porto Alegre, Rio Grande do Sul, Brazil; Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/1° andar, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil. Electronic address: marcelo.arbo@ufrgs.br.</Affiliation>
      </Author>
      <Author>
        <Name>Mirna Bainy Leal</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Biológicas, Farmacologia e Terapêutica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/305, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil; Laboratório de Farmacologia e Toxicologia Neurocomportamental, Departamento de Farmacologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/305, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil; Programa de Pós-Graduação em Ciências Biológicas: Neurociências, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/209, 90046-900 Porto Alegre, Rio Grande do Sul, Brazil. Electronic address: mirnablufrgs@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Wood smoke particle exposure in mice reduces the severity of influenza infection.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34271066</pubmedLink>
    <GrantList>
      <Grant>K08 HL105537</Grant>
      <Grant>R01 ES013611</Grant>
      <Grant>R01 ES027574</Grant>
      <Grant>T32 HL007538</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00249-0</DOI>
    <KeywordList>
      <Keywords>Airspace Inflammation</Keywords>
      <Keywords>Influenza</Keywords>
      <Keywords>Macrophages</Keywords>
      <Keywords>Wood Smoke</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aaron Vose</Name>
        <Affiliation>Department of Medicine, Duke University, Durham, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew McCravy</Name>
        <Affiliation>Department of Medicine, Duke University, Durham, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Anastasiya Birukova</Name>
        <Affiliation>Department of Medicine, Duke University, Durham, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Zhonghui Yang</Name>
        <Affiliation>Department of Medicine, Duke University, Durham, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John W. Hollingsworth</Name>
        <Affiliation>Department of Medicine, Duke University, Durham, NC, United States; Department of Medicine, Texas Christian University School of Medicine, Fort Worth, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Loretta G. Que</Name>
        <Affiliation>Department of Medicine, Duke University, Durham, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Robert M. Tighe</Name>
        <Affiliation>Department of Medicine, Duke University, Durham, NC, United States. Electronic address: robert.tighe@duke.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acrolein but not its metabolite, 3-Hydroxypropylmercapturic acid (3HPMA), activates vascular transient receptor potential Ankyrin-1 (TRPA1): Physiological to toxicological implications.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34271065</pubmedLink>
    <GrantList>
      <Grant>P30 ES030283</Grant>
      <Grant>R01 HL146134</Grant>
      <Grant>P42 ES023716</Grant>
      <Grant>P30 GM127607</Grant>
      <Grant>R01 HL122676</Grant>
      <Grant>U54 HL120163</Grant>
      <Grant>R01 HL149351</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00251-9</DOI>
    <KeywordList>
      <Keywords>Aldehydes</Keywords>
      <Keywords>Endothelium</Keywords>
      <Keywords>Mesenteric artery</Keywords>
      <Keywords>Nitric oxide (NO)</Keywords>
      <Keywords>Vasospasm</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>L. Jin</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation and Addiction Center, University of Louisville, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. Lorkiewicz</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation and Addiction Center, University of Louisville, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Z. Xie</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Bhatnagar</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation and Addiction Center, University of Louisville, Louisville, KY, USA; Superfund Research Center, University of Louisville, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. Srivastava</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation and Addiction Center, University of Louisville, Louisville, KY, USA; Superfund Research Center, University of Louisville, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. J. Conklin</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation and Addiction Center, University of Louisville, Louisville, KY, USA; Superfund Research Center, University of Louisville, Louisville, KY, USA. Electronic address: dj.conklin@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The efficacy of γ-aminobutyric acid type A receptor (GABA </ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34265354</pubmedLink>
    <GrantList>
      <Grant>R21 NS072094</Grant>
      <Grant>R21 NS110647</Grant>
      <Grant>U54 NS079202</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00247-7</DOI>
    <KeywordList>
      <Keywords>Benzodiazepine</Keywords>
      <Keywords>Chemical Threat Agent</Keywords>
      <Keywords>GABA(A)R</Keywords>
      <Keywords>Seizures</Keywords>
      <Keywords>Tetramethylenedisulfotetramine</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paige C. Mundy</Name>
        <Affiliation>Department of Molecular Biosciences, University of California, School of Veterinary Medicine, Davis, CA 95616, United States. Electronic address: pacmundy@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Brandon Pressly</Name>
        <Affiliation>Department of Pharmacology, University of California, School of Medicine, Davis, CA 95616, United States. Electronic address: bpressly@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Dennis R. Carty</Name>
        <Affiliation>Department of Molecular Biosciences, University of California, School of Veterinary Medicine, Davis, CA 95616, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bianca Yaghoobi</Name>
        <Affiliation>Department of Molecular Biosciences, University of California, School of Veterinary Medicine, Davis, CA 95616, United States. Electronic address: byaghoobi@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Heike Wulff</Name>
        <Affiliation>Department of Pharmacology, University of California, School of Medicine, Davis, CA 95616, United States. Electronic address: hwulff@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Pamela J. Lein</Name>
        <Affiliation>Department of Molecular Biosciences, University of California, School of Veterinary Medicine, Davis, CA 95616, United States. Electronic address: pjlein@ucdavis.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The Aryl hydrocarbon receptor mediates reproductive toxicity of polychlorinated biphenyl congener 126 in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34256052</pubmedLink>
    <GrantList>
      <Grant>P42 ES013661</Grant>
      <Grant>R01 ES029280</Grant>
      <Grant>R21 ES028957</Grant>
      <Grant>R24 HD102061</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00243-X</DOI>
    <KeywordList>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Aryl hydrocarbon receptor knock out</Keywords>
      <Keywords>PCB126</Keywords>
      <Keywords>Polychlorinated biphenyl</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Violet Klenov</Name>
        <Affiliation>Dept of Ob/Gyn, University of Iowa, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Flor</Name>
        <Affiliation>Interdisciplinary Graduate Program in Human Toxicology and Dept of Occupational and Environmental Health, University of Iowa, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Shanthi Ganesan</Name>
        <Affiliation>Dept of Animal Science, Iowa State University, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Malavika Adur</Name>
        <Affiliation>Dept of Animal Science, Iowa State University, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Nazmin Eti</Name>
        <Affiliation>Interdisciplinary Graduate Program in Human Toxicology and Dept of Occupational and Environmental Health, University of Iowa, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Khursheed Iqbal</Name>
        <Affiliation>Institute for Reproduction and Perinatal Research and Department of Pathology, University of Kansas Medical Center, Kansas City, KS, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Soares</Name>
        <Affiliation>Institute for Reproduction and Perinatal Research and Department of Pathology, University of Kansas Medical Center, Kansas City, KS, United States of America; Departments of Pediatrics and Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, KS, United States of America; Center for Perinatal Research, Children's Research Institute, Children's Mercy, Kansas City, MO, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriele Ludewig</Name>
        <Affiliation>Interdisciplinary Graduate Program in Human Toxicology and Dept of Occupational and Environmental Health, University of Iowa, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jason W. Ross</Name>
        <Affiliation>Dept of Animal Science, Iowa State University, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Larry W. Robertson</Name>
        <Affiliation>Interdisciplinary Graduate Program in Human Toxicology and Dept of Occupational and Environmental Health, University of Iowa, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Aileen F. Keating</Name>
        <Affiliation>Dept of Animal Science, Iowa State University, United States of America. Electronic address: akeating@iastate.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPARα mice fed an American diet.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34252412</pubmedLink>
    <GrantList>
      <Grant>P42 ES007381</Grant>
      <Grant>R01 ES027813</Grant>
      <Grant>S10 OD023663</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00248-9</DOI>
    <KeywordList>
      <Keywords>Lipid homeostasis</Keywords>
      <Keywords>Perfluorooctanoic acid</Keywords>
      <Keywords>Peroxisome proliferator activated receptor α</Keywords>
      <Keywords>Triacylglyceride</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. J. Schlezinger</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston, MA 02118, USA. Electronic address: jschlezi@bu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>T. Hyötyläinen</Name>
        <Affiliation>MTM Research Centre, School of Science and Technology, Örebro University, Örebro 702 81, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>T. Sinioja</Name>
        <Affiliation>MTM Research Centre, School of Science and Technology, Örebro University, Örebro 702 81, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>C. Boston</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston, MA 02118, USA.</Affiliation>
      </Author>
      <Author>
        <Name>H. Puckett</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston, MA 02118, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Oliver</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston, MA 02118, USA.</Affiliation>
      </Author>
      <Author>
        <Name>W. Heiger-Bernays</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston, MA 02118, USA.</Affiliation>
      </Author>
      <Author>
        <Name>T. F. Webster</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston, MA 02118, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Does maternal exposure to nicotine affect the oocyte quality and reproductive capacity in adult offspring?</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34242569</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00242-8</DOI>
    <KeywordList>
      <Keywords>Embryo</Keywords>
      <Keywords>Female Reproduction</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Oocyte</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. C. Paccola</Name>
        <Affiliation>Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil. Electronic address: camila.paccola@unifesp.br.</Affiliation>
      </Author>
      <Author>
        <Name>G. S. Souza</Name>
        <Affiliation>Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>I. M. M. Freitas</Name>
        <Affiliation>Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>J. C. Souza</Name>
        <Affiliation>Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>L. L. Martins</Name>
        <Affiliation>Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>V. Vendramini</Name>
        <Affiliation>Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>S. M. Miraglia</Name>
        <Affiliation>Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developmental exposure of bisphenol A induces spatial memory deficits by weakening the excitatory neural circuits of CA3-CA1 and EC-CA1 in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34242568</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00245-3</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Hippocampus</Keywords>
      <Keywords>Neural circuit</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Spatial memory</Keywords>
      <Keywords>Virus tracing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nanxi Bi</Name>
        <Affiliation>Engineering Research Center of Bio-process, Ministry of Education, Hefei University of Technology, 193 Tunxi Road, Hefei, Anhui 230009, PR China; School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinjun Ding</Name>
        <Affiliation>School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Rongxin Zou</Name>
        <Affiliation>School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaozhen Gu</Name>
        <Affiliation>Engineering Research Center of Bio-process, Ministry of Education, Hefei University of Technology, 193 Tunxi Road, Hefei, Anhui 230009, PR China; School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Hua Liu</Name>
        <Affiliation>Engineering Research Center of Bio-process, Ministry of Education, Hefei University of Technology, 193 Tunxi Road, Hefei, Anhui 230009, PR China; School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Li Wang</Name>
        <Affiliation>Engineering Research Center of Bio-process, Ministry of Education, Hefei University of Technology, 193 Tunxi Road, Hefei, Anhui 230009, PR China; School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, PR China. Electronic address: wanghl@hfut.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The interaction of disulfiram and H</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34242567</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00246-5</DOI>
    <KeywordList>
      <Keywords>Aldehyde dehydrogenase</Keywords>
      <Keywords>Cystathionine gamma-lyase</Keywords>
      <Keywords>Disulfiram</Keywords>
      <Keywords>H(2)S</Keywords>
      <Keywords>Liver cancer stem cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ethan Read</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Laurentian University, Sudbury, Canada; Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jarod Milford</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Laurentian University, Sudbury, Canada; Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jiechun Zhu</Name>
        <Affiliation>Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Canada; Department of Biology, Laurentian University, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Lingyun Wu</Name>
        <Affiliation>Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Canada; School of Kinesiology and Health Sciences, Laurentian University, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Marc Bilodeau</Name>
        <Affiliation>Laboratoire d'Hépatologie Cellulaire, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Québec, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Guangdong Yang</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Laurentian University, Sudbury, Canada; Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Canada; Department of Biology, Laurentian University, Sudbury, Canada. Electronic address: gyang2@laurentian.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Untargeted metabolomics and lipidomics analysis identified the role of FOXA1 in remodeling the metabolic pattern of BaP-transformed 16HBE cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34242566</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00244-1</DOI>
    <KeywordList>
      <Keywords>Benzo[a]Pyrene</Keywords>
      <Keywords>FOXA1</Keywords>
      <Keywords>Lipidomics</Keywords>
      <Keywords>Lung Cancer</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>THBEc1 cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chuan Zhou</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Ma</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Chen</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ludi Li</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Wang</Name>
        <Affiliation>National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunkun Xing</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Juanling Fu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Biyun Yao</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Chang</Name>
        <Affiliation>National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing 100050, PR China. Electronic address: bjchangbing@sohu.com.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Zhao</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China. Electronic address: zhaopeng@bjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MicroRNA-30c-5p protects against myocardial ischemia/reperfusion injury via regulation of Bach1/Nrf2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34217758</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00241-6</DOI>
    <KeywordList>
      <Keywords>Bach1</Keywords>
      <Keywords>Hhypoxia/re-oxygenation</Keywords>
      <Keywords>Mmyocardial ischemia/reperfusion injury</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>miR-30c-5p</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Meng Sun</Name>
        <Affiliation>Department of Cardiology, The First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Taiyuan 030001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Guo</Name>
        <Affiliation>Department of Cardiology, The First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Taiyuan 030001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guijin Ma</Name>
        <Affiliation>Department of Cardiology, The First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Taiyuan 030001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Nan Zhang</Name>
        <Affiliation>Department of Cardiology, The First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Taiyuan 030001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feifei Pan</Name>
        <Affiliation>Department of Cardiology, The First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Taiyuan 030001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoling Fan</Name>
        <Affiliation>Department of Geriatrics, The First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Taiyuan 030001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Wang</Name>
        <Affiliation>Department of Cardiology, The First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Taiyuan 030001, China. Electronic address: wang_ruismu@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective effect of genistein pre-treatment on paraquat hepatotoxicity in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34214573</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00240-4</DOI>
    <KeywordList>
      <Keywords>Genistein</Keywords>
      <Keywords>Glutathione-S-transferase</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>P-Glycoprotein</Keywords>
      <Keywords>Paraquat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mariana Semeniuk</Name>
        <Affiliation>Instituto de Fisiología Experimental (CONICET) - Facultad de Ciencias Bioquímicas y Farmacéuticas (UNR), Suipacha 570, (2000) Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Lucila Inés Ceré</Name>
        <Affiliation>Instituto de Fisiología Experimental (CONICET) - Facultad de Ciencias Bioquímicas y Farmacéuticas (UNR), Suipacha 570, (2000) Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Nadia Ciriaci</Name>
        <Affiliation>Instituto de Fisiología Experimental (CONICET) - Facultad de Ciencias Bioquímicas y Farmacéuticas (UNR), Suipacha 570, (2000) Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>María Bucci-Muñoz</Name>
        <Affiliation>Instituto de Fisiología Experimental (CONICET) - Facultad de Ciencias Bioquímicas y Farmacéuticas (UNR), Suipacha 570, (2000) Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Ariel Dario Quiroga</Name>
        <Affiliation>Instituto de Fisiología Experimental (CONICET) - Facultad de Ciencias Bioquímicas y Farmacéuticas (UNR), Suipacha 570, (2000) Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Marcelo Gabriel Luquita</Name>
        <Affiliation>Instituto de Fisiología Experimental (CONICET) - Facultad de Ciencias Bioquímicas y Farmacéuticas (UNR), Suipacha 570, (2000) Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Stella Roma</Name>
        <Affiliation>Cátedra de Histología y Embriología, Facultad de Ciencias Médicas-UNR, Santa Fe 3100, (2000) Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Viviana Alicia Catania</Name>
        <Affiliation>Instituto de Fisiología Experimental (CONICET) - Facultad de Ciencias Bioquímicas y Farmacéuticas (UNR), Suipacha 570, (2000) Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Aldo Domingo Mottino</Name>
        <Affiliation>Instituto de Fisiología Experimental (CONICET) - Facultad de Ciencias Bioquímicas y Farmacéuticas (UNR), Suipacha 570, (2000) Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Pablo Rigalli</Name>
        <Affiliation>Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>María Laura Ruiz</Name>
        <Affiliation>Instituto de Fisiología Experimental (CONICET) - Facultad de Ciencias Bioquímicas y Farmacéuticas (UNR), Suipacha 570, (2000) Rosario, Argentina. Electronic address: ruiz@ifise-conicet.gov.ar.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prasugrel anti-ischemic effect in rats: Modulation of hippocampal SUMO2/3-IкBα/Ubc9 and SIRT-1/miR-22 trajectories.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34174262</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00239-8</DOI>
    <KeywordList>
      <Keywords>Cerebral I/R</Keywords>
      <Keywords>GFAP</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>SUMOylation</Keywords>
      <Keywords>Y-maze</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Asmaa A. Gomaa</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Hanan S. El-Abhar</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Dalaal M. Abdallah</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: dalaal.abdallah@pharma.cu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Azza S. Awad</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Ayman A. Soubh</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bisphenol analogs AF and S: Effects on cell status and production of angiogenesis-related factors by COV434 human granulosa cell line.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34174261</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00238-6</DOI>
    <KeywordList>
      <Keywords>Bisphenol analogs</Keywords>
      <Keywords>Cell viability</Keywords>
      <Keywords>Granulosa cell line</Keywords>
      <Keywords>Matrix metalloproteinase</Keywords>
      <Keywords>Platelet-derived growth factor</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Vascular endothelial growth factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alzbeta Bujnakova Mlynarcikova</Name>
        <Affiliation>Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia. Electronic address: ueenamly@savba.sk.</Affiliation>
      </Author>
      <Author>
        <Name>Sona Scsukova</Name>
        <Affiliation>Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The role of PD-1/PD-L1 checkpoint in arsenic lung tumorigenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34166680</pubmedLink>
    <GrantList>
      <Grant>P30 CA177558</Grant>
      <Grant>R01 ES026657</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00237-4</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>PD-1</Keywords>
      <Keywords>PD-L1</Keywords>
      <Keywords>T cell</Keywords>
      <Keywords>Tumor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wenhua Xu</Name>
        <Affiliation>Department Pharmacology &amp; Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, USA; Department of Neurology, the First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui 230001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiajun Cui</Name>
        <Affiliation>Department Pharmacology &amp; Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, USA; Department of Biochemistry, College of Medicine, Yichun University, Yichun, Jiangxi 336000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Linqing Wu</Name>
        <Affiliation>Department Pharmacology &amp; Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, USA; Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, FuZhou, Fujian 350003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Caigu He</Name>
        <Affiliation>Department Pharmacology &amp; Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, USA; Department of Histology and Embryology, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 361000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gang Chen</Name>
        <Affiliation>Department Pharmacology &amp; Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, USA. Electronic address: gangchen6@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A coordinated ruthenium-rifampicin complex reprogramming the colon carcinoma micro-environment mediated by modulation of p53/AkT/mTOR/VEGF pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34126112</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00222-2</DOI>
    <KeywordList>
      <Keywords>ACF</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Chemotherapy</Keywords>
      <Keywords>Colon cancer</Keywords>
      <Keywords>Metal complex</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jie Zeng</Name>
        <Affiliation>Department of Emergency Surgery, Sichuan Academy of Medical Sciences &amp; Sichuan ProvinciA People's Hospital, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, Sichuan 610072, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Zhao</Name>
        <Affiliation>Department of Emergency Surgery, Sichuan Academy of Medical Sciences &amp; Sichuan ProvinciA People's Hospital, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, Sichuan 610072, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kexun Li</Name>
        <Affiliation>Department of Emergency Surgery, Sichuan Academy of Medical Sciences &amp; Sichuan ProvinciA People's Hospital, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, Sichuan 610072, China.</Affiliation>
      </Author>
      <Author>
        <Name>Daoling Long</Name>
        <Affiliation>Department of Emergency Surgery, Sichuan Academy of Medical Sciences &amp; Sichuan ProvinciA People's Hospital, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, Sichuan 610072, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Li</Name>
        <Affiliation>Department of Emergency Surgery, Sichuan Academy of Medical Sciences &amp; Sichuan ProvinciA People's Hospital, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, Sichuan 610072, China. Electronic address: leewww1980@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Liang</Name>
        <Affiliation>Department of Cancer Center, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People's Hospital, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, Sichuan 610072, China. Electronic address: liangliang202010@sina.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Liver-specific Nrf2 deficiency accelerates ethanol-induced lethality and hepatic injury in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34116071</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00221-0</DOI>
    <KeywordList>
      <Keywords>Ethanol</Keywords>
      <Keywords>Ethanol detoxification</Keywords>
      <Keywords>Lipid metabolism</Keywords>
      <Keywords>Liver injury</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Sun</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhixuan Hong</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuai Shao</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Li</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bei Yang</Name>
        <Affiliation>Department of Histology and Embryology, School of Basic Medical Sciences, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongyong Hou</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Huihui Wang</Name>
        <Affiliation>Group of Chronic Disease and Environmental Genomics, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyuan Xu</Name>
        <Affiliation>Group of Chronic Disease and Environmental Genomics, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China; Key Laboratory of Liaoning Province on Toxic and Biological Effects of Arsenic, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Zhang</Name>
        <Affiliation>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China; Key Laboratory of Liaoning Province on Toxic and Biological Effects of Arsenic, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China. Electronic address: jbpi@cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jingqi Fu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China. Electronic address: jqfu@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oxytetracycline induces anxiety-like behavior in adult zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34102243</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00220-9</DOI>
    <KeywordList>
      <Keywords>Anxiety</Keywords>
      <Keywords>Behavior</Keywords>
      <Keywords>Cortisol</Keywords>
      <Keywords>Oxytetracycline</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Darlan Gusso</Name>
        <Affiliation>Programa de Pós-Graduação em Biologia Celular e Molecular, Escola de Ciências da Saúde e da Vida, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Stefani Altenhofen</Name>
        <Affiliation>Programa de Pós-Graduação em Medicina e Ciências da Saúde, Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Pâmella Moreira Fritsch</Name>
        <Affiliation>Programa de Pós-Graduação em Biologia Celular e Molecular, Escola de Ciências da Saúde e da Vida, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriel Rübensam</Name>
        <Affiliation>Centro de Pesquisa em Toxicologia e Farmacologia, Escola de Ciências da Saúde e da Vida, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carla Denise Bonan</Name>
        <Affiliation>Programa de Pós-Graduação em Biologia Celular e Molecular, Escola de Ciências da Saúde e da Vida, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil; Programa de Pós-Graduação em Medicina e Ciências da Saúde, Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil. Electronic address: cbonan@pucrs.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prenatal endothelin or thromboxane receptor antagonism surpasses sympathoinhibition in improving cardiorenal malfunctions in preeclamptic rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34102242</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00219-2</DOI>
    <KeywordList>
      <Keywords>End-organ damage</Keywords>
      <Keywords>Endothelin receptors</Keywords>
      <Keywords>Preeclampsia</Keywords>
      <Keywords>Thromboxane receptors</Keywords>
      <Keywords>Tissue inflammation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yasser H. Habib</Name>
        <Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Sherien A. Abdelhady</Name>
        <Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mennatallah A. Gowayed</Name>
        <Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Nevine M. El-Deeb</Name>
        <Affiliation>Department of Clinical Pathology, Faculty of Medicine, Alexandria University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Inas E. Darwish</Name>
        <Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt; Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mahmoud M. El-Mas</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Egypt; Department of Pharmacology and Toxicology, Faculty of Medicine, Kuwait University, Kuwait. Electronic address: mahmoud.elmas@ku.edu.kw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The inhibition of microtubule dynamics instability alters lipid homeostasis in TM4 Sertoli cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34089742</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00211-8</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Cytoskeleton</Keywords>
      <Keywords>Lipid metabolism</Keywords>
      <Keywords>Microtubule dynamics instability</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Nocodazole</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. S. Vallés</Name>
        <Affiliation>Instituto de Investigaciones Bioquıímicas de Bahía Blanca, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional del Sur (UNS), Bahía Blanca, Argentina. Electronic address: svalles@criba.edu.ar.</Affiliation>
      </Author>
      <Author>
        <Name>P. E. Tenconi</Name>
        <Affiliation>Instituto de Investigaciones Bioquıímicas de Bahía Blanca, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional del Sur (UNS), Bahía Blanca, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>J. M. Luquez</Name>
        <Affiliation>Instituto de Investigaciones Bioquıímicas de Bahía Blanca, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional del Sur (UNS), Bahía Blanca, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>N. E. Furland</Name>
        <Affiliation>Instituto de Investigaciones Bioquıímicas de Bahía Blanca, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional del Sur (UNS), Bahía Blanca, Argentina.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Triptolide impairs glycolysis by suppressing GATA4/Sp1/PFKP signaling axis in mouse Sertoli cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34087332</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00210-6</DOI>
    <KeywordList>
      <Keywords>GATA4</Keywords>
      <Keywords>Glycolysis</Keywords>
      <Keywords>Sp1</Keywords>
      <Keywords>Testicular toxicity</Keywords>
      <Keywords>Triptolide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yunhui Zhang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yinru Tang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuping Luo</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Luo</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Feihai Shen</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China. Electronic address: shenfh3@mail.sysu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiying Huang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China. Electronic address: hzhiying@mail.sysu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Microarray-based identification of differentially expressed genes associated with andrographolide derivatives-induced resistance in colon and prostate cancer cell lines.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34087331</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00209-X</DOI>
    <KeywordList>
      <Keywords>Chemoresistance</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Microarray analysis</Keywords>
      <Keywords>SRJ09</Keywords>
      <Keywords>SRJ23</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shun Ying Quah</Name>
        <Affiliation>Pharmacotherapeutics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Charng Choon Wong</Name>
        <Affiliation>Pharmacotherapeutics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Chyn Wong</Name>
        <Affiliation>Pharmacotherapeutics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Kok Lian Ho</Name>
        <Affiliation>Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Nizar Abdul Manan</Name>
        <Affiliation>Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Pran Kishore Deb</Name>
        <Affiliation>Faculty of Pharmacy, P.O.BOX (1), Philadelphia University, 19392 Amman, Jordan.</Affiliation>
      </Author>
      <Author>
        <Name>Sreenivasa Rao Sagineedu</Name>
        <Affiliation>Department of Pharmaceutical Chemistry, School of Pharmacy, International Medical University, 57000 Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Johnson Stanslas</Name>
        <Affiliation>Pharmacotherapeutics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia. Electronic address: rcxjs@upm.edu.my.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Agomelatine protects against obesity-induced renal injury by inhibiting endoplasmic reticulum stress/apoptosis pathway in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34081941</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00208-8</DOI>
    <KeywordList>
      <Keywords>Agomelatine</Keywords>
      <Keywords>ER stress</Keywords>
      <Keywords>Kidney function</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Organic anion transporter 3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rada Cherngwelling</Name>
        <Affiliation>Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Nattavadee Pengrattanachot</Name>
        <Affiliation>Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Myat Theingi Swe</Name>
        <Affiliation>Department of Physiology, University of Medicine 2, Yangon, Myanmar.</Affiliation>
      </Author>
      <Author>
        <Name>Laongdao Thongnak</Name>
        <Affiliation>Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Sasivimon Promsan</Name>
        <Affiliation>Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Nichakorn Phengpol</Name>
        <Affiliation>Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Prempree Sutthasupha</Name>
        <Affiliation>Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Anusorn Lungkaphin</Name>
        <Affiliation>Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai, Thailand. Electronic address: anusorn.lungka@cmu.ac.th.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A new clinically-relevant rat model of letrozole-induced chronic nociceptive disorders.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34081940</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00207-6</DOI>
    <KeywordList>
      <Keywords>Arthralgia</Keywords>
      <Keywords>Letrozole</Keywords>
      <Keywords>Myalgia</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>TRPA1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aurore Collin</Name>
        <Affiliation>Université Clermont Auvergne, INSERM, U1107, NEURO-DOL, F-63000 Clermont-Ferrand, France. Electronic address: aurore.collin@uca.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Julie Vein</Name>
        <Affiliation>Université Clermont Auvergne, INSERM, U1107, NEURO-DOL, F-63000 Clermont-Ferrand, France.</Affiliation>
      </Author>
      <Author>
        <Name>Yohann Wittrant</Name>
        <Affiliation>Université Clermont Auvergne, INRA, UNH, 63000 Clermont-Ferrand, France; INRAE, UMR 1019, UNH, 63122 Saint-Genès Champanelle, France.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Pereira</Name>
        <Affiliation>CHU Clermont-Ferrand, Direction de la recherche clinique et de l'innovation, F-63000 Clermont-Ferrand, France.</Affiliation>
      </Author>
      <Author>
        <Name>Raalib Amode</Name>
        <Affiliation>School of Pharmacy, Faculty of Science, University of East Anglia, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christelle Guillet</Name>
        <Affiliation>Université Clermont Auvergne, INRA, UMR1019, UNH, CRNH Auvergne, F-63000 Clermont-Ferrand, France.</Affiliation>
      </Author>
      <Author>
        <Name>Damien Richard</Name>
        <Affiliation>Université Clermont Auvergne, INSERM U1107, NEURO-DOL, CHU Clermont-Ferrand, Laboratoire de Pharmacologie et de Toxicologie, F-63000 Clermont-Ferrand, France.</Affiliation>
      </Author>
      <Author>
        <Name>Alain Eschalier</Name>
        <Affiliation>Université Clermont Auvergne, INSERM, U1107, NEURO-DOL, F-63000 Clermont-Ferrand, France.</Affiliation>
      </Author>
      <Author>
        <Name>David Balayssac</Name>
        <Affiliation>Université Clermont Auvergne, INSERM U1107, NEURO-DOL, CHU Clermont-Ferrand, Direction de la recherche clinique et de l'innovation, F-63000 Clermont-Ferrand, France. Electronic address: david.balayssac@uca.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A review of rodent models for metabolic syndromes and pulmonary hypertension.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34081939</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00206-4</DOI>
    <KeywordList>
      <Keywords>Animal model</Keywords>
      <Keywords>Diabetes</Keywords>
      <Keywords>Novel treatments</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Pulmonary hypertension</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Magdalena Jasińska-Stroschein</Name>
        <Affiliation>Department of Biopharmacy, Medical University of Łódź, ul. Muszyńskiego 1, 90-151 Lodz, Poland. Electronic address: magdalena.jasinska-stroschein@umed.lodz.pl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Final results from a 90-day quantitative inhalation toxicology study evaluating the dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to TiO</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34077769</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00205-2</DOI>
    <KeywordList>
      <Keywords>Amphibole</Keywords>
      <Keywords>Asbestos</Keywords>
      <Keywords>Brake dust</Keywords>
      <Keywords>Chrysotile</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Pathology</Keywords>
      <Keywords>Tumors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David M. Bernstein</Name>
        <Affiliation>Consultant in Toxicology, 40 ch de la Petite-Boissière, 1208 Geneva, Switzerland. Electronic address: davidb@itox.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Balazs Toth</Name>
        <Affiliation>Charles River Laboratories Hungary Kft., Szabadságpuszta, Veszprém 8200, Hungary. Electronic address: Balazs.Toth@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rick A. Rogers</Name>
        <Affiliation>Rogers Imaging, 17 Erie Dr, Natick, MA 01760-1312, USA. Electronic address: rarogers5@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Kunzendorf</Name>
        <Affiliation>GSA Gesellschaft für Schadstoffanalytik mbH, Christinenstrasse 3, D-40880 Ratingen, Germany. Electronic address: kunzendorf@gsas.ch.</Affiliation>
      </Author>
      <Author>
        <Name>James I. Phillips</Name>
        <Affiliation>National Institute for Occupational Health, National Health Laboratory Service, Johannesburg South Africa and Department of Biomedical Technology, Faculty of Health Sciences, University of Johannesburg, Johannesburg 2000, South Africa. Electronic address: jimphillipsy@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dirk Schaudien</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine, 1 Nikolai-Fuchs-Strasse, D-30625 Hannover, Germany. Electronic address: dirk.schaudien@item.fraunhofer.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gut microbiome-host interactions in driving environmental pollutant trichloroethene-mediated autoimmunity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34051218</pubmedLink>
    <GrantList>
      <Grant>R01 ES016302</Grant>
      <Grant>R01 ES026887</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00204-0</DOI>
    <KeywordList>
      <Keywords>Autoimmunity</Keywords>
      <Keywords>Environmental pollutant</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Microbiome</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Permeability</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Nivedita Banerjee</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Yuejin Liang</Name>
        <Affiliation>Department of Microbiology and Immunology, University of Texas Medical Branch, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Gangduo Wang</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Kristi L. Hoffman</Name>
        <Affiliation>Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>M. Firoze Khan</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, TX, United States of America. Electronic address: mfkhan@utmb.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Network pharmacology and molecular docking analysis on molecular targets: Mechanisms of baicalin and baicalein against hyperuricemic nephropathy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34044073</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00201-5</DOI>
    <KeywordList>
      <Keywords>Baicalein</Keywords>
      <Keywords>Baicalin</Keywords>
      <Keywords>Hyperuricemic nephropathy</Keywords>
      <Keywords>Molecular docking.</Keywords>
      <Keywords>Network pharmacology</Keywords>
      <Keywords>Xanthine oxidase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Huilong Xiang</Name>
        <Affiliation>College of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huan Lei</Name>
        <Affiliation>College of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ziyuan Liu</Name>
        <Affiliation>College of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongjie Liu</Name>
        <Affiliation>College of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Li</Name>
        <Affiliation>College of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yinsheng Qiu</Name>
        <Affiliation>School of Animal Science and Nutrition Engineering, Wuhan Polytechnic University, Wuhan 430023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingyun Xu</Name>
        <Affiliation>College of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430023, China. Electronic address: doctorxly9898@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The protective mechanism of resveratrol against hepatic injury induced by iron overload in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34044072</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00203-9</DOI>
    <KeywordList>
      <Keywords>Iron deposition</Keywords>
      <Keywords>Iron overload</Keywords>
      <Keywords>Liver injury</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>RES</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jinghan Li</Name>
        <Affiliation>School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.</Affiliation>
      </Author>
      <Author>
        <Name>Simeng Wang</Name>
        <Affiliation>College of Nursing, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiaqi Duan</Name>
        <Affiliation>College of Acupuncture and Massage, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peixin Le</Name>
        <Affiliation>School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Li</Name>
        <Affiliation>College of Acupuncture and Massage, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongpei Ding</Name>
        <Affiliation>College of Acupuncture and Massage, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Wang</Name>
        <Affiliation>School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, China. Electronic address: wangrui7777@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yonggang Gao</Name>
        <Affiliation>School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, China. Electronic address: gyg3177@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of the drug-drug interactions potential of ibrutinib and acalabrutinib via inhibition of UDP-glucuronosyltransferase.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34038714</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00202-7</DOI>
    <KeywordList>
      <Keywords>Acalabrutinib</Keywords>
      <Keywords>Drug-drug interaction</Keywords>
      <Keywords>Ibrutinib</Keywords>
      <Keywords>UDP-glucuronosyltransferase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaoyu Wang</Name>
        <Affiliation>School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin 124221, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Wang</Name>
        <Affiliation>School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin 124221, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyu Fan</Name>
        <Affiliation>School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin 124221, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingrui Yan</Name>
        <Affiliation>School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin 124221, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lili Jiang</Name>
        <Affiliation>School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin 124221, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yangliu Xia</Name>
        <Affiliation>School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin 124221, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Cao</Name>
        <Affiliation>Department of Occupational and Environmental Health, Dalian Medical University, Dalian 116044, China. Electronic address: caojunly@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Liu</Name>
        <Affiliation>School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin 124221, China. Electronic address: yliu@dlut.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Molecular and clinical insights of matrix metalloproteinases into cancer spread and potential therapeutic interventions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34038713</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00200-3</DOI>
    <KeywordList>
      <Keywords>Cancer therapy</Keywords>
      <Keywords>Extracellular matrix</Keywords>
      <Keywords>Matrix metalloproteinases</Keywords>
      <Keywords>Matrix metalloproteinases inhibitors</Keywords>
      <Keywords>Tumor microenvironment</Keywords>
      <Keywords>Tumorigenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rohit Siddhartha</Name>
        <Affiliation>Department of Biochemistry, University of Lucknow, Lucknow 226007, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Minal Garg</Name>
        <Affiliation>Department of Biochemistry, University of Lucknow, Lucknow 226007, Uttar Pradesh, India. Electronic address: garg_minal@lkouniv.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Physical analysis reveals distinct responses of human bronchial epithelial cells to guanidine and isothiazolinone biocides.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34029620</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00196-4</DOI>
    <KeywordList>
      <Keywords>Biomechanical endpoints</Keywords>
      <Keywords>CMIT/MIT</Keywords>
      <Keywords>Heterogeneity</Keywords>
      <Keywords>Monolayer stress microscopy</Keywords>
      <Keywords>PHMG</Keywords>
      <Keywords>Traction force microscopy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tae Yoon Kwon</Name>
        <Affiliation>Department of Mechanical Engineering, KAIST, 291 Daehakro, Yuseong-gu, Daejeon 34034, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jaeseong Jeong</Name>
        <Affiliation>School of Environmental Engineering, University of Seoul, 163 Seoulsiripdae-ro, Dongdaemun-gu, Seoul 02504, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eunyoung Park</Name>
        <Affiliation>Department of Mechanical Engineering, KAIST, 291 Daehakro, Yuseong-gu, Daejeon 34034, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Youngbin Cho</Name>
        <Affiliation>Department of Mechanical Engineering, KAIST, 291 Daehakro, Yuseong-gu, Daejeon 34034, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dongyoung Lim</Name>
        <Affiliation>School of Environmental Engineering, University of Seoul, 163 Seoulsiripdae-ro, Dongdaemun-gu, Seoul 02504, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ung Hyun Ko</Name>
        <Affiliation>Department of Mechanical Engineering, KAIST, 291 Daehakro, Yuseong-gu, Daejeon 34034, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer H. Shin</Name>
        <Affiliation>Department of Mechanical Engineering, KAIST, 291 Daehakro, Yuseong-gu, Daejeon 34034, Republic of Korea. Electronic address: j_shin@kaist.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Jinhee Choi</Name>
        <Affiliation>School of Environmental Engineering, University of Seoul, 163 Seoulsiripdae-ro, Dongdaemun-gu, Seoul 02504, Republic of Korea. Electronic address: jinhchoi@uos.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bongkrekic acid induced neutrophil extracellular traps via p38, ERK, PAD4, and P2X1-mediated signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34019862</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00187-3</DOI>
    <KeywordList>
      <Keywords>Bongkrekic acid</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Neutrophil extracellular traps</Keywords>
      <Keywords>Signaling pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ershun Zhou</Name>
        <Affiliation>College of Life Sciences and Engineering, Foshan University, Foshan 528225, Guangdong Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Youpeng Sun</Name>
        <Affiliation>College of Life Sciences and Engineering, Foshan University, Foshan 528225, Guangdong Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiwu Fu</Name>
        <Affiliation>College of Life Sciences and Engineering, Foshan University, Foshan 528225, Guangdong Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xia Wang</Name>
        <Affiliation>College of Life Sciences and Engineering, Foshan University, Foshan 528225, Guangdong Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xingyi Zhu</Name>
        <Affiliation>College of Life Sciences and Engineering, Foshan University, Foshan 528225, Guangdong Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhikai Wu</Name>
        <Affiliation>College of Life Sciences and Engineering, Foshan University, Foshan 528225, Guangdong Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Peixuan Li</Name>
        <Affiliation>College of Life Sciences and Engineering, Foshan University, Foshan 528225, Guangdong Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingjing Wang</Name>
        <Affiliation>College of Life Sciences and Engineering, Foshan University, Foshan 528225, Guangdong Province, PR China. Electronic address: 18246066760@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengtao Yang</Name>
        <Affiliation>College of Life Sciences and Engineering, Foshan University, Foshan 528225, Guangdong Province, PR China. Electronic address: yangzhengtao01@sina.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mitochondrial dynamics imbalance and mitochondrial dysfunction contribute to the molecular cardiotoxic effects of lenvatinib.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34019861</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00184-8</DOI>
    <KeywordList>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Lenvatinib</Keywords>
      <Keywords>Mitochondrial damage</Keywords>
      <Keywords>Mitochondrial toxicity</Keywords>
      <Keywords>Tyrosine kinase inhibitors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aysenur Gunaydin Akyildiz</Name>
        <Affiliation>Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, 34116 Beyazit, Istanbul, Turkey; Bezmialem Vakif University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Vatan Street, 34093 Fatih, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Tugce Boran</Name>
        <Affiliation>Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, 34116 Beyazit, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ayse Tarbin Jannuzzi</Name>
        <Affiliation>Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, 34116 Beyazit, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Buket Alpertunga</Name>
        <Affiliation>Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, 34116 Beyazit, Istanbul, Turkey. Electronic address: tunga@istanbul.edu.tr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safranal inhibits NLRP3 inflammasome activation by preventing ASC oligomerization.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34019860</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00189-7</DOI>
    <KeywordList>
      <Keywords>ASC</Keywords>
      <Keywords>Caspase-1</Keywords>
      <Keywords>IL-1β</Keywords>
      <Keywords>Macrophages</Keywords>
      <Keywords>NLRP3 inflammasome</Keywords>
      <Keywords>Saffron</Keywords>
      <Keywords>Safranal</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mehak Gupta</Name>
        <Affiliation>PK-PD-Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Abubakar Wani</Name>
        <Affiliation>PK-PD-Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Aitizaz Ul Ahsan</Name>
        <Affiliation>Cytogenetics Laboratory, Department of Zoology, Panjab University, Chandigarh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mehboob Ali</Name>
        <Affiliation>PK-PD-Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pankaj Chibber</Name>
        <Affiliation>PK-PD-Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Surjeet Singh</Name>
        <Affiliation>PK-PD-Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sanjeev K. Digra</Name>
        <Affiliation>Department of Paediatrics, Government Medical College, Jammu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Manish Datt</Name>
        <Affiliation>Biological and Life Sciences Division, School of Arts and Sciences, Ahmedabad University, Ahmedabad, Gujarat 380009, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sandip B. Bharate</Name>
        <Affiliation>Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India; Medicinal Chemistry Division, Indian Institute of Integrative Medicine, CSIR, Jammu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ram A. Vishwakarma</Name>
        <Affiliation>Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India; Medicinal Chemistry Division, Indian Institute of Integrative Medicine, CSIR, Jammu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Gurdarshan Singh</Name>
        <Affiliation>PK-PD-Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. Electronic address: singh_gd@iiim.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Ajay Kumar</Name>
        <Affiliation>PK-PD-Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. Electronic address: ajaykumar@iiim.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Isoorientin inhibits epithelial-to-mesenchymal properties and cancer stem-cell-like features in oral squamous cell carcinoma by blocking Wnt/β-catenin/STAT3 axis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34019859</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00188-5</DOI>
    <KeywordList>
      <Keywords>Isoorientin</Keywords>
      <Keywords>Oral squamous cell carcinoma</Keywords>
      <Keywords>STAT3/Wnt/β-catenin pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shao Cheng Liu</Name>
        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei City 114, Taiwan. Electronic address: m871435@mail.ndmctsgh.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chin Sheng Huang</Name>
        <Affiliation>Division of Oral and Maxillofacial Surgery, Department of Dentistry, Taipei Medical University-Shuang Ho Hospital, New Taipei City 235, Taiwan; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei City 110, Taiwan. Electronic address: 09520@s.tmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Ming Huang</Name>
        <Affiliation>Department of Otolaryngology, Taitung Mackay Memorial Hospital, Taitung City 950, Taiwan. Electronic address: mmh4621@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Shou Hsieh</Name>
        <Affiliation>Division of Oral and Maxillofacial Surgery, Department of Dentistry, Taipei Medical University-Shuang Ho Hospital, New Taipei City 235, Taiwan; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei City 110, Taiwan. Electronic address: dr7d9eddd@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mao Suan Huang</Name>
        <Affiliation>Division of Oral and Maxillofacial Surgery, Department of Dentistry, Taipei Medical University-Shuang Ho Hospital, New Taipei City 235, Taiwan; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei City 110, Taiwan. Electronic address: 08686@s.tmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Iat Hang Fong</Name>
        <Affiliation>Department of Medical Research &amp; Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City 235, Taiwan; Department of Hematology and Oncology, Cancer Center, Taipei Medical University-Shuang Ho Hospital, New Taipei City 235, Taiwan. Electronic address: 18149@s.tmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chi Tai Yeh</Name>
        <Affiliation>Department of Medical Research &amp; Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City 235, Taiwan; Department of Hematology and Oncology, Cancer Center, Taipei Medical University-Shuang Ho Hospital, New Taipei City 235, Taiwan; Department of Medical Laboratory Science and Biotechnology, Yuanpei University of Medical Technology, Hsinchu 300, Taiwan. Electronic address: ctyeh@s.tmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Cheng Lin</Name>
        <Affiliation>Department of Biotechnology and Pharmaceutical Technology, Yuanpei University of Medical Technology, No. 306, Yuanpei Street, Hsinchu, Taiwan. Electronic address: lcc@mail.ypu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Phenomapping for classification of doxorubicin-induced cardiomyopathy in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34015281</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00186-1</DOI>
    <KeywordList>
      <Keywords>Cardiomyopathy</Keywords>
      <Keywords>Cardiovascular Variability</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Myh6</Keywords>
      <Keywords>Myh7</Keywords>
      <Keywords>Phenotype</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vladislav Pajović</Name>
        <Affiliation>University of Belgrade Faculty of Medicine, Faculty of Medicine, Institute of Pharmacology, Clinical Pharmacology and Toxicology, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Csenger Kovácsházi</Name>
        <Affiliation>Semmelweis University Department of Pharmacology and Pharmacotherapy, Budapest, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Marija Kosić</Name>
        <Affiliation>University of Belgrade Faculty of Medicine, Faculty of Medicine, Institute of Pharmacology, Clinical Pharmacology and Toxicology, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Marko Vasić</Name>
        <Affiliation>University of Belgrade Faculty of Medicine, Faculty of Medicine, Institute of Pharmacology, Clinical Pharmacology and Toxicology, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Ljiljana Đukić</Name>
        <Affiliation>University of Belgrade, Faculty of Dentistry, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Gábor B. Brenner</Name>
        <Affiliation>Semmelweis University Department of Pharmacology and Pharmacotherapy, Budapest, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Zoltán Giricz</Name>
        <Affiliation>Semmelweis University Department of Pharmacology and Pharmacotherapy, Budapest, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Dragana Bajić</Name>
        <Affiliation>University of Novi Sad Faculty of Technical Sciences, Novi Sad, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Péter Ferdinandy</Name>
        <Affiliation>Semmelweis University Department of Pharmacology and Pharmacotherapy, Budapest, Hungary; Pharmahungary Group, Szeged, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Nina Japundžić-Žigon</Name>
        <Affiliation>University of Belgrade Faculty of Medicine, Faculty of Medicine, Institute of Pharmacology, Clinical Pharmacology and Toxicology, Belgrade, Serbia. Electronic address: nina.zigon@med.bg.ac.rs.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRAS</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34004237</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00185-X</DOI>
    <KeywordList>
      <Keywords>KRAS</Keywords>
      <Keywords>Kidney toxicity</Keywords>
      <Keywords>Mercapturic acid pathway</Keywords>
      <Keywords>Metabolite</Keywords>
      <Keywords>Sotorasib</Keywords>
      <Keywords>Sprague Dawley rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jonathan A. Werner</Name>
        <Affiliation>Amgen Research, Translational Safety and Bioanalytical Sciences, Thousand Oaks, CA, USA. Electronic address: jowerner@amgen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rhian Davies</Name>
        <Affiliation>Amgen Research, Translational Safety and Bioanalytical Sciences, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Wahlstrom</Name>
        <Affiliation>Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Upendra P. Dahal</Name>
        <Affiliation>Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Min Jiang</Name>
        <Affiliation>Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Stauber</Name>
        <Affiliation>Imabiotech Corp, Billerica, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Benjamin David</Name>
        <Affiliation>Imabiotech Corp, Billerica, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William Siska</Name>
        <Affiliation>Amgen Research, Translational Safety and Bioanalytical Sciences, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Thomas</Name>
        <Affiliation>Amgen Research Operations, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katsu Ishida</Name>
        <Affiliation>Amgen Research, Translational Safety and Bioanalytical Sciences, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>W. Griffith Humphreys</Name>
        <Affiliation>Aranmore Pharma Consulting, Lawrenceville, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Russell Lipford</Name>
        <Affiliation>Amgen Research, Oncology, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas M. Monticello</Name>
        <Affiliation>Amgen Research, Translational Safety and Bioanalytical Sciences, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of IQOS (heated tobacco) and cigarette smoking on cardiac functions by two-dimensional speckle tracking echocardiography.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34000265</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00182-4</DOI>
    <KeywordList>
      <Keywords>Diastolic function</Keywords>
      <Keywords>Myocardial strain</Keywords>
      <Keywords>Strain</Keywords>
      <Keywords>Systolic function</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Belma Yaman</Name>
        <Affiliation>Near East University, Faculty of Medicine, Department of Cardiology, Nicosia, Cyprus. Electronic address: belmayaman@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Onur Akpınar</Name>
        <Affiliation>Near East University, Faculty of Medicine, Department of Cardiology, Nicosia, Cyprus.</Affiliation>
      </Author>
      <Author>
        <Name>Hatice S. Kemal</Name>
        <Affiliation>Near East University, Faculty of Medicine, Department of Cardiology, Nicosia, Cyprus.</Affiliation>
      </Author>
      <Author>
        <Name>Levent Cerit</Name>
        <Affiliation>Near East University, Faculty of Medicine, Department of Cardiology, Nicosia, Cyprus.</Affiliation>
      </Author>
      <Author>
        <Name>Ümit Yüksek</Name>
        <Affiliation>Near East University, Faculty of Medicine, Department of Cardiology, Nicosia, Cyprus.</Affiliation>
      </Author>
      <Author>
        <Name>Nihat Söylemez</Name>
        <Affiliation>Mersin City Training and Research Hospital, Department of Cardiology, Mersin, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Hamza Duygu</Name>
        <Affiliation>Near East University, Faculty of Medicine, Department of Cardiology, Nicosia, Cyprus.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Network pharmacology-based evaluation of natural compounds with paclitaxel for the treatment of metastatic breast cancer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34000264</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00183-6</DOI>
    <KeywordList>
      <Keywords>CAM assay</Keywords>
      <Keywords>Metastatic breast cancer</Keywords>
      <Keywords>Molecular docking</Keywords>
      <Keywords>Network pharmacology</Keywords>
      <Keywords>Synergistic effect</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pooja Rathaur</Name>
        <Affiliation>Department of Life Science, School of Sciences, Gujarat University, Ahmedabad, Gujarat, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mehul N. Soni</Name>
        <Affiliation>Department of Bioinformatics, School of Sciences, Gujarat University, Ahmedabad, Gujarat, India.</Affiliation>
      </Author>
      <Author>
        <Name>Brijesh Gelat</Name>
        <Affiliation>Department of Zoology, Biomedical Technology and Human Genetics, School of Sciences, Gujarat University, Ahmedabad, Gujarat, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rakesh Rawal</Name>
        <Affiliation>Department of Life Science, School of Sciences, Gujarat University, Ahmedabad, Gujarat, India.</Affiliation>
      </Author>
      <Author>
        <Name>Himanshu A. Pandya</Name>
        <Affiliation>Department of Bioinformatics, School of Sciences, Gujarat University, Ahmedabad, Gujarat, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kaid Johar</Name>
        <Affiliation>Department of Zoology, Biomedical Technology and Human Genetics, School of Sciences, Gujarat University, Ahmedabad, Gujarat, India. Electronic address: kaidjohar@gujaratuniversity.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Delivery of oxaliplatin to colorectal cancer cells by folate-targeted UiO-66-NH</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33991535</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00180-0</DOI>
    <KeywordList>
      <Keywords>Metal-organic framework</Keywords>
      <Keywords>microporous nanomaterials</Keywords>
      <Keywords>smart drug delivery system host-guest interactions</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alireza Hashemzadeh</Name>
        <Affiliation>Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Forouzan Amerizadeh</Name>
        <Affiliation>Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Fereshteh Asgharzadeh</Name>
        <Affiliation>Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Majid Darroudi</Name>
        <Affiliation>Department of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Amir Avan</Name>
        <Affiliation>Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Seyed Mahdi Hassanian</Name>
        <Affiliation>Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Landarani</Name>
        <Affiliation>Faculty of chemistry, Shahid Beheshti University, Evin, 1983963113, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Majid Khazaei</Name>
        <Affiliation>Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: Khazaeim@mums.ac.ir.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Macrophage activation in the lung during the progression of nitrogen mustard induced injury is associated with histone modifications and altered miRNA expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33971176</pubmedLink>
    <GrantList>
      <Grant>R01 HL086621</Grant>
      <Grant>T32 ES007148</Grant>
      <Grant>P30 ES005022</Grant>
      <Grant>F32 ES030984</Grant>
      <Grant>U54 AR055073</Grant>
      <Grant>R21 ES029254</Grant>
      <Grant>R01 ES004738</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00176-9</DOI>
    <KeywordList>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Histones</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Macrophages</Keywords>
      <Keywords>Nitrogen mustard</Keywords>
      <Keywords>miRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alessandro Venosa</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA.</Affiliation>
      </Author>
      <Author>
        <Name>L. Cody Smith</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Rutgers University Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Gow</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Rutgers University Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA; Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Helmut Zarbl</Name>
        <Affiliation>Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ 08854, USA; Department of Environmental and Occupational Health and Justice, Rutgers University School of Public Health, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey D. Laskin</Name>
        <Affiliation>Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ 08854, USA; Department of Environmental and Occupational Health and Justice, Rutgers University School of Public Health, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Debra L. Laskin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Rutgers University Ernest Mario School of Pharmacy, Piscataway, NJ 08854, USA; Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: laskin@eohsi.rutgers.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Downregulated expression of intestinal P-glycoprotein in rats with cisplatin-induced acute kidney injury causes amplification of its transport capacity to maintain "gatekeeper" function.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33965372</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00177-0</DOI>
    <KeywordList>
      <Keywords>6α-methylprednisolone</Keywords>
      <Keywords>Breast cancer resistance protein</Keywords>
      <Keywords>Cisplatin-induced acute kidney injury</Keywords>
      <Keywords>P-glycoprotein</Keywords>
      <Keywords>Rat small intestine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fuyo Takeda</Name>
        <Affiliation>Department of Pharmaceutics, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masako Oda</Name>
        <Affiliation>Department of Pharmaceutics, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masaru Terasaki</Name>
        <Affiliation>Department of Health and Environmental Sciences, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuichi Ichimura</Name>
        <Affiliation>Department of Pharmaceutics, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroyuki Kojima</Name>
        <Affiliation>Department of Health and Environmental Sciences, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Saitoh</Name>
        <Affiliation>Department of Pharmaceutics, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan. Electronic address: saitoh@hoku-iryo-u.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure to the bromodomain inhibitor N-methyl pyrrolidone blocks spermatogenesis in a hormonal and non-hormonal fashion.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33965371</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00175-7</DOI>
    <KeywordList>
      <Keywords>BET inhibitor</Keywords>
      <Keywords>Bromodomains</Keywords>
      <Keywords>N-methyl pyrrolidone</Keywords>
      <Keywords>Reproductive toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nupur Khera</Name>
        <Affiliation>University of Zurich, Center of Dental Medicine, Oral Biotechnology &amp; Bioengineering, Plattenstrasse11, 8032 Zürich, Switzerland; Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Chafik Ghayor</Name>
        <Affiliation>University of Zurich, Center of Dental Medicine, Oral Biotechnology &amp; Bioengineering, Plattenstrasse11, 8032 Zürich, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Ekaterina Pavlova</Name>
        <Affiliation>Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Sofia, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Nina Atanassova</Name>
        <Affiliation>Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Sofia, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Franz E. Weber</Name>
        <Affiliation>University of Zurich, Center of Dental Medicine, Oral Biotechnology &amp; Bioengineering, Plattenstrasse11, 8032 Zürich, Switzerland; Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Switzerland; CABMM, Center for Applied Biotechnology and Molecular Medicine, University of Zurich, Zürich, Switzerland. Electronic address: franz.weber@zzm.uzh.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>SPP1 derived from silica-exposed macrophage exosomes triggers fibroblast transdifferentiation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33961903</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00166-6</DOI>
    <KeywordList>
      <Keywords>Exosome</Keywords>
      <Keywords>Proteome</Keywords>
      <Keywords>SPP1</Keywords>
      <Keywords>Silicosis</Keywords>
      <Keywords>Transdifferentiation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ruoxuan Huang</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changfu Hao</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Di Wang</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiuyan Zhao</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Li</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Wang</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wu Yao</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan, China. Electronic address: yaowu@zzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hydrogen sulfide attenuates induction and prevents progress of the 6-hydroxydopamine-induced Parkinsonism in rat through activation of ATP-sensitive potassium channels and suppression of ER stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33961902</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00165-4</DOI>
    <KeywordList>
      <Keywords>6-hydroxydopamine-induced Parkinsonism</Keywords>
      <Keywords>CHOP</Keywords>
      <Keywords>GRP78</Keywords>
      <Keywords>Hydrogen sulfide</Keywords>
      <Keywords>K-ATP channels</Keywords>
      <Keywords>TH-positive neurons</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Azita Minaei</Name>
        <Affiliation>Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Reza Sarookhani</Name>
        <Affiliation>Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Hashem Haghdoost-Yazdi</Name>
        <Affiliation>Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran. Electronic address: hhaghdoost@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Farzad Rajaei</Name>
        <Affiliation>Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic exposure in drinking water reduces Lgr5 and secretory cell marker gene expression in mouse intestines.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33957193</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00168-X</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Intestinal stem cell</Keywords>
      <Keywords>Intestine</Keywords>
      <Keywords>Lgr5</Keywords>
      <Keywords>Wnt signaling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jordan T. Jatko</Name>
        <Affiliation>Environmental Toxicology Graduate Program, Clemson University, 132 Long Hall, Clemson, SC 29634, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Caitlin L. Darling</Name>
        <Affiliation>Department of Biological Sciences, Clemson University, 132 Long Hall, Clemson, SC 29634, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael P. Kellett</Name>
        <Affiliation>Department of Biological Sciences, Clemson University, 132 Long Hall, Clemson, SC 29634, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa J. Bain</Name>
        <Affiliation>Environmental Toxicology Graduate Program, Clemson University, 132 Long Hall, Clemson, SC 29634, USA; Department of Biological Sciences, Clemson University, 132 Long Hall, Clemson, SC 29634, USA. Electronic address: lbain@clemson.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Clozapine affects the pharmacokinetics of risperidone and inhibits its metabolism and P-glycoprotein-mediated transport in vivo and in vitro: A safety attention to antipsychotic polypharmacy with clozapine and risperidone.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33957192</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00167-8</DOI>
    <KeywordList>
      <Keywords>Antipsychotic polypharmacy</Keywords>
      <Keywords>Clozapine</Keywords>
      <Keywords>Drug–drug interactions</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Risperidone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xinghua Liu</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Heyuan Sun</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yumu Zhang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufei Sun</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenyan Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China. Electronic address: ytuwwy@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lixiao Xu</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanhui Liu</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative analysis of the physicochemical, toxicokinetic, and toxicological properties of ether-PFAS.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33933458</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00138-1</DOI>
    <KeywordList>
      <Keywords>ADONA</Keywords>
      <Keywords>EEA-NH4</Keywords>
      <Keywords>Ether-PFAS</Keywords>
      <Keywords>GENX</Keywords>
      <Keywords>HFPO-DA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Penelope A. Rice</Name>
        <Affiliation>FDA/CFSAN/OFAS/DFCS, 5001 Campus Drive, HFS 275, College Park, MD 20740, United States of America. Electronic address: penelope.rice@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica Cooper</Name>
        <Affiliation>FDA/CFSAN/OFAS/DFCS, 5001 Campus Drive, HFS 275, College Park, MD 20740, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Sharon E. Koh-Fallet</Name>
        <Affiliation>FDA/CFSAN/OFAS/DFCS, 5001 Campus Drive, HFS 275, College Park, MD 20740, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Shruti V. Kabadi</Name>
        <Affiliation>FDA/CFSAN/OFAS/DFCS, 5001 Campus Drive, HFS 275, College Park, MD 20740, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genome-wide identification and functional analysis of long non-coding RNAs and mRNAs in male mice testes at the onset of puberty after low dose lead exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33932463</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00163-0</DOI>
    <KeywordList>
      <Keywords>Long non-coding RNA</Keywords>
      <Keywords>Low-dose lead</Keywords>
      <Keywords>Puberty</Keywords>
      <Keywords>Sertoli cells</Keywords>
      <Keywords>Testis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haitao Ma</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan, 430071, Hubei Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Yu</Name>
        <Affiliation>Department of Preventive Medicine, School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning, 437100, Hubei Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Xie</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan, 430071, Hubei Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Duanya Liu</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan, 430071, Hubei Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhaoyu Zhang</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan, 430071, Hubei Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ziqiong Wang</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan, 430071, Hubei Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunhong Wang</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan, 430071, Hubei Province, China. Electronic address: wchunhong027@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Co-administration of CSL112 (apolipoprotein A-I [human]) with atorvastatin and alirocumab is not associated with increased hepatotoxic or toxicokinetic effects in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33932462</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00164-2</DOI>
    <KeywordList>
      <Keywords>CSL112</Keywords>
      <Keywords>HMG-CoA reductase inhibitors</Keywords>
      <Keywords>Liver toxicity</Keywords>
      <Keywords>PCSK9 inhibitors</Keywords>
      <Keywords>Rat model</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrea Beyerle</Name>
        <Affiliation>CSL Behring GmbH, Marburg, Emil-von-Behring-Str. 76, 35041 Marburg, Germany. Electronic address: Andrea.Beyerle@cslbehring.com.</Affiliation>
      </Author>
      <Author>
        <Name>Brandon Greene</Name>
        <Affiliation>CSL Behring GmbH, Marburg, Emil-von-Behring-Str. 76, 35041 Marburg, Germany. Electronic address: Brandon.Greene@cslbehring.com.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Dietrich</Name>
        <Affiliation>CSL Behring GmbH, Walcherstraße 1A/Stiege 1, 1020 Vienna, Austria. Electronic address: Barbara.Dietrich@cslbehring.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bronwyn A. Kingwell</Name>
        <Affiliation>CSL Limited, Bio21 30 Flemington Rd, Parkville, VIC 3010, Australia. Electronic address: bronwyn.kingwell@csl.com.au.</Affiliation>
      </Author>
      <Author>
        <Name>Priya Panjwani</Name>
        <Affiliation>CSL Behring GmbH, Marburg, Emil-von-Behring-Str. 76, 35041 Marburg, Germany. Electronic address: priya.panjwani@cslbehring.com.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel D. Wright</Name>
        <Affiliation>CSL Behring LLC, 1020 1st Ave, King of Prussia, PA 19406, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eva Herzog</Name>
        <Affiliation>CSL Behring LLC, 1020 1st Ave, King of Prussia, PA 19406, USA. Electronic address: Eva.Herzog@cslbehring.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluating the protective effects of individual or combined ginsenoside compound K and the downregulation of soluble epoxide hydrolase expression against sodium valproate-induced liver cell damage.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33915122</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00162-9</DOI>
    <KeywordList>
      <Keywords>Ginsenoside compound K</Keywords>
      <Keywords>Mitochondrial membrane potential</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Sodium valproate</Keywords>
      <Keywords>Soluble epoxide hydrolase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Luping Zhou</Name>
        <Affiliation>Department of Clinical Pharmacology, , Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangchang Zeng</Name>
        <Affiliation>Department of Clinical Pharmacology, , Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Tai Rao</Name>
        <Affiliation>Department of Clinical Pharmacology, , Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhirong Tan</Name>
        <Affiliation>Department of Clinical Pharmacology, , Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Gan Zhou</Name>
        <Affiliation>Department of Clinical Pharmacology, , Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha 410008, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongsheng Ouyang</Name>
        <Affiliation>Department of Clinical Pharmacology, , Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha 410000, PR China. Electronic address: 801940@csu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Lulu Chen</Name>
        <Affiliation>Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha 410000, PR China. Electronic address: lulu.chen@duxact.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of human sulfotransferases catalyzing the formation of p-cresol sulfate and identification of mefenamic acid as a potent metabolism inhibitor and potential therapeutic agent for detoxification.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33915121</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00160-5</DOI>
    <KeywordList>
      <Keywords>Human sulfotransferases</Keywords>
      <Keywords>Mefenamic acid</Keywords>
      <Keywords>Metabolism inhibitors</Keywords>
      <Keywords>Nonsteroidal anti-inflammatory agents</Keywords>
      <Keywords>SULT1A1</Keywords>
      <Keywords>p-Cresol sulfate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Rong</Name>
        <Affiliation>Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada. Electronic address: yrong1@ualberta.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Tony K. L. Kiang</Name>
        <Affiliation>Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada. Electronic address: tkiang@ualberta.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human-relevant concentrations of the antifungal drug clotrimazole disrupt maternal and fetal steroid hormone profiles in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33910022</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00161-7</DOI>
    <KeywordList>
      <Keywords>Azoles</Keywords>
      <Keywords>Canesten</Keywords>
      <Keywords>Endocrine disruptors</Keywords>
      <Keywords>Fungicides</Keywords>
      <Keywords>Lotrimin</Keywords>
      <Keywords>Reproduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Monica Kam Draskau</Name>
        <Affiliation>Division of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Kemitorvet Building 202, Kongens Lyngby DK-2800, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Kjerstine Rosenmai</Name>
        <Affiliation>Division of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Kemitorvet Building 202, Kongens Lyngby DK-2800, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Scholze</Name>
        <Affiliation>Division of Environmental Studies, College of Health, Medicine and Life Sciences, Brunel University London, Kingston Lane, Uxbridge UB8 3PH, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mikael Pedersen</Name>
        <Affiliation>Research Group for Analytical Food Chemistry, National Food Institute, Technical University of Denmark, Kemitorvet Building 202, Kongens Lyngby DK-2800, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Julie Boberg</Name>
        <Affiliation>Division of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Kemitorvet Building 202, Kongens Lyngby DK-2800, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Sofie Christiansen</Name>
        <Affiliation>Division of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Kemitorvet Building 202, Kongens Lyngby DK-2800, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Terje Svingen</Name>
        <Affiliation>Division of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Kemitorvet Building 202, Kongens Lyngby DK-2800, Denmark. Electronic address: tesv@food.dtu.dk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Internal dose of vanadium in rats following repeated exposure to vanadyl sulfate and sodium orthovanadate via drinking water" [Toxicology and Applied Pharmacology 412 (2021) 115395].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33905758</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00153-8</DOI>
    <AuthorList>
      <Author>
        <Name>James M. Harrington</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Laura G. Haines</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Keith E. Levine</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Chamindu Liyanapatirana</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Amal S. Essader</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Reshan A. Fernando</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Veronica G. Robinson</Name>
        <Affiliation>Division of the National Toxicology Program, NIEHS, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Georgia K. Roberts</Name>
        <Affiliation>Division of the National Toxicology Program, NIEHS, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew D. Stout</Name>
        <Affiliation>Division of the National Toxicology Program, NIEHS, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle J. Hooth</Name>
        <Affiliation>Division of the National Toxicology Program, NIEHS, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Suramya Waidyanatha</Name>
        <Affiliation>Division of the National Toxicology Program, NIEHS, Research Triangle Park, NC, United States. Electronic address: waidyanathas@niehs.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dose-dependent effects of prenatal exposure of pioglitazone, the PPARγ agonist, on the hippocampus development and learning and memory performance of rat offspring.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33894214</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00151-4</DOI>
    <KeywordList>
      <Keywords>Glial fibrillar acidic protein (GFAP)</Keywords>
      <Keywords>Hippocampus</Keywords>
      <Keywords>Learning and memory</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>PPARγ</Keywords>
      <Keywords>Pioglitazone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dilek Sağır</Name>
        <Affiliation>Faculty of Health Sciences, Sinop University, 57000 Sinop, Turkey. Electronic address: bio_dilek@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sulforaphane inhibits blue light-induced inflammation and apoptosis by upregulating the SIRT1/PGC-1α/Nrf2 pathway and autophagy in retinal pigment epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33894213</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00152-6</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Blue light</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Retinal pigment epithelial cells</Keywords>
      <Keywords>Sulforaphane</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Po Min Yang</Name>
        <Affiliation>Department of Ophthalmology, Chiayi Christian Hospital, Chiayi 60002, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Chun Cheng</Name>
        <Affiliation>Department of Ophthalmology, Kaohsiung Municipal Hsiao-kang Hospital, Kaohsiung 81267, Taiwan; Department of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung 807378, Taiwan; Department of Ophthalmology, college of medicine, Kaohsiung Medical University, Kaohsiung 807378, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Yao Huang</Name>
        <Affiliation>Department of Microbiology, Immunology and Biopharmaceuticals, National Chiayi University, Chiayi 60002, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shih Yun Wang</Name>
        <Affiliation>Department of Microbiology, Immunology and Biopharmaceuticals, National Chiayi University, Chiayi 60002, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yung Ni Lin</Name>
        <Affiliation>Department of Microbiology, Immunology and Biopharmaceuticals, National Chiayi University, Chiayi 60002, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yen Tzu Tseng</Name>
        <Affiliation>Department of Microbiology, Immunology and Biopharmaceuticals, National Chiayi University, Chiayi 60002, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Wen Hsieh</Name>
        <Affiliation>Department of Microbiology, Immunology and Biopharmaceuticals, National Chiayi University, Chiayi 60002, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Being Sun Wung</Name>
        <Affiliation>Department of Microbiology, Immunology and Biopharmaceuticals, National Chiayi University, Chiayi 60002, Taiwan. Electronic address: bswung@mail.ncyu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nimodipine inhibits intestinal and aortic smooth muscle contraction by regulating Ca</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33872679</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00150-2</DOI>
    <KeywordList>
      <Keywords>CaCCs</Keywords>
      <Keywords>Inhibitor</Keywords>
      <Keywords>Nimodipine</Keywords>
      <Keywords>Short-circuit current</Keywords>
      <Keywords>Smooth muscle contraction</Keywords>
      <Keywords>TMEM16A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hao Wang</Name>
        <Affiliation>Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, School of Life Sciences, Liaoning Normal University, Dalian 116000, PR China; Laboratory medical college, Jilin Medical University, Jilin 132013, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Di Ma</Name>
        <Affiliation>Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, School of Life Sciences, Liaoning Normal University, Dalian 116000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojuan Zhu</Name>
        <Affiliation>Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, School of Life Sciences, Liaoning Normal University, Dalian 116000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Panyue Liu</Name>
        <Affiliation>Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, School of Life Sciences, Liaoning Normal University, Dalian 116000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuai Li</Name>
        <Affiliation>Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, School of Life Sciences, Liaoning Normal University, Dalian 116000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Yu</Name>
        <Affiliation>Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, School of Life Sciences, Liaoning Normal University, Dalian 116000, PR China. Electronic address: yubo821208@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Yang</Name>
        <Affiliation>Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, School of Life Sciences, Liaoning Normal University, Dalian 116000, PR China. Electronic address: hyanglnnu@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>C-myc promotes miR-92a-2-5p transcription in rat ovarian granulosa cells after cadmium exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33865896</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00143-5</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>DNA methylation</Keywords>
      <Keywords>Ovarian granulosa cells</Keywords>
      <Keywords>Transcription factors</Keywords>
      <Keywords>m(6)A methylation</Keywords>
      <Keywords>miR-92a-2-5p</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yi Sun</Name>
        <Affiliation>Department of Preventive Medicine, Fujian Provincial Key Laboratory of Environment Factors and Cancer, Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chaowei Zong</Name>
        <Affiliation>Department of Preventive Medicine, Fujian Provincial Key Laboratory of Environment Factors and Cancer, Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, China; School of Medicine, Jiangsu University, Zhenjiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Liu</Name>
        <Affiliation>Department of Preventive Medicine, Fujian Provincial Key Laboratory of Environment Factors and Cancer, Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingfeng Zeng</Name>
        <Affiliation>Department of Preventive Medicine, Fujian Provincial Key Laboratory of Environment Factors and Cancer, Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, China; School Key Discipline of Nutrition and Food Hygiene, Public Health School, Changsha Medical University, Changsha, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingyu Li</Name>
        <Affiliation>Department of Preventive Medicine, Fujian Provincial Key Laboratory of Environment Factors and Cancer, Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhangpin Liu</Name>
        <Affiliation>Department of Preventive Medicine, Fujian Provincial Key Laboratory of Environment Factors and Cancer, Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuchen Li</Name>
        <Affiliation>Department of Preventive Medicine, Fujian Provincial Key Laboratory of Environment Factors and Cancer, Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianlin Zhu</Name>
        <Affiliation>Department of Preventive Medicine, Fujian Provincial Key Laboratory of Environment Factors and Cancer, Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingfang Li</Name>
        <Affiliation>Department of Preventive Medicine, Fujian Provincial Key Laboratory of Environment Factors and Cancer, Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenyun Zhang</Name>
        <Affiliation>Department of Health Law and Policy, School of Public Health, Fujian Medical University, Fuzhou, China. Electronic address: zhangchenyun198724@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wenchang Zhang</Name>
        <Affiliation>Department of Preventive Medicine, Fujian Provincial Key Laboratory of Environment Factors and Cancer, Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, China. Electronic address: wenchang2008@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Microtubule and tubulin binding and regulation of microtubule dynamics by the antibody drug conjugate (ADC) payload, monomethyl auristatin E (MMAE): Mechanistic insights into MMAE ADC peripheral neuropathy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33852878</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00141-1</DOI>
    <KeywordList>
      <Keywords>Anti-cancer</Keywords>
      <Keywords>Antibody drug conjugate</Keywords>
      <Keywords>Auristatin</Keywords>
      <Keywords>Microtubule-targeting agent</Keywords>
      <Keywords>Peripheral nervous system</Keywords>
      <Keywords>Peripheral neuropathy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rebecca L. Best</Name>
        <Affiliation>Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, CA 93106, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nichole E. LaPointe</Name>
        <Affiliation>Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, CA 93106, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Olga Azarenko</Name>
        <Affiliation>Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, CA 93106, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Herb Miller</Name>
        <Affiliation>Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, CA 93106, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christine Genualdi</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Chih</Name>
        <Affiliation>Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, CA 93106, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ben Quan Shen</Name>
        <Affiliation>Preclinical and Translational PK, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Ann Jordan</Name>
        <Affiliation>Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, CA 93106, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Leslie Wilson</Name>
        <Affiliation>Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, CA 93106, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stuart C. Feinstein</Name>
        <Affiliation>Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, CA 93106, USA. Electronic address: feinstei@lifesci.ucsb.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Nicola J. Stagg</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address: stagg.nicola@gene.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nannocystin Ax, a natural elongation factor 1α inhibitor from Nannocystis sp., suppresses epithelial-mesenchymal transition, adhesion and migration in lung cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33848516</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00142-3</DOI>
    <KeywordList>
      <Keywords>EMT</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Metastasis</Keywords>
      <Keywords>Nannocystin Ax</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chong Sun</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Liu</Name>
        <Affiliation>Key Laboratory of Green Chemistry &amp; Technology of Ministry of Education, College of Chemistry, Sichuan University, Chengdu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengwei Xia</Name>
        <Affiliation>Key Laboratory of Green Chemistry &amp; Technology of Ministry of Education, College of Chemistry, Sichuan University, Chengdu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Hou</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xumei Wang</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Jian Lu</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Liu</Name>
        <Affiliation>Key Laboratory of Green Chemistry &amp; Technology of Ministry of Education, College of Chemistry, Sichuan University, Chengdu, China. Electronic address: chembliu@scu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuping Chen</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China. Electronic address: xpchen@um.edu.mo.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cinacalcet as a surrogate therapy for diabetic cardiomyopathy in rats through AMPK-mediated promotion of mitochondrial and autophagic function.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33848515</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00140-X</DOI>
    <KeywordList>
      <Keywords>AMPK</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Cinacalcet</Keywords>
      <Keywords>Diabetic cardiomyopathy</Keywords>
      <Keywords>Type 2 diabetic rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rania A. Elrashidy</Name>
        <Affiliation>Biochemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt. Electronic address: raelrashidy@zu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Samah E. Ibrahim</Name>
        <Affiliation>Physiology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fraxinellone alleviates kidney fibrosis by inhibiting CUG-binding protein 1-mediated fibroblast activation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33845055</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00137-X</DOI>
    <KeywordList>
      <Keywords>CUGBP1</Keywords>
      <Keywords>Fibroblast activation</Keywords>
      <Keywords>Fraxinellone</Keywords>
      <Keywords>Kidney fibrosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bingfeng Zheng</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Manman Yuan</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shenglan Wang</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Tan</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yizhu Xu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Ye</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanjie Gao</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xueqing Sun</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tianyi Wang</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingdong Kong</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xingxin Wu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China. Electronic address: xingxin.wu@nju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Xu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China. Electronic address: qiangxu@nju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>T helper 2-driven immune dysfunction in chronic arsenic-exposed individuals and its link to the features of allergic asthma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33845054</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00139-3</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Asthma</Keywords>
      <Keywords>Immunomodulation</Keywords>
      <Keywords>Th2 cytokine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Atiqur Rahman</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Md Shofikul Islam</Name>
        <Affiliation>Department of Applied Nutrition and Food Technology, Islamic University, Kushtia 7003, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Selim Reza Tony</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Abu Eabrahim Siddique</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Victor Mondal</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Zubaer Hosen</Name>
        <Affiliation>Department of Applied Nutrition and Food Technology, Islamic University, Kushtia 7003, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Zohurul Islam</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Md Imam Hossain</Name>
        <Affiliation>Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science &amp; Technology University, Tangail 1902, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Mizanur Rahman</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Adiba Anjum</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Mawlana Bhashani Science &amp; Technology University, Tangail 1902, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Sudip Kumar Paul</Name>
        <Affiliation>Department of Applied Nutrition and Food Technology, Islamic University, Kushtia 7003, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Faruk Hossen</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Md Khalequzzaman Sarker</Name>
        <Affiliation>Department of Gastroenterology, Rajshahi Medical College, Rajshahi 6000, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Shakhawoat Hossain</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Kazi Abdus Salam</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Azizul Haque</Name>
        <Affiliation>Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Md Ashraful Hoque</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Zahangir Alam Saud</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Lian Xin</Name>
        <Affiliation>Laboratory of Molecular Nutrition and Toxicology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Daigo Sumi</Name>
        <Affiliation>Laboratory of Molecular Nutrition and Toxicology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Seiichiro Himeno</Name>
        <Affiliation>Laboratory of Molecular Nutrition and Toxicology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan; Division of Health Chemistry, School of Pharmacy, Showa University, Tokyo 142-8555, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Khaled Hossain</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh. Electronic address: khossain@ru.ac.bd.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting SH3GL1 and negatively regulating EGFR/ERK/NF-κB signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33838155</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00129-0</DOI>
    <KeywordList>
      <Keywords>Baicalein</Keywords>
      <Keywords>Erk signal pathway</Keywords>
      <Keywords>Hepatocellular carcinoma</Keywords>
      <Keywords>SH3GL1</Keywords>
      <Keywords>miR-3663-3p</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Tian</Name>
        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China; Shaanxi Provincial Clinical Research Center for Hepatic &amp; Splenic Diseases, Xi'an, Shaanxi 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Li</Name>
        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China; Shaanxi Provincial Clinical Research Center for Hepatic &amp; Splenic Diseases, Xi'an, Shaanxi 710004, China; Center for Tumor and Immunology, the Precision Medical Institute, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Beibei Bie</Name>
        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Sun</Name>
        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China; Shaanxi Provincial Clinical Research Center for Hepatic &amp; Splenic Diseases, Xi'an, Shaanxi 710004, China; Center for Tumor and Immunology, the Precision Medical Institute, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanhua Mu</Name>
        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China; Shaanxi Provincial Clinical Research Center for Hepatic &amp; Splenic Diseases, Xi'an, Shaanxi 710004, China; Center for Tumor and Immunology, the Precision Medical Institute, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengjiao Shi</Name>
        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China; Shaanxi Provincial Clinical Research Center for Hepatic &amp; Splenic Diseases, Xi'an, Shaanxi 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuqun Zhang</Name>
        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China; Center for Tumor and Immunology, the Precision Medical Institute, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangyao Kong</Name>
        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China; Shaanxi Provincial Clinical Research Center for Hepatic &amp; Splenic Diseases, Xi'an, Shaanxi 710004, China; Center for Tumor and Immunology, the Precision Medical Institute, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zongfang Li</Name>
        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China; Shaanxi Provincial Clinical Research Center for Hepatic &amp; Splenic Diseases, Xi'an, Shaanxi 710004, China; Center for Tumor and Immunology, the Precision Medical Institute, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China; Department of Geriatric General Surgery, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China; Key Laboratory of Environment and Disease-Related Gene, Ministry of Education, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. Electronic address: lzf2568@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Guo</Name>
        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China; Shaanxi Provincial Clinical Research Center for Hepatic &amp; Splenic Diseases, Xi'an, Shaanxi 710004, China; Center for Tumor and Immunology, the Precision Medical Institute, the Second Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi 710004, China. Electronic address: sherylyg@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metformin leads to accumulation of reactive oxygen species by inhibiting the NFE2L1 expression in human hepatocellular carcinoma cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33838154</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00130-7</DOI>
    <KeywordList>
      <Keywords>AMPK</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Metformin</Keywords>
      <Keywords>NFE2L1/Nrf1</Keywords>
      <Keywords>Reactive oxygen species/ROS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shanshan Gou</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Qiu</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China. Electronic address: qiulu@zzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Qiufang Yang</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Li</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowen Zhou</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yixuan Sun</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuman Zhou</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenshan Zhao</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjie Zhai</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guodong Li</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yahong Wu</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonggang Ren</Name>
        <Affiliation>Department of Biochemistry, North Sichuan Medical College, Nanchong 637000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanming Qi</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiguo Zhang</Name>
        <Affiliation>The Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, Chongqing 400044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanfeng Gao</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China; School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China. Electronic address: gaoyf29@mail.sysu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Isorhynchophylline ameliorates paraquat-induced acute kidney injury by attenuating oxidative stress and mitochondrial damage via regulating toll-interacting expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33838153</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00128-9</DOI>
    <KeywordList>
      <Keywords>Acute kidney injury</Keywords>
      <Keywords>Isorhynchophylline</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Paraquat</Keywords>
      <Keywords>Toll-interacting protein</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qiang Zheng</Name>
        <Affiliation>Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Zhang</Name>
        <Affiliation>Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Zhao</Name>
        <Affiliation>Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haitao Shen</Name>
        <Affiliation>Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongyu Zhao</Name>
        <Affiliation>Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Zhao</Name>
        <Affiliation>Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China. Electronic address: zhaomincmu2h@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neuroprotection by delayed triple therapy following sarin nerve agent insult in the rat.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33823148</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00126-5</DOI>
    <KeywordList>
      <Keywords>Ketamine</Keywords>
      <Keywords>Midazolam</Keywords>
      <Keywords>Organophosphates</Keywords>
      <Keywords>Sarin</Keywords>
      <Keywords>Seizure</Keywords>
      <Keywords>Valproic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ariel Gore</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological, Chemical and Environmental Sciences, Ness-Ziona 74100, Israel. Electronic address: arielg@iibr.gov.il.</Affiliation>
      </Author>
      <Author>
        <Name>Adi Neufeld-Cohen</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological, Chemical and Environmental Sciences, Ness-Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Inbal Egoz</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological, Chemical and Environmental Sciences, Ness-Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Shlomi Baranes</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological, Chemical and Environmental Sciences, Ness-Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Rellie Gez</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological, Chemical and Environmental Sciences, Ness-Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Rahav Efrati</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological, Chemical and Environmental Sciences, Ness-Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Tse'ela David</Name>
        <Affiliation>The Veterinary Center for Pre-clinical Research, Israel Institute for Biological, Chemical and Environmental Sciences, Ness- Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Hani Dekel Jaoui</Name>
        <Affiliation>The Veterinary Center for Pre-clinical Research, Israel Institute for Biological, Chemical and Environmental Sciences, Ness- Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Yampolsky</Name>
        <Affiliation>The Veterinary Center for Pre-clinical Research, Israel Institute for Biological, Chemical and Environmental Sciences, Ness- Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Ettie Grauer</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological, Chemical and Environmental Sciences, Ness-Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Shira Chapman</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological, Chemical and Environmental Sciences, Ness-Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Shlomi Lazar</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological, Chemical and Environmental Sciences, Ness-Ziona 74100, Israel. Electronic address: shlomil@iibr.gov.il.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Improved bioavailability and anticancer efficacy of Hesperetin on breast cancer via a self-assembled rebaudioside A nanomicelles system.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33819459</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00118-6</DOI>
    <KeywordList>
      <Keywords>Anticancer</Keywords>
      <Keywords>Hesperetin</Keywords>
      <Keywords>Nanomicelles</Keywords>
      <Keywords>Rebaudioside A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Wang</Name>
        <Affiliation>Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiqi Li</Name>
        <Affiliation>Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zekun Chen</Name>
        <Affiliation>Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xueju Qi</Name>
        <Affiliation>Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xianggen Wu</Name>
        <Affiliation>Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guohu Di</Name>
        <Affiliation>School of Basic Medicine, Qingdao University, Qingdao 266071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junting Fan</Name>
        <Affiliation>Department of Pharmaceutical Analysis, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chuanlong Guo</Name>
        <Affiliation>Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China. Electronic address: guochuanlong@qust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Polyphyllin I reverses the resistance of osimertinib in non-small cell lung cancer cell through regulation of PI3K/Akt signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33812963</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00125-3</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Osimertinib-resistance</Keywords>
      <Keywords>PI3K</Keywords>
      <Keywords>Polyphyllin I</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lei Lai</Name>
        <Affiliation>Department of Medical Oncology, Tongxiang First People's Hospital, Tongxiang, Zhejiang 314500, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiuping Shen</Name>
        <Affiliation>Department of Medical Oncology, Tongxiang First People's Hospital, Tongxiang, Zhejiang 314500, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingjie Wang</Name>
        <Affiliation>Department of Medical Oncology, Tongxiang First People's Hospital, Tongxiang, Zhejiang 314500, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liting Chen</Name>
        <Affiliation>Department of Oncology, Zhejiang Hospital, Hangzhou, Zhejiang 310013, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianjun Lai</Name>
        <Affiliation>Department of Oncology, Zhejiang Hospital, Hangzhou, Zhejiang 310013, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhibing Wu</Name>
        <Affiliation>Department of Oncology, Zhejiang Hospital, Hangzhou, Zhejiang 310013, PR China. Electronic address: wu_zhibing@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Jiang</Name>
        <Affiliation>Department of Oncology, Zhejiang Hospital, Hangzhou, Zhejiang 310013, PR China. Electronic address: zjhoncol@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The role of MEG3 in the proliferation of palatal mesenchymal cells is related to the TGFβ/Smad pathway in TCDD inducing cleft palate.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33812962</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00124-1</DOI>
    <KeywordList>
      <Keywords>2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD)</Keywords>
      <Keywords>Cleft palate</Keywords>
      <Keywords>MEG3</Keywords>
      <Keywords>Proliferation</Keywords>
      <Keywords>TGF-β/Smad</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhidong He</Name>
        <Affiliation>School of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>XinXin Liu</Name>
        <Affiliation>School of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaozhuan Liu</Name>
        <Affiliation>Center for Clinical Single-Cell Biomedicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingling Cui</Name>
        <Affiliation>School of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yangyang Yuan</Name>
        <Affiliation>The third affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huanhuan Zhang</Name>
        <Affiliation>School of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yao Chen</Name>
        <Affiliation>School of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuchang Tao</Name>
        <Affiliation>School of Public Health, Zhengzhou University, Zhengzhou, Henan, China; Center for Clinical Single-Cell Biomedicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zengli Yu</Name>
        <Affiliation>School of Public Health, Zhengzhou University, Zhengzhou, Henan, China. Electronic address: zly@zzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In utero exposure to dipentyl phthalate disrupts fetal and adult Leydig cell development.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33798595</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00121-6</DOI>
    <KeywordList>
      <Keywords>Adult Leydig cell</Keywords>
      <Keywords>Dipentyl phthalate</Keywords>
      <Keywords>Fetal Leydig cell</Keywords>
      <Keywords>Inhibition</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haiqiong Chen</Name>
        <Affiliation>Department of Pediatrics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiu Xin</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Miaoqing Liu</Name>
        <Affiliation>Department of Pediatrics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feifei Ma</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yige Yu</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Huang</Name>
        <Affiliation>Department of Pediatrics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haipeng Dai</Name>
        <Affiliation>Department of Pediatrics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongrong Li</Name>
        <Affiliation>Department of Pediatrics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: wmclzr@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ren Shan Ge</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: r_ge@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nabumetone induced photogenotoxicity mechanism mediated by ROS generation under environmental UV radiation in human keratinocytes (HaCaT) cell line.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33798594</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00123-X</DOI>
    <KeywordList>
      <Keywords>Keratinocytes</Keywords>
      <Keywords>Nabumetone</Keywords>
      <Keywords>Photogenotoxicity</Keywords>
      <Keywords>Phototoxicity</Keywords>
      <Keywords>ROS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Saba Qureshi</Name>
        <Affiliation>Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31, Mahatma Gandhi Marg, Lucknow, 226 001, Uttar Pradesh, India; Academy of Scientific and Innovative Research, AcSIR Headquarters, CSIR-HRDC Campus, Sector 19, Kamla Nehru Nagar, Ghaziabad, Uttar Pradesh-, 201 002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sonam Chandra</Name>
        <Affiliation>Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31, Mahatma Gandhi Marg, Lucknow, 226 001, Uttar Pradesh, India; Academy of Scientific and Innovative Research, AcSIR Headquarters, CSIR-HRDC Campus, Sector 19, Kamla Nehru Nagar, Ghaziabad, Uttar Pradesh-, 201 002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Deepti Chopra</Name>
        <Affiliation>Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31, Mahatma Gandhi Marg, Lucknow, 226 001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Divya Dubey</Name>
        <Affiliation>Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31, Mahatma Gandhi Marg, Lucknow, 226 001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Veena Jain</Name>
        <Affiliation>Analytical Chemistry Laboratory, Regulatory Toxicology Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31, Mahatma Gandhi Marg, Lucknow, 226001, India; Academy of Scientific and Innovative Research, AcSIR Headquarters, CSIR-HRDC Campus, Sector 19, Kamla Nehru Nagar, Ghaziabad, Uttar Pradesh-, 201 002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Somendu Kumar Roy</Name>
        <Affiliation>Analytical Chemistry Laboratory, Regulatory Toxicology Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31, Mahatma Gandhi Marg, Lucknow, 226001, India; Academy of Scientific and Innovative Research, AcSIR Headquarters, CSIR-HRDC Campus, Sector 19, Kamla Nehru Nagar, Ghaziabad, Uttar Pradesh-, 201 002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ratan Singh Ray</Name>
        <Affiliation>Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31, Mahatma Gandhi Marg, Lucknow, 226 001, Uttar Pradesh, India; Academy of Scientific and Innovative Research, AcSIR Headquarters, CSIR-HRDC Campus, Sector 19, Kamla Nehru Nagar, Ghaziabad, Uttar Pradesh-, 201 002, India. Electronic address: rsray@iitr.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Intramuscularly administered A1 adenosine receptor agonists as delayed treatment for organophosphorus nerve agent-induced Status Epilepticus.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33798593</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00122-8</DOI>
    <KeywordList>
      <Keywords>Adenosine receptor agonists</Keywords>
      <Keywords>Delayed therapy</Keywords>
      <Keywords>Neuroprotection</Keywords>
      <Keywords>Sarin</Keywords>
      <Keywords>Soman</Keywords>
      <Keywords>Status epilepticus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tara N. Loughery</Name>
        <Affiliation>Neuroscience Department, Medical Toxicology Research Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5400, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kimberly A. Whitten</Name>
        <Affiliation>Comparative Pathology Department, Research Support Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5400, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cindy Acon-Chen</Name>
        <Affiliation>Neuroscience Department, Medical Toxicology Research Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5400, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tsung Ming Shih</Name>
        <Affiliation>Neuroscience Department, Medical Toxicology Research Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5400, USA. Electronic address: tsungming.a.shih.civ@mail.mil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Efficacy of atropine and scopolamine on airway contractions following exposure to the nerve agent VX.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33785355</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00119-8</DOI>
    <KeywordList>
      <Keywords>Airway contractions</Keywords>
      <Keywords>Antimuscarinics</Keywords>
      <Keywords>Cholinergic responses</Keywords>
      <Keywords>Nerve agents</Keywords>
      <Keywords>Precision-cut lung slices</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>E. Wigenstam</Name>
        <Affiliation>Swedish Defence Research Agency, CBRN Defence and Security, Umeå, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>E. Forsberg</Name>
        <Affiliation>Swedish Defence Research Agency, CBRN Defence and Security, Umeå, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>A. Bucht</Name>
        <Affiliation>Swedish Defence Research Agency, CBRN Defence and Security, Umeå, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>L. Thors</Name>
        <Affiliation>Swedish Defence Research Agency, CBRN Defence and Security, Umeå, Sweden. Electronic address: lina.thors@foi.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Functional characterization of N-octyl 4-methylamphetamine variants and related bivalent compounds at the dopamine and serotonin transporters using Ca</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33785354</pubmedLink>
    <GrantList>
      <Grant>R01 DA033930</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00120-4</DOI>
    <KeywordList>
      <Keywords>Calcium imaging</Keywords>
      <Keywords>Monoamine transporters</Keywords>
      <Keywords>Psychostimulants</Keywords>
      <Keywords>Reuptake inhibitors</Keywords>
      <Keywords>Voltage-gated calcium channels</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Iwona Ruchala</Name>
        <Affiliation>Department of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Umberto M. Battisti</Name>
        <Affiliation>Deparment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Vy T. Nguyen</Name>
        <Affiliation>Department of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Rita Yu Tzu Chen</Name>
        <Affiliation>Department of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Glennon</Name>
        <Affiliation>Deparment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jose M. Eltit</Name>
        <Affiliation>Department of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, United States of America. Electronic address: jose.eltit@vcuhealth.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Trans-resveratrol imparts disparate effects on transcription of DNA damage sensing/repair pathway genes in euglycemic and hyperglycemic rat testis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33775663</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00117-4</DOI>
    <KeywordList>
      <Keywords>Antioxidants</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Cell cycle control</Keywords>
      <Keywords>DNA damage repair</Keywords>
      <Keywords>Diabetes</Keywords>
      <Keywords>Testis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Narayana Kilarkaje</Name>
        <Affiliation>Department of Anatomy Faculty of Medicine, Kuwait University, Kuwait. Electronic address: narayana.krishna@ku.edu.kw.</Affiliation>
      </Author>
      <Author>
        <Name>Mariam Al-Qaryyan</Name>
        <Affiliation>Department of Physiology Faculty of Medicine, Kuwait University, Kuwait.</Affiliation>
      </Author>
      <Author>
        <Name>Maie D. Al-Bader</Name>
        <Affiliation>Department of Physiology Faculty of Medicine, Kuwait University, Kuwait.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dibenzyl trisulfide binds to and competitively inhibits the cytochrome P450 1A1 active site without impacting the expression of the aryl hydrocarbon receptor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33774063</pubmedLink>
    <GrantList>
      <Grant>F31 ES030975</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00109-5</DOI>
    <KeywordList>
      <Keywords>AHR pathway</Keywords>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>CYP1</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Chemoprevention</Keywords>
      <Keywords>Cytochrome P450 1</Keywords>
      <Keywords>Dibenzyl trisulfide</Keywords>
      <Keywords>Ethnomedicine</Keywords>
      <Keywords>Petiveria alliacea</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shaniece Wauchope</Name>
        <Affiliation>Natural Products Institute, University of the West Indies, Mona, Kingston 7, Jamaica.</Affiliation>
      </Author>
      <Author>
        <Name>Monika A. Roy</Name>
        <Affiliation>Department of Environmental Health Sciences, University of Massachusetts Amherst, Amherst, MA 01003, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William Irvine</Name>
        <Affiliation>Natural Products Institute, University of the West Indies, Mona, Kingston 7, Jamaica.</Affiliation>
      </Author>
      <Author>
        <Name>Isaac Morrison</Name>
        <Affiliation>Natural Products Institute, University of the West Indies, Mona, Kingston 7, Jamaica.</Affiliation>
      </Author>
      <Author>
        <Name>Eileen Brantley</Name>
        <Affiliation>Department of Basic Sciences, Center for Health Disparities and Molecular Medicine, Loma Linda University Health School of Medicine, Loma Linda, CA 92350, USA; Department of Pharmaceutical and Administrative Sciences, Loma Linda University Health School of Pharmacy, Loma Linda, CA 92350, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maxine Gossell-Williams</Name>
        <Affiliation>Department of Basic Medical Sciences, University of the West Indies, Mona, Kingston 7, Jamaica.</Affiliation>
      </Author>
      <Author>
        <Name>Alicia R. Timme-Laragy</Name>
        <Affiliation>Department of Environmental Health Sciences, University of Massachusetts Amherst, Amherst, MA 01003, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rupika Delgoda</Name>
        <Affiliation>Natural Products Institute, University of the West Indies, Mona, Kingston 7, Jamaica. Electronic address: thejani.delgoda@uwimona.edu.jm.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Simvastatin attenuates acute lung injury by activation of A2B adenosine receptor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33774062</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00067-3</DOI>
    <KeywordList>
      <Keywords>A2B adenosine receptor</Keywords>
      <Keywords>Acute lung injury</Keywords>
      <Keywords>CFTR</Keywords>
      <Keywords>Claudin18</Keywords>
      <Keywords>Claudin4</Keywords>
      <Keywords>Simvastatin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hong Xia Li</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, The Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Yan Liang</Name>
        <Affiliation>Department of Respiratory Medicine in Special Wards, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiong He Wu</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, The Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Ping Yuan</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, The Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Gao</Name>
        <Affiliation>Beijing Institute of Radiation Medicine, AMMS, Haidian, Beijing 100039, China. Electronic address: gaoyue@bmi.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shao Hua Cai</Name>
        <Affiliation>Department of Respiratory Medicine in Special Wards, Chinese PLA General Hospital, Beijing 100853, China. Electronic address: csh301@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Detection of intracellular lamellar bodies as a screening marker for fibrotic lesions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33771551</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00108-3</DOI>
    <KeywordList>
      <Keywords>Disinfectants</Keywords>
      <Keywords>Interstitial fibrosis</Keywords>
      <Keywords>Lamellar bodies</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>The nuclear matrix cleavage</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eun Jung Park</Name>
        <Affiliation>East-West Medical Science Research Institute, Kyung Hee Medical Science Research Institute, Kyung Hee University, Seoul 02447, Republic of Korea; Human Health and Environmental Toxins Research Center, Kyung Hee Medical Science Research Institute, Kyung Hee University, 02447, Republic of Korea; Department of Biomedical Science and Technology, Graduate school, Kyung Hee University, Republic of Korea. Electronic address: pejtoxic@khu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Min Sung Kang</Name>
        <Affiliation>Department of Biomedical Science and Technology, Graduate school, Kyung Hee University, Republic of Korea; General Toxicology &amp; Research Group, Jeonbuk Branch Institute, Korea Institute of Toxicology, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Ji Lim</Name>
        <Affiliation>Department of Biomedical Science and Technology, Graduate school, Kyung Hee University, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Kyu Kang</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, 28644, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Woo Jin</Name>
        <Affiliation>Department of Biomedical Science and Technology, Graduate school, Kyung Hee University, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyeun Lee</Name>
        <Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University School of Medicine, 02447, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Hwa Baek</Name>
        <Affiliation>Department of Chemical and Biological Engineering, Korea University, 0284, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Won Kang</Name>
        <Affiliation>Department of Chemical and Biological Engineering, Korea University, 0284, Republic of Korea; Graduate School of Energy and Environment, Korea University, 0284, Republic of Korea. Electronic address: jwkang@korea.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicokinetic evaluation of the common indoor air pollutant, α-pinene, and its potential reactive metabolite, α-pinene oxide, following inhalation exposure in rodents.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33744279</pubmedLink>
    <GrantList>
      <Grant>HHSN273201400015C</Grant>
      <Grant>HHSN273201400022C</Grant>
      <Grant>ZIA ES103316</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00103-4</DOI>
    <KeywordList>
      <Keywords>Inhalation exposure</Keywords>
      <Keywords>Toxicokinetics</Keywords>
      <Keywords>α-Pinene</Keywords>
      <Keywords>α-pinene oxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suramya Waidyanatha</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA. Electronic address: waidyanathas@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Hackett</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sherry R. Black</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mathew D. Stout</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy R. Fennell</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melanie R. Silinski</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott L. Watson</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph Licause</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Veronica G. Robinson</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Barney Sparrow</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Reshan A. Fernando</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Cooper</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cynthia V. Rider</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TGF-β1-induced EMT activation via both Smad-dependent and MAPK signaling pathways in Cu-induced pulmonary fibrosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33744278</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00107-1</DOI>
    <KeywordList>
      <Keywords>CuSO(4)</Keywords>
      <Keywords>EMT</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>MAPKs</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>TGF-β1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hongrui Guo</Name>
        <Affiliation>College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu 611130, China; Key Laboratory of Animal Diseases and Environmental Hazards of Sichuan Province, Sichuan Agriculture University, Wenjiang, Chengdu 611130, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhijie Jian</Name>
        <Affiliation>College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu 611130, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huan Liu</Name>
        <Affiliation>College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu 611130, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hengmin Cui</Name>
        <Affiliation>College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu 611130, China; Key Laboratory of Animal Diseases and Environmental Hazards of Sichuan Province, Sichuan Agriculture University, Wenjiang, Chengdu 611130, China; Key Laboratory of Agricultural information engineering of Sichuan Province, Sichuan Agriculture University, Yaan, Sichuan, 625014, China. Electronic address: chm2020@sicau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Huidan Deng</Name>
        <Affiliation>College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu 611130, China; Key Laboratory of Animal Diseases and Environmental Hazards of Sichuan Province, Sichuan Agriculture University, Wenjiang, Chengdu 611130, China. Electronic address: denghuidan@sicau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Fang</Name>
        <Affiliation>College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu 611130, China; Key Laboratory of Animal Diseases and Environmental Hazards of Sichuan Province, Sichuan Agriculture University, Wenjiang, Chengdu 611130, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhicai Zuo</Name>
        <Affiliation>College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu 611130, China; Key Laboratory of Animal Diseases and Environmental Hazards of Sichuan Province, Sichuan Agriculture University, Wenjiang, Chengdu 611130, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xun Wang</Name>
        <Affiliation>College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu 611130, China; Key Laboratory of Animal Diseases and Environmental Hazards of Sichuan Province, Sichuan Agriculture University, Wenjiang, Chengdu 611130, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Zhao</Name>
        <Affiliation>College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu 611130, China; Key Laboratory of Animal Diseases and Environmental Hazards of Sichuan Province, Sichuan Agriculture University, Wenjiang, Chengdu 611130, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Geng</Name>
        <Affiliation>College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu 611130, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Ouyang</Name>
        <Affiliation>College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu 611130, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huaqiao Tang</Name>
        <Affiliation>College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu 611130, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>α-Phellandrene exhibits antinociceptive and tumor-reducing effects in a mouse model of oncologic pain.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33744277</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00104-6</DOI>
    <KeywordList>
      <Keywords>Adjuvant therapy</Keywords>
      <Keywords>Cancer-related allodynia</Keywords>
      <Keywords>Interleukins</Keywords>
      <Keywords>Monoterpenes</Keywords>
      <Keywords>Sarcoma 180</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Flaviano Ribeiro Pinheiro-Neto</Name>
        <Affiliation>Posgraduate Program in Pharmacology, Federal University of Piaui, 64049-550 Teresina, Brazil; Department of Biochemistry and Pharmacology, Research Center of Medicinal Plants, Federal University of Piauí, 64049-550 Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Everton Moraes Lopes</Name>
        <Affiliation>Posgraduate Program in Pharmacology, Federal University of Piaui, 64049-550 Teresina, Brazil; Department of Biochemistry and Pharmacology, Research Center of Medicinal Plants, Federal University of Piauí, 64049-550 Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Boris Timah Acha</Name>
        <Affiliation>Posgraduate Program in Pharmacology, Federal University of Piaui, 64049-550 Teresina, Brazil; Department of Biochemistry and Pharmacology, Research Center of Medicinal Plants, Federal University of Piauí, 64049-550 Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Laércio da Silva Gomes</Name>
        <Affiliation>Posgraduate Program in Pharmacology, Federal University of Piaui, 64049-550 Teresina, Brazil; Department of Biochemistry and Pharmacology, Research Center of Medicinal Plants, Federal University of Piauí, 64049-550 Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Willian Amorim Dias</Name>
        <Affiliation>Posgraduate Program in Pharmacology, Federal University of Piaui, 64049-550 Teresina, Brazil; Department of Biochemistry and Pharmacology, Research Center of Medicinal Plants, Federal University of Piauí, 64049-550 Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio Carlos Dos Reis Filho</Name>
        <Affiliation>Posgraduate Program in Pharmacology, Federal University of Piaui, 64049-550 Teresina, Brazil; Department of Biochemistry and Pharmacology, Research Center of Medicinal Plants, Federal University of Piauí, 64049-550 Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bianca de Sousa Leal</Name>
        <Affiliation>Posgraduate Program in Pharmacology, Federal University of Piaui, 64049-550 Teresina, Brazil; Laboratory of Experimental Cancerology, Department of Biophysics and Physiology, Posgraduate Program in Pharmaceutical Sciences, Federal University of Piauí, 64049-550 Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Débora Caroline do Nascimento Rodrigues</Name>
        <Affiliation>Laboratory of Experimental Cancerology, Department of Biophysics and Physiology, Posgraduate Program in Pharmaceutical Sciences, Federal University of Piauí, 64049-550 Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jurandy do Nascimento Silva</Name>
        <Affiliation>Laboratory of Experimental Cancerology, Department of Biophysics and Physiology, Posgraduate Program in Pharmaceutical Sciences, Federal University of Piauí, 64049-550 Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Dalton Dittz</Name>
        <Affiliation>Department of Biochemistry and Pharmacology, Research Center of Medicinal Plants, Federal University of Piauí, 64049-550 Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Paulo Michel Pinheiro Ferreira</Name>
        <Affiliation>Posgraduate Program in Pharmacology, Federal University of Piaui, 64049-550 Teresina, Brazil; Laboratory of Experimental Cancerology, Department of Biophysics and Physiology, Posgraduate Program in Pharmaceutical Sciences, Federal University of Piauí, 64049-550 Teresina, Brazil. Electronic address: pmpf@ufpi.edu.br.</Affiliation>
      </Author>
      <Author>
        <Name>Fernanda Regina de Castro Almeida</Name>
        <Affiliation>Posgraduate Program in Pharmacology, Federal University of Piaui, 64049-550 Teresina, Brazil; Department of Biochemistry and Pharmacology, Research Center of Medicinal Plants, Federal University of Piauí, 64049-550 Teresina, Brazil. Electronic address: ferecal@ufpi.edu.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>NLRP3 protects mice from radiation-induced colon and skin damage via attenuating cGAS-STING signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33741346</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00102-2</DOI>
    <KeywordList>
      <Keywords>NLRP3 Inflammasome</Keywords>
      <Keywords>Radiation</Keywords>
      <Keywords>Tissue Damage</Keywords>
      <Keywords>cGAS-STING</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tiancong Wu</Name>
        <Affiliation>Department of Gastroenterology and Hepatology, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing 210002, China; Jinling Hospital, Department of Radiation Oncology, Nanjing University, School Medicine, Nanjing 210002, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianhua Gao</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Science, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Liu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Science, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Cui</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Science, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Miaofang Yang</Name>
        <Affiliation>Department of Gastroenterology and Hepatology, Jinling Hospital, Medical School of Nanjing University, 305 Zhongshan East Road, Nanjing 210002, Jiangsu Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjie Guo</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Science, Nanjing University, Nanjing 210093, China. Electronic address: guowj@nju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Yu Wang</Name>
        <Affiliation>Department of Gastroenterology and Hepatology, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing 210002, China; Department of Gastroenterology and Hepatology, Jinling Hospital, Medical School of Nanjing University, 305 Zhongshan East Road, Nanjing 210002, Jiangsu Province, China. Electronic address: wangfy65@nju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pyrazole (1, 2-diazole) induce apoptosis in lymphoma cells by targeting BCL-2 and BCL-XL genes and mitigate murine solid tumour development by regulating cyclin-D1 and Ki-67 expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33737021</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00098-3</DOI>
    <KeywordList>
      <Keywords>AO/EB</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Dalton's Lymphoma Ascites</Keywords>
      <Keywords>Pyrazole</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Walsan Kalarikkal Vishnu</Name>
        <Affiliation>Laboratory of Immunopharmacology and Experimental Therapeutics, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram, 695011 Kerala, India.</Affiliation>
      </Author>
      <Author>
        <Name>Prathapan Abeesh</Name>
        <Affiliation>Laboratory of Immunopharmacology and Experimental Therapeutics, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram, 695011 Kerala, India.</Affiliation>
      </Author>
      <Author>
        <Name>Chandrasekharan Guruvayoorappan</Name>
        <Affiliation>Laboratory of Immunopharmacology and Experimental Therapeutics, Division of Cancer Research, Regional Cancer Centre (Research Centre, University of Kerala), Thiruvananthapuram, 695011 Kerala, India. Electronic address: guruvayoorappan@rcctvm.gov.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33727089</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00100-9</DOI>
    <KeywordList>
      <Keywords>4-AAQB</Keywords>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Cyclin-dependent kinase 2/4</Keywords>
      <Keywords>Triple-negative breast cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pamungkas Bagus Satriyo</Name>
        <Affiliation>College of Medicine, Taipei Medical University, Taipei City 11031, Taiwan; Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia; Department of Pharmacology and Therapy, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Ming Su</Name>
        <Affiliation>Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Jiann Ruey Ong</Name>
        <Affiliation>Department of Emergency Medicine, Taipei Medical University-Shuang Ho Hospital, New Taipei City 235, Taiwan; Graduate Institute of Injury Prevention and Control, Taipei Medical University, Taipei 110, Taiwan; Department of Emergency Medicine, School of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Chien Huang</Name>
        <Affiliation>Department of Medicine, MacKay Medical College, Taipei 110, Taiwan, ROC; Division of Thoracic Surgery, Department of Surgery, MacKay Memorial Hospital, Taipei 110, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Iat Hang Fong</Name>
        <Affiliation>Department of Medical Research &amp; Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City 23561, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Cheng Lin</Name>
        <Affiliation>Department of Medical Laboratory Science and Biotechnology, Yuanpei University of Medical Technology, Hsinchu City 30015, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Teguh Aryandono</Name>
        <Affiliation>Department of Surgery, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.</Affiliation>
      </Author>
      <Author>
        <Name>Sofia Mubarika Haryana</Name>
        <Affiliation>Department of Histology and Cellular Biology, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.</Affiliation>
      </Author>
      <Author>
        <Name>Li Deng</Name>
        <Affiliation>Beijing Bioprocess Key Laboratory, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China; Amoy-BUCT Industrial Bio-Technovation Institute, Amoy 361022, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Chih Huang</Name>
        <Affiliation>Center for General Education, National Taitung University, Taitung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yew Min Tzeng</Name>
        <Affiliation>Center for General Education, National Taitung University, Taitung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Tsu Yi Chao</Name>
        <Affiliation>College of Medicine, Taipei Medical University, Taipei City 11031, Taiwan; Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; Department of Medical Research &amp; Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City 23561, Taiwan; Department of Hematology &amp; Oncology, Taipei Medical University-Shuang Ho Hospital, New Taipei City 23561, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wen Liu</Name>
        <Affiliation>College of Medicine, Taipei Medical University, Taipei City 11031, Taiwan; Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; Department of Medical Research &amp; Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City 23561, Taiwan; Department of Hematology &amp; Oncology, Taipei Medical University-Shuang Ho Hospital, New Taipei City 23561, Taiwan. Electronic address: 19290@s.tmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chi Tai Yeh</Name>
        <Affiliation>College of Medicine, Taipei Medical University, Taipei City 11031, Taiwan; Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; Department of Medical Research &amp; Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City 23561, Taiwan; Department of Medical Laboratory Science and Biotechnology, Yuanpei University of Medical Technology, Hsinchu City 30015, Taiwan; Department of Hematology &amp; Oncology, Taipei Medical University-Shuang Ho Hospital, New Taipei City 23561, Taiwan. Electronic address: ctyeh@s.tmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tpl2 kinase regulates inflammation but not tumorigenesis in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33722668</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00101-0</DOI>
    <KeywordList>
      <Keywords>Mouse model</Keywords>
      <Keywords>Phenotyping</Keywords>
      <Keywords>Spontaneous tumor</Keywords>
      <Keywords>Tpl2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kai Connie Wu</Name>
        <Affiliation>Safety Assessment, Genentech, Inc., South San Francisco, CA 94080, USA. Electronic address: wu.kai@gene.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Cain</Name>
        <Affiliation>Safety Assessment, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Janice Corpuz</Name>
        <Affiliation>Safety Assessment, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daqi Xu</Name>
        <Affiliation>Immunology Department, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nina Ljumanovic</Name>
        <Affiliation>Safety Assessment, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ali A. Zarrin</Name>
        <Affiliation>Immunology Department, Genentech, Inc., South San Francisco, CA 94080, USA. Electronic address: ali@trex.bio.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Zebrafish early life stages as alternative model to study 'designer drugs': Concordance with mammals in response to opioids.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33722667</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00090-9</DOI>
    <KeywordList>
      <Keywords>Behaviour</Keywords>
      <Keywords>Biotransformation</Keywords>
      <Keywords>New Psychoactive Substances</Keywords>
      <Keywords>Opioids</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Krishna Tulasi Kirla</Name>
        <Affiliation>University of Zurich, Zurich Institute of Forensic Medicine, Department of Forensic Pharmacology and Toxicology, Zurich 8057, Switzerland; Eawag, Swiss Federal Institute of Aquatic Science and Technology, Department of Environmental Toxicology, Duebendorf 8600, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Erhart</Name>
        <Affiliation>Eawag, Swiss Federal Institute of Aquatic Science and Technology, Department of Environmental Toxicology, Duebendorf 8600, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Ksenia J. Groh</Name>
        <Affiliation>Food Packaging Forum Foundation, Zurich 8045, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Julita Stadnicka-Michalak</Name>
        <Affiliation>Eawag, Swiss Federal Institute of Aquatic Science and Technology, Department of Environmental Toxicology, Duebendorf 8600, Switzerland; EPFL, School of Architecture, Civil and Environmental Engineering, Lausanne 1015, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Rik I. L. Eggen</Name>
        <Affiliation>Eawag, Swiss Federal Institute of Aquatic Science and Technology, Department of Environmental Toxicology, Duebendorf 8600, Switzerland; ETHZ, Institute of Biogeochemistry and Pollutant Dynamics, Zurich 8092, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Schirmer</Name>
        <Affiliation>Eawag, Swiss Federal Institute of Aquatic Science and Technology, Department of Environmental Toxicology, Duebendorf 8600, Switzerland; EPFL, School of Architecture, Civil and Environmental Engineering, Lausanne 1015, Switzerland; ETHZ, Institute of Biogeochemistry and Pollutant Dynamics, Zurich 8092, Switzerland. Electronic address: kristin.schirmer@eawag.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Kraemer</Name>
        <Affiliation>University of Zurich, Zurich Institute of Forensic Medicine, Department of Forensic Pharmacology and Toxicology, Zurich 8057, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Anthraquinone derivative C10 inhibits proliferation and cell cycle progression in colon cancer cells via the Jak2/Stat3 signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33722666</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00088-0</DOI>
    <KeywordList>
      <Keywords>Anthraquinone derivatives</Keywords>
      <Keywords>Colon cancer</Keywords>
      <Keywords>Cycle arrest</Keywords>
      <Keywords>Jak2/Stat3 signal pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuying Li</Name>
        <Affiliation>Key Laboratory of Chemical Biology and Molecular Engineering of the Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan 030006, China. Electronic address: lyy9030@sxu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Guo</Name>
        <Affiliation>Key Laboratory of Chemical Biology and Molecular Engineering of the Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tinggui Chen</Name>
        <Affiliation>Key Laboratory of Chemical Biology and Molecular Engineering of the Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liwei Zhang</Name>
        <Affiliation>Key Laboratory of Chemical Biology and Molecular Engineering of the Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Qin</Name>
        <Affiliation>Key Laboratory of Chemical Biology and Molecular Engineering of the Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan 030006, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>NAM protects against cisplatin-induced acute kidney injury by suppressing the PARP1/p53 pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33722665</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00099-5</DOI>
    <KeywordList>
      <Keywords>Acute Kidney Injury</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Nicotinamide</Keywords>
      <Keywords>PARP1</Keywords>
      <Keywords>p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wenwen Wu</Name>
        <Affiliation>Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital, Central South University; Changsha 410011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Fu</Name>
        <Affiliation>Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital, Central South University; Changsha 410011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiwen Liu</Name>
        <Affiliation>Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital, Central South University; Changsha 410011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaoqun Shu</Name>
        <Affiliation>Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital, Central South University; Changsha 410011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Wang</Name>
        <Affiliation>Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital, Central South University; Changsha 410011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chengyuan Tang</Name>
        <Affiliation>Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital, Central South University; Changsha 410011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Cai</Name>
        <Affiliation>Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital, Central South University; Changsha 410011, China. Electronic address: cjane218@csu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Dong</Name>
        <Affiliation>Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital, Central South University; Changsha 410011, China; Department of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University and Charlie Norwood VA Medical Center, Augusta, GA, USA.. Electronic address: zdong@augusta.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Berberine-photodynamic therapy sensitizes melanoma cells to cisplatin-induced apoptosis through ROS-mediated P38 MAPK pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33716044</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00091-0</DOI>
    <KeywordList>
      <Keywords>Berberine</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Melanoma cancer</Keywords>
      <Keywords>Photodynamic therapy (PDT)</Keywords>
      <Keywords>ROS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaotong Wang</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qianyi Gong</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Changfeng Song</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiaping Fang</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Yang</Name>
        <Affiliation>Department of Pharmacy, School of Medicine, Jiaxing University, Jiaxing, Zhejiang 314001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Liang</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, PR China. Electronic address: xin.liang@ecust.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xuan Huang</Name>
        <Affiliation>Department of Pharmacy, School of Medicine, Jiaxing University, Jiaxing, Zhejiang 314001, China; Natural Medicine and Health Food Research &amp; Technology Innovation Team of Jiaxing, Jiaxing, Zhejiang 314001, China; Jiaxing Key Laboratory of Oncological Photodynamic Therapy and Targeted Drug Research, China. Electronic address: waynett2021@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jianwen Liu</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, PR China. Electronic address: liujian@ecust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Notoginsenoside R1 alleviates TEGDMA-induced mitochondrial apoptosis in preodontoblasts through activation of Akt/Nrf2 pathway-dependent mitophagy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33689844</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00089-2</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Mitophagy</Keywords>
      <Keywords>Notoginsenoside R1</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>TEGDMA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Konghuai Wang</Name>
        <Affiliation>Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China; Department of Endodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Danni Wu</Name>
        <Affiliation>Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China; Department of Endodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuekun Ren</Name>
        <Affiliation>Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China; Department of Endodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qihao Yu</Name>
        <Affiliation>Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China; Department of Endodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruona Liu</Name>
        <Affiliation>Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China; Department of Endodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengbin Huang</Name>
        <Affiliation>Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China; Department of Prosthodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China. Electronic address: huangsb003@wmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yihuai Pan</Name>
        <Affiliation>Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China; Department of Endodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China. Electronic address: yihuaipan@wmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shufan Zhao</Name>
        <Affiliation>Department of Oral Maxillofacial Surgery, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China. Electronic address: shufan.zhao@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Improving reliability and reducing costs of cardiotoxicity assessments using laser-induced cell poration on microelectrode arrays.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33689843</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00087-9</DOI>
    <KeywordList>
      <Keywords>CMOS-MEA</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Intracellular recording</Keywords>
      <Keywords>Plasmonic optoacoustic poration</Keywords>
      <Keywords>hiPSC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Giuseppina Iachetta</Name>
        <Affiliation>Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Nicolò Colistra</Name>
        <Affiliation>Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Giovanni Melle</Name>
        <Affiliation>Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Lieselot Deleye</Name>
        <Affiliation>Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Francesco Tantussi</Name>
        <Affiliation>Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Francesco De Angelis</Name>
        <Affiliation>Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy. Electronic address: francesco.deangelis@iit.it.</Affiliation>
      </Author>
      <Author>
        <Name>Michele Dipalo</Name>
        <Affiliation>Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy. Electronic address: michele.dipalo@iit.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute exposure to N-Ethylpentylone induces developmental toxicity and dopaminergic receptor-regulated aberrances in zebrafish larvae.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33667508</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00084-3</DOI>
    <KeywordList>
      <Keywords>Behavior</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Dopaminergic receptor</Keywords>
      <Keywords>Heart rate</Keywords>
      <Keywords>N-Ethylpentylone (NEP)</Keywords>
      <Keywords>Zebrafish larvae</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Enshan Fan</Name>
        <Affiliation>Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai 200032, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiru Xu</Name>
        <Affiliation>State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Yan</Name>
        <Affiliation>Department of Forensic Science, School of Basic Medical Sciences, Central South University, Changsha 410013, Hunan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fanglin Wang</Name>
        <Affiliation>Institute of Forensic Science, Ministry of Public Security, Beijing 100038, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaoyang Sun</Name>
        <Affiliation>Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yurong Zhang</Name>
        <Affiliation>Shanghai Institute of Forensic Science, Shanghai Key Laboratory of Crime Scene Evidence, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuiqing Zheng</Name>
        <Affiliation>Shanghai Institute of Forensic Science, Shanghai Key Laboratory of Crime Scene Evidence, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Wang</Name>
        <Affiliation>Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, PR China; Cancer Institute, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, PR China. Electronic address: wangxu2013@fudan.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yulan Rao</Name>
        <Affiliation>Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai 200032, PR China. Electronic address: yulan_rao@fudan.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Myeloid cell dynamics in bleomycin-induced pulmonary injury in mice; effects of anti-TNFα antibody.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33647319</pubmedLink>
    <GrantList>
      <Grant>F31 GM108463</Grant>
      <Grant>R01 HL086621</Grant>
      <Grant>T32 ES007148</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00077-6</DOI>
    <AuthorList>
      <Author>
        <Name>Alessandro Venosa</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James G. Gow</Name>
        <Affiliation>Dartmouth College, Hanover, NH 03755, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sheryse Taylor</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thea N. Golden</Name>
        <Affiliation>Center for Research on Reproduction and Women's Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 18015, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexa Murray</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elena Abramova</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rama Malaviya</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Debra L. Laskin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Gow</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: gow@pharmacy.rutgers.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>S-allyl cysteine ameliorates heat stress-induced oxidative stress by activating Nrf2/HO-1 signaling pathway in BMECs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33640343</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00076-4</DOI>
    <KeywordList>
      <Keywords>Bovine mammary epithelial cells</Keywords>
      <Keywords>Heat stress</Keywords>
      <Keywords>Nrf2/HO-1</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>S-allyl cysteine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yue Wang</Name>
        <Affiliation>Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China; College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Li Wang</Name>
        <Affiliation>Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guang Dong Xing</Name>
        <Affiliation>Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Qian</Name>
        <Affiliation>Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Feng Zhong</Name>
        <Affiliation>Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China; Youyuan Research Institute of Dairy Industry Co., Ltd, Nanjing 211100, China. Electronic address: zhongjifeng64@sina.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Kun Lin Chen</Name>
        <Affiliation>Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China. Electronic address: chenkunlin@jaas.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Salidroside alleviates diabetic neuropathic pain through regulation of the AMPK-NLRP3 inflammasome axis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33639149</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00075-2</DOI>
    <KeywordList>
      <Keywords>AMP-activated protein kinase</Keywords>
      <Keywords>Diabetes mellitus</Keywords>
      <Keywords>NLRP3 inflammasome</Keywords>
      <Keywords>Neuropathic pain</Keywords>
      <Keywords>Salidroside</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tao Zheng</Name>
        <Affiliation>Institute of Wudang Traditional Chinese Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China; Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China. Electronic address: ztice@foxmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Qibin Wang</Name>
        <Affiliation>Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Bian</Name>
        <Affiliation>Department of Pharmacy, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhao</Name>
        <Affiliation>Institute of Wudang Traditional Chinese Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weidong Ma</Name>
        <Affiliation>Institute of Wudang Traditional Chinese Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonghong Zhang</Name>
        <Affiliation>Institute of Wudang Traditional Chinese Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Lu</Name>
        <Affiliation>Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pan Lei</Name>
        <Affiliation>Institute of Wudang Traditional Chinese Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China; Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, Shiyan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lulu Zhang</Name>
        <Affiliation>Department of Hematology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xincai Hao</Name>
        <Affiliation>Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, Shiyan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Chen</Name>
        <Affiliation>Institute of Wudang Traditional Chinese Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China; Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China. Electronic address: chenli0201@sina.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of desaminotyrosine: Acute, subchronic oral toxicity, and its effects on intestinal microbiota in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33636197</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00071-5</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Desaminotyrosine</Keywords>
      <Keywords>Intestinal microflora</Keywords>
      <Keywords>Metabolites of flavonoid</Keywords>
      <Keywords>Subachronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Feng Li</Name>
        <Affiliation>College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian 350108, China; Institute of Pharmaceutical Biotechnology and Bioengineering, Fuzhou University, Fuzhou, Fujian 350108, China; Fujian Key Lab of Medical Instrument and Pharmaceutical Technology, Fuzhou University, Fuzhou, Fujian 350108, China. Electronic address: lqlchfengli@fzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Liping Wang</Name>
        <Affiliation>College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian 350108, China; Institute of Pharmaceutical Biotechnology and Bioengineering, Fuzhou University, Fuzhou, Fujian 350108, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yilei Cai</Name>
        <Affiliation>College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian 350108, China; Institute of Pharmaceutical Biotechnology and Bioengineering, Fuzhou University, Fuzhou, Fujian 350108, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yihuo Luo</Name>
        <Affiliation>College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian 350108, China; Institute of Pharmaceutical Biotechnology and Bioengineering, Fuzhou University, Fuzhou, Fujian 350108, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xianai Shi</Name>
        <Affiliation>College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian 350108, China; Institute of Pharmaceutical Biotechnology and Bioengineering, Fuzhou University, Fuzhou, Fujian 350108, China; Fujian Key Lab of Medical Instrument and Pharmaceutical Technology, Fuzhou University, Fuzhou, Fujian 350108, China. Electronic address: shixa@fzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integration of paraquat pharmacokinetic data across species using PBPK modelling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33631233</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00069-7</DOI>
    <KeywordList>
      <Keywords>Dog</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>PBPK model</Keywords>
      <Keywords>Paraquat dichloride</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jerry L. Campbell</Name>
        <Affiliation>Ramboll Environment and Health Consulting, 3214 Charles B. Root Wynd Suite 130, Raleigh, NC 27612, USA. Electronic address: JCampbell@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kim Z. Travis</Name>
        <Affiliation>Syngenta Ltd, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK. Electronic address: kim.travis@regulatoryscience.com.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>Ramboll Environment and Health Consulting, 3214 Charles B. Root Wynd Suite 130, Raleigh, NC 27612, USA. Electronic address: hclewell@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander J. Stevens</Name>
        <Affiliation>Syngenta Ltd, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK. Electronic address: alex.stevens@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paul M. Hinderliter</Name>
        <Affiliation>Syngenta Crop Protection LLC, P.O. Box 18300, Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>Andersen ToxConsulting LLC, 424 Granite Lake CT, Denver, NC 28037, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Philip A. Botham</Name>
        <Affiliation>Syngenta Ltd, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK. Electronic address: phil.botham@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew R. Cook</Name>
        <Affiliation>Syngenta Ltd, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK. Electronic address: andy.cook@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel J. Minnema</Name>
        <Affiliation>Syngenta Crop Protection LLC, P.O. Box 18300, Greensboro, NC, USA. Electronic address: daniel.minnema@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas C. Wolf</Name>
        <Affiliation>Syngenta Crop Protection LLC, Research Triangle Park, NC 27709, USA. Electronic address: doug.wolf@syngenta.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Paraquat pharmacokinetics in primates and extrapolation to humans.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33631232</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00070-3</DOI>
    <KeywordList>
      <Keywords>Excretion</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>Non-human primate</Keywords>
      <Keywords>PBPK model</Keywords>
      <Keywords>Paraquat dichloride</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alexander J. Stevens</Name>
        <Affiliation>Syngenta Ltd, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK. Electronic address: alex.stevens@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jerry L. Campbell</Name>
        <Affiliation>Ramboll Environment and Health Consulting, 3214 Charles B. Root Wynd Suite 130, Raleigh, NC 27612, USA. Electronic address: jcampbell@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kim Z. Travis</Name>
        <Affiliation>Syngenta Ltd, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK. Electronic address: kim.travis@regulatoryscience.com.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>Ramboll Environment and Health Consulting, 3214 Charles B. Root Wynd Suite 130, Raleigh, NC 27612, USA. Electronic address: hclewell@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paul M. Hinderliter</Name>
        <Affiliation>Syngenta Crop Protection LLC, P.O. Box 18300, Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Philip A. Botham</Name>
        <Affiliation>Syngenta Ltd, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK. Electronic address: phil.botham@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew R. Cook</Name>
        <Affiliation>Syngenta Ltd, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK. Electronic address: andy.cook@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel J. Minnema</Name>
        <Affiliation>Syngenta Crop Protection LLC, P.O. Box 18300, Greensboro, NC, USA. Electronic address: daniel.minnema@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas C. Wolf</Name>
        <Affiliation>Syngenta Crop Protection LLC, Research Triangle Park, NC 27709, USA. Electronic address: doug.wolf@syngenta.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Natural products in the reprogramming of cancer epigenetics.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33631231</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00074-0</DOI>
    <KeywordList>
      <Keywords>Chemoprevention</Keywords>
      <Keywords>DNA methylation</Keywords>
      <Keywords>Epi-drugs</Keywords>
      <Keywords>Histone modifications</Keywords>
      <Keywords>Natural products</Keywords>
      <Keywords>ncRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rasha Irshad</Name>
        <Affiliation>Department of Biotechnology, Faculty of Natural Sciences, Jamia Millia Islamia, New Delhi 110025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Husain</Name>
        <Affiliation>Department of Biotechnology, Faculty of Natural Sciences, Jamia Millia Islamia, New Delhi 110025, India. Electronic address: mhusain2@jmi.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>CDK9 inhibition improves diabetic nephropathy by reducing inflammation in the kidneys.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33631230</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00072-7</DOI>
    <KeywordList>
      <Keywords>Cyclin-dependent kinase 9</Keywords>
      <Keywords>Diabetic nephropathy</Keywords>
      <Keywords>High glucose</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Renal fibrosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaojing Yang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wu Luo</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Li</Name>
        <Affiliation>Department of Anesthesiology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiang Hu</Name>
        <Affiliation>Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingjiang Xu</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Wang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianpeng Feng</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianchang Qian</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinfu Guan</Name>
        <Affiliation>The Affiliated Cangnan Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunjie Zhao</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: aabye1100@aliyun.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guang Liang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China; The Affiliated Cangnan Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: wzmcliangguang@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of adenosine A1 receptor agonists as neuroprotective countermeasures against Soman intoxication in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33631229</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00073-9</DOI>
    <KeywordList>
      <Keywords>Adenosine receptor agonist</Keywords>
      <Keywords>Behavior</Keywords>
      <Keywords>Neuropathology</Keywords>
      <Keywords>Seizure activity</Keywords>
      <Keywords>Shuttle box</Keywords>
      <Keywords>Soman</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kristy L. Meads</Name>
        <Affiliation>U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5400, United States of America. Electronic address: kristy.l.meads.ctr@mail.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Thaddeus P. Thomas</Name>
        <Affiliation>U.S. Army Research Laboratory, Aberdeen Proving Ground, MD 21005-5425, United States of America. Electronic address: thaddeus.p.thomas.civ@mail.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey L. Langston</Name>
        <Affiliation>U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5400, United States of America. Electronic address: jeffrey.l.langston.ctr@mail.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Todd M. Myers</Name>
        <Affiliation>U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5400, United States of America. Electronic address: todd.m.myers14.civ@mail.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Tsung Ming Shih</Name>
        <Affiliation>U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5400, United States of America. Electronic address: tsungming.a.shih.civ@mail.mil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A quantitative weight of evidence assessment of Hill's guidelines for causal inference for cosmetic talc as a cause of mesothelioma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33617892</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00068-5</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>Causal criteria</Keywords>
      <Keywords>Causal viewpoints</Keywords>
      <Keywords>Pleural mesothelioma</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Sir Bradford Hill</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Michael Ierardi</Name>
        <Affiliation>Cardno ChemRisk, 231 Front Street, Suite 212, Brooklyn, NY, 11201, USA. Electronic address: Michael.Ierardi@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ania Urban</Name>
        <Affiliation>Cardno ChemRisk, 235 Pine Street, 23rd Floor, San Francisco, CA, 94104, USA. Electronic address: Ania.Urban@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gary M. Marsh</Name>
        <Affiliation>Cardno ChemRisk, 20 Stanwix Street, Suite 505, Pittsburgh, PA, 15222, USA. Electronic address: Gary.Marsh@cardno.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>HDN-1 induces cell differentiation toward apoptosis in promyelocytic leukemia cells depending on its selective effect on client proteins of Hsp90.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33609515</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00066-1</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Client protein</Keywords>
      <Keywords>Differentiation</Keywords>
      <Keywords>HDN-1</Keywords>
      <Keywords>Hsp90</Keywords>
      <Keywords>Selectivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xin Qi</Name>
        <Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xintong Zhang</Name>
        <Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaochun Liu</Name>
        <Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Tang</Name>
        <Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiajia Dai</Name>
        <Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ao Chen</Name>
        <Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Lin</Name>
        <Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Tianjiao Zhu</Name>
        <Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, PR China; Open Studio for Druggability Research of Marine Natural Products, Laboratory for Marine Drugs and Bioproducts, Pilot National Laboratory for Marine Science and Technology (Qingdao), 1 Wenhai Road, Aoshanwei, Jimo, Qingdao 266237, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Li</Name>
        <Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, PR China; Open Studio for Druggability Research of Marine Natural Products, Laboratory for Marine Drugs and Bioproducts, Pilot National Laboratory for Marine Science and Technology (Qingdao), 1 Wenhai Road, Aoshanwei, Jimo, Qingdao 266237, PR China. Electronic address: lijing_ouc@ouc.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>S-(+)-Pentedrone and R-(+)-methylone as the most oxidative and cytotoxic enantiomers to dopaminergic SH-SY5Y cells: Role of MRP1 and P-gp in cathinones enantioselectivity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33609514</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00049-1</DOI>
    <KeywordList>
      <Keywords>ABC transporters</Keywords>
      <Keywords>Dopaminergic SH-SY5Y</Keywords>
      <Keywords>Enantioselectivity</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Pentedrone and methylone enantiomers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bárbara Silva</Name>
        <Affiliation>UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: barbarapolerisilva@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andreia Palmeira</Name>
        <Affiliation>Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Renata Silva</Name>
        <Affiliation>UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Carla Fernandes</Name>
        <Affiliation>Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR), Universidade do Porto, Avenida General Norton de Matos, 4450-208 Matosinhos, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Paula Guedes de Pinho</Name>
        <Affiliation>UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Remião</Name>
        <Affiliation>UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: remiao@ff.up.pt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Involvement of TCF7L2 in generation of morphine-induced antinociceptive tolerance and hyperalgesia by modulating TLR4/ NF-κB/NLRP3 in microglia.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33607128</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00065-X</DOI>
    <KeywordList>
      <Keywords>Hyperalgesia</Keywords>
      <Keywords>Morphine tolerance</Keywords>
      <Keywords>NLRP3</Keywords>
      <Keywords>TCF7L2</Keywords>
      <Keywords>TLR4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Chen</Name>
        <Affiliation>Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province 150081, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guonian Wang</Name>
        <Affiliation>Harbin Medical University Sino-Russian Research Center Pain Management Research Institute, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150001, China. Electronic address: wangguonian053@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tingting Sun</Name>
        <Affiliation>Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province 150081, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Ma</Name>
        <Affiliation>Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province 150081, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xing Huo</Name>
        <Affiliation>Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province 150081, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiran Kong</Name>
        <Affiliation>Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province 150081, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cadmium induced inflammation and apoptosis of porcine epididymis via activating RAF1/MEK/ERK and NF-κB pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33577919</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00056-9</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Epididymis</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>NF-κB payhway</Keywords>
      <Keywords>RAF1/MEK/ERK pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yue Zhang</Name>
        <Affiliation>College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yulong Li</Name>
        <Affiliation>College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinxi Zhang</Name>
        <Affiliation>College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Qi</Name>
        <Affiliation>College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Cui</Name>
        <Affiliation>College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Yin</Name>
        <Affiliation>College of Wildlife Resources, Northeast Forestry University, Harbin 150040, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongjin Lin</Name>
        <Affiliation>College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China; Key Laboratory of the Provincial Education Department of Heilongjiang for Common Animal Disease Prevention and Treatment, College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China. Electronic address: linhongjin@neau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>U0126 pretreatment inhibits cisplatin-induced apoptosis and autophagy in HEI-OC1 cells and cochlear hair cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33577918</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00054-5</DOI>
    <KeywordList>
      <Keywords>Cisplatin</Keywords>
      <Keywords>ERK signaling pathway</Keywords>
      <Keywords>Hair cell</Keywords>
      <Keywords>Ototoxicity</Keywords>
      <Keywords>U0126</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dan Wang</Name>
        <Affiliation>ENT Institute and Otorhinolaryngology Department, Affiliated Eye and ENT Hospital, Fudan University and Key Laboratory of Hearing Medicine of National Health and Family Planning Commission (NHFPC), Shanghai 200031, China.</Affiliation>
      </Author>
      <Author>
        <Name>Suming Shi</Name>
        <Affiliation>ENT Institute and Otorhinolaryngology Department, Affiliated Eye and ENT Hospital, Fudan University and Key Laboratory of Hearing Medicine of National Health and Family Planning Commission (NHFPC), Shanghai 200031, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tongli Ren</Name>
        <Affiliation>ENT Institute and Otorhinolaryngology Department, Affiliated Eye and ENT Hospital, Fudan University and Key Laboratory of Hearing Medicine of National Health and Family Planning Commission (NHFPC), Shanghai 200031, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanping Zhang</Name>
        <Affiliation>ENT Institute and Otorhinolaryngology Department, Affiliated Eye and ENT Hospital, Fudan University and Key Laboratory of Hearing Medicine of National Health and Family Planning Commission (NHFPC), Shanghai 200031, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Guo</Name>
        <Affiliation>ENT Institute and Otorhinolaryngology Department, Affiliated Eye and ENT Hospital, Fudan University and Key Laboratory of Hearing Medicine of National Health and Family Planning Commission (NHFPC), Shanghai 200031, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiali Wang</Name>
        <Affiliation>ENT Institute and Otorhinolaryngology Department, Affiliated Eye and ENT Hospital, Fudan University and Key Laboratory of Hearing Medicine of National Health and Family Planning Commission (NHFPC), Shanghai 200031, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wuqing Wang</Name>
        <Affiliation>ENT Institute and Otorhinolaryngology Department, Affiliated Eye and ENT Hospital, Fudan University and Key Laboratory of Hearing Medicine of National Health and Family Planning Commission (NHFPC), Shanghai 200031, China. Electronic address: wwuqing@eent.shmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33577917</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00057-0</DOI>
    <KeywordList>
      <Keywords>Colorectal cancer</Keywords>
      <Keywords>Histone methylation</Keywords>
      <Keywords>PRMT5</Keywords>
      <Keywords>Ribavirin</Keywords>
      <Keywords>eIF4E</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suyin Ge</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, People's Republic of China. Electronic address: gesy17@lzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Qingqing Zhang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, People's Republic of China. Electronic address: qqzhang18@lzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yonglin Chen</Name>
        <Affiliation>Department of Pathology, First Hospital, Lanzhou University, Lanzhou 730000, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yizhen Tian</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, People's Republic of China. Electronic address: tianyzh18@lzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Ruiying Yang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, People's Republic of China. Electronic address: yangry20@lzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Chen</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, People's Republic of China. Electronic address: chenxu15@lzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Li</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, People's Republic of China. Electronic address: fli2019@lzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Baolai Zhang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, People's Republic of China. Electronic address: zhangbl@lzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low-level Eexposure to lead dust in unusual work schedules and hematologic, renal, and hepatic parameters.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33577916</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00055-7</DOI>
    <KeywordList>
      <Keywords>CBC</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Kidney function test</Keywords>
      <Keywords>Lead dust</Keywords>
      <Keywords>Liver function test</Keywords>
      <Keywords>Mine workers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fateme Kooshki</Name>
        <Affiliation>Student's Research Committee, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Masoud Neghab</Name>
        <Affiliation>Department of Occupational Health Engineering, Research Center for Health Sciences, Institute of Health, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Esmaeel Soleimani</Name>
        <Affiliation>Department of Occupational Health Engineering, Research Center for Health Sciences, Institute of Health, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: esoleimani61@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jafar Hasanzadeh</Name>
        <Affiliation>Department of Clinical Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Zearalenone and deoxynivalenol inhibited IL-4 receptor-mediated Th2 cell differentiation and aggravated bacterial infection in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33556388</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00048-X</DOI>
    <KeywordList>
      <Keywords>Combined mycotoxins</Keywords>
      <Keywords>Deoxynivalenol</Keywords>
      <Keywords>IL-4R</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Th2</Keywords>
      <Keywords>Zearalenone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guodong Cai</Name>
        <Affiliation>College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, Jiangsu, China; Joint International Research Laboratory of Agriculture and Agri-Product Safety of the Ministry of Education of China, Yangzhou University, Yangzhou 225009, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuangshuang Liu</Name>
        <Affiliation>College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Zhong</Name>
        <Affiliation>College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianhong Gu</Name>
        <Affiliation>College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Yuan</Name>
        <Affiliation>College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>JiaQiao Zhu</Name>
        <Affiliation>College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guoqiang Zhu</Name>
        <Affiliation>College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zongping Liu</Name>
        <Affiliation>College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, Jiangsu, China; Joint International Research Laboratory of Agriculture and Agri-Product Safety of the Ministry of Education of China, Yangzhou University, Yangzhou 225009, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Zou</Name>
        <Affiliation>College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, Jiangsu, China; Joint International Research Laboratory of Agriculture and Agri-Product Safety of the Ministry of Education of China, Yangzhou University, Yangzhou 225009, Jiangsu, China. Electronic address: zouhui@yzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jianchun Bian</Name>
        <Affiliation>College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, Jiangsu, China; Joint International Research Laboratory of Agriculture and Agri-Product Safety of the Ministry of Education of China, Yangzhou University, Yangzhou 225009, Jiangsu, China. Electronic address: jcbian@yzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reduced hepatic global hydroxymethylation in mice treated with non-genotoxic carcinogens is transiently reversible with a methyl supplemented diet.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33549593</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00046-6</DOI>
    <KeywordList>
      <Keywords>Clofibrate</Keywords>
      <Keywords>DNA methylation</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Hydroxymethylation</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Methyl supplemented diet</Keywords>
      <Keywords>Non-genotoxic carcinogenesis</Keywords>
      <Keywords>Phenobarbital</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>T. Sharapova</Name>
        <Affiliation>Investigative Toxicology and Pathology, AbbVie Inc., North Chicago, IL, United States. Electronic address: Tatsiana.sharapova@abbvie.com.</Affiliation>
      </Author>
      <Author>
        <Name>N. Talaty</Name>
        <Affiliation>Discovery Platform Technologies, AbbVie Inc., North Chicago, IL, United States.</Affiliation>
      </Author>
      <Author>
        <Name>W. R. Buck</Name>
        <Affiliation>Investigative Toxicology and Pathology, AbbVie Inc., North Chicago, IL, United States.</Affiliation>
      </Author>
      <Author>
        <Name>S. Fossey</Name>
        <Affiliation>Investigative Toxicology and Pathology, AbbVie Inc., North Chicago, IL, United States.</Affiliation>
      </Author>
      <Author>
        <Name>M. J. Liguori</Name>
        <Affiliation>Investigative Toxicology and Pathology, AbbVie Inc., North Chicago, IL, United States.</Affiliation>
      </Author>
      <Author>
        <Name>T. R. Van Vleet</Name>
        <Affiliation>Investigative Toxicology and Pathology, AbbVie Inc., North Chicago, IL, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Perfluoroundecanoic acid inhibits Leydig cell development in pubertal male rats via inducing oxidative stress and autophagy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33549592</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00047-8</DOI>
    <KeywordList>
      <Keywords>Leydig cells</Keywords>
      <Keywords>Perfluoroundecanoic acid</Keywords>
      <Keywords>Pubertal development</Keywords>
      <Keywords>Steroidogenesis</Keywords>
      <Keywords>Tstosterone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haoni Yan</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changchang Li</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Zou</Name>
        <Affiliation>Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiu Xin</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoheng Li</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huitao Li</Name>
        <Affiliation>Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Li</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zengqiang Li</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiyan Wang</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haolin Chen</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: chenhaolin@wmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Ren Shan Ge</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: r_ge@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health disparities: Intracellular consequences of social determinants of health.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33549591</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00051-X</DOI>
    <AuthorList>
      <Author>
        <Name>Rebecca T. Emeny</Name>
        <Affiliation>The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth &amp; Department of Psychiatry, Dartmouth Hitchcock, Lebanon, NH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David O. Carpenter</Name>
        <Affiliation>University at Albany School of Public Health, Rensselaer, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David A. Lawrence</Name>
        <Affiliation>University at Albany School of Public Health, Rensselaer, NY, USA; Wadsworth Center, New York State Department of Health, Albany, NY, USA. Electronic address: david.lawrence@health.ny.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic as an environmental toxicant and a therapeutic agent: Foe and friend.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33548274</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00045-4</DOI>
    <AuthorList>
      <Author>
        <Name>Yuanyuan Xu</Name>
        <Affiliation>Laboratory of Chronic Diseases and Environmental Genetics, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning Province 110122, PR China. Electronic address: yyxu@cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Erik J. Tokar</Name>
        <Affiliation>Stem Cell Toxicology Group, National Toxicology Program Laboratory, Division of the National Toxicology Program, NIEHS, 111 TW Alexander Drive, Building 101, Room E-105, RTP, NC 27709, USA. Electronic address: erik.tokar@nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning Province 110122, PR China. Electronic address: jbpi@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The tertiary oxime monoisonitrosoacetone penetrates the brain, reactivates inhibited acetylcholinesterase, and reduces mortality and morbidity following lethal sarin intoxication in guinea pigs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33548273</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00050-8</DOI>
    <KeywordList>
      <Keywords>Acetylcholinesterase</Keywords>
      <Keywords>In vivo Microdialysis</Keywords>
      <Keywords>LC-MS/MS Analysis of Monoisonitrosoacetone</Keywords>
      <Keywords>Lethality</Keywords>
      <Keywords>Monoisonitrosoacetone</Keywords>
      <Keywords>Oxime</Keywords>
      <Keywords>Sarin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tsung Ming Shih</Name>
        <Affiliation>Medical Toxicology Research Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5400, USA. Electronic address: tsungming.a.shih.civ@mail.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Benjamin L. Oyler</Name>
        <Affiliation>Medical Toxicology Research Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5400, USA. Electronic address: benjamin.oyler@nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Benedict R. Capacio</Name>
        <Affiliation>Medical Toxicology Research Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5400, USA. Electronic address: benedict.r.capacio.civ@mail.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Irwin Koplovitz</Name>
        <Affiliation>Medical Toxicology Research Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5400, USA. Electronic address: irvman30@comcast.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of calcitonin gene-related peptide in pain regulation in the parabrachial nucleus of naive rats and rats with neuropathic pain.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33524449</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00035-1</DOI>
    <KeywordList>
      <Keywords>Calcitonin gene-related peptide</Keywords>
      <Keywords>Calcitonin receptor-like receptor</Keywords>
      <Keywords>Knockdown calcitonin receptor-like receptor</Keywords>
      <Keywords>Neuropathic pain</Keywords>
      <Keywords>Parabrachial nucleus</Keywords>
      <Keywords>Small interfering RNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lin Lin Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Bo Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Hua Fu</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China. Electronic address: fenghua@luye.com.</Affiliation>
      </Author>
      <Author>
        <Name>Long Chuan Yu</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China; Neurobiology Laboratory, School of Life Sciences, Peking University, Beijing 100871, PR China. Electronic address: yulc@pku.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Peripheral metabolic effects of ozone exposure in healthy and diabetic rats on normal or high-cholesterol diet.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33524448</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00034-X</DOI>
    <KeywordList>
      <Keywords>Adipose tissue</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Metabolic response</Keywords>
      <Keywords>Ozone</Keywords>
      <Keywords>Type-2 diabetes rat model</Keywords>
      <Keywords>Western high-cholesterol diet</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Samantha J. Snow</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andres R. Henriquez</Name>
        <Affiliation>Oak Ridge Institute for Science and Education Research Participation Program, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Fisher</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Beena Vallanat</Name>
        <Affiliation>Biomolecular and Computational Toxicology Division, Center for Computational Toxicology and Exposure, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John S. House</Name>
        <Affiliation>Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mette C. Schladweiler</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Charles E. Wood</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Urmila P. Kodavanti</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States; Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC, United States. Electronic address: kodavanti.urmila@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of classic antiseizure drugs on seizure activity and anxiety-like behavior in adult zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33524447</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00036-3</DOI>
    <KeywordList>
      <Keywords>Classic ASDs</Keywords>
      <Keywords>Color preference</Keywords>
      <Keywords>Pentylenetetrazole</Keywords>
      <Keywords>Seizure</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mateusz Pieróg</Name>
        <Affiliation>Department of Animal Physiology and Pharmacology, Institute of Biological Sciences, Maria Curie-Sklodowska University, Akademicka 19, PL 20-033 Lublin, Poland. Electronic address: mateusz.pierog@umcs.lublin.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Katarzyna Socała</Name>
        <Affiliation>Department of Animal Physiology and Pharmacology, Institute of Biological Sciences, Maria Curie-Sklodowska University, Akademicka 19, PL 20-033 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Urszula Doboszewska</Name>
        <Affiliation>Department of Animal Physiology and Pharmacology, Institute of Biological Sciences, Maria Curie-Sklodowska University, Akademicka 19, PL 20-033 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Elżbieta Wyska</Name>
        <Affiliation>Department of Pharmacokinetics and Physical Pharmacy, Jagiellonian University Medical College, Medyczna 9, PL 30-688 Kraków, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Leszek Guz</Name>
        <Affiliation>Department of Fish Diseases and Biology, Institute of Biological Bases of Animal Diseases, University of Life Sciences, Akademicka 12, PL 20-033 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Aleksandra Szopa</Name>
        <Affiliation>Laboratory of Preclinical Testing, Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, Chodźki 1, PL 20-093, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Serefko</Name>
        <Affiliation>Laboratory of Preclinical Testing, Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, Chodźki 1, PL 20-093, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Ewa Poleszak</Name>
        <Affiliation>Laboratory of Preclinical Testing, Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, Chodźki 1, PL 20-093, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Piotr Wlaź</Name>
        <Affiliation>Department of Animal Physiology and Pharmacology, Institute of Biological Sciences, Maria Curie-Sklodowska University, Akademicka 19, PL 20-033 Lublin, Poland. Electronic address: piotr.wlaz@umcs.lublin.pl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pulmonary and vascular effects of acute ozone exposure in diabetic rats fed an atherogenic diet.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33524446</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00037-5</DOI>
    <KeywordList>
      <Keywords>Ozone</Keywords>
      <Keywords>Pulmonary Injury</Keywords>
      <Keywords>Systemic Inflammation</Keywords>
      <Keywords>Type 2 Diabetes Rat Model</Keywords>
      <Keywords>Vasocontraction</Keywords>
      <Keywords>Western High-Cholesterol Diet</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Samantha J. Snow</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andres R. Henriquez</Name>
        <Affiliation>Oak Ridge Institute for Science and Education Research Participation Program, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Leslie C. Thompson</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Cynthia Fisher</Name>
        <Affiliation>School of Public Health, University of North Carolina, Chapel Hill, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mette C. Schladweiler</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Charles E. Wood</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Urmila P. Kodavanti</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, United States. Electronic address: kodavanti.urmila@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical mitochondrial uncouplers share common inhibitory effect on NLRP3 inflammasome activation through inhibiting NFκB nuclear translocation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33524445</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00033-8</DOI>
    <KeywordList>
      <Keywords>IL-1β</Keywords>
      <Keywords>Macrophages</Keywords>
      <Keywords>Mitochondrial Uncouplers</Keywords>
      <Keywords>NLRP3 Inflammasome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nan Hu</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin Medical University, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yao Fu</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin Medical University, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Feng Li</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin Medical University, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Rui Yang</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin Medical University, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Cao</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin Medical University, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Feng Li</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin Medical University, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Hui Chen</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin Medical University, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Yang Chen</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin Medical University, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Zhao</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin Medical University, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Jie Sun</Name>
        <Affiliation>Department of Pharmacology, China Pharmaceutical University, Nanjing, People's Republic of China. Electronic address: sunzhijie@cpu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>De Li Dong</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin Medical University, People's Republic of China. Electronic address: dongdeli@ems.hrbmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Multistate models of developmental toxicity: Application to valproic acid-induced malformations in the zebrafish embryo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33524444</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00031-4</DOI>
    <KeywordList>
      <Keywords>Dose-response analysis</Keywords>
      <Keywords>Malformations</Keywords>
      <Keywords>Multistate model</Keywords>
      <Keywords>Survival analysis</Keywords>
      <Keywords>Zebrafish embryo</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ségolène Siméon</Name>
        <Affiliation>INERIS, METO Unit, Parc ALATA BP2, Verneuil en Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Rémy Beaudouin</Name>
        <Affiliation>UMR-I 02 SEBIO, INERIS, Parc ALATA BP2, Verneuil en Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Katharina Brotzmann</Name>
        <Affiliation>University of Heidelberg, Aquatic Ecology and Toxicology, Centre for Organismal Studies (COS), Im Neuenheimer Feld 504, D-69120 Heidelberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Braunbeck</Name>
        <Affiliation>University of Heidelberg, Aquatic Ecology and Toxicology, Centre for Organismal Studies (COS), Im Neuenheimer Feld 504, D-69120 Heidelberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Frédéric Y. Bois</Name>
        <Affiliation>CERTARA UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, United Kingdom. Electronic address: frederic.bois@certara.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Edible plant-derived exosomal microRNAs: Exploiting a cross-kingdom regulatory mechanism for targeting SARS-CoV-2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33516820</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00032-6</DOI>
    <KeywordList>
      <Keywords>COVID-19</Keywords>
      <Keywords>Edible nanoparticles</Keywords>
      <Keywords>Extracellular vesicles</Keywords>
      <Keywords>SARS-CoV-2</Keywords>
      <Keywords>microRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sreeram Peringattu Kalarikkal</Name>
        <Affiliation>Department of Molecular Nutrition, CSIR-Central Food Technological Research Institute, Mysuru, Karnataka 570020, India.</Affiliation>
      </Author>
      <Author>
        <Name>Gopinath M. Sundaram</Name>
        <Affiliation>Department of Molecular Nutrition, CSIR-Central Food Technological Research Institute, Mysuru, Karnataka 570020, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-CFTRI Campus, Mysuru, Karnataka, India. Electronic address: gopinath@cftri.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Diosgenin alleviates hypercholesterolemia via SRB1/CES-1/CYP7A1/FXR pathway in high-fat diet-fed rats" Toxicology and Applied Pharmacology, volume 412C (2021).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33508267</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00030-2</DOI>
    <AuthorList>
      <Author>
        <Name>Lu Yu</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haifei Lu</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiufen Yang</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruoqi Li</Name>
        <Affiliation>Zhejiang Chinese Medical University, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingjing Shi</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yantong Yu</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chaoqun Ma</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengcui Sun</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shizhao Zhang</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengxia Zhang</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China. Electronic address: fxzhang0987@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sorafenib not only impairs endothelium-dependent relaxation but also promotes vasoconstriction through the upregulation of vasoconstrictive endothelin type B receptors.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33503445</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00027-2</DOI>
    <KeywordList>
      <Keywords>ET(B) receptor</Keywords>
      <Keywords>Endothelium</Keywords>
      <Keywords>Hypertension</Keywords>
      <Keywords>Sorafenib</Keywords>
      <Keywords>Vasoconstriction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qi Yu</Name>
        <Affiliation>Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases &amp; Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China; Department of Histology and Embryology, Xi'an Medical University, Xi'an 710021, China; Department of Pharmacology, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China. Electronic address: yuqi_jzs@xiyi.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Kun Li</Name>
        <Affiliation>Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases &amp; Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Andong Zhao</Name>
        <Affiliation>Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases &amp; Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengqian Wei</Name>
        <Affiliation>Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases &amp; Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenhao Huang</Name>
        <Affiliation>Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases &amp; Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunting Zhang</Name>
        <Affiliation>Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases &amp; Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Chen</Name>
        <Affiliation>School of Computer Science and Technology, Xi'an University of Posts and Telecommunications, Xi'an 710121, China. Electronic address: chenying@xupt.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Lian</Name>
        <Affiliation>Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases &amp; Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chuan Wang</Name>
        <Affiliation>Department of Pharmacology, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Xu</Name>
        <Affiliation>Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases &amp; Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaping Zhang</Name>
        <Affiliation>Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases &amp; Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cangbao Xu</Name>
        <Affiliation>Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases &amp; Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fuqiang Liu</Name>
        <Affiliation>Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases &amp; Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an 710021, China; Cardiovascular Department, Shaanxi Provincial People's Hospital, Xi'an 710010, China. Electronic address: liufuqiang0909@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chloroquine may induce endothelial injury through lysosomal dysfunction and oxidative stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33484708</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00019-3</DOI>
    <KeywordList>
      <Keywords>Agalsidase-β</Keywords>
      <Keywords>COVID-19</Keywords>
      <Keywords>Endothelial cells</Keywords>
      <Keywords>Fabry disease</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Therapy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>PauloC Gregório</Name>
        <Affiliation>Experimental Nephrology Laboratory, Basic Pathology Department, Universidade Federal do Paraná, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Regiane S. da Cunha</Name>
        <Affiliation>Experimental Nephrology Laboratory, Basic Pathology Department, Universidade Federal do Paraná, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gilson Biagini</Name>
        <Affiliation>Department of Internal Medicine, Universidade Federal do Paraná, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bruna Bosquetti</Name>
        <Affiliation>Experimental Nephrology Laboratory, Basic Pathology Department, Universidade Federal do Paraná, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Júlia Budag</Name>
        <Affiliation>Experimental Nephrology Laboratory, Basic Pathology Department, Universidade Federal do Paraná, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alberto Ortiz</Name>
        <Affiliation>Nephrology and Hypertension, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain; IIS-Fundación Jimenez Diaz UAM, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Dolores Sánchez-Niño</Name>
        <Affiliation>IIS-Fundación Jimenez Diaz UAM, Madrid, Spain; Department of Pharmacology, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Fellype C. Barreto</Name>
        <Affiliation>Department of Internal Medicine, Division of Nephrology, Universidade Federal do Paraná, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Andréa E. M. Stinghen</Name>
        <Affiliation>Experimental Nephrology Laboratory, Basic Pathology Department, Universidade Federal do Paraná, Curitiba, PR, Brazil. Electronic address: andreastinghen@ufpr.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mathermycin, an anti-cancer molecule that targets cell surface phospholipids.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33476679</pubmedLink>
    <GrantList>
      <Grant>R01 ES030425</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00017-X</DOI>
    <KeywordList>
      <Keywords>Anti-cancer</Keywords>
      <Keywords>Mathermycin</Keywords>
      <Keywords>Phosphatidylethanolamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cuilin Cheng</Name>
        <Affiliation>Edison Biotechnology Institute, Ohio University, Athens, OH 45701, USA; School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin 150001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haotong Chen</Name>
        <Affiliation>Edison Biotechnology Institute, Ohio University, Athens, OH 45701, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lingying Tong</Name>
        <Affiliation>Edison Biotechnology Institute, Ohio University, Athens, OH 45701, USA; Department of Chemistry and Biochemistry, Ohio University, Athens, OH 45701, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenyu Li</Name>
        <Affiliation>Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuehan Yang</Name>
        <Affiliation>Edison Biotechnology Institute, Ohio University, Athens, OH 45701, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shiyong Wu</Name>
        <Affiliation>Edison Biotechnology Institute, Ohio University, Athens, OH 45701, USA; Department of Chemistry and Biochemistry, Ohio University, Athens, OH 45701, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey S. Wiseman</Name>
        <Affiliation>Edison Biotechnology Institute, Ohio University, Athens, OH 45701, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Han</Name>
        <Affiliation>Edison Biotechnology Institute, Ohio University, Athens, OH 45701, USA. Electronic address: hany@ohio.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Food emulsifier polysorbate 80 promotes the intestinal absorption of mono-2-ethylhexyl phthalate by disturbing intestinal barrier.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33476678</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00018-1</DOI>
    <KeywordList>
      <Keywords>Emulsifier</Keywords>
      <Keywords>Intestinal absorption</Keywords>
      <Keywords>Intestinal mucosa barrier</Keywords>
      <Keywords>Intestinal mucus barrier</Keywords>
      <Keywords>MEHP</Keywords>
      <Keywords>Plasticizers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Ting Zhu</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210046, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Zhen Yuan</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210046, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiu Ping Feng</Name>
        <Affiliation>College of Food Sciences and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210046, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Yuan Hu</Name>
        <Affiliation>College of Food Sciences and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210046, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Jie Li</Name>
        <Affiliation>College of Food Sciences and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210046, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiu Wu</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210046, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Su Yun Xiang</Name>
        <Affiliation>College of Food Sciences and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210046, People's Republic of China. Electronic address: xiangsy@njnu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Qin Yu</Name>
        <Affiliation>Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210046, People's Republic of China. Electronic address: yushuqin@njnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metformin relieves H/R-induced cardiomyocyte injury through miR-19a/ACSL axis - possible therapeutic target for myocardial I/R injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33476677</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00015-6</DOI>
    <KeywordList>
      <Keywords>Hypoxia/reoxygenation</Keywords>
      <Keywords>Metformin</Keywords>
      <Keywords>Myocardial injury</Keywords>
      <Keywords>miR-19a/ACSL axis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cai Liang Peng</Name>
        <Affiliation>Department of Cardiovascular Diseases, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ning Jiang</Name>
        <Affiliation>Department of Cardiovascular Diseases, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Fei Zhao</Name>
        <Affiliation>Department of Cardiovascular Diseases, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Kun Liu</Name>
        <Affiliation>Department of Cardiovascular Diseases, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Jiang</Name>
        <Affiliation>Department of Cardiovascular Diseases, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pei Gang Cao</Name>
        <Affiliation>Department of Cardiology, General Hospital of Heilongjiang Agricultural Reclamation Bureau, Harbin, PR China. Electronic address: peigangcao@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure to alternative bisphenols BPS and BPF through breast milk: Noxious heritage effect during nursing associated with idiopathic infertility.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33476676</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00016-8</DOI>
    <KeywordList>
      <Keywords>Bisphenol</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Oocyte maturation</Keywords>
      <Keywords>Spindle formation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jan Nevoral</Name>
        <Affiliation>Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic; Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Electronic address: jan.nevoral@lfp.cuni.cz.</Affiliation>
      </Author>
      <Author>
        <Name>Jiřina Havránková</Name>
        <Affiliation>Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Yaroslav Kolinko</Name>
        <Affiliation>Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic; Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Šárka Prokešová</Name>
        <Affiliation>Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic; Institute of Animal Science, Prague 10-Uhrineves, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Tereza Fenclová</Name>
        <Affiliation>Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Ladan Monsef</Name>
        <Affiliation>Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Tereza Žalmanová</Name>
        <Affiliation>Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic; Institute of Animal Science, Prague 10-Uhrineves, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Jaroslav Petr</Name>
        <Affiliation>Institute of Animal Science, Prague 10-Uhrineves, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Milena Králíčková</Name>
        <Affiliation>Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic; Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lead and mercury 28 day exposure at small concentrations reduces smooth muscle relaxation by decreasing cGMP.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33444613</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00012-0</DOI>
    <KeywordList>
      <Keywords>Arterial Pressure</Keywords>
      <Keywords>Lead</Keywords>
      <Keywords>Mercury</Keywords>
      <Keywords>Mesenteric Artery</Keywords>
      <Keywords>Vascular Reactivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bárbara Ahnert Blanco de Moura Magalhães</Name>
        <Affiliation>School of Sciences of Santa Casa de Misericórdia de Vitoria - EMESCAM, Vitória, ES CEP 29045-402, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Larissa Firme Rodrigues</Name>
        <Affiliation>School of Sciences of Santa Casa de Misericórdia de Vitoria - EMESCAM, Vitória, ES CEP 29045-402, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Thiago Fernandes de Oliveira</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espírito Santo, Vitória, ES CEP 29040-091, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Dalton Valentim Vassallo</Name>
        <Affiliation>School of Sciences of Santa Casa de Misericórdia de Vitoria - EMESCAM, Vitória, ES CEP 29045-402, Brazil; Department of Physiological Sciences, Federal University of Espírito Santo, Vitória, ES CEP 29040-091, Brazil. Electronic address: daltonv2@outlook.com.</Affiliation>
      </Author>
      <Author>
        <Name>Maylla Ronacher Simões</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espírito Santo, Vitória, ES CEP 29040-091, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical safety assessment of a therapeutic human papillomavirus DNA vaccine combined with intravaginal interleukin-7 fused with hybrid Fc in female rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33434572</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00013-2</DOI>
    <KeywordList>
      <Keywords>IL-7hyFc treatment</Keywords>
      <Keywords>No observed adverse effect level</Keywords>
      <Keywords>Repeated toxicity study</Keywords>
      <Keywords>Therapeutic HPV DNA vaccine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kang Hyun Han</Name>
        <Affiliation>College of Pharmacy, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea; Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Min Seong Jang</Name>
        <Affiliation>Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyoung Yun Han</Name>
        <Affiliation>Department of Predictive Toxicology, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wan Jung Im</Name>
        <Affiliation>Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Jin Jung</Name>
        <Affiliation>Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ki Seok Park</Name>
        <Affiliation>Research Institute, Genexine Inc., Korea Bio Park, Seongnam, Gyeonggi-do 13488, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Donghoon Choi</Name>
        <Affiliation>Research Institute, NeoImmunetech, Inc., Rm501-1 Uspace2 B, Seongnam, Gyeonggi-do 13494, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hye Gwang Jeong</Name>
        <Affiliation>College of Pharmacy, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Kyum Kim</Name>
        <Affiliation>College of Pharmacy, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea. Electronic address: sangkim@cnu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Kyoung Sik Moon</Name>
        <Affiliation>Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea; Human and Environmental Toxicology, University of Science and Technology, Daejeon 34114, Republic of Korea. Electronic address: ksmoon@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicant exposure during pregnancy increases protective proteins in the dam and a sexually dimorphic response in the fetus.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33434571</pubmedLink>
    <GrantList>
      <Grant>R15 ES028436</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00014-4</DOI>
    <KeywordList>
      <Keywords>Detoxification</Keywords>
      <Keywords>Endocrine Disrupting Compounds</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Proteomics</Keywords>
      <Keywords>Vinclozolin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alana L. Rister</Name>
        <Affiliation>Department of Biology, East Carolina University, Greenville, NC 27858, USA. Electronic address: arister2@huskers.unl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ciro M. Amato</Name>
        <Affiliation>Department of Biology, East Carolina University, Greenville, NC 27858, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tara Nash</Name>
        <Affiliation>Center for Human Health and the Environment, North Carolina State University, Raleigh, NC 27695, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael W. McCoy</Name>
        <Affiliation>Department of Biology, East Carolina University, Greenville, NC 27858, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Bereman</Name>
        <Affiliation>Center for Human Health and the Environment, North Carolina State University, Raleigh, NC 27695, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Krista A. McCoy</Name>
        <Affiliation>Department of Biology, East Carolina University, Greenville, NC 27858, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Differential effects of arsenic species on Nrf2 and Bach1 nuclear localization in cultured hepatocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33434570</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00011-9</DOI>
    <KeywordList>
      <Keywords>Inorganic arsenic</Keywords>
      <Keywords>Nuclear factor erythroid 2-related factor</Keywords>
      <Keywords>Organic arsenic</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Transcriptional repressor BTB and CNC homology 1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dan Liu</Name>
        <Affiliation>Environment and Non-Communicable Disease Research Center, Key Laboratory of Arsenic-related Biological Effects and Prevention and Treatment in Liaoning Province, School of Public Health, China Medical University, Shenyang, PR China; Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital, China Medical University, Shenyang, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guowei Xu</Name>
        <Affiliation>Environment and Non-Communicable Disease Research Center, Key Laboratory of Arsenic-related Biological Effects and Prevention and Treatment in Liaoning Province, School of Public Health, China Medical University, Shenyang, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Caijun Bai</Name>
        <Affiliation>Environment and Non-Communicable Disease Research Center, Key Laboratory of Arsenic-related Biological Effects and Prevention and Treatment in Liaoning Province, School of Public Health, China Medical University, Shenyang, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuqin Gu</Name>
        <Affiliation>Environment and Non-Communicable Disease Research Center, Key Laboratory of Arsenic-related Biological Effects and Prevention and Treatment in Liaoning Province, School of Public Health, China Medical University, Shenyang, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Da Wang</Name>
        <Affiliation>Environment and Non-Communicable Disease Research Center, Key Laboratory of Arsenic-related Biological Effects and Prevention and Treatment in Liaoning Province, School of Public Health, China Medical University, Shenyang, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Li</Name>
        <Affiliation>Environment and Non-Communicable Disease Research Center, Key Laboratory of Arsenic-related Biological Effects and Prevention and Treatment in Liaoning Province, School of Public Health, China Medical University, Shenyang, PR China. Electronic address: bli10@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of combined exposure to environmental aliphatic electrophiles from plants on Keap1/Nrf2 activation and cytotoxicity in HepG2 cells: A model of an electrophile exposome.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33428920</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30514-7</DOI>
    <KeywordList>
      <Keywords>Combined Exposure</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Electrophile</Keywords>
      <Keywords>Hexenal</Keywords>
      <Keywords>Naphthoquione</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yumi Abiko</Name>
        <Affiliation>Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan; Doctoral Program in Biomedical Sciences, Graduate School of Comprehensive Human, Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hanako Aoki</Name>
        <Affiliation>Doctoral Program in Biomedical Sciences, Graduate School of Comprehensive Human, Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshito Kumagai</Name>
        <Affiliation>Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan; Doctoral Program in Biomedical Sciences, Graduate School of Comprehensive Human, Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan. Electronic address: yk-em-tu@md.tsukuba.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Internal dose of vanadium in rats following repeated exposure to vanadyl sulfate and sodium orthovanadate via drinking water.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33421504</pubmedLink>
    <GrantList>
      <Grant>HHSN273201400022C</Grant>
      <Grant>ZIA ES103316</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00002-8</DOI>
    <KeywordList>
      <Keywords>Oral exposure</Keywords>
      <Keywords>Sodium orthovanadate</Keywords>
      <Keywords>Speciation</Keywords>
      <Keywords>Vanadium</Keywords>
      <Keywords>Vanadyl sulfate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James M. Harrington</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Laura G. Haines</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Keith E. Levine</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Chamindu Liyanapatirana</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Amal S. Essader</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Reshan A. Fernando</Name>
        <Affiliation>RTI International, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Veronica G. Robinson</Name>
        <Affiliation>Division of the National Toxicology Program, NIEHS, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Georgia K. Roberts</Name>
        <Affiliation>Division of the National Toxicology Program, NIEHS, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew D. Stout</Name>
        <Affiliation>Division of the National Toxicology Program, NIEHS, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle J. Hooth</Name>
        <Affiliation>Division of the National Toxicology Program, NIEHS, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Suramya Waidyanatha</Name>
        <Affiliation>Division of the National Toxicology Program, NIEHS, Research Triangle Park, NC, United States. Electronic address: waidyanathas@niehs.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>CREB1 protects against the renal injury in a rat model of kidney stone disease and calcium oxalate monohydrate crystals-induced injury in NRK-52E cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33421503</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(21)00001-6</DOI>
    <KeywordList>
      <Keywords>CREB1</Keywords>
      <Keywords>Calcium Oxalate</Keywords>
      <Keywords>Kidney Stone Disease</Keywords>
      <Keywords>Oxidative Stress</Keywords>
      <Keywords>Renal Epithelial Cell Injury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lei Yu</Name>
        <Affiliation>Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, Heilongjiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuguo Gan</Name>
        <Affiliation>Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, Heilongjiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufeng Bai</Name>
        <Affiliation>Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, Heilongjiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruihua An</Name>
        <Affiliation>Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, Heilongjiang, China. Electronic address: arhuajiaoshou@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rifampicin impairs adipogenesis by suppressing NRF2-ARE activity in mice fed a high-fat diet.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33412187</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30515-9</DOI>
    <KeywordList>
      <Keywords>Adipogenesis</Keywords>
      <Keywords>Antioxidant response element</Keywords>
      <Keywords>High-fat diet</Keywords>
      <Keywords>NRF2</Keywords>
      <Keywords>RFP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tianchang Gao</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China; The Fourth Affiliated Hospital, China Medical University, No. 4 Chongshan East Road, Huanggu Area, Shenyang, Liaoning 110032, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Miao Lai</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xihe Zhu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Suping Ren</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyuan Yin</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhendi Wang</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiyuan Liu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuo Zuo</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongyong Hou</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China. Electronic address: jbpi@cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yanyan Chen</Name>
        <Affiliation>The First Affiliated Hospital, China Medical University, No. 155 Nanjing North Road, Heping Area, Shenyang, Liaoning 110001, PR China. Electronic address: chenyanyan_cmu@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33387578</pubmedLink>
    <GrantList>
      <Grant>T32 GM008715</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30512-3</DOI>
    <KeywordList>
      <Keywords>Kidney</Keywords>
      <Keywords>Kidney Metabolism</Keywords>
      <Keywords>Metabolic Modeling</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Nephrotoxicity</Keywords>
      <Keywords>Transcriptomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kristopher D. Rawls</Name>
        <Affiliation>Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bonnie V. Dougherty</Name>
        <Affiliation>Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kalyan C. Vinnakota</Name>
        <Affiliation>Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Development Command, Fort Detrick, MD 21702, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), Bethesda, MD 20817, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Venkat R. Pannala</Name>
        <Affiliation>Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Development Command, Fort Detrick, MD 21702, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), Bethesda, MD 20817, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anders Wallqvist</Name>
        <Affiliation>Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Development Command, Fort Detrick, MD 21702, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Glynis L. Kolling</Name>
        <Affiliation>Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA; Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA 22908, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jason A. Papin</Name>
        <Affiliation>Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA; Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA 22908, USA; Department of Biochemistry &amp; Molecular Genetics, University of Virginia, Charlottesville, VA 22908, USA. Electronic address: papin@virginia.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazole.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33387577</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30509-3</DOI>
    <KeywordList>
      <Keywords>11beta-Hydroxysteroid Dehydrogenase</Keywords>
      <Keywords>Azole Fungicide</Keywords>
      <Keywords>Glucocorticoid</Keywords>
      <Keywords>Hypertension</Keywords>
      <Keywords>Pseudohyperaldosteronism</Keywords>
      <Keywords>Species Difference</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Silvia G. Inderbinen</Name>
        <Affiliation>Swiss Centre for Applied Human Toxicology and Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, Basel 4056, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Zogg</Name>
        <Affiliation>Swiss Centre for Applied Human Toxicology and Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, Basel 4056, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Manuel Kley</Name>
        <Affiliation>Swiss Centre for Applied Human Toxicology and Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, Basel 4056, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Smieško</Name>
        <Affiliation>Computational Pharmacy, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 61, Basel 4056, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Alex Odermatt</Name>
        <Affiliation>Swiss Centre for Applied Human Toxicology and Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, Basel 4056, Switzerland. Electronic address: Alex.Odermatt@unibas.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification of four methylation-driven genes as candidate biomarkers for monitoring single-walled carbon nanotube-induced malignant transformation of the lung.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33387576</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30513-5</DOI>
    <KeywordList>
      <Keywords>Bioinformatics</Keywords>
      <Keywords>Carbon nanotubes</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Malignant transformation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dongli Xie</Name>
        <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaogang Luo</Name>
        <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China. Electronic address: luoxiaogang@dhu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Variation in the expression of cytochrome P450-related miRNAs and transcriptional factors in human livers: Correlation with cytochrome P450 gene phenotypes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33385404</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30511-1</DOI>
    <KeywordList>
      <Keywords>Correlation Analysis</Keywords>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Interindividual Variation</Keywords>
      <Keywords>Transcription Factors</Keywords>
      <Keywords>microRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hai Feng Zhang</Name>
        <Affiliation>Institute of Clinical Pharmacology, Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Li Zhu</Name>
        <Affiliation>Institute of Clinical Pharmacology, Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Bei Yang</Name>
        <Affiliation>Institute of Clinical Pharmacology, Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Gao</Name>
        <Affiliation>Institute of Clinical Pharmacology, Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Fang</Name>
        <Affiliation>Institute of Clinical Pharmacology, Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Wen</Name>
        <Affiliation>Institute of Clinical Pharmacology, Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hai Ling Qiao</Name>
        <Affiliation>Institute of Clinical Pharmacology, Zhengzhou University, Zhengzhou 450052, Henan, China. Electronic address: qiaohl@zzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Diosgenin alleviates hypercholesterolemia via SRB1/CES-1/CYP7A1/FXR pathway in high-fat diet-fed rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33383043</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30510-X</DOI>
    <KeywordList>
      <Keywords>CYP7A1</Keywords>
      <Keywords>Cholesterol metabolism</Keywords>
      <Keywords>Diosgenin</Keywords>
      <Keywords>FXR</Keywords>
      <Keywords>Hypercholesterolemia</Keywords>
      <Keywords>SRB1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lu Yu</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haifei Lu</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiufen Yang</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruoqi Li</Name>
        <Affiliation>Zhejiang Chinese Medical University, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingjing Shi</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yantong Yu</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chaoqun Ma</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengcui Sun</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shizhao Zhang</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengxia Zhang</Name>
        <Affiliation>Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China. Electronic address: fxzhang0987@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Molecular docking analyses of Escin as regards cyclophosphamide-induced cardiotoxicity: In vivo and in Silico studies.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33383042</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30508-1</DOI>
    <KeywordList>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Cyclophosphamide</Keywords>
      <Keywords>Escin</Keywords>
      <Keywords>Ischemia Modified Albumin</Keywords>
      <Keywords>Molecular Modeling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fatma Gür</Name>
        <Affiliation>Department of Medical Services and Techniques, Health Services Vocational School, Ataturk University, Erzurum 25240, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Mustafa Cengiz</Name>
        <Affiliation>Department of Elementary Education, Faculty of Education, Siirt University, Siirt, Turkey. Electronic address: mustafacengizogu@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hatice Mehtap Kutlu</Name>
        <Affiliation>Department of Biology, Faculty of Education, Eskisehir Technical University, Eskisehir, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Betül Peker Cengiz</Name>
        <Affiliation>Department of Pathology, Yunus Emre State Hospital, Eskisehir, Eskişehir, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Adnan Ayhancı</Name>
        <Affiliation>Department of Biology, Faculty of Arts and Science, Eskişehir Osmangazi University, Eskisehir, Turkey.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Malformations and mortality in zebrafish early stages associated with elevated caspase activity after 24 h exposure to MS-222.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33370555</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30507-X</DOI>
    <KeywordList>
      <Keywords>Behaviour</Keywords>
      <Keywords>Development</Keywords>
      <Keywords>MS-222</Keywords>
      <Keywords>Molecular Responses</Keywords>
      <Keywords>Morphology</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Luís M. Félix</Name>
        <Affiliation>i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal; Laboratory Animal Science, IBMC - Instituto de Biologia Molecular Celular, Universidade do Porto, Porto, Portugal; Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal. Electronic address: luis.felix@ibmc.up.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Luzio</Name>
        <Affiliation>Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal; School of Life and Environmental Sciences (ECVA), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Luís Antunes</Name>
        <Affiliation>Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal; School of Agrarian and Veterinary Sciences (ECAV), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Ana M. Coimbra</Name>
        <Affiliation>Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal; School of Life and Environmental Sciences (ECVA), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Ana M. Valentim</Name>
        <Affiliation>i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal; Laboratory Animal Science, IBMC - Instituto de Biologia Molecular Celular, Universidade do Porto, Porto, Portugal; Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33359661</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30506-8</DOI>
    <KeywordList>
      <Keywords>Benign prostatic hyperplasia</Keywords>
      <Keywords>Epithelial cells</Keywords>
      <Keywords>Epithelial-mesenchymal transition</Keywords>
      <Keywords>Exosome-like vesicles</Keywords>
      <Keywords>Stromal cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jinglou Chen</Name>
        <Affiliation>The Gerontology Research Center of Jianghan University, The Sixth Hospital of Wuhan (Affiliated Hospital of Jianghan University), Jianghan University, Wuhan, China; Wuhan Institute of Biomedical Sciences, School of Medical, Jianghan University, Wuhan, China. Electronic address: jinglouchen@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nan Rong</Name>
        <Affiliation>The Gerontology Research Center of Jianghan University, The Sixth Hospital of Wuhan (Affiliated Hospital of Jianghan University), Jianghan University, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Liu</Name>
        <Affiliation>The Gerontology Research Center of Jianghan University, The Sixth Hospital of Wuhan (Affiliated Hospital of Jianghan University), Jianghan University, Wuhan, China. Electronic address: minliu6yy@sina.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Congyue Xu</Name>
        <Affiliation>Wuhan Institute of Biomedical Sciences, School of Medical, Jianghan University, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Xiong</Name>
        <Affiliation>Wuhan Institute of Biomedical Sciences, School of Medical, Jianghan University, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongfang Lei</Name>
        <Affiliation>Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low dose spironolactone-mediated androgen-adiponectin modulation alleviates endocrine-metabolic disturbances in letrozole-induced PCOS.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33359182</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30503-2</DOI>
    <KeywordList>
      <Keywords>Adiponectin</Keywords>
      <Keywords>Endocrine</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>PCOS</Keywords>
      <Keywords>Spironolactone</Keywords>
      <Keywords>Testosterone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kehinde S. Olaniyi</Name>
        <Affiliation>Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti 360101, Nigeria. Electronic address: olaniyisk@abuad.edu.ng.</Affiliation>
      </Author>
      <Author>
        <Name>Adesola A. Oniyide</Name>
        <Affiliation>Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti 360101, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Oluwaseun A. Adeyanju</Name>
        <Affiliation>Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti 360101, Nigeria. Electronic address: adeyanjuoa@abuad.edu.ng.</Affiliation>
      </Author>
      <Author>
        <Name>Lekan S. Ojulari</Name>
        <Affiliation>Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti 360101, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Adams O. Omoaghe</Name>
        <Affiliation>Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti 360101, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Oluranti E. Olaiya</Name>
        <Affiliation>Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti 360101, Nigeria.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Autoantibodies in outbred Swiss Webster mice following exposure to gold and mercury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33358697</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30501-9</DOI>
    <KeywordList>
      <Keywords>Autoimmunity</Keywords>
      <Keywords>Gold</Keywords>
      <Keywords>Mercury</Keywords>
      <Keywords>Outbred mice</Keywords>
      <Keywords>Swiss Webster mice</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mehdi Amirhosseini</Name>
        <Affiliation>Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Hammoudi Alkaissi</Name>
        <Affiliation>Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Per A. Hultman</Name>
        <Affiliation>Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden; Department of Clinical Pathology, Linköping University, Linköping, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Said Havarinasab</Name>
        <Affiliation>Division of Clinical Chemistry, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden. Electronic address: said.havarinasab@liu.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Co-administration of Luteolin mitigated toxicity in rats' lungs associated with doxorubicin treatment.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33358696</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30502-0</DOI>
    <KeywordList>
      <Keywords>Chemoprevention</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Inflammation and haematopoietic damage</Keywords>
      <Keywords>Luteolin</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Pulmonary toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Solomon E. Owumi</Name>
        <Affiliation>Cancer Research and Molecular Biology Laboratories, University of Ibadan, Ibadan, Nigeria. Electronic address: zicri@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah O. Nwozo</Name>
        <Affiliation>Nutrition and Industrial Biochemistry Laboratories, Department of Biochemistry, Faculty of Basic Medical Sciences, University of Ibadan, Ibadan, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Uche O. Arunsi</Name>
        <Affiliation>Cancer Immunology and Biotechnology Center, The University of Nottingham, Nottingham NG8 1AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Adegboyega K. Oyelere</Name>
        <Affiliation>School of Chemistry &amp; Biochemistry, Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332-0400, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Oyeronke A. Odunola</Name>
        <Affiliation>Cancer Research and Molecular Biology Laboratories, University of Ibadan, Ibadan, Nigeria.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Astaxanthin attenuates alcoholic cardiomyopathy via inhibition of endoplasmic reticulum stress-mediated cardiac apoptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33352188</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30500-7</DOI>
    <KeywordList>
      <Keywords>Alcoholic cardiomyopathy</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Astaxanthin</Keywords>
      <Keywords>Endoplasmic reticulum stress</Keywords>
      <Keywords>Ethanol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wenhan Wang</Name>
        <Affiliation>Ruian Center of Chinese-American Research Institute for Diabetic Complications, the Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tinghao Liu</Name>
        <Affiliation>Ruian Center of Chinese-American Research Institute for Diabetic Complications, the Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyuan Liu</Name>
        <Affiliation>Ruian Center of Chinese-American Research Institute for Diabetic Complications, the Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lechu Yu</Name>
        <Affiliation>Ruian Center of Chinese-American Research Institute for Diabetic Complications, the Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqing Yan</Name>
        <Affiliation>School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenya Weng</Name>
        <Affiliation>Ruian Center of Chinese-American Research Institute for Diabetic Complications, the Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuemian Lu</Name>
        <Affiliation>Ruian Center of Chinese-American Research Institute for Diabetic Complications, the Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Electronic address: 13705871118@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chi Zhang</Name>
        <Affiliation>Ruian Center of Chinese-American Research Institute for Diabetic Complications, the Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China. Electronic address: zhangchi515@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic toxicity evaluation of glucosamine and glucosamine in combination with chondroitin sulfate in obese Zucker rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33345901</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30493-2</DOI>
    <KeywordList>
      <Keywords>Chondroitin sulfate</Keywords>
      <Keywords>Diabetes</Keywords>
      <Keywords>Glucosamine</Keywords>
      <Keywords>Subchronic study</Keywords>
      <Keywords>TGFbeta</Keywords>
      <Keywords>Zucker rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julian E. A. Leakey</Name>
        <Affiliation>Office of Scientific Coordination, 3900 NCTR Rd., Jefferson, AR 72079, United States of America. Electronic address: julian.leakey@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>A. Afshan Ali</Name>
        <Affiliation>Office of Scientific Coordination, 3900 NCTR Rd., Jefferson, AR 72079, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Amy R. Babb</Name>
        <Affiliation>Office of Scientific Coordination, 3900 NCTR Rd., Jefferson, AR 72079, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Heidi L. Badgley</Name>
        <Affiliation>Toxicologic Pathology Associates, 3900 NCTR Rd., Jefferson, AR 72079, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Kelly J. Davis</Name>
        <Affiliation>Toxicologic Pathology Associates, 3900 NCTR Rd., Jefferson, AR 72079, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Beth E. Juliar</Name>
        <Affiliation>Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Rd., Jefferson, AR 72079, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Tatiana I. Leakey</Name>
        <Affiliation>Office of Scientific Coordination, 3900 NCTR Rd., Jefferson, AR 72079, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Sherry M. Lewis</Name>
        <Affiliation>Office of Scientific Coordination, 3900 NCTR Rd., Jefferson, AR 72079, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Ralph E. Patton</Name>
        <Affiliation>Toxicologic Pathology Associates, 3900 NCTR Rd., Jefferson, AR 72079, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>John E. Seng</Name>
        <Affiliation>Toxicologic Pathology Associates, 3900 NCTR Rd., Jefferson, AR 72079, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>T4-mediated rescue of aortic malformations in hypothyroid rats indicates maternal thyroid status can affect great vessel development.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33340518</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30489-0</DOI>
    <KeywordList>
      <Keywords>4th Pharyngeal arch artery</Keywords>
      <Keywords>Great vessel defects</Keywords>
      <Keywords>Interrupted aortic rch</Keywords>
      <Keywords>Maternal hypothyroidism</Keywords>
      <Keywords>Pharyngeal arch arteries</Keywords>
      <Keywords>Thyroxine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Karen Augustine-Rauch</Name>
        <Affiliation>Discovery Toxicology, Bristol Myers Squibb, Lawrenceville, NJ, USA. Electronic address: karen.augustine@bms.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jiin Jia Liaw</Name>
        <Affiliation>Non Clinical Safety, Bristol Myers Squibb, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Graziano</Name>
        <Affiliation>Non Clinical Safety, Bristol Myers Squibb, New Brunswick, NJ, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Generating adverse outcome pathway (AOP) of inorganic arsenic-induced adult male reproductive impairment via integration of phenotypic analysis in comparative toxicogenomics database (CTD) and AOP wiki.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33338516</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30492-0</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Phenotype</Keywords>
      <Keywords>Reproduction</Keywords>
      <Keywords>Systemic biology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zili Chai</Name>
        <Affiliation>Key Lab of Medical Protection for Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenhao Zhao</Name>
        <Affiliation>Information and Navigation College, Air Force Engineering University, Xi'an 710077, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Jin</Name>
        <Affiliation>School of Public Health, Qingdao University, Qingdao 266000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yimeng Wang</Name>
        <Affiliation>Key Lab of Medical Protection for Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Zou</Name>
        <Affiliation>Key Lab of Medical Protection for Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xi Ling</Name>
        <Affiliation>Key Lab of Medical Protection for Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huan Yang</Name>
        <Affiliation>Key Lab of Medical Protection for Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Niya Zhou</Name>
        <Affiliation>Key Lab of Medical Protection for Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Chen</Name>
        <Affiliation>Key Lab of Medical Protection for Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Sun</Name>
        <Affiliation>Key Lab of Medical Protection for Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Chen</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Ao</Name>
        <Affiliation>Key Lab of Medical Protection for Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Cao</Name>
        <Affiliation>Key Lab of Medical Protection for Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China. Electronic address: caojia1962@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jinyi Liu</Name>
        <Affiliation>Key Lab of Medical Protection for Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China. Electronic address: jinyiliutmmu@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An investigation of systemic exposure to bisphenol AF during critical periods of development in the rat.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33338515</pubmedLink>
    <GrantList>
      <Grant>HHSN273201400020C</Grant>
      <Grant>HHSN273201600011C</Grant>
      <Grant>N01ES75564</Grant>
      <Grant>ZIA ES103316</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30491-9</DOI>
    <AuthorList>
      <Author>
        <Name>Suramya Waidyanatha</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA. Electronic address: waidyanathas@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Bradley J. Collins</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Helen Cunny</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Aillon</Name>
        <Affiliation>MRI Global, Kansas City, MO, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Felicia Riordan</Name>
        <Affiliation>MRI Global, Kansas City, MO, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katie Turner</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra McBride</Name>
        <Affiliation>Social and Scientific Systems, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Betz</Name>
        <Affiliation>Social and Scientific Systems, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vicki Sutherland</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33338514</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30490-7</DOI>
    <KeywordList>
      <Keywords>Cannabidiol</Keywords>
      <Keywords>Cannabinoid receptor</Keywords>
      <Keywords>Hypertension</Keywords>
      <Keywords>Isolated atrium</Keywords>
      <Keywords>Isolated heart</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anna Pędzińska-Betiuk</Name>
        <Affiliation>Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland. Electronic address: anna.pedzinska-betiuk@umb.edu.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Jolanta Weresa</Name>
        <Affiliation>Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Eberhard Schlicker</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Bonn, Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ewa Harasim-Symbor</Name>
        <Affiliation>Department of Physiology, Medical University of Białystok, Białystok, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Marek Toczek</Name>
        <Affiliation>Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Irena Kasacka</Name>
        <Affiliation>Department of Histology and Cytophysiology, Medical University of Białystok, Białystok, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Bernadetta Gajo</Name>
        <Affiliation>Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Malinowska</Name>
        <Affiliation>Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Time-to-treatment window and cross-sex potential of β</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33316273</pubmedLink>
    <GrantList>
      <Grant>IK2 BX005218</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30488-9</DOI>
    <KeywordList>
      <Keywords>Formoterol</Keywords>
      <Keywords>Locomotor recovery</Keywords>
      <Keywords>Mitochondrial biogenesis</Keywords>
      <Keywords>Spinal cord injury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Natalie E. Scholpa</Name>
        <Affiliation>Southern Arizona VA Health Care System, Tucson, AZ, United States of America; Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, United States of America. Electronic address: scholpa@pharmacy.arizona.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Epiphani C. Simmons</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, United States of America; Department of Neurosciences, College of Medicine, University of Arizona, Tucson, AZ, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Josh D. Crossman</Name>
        <Affiliation>Southern Arizona VA Health Care System, Tucson, AZ, United States of America; Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Rick G. Schnellmann</Name>
        <Affiliation>Southern Arizona VA Health Care System, Tucson, AZ, United States of America; Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, United States of America; Department of Neurosciences, College of Medicine, University of Arizona, Tucson, AZ, United States of America; Southwest Environmental Health Science Center, University of Arizona, Tucson, AZ, United States of America; Center for Innovation in Brain Science, University of Arizona, Tucson, AZ, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-dioxin-like polychlorinated biphenyl 19 has distinct effects on human Kv1.3 and Kv1.5 channels.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33316272</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30487-7</DOI>
    <KeywordList>
      <Keywords>Kv1.3 channel</Keywords>
      <Keywords>Kv1.5 channel</Keywords>
      <Keywords>PCB19</Keywords>
      <Keywords>Polychlorinated biphenyls</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jong Hui Kim</Name>
        <Affiliation>Department of Physiology, Institute of Bioscience and Biotechnology, Interdisciplinary Graduate Program in BIT Medical Convergence, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soobeen Hwang</Name>
        <Affiliation>Department of Physiology, Institute of Bioscience and Biotechnology, Interdisciplinary Graduate Program in BIT Medical Convergence, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Su Hyun Jo</Name>
        <Affiliation>Department of Physiology, Institute of Bioscience and Biotechnology, Interdisciplinary Graduate Program in BIT Medical Convergence, Kangwon National University School of Medicine, Chuncheon 24341, South Korea. Electronic address: suhyunjo@kangwon.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenite suppresses IL-2-dependent tumoricidal activities of natural killer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33301752</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30475-0</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Granzyme</Keywords>
      <Keywords>Inhibitory receptor</Keywords>
      <Keywords>Natural killer cell</Keywords>
      <Keywords>Tumor immunity</Keywords>
      <Keywords>Tumoricidal activity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daigo Sumi</Name>
        <Affiliation>Laboratory of Molecular Nutrition and Toxicology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima 770-8514, Japan. Electronic address: sdaigo@ph.bunri-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hiromasa Tsuyama</Name>
        <Affiliation>Laboratory of Molecular Nutrition and Toxicology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima 770-8514, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoko Ogawa</Name>
        <Affiliation>Laboratory of Molecular Nutrition and Toxicology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima 770-8514, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masatoshi Ogawa</Name>
        <Affiliation>Laboratory of Molecular Nutrition and Toxicology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima 770-8514, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Seiichiro Himeno</Name>
        <Affiliation>Laboratory of Molecular Nutrition and Toxicology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima 770-8514, Japan; Department of Health and Regulation Sciences Division of Health Chemistry, Showa University School of Pharmacy, 1-5-8, Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Death by histone deacetylase inhibitor quisinostat in tongue squamous cell carcinoma via apoptosis, pyroptosis, and ferroptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33290780</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30485-3</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Ferroptosis</Keywords>
      <Keywords>HDACi</Keywords>
      <Keywords>Pyroptosis</Keywords>
      <Keywords>Quisinostat</Keywords>
      <Keywords>p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xinhuan Wang</Name>
        <Affiliation>Department of Oral and Maxillofacial Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Liu</Name>
        <Affiliation>Department of Oral and Maxillofacial Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Huimin Gong</Name>
        <Affiliation>Department of Oral, Dalian Stomatological Hospital, Dalian, Liaoning 116021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Dezhi Li</Name>
        <Affiliation>Department of Oral and Maxillofacial Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenfeng Chu</Name>
        <Affiliation>Department of Pharmacology (The State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Zhao</Name>
        <Affiliation>Department of Clinical Pharmacy (Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment), the 2nd Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofeng Wang</Name>
        <Affiliation>Department of Oral and Maxillofacial Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, PR China. Electronic address: 13633617656@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dongyang Xu</Name>
        <Affiliation>Department of Oral and Maxillofacial Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, PR China. Electronic address: 13945159315@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Anacardic 6-pentadecyl salicylic acid induces apoptosis in breast cancer tumor cells, immunostimulation in the host and decreases blood toxic effects of taxol in an animal model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33290779</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30481-6</DOI>
    <KeywordList>
      <Keywords>Anacardic acid</Keywords>
      <Keywords>Antitumoral</Keywords>
      <Keywords>Immunomodulation</Keywords>
      <Keywords>Leukopenia</Keywords>
      <Keywords>Myelosuppression</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. N. Rashida Gnanaprakasam</Name>
        <Affiliation>Department of Toxicology, Center for Research and Advanced Studies of the National Polytechnic Institute, Av. IPN, 2508, San Pedro Zacatenco, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Laura López-Bañuelos</Name>
        <Affiliation>Department of Toxicology, Center for Research and Advanced Studies of the National Polytechnic Institute, Av. IPN, 2508, San Pedro Zacatenco, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Libia Vega</Name>
        <Affiliation>Department of Toxicology, Center for Research and Advanced Studies of the National Polytechnic Institute, Av. IPN, 2508, San Pedro Zacatenco, Mexico City 07360, Mexico. Electronic address: lvega@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Semaphorin 4A antibody alleviates arsenic-induced hepatotoxicity in mice via inhibition of AKT2/NF-κB inflammatory signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33290778</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30486-5</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Inflammatory Signaling</Keywords>
      <Keywords>Sema 3A</Keywords>
      <Keywords>Sema 4A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuan Yang</Name>
        <Affiliation>Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang, Guizhou 550025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qinling Wang</Name>
        <Affiliation>Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang, Guizhou 550025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjuan Wang</Name>
        <Affiliation>Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang, Guizhou 550025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaofeng Wei</Name>
        <Affiliation>Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang, Guizhou 550025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qibing Zeng</Name>
        <Affiliation>Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang, Guizhou 550025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Aihua Zhang</Name>
        <Affiliation>Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang, Guizhou 550025, China. Electronic address: aihuagzykd@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Astragaloside IV protects against retinal iron overload toxicity through iron regulation and the inhibition of MAPKs and NF-κB activation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33285147</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30483-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Astragaloside IV</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Iron overload</Keywords>
      <Keywords>Iron-handling protein</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qiongtao Song</Name>
        <Affiliation>Eye School of Chengdu University of TCM, No.37 Twelve Bridge Road, Chengdu 610075, Sichuan, China; Ineye Hospital of Chengdu University of TCM, No.8 Xinghui Road, Chengdu 610084, Sichuan, China; Key Laboratory of Sichuan Province Ophthalmopathy Prevention &amp; Cure and Visual Function Protection, No.37 Twelve Bridge Road, Chengdu 610075, Sichuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Zhao</Name>
        <Affiliation>Eye School of Chengdu University of TCM, No.37 Twelve Bridge Road, Chengdu 610075, Sichuan, China; Ineye Hospital of Chengdu University of TCM, No.8 Xinghui Road, Chengdu 610084, Sichuan, China; Key Laboratory of Sichuan Province Ophthalmopathy Prevention &amp; Cure and Visual Function Protection, No.37 Twelve Bridge Road, Chengdu 610075, Sichuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanrong Yang</Name>
        <Affiliation>Eye School of Chengdu University of TCM, No.37 Twelve Bridge Road, Chengdu 610075, Sichuan, China; Ineye Hospital of Chengdu University of TCM, No.8 Xinghui Road, Chengdu 610084, Sichuan, China; Key Laboratory of Sichuan Province Ophthalmopathy Prevention &amp; Cure and Visual Function Protection, No.37 Twelve Bridge Road, Chengdu 610075, Sichuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Han</Name>
        <Affiliation>Hebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns, No.326 Xinshi South Road, Shijiazhuang 050200, Hebei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junguo Duan</Name>
        <Affiliation>Eye School of Chengdu University of TCM, No.37 Twelve Bridge Road, Chengdu 610075, Sichuan, China; Ineye Hospital of Chengdu University of TCM, No.8 Xinghui Road, Chengdu 610084, Sichuan, China; Key Laboratory of Sichuan Province Ophthalmopathy Prevention &amp; Cure and Visual Function Protection, No.37 Twelve Bridge Road, Chengdu 610075, Sichuan, China. Electronic address: ineyeduan@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Uranium directly interacts with the DNA repair protein poly (ADP-ribose) polymerase 1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33279515</pubmedLink>
    <GrantList>
      <Grant>P42 ES025589</Grant>
      <Grant>P30 CA118100</Grant>
      <Grant>R01 ES030993</Grant>
      <Grant>R01 ES029369</Grant>
      <Grant>P20 GM130422</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30482-8</DOI>
    <KeywordList>
      <Keywords>DNA Repair</Keywords>
      <Keywords>Protein Binding</Keywords>
      <Keywords>Uranium</Keywords>
      <Keywords>Zinc Finger Protein</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xixi Zhou</Name>
        <Affiliation>Department of Pharmaceutical Sciences, The University of New Mexico College of Pharmacy, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bingye Xue</Name>
        <Affiliation>Department of Pharmaceutical Sciences, The University of New Mexico College of Pharmacy, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastian Medina</Name>
        <Affiliation>Department of Pharmaceutical Sciences, The University of New Mexico College of Pharmacy, Albuquerque, NM, USA; New Mexico Highlands University, Department of Biology, Las Vegas, NM 87701, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Scott W. Burchiel</Name>
        <Affiliation>Department of Pharmaceutical Sciences, The University of New Mexico College of Pharmacy, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Liu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, The University of New Mexico College of Pharmacy, Albuquerque, NM, USA. Electronic address: KLiu@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modulation of PARP activity by Monomethylarsonous (MMA</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33279514</pubmedLink>
    <GrantList>
      <Grant>P30 CA118100</Grant>
      <Grant>P42 ES025589</Grant>
      <Grant>R01 ES029369</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30484-1</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Monomethylarsonous Acid (MMA(+3))</Keywords>
      <Keywords>Poly-ADP-Ribose Polymerase-1 (PARP-1)</Keywords>
      <Keywords>T Cells</Keywords>
      <Keywords>Uranium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sebastian Medina</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM, USA; Department of Biology, New Mexico Highlands University, Las Vegas, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xixi Zhou</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fredine T. Lauer</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Haikun Zhang</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Liu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Johnnye Lewis</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott W. Burchiel</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM, USA. Electronic address: sburchiel@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>CoQ10 protects against acetaminophen-induced liver injury by enhancing mitophagy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33271250</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30477-4</DOI>
    <KeywordList>
      <Keywords>APAP</Keywords>
      <Keywords>Coenzyme Q10</Keywords>
      <Keywords>Liver Injury</Keywords>
      <Keywords>Mitophagy</Keywords>
      <Keywords>ROS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peiwen Zhang</Name>
        <Affiliation>Department of Nutrition, School of Public Health, Guangdong Medical University, People's Republic of China; School of Public Health, Dongguan Key Laboratory of Environmental Medicine, Guangdong Medical University, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Shen Chen</Name>
        <Affiliation>Department of Nutrition, School of Public Health, Guangdong Medical University, People's Republic of China; Department of Toxicology, School of Public Health, Sun Yat-sen University, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Huanwen Tang</Name>
        <Affiliation>School of Public Health, Dongguan Key Laboratory of Environmental Medicine, Guangdong Medical University, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanjun Fang</Name>
        <Affiliation>Department of Clinical Nutrition, Ningbo Women and Children's Hospital, Ningbo, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Chen</Name>
        <Affiliation>Department of Clinical Nutrition, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, People's Republic of China; Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Chen</Name>
        <Affiliation>Department of Nutrition, School of Public Health, Guangdong Medical University, People's Republic of China; Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People's Republic of China. Electronic address: cxu1024@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ethyl maltol enhances copper mediated cytotoxicity in lung epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33271249</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30476-2</DOI>
    <AuthorList>
      <Author>
        <Name>Kulsoom Durrani</Name>
        <Affiliation>Department of Neurology, Hugo W. Moser Research Institute at Kennedy Krieger, 707 N. Broadway, Baltimore 21205, MD, USA; Environmental Health and Engineering, The Johns Hopkins University, Bloomberg School of Public Health, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Marie Alam El Din</Name>
        <Affiliation>Department of Neurology, Hugo W. Moser Research Institute at Kennedy Krieger, 707 N. Broadway, Baltimore 21205, MD, USA; Environmental Health and Engineering, The Johns Hopkins University, Bloomberg School of Public Health, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuchen Sun</Name>
        <Affiliation>Department of Neurology, Hugo W. Moser Research Institute at Kennedy Krieger, 707 N. Broadway, Baltimore 21205, MD, USA; Environmental Health and Engineering, The Johns Hopkins University, Bloomberg School of Public Health, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ana M. Rule</Name>
        <Affiliation>Environmental Health and Engineering, The Johns Hopkins University, Bloomberg School of Public Health, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph Bressler</Name>
        <Affiliation>Department of Neurology, Hugo W. Moser Research Institute at Kennedy Krieger, 707 N. Broadway, Baltimore 21205, MD, USA; Environmental Health and Engineering, The Johns Hopkins University, Bloomberg School of Public Health, USA. Electronic address: bressler@kennedykrieger.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Octreotide and melatonin alleviate inflammasome-induced pyroptosis through inhibition of TLR4-NF-κB-NLRP3 pathway in hepatic ischemia/reperfusion injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33264646</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30462-2</DOI>
    <KeywordList>
      <Keywords>Hepatic ischemia/reperfusion injury</Keywords>
      <Keywords>Melatonin</Keywords>
      <Keywords>NLRP3</Keywords>
      <Keywords>Octreotide</Keywords>
      <Keywords>Pyroptosis</Keywords>
      <Keywords>TLR4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alaa El Din El Sayed El-Sisi</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Samia Salim Sokar</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Abdelhadi Mohamed Shebl</Name>
        <Affiliation>Department of Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt; Sultan Qaboos University Hospital, Muscat, Oman.</Affiliation>
      </Author>
      <Author>
        <Name>Dina Zakaria Mohamed</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt. Electronic address: PG_55472@pharm.tanta.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Sally El Sayed Abu-Risha</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic metabolism differs between child and adult patients during acute arsenic poisoning.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33264645</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30474-9</DOI>
    <KeywordList>
      <Keywords>Acute arsenic poisoning</Keywords>
      <Keywords>Adults</Keywords>
      <Keywords>Arsenic trioxide</Keywords>
      <Keywords>Children</Keywords>
      <Keywords>Methylation capacity</Keywords>
      <Keywords>Methylation efficiency</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hiroshi Yamauchi</Name>
        <Affiliation>Department of Preventive Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki 216-8511, Japan. Electronic address: hyama@marianna-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Ayako Takata</Name>
        <Affiliation>Department of Preventive Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki 216-8511, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ozone-induced changes in oxidative stress parameters in brain regions of adult, middle-age, and senescent Brown Norway rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33249117</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30473-7</DOI>
    <KeywordList>
      <Keywords>Aging</Keywords>
      <Keywords>Air pollution</Keywords>
      <Keywords>Antioxidants</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Ozone</Keywords>
      <Keywords>Protein carbonyls</Keywords>
      <Keywords>Susceptibility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Prasada Rao S. Kodavanti</Name>
        <Affiliation>Neurological and Endocrine Toxicology Branch, Public Health and Integrated Toxicology Division, CPHEA, ORD, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: kodavanti.prasada@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Valdez</Name>
        <Affiliation>Neurological and Endocrine Toxicology Branch, Public Health and Integrated Toxicology Division, CPHEA, ORD, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Judy E. Richards</Name>
        <Affiliation>Cardiopulmonary and Immunotoxicology Branch, Public Health and Integrated Toxicology Division, CPHEA, ORD, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Datonye I. Agina-Obu</Name>
        <Affiliation>Neurological and Endocrine Toxicology Branch, Public Health and Integrated Toxicology Division, CPHEA, ORD, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pamela M. Phillips</Name>
        <Affiliation>Neurological and Endocrine Toxicology Branch, Public Health and Integrated Toxicology Division, CPHEA, ORD, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kimberly A. Jarema</Name>
        <Affiliation>Neurological and Endocrine Toxicology Branch, Public Health and Integrated Toxicology Division, CPHEA, ORD, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Urmila P. Kodavanti</Name>
        <Affiliation>Cardiopulmonary and Immunotoxicology Branch, Public Health and Integrated Toxicology Division, CPHEA, ORD, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: kodavanti.prasada@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cisplatin-induced hair cell loss in zebrafish neuromasts is accompanied by protein nitration and Lmo4 degradation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33245977</pubmedLink>
    <GrantList>
      <Grant>K01 ES028750</Grant>
      <Grant>P30 ES020957</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30464-6</DOI>
    <KeywordList>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Lmo4</Keywords>
      <Keywords>Neuromast</Keywords>
      <Keywords>Nitrative stress</Keywords>
      <Keywords>Ototoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Monazza Shahab</Name>
        <Affiliation>Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA; Department of Pharmacology, Wayne State University, Detroit, MI 48201, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rita Rosati</Name>
        <Affiliation>Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Danielle N. Meyer</Name>
        <Affiliation>Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA; Department of Pharmacology, Wayne State University, Detroit, MI 48201, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeremiah N. Shields</Name>
        <Affiliation>Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Emily Crofts</Name>
        <Affiliation>Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tracie R. Baker</Name>
        <Affiliation>Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA; Department of Pharmacology, Wayne State University, Detroit, MI 48201, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samson Jamesdaniel</Name>
        <Affiliation>Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA; Department of Pharmacology, Wayne State University, Detroit, MI 48201, USA. Electronic address: sjamesdaniel@wayne.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Andrographolide inhibits IL-1β release in bone marrow-derived macrophages and monocyte infiltration in mouse knee joints induced by monosodium urate.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33242555</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30463-4</DOI>
    <KeywordList>
      <Keywords>Andrographolide (AND)</Keywords>
      <Keywords>Bone marrow-derived macrophages (BMDMs)</Keywords>
      <Keywords>Gout</Keywords>
      <Keywords>Interleukin 1β (IL-1β)</Keywords>
      <Keywords>Monosodium urate (MSU)</Keywords>
      <Keywords>NLR family pyrin domain containing 3 (NLRP3) inflammasome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chia Wen Lo</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chong Kuei Lii</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan; Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Jhe Hong</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Ting Chuang</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Chen Yang</Name>
        <Affiliation>Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chin Shiu Huang</Name>
        <Affiliation>Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Haw Wen Chen</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan. Electronic address: chenhw@mail.cmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A transcriptomic overview of lung and liver changes one day after pulmonary exposure to graphene and graphene oxide.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33227293</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30465-8</DOI>
    <KeywordList>
      <Keywords>Acute phase response</Keywords>
      <Keywords>DNA microarray</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Nanotoxicology</Keywords>
      <Keywords>Toxicogenomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sarah S. Poulsen</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen Ø, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Bengtson</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen Ø, Denmark; Department of Science and Environment, Roskilde University, Roskilde, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Williams</Name>
        <Affiliation>Environmental and Radiation Health Sciences Directorate, Health Canada, Ottawa, Ontario K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Nicklas R. Jacobsen</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen Ø, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Jesper T. Troelsen</Name>
        <Affiliation>Department of Science and Environment, Roskilde University, Roskilde, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Sabina Halappanavar</Name>
        <Affiliation>Environmental and Radiation Health Sciences Directorate, Health Canada, Ottawa, Ontario K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ulla Vogel</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen Ø, Denmark; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark. Electronic address: ubv@nrcwe.dk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gender differences and dose proportionality in the toxicokinetics of udenafil and its active metabolite following oral administration in rodents.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33221319</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30461-0</DOI>
    <KeywordList>
      <Keywords>Dose proportionality</Keywords>
      <Keywords>Gender differences</Keywords>
      <Keywords>Rodent</Keywords>
      <Keywords>Toxicokinetics</Keywords>
      <Keywords>Udenafil</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jong Hwa Lee</Name>
        <Affiliation>Bioanalysis and Pharmacokinetic Study Group, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dae Young Lee</Name>
        <Affiliation>Dong-A Socio R&amp;D Center, 21, Geumhwa-Ro, 105beon-Gil, Giheung-Gu, Yongin-Si, Gyeonggi-Do 17073, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Koo Kang</Name>
        <Affiliation>Dong-A Socio R&amp;D Center, 21, Geumhwa-Ro, 105beon-Gil, Giheung-Gu, Yongin-Si, Gyeonggi-Do 17073, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Ju Jeong</Name>
        <Affiliation>Chemical Risk Assessment Research Committee, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Christine E. Staatz</Name>
        <Affiliation>School of Pharmacy, The University of Queensland, Pharmacy Australia Centre of Excellence, 20 Cornwall St, Woolloongabba, Brisbane, QLD 4102, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>In Hwan Baek</Name>
        <Affiliation>College of Pharmacy, Kyungsung University, 309, Suyeong-ro, Nam-gu, Busan 48434, Republic of Korea. Electronic address: baek@ks.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Examining the evidence of non-monotonic dose-response in Androgen Receptor agonism high-throughput screening assay.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33217376</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30460-9</DOI>
    <KeywordList>
      <Keywords>Androgen receptor ligands</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Luciferase inhibition</Keywords>
      <Keywords>Non-monotonic dose-response</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kyrylo Klimenko</Name>
        <Affiliation>Private consultant in Computational Toxicology, Av. 1 de Maio, 11, 2825-396 Costa de Caparica, Portugal. Electronic address: kyrylo.klimenko@outlook.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Diets enriched with coconut, fish, or olive oil modify peripheral metabolic effects of ozone in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33217375</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30459-2</DOI>
    <KeywordList>
      <Keywords>Coconut-oil-enriched diet</Keywords>
      <Keywords>Fish-oil-enriched diet</Keywords>
      <Keywords>Metabolic homeostasis</Keywords>
      <Keywords>Olive oil-enriched diet</Keywords>
      <Keywords>Ozone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Samantha J. Snow</Name>
        <Affiliation>Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andres R. Henriquez</Name>
        <Affiliation>Oak Ridge Institute for Science and Education Research Participation Program, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jenifer I. Fenton</Name>
        <Affiliation>Department of Food Science and Human Nutrition, Michigan State University, East Lansing, MI, 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Travis Goeden</Name>
        <Affiliation>Department of Food Science and Human Nutrition, Michigan State University, East Lansing, MI, 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Fisher</Name>
        <Affiliation>Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Beena Vallanat</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Angrish</Name>
        <Affiliation>Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Judy E. Richards</Name>
        <Affiliation>Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mette C. Schladweiler</Name>
        <Affiliation>Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Wan Yun Cheng</Name>
        <Affiliation>Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Charles E. Wood</Name>
        <Affiliation>Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyan Tong</Name>
        <Affiliation>Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Urmila P. Kodavanti</Name>
        <Affiliation>Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States. Electronic address: kodavanti.urmila@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ligustilide inhibits the proliferation of non-small cell lung cancer via glycolytic metabolism.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33212065</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30458-0</DOI>
    <KeywordList>
      <Keywords>Glycolysis</Keywords>
      <Keywords>Ligustilide</Keywords>
      <Keywords>Non-small cell lung cancer</Keywords>
      <Keywords>PTEN/AKT signaling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiufeng Jiang</Name>
        <Affiliation>Wuxi Fifth People's Hospital, Wuxi 214016, Jiangsu, China. Electronic address: jiangxiufeng12@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhao</Name>
        <Affiliation>Wuxi Fifth People's Hospital, Wuxi 214016, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Zhu</Name>
        <Affiliation>Wuxi Fifth People's Hospital, Wuxi 214016, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wu</Name>
        <Affiliation>Wuxi Fifth People's Hospital, Wuxi 214016, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Ding</Name>
        <Affiliation>Wuxi Fifth People's Hospital, Wuxi 214016, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinmei Bai</Name>
        <Affiliation>Wuxi Fifth People's Hospital, Wuxi 214016, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqing Zhang</Name>
        <Affiliation>Wuxi Fifth People's Hospital, Wuxi 214016, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meifang Qian</Name>
        <Affiliation>Wuxi Fifth People's Hospital, Wuxi 214016, Jiangsu, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Famciclovir leads to failure of hematopoiesis, but may have the benefit of relieving myeloid expansion in MDS-like zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33207248</pubmedLink>
    <Year>2021</Year>
    <DOI>S0041-008X(20)30456-7</DOI>
    <KeywordList>
      <Keywords>Famciclovir</Keywords>
      <Keywords>Hematotoxicity</Keywords>
      <Keywords>MDS</Keywords>
      <Keywords>c-myb</Keywords>
      <Keywords>zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Li</Name>
        <Affiliation>Key Laboratory of Zebrafish Modeling and Drug Screening for Human Diseases of Guangdong Higher Education Institutes, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, PR China; Division of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Panpan Meng</Name>
        <Affiliation>Key Laboratory of Zebrafish Modeling and Drug Screening for Human Diseases of Guangdong Higher Education Institutes, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, PR China; Division of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Riyang Zhou</Name>
        <Affiliation>Key Laboratory of Zebrafish Modeling and Drug Screening for Human Diseases of Guangdong Higher Education Institutes, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiyue Zhang</Name>
        <Affiliation>Key Laboratory of Zebrafish Modeling and Drug Screening for Human Diseases of Guangdong Higher Education Institutes, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, PR China; Division of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou 510006, PR China. Electronic address: mczhangyy@scut.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Lin</Name>
        <Affiliation>Division of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou 510006, PR China. Electronic address: qinglin@scut.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>2,5-Hexanedione influences primordial follicular development in cultured neonatal mouse ovaries by interfering with the PI3K signaling pathway via miR-214-3p.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33197454</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30457-9</DOI>
    <KeywordList>
      <Keywords>2,5-Hexanedione</Keywords>
      <Keywords>Follicular development</Keywords>
      <Keywords>PI3K signaling pathway</Keywords>
      <Keywords>microRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jingwen Zeng</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health, Fujian Medical University, Xueyan Road No. 1, Minhou County, Fuzhou 350108, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Sun</Name>
        <Affiliation>Reproductive Medicine Center, Fujian Provincial Maternity and Children's Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqin Li</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health, Fujian Medical University, Xueyan Road No. 1, Minhou County, Fuzhou 350108, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianlin Zhu</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health, Fujian Medical University, Xueyan Road No. 1, Minhou County, Fuzhou 350108, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenchang Zhang</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health, Fujian Medical University, Xueyan Road No. 1, Minhou County, Fuzhou 350108, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenmin Lu</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health, Fujian Medical University, Xueyan Road No. 1, Minhou County, Fuzhou 350108, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuyao Weng</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health, Fujian Medical University, Xueyan Road No. 1, Minhou County, Fuzhou 350108, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Liu</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health, Fujian Medical University, Xueyan Road No. 1, Minhou County, Fuzhou 350108, China. Electronic address: liujin@fjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biological effects of inhaled hydraulic fracturing sand dust. I. Scope of the investigation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33181145</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
      <Grant>U54 GM104942</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30451-8</DOI>
    <KeywordList>
      <Keywords>Characterization</Keywords>
      <Keywords>Fracking sand dust</Keywords>
      <Keywords>Inhalation exposure system</Keywords>
      <Keywords>Silica</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeffrey S. Fedan</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America. Electronic address: jsf2@cdc.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of thrombospondin-1 reduces glutathione activity and worsens acute liver injury during acetaminophen hepatotoxicity in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33176120</pubmedLink>
    <GrantList>
      <Grant>IK2 BX003486</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30449-X</DOI>
    <KeywordList>
      <Keywords>Acute liver failure</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Transforming growth factor beta 1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gabriel Frampton</Name>
        <Affiliation>Central Texas Veterans Health Care System, Austin, TX, United States of America; The University of Texas at Austin Dell Medical School, Department of Internal Medicine, Austin, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Priyanka Reddy</Name>
        <Affiliation>Central Texas Veterans Health Care System, Austin, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Brandi Jefferson</Name>
        <Affiliation>Central Texas Veterans Health Care System, Austin, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Malaika Ali</Name>
        <Affiliation>Central Texas Veterans Health Care System, Austin, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Durreshahwar Khan</Name>
        <Affiliation>Central Texas Veterans Health Care System, Austin, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew McMillin</Name>
        <Affiliation>Central Texas Veterans Health Care System, Austin, TX, United States of America; The University of Texas at Austin Dell Medical School, Department of Internal Medicine, Austin, TX, United States of America. Electronic address: matthew.mcmillin@austin.utexas.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Daphnetin ameliorates glucocorticoid-induced osteoporosis via activation of Wnt/GSK-3β/β-catenin signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33171191</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30455-5</DOI>
    <KeywordList>
      <Keywords>Daphnetin</Keywords>
      <Keywords>Glucocorticoid-Induced Osteoporosis</Keywords>
      <Keywords>Wnt/GSK-3β/β-Catenin Signaling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yongkui Wang</Name>
        <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Chen</Name>
        <Affiliation>Department of Vascular Disease, Shanghai TCM-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China; Institute of Vascular Anomalies, Shanghai Academy of Traditional Chinese Medicine, Shanghai 200082, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Chen</Name>
        <Affiliation>Department of Clinical Laboratory, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Dong</Name>
        <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Yan</Name>
        <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongpei Zhu</Name>
        <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pan Lu</Name>
        <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zongmian Song</Name>
        <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongjian Liu</Name>
        <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Electronic address: fccliuhj@zzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Songfeng Chen</Name>
        <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Electronic address: csfzdyfygk@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mdr1a, Bcrp and Mrp2 regulate the efficacy and toxicity of mesaconitine and hypaconitine by altering their tissue accumulation and in vivo residence.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33171190</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30454-3</DOI>
    <KeywordList>
      <Keywords>Efficacy</Keywords>
      <Keywords>Efflux Transporters</Keywords>
      <Keywords>Hypaconitine</Keywords>
      <Keywords>Mesaconitine</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaocui Li</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowen Ou</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangkuo Luo</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojun Ou</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yushan Xie</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengdi Ying</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Qu</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Huilin Zuo</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoxiao Qi</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Wang</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongqiu Liu</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, PR China. Electronic address: liuzq@gzucm.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Lijun Zhu</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, PR China. Electronic address: zhulijun@gzucm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel salviadione derivative, compound 15a, attenuates diabetes-induced renal injury by inhibiting NF-κB-mediated inflammatory responses.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33171189</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30448-8</DOI>
    <KeywordList>
      <Keywords>Cytokines</Keywords>
      <Keywords>Diabetic nephropathy</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Macrophage infiltration</Keywords>
      <Keywords>Nuclear factor-kappa B</Keywords>
      <Keywords>Salviadione derivative 15a</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Li Li</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China; Department of Anesthesiology, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunyong Ding</Name>
        <Affiliation>School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunpeng Zou</Name>
        <Affiliation>Department of Ultrasonography, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Xiong</Name>
        <Affiliation>Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Pharmacy, Nanchang University, Nanchang 330031, Jiangxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiwei Zhu</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianchang Qian</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingjiang Xu</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ao Zhang</Name>
        <Affiliation>School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Electronic address: ao6919zhang@sjtu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Guang Liang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: wzmcliangguang@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Down-regulation of Survivin and Bcl-2 concomitant with the activation of caspase-3 as a mechanism of apoptotic death in KG1a and K562 cells upon exposure to a derivative from ciprofloxacin family.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33171188</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30453-1</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Bcl-2</Keywords>
      <Keywords>Caspase-3</Keywords>
      <Keywords>Ciprofloxacin</Keywords>
      <Keywords>Leukemia</Keywords>
      <Keywords>Survivin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Farhad Eslami</Name>
        <Affiliation>Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Majid Mahdavi</Name>
        <Affiliation>Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran. Electronic address: majid.mahdavi@tabrizu.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Esmaeil Babaei</Name>
        <Affiliation>Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Bashdar Mahmud Hussen</Name>
        <Affiliation>Pharmacognosy Department, College of Pharmacy, Hawler Medical University, Erbil, Iraq.</Affiliation>
      </Author>
      <Author>
        <Name>Hossein Mostafavi</Name>
        <Affiliation>Department of Organic Chemistry &amp; Biochemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmad Shahbazi</Name>
        <Affiliation>Department of Organic Chemistry &amp; Biochemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Hazha Jamal Hidayat</Name>
        <Affiliation>Department of Biology, College of Education, Salahaddin University-Erbil, Erbil, Kurdistan Region, Iraq.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Forsythoside A inhibits adhesion and migration of monocytes to type II alveolar epithelial cells in lipopolysaccharide-induced acute lung injury through upregulating miR-124" [TOXICOL APPL PHARM 407 (2020) 115252].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33166546</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30450-6</DOI>
    <AuthorList>
      <Author>
        <Name>Zi Bin Lu</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shan Hong Liu</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Ying Ou</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Hui Cao</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Zhu Shi</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Yi Liu</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Yang Tian</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Ru Zheng</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Ling Zhou</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Shan Liu</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China. Electronic address: liujunshan@smu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Zhong Yu</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China. Electronic address: yulzh@smu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biological effects of inhaled hydraulic fracturing sand dust. IX. Summary and significance.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33166545</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
      <Grant>U54 GM104942</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30452-X</DOI>
    <KeywordList>
      <Keywords>Animal model</Keywords>
      <Keywords>Fracking sand dust</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Silica</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing the impacts on fetal dosimetry of the modelling of the placental transfers of xenobiotics in a pregnancy physiologically based pharmacokinetic model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33160985</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30444-0</DOI>
    <KeywordList>
      <Keywords>Chemicals</Keywords>
      <Keywords>Drugs</Keywords>
      <Keywords>Fetal exposure</Keywords>
      <Keywords>Physiologically based pharmacokinetic model</Keywords>
      <Keywords>Placental transfer</Keywords>
      <Keywords>Pregnancy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marc Codaccioni</Name>
        <Affiliation>Models for Ecotoxicology and Toxicology unit (DRC/VIVA/METO), Institut National de l'Environnement Industriel et des Risques, 60550 Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Céline Brochot</Name>
        <Affiliation>Models for Ecotoxicology and Toxicology unit (DRC/VIVA/METO), Institut National de l'Environnement Industriel et des Risques, 60550 Verneuil-en-Halatte, France. Electronic address: celine.brochot@ineris.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gestational arsenic exposure and paternal intergenerational epigenetic inheritance.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33160984</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30445-2</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>DNA Methylation</Keywords>
      <Keywords>Gestational Exposure</Keywords>
      <Keywords>Hepatic Tumors</Keywords>
      <Keywords>Intergenerational Effects</Keywords>
      <Keywords>Sperm</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Keiko Nohara</Name>
        <Affiliation>Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Tsukuba 305-8506, Japan. Electronic address: keikon@nies.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Takehiro Suzuki</Name>
        <Affiliation>Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Tsukuba 305-8506, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuyuki Okamura</Name>
        <Affiliation>Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Tsukuba 305-8506, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>4-methylpyrazole protects against acetaminophen-induced acute kidney injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33157119</pubmedLink>
    <GrantList>
      <Grant>F31 DK120194</Grant>
      <Grant>P20 GM103549</Grant>
      <Grant>P30 GM118247</Grant>
      <Grant>R01 DK102142</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30443-9</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Fomepizole</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>N-Acetylcysteine</Keywords>
      <Keywords>Nephrotoxicity</Keywords>
      <Keywords>Protein Adducts</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jephte Y. Akakpo</Name>
        <Affiliation>Department of Pharmacology, Toxicology &amp; Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anup Ramachandran</Name>
        <Affiliation>Department of Pharmacology, Toxicology &amp; Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hilmi Orhan</Name>
        <Affiliation>Department of Toxicology, Faculty of Pharmacy, Ege University, Izmir, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Steven C. Curry</Name>
        <Affiliation>Division of Clinical Data Analytics and Decision Support, and Division of Medical Toxicology and Precision Medicine, Department of Medicine, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Barry H. Rumack</Name>
        <Affiliation>Department of Emergency Medicine and Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hartmut Jaeschke</Name>
        <Affiliation>Department of Pharmacology, Toxicology &amp; Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA. Electronic address: hjaeschke@kumc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Differential responses of murine alveolar macrophages to elongate mineral particles of asbestiform and non-asbestiform varieties: Cytotoxicity, cytokine secretion and transcriptional changes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33148505</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30428-2</DOI>
    <KeywordList>
      <Keywords>Alveolar macrophage</Keywords>
      <Keywords>Asbestos</Keywords>
      <Keywords>Cleavage fragments</Keywords>
      <Keywords>Elongate mineral particle</Keywords>
      <Keywords>RNAseq</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>T. O. Khaliullin</Name>
        <Affiliation>West Virginia University, Morgantown, WV, United States of America; HELD, NIOSH, CDC, Morgantown, WV, United States of America. Electronic address: ved2@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>E. R. Kisin</Name>
        <Affiliation>HELD, NIOSH, CDC, Morgantown, WV, United States of America. Electronic address: edk8@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>S. Guppi</Name>
        <Affiliation>HELD, NIOSH, CDC, Morgantown, WV, United States of America. Electronic address: mzi6@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>N. Yanamala</Name>
        <Affiliation>West Virginia University, Morgantown, WV, United States of America; Carnegie Mellon University, Pittsburgh, PA, United States of America. Electronic address: naveena.yanamala.m@wvumedicine.org.</Affiliation>
      </Author>
      <Author>
        <Name>V. Zhernovkov</Name>
        <Affiliation>University College Dublin, Dublin, Ireland. Electronic address: vadim.zhernovkov@ucd.ie.</Affiliation>
      </Author>
      <Author>
        <Name>A. A. Shvedova</Name>
        <Affiliation>West Virginia University, Morgantown, WV, United States of America; HELD, NIOSH, CDC, Morgantown, WV, United States of America. Electronic address: ats1@cdc.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic induced redox imbalance triggers the unfolded protein response in the liver of zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33147493</pubmedLink>
    <GrantList>
      <Grant>R01 AA018886</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30433-6</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>ER stress</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Unfolded protein response</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Patrice Delaney</Name>
        <Affiliation>Program in Biology, New York University Abu Dhabi, Saadiyat Island, United Arab Emirates.</Affiliation>
      </Author>
      <Author>
        <Name>Anjana Ramdas Nair</Name>
        <Affiliation>Program in Biology, New York University Abu Dhabi, Saadiyat Island, United Arab Emirates.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Palmer</Name>
        <Affiliation>Program in Biology, New York University Abu Dhabi, Saadiyat Island, United Arab Emirates.</Affiliation>
      </Author>
      <Author>
        <Name>Nouf Khan</Name>
        <Affiliation>Program in Biology, New York University Abu Dhabi, Saadiyat Island, United Arab Emirates.</Affiliation>
      </Author>
      <Author>
        <Name>Kirsten C. Sadler</Name>
        <Affiliation>Program in Biology, New York University Abu Dhabi, Saadiyat Island, United Arab Emirates. Electronic address: kirsten.edepli@nyu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of As3mt and Mth1 in the genotoxic and carcinogenic effects induced by long-term exposures to arsenic in MEF cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33141059</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30429-4</DOI>
    <KeywordList>
      <Keywords>Arsenic in vitro long-term exposure</Keywords>
      <Keywords>As3mt</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Cell transformation</Keywords>
      <Keywords>Fibroblasts</Keywords>
      <Keywords>Genotoxic DNA damage</Keywords>
      <Keywords>MEF</Keywords>
      <Keywords>Mth1</Keywords>
      <Keywords>ODD</Keywords>
      <Keywords>Oncogenic phenotype</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Irene Barguilla</Name>
        <Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Bellaterra, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Jana Peremartí</Name>
        <Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Bellaterra, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Jordi Bach</Name>
        <Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Bellaterra, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ricard Marcos</Name>
        <Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Bellaterra, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Carlos III Institute of Health, Madrid, Spain. Electronic address: ricard.marcos@uab.es.</Affiliation>
      </Author>
      <Author>
        <Name>Alba Hernández</Name>
        <Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Bellaterra, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Carlos III Institute of Health, Madrid, Spain. Electronic address: alba.hernandez@uab.cat.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biological effects of inhaled hydraulic fracturing sand dust VII. Neuroinflammation and altered synaptic protein expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33141058</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
      <Grant>U54 GM104942</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30426-9</DOI>
    <KeywordList>
      <Keywords>Aluminum Silicates</Keywords>
      <Keywords>Fracking Sand Dust</Keywords>
      <Keywords>Hydraulic Fracturing</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Occupational Hazards</Keywords>
      <Keywords>Silica</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Krishnan Sriram</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America. Electronic address: kos4@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Gary X. Lin</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Amy M. Jefferson</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Walter McKinney</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Mark C. Jackson</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Amy Cumpston</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jared L. Cumpston</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>James B. Cumpston</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Howard D. Leonard</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Kashon</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey S. Fedan</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The interrupted cross-talk of inflammatory and oxidative stress trajectories signifies the effect of artesunate against hepatic ischemia/reperfusion-induced inflammasomopathy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33130049</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30435-X</DOI>
    <KeywordList>
      <Keywords>Inflammatory mediators</Keywords>
      <Keywords>NLRP3</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Pyroptosis</Keywords>
      <Keywords>TLR4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mai El Sayed Ghoneim</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Sadat City (USC), Menoufia, Egypt. Electronic address: mai.ghoneim@fop.usc.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Dalaal M. Abdallah</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Κasr El-Aini Str., 11562 Cairo, Egypt. Electronic address: Dalaal.Abdallah@pharma.cu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Abdelhadi Mohamed Shebl</Name>
        <Affiliation>Department of Pathology, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman.</Affiliation>
      </Author>
      <Author>
        <Name>Hanan S. El-Abhar</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Biochemistry, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University in Egypt (FUE), 11835 Cairo, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inorganic arsenic and its methylated metabolites as endocrine disruptors in the placenta: Mechanisms underpinning glucocorticoid receptor (GR) pathway perturbations.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33129825</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30431-2</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Dimethylarsenic</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Glucocorticoid receptor</Keywords>
      <Keywords>Monomethylarsenic</Keywords>
      <Keywords>Nuclear receptor</Keywords>
      <Keywords>Placenta</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cassandra J. Meakin</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John T. Szilagyi</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA; Curriculum in Toxicology and Environmental Medicine, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vennela Avula</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca C. Fry</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA; Curriculum in Toxicology and Environmental Medicine, University of North Carolina, Chapel Hill, NC, USA; Institute for Environmental Health Solutions, University of North Carolina, Chapel Hill, NC, USA. Electronic address: rfry@unc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of the PI3K/Akt pathway in cadmium induced malignant transformation of normal prostate epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33129824</pubmedLink>
    <GrantList>
      <Grant>IK6 BX004473</Grant>
      <Grant>I01 BX001123</Grant>
      <Grant>R01 CA199694</Grant>
      <Grant>R01 CA196848</Grant>
      <Grant>U01 CA184966</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30434-8</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>PI3K/Akt pathway</Keywords>
      <Keywords>Prostate cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Priyanka Kulkarni</Name>
        <Affiliation>Department of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pritha Dasgupta</Name>
        <Affiliation>Department of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nadeem S. Bhat</Name>
        <Affiliation>Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yutaka Hashimoto</Name>
        <Affiliation>Department of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sharanjot Saini</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Varahram Shahryari</Name>
        <Affiliation>Department of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Soichiro Yamamura</Name>
        <Affiliation>Department of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marisa Shiina</Name>
        <Affiliation>Department of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuichiro Tanaka</Name>
        <Affiliation>Department of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rajvir Dahiya</Name>
        <Affiliation>Department of Urology, VA Medical Center and UCSF, San Francisco, CA, USA. Electronic address: rdahiya@ucsf.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Shahana Majid</Name>
        <Affiliation>Department of Urology, VA Medical Center and UCSF, San Francisco, CA, USA. Electronic address: Shahana.Majid@ucsf.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prepubertal exposure to arsenic alters male reproductive parameters in pubertal and adult rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33127376</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30430-0</DOI>
    <KeywordList>
      <Keywords>Arsenite</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Recovery</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Felipe Couto-Santos</Name>
        <Affiliation>Department of General Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Cláudia Ferreira Souza</Name>
        <Affiliation>Department of General Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil; Department of Animal Biology, Universidade Federal Rural do Rio de Janeiro, Seropédica, Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Silva Sena Bastos</Name>
        <Affiliation>Department of General Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luiz Otávio Guimarães Ervilha</Name>
        <Affiliation>Department of General Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Fernanda Carolina Ribeiro Dias</Name>
        <Affiliation>Department of Structural Bioloy, Universidade Federal do Triângulo Mineiro, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Larissa de Sales Araújo</Name>
        <Affiliation>Department of Animal Science, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Simone Eliza Facioni Guimarães</Name>
        <Affiliation>Department of Animal Science, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Leandro Licursi de Oliveira</Name>
        <Affiliation>Department of General Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mariana Machado-Neves</Name>
        <Affiliation>Department of General Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil. Electronic address: mariana.mneves@ufv.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic-induced changes in miRNA expression in cancer and other diseases.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33127375</pubmedLink>
    <GrantList>
      <Grant>P30 ES030283</Grant>
      <Grant>R01 ES027778</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30432-4</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>miRNA dysregulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ana P. Ferragut Cardoso</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karen T. Udoh</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Christopher States</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202, USA. Electronic address: jcstates@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Co-exposure to PCB126 and PFOS increases biomarkers associated with cardiovascular disease risk and liver injury in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33096110</pubmedLink>
    <GrantList>
      <Grant>S10 OD021753</Grant>
      <Grant>P42 ES007380</Grant>
      <Grant>P30 GM127211</Grant>
      <Grant>T32 ES011564</Grant>
      <Grant>P20 GM103527</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30427-0</DOI>
    <KeywordList>
      <Keywords>Cardiovascular disease</Keywords>
      <Keywords>Lipid</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>PCB126</Keywords>
      <Keywords>PFAS</Keywords>
      <Keywords>PFOS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pan Deng</Name>
        <Affiliation>Superfund Research Center, University of Kentucky, Lexington, KY 40536, USA; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chunyan Wang</Name>
        <Affiliation>Superfund Research Center, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Banrida Wahlang</Name>
        <Affiliation>Superfund Research Center, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Travis Sexton</Name>
        <Affiliation>Division of Cardiovascular Medicine, The Gill Heart and Vascular Institute, College of Medicine, University of Kentucky, and Lexington Veterans Affairs Medical Center, Lexington, KY, 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Morris</Name>
        <Affiliation>Superfund Research Center, University of Kentucky, Lexington, KY 40536, USA; Division of Cardiovascular Medicine, The Gill Heart and Vascular Institute, College of Medicine, University of Kentucky, and Lexington Veterans Affairs Medical Center, Lexington, KY, 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bernhard Hennig</Name>
        <Affiliation>Superfund Research Center, University of Kentucky, Lexington, KY 40536, USA; Department of Animal and Food Sciences, College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY 40536, USA. Electronic address: bhennig@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Zafirlukast prevented ox-LDL-induced formation of foam cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33096109</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30421-X</DOI>
    <KeywordList>
      <Keywords>ABCA1</Keywords>
      <Keywords>ABCG1</Keywords>
      <Keywords>Atherosclerosis</Keywords>
      <Keywords>CD36</Keywords>
      <Keywords>LOX-1</Keywords>
      <Keywords>PI3K/AKT</Keywords>
      <Keywords>Scavenger receptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qiang Song</Name>
        <Affiliation>Department of Structural Heart Disease, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Hu</Name>
        <Affiliation>Department of Structural Heart Disease, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinming Xie</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Cai</Name>
        <Affiliation>Department of vascular surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shanxi, China. Electronic address: caihui6081@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fish oil and olive oil-enriched diets alleviate acute ozone-induced cardiovascular effects in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33091443</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30422-1</DOI>
    <KeywordList>
      <Keywords>Cardiac contractility</Keywords>
      <Keywords>Cardiac function</Keywords>
      <Keywords>Fish oil diet</Keywords>
      <Keywords>Olive oil diet</Keywords>
      <Keywords>Ozone</Keywords>
      <Keywords>microRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haiyan Tong</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Chapel Hill, NC 27514, United States. Electronic address: tong.haiyan@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Samantha J. Snow</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Chen</Name>
        <Affiliation>Oak Ridge Institute of Science and Education, Oak Ridge, TN 37830, United States. Electronic address: chen.hao@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Mette C. Schladweiler</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, United States. Electronic address: schladweiler.mette@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Gleta Carswell</Name>
        <Affiliation>Biomolecular and Computational Toxicology Division, Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, United States. Electronic address: Carswell.gleta@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Chorley</Name>
        <Affiliation>Biomolecular and Computational Toxicology Division, Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, United States. Electronic address: Chorley.brian@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Urmila P. Kodavanti</Name>
        <Affiliation>Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, United States. Electronic address: kodavanti.urmila@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Induction of apoptosis in breast cancer cells by naphthylisoquinoline alkaloids.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33091442</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30423-3</DOI>
    <KeywordList>
      <Keywords>Antiproliferative activity</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Naphthylisoquinoline alkaloids</Keywords>
      <Keywords>ROS production</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Prem Prakash Kushwaha</Name>
        <Affiliation>Department of Biochemistry, Central University of Punjab, Bathinda 151401, Punjab, India.</Affiliation>
      </Author>
      <Author>
        <Name>Atul Kumar Singh</Name>
        <Affiliation>Department of Biochemistry, Central University of Punjab, Bathinda 151401, Punjab, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kumari Sunita Prajapati</Name>
        <Affiliation>Department of Biochemistry, Central University of Punjab, Bathinda 151401, Punjab, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mohd Shuaib</Name>
        <Affiliation>Department of Biochemistry, Central University of Punjab, Bathinda 151401, Punjab, India.</Affiliation>
      </Author>
      <Author>
        <Name>Shaimaa Fayez</Name>
        <Affiliation>Institute of Organic Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, Germany; Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Organization of African Unity Street 1, 11566 Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Gerhard Bringmann</Name>
        <Affiliation>Institute of Organic Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, Germany. Electronic address: Bringmann@chemie.uni-wuerzburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>Shashank Kumar</Name>
        <Affiliation>Department of Biochemistry, Central University of Punjab, Bathinda 151401, Punjab, India. Electronic address: shashankbiochemau@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Maternal nicotine exposure during pregnancy and lactation induces brown adipose tissue whitening in female offspring.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33091441</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30424-5</DOI>
    <KeywordList>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>Brown adipose tissue whitening</Keywords>
      <Keywords>Lactation</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>PGC-1αUCP1 signals</Keywords>
      <Keywords>Pregnancy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hui Jian Chen</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gai Ling Li</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wan Xia Zhang</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Fan</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Hu</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Zhang</Name>
        <Affiliation>Demonstration Center for Experimental Basic Medicine Education, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Zhang</Name>
        <Affiliation>Center for Animal Experiment/Animal Biosafety Level 3 Laboratory, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>You E. Yan</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China. Electronic address: yanyoue@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Balance between the toxicity and anticancer activity of arsenic trioxide in treatment of acute promyelocytic leukemia.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33091440</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30425-7</DOI>
    <KeywordList>
      <Keywords>Acute Promyelocytic Leukemia</Keywords>
      <Keywords>Adverse Effect</Keywords>
      <Keywords>Arsenic Trioxide</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Methylated Arsenicals</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qian Qian Wang</Name>
        <Affiliation>Department of Hematology of First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Department of Toxicology, School of Medicine and Public Health, Zhejiang University, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Ying Hua</Name>
        <Affiliation>Department of Biomedical Engineering, Southern Medical University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Naranmandura</Name>
        <Affiliation>Department of Hematology of First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Department of Toxicology, School of Medicine and Public Health, Zhejiang University, Hangzhou, China. Electronic address: narenman@zju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Hu Zhu</Name>
        <Affiliation>Department of Toxicology, School of Medicine and Public Health, Zhejiang University, Hangzhou, China. Electronic address: zhuhhdoc@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Decreased immune response in monkeys administered a human T-effector cell agonist (OX40) antibody.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33069749</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30411-7</DOI>
    <KeywordList>
      <Keywords>Anti-drug antibodies</Keywords>
      <Keywords>Biphasic response</Keywords>
      <Keywords>Immuno-oncology</Keywords>
      <Keywords>Non-human primate</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joshua T. Gamse</Name>
        <Affiliation>Drug Safety Evaluation, Bristol Myers Squibb Company, New Brunswick, NJ, 08903, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Wendy Freebern</Name>
        <Affiliation>Drug Safety Evaluation, Bristol Myers Squibb Company, New Brunswick, NJ, 08903, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Rashade Haynes Ii</Name>
        <Affiliation>Drug Safety Evaluation, Bristol Myers Squibb Company, New Brunswick, NJ, 08903, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Simutis</Name>
        <Affiliation>Drug Safety Evaluation, Bristol Myers Squibb Company, New Brunswick, NJ, 08903, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Pazian</Name>
        <Affiliation>Drug Safety Evaluation, Bristol Myers Squibb Company, New Brunswick, NJ, 08903, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>James Crona</Name>
        <Affiliation>Drug Safety Evaluation, Bristol Myers Squibb Company, New Brunswick, NJ, 08903, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Helen G. Haggerty</Name>
        <Affiliation>Drug Safety Evaluation, Bristol Myers Squibb Company, New Brunswick, NJ, 08903, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Graziano</Name>
        <Affiliation>Drug Safety Evaluation, Bristol Myers Squibb Company, New Brunswick, NJ, 08903, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Roderick Todd Bunch</Name>
        <Affiliation>Drug Safety Evaluation, Bristol Myers Squibb Company, New Brunswick, NJ, 08903, United States of America. Electronic address: todd.bunch@bms.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Restoration of PP2A levels in inflamed microglial cells: Important for neuroprotective M2 microglial viability.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33069748</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30420-8</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Co-treatment</Keywords>
      <Keywords>Microglial polarization</Keywords>
      <Keywords>Neuroinflammation</Keywords>
      <Keywords>Protein phosphatase 2A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Md Nematullah</Name>
        <Affiliation>Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi 110062, India.</Affiliation>
      </Author>
      <Author>
        <Name>M. N. Hoda</Name>
        <Affiliation>Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Centre, Dignity Health, Phoenix, AZ 85013, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shwetanjali Nimker</Name>
        <Affiliation>BD Biosciences India Pvt. Ltd., Jamia Hamdard, New Delhi 110062, India.</Affiliation>
      </Author>
      <Author>
        <Name>Farah Khan</Name>
        <Affiliation>Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi 110062, India. Electronic address: fkhan@jamiahamdard.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biological effects of inhaled hydraulic fracturing sand dust. II. Particle characterization and pulmonary effects 30 d following intratracheal instillation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33068622</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
      <Grant>U54 GM104942</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30408-7</DOI>
    <KeywordList>
      <Keywords>Fracking sand dust</Keywords>
      <Keywords>MIN-U-SIL®</Keywords>
      <Keywords>Particle characterization</Keywords>
      <Keywords>Rat model</Keywords>
      <Keywords>Silica</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeffrey S. Fedan</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America. Electronic address: jsf2@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Ann F. Hubbs</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Barger</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Diane Schwegler-Berry</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Sherri A. Friend</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen S. Leonard</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Janet A. Thompson</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Mark C. Jackson</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>John E. Snawder</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Alan K. Dozier</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jayme Coyle</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Michael L. Kashon</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Ju Hyeong Park</Name>
        <Affiliation>Respiratory Health Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Walter McKinney</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jenny R. Roberts</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hydrogen sulfide attenuates postoperative cognitive dysfunction through promoting the pathway of Warburg effect-synaptic plasticity in hippocampus.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33068621</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30412-9</DOI>
    <KeywordList>
      <Keywords>Hippocampus</Keywords>
      <Keywords>Hydrogen sulfide</Keywords>
      <Keywords>Postoperative cognitive dysfunction</Keywords>
      <Keywords>Synaptic plasticity</Keywords>
      <Keywords>Warburg effect</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Si Min Chen</Name>
        <Affiliation>Institute of Neurology, the First Affiliated Hospital, University of South China, Hengyang 421001, Hunan, PR China; Institute of Neuroscience, Hengyang Medical College, University of South China, Hengyang 421001, Hunan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Li</Name>
        <Affiliation>Institute of Neuroscience, Hengyang Medical College, University of South China, Hengyang 421001, Hunan, PR China; Department of Neurology, Affiliated Nanhua Hospital, University of South China, Hengyang 421001, Hunan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Xie</Name>
        <Affiliation>Institute of Neuroscience, Hengyang Medical College, University of South China, Hengyang 421001, Hunan, PR China; Department of Neurology, Affiliated Nanhua Hospital, University of South China, Hengyang 421001, Hunan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Sha Li</Name>
        <Affiliation>Institute of Neurology, the First Affiliated Hospital, University of South China, Hengyang 421001, Hunan, PR China; Department of Anesthesiology, the First Affiliated Hospital, University of South China, Hengyang 421001, Hunan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shi Shi Xiang</Name>
        <Affiliation>Institute of Neurology, the First Affiliated Hospital, University of South China, Hengyang 421001, Hunan, PR China; Department of Anesthesiology, the First Affiliated Hospital, University of South China, Hengyang 421001, Hunan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hai Yao Liu</Name>
        <Affiliation>Institute of Neuroscience, Hengyang Medical College, University of South China, Hengyang 421001, Hunan, PR China; Department of Neurology, Affiliated Nanhua Hospital, University of South China, Hengyang 421001, Hunan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuo Chen</Name>
        <Affiliation>Institute of Neuroscience, Hengyang Medical College, University of South China, Hengyang 421001, Hunan, PR China; Department of Neurology, Affiliated Nanhua Hospital, University of South China, Hengyang 421001, Hunan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Zhang</Name>
        <Affiliation>Institute of Neuroscience, Hengyang Medical College, University of South China, Hengyang 421001, Hunan, PR China; Department of Neurology, Affiliated Nanhua Hospital, University of South China, Hengyang 421001, Hunan, PR China. Electronic address: zhangp415@usc.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Kuang</Name>
        <Affiliation>Institute of Neurology, the First Affiliated Hospital, University of South China, Hengyang 421001, Hunan, PR China; Department of Anesthesiology, the First Affiliated Hospital, University of South China, Hengyang 421001, Hunan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Qing Tang</Name>
        <Affiliation>Institute of Neurology, the First Affiliated Hospital, University of South China, Hengyang 421001, Hunan, PR China; Institute of Neuroscience, Hengyang Medical College, University of South China, Hengyang 421001, Hunan, PR China. Electronic address: tangxq-usc@usc.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Synthetic cannabinoids enhanced ethanol-induced motor impairments through reduction of central glutamate neurotransmission.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33068620</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30409-9</DOI>
    <KeywordList>
      <Keywords>Biosensors</Keywords>
      <Keywords>Glutamate</Keywords>
      <Keywords>Microelectrode Array</Keywords>
      <Keywords>Motor Impairment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Masahiko Funada</Name>
        <Affiliation>Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-higashi, Kodaira, Tokyo 187-8553, Japan. Electronic address: mfunada@ncnp.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Mika Takebayashi-Ohsawa</Name>
        <Affiliation>Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-higashi, Kodaira, Tokyo 187-8553, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ken Ich Tomiyama</Name>
        <Affiliation>Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-higashi, Kodaira, Tokyo 187-8553, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biological effects of inhaled hydraulic fracturing sand dust. IV. Pulmonary effects.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33068619</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
      <Grant>U54 GM104942</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30410-5</DOI>
    <KeywordList>
      <Keywords>Fracking sand dust</Keywords>
      <Keywords>Hydraulic fracturing</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Pulmonary toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kristen A. Russ</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Janet A. Thompson</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey S. Reynolds</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Robert R. Mercer</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Dale W. Porter</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Walter McKinney</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Richard D. Dey</Name>
        <Affiliation>Department of Physiology and Pharmacology, Anatomy and Laboratory Medicine, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States of America; Department of Pathology, Anatomy and Laboratory Medicine, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Barger</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jared Cumpston</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas P. Batchelor</Name>
        <Affiliation>Department of Physiology and Pharmacology, Anatomy and Laboratory Medicine, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States of America; Department of Pathology, Anatomy and Laboratory Medicine, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Michael L. Kashon</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Vamsi Kodali</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Mark C. Jackson</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Krishnan Sriram</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey S. Fedan</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America. Electronic address: jsf2@cdc.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>HepG2 (C3A) spheroids show higher sensitivity compared to HepaRG spheroids for drug-induced liver injury (DILI).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33068618</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30405-1</DOI>
    <KeywordList>
      <Keywords>3D cell culture</Keywords>
      <Keywords>Acoustic dispensing</Keywords>
      <Keywords>Hepatocyte</Keywords>
      <Keywords>Microtissue</Keywords>
      <Keywords>Physiological-relevance</Keywords>
      <Keywords>in vitro in vivo correlation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aneesha Basharat</Name>
        <Affiliation>Faculty of Biological Sciences, University of Leeds, Leeds, West Yorkshire LS2 9JT, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Helen E. Rollison</Name>
        <Affiliation>Clinical Pharmacology and Safety Sciences, R&amp;D, AstraZeneca, Cambridge, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Dominic P. Williams</Name>
        <Affiliation>Clinical Pharmacology and Safety Sciences, R&amp;D, AstraZeneca, Cambridge, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Delyan P. Ivanov</Name>
        <Affiliation>Mechanistic Biology and Profiling, Discovery Sciences, R&amp;D, AstraZeneca, Cambridge, United Kingdom. Electronic address: delyan.ivanov1@astrazeneca.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biological effects of inhaled hydraulic fracturing sand dust. III. Cytotoxicity and pro-inflammatory responses in cultured murine macrophage cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33065155</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
      <Grant>U54 GM104942</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30407-5</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Fracking sand dust</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Macrophages</Keywords>
      <Keywords>Occupational exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicole S. Olgun</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America. Electronic address: nolgun@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Anna M. Morris</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Aleksandr B. Stefaniak</Name>
        <Affiliation>Respiratory Health Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Lauren N. Bowers</Name>
        <Affiliation>Respiratory Health Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Alycia K. Knepp</Name>
        <Affiliation>Respiratory Health Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew G. Duling</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Robert R. Mercer</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Michael L. Kashon</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey S. Fedan</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen S. Leonard</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biological effects of inhaled hydraulic fracturing sand dust. V. Pulmonary inflammatory, cytotoxic and oxidant effects.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33065154</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
      <Grant>U54 GM104942</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30406-3</DOI>
    <KeywordList>
      <Keywords>Fracking sand dust</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Pulmonary toxicity</Keywords>
      <Keywords>Rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tina M. Sager</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505, United States of America. Electronic address: sst2@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Jenny R. Roberts</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Christina M. Umbright</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Barger</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Michael L. Kashon</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey S. Fedan</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Pius Joseph</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Targeting autophagy by natural product Ursolic acid for prevention and treatment of osteoporosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33065153</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30397-5</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Osteoclast</Keywords>
      <Keywords>Osteoporosis</Keywords>
      <Keywords>Ursolic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haoyi Zheng</Name>
        <Affiliation>Qingdao University Medical College, 308 Ningxia Road, Qingdao, Shandong 266021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haitao Feng</Name>
        <Affiliation>Department of Applied Chemistry, Faculty of Engineering, Kyushu University, Fukuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Wenzhong Zhang</Name>
        <Affiliation>Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yantao Han</Name>
        <Affiliation>Qingdao University Medical College, 308 Ningxia Road, Qingdao, Shandong 266021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenwen Zhao</Name>
        <Affiliation>Qingdao University Medical College, 308 Ningxia Road, Qingdao, Shandong 266021, China. Electronic address: daisy@qdu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>How the CORAL software can be used to select compounds for efficient treatment of neurodegenerative diseases?</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33058887</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30402-6</DOI>
    <KeywordList>
      <Keywords>Alzheimer's Disease</Keywords>
      <Keywords>Bioinformatics</Keywords>
      <Keywords>In Silico Design</Keywords>
      <Keywords>Neurodegenerative Diseases</Keywords>
      <Keywords>Neuroprotection</Keywords>
      <Keywords>Parkinson's Disease</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alla P. Toropova</Name>
        <Affiliation>Laboratory of Environmental Chemistry and Toxicology, Department of Environmental Health Science, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milano, Italy. Electronic address: alla.toropova@marionegri.it.</Affiliation>
      </Author>
      <Author>
        <Name>Andrey A. Toropov</Name>
        <Affiliation>Laboratory of Environmental Chemistry and Toxicology, Department of Environmental Health Science, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milano, Italy. Electronic address: andrey.toropov@marionegri.it.</Affiliation>
      </Author>
      <Author>
        <Name>Danuta Leszczynska</Name>
        <Affiliation>Interdisciplinary Nanotoxicity Center, Department of Civil and Environmental Engineering, Jackson State University, 1325 Lynch Street, Jackson, MS 39217-0510, USA. Electronic address: danuta@icnanotox.org.</Affiliation>
      </Author>
      <Author>
        <Name>Jerzy Leszczynski</Name>
        <Affiliation>Interdisciplinary Nanotoxicity Center, Department of Chemistry, Physics and Atmospheric Sciences, Jackson State University, 1400 J. R. Lynch Street, P.O. Box 17910, Jackson, MS 39217, USA. Electronic address: Jerzy@icnanotox.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Activation of Lrrk2 and α-Synuclein in substantia nigra, striatum, and cerebellum after chronic exposure to arsenite.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33053406</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30404-X</DOI>
    <KeywordList>
      <Keywords>Arsenite</Keywords>
      <Keywords>Cerebellum</Keywords>
      <Keywords>Lrrk2</Keywords>
      <Keywords>Striatum</Keywords>
      <Keywords>Substantia nigra</Keywords>
      <Keywords>α-Synuclein</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zuzana Drobna</Name>
        <Affiliation>Department of Biological Sciences, Department of Chemical and Biomolecular Engineering, Center for Human Health and the Environment, North Carolina State University, Raleigh, NC 27695, USA. Electronic address: zdrobna@ncsu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Transgenerational effects of developmental exposure to chlorpyrifos-oxon in zebrafish (DANIO RERIO).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33049267</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30401-4</DOI>
    <KeywordList>
      <Keywords>Acetylcholine</Keywords>
      <Keywords>Chlorpyrifos</Keywords>
      <Keywords>Chlorpyrifos-oxon</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Neurodevelopment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cassandra Schmitt</Name>
        <Affiliation>Department of Environmental Toxicology, Texas Tech University, PO Box 41,163, Lubbock, TX 79409, USA. Electronic address: Cassandra.schmitt@ttu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Peterson</Name>
        <Affiliation>Department of Environmental Toxicology, Texas Tech University, PO Box 41,163, Lubbock, TX 79409, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Audrey Willis</Name>
        <Affiliation>Department of Environmental Toxicology, Texas Tech University, PO Box 41,163, Lubbock, TX 79409, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naveen Kumar</Name>
        <Affiliation>Department of Environmental Toxicology, Texas Tech University, PO Box 41,163, Lubbock, TX 79409, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle McManus</Name>
        <Affiliation>Department of Environmental Toxicology, Texas Tech University, PO Box 41,163, Lubbock, TX 79409, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Seenivasan Subbiah</Name>
        <Affiliation>Department of Environmental Toxicology, Texas Tech University, PO Box 41,163, Lubbock, TX 79409, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jordan Crago</Name>
        <Affiliation>Department of Environmental Toxicology, Texas Tech University, PO Box 41,163, Lubbock, TX 79409, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Teratogenesis in the chick embryo following post-gastrulation exposure to Y-27632 -effect of Y-27632 on embryonic development.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33049266</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30403-8</DOI>
    <KeywordList>
      <Keywords>Chick Embryo</Keywords>
      <Keywords>Post-Gastrulation</Keywords>
      <Keywords>ROCK</Keywords>
      <Keywords>Somite</Keywords>
      <Keywords>Ventral Body Wall Defect</Keywords>
      <Keywords>Y-27632</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Johannes W. Duess</Name>
        <Affiliation>Department of Pediatric Surgery, University of Leipzig, Leipzig, Germany; National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin 12, Ireland; School of Medicine and Medical Science, University College Dublin, Belfield, Dublin 4, Ireland. Electronic address: johannes.duess@medizin.uni-leipzig.de.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Hendrik Gosemann</Name>
        <Affiliation>Department of Pediatric Surgery, University of Leipzig, Leipzig, Germany; National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin 12, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>Prem Puri</Name>
        <Affiliation>National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin 12, Ireland; School of Medicine and Medical Science, University College Dublin, Belfield, Dublin 4, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Thompson</Name>
        <Affiliation>National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin 12, Ireland; School of Medicine and Medical Science, University College Dublin, Belfield, Dublin 4, Ireland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nano selenium protects against deltamethrin-induced reproductive toxicity in male rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33038357</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30400-2</DOI>
    <KeywordList>
      <Keywords>Deltamethrin</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Nano selenium</Keywords>
      <Keywords>Oxidative status</Keywords>
      <Keywords>Sexual behavior</Keywords>
      <Keywords>Sperm characteristics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heba F. Hozyen</Name>
        <Affiliation>Animal Reproduction and Artificial Insemination Department, National Research Centre, Egypt. Electronic address: hf.hozyen@nrc.sci.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Heba M. A. Khalil</Name>
        <Affiliation>Veterinary Hygiene and Management Department, Faculty of Veterinary Medicine, Cairo University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Rehab A. Ghandour</Name>
        <Affiliation>Physiology Department, Faculty of Veterinary Medicine, Cairo University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Asmaa K. Al-Mokaddem</Name>
        <Affiliation>Pathology Department, Faculty of Veterinary Medicine, Cairo University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>M. S. Amer</Name>
        <Affiliation>Surgery, Anesthesiology, and Radiology Department, Faculty of Veterinary Medicine, Cairo University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Rehab A. Azouz</Name>
        <Affiliation>Toxicology and Forensic Medicine Department, Faculty of Veterinary Medicine, Cairo University, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Physapubescin B enhances the sensitivity of gastric cancer cells to trametinib by inhibiting the STAT3 signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33035574</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30399-9</DOI>
    <KeywordList>
      <Keywords>Anti-tumor</Keywords>
      <Keywords>Gastric cancer</Keywords>
      <Keywords>MEK inhibitor trametinib</Keywords>
      <Keywords>Physapubescin B</Keywords>
      <Keywords>STAT3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chunyan Dai</Name>
        <Affiliation>Key Laboratory of Digestive Pathophysiology of Zhejiang Province, the First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Shen</Name>
        <Affiliation>Institute of Basic Theory of TCM, China Academy of Chinese Medical Sciences, Beijing 100700, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiyang Jin</Name>
        <Affiliation>College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Lv</Name>
        <Affiliation>Key Laboratory of Digestive Pathophysiology of Zhejiang Province, the First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pei Liu</Name>
        <Affiliation>Key Laboratory of Digestive Pathophysiology of Zhejiang Province, the First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xi Wang</Name>
        <Affiliation>Key Laboratory of Digestive Pathophysiology of Zhejiang Province, the First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yifei Yin</Name>
        <Affiliation>Key Laboratory of Digestive Pathophysiology of Zhejiang Province, the First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufei Fu</Name>
        <Affiliation>Key Laboratory of Digestive Pathophysiology of Zhejiang Province, the First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liguo Liang</Name>
        <Affiliation>Key Laboratory of Digestive Pathophysiology of Zhejiang Province, the First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongjun Ma</Name>
        <Affiliation>School of Pharmaceutical Sciences, Zhejiang University, 866 Yu-Hang-Tang Road, Hangzhou 310058, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojian Zhang</Name>
        <Affiliation>Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiping Wang</Name>
        <Affiliation>Key Laboratory of Digestive Pathophysiology of Zhejiang Province, the First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, China. Electronic address: ypwang@zcmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Daogun Xu</Name>
        <Affiliation>Department of Colorectal Surgery, Wenling Hospital of Traditional Chinese Medicine, Zhejiang Chinese Medical University, Wenling, China. Electronic address: Wlzyy01@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Chen</Name>
        <Affiliation>Key Laboratory of Digestive Pathophysiology of Zhejiang Province, the First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, China. Electronic address: chenzhe@zju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33031836</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30398-7</DOI>
    <KeywordList>
      <Keywords>fibroblasts</Keywords>
      <Keywords>fibrosis</Keywords>
      <Keywords>immune cells</Keywords>
      <Keywords>inflammation</Keywords>
      <Keywords>macrophages</Keywords>
      <Keywords>mustard vesicants</Keywords>
      <Keywords>toxicants</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rama Malaviya</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, School of Public Health, Rutgers University, Piscataway, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Howard M. Kipen</Name>
        <Affiliation>Department of Environmental and Occupational Health and Justice, School of Public Health, Rutgers University, Piscataway, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rita Businaro</Name>
        <Affiliation>Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey D. Laskin</Name>
        <Affiliation>Department of Environmental and Occupational Health and Justice, School of Public Health, Rutgers University, Piscataway, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Debra L. Laskin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, School of Public Health, Rutgers University, Piscataway, NJ, USA. Electronic address: laskin@eohsi.rutgers.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Telomeres as targets for the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and polychlorinated biphenyls (PCBs) in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33022284</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30390-2</DOI>
    <KeywordList>
      <Keywords>Polychlorinated Biphenyls</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>TCDD</Keywords>
      <Keywords>Telomere Length</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Samantha L. VanEtten</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew R. Bonner</Name>
        <Affiliation>Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xuefeng Ren</Name>
        <Affiliation>Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Linda S. Birnbaum</Name>
        <Affiliation>Scientist Emeritus, National Institute of Environmental Health Sciences and National Toxicology Program, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul J. Kostyniak</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA; Department of Biotechnical and Clinical Laboratory Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Wang</Name>
        <Affiliation>Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Institute, Buffalo, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James R. Olson</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA; Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA. Electronic address: jolson@buffalo.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Budlein A methylacrylate demonstrates potent activity against triple-negative breast cancer by targeting IκBα kinase and exportin-1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33022283</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30389-6</DOI>
    <KeywordList>
      <Keywords>IKKβ</Keywords>
      <Keywords>NF-κB pathway</Keywords>
      <Keywords>Triple-negative breast cancer</Keywords>
      <Keywords>XPO-1</Keywords>
      <Keywords>budlein A methylacrylate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xin Zhi Wang</Name>
        <Affiliation>College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210046, China. Electronic address: wxzatnj@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yin Feng</Name>
        <Affiliation>College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210046, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ye Fan Han</Name>
        <Affiliation>College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210046, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Bian</Name>
        <Affiliation>College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210046, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Liang</Name>
        <Affiliation>College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210046, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Mei Wen</Name>
        <Affiliation>College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210046, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Wu</Name>
        <Affiliation>College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210046, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Repeated toluene exposure leads to neuroadaptation in dopamine release mechanisms within the nucleus accumbens core.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33017594</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30386-0</DOI>
    <KeywordList>
      <Keywords>Caudate-putamen</Keywords>
      <Keywords>Fast-scan cyclic voltammetry</Keywords>
      <Keywords>Inhalant</Keywords>
      <Keywords>Microdialysis</Keywords>
      <Keywords>Nucleus accumbens</Keywords>
      <Keywords>Toluene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aaron K. Apawu</Name>
        <Affiliation>Wayne State University, Department of Chemistry, Detroit, MI 48202, United States of America. Electronic address: aaron.apawu@unco.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Sean P. Callan</Name>
        <Affiliation>Wayne State University, Department of Psychology, Detroit, MI 48202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Tiffany A. Mathews</Name>
        <Affiliation>Wayne State University, Department of Chemistry, Detroit, MI 48202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Scott E. Bowen</Name>
        <Affiliation>Wayne State University, Department of Psychology, Detroit, MI 48202, United States of America. Electronic address: scottbowen@wayne.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Emerging technology and platforms for cardiotoxicity testing.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33017593</pubmedLink>
    <GrantList>
      <Grant>P50 HL120163</Grant>
      <Grant>R01 HL147921</Grant>
      <Grant>P42 ES023716</Grant>
      <Grant>U54 HL120163</Grant>
      <Grant>P30 GM127607</Grant>
      <Grant>R01 HL122676</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30388-4</DOI>
    <KeywordList>
      <Keywords>Anticancer drugs</Keywords>
      <Keywords>Cardiomyocyte</Keywords>
      <Keywords>Embryonic stem cells</Keywords>
      <Keywords>High throughput</Keywords>
      <Keywords>Human-induced pluripotent stem cells</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tamer M. A. Mohamed</Name>
        <Affiliation>Institute of Molecular Cardiology, University of Louisville, Louisville, KY 40292, United States; Diabetes and Obesity Center, University of Louisville, Louisville, KY 40292, United States; Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY 40292, United States; Department of Medicine, University of Louisville, Louisville, KY 40292, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel J. Conklin</Name>
        <Affiliation>Diabetes and Obesity Center, University of Louisville, Louisville, KY 40292, United States; Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY 40292, United States; Department of Medicine, University of Louisville, Louisville, KY 40292, United States. Electronic address: dj.conklin@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gestational arsenite exposure augments hepatic tumors of C3H mice by promoting senescence in F1 and F2 offspring via different pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33010264</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30385-9</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Multigenerational Effect</Keywords>
      <Keywords>SASP</Keywords>
      <Keywords>Senescence</Keywords>
      <Keywords>Tumor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kazuyuki Okamura</Name>
        <Affiliation>Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Tsukuba 305-8506, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takehiro Suzuki</Name>
        <Affiliation>Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Tsukuba 305-8506, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Keiko Nohara</Name>
        <Affiliation>Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Tsukuba 305-8506, Japan. Electronic address: keikon@nies.go.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Resveratrol ameliorates lipopolysaccharide-induced anxiety-like behavior by attenuating YAP-mediated neuro-inflammation and promoting hippocampal autophagy in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33010263</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30387-2</DOI>
    <KeywordList>
      <Keywords>Anxiety-like behavior</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Lipopolysaccharide</Keywords>
      <Keywords>Resveratrol</Keywords>
      <Keywords>Yes-associated protein</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qiuyun Tian</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofang Fan</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianshe Ma</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yujiao Han</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dantong Li</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shan Jiang</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fukun Zhang</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Guang</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqiong Shan</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ran Chen</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Wang</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Wang</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinge Yang</Name>
        <Affiliation>Department of Medical Technology, Jiangxi Medical College, Shangrao, Jiangxi 334709, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongyu Wang</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lianggang Hu</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yangping Shentu</Name>
        <Affiliation>Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China. Electronic address: styp@wmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yongsheng Gong</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. Electronic address: fxbwzmc@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Junming Fan</Name>
        <Affiliation>Institute of Hypoxia Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. Electronic address: fjmelite@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33007385</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30381-1</DOI>
    <KeywordList>
      <Keywords>Ac-SDKP</Keywords>
      <Keywords>Epithelial–mesenchymal transition</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Renin–angiotensin system</Keywords>
      <Keywords>Silicosis fibrosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shumin Li</Name>
        <Affiliation>School of Public Health, North China University of Science and Technology, Tangshan 063210, Hebei, China; School of Basic Medical Sciences, North China University of Science and Technology, Tangshan 063210, Hebei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaqian Li</Name>
        <Affiliation>School of Basic Medical Sciences, North China University of Science and Technology, Tangshan 063210, Hebei, China; Hebei Key Laboratory for Organ Fibrosis, North China University of Science and Technology, Tangshan 063210, Hebei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Zhang</Name>
        <Affiliation>School of Basic Medical Sciences, North China University of Science and Technology, Tangshan 063210, Hebei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shifeng Li</Name>
        <Affiliation>School of Public Health, North China University of Science and Technology, Tangshan 063210, Hebei, China; Hebei Key Laboratory for Organ Fibrosis, North China University of Science and Technology, Tangshan 063210, Hebei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Zhang</Name>
        <Affiliation>Hebei Key Laboratory for Organ Fibrosis, North China University of Science and Technology, Tangshan 063210, Hebei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fuyu Jin</Name>
        <Affiliation>School of Basic Medical Sciences, North China University of Science and Technology, Tangshan 063210, Hebei, China; Hebei Key Laboratory for Organ Fibrosis, North China University of Science and Technology, Tangshan 063210, Hebei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongqiu Wei</Name>
        <Affiliation>School of Basic Medical Sciences, North China University of Science and Technology, Tangshan 063210, Hebei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Yang</Name>
        <Affiliation>School of Basic Medical Sciences, North China University of Science and Technology, Tangshan 063210, Hebei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuemin Gao</Name>
        <Affiliation>Hebei Key Laboratory for Organ Fibrosis, North China University of Science and Technology, Tangshan 063210, Hebei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Mao</Name>
        <Affiliation>School of Public Health, North China University of Science and Technology, Tangshan 063210, Hebei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xingchen Ge</Name>
        <Affiliation>Hebei Key Laboratory for Organ Fibrosis, North China University of Science and Technology, Tangshan 063210, Hebei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Xu</Name>
        <Affiliation>School of Public Health, North China University of Science and Technology, Tangshan 063210, Hebei, China; Hebei Key Laboratory for Organ Fibrosis, North China University of Science and Technology, Tangshan 063210, Hebei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Yang</Name>
        <Affiliation>School of Public Health, North China University of Science and Technology, Tangshan 063210, Hebei, China; Hebei Key Laboratory for Organ Fibrosis, North China University of Science and Technology, Tangshan 063210, Hebei, China. Electronic address: fangyang@ncst.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biological effects of inhaled hydraulic fracturing sand dust. VIII. Immunotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33007384</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
      <Grant>U54 GM104942</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30382-3</DOI>
    <KeywordList>
      <Keywords>Fracking</Keywords>
      <Keywords>Fracking sand dust</Keywords>
      <Keywords>Immune phenotyping</Keywords>
      <Keywords>Immunosuppression</Keywords>
      <Keywords>Immunotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stacey E. Anderson</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America. Electronic address: sanderson4@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Hillary Shane</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Carrie Long</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Antonella Marrocco</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Ewa Lukomska</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jenny R. Roberts</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Nikki Marshall</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey S. Fedan</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MST2 silencing induces apoptosis and inhibits tumor growth for estrogen receptor alpha-positive MCF-7 breast cancer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33007383</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30383-5</DOI>
    <KeywordList>
      <Keywords>ERα-positive breast cancer</Keywords>
      <Keywords>Gene silencing</Keywords>
      <Keywords>MST2</Keywords>
      <Keywords>Nanoparticle</Keywords>
      <Keywords>siRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joonwoo Park</Name>
        <Affiliation>Department of Integrative Bioscience and Biotechnology, College of Life Science, Sejong University, Kwangjin-gu, Seoul 05006, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ga Hee Kim</Name>
        <Affiliation>Department of Immunology, School of Medicine, Konkuk University, Chungju 380-701, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeonggeun Lee</Name>
        <Affiliation>Department of Integrative Bioscience and Biotechnology, College of Life Science, Sejong University, Kwangjin-gu, Seoul 05006, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Bui Thi Chau Phuong</Name>
        <Affiliation>Department of Integrative Bioscience and Biotechnology, College of Life Science, Sejong University, Kwangjin-gu, Seoul 05006, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byounguk Kong</Name>
        <Affiliation>Department of Integrative Bioscience and Biotechnology, College of Life Science, Sejong University, Kwangjin-gu, Seoul 05006, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Eun Won</Name>
        <Affiliation>Department of Immunology, School of Medicine, Konkuk University, Chungju 380-701, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gun Woo Won</Name>
        <Affiliation>Department of Biochemistry, College of Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Hee Lee</Name>
        <Affiliation>Department of Biochemistry, College of Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hee Dong Han</Name>
        <Affiliation>Department of Immunology, School of Medicine, Konkuk University, Chungju 380-701, South Korea. Electronic address: hanhd@kku.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>YoungJoo Lee</Name>
        <Affiliation>Department of Integrative Bioscience and Biotechnology, College of Life Science, Sejong University, Kwangjin-gu, Seoul 05006, South Korea. Electronic address: yjlee@sejong.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Interplay and roles of oxidative stress, toll-like receptor 4 and Nrf2 in trichloroethene-mediated autoimmunity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33007382</pubmedLink>
    <GrantList>
      <Grant>R01 ES016302</Grant>
      <Grant>R01 ES026887</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30384-7</DOI>
    <KeywordList>
      <Keywords>4-Hydroxynonenal-protein adducts</Keywords>
      <Keywords>Autoimmunity</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Toll-like receptor 4</Keywords>
      <Keywords>Trichloroethene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gangduo Wang</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Nivedita Banerjee</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>M. Firoze Khan</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, United States of America. Electronic address: mfkhan@utmb.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The ubiquitination and acetylation of histones are associated with male reproductive disorders induced by chronic exposure to arsenite.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32991915</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30379-3</DOI>
    <KeywordList>
      <Keywords>Arsenic Poisoning</Keywords>
      <Keywords>Histone Modification</Keywords>
      <Keywords>Male Reproductive Toxicity</Keywords>
      <Keywords>Spermiogenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lu Wu</Name>
        <Affiliation>Center for Global Health, China International Cooperation Center for Environment and Human Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongyue Wei</Name>
        <Affiliation>Center for Global Health, China International Cooperation Center for Environment and Human Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Han Li</Name>
        <Affiliation>Center for Global Health, China International Cooperation Center for Environment and Human Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenqi Li</Name>
        <Affiliation>Center for Global Health, China International Cooperation Center for Environment and Human Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenxi Gu</Name>
        <Affiliation>Center for Global Health, China International Cooperation Center for Environment and Human Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Sun</Name>
        <Affiliation>Center for Global Health, China International Cooperation Center for Environment and Human Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Haibo Xia</Name>
        <Affiliation>Center for Global Health, China International Cooperation Center for Environment and Human Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingshu Zhang</Name>
        <Affiliation>Center for Global Health, China International Cooperation Center for Environment and Human Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; Jiangsu Safety Assessment and Research Center for Drug, Pesticide, and Veterinary Drug, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Chen</Name>
        <Affiliation>Center for Global Health, China International Cooperation Center for Environment and Human Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China. Electronic address: fengchen@njmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Qizhan Liu</Name>
        <Affiliation>Center for Global Health, China International Cooperation Center for Environment and Human Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China. Electronic address: drqzliu@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effects of ozone exposure and sedentary lifestyle on neuronal microglia and mitochondrial bioenergetics of female Long-Evans rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32991914</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30380-X</DOI>
    <KeywordList>
      <Keywords>Astrocytes</Keywords>
      <Keywords>Bioenergetics</Keywords>
      <Keywords>Exercise</Keywords>
      <Keywords>GFAP</Keywords>
      <Keywords>Iba1</Keywords>
      <Keywords>Microglia</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Oxidative Stress Genes</Keywords>
      <Keywords>Ozone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Matthew Valdez</Name>
        <Affiliation>Neurological and Endocrine Toxicology Branch, Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA; Oak Ridge Institute for Science and Education, U.S. Department of Energy, Oak Ridge, TN 37831, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph M. Valdez</Name>
        <Affiliation>Neurological and Endocrine Toxicology Branch, Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Danielle Freeborn</Name>
        <Affiliation>Neurological and Endocrine Toxicology Branch, Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew F. M. Johnstone</Name>
        <Affiliation>Neurological and Endocrine Toxicology Branch, Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Prasada Rao S. Kodavanti</Name>
        <Affiliation>Neurological and Endocrine Toxicology Branch, Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: kodavanti.prasada@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Forsythoside A inhibits adhesion and migration of monocytes to type II alveolar epithelial cells in lipopolysaccharide-induced acute lung injury through upregulating miR-124.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32987027</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30378-1</DOI>
    <KeywordList>
      <Keywords>Acute lung injury</Keywords>
      <Keywords>CCL2</Keywords>
      <Keywords>Forsythoside A</Keywords>
      <Keywords>Monocytes</Keywords>
      <Keywords>Type II alveolar epithelial cells</Keywords>
      <Keywords>miR-124</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zi Bin Lu</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China. Electronic address: huang624@smu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shan Hong Liu</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Ying Ou</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China. Electronic address: ojy@smu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Hui Cao</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Zhu Shi</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Yi Liu</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Yang Tian</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Ru Zheng</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Ling Zhou</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Shan Liu</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China. Electronic address: liujunshan@smu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Zhong Yu</Name>
        <Affiliation>Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou 510515, China. Electronic address: yulzh@smu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Long-isoform NRF1 protects against arsenic cytotoxicity in mouse bone marrow-derived mesenchymal stem cells by suppressing mitochondrial ROS and facilitating arsenic efflux.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32980394</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30377-X</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>NRF1</Keywords>
      <Keywords>Oxidative Stress</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>mBM-MSCs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bin Lou</Name>
        <Affiliation>Laboratory of Chronic Diseases and Environmental Genetics, School of Public Health, China Medical University, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuxin Hu</Name>
        <Affiliation>Experimental Teaching Center, School of Public Health, China Medical University, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyu Lu</Name>
        <Affiliation>Laboratory of Chronic Diseases and Environmental Genetics, School of Public Health, China Medical University, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinyu Zhang</Name>
        <Affiliation>Laboratory of Chronic Diseases and Environmental Genetics, School of Public Health, China Medical University, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongfang Li</Name>
        <Affiliation>The Key Laboratory of Liaoning Province on Toxic and Biological Effects of Arsenic, School of Public Health, China Medical University, Shenyang, Liaoning 110122, PR China; Research Center of Environment and Non-Communicable Diseases, School of Public Health, China Medical University, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>Experimental Teaching Center, School of Public Health, China Medical University, Shenyang, Liaoning 110122, PR China; The Key Laboratory of Liaoning Province on Toxic and Biological Effects of Arsenic, School of Public Health, China Medical University, Shenyang, Liaoning 110122, PR China; Program of Environmental Toxicology, School of Public Health, China Medical University, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyuan Xu</Name>
        <Affiliation>Laboratory of Chronic Diseases and Environmental Genetics, School of Public Health, China Medical University, Shenyang, Liaoning 110122, PR China; Experimental Teaching Center, School of Public Health, China Medical University, Shenyang, Liaoning 110122, PR China; The Key Laboratory of Liaoning Province on Toxic and Biological Effects of Arsenic, School of Public Health, China Medical University, Shenyang, Liaoning 110122, PR China. Electronic address: yyxu@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Perfluorooctanesulfonic acid (PFOS) administration shifts the hepatic proteome and augments dietary outcomes related to hepatic steatosis in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32979393</pubmedLink>
    <GrantList>
      <Grant>P20 GM103430</Grant>
      <Grant>P42 ES027706</Grant>
      <Grant>R01 ES016042</Grant>
      <Grant>R15 ES025404</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30376-8</DOI>
    <KeywordList>
      <Keywords>Liver</Keywords>
      <Keywords>NAFLD</Keywords>
      <Keywords>PFAS</Keywords>
      <Keywords>PFOS</Keywords>
      <Keywords>Perfluorinated Compounds</Keywords>
      <Keywords>Weight Loss</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Emily Marques</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marisa Pfohl</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Adam Auclair</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rohitash Jamwal</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Benjamin J. Barlock</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ferass M. Sammoura</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Goedken</Name>
        <Affiliation>Rutgers Translational Sciences, Rutgers University, 33 Knightsbridge Road, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fatemeh Akhlaghi</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angela L. Slitt</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA. Electronic address: aslitt@uri.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effects of aliphatic alcohols and related acid metabolites in zebrafish embryos - correlations with rat developmental toxicity and with effects in advanced life stages in fish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32979392</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30375-6</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathways</Keywords>
      <Keywords>Alkoxy alcohols</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Zebrafish embryos</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Leo T. M. van der Ven</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Electronic address: leo.van.der.ven@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Willem G. Schoonen</Name>
        <Affiliation>Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Renate M. Groot</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Fatima den Ouden</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Harm J. Heusinkveld</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Edwin P. Zwart</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Hennie M. Hodemaekers</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Emiel Rorije</Name>
        <Affiliation>Centre for Safety of Substances and Products, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Joop de Knecht</Name>
        <Affiliation>Centre for Safety of Substances and Products, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32976922</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30374-4</DOI>
    <KeywordList>
      <Keywords>AMPK</Keywords>
      <Keywords>ANIT</Keywords>
      <Keywords>Bile Acid</Keywords>
      <Keywords>Cholestatic Liver Injury</Keywords>
      <Keywords>FXR</Keywords>
      <Keywords>Picroside II</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tingting Li</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China; School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, China. Electronic address: lttcpu@cpu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Rongyao Zheng</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China; School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, China; Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lijie Xu</Name>
        <Affiliation>School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, China; Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingxuan Zhou</Name>
        <Affiliation>School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinjie Wang</Name>
        <Affiliation>School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qianqian Guo</Name>
        <Affiliation>Department of Pharmacy, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Ji</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China; School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liwen Li</Name>
        <Affiliation>School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, China. Electronic address: liwenli@cpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Thymol activates TRPM8-mediated Ca</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32971067</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30373-2</DOI>
    <KeywordList>
      <Keywords>Inflammation</Keywords>
      <Keywords>Pruritus</Keywords>
      <Keywords>Psoriasis</Keywords>
      <Keywords>TRPM8</Keywords>
      <Keywords>Thymol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wen Wang</Name>
        <Affiliation>School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Wang</Name>
        <Affiliation>College of Life Sciences, South-Central University for Nationalities, Wuhan 430074, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongqiu Zhao</Name>
        <Affiliation>Washington University School of Medicine, St. Louis, MO 63110, United States; Barnes-Jewish Hospital, St. Louis, MO 63110, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqing Huang</Name>
        <Affiliation>Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Ministry of Education), School of Pharmaceutical Sciences, Wuhan University, Wuhan 430072, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hairong Xiong</Name>
        <Affiliation>College of Life Sciences, South-Central University for Nationalities, Wuhan 430074, China. Electronic address: xionghr@mail.scuec.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhinan Mei</Name>
        <Affiliation>School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China. Electronic address: meizhinan@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>NURA: A curated dataset of nuclear receptor modulators.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32961130</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30370-7</DOI>
    <KeywordList>
      <Keywords>In Silico</Keywords>
      <Keywords>In Vitro</Keywords>
      <Keywords>Medicinal Chemistry</Keywords>
      <Keywords>NURA</Keywords>
      <Keywords>Nuclear Receptors</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cecile Valsecchi</Name>
        <Affiliation>Department of Earth and Environmental Sciences, University of Milano-Bicocca, P.za della Scienza 1, 20126 Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Francesca Grisoni</Name>
        <Affiliation>ETH Zurich, Department of Chemistry and Applied Biosciences, RETHINK, Vladimir-Prelog-Weg 4, 8049 Zurich, Switzerland. Electronic address: francesca.grisoni@pharma.ethz.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Stefano Motta</Name>
        <Affiliation>Department of Earth and Environmental Sciences, University of Milano-Bicocca, P.za della Scienza 1, 20126 Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Bonati</Name>
        <Affiliation>Department of Earth and Environmental Sciences, University of Milano-Bicocca, P.za della Scienza 1, 20126 Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Davide Ballabio</Name>
        <Affiliation>Department of Earth and Environmental Sciences, University of Milano-Bicocca, P.za della Scienza 1, 20126 Milano, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32956689</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30372-0</DOI>
    <KeywordList>
      <Keywords>ERK1/2</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>GLP-1R</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>Vildagliptin</Keywords>
      <Keywords>p38α</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rania Khalil</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmed Shata</Name>
        <Affiliation>Department of Clinical pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt; Department of Clinical Pharmacy, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Eman M. Abd El-Kader</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Hossam Sharaf</Name>
        <Affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Walied S. Abdo</Name>
        <Affiliation>Department of Pathology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Noha A. Amin</Name>
        <Affiliation>Department of Haematology, Theodor Bilharz Research Institute, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Sameh Saber</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt. Electronic address: sameh.mohamed@deltauniv.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Menthol in electronic cigarettes: A contributor to respiratory disease?</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32950532</pubmedLink>
    <GrantList>
      <Grant>R01 DA036493</Grant>
      <Grant>R01 ES029741</Grant>
      <Grant>S10 OD010669</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30364-1</DOI>
    <KeywordList>
      <Keywords>Air-liquid interface exposure</Keywords>
      <Keywords>Electronic cigarettes</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Menthol</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Respiratory cells</Keywords>
      <Keywords>TRPM8</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vijayalekshmi Nair</Name>
        <Affiliation>Department of Molecular, Cell and Systems Biology, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Malcolm Tran</Name>
        <Affiliation>Department of Molecular, Cell and Systems Biology, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel Z. Behar</Name>
        <Affiliation>Department of Molecular, Cell and Systems Biology, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Song Zhai</Name>
        <Affiliation>Department of Statistics, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xinping Cui</Name>
        <Affiliation>Department of Statistics, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rattapol Phandthong</Name>
        <Affiliation>Department of Molecular, Cell and Systems Biology, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuhuan Wang</Name>
        <Affiliation>Department of Molecular, Cell and Systems Biology, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Songqin Pan</Name>
        <Affiliation>Proteomics Facility IIGB, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wentai Luo</Name>
        <Affiliation>Department of Civil and Environmental Engineering, Portland State University, Portland, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James F. Pankow</Name>
        <Affiliation>Department of Civil and Environmental Engineering, Portland State University, Portland, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David C. Volz</Name>
        <Affiliation>Department of Environmental Sciences, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Prue Talbot</Name>
        <Affiliation>Department of Molecular, Cell and Systems Biology, University of California, Riverside, CA 92521, USA. Electronic address: talbot@ucr.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Selection and identification of the panel of reference genes for quantitative real-time PCR normalization in rat testis at different development periods.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32949581</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30369-0</DOI>
    <KeywordList>
      <Keywords>Different developmental periods</Keywords>
      <Keywords>Panel of reference genes</Keywords>
      <Keywords>Prenatal dexamethasone exposure</Keywords>
      <Keywords>Testis</Keywords>
      <Keywords>qRT-PCR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yi Liu</Name>
        <Affiliation>Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Liu</Name>
        <Affiliation>Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Zhang</Name>
        <Affiliation>Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guanghui Chen</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China; Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest No conflicts of interest are declared by the authors.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dosing algorithm for Tacrolimus in Tunisian Kidney transplant patients: Effect of CYP 3A4*1B and CYP3A4*22 polymorphisms.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32949580</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30371-9</DOI>
    <KeywordList>
      <Keywords>CYP3A polymorphisms</Keywords>
      <Keywords>Dosing algorithm</Keywords>
      <Keywords>Tacrolimus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nadia Ben-Fredj</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Ibtissem Hannachi</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia; Faculty of Sciences of Bizerte, Carthage University, Tunisia. Electronic address: hannachi_ibtissem@yahoo.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Zohra Chadli</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Haifa Ben-Romdhane</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Naceur A Boughattas</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Najah Ben-Fadhel</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Karim Aouam</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>ATP and ADP enhance DNA damage repair in γ-irradiated BEAS-2B human bronchial epithelial cells through activation of P2X7 and P2Y12 receptors.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32941855</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30366-5</DOI>
    <KeywordList>
      <Keywords>DNA Damage</Keywords>
      <Keywords>Lung Cell</Keywords>
      <Keywords>Nucleotide</Keywords>
      <Keywords>P2 Receptor</Keywords>
      <Keywords>Radiation</Keywords>
      <Keywords>Radioprotectants</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kazuki Kitabatake</Name>
        <Affiliation>Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-0022, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshiyuki Kaji</Name>
        <Affiliation>Department of Environmental Health, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-0022, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mitsutoshi Tsukimoto</Name>
        <Affiliation>Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-0022, Japan. Electronic address: tsukim@rs.noda.tus.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Asenapine and iloperidone decrease the expression of major cytochrome P450 enzymes CYP1A2 and CYP3A4 in human hepatocytes. A significance for drug-drug interactions during combined therapy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32941854</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30365-3</DOI>
    <KeywordList>
      <Keywords>Asenapine</Keywords>
      <Keywords>Cytochrome P450 expression inhibition</Keywords>
      <Keywords>Drug-drug interactions</Keywords>
      <Keywords>Human hepatocytes</Keywords>
      <Keywords>Iloperidone</Keywords>
      <Keywords>Lurasidone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Przemysław J. Danek</Name>
        <Affiliation>Department of Pharmacokinetics and Drug Metabolism, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Jacek Wójcikowski</Name>
        <Affiliation>Department of Pharmacokinetics and Drug Metabolism, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Władysława A. Daniel</Name>
        <Affiliation>Department of Pharmacokinetics and Drug Metabolism, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland. Electronic address: nfdaniel@cyf-kr.edu.pl.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The Authors declare that they have no conflicts of interest to disclose.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fostered Nrf2 expression antagonizes iron overload and glutathione depletion to promote resistance of neuron-like cells to ferroptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32937103</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30367-7</DOI>
    <KeywordList>
      <Keywords>Ferroptosis</Keywords>
      <Keywords>Glutathione Synthesis</Keywords>
      <Keywords>Iron Metabolism</Keywords>
      <Keywords>Neurological Diseases</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zixuan Liu</Name>
        <Affiliation>Key Laboratory of Luminescence Analysis and Molecular Sensing, Southwest University, Ministry of Education, College of Pharmaceutical Sciences, Chongqing 400715, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuying Lv</Name>
        <Affiliation>Key Laboratory of Luminescence Analysis and Molecular Sensing, Southwest University, Ministry of Education, College of Pharmaceutical Sciences, Chongqing 400715, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Erqun Song</Name>
        <Affiliation>Key Laboratory of Luminescence Analysis and Molecular Sensing, Southwest University, Ministry of Education, College of Pharmaceutical Sciences, Chongqing 400715, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Song</Name>
        <Affiliation>Key Laboratory of Luminescence Analysis and Molecular Sensing, Southwest University, Ministry of Education, College of Pharmaceutical Sciences, Chongqing 400715, People's Republic of China. Electronic address: songyangwenrong@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biological effects of inhaled hydraulic fracturing sand dust. VI. Cardiovascular effects.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32931794</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
      <Grant>U54 GM104942</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30368-9</DOI>
    <KeywordList>
      <Keywords>Blood pressure</Keywords>
      <Keywords>Heart rate variability</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Renal injury</Keywords>
      <Keywords>Vasoconstriction</Keywords>
      <Keywords>Vasodilation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kristine Krajnak</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America. Electronic address: ksk1@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Kan</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Kristen A. Russ</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Walter McKinney</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Stacey Waugh</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Zheng</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Michael L. Kashon</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Claud Johnson</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jared Cumpston</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey S. Fedan</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no conflicts of interest in relation to this publication.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fatty acid nitroalkenes inhibit the inflammatory response to bleomycin-mediated lung injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32931793</pubmedLink>
    <GrantList>
      <Grant>R01 HL086621</Grant>
      <Grant>R01 HL132550</Grant>
      <Grant>R01 HL064937</Grant>
      <Grant>P01 HL103455</Grant>
      <Grant>T32 ES007148</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30362-8</DOI>
    <KeywordList>
      <Keywords>Acute Lung Injury</Keywords>
      <Keywords>Bleomycin</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Macrophage</Keywords>
      <Keywords>Nitro-Oleic Acid</Keywords>
      <Keywords>Nitroalkene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melissa L. Wilkinson</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA; Environmental and Occupational Health Sciences Institute, Rutgers, The State University of New Jersey, 170 Frelinghuysen Road, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elena Abramova</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA; Environmental and Occupational Health Sciences Institute, Rutgers, The State University of New Jersey, 170 Frelinghuysen Road, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Changjiang Guo</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA; Environmental and Occupational Health Sciences Institute, Rutgers, The State University of New Jersey, 170 Frelinghuysen Road, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James G. Gow</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA; Dartmouth College, Hanover, NH 03755, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexa Murray</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA; Environmental and Occupational Health Sciences Institute, Rutgers, The State University of New Jersey, 170 Frelinghuysen Road, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Adolf Koudelka</Name>
        <Affiliation>Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, 3550 Terrace St, Pittsburgh, PA 15213, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Veronika Cechova</Name>
        <Affiliation>Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, 3550 Terrace St, Pittsburgh, PA 15213, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce A. Freeman</Name>
        <Affiliation>Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, 3550 Terrace St, Pittsburgh, PA 15213, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Gow</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA; Environmental and Occupational Health Sciences Institute, Rutgers, The State University of New Jersey, 170 Frelinghuysen Road, Piscataway, NJ 08854, USA. Electronic address: gow@pharmacy.rutgers.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32920000</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30363-X</DOI>
    <KeywordList>
      <Keywords>Anti-COVID-19 Therapy</Keywords>
      <Keywords>Azithromycin</Keywords>
      <Keywords>Chloroquine</Keywords>
      <Keywords>Lopinavir</Keywords>
      <Keywords>Ritonavir</Keywords>
      <Keywords>in silico Approach</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katarina Baralić</Name>
        <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Serbia. Electronic address: katarinab@pharmacy.bg.ac.rs.</Affiliation>
      </Author>
      <Author>
        <Name>Dragica Jorgovanović</Name>
        <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Katarina Živančević</Name>
        <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Evica Antonijević Miljaković</Name>
        <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Serbia. Electronic address: evica.antonijevic@pharmacy.bg.ac.rs.</Affiliation>
      </Author>
      <Author>
        <Name>Biljana Antonijević</Name>
        <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Serbia. Electronic address: biljana.antonijevic@pharmacy.bg.ac.rs.</Affiliation>
      </Author>
      <Author>
        <Name>Aleksandra Buha Djordjevic</Name>
        <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Serbia. Electronic address: aleksandra.buha@pharmacy.bg.ac.rs.</Affiliation>
      </Author>
      <Author>
        <Name>Marijana Ćurčić</Name>
        <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Serbia. Electronic address: marijana.curcic@pharmacy.bg.ac.rs.</Affiliation>
      </Author>
      <Author>
        <Name>Danijela Đukić-Ćosić</Name>
        <Affiliation>Department of Toxicology "Akademik Danilo Soldatović", Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Serbia. Electronic address: danijela.djukic.cosic@pharmacy.bg.ac.rs.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic electronic cigarette use elicits molecular changes related to pulmonary pathogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32890605</pubmedLink>
    <GrantList>
      <Grant>P20 GM103434</Grant>
      <Grant>R15 ES026789</Grant>
      <Grant>U54 GM104942</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30350-1</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Oxidative Stress</Keywords>
      <Keywords>Smoking</Keywords>
      <Keywords>Vaping</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kent Marshall</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, West Virginia University School of Public Health, Morgantown, WV 26506, United States of America; West Virginia Clinical and Translational Science Institute, Morgantown, WV 26506, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongwei Liu</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, West Virginia University School of Public Health, Morgantown, WV 26506, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>I. Mark Olfert</Name>
        <Affiliation>West Virginia Clinical and Translational Science Institute, Morgantown, WV 26506, United States of America; Center for Inhalation Toxicology, Morgantown, WV 26506, United States of America; West Virginia University School of Medicine, Division of Exercise Physiology, Morgantown, WV 26506, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Weimin Gao</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, West Virginia University School of Public Health, Morgantown, WV 26506, United States of America; West Virginia Clinical and Translational Science Institute, Morgantown, WV 26506, United States of America; Center for Inhalation Toxicology, Morgantown, WV 26506, United States of America. Electronic address: weimin.gao@hsc.wvu.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic induced epigenetic changes and relevance to treatment of acute promyelocytic leukemia and beyond.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32882258</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30338-0</DOI>
    <KeywordList>
      <Keywords>Acute promyelocytic leukemia</Keywords>
      <Keywords>Arsenic trioxide</Keywords>
      <Keywords>DNA methylation</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Histone modification</Keywords>
      <Keywords>Non-coding RNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yasen Maimaitiyiming</Name>
        <Affiliation>Department of Hematology of First Affiliated Hospital, Department of Public Health, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Qian Wang</Name>
        <Affiliation>Department of Hematology of First Affiliated Hospital, Department of Public Health, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Hung Hsu</Name>
        <Affiliation>Department of Public Health, and Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Electronic address: ch_hsu@zju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Naranmandura</Name>
        <Affiliation>Department of Hematology of First Affiliated Hospital, Department of Public Health, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: narenman@zju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there is no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Heart slice culture system reliably demonstrates clinical drug-related cardiotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32877659</pubmedLink>
    <GrantList>
      <Grant>R01 HL147844</Grant>
      <Grant>R44 HL139248</Grant>
      <Grant>P30 GM127607</Grant>
      <Grant>P01 HL078825</Grant>
      <Grant>R01 HL130174</Grant>
      <Grant>UM1 HL113530</Grant>
      <Grant>R01 HL126802</Grant>
      <Grant>R01 HL147921</Grant>
      <Grant>R01 ES028268</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30339-2</DOI>
    <AuthorList>
      <Author>
        <Name>Jessica M. Miller</Name>
        <Affiliation>Institute of Molecular Cardiology, Department of Medicine, University of Louisville, KY, USA; Department of Bioengineering, University of Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Moustafa H. Meki</Name>
        <Affiliation>Institute of Molecular Cardiology, Department of Medicine, University of Louisville, KY, USA; Department of Bioengineering, University of Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Qinghui Ou</Name>
        <Affiliation>Institute of Molecular Cardiology, Department of Medicine, University of Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sharon A. George</Name>
        <Affiliation>Department of Biomedical Engineering, The George Washington University, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Gams</Name>
        <Affiliation>Department of Biomedical Engineering, The George Washington University, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Riham R. E. Abouleisa</Name>
        <Affiliation>Institute of Molecular Cardiology, Department of Medicine, University of Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xian Liang Tang</Name>
        <Affiliation>Institute of Molecular Cardiology, Department of Medicine, University of Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brooke M. Ahern</Name>
        <Affiliation>Department of Physiology, University of Kentucky, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Guruprasad A. Giridharan</Name>
        <Affiliation>Department of Bioengineering, University of Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ayman El-Baz</Name>
        <Affiliation>Department of Bioengineering, University of Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bradford G. Hill</Name>
        <Affiliation>Envirome Institute, Diabetes and Obesity Center, Department of Medicine, University of Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Satin</Name>
        <Affiliation>Department of Physiology, University of Kentucky, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel J. Conklin</Name>
        <Affiliation>Envirome Institute, Diabetes and Obesity Center, Department of Medicine, University of Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Javid Moslehi</Name>
        <Affiliation>Division of Cardiology, Cardio-Oncology Program, Vanderbilt University Medical Center, 2220 Pierce Avenue, Nashville, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Roberto Bolli</Name>
        <Affiliation>Institute of Molecular Cardiology, Department of Medicine, University of Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandre J. S. Ribeiro</Name>
        <Affiliation>U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Science, Office of Clinical Pharmacology, Division of Applied Regulatory Science, Silver Spring, MD, USA. Electronic address: Alexandre.Ribeiro@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Igor R. Efimov</Name>
        <Affiliation>Department of Biomedical Engineering, The George Washington University, Washington, DC, USA. Electronic address: efimov@gwu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Tamer M. A. Mohamed</Name>
        <Affiliation>Institute of Molecular Cardiology, Department of Medicine, University of Louisville, KY, USA; Department of Bioengineering, University of Louisville, KY, USA; Envirome Institute, Diabetes and Obesity Center, Department of Medicine, University of Louisville, KY, USA; Department of Pharmacology and Toxicology, University of Louisville, KY, USA; Institute of Cardiovascular Sciences, University of Manchester, UK; Faculty of Pharmacy, Zagazig University, Egypt. Electronic address: tamer.mohamed@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest Tamer M. A. Mohamed, holds equities in Tenaya Therapeutics. Guruprasad A. Giridharan, is consultant for NuPulseCV. The other authors report no conflicts.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32871117</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30342-2</DOI>
    <AuthorList>
      <Author>
        <Name>Amy G. Aslamkhan</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA; 770 Sumneytown Pike, WP45-313; West Point, PA 19486, USA. Electronic address: amy_aslamkhan@merck.com.</Affiliation>
      </Author>
      <Author>
        <Name>Qiuwei Xu</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amy Loughlin</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Heather Vu</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Pacchione</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bhavana Bhatt</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ivy Garfinkel</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tara Grady Styring</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa LaFranco-Scheuch</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kara Pearson</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Spencer Reynolds</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nianyu Li</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Heather Zhou</Name>
        <Affiliation>Genetics and Pharmacogenomics, Merck &amp; Co, Inc., Kenilworth, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Richard Miller</Name>
        <Affiliation>Quantitative Biosciences, Merck &amp; Co, Inc., Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nicolas Solban</Name>
        <Affiliation>Quantitative Biosciences, Merck &amp; Co, Inc., Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Bass</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Warren E. Glaab</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources, Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no competing financial interests or personal relationships that could influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32866524</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30340-9</DOI>
    <KeywordList>
      <Keywords>Adipokine</Keywords>
      <Keywords>Antipsychotic</Keywords>
      <Keywords>Lipid Profile</Keywords>
      <Keywords>Methylazoxymethanol</Keywords>
      <Keywords>Rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katerina Horska</Name>
        <Affiliation>Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho trida 1946/1, 612 00 Brno, Czech Republic; Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, Masaryk University, Palackeho trida 1946/1, 612 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Hana Kotolova</Name>
        <Affiliation>Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho trida 1946/1, 612 00 Brno, Czech Republic; Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, Masaryk University, Palackeho trida 1946/1, 612 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Michal Karpisek</Name>
        <Affiliation>Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho trida 1946/1, 612 00 Brno, Czech Republic; Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, Masaryk University, Palackeho trida 1946/1, 612 00 Brno, Czech Republic; R&amp;D Department, Biovendor - Laboratorni Medicina, Karasek 1, 621 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Zuzana Babinska</Name>
        <Affiliation>Department of Pharmacology, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Tomas Hammer</Name>
        <Affiliation>Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho trida 1946/1, 612 00 Brno, Czech Republic; Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, Masaryk University, Palackeho trida 1946/1, 612 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Jiri Prochazka</Name>
        <Affiliation>Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho trida 1946/1, 612 00 Brno, Czech Republic; Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, Masaryk University, Palackeho trida 1946/1, 612 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Tibor Stark</Name>
        <Affiliation>Department of Pharmacology, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic; Department of Stress Neurobiology and Neurogenetics, Neuronal Plasticity Group, Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Vincenzo Micale</Name>
        <Affiliation>Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Via Santa Sofia 97, I-95123 Catania, Italy; National Institute of Mental Health, Topolova 748, 250 67 Klecany, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Jana Ruda-Kucerova</Name>
        <Affiliation>Department of Pharmacology, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. Electronic address: jkucer@med.muni.cz.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All authors declare no conflict of interest. Michal Karpisek works in the company Biovendor-Laboratorni medicina, which provided ELISA kits for the laboratory measurements.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel monovalent FGFR1 antagonist: Preclinical safety profiles in rodents and non-human primates.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32866523</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30341-0</DOI>
    <KeywordList>
      <Keywords>ADCC</Keywords>
      <Keywords>Anti-tumor</Keywords>
      <Keywords>FGFR1 blocking</Keywords>
      <Keywords>Non-human primates</Keywords>
      <Keywords>Preclinical safety profile in vivo</Keywords>
      <Keywords>Rodents</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ping Yu</Name>
        <Affiliation>Global R&amp;D, Merck KGaA, RBM S.p.A, Via Ribes, 1, Colleretto Giacosa, 10010 (TO), Italy. Electronic address: ping.yu@merckgroup.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anja Knippel</Name>
        <Affiliation>Global R&amp;D, Merck KGaA, Frankfurter Straße 250, 64293 Darmstadt, Germany. Electronic address: anja.knippel@merckgroup.com.</Affiliation>
      </Author>
      <Author>
        <Name>Manuela Onidi</Name>
        <Affiliation>Global R&amp;D, Merck KGaA, RBM S.p.A, Via Ribes, 1, Colleretto Giacosa, 10010 (TO), Italy. Electronic address: manuela.onidi@merckgroup.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Paoletti</Name>
        <Affiliation>Global R&amp;D, Merck KGaA, RBM S.p.A, Via Ribes, 1, Colleretto Giacosa, 10010 (TO), Italy. Electronic address: andrea.paoletti@merckgroup.com.</Affiliation>
      </Author>
      <Author>
        <Name>Enrico Vigna</Name>
        <Affiliation>Global R&amp;D, Merck KGaA, RBM S.p.A, Via Ribes, 1, Colleretto Giacosa, 10010 (TO), Italy. Electronic address: enrico.vigna@merckgroup.com.</Affiliation>
      </Author>
      <Author>
        <Name>Juergen Hellmann</Name>
        <Affiliation>Global R&amp;D, Merck KGaA, Frankfurter Straße 250, 64293 Darmstadt, Germany. Electronic address: juergen.hellmann@merckgroup.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christina Esdar</Name>
        <Affiliation>Global R&amp;D, Merck KGaA, Frankfurter Straße 250, 64293 Darmstadt, Germany. Electronic address: christina.esdar@merckgroup.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest Ping Yu, Anja Knippel, Manuela Onidi, Andrea Paoletti, Enrico Vigna, Juergen Hellman and Christina Esdar are employees of Merck KGaA. There are no competing interests to declare.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integrative systems toxicology to predict human biological systems affected by exposure to environmental chemicals.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32860831</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30336-7</DOI>
    <KeywordList>
      <Keywords>Chemical exposome</Keywords>
      <Keywords>Computational model</Keywords>
      <Keywords>Endocrine-disrupting chemical</Keywords>
      <Keywords>Integrative systems biology</Keywords>
      <Keywords>Network science</Keywords>
      <Keywords>New approaches methodologies (NAMs)</Keywords>
      <Keywords>OBERON</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Olivier Taboureau</Name>
        <Affiliation>Université de Paris, BFA, CNRS UMR 8251, ERL Inserm U1133, F-75013 Paris, France. Electronic address: olivier.taboureau@u-paris.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Walid El M'Selmi</Name>
        <Affiliation>Université de Paris, BFA, CNRS UMR 8251, ERL Inserm U1133, F-75013 Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Karine Audouze</Name>
        <Affiliation>Université de Paris, T3S, Inserm UMR-S 1124, F-75006 Paris, France. Electronic address: karine.audouze@u-paris.fr.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative toxicokinetics of bisphenol S in rats and mice following gavage administration.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32853628</pubmedLink>
    <GrantList>
      <Grant>HHSN273201400022C</Grant>
      <Grant>ZIA ES103316</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30333-1</DOI>
    <KeywordList>
      <Keywords>Absorption</Keywords>
      <Keywords>Bisphenol S</Keywords>
      <Keywords>Distribution</Keywords>
      <Keywords>Elimination</Keywords>
      <Keywords>Oral Bioavailability</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suramya Waidyanatha</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA. Electronic address: waidyanathas@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Sherry R. Black</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melanie Silinski</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vicki Sutherland</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brenda L. Fletcher</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Reshan A. Fernando</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy R. Fennell</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors report no declarations of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of notch enhances the anti-atherosclerotic effects of LXR agonists while reducing fatty liver development in ApoE-deficient mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32853627</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30337-9</DOI>
    <KeywordList>
      <Keywords>ABCA1</Keywords>
      <Keywords>Anti-Inflammatory</Keywords>
      <Keywords>Atherosclerosis</Keywords>
      <Keywords>DAPT (PubChem: 5311272)</Keywords>
      <Keywords>Fatty Liver</Keywords>
      <Keywords>LXR</Keywords>
      <Keywords>Notch</Keywords>
      <Keywords>T0901317 (PubChem CID: 447912)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yanfei Hao</Name>
        <Affiliation>Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, School of Pharmacy, Yantai University, Yantai 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinlin Wang</Name>
        <Affiliation>Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, School of Pharmacy, Yantai University, Yantai 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fenglan Zhang</Name>
        <Affiliation>Yantai Yuhuangding Hospital, The Affiliated Hospital of Qingdao University, Yantai 264000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meiling Wang</Name>
        <Affiliation>Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, School of Pharmacy, Yantai University, Yantai 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanfang Wang</Name>
        <Affiliation>Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, School of Pharmacy, Yantai University, Yantai 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Wang</Name>
        <Affiliation>Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, School of Pharmacy, Yantai University, Yantai 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Du</Name>
        <Affiliation>Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, School of Pharmacy, Yantai University, Yantai 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tian Wang</Name>
        <Affiliation>Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, School of Pharmacy, Yantai University, Yantai 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fenghua Fu</Name>
        <Affiliation>Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, School of Pharmacy, Yantai University, Yantai 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuye Gao</Name>
        <Affiliation>Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100089, China. Electronic address: zhuyegao@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Leiming Zhang</Name>
        <Affiliation>Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, School of Pharmacy, Yantai University, Yantai 264005, China. Electronic address: zhangleiming2009@126.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Triclosan disrupts immune cell function by depressing Ca</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32835763</pubmedLink>
    <GrantList>
      <Grant>P20 GM103423</Grant>
      <Grant>R15 ES024593</Grant>
      <Grant>R15 GM116002</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30331-8</DOI>
    <KeywordList>
      <Keywords>Acidification</Keywords>
      <Keywords>Genetically encoded voltage indicator</Keywords>
      <Keywords>Mast cell</Keywords>
      <Keywords>Store-operated calcium entry</Keywords>
      <Keywords>Super-resolution microscopy</Keywords>
      <Keywords>T cell</Keywords>
      <Keywords>Triclosan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suraj Sangroula</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Y. Baez Vasquez</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Prakash Raut</Name>
        <Affiliation>Department of Physics and Astronomy, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bright Obeng</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Juyoung K. Shim</Name>
        <Affiliation>Department of Biology, University of Maine at Augusta, Augusta, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Grace D. Bagley</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bailey E. West</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John E. Burnell</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marissa S. Kinney</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christian M. Potts</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sasha R. Weller</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua B. Kelley</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel T. Hess</Name>
        <Affiliation>Department of Physics and Astronomy, University of Maine, Orono, ME, USA; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julie A. Gosse</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME, USA. Electronic address: Julie.gosse@maine.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Paris saponin II-induced paraptosis-associated cell death increased the sensitivity of cisplatin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32835762</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30332-X</DOI>
    <KeywordList>
      <Keywords>Cytoplasmic Vacuolation</Keywords>
      <Keywords>Endoplasmic Reticulum Stress</Keywords>
      <Keywords>Mitochondrial Swelling</Keywords>
      <Keywords>Paraptosis</Keywords>
      <Keywords>Paris Saponin II</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shuli Man</Name>
        <Affiliation>State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Microbiology, Ministry of Education, Tianjin Key Laboratory of Industry Microbiology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science &amp; Technology, Tianjin 300457, China. Electronic address: msl@tust.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Panpan Lv</Name>
        <Affiliation>State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Microbiology, Ministry of Education, Tianjin Key Laboratory of Industry Microbiology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science &amp; Technology, Tianjin 300457, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingxia Cui</Name>
        <Affiliation>State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Microbiology, Ministry of Education, Tianjin Key Laboratory of Industry Microbiology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science &amp; Technology, Tianjin 300457, China.</Affiliation>
      </Author>
      <Author>
        <Name>Furui Liu</Name>
        <Affiliation>State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Microbiology, Ministry of Education, Tianjin Key Laboratory of Industry Microbiology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science &amp; Technology, Tianjin 300457, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Peng</Name>
        <Affiliation>State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Microbiology, Ministry of Education, Tianjin Key Laboratory of Industry Microbiology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science &amp; Technology, Tianjin 300457, China.</Affiliation>
      </Author>
      <Author>
        <Name>Long Ma</Name>
        <Affiliation>State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Microbiology, Ministry of Education, Tianjin Key Laboratory of Industry Microbiology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, National and Local United Engineering Lab of Metabolic Control Fermentation Technology, China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science &amp; Technology, Tianjin 300457, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changxiao Liu</Name>
        <Affiliation>The State Key Laboratories of Pharmacodynamics and Pharmacokinetics, Tianjin 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenyuan Gao</Name>
        <Affiliation>Tianjin Key Laboratory for Modern Drug Delivery and High Efficiency, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China. Electronic address: biochemgao@163.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oxymatrine ameliorates imiquimod-induced psoriasis pruritus and inflammation through inhibiting heat shock protein 90 and heat shock protein 60 expression in keratinocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32835761</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30335-5</DOI>
    <KeywordList>
      <Keywords>Chemical compounds enlisted in this article: oxymatrine (PubChem CID: 114850).</Keywords>
      <Keywords>Heat shock protein 60</Keywords>
      <Keywords>Heat shock protein 90</Keywords>
      <Keywords>Oxymatrine</Keywords>
      <Keywords>Psoriasis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xuechuan Xiang</Name>
        <Affiliation>School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chuyue Tu</Name>
        <Affiliation>School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiaoyun Li</Name>
        <Affiliation>School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Wang</Name>
        <Affiliation>School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqing Huang</Name>
        <Affiliation>Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Ministry of Education), and School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongqiu Zhao</Name>
        <Affiliation>Washington University School of Medicine in St. Louis, St. Louis, MO, United States.; Barnes-Jewish Hospital, St. Louis, MO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Xiong</Name>
        <Affiliation>School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China. Electronic address: xionghui0311020@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhinan Mei</Name>
        <Affiliation>School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China. Electronic address: meizhinan@163.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>WITHDRAWN: PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor coordination-associated side effects in neuropathic pain model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32828906</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30334-3</DOI>
    <AuthorList>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunyu Su</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhezhe Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Han</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongbo Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwei Tian</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China. Electronic address: tianjingwei@luye.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Science, Yantai University, Yantai 264005, China. Electronic address: gaoyonglin@luye.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological implication of prostaglandin transporter SLCO2A1 inhibition by cigarette smoke in exacerbation of lung inflammation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32828905</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30327-6</DOI>
    <KeywordList>
      <Keywords>Cigarette Smoke</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Prostaglandin</Keywords>
      <Keywords>SLCO2A1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Takeo Nakanishi</Name>
        <Affiliation>Faculty of Pharmacy, Takasaki University of Health and Welfare, 60 Nakaorui-machi, Takasaki, Japan. Electronic address: nakanishi@takasaki-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Shiori Sakiyama</Name>
        <Affiliation>School of Pharmaceutical Sciences, Kakuma-machi, Kanazawa 920-1192, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroki Takashima</Name>
        <Affiliation>School of Pharmaceutical Sciences, Kakuma-machi, Kanazawa 920-1192, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ryokichi Honda</Name>
        <Affiliation>School of Pharmaceutical Sciences, Kakuma-machi, Kanazawa 920-1192, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Melody N. Shumba</Name>
        <Affiliation>Depatiment of Nutrition, Faculty of Health and Welfare, Takasaki University of Health and Welfare, Takasaki, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshinobu Nakamura</Name>
        <Affiliation>Faculty of Pharmacy, Takasaki University of Health and Welfare, 60 Nakaorui-machi, Takasaki, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuo Kasahara</Name>
        <Affiliation>School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-0934, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ikumi Tamai</Name>
        <Affiliation>School of Pharmaceutical Sciences, Kakuma-machi, Kanazawa 920-1192, Japan.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest There is no conflict of interest to report.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32822738</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30329-X</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Indoleamine-2,3-Dioxygenase</Keywords>
      <Keywords>Interferon γ</Keywords>
      <Keywords>Kynurenine</Keywords>
      <Keywords>Salinomycin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Azubuike Peter Ebokaiwe</Name>
        <Affiliation>Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; Department of Chemistry/Biochemistry and Molecular Biology, Alex Ekwueme Federal University Ndufu Alike-, Ikwo, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Emmanuel Mfotie Njoya</Name>
        <Affiliation>Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; Department of Biochemistry, Faculty of Science, University of Yaoundé I, P.O Box 812, Yaoundé, Cameroon.</Affiliation>
      </Author>
      <Author>
        <Name>Yuwen Sheng</Name>
        <Affiliation>Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhonghui Zhang</Name>
        <Affiliation>College of Chemical Engineering, Sichuan University, Chengdu 610064, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sheng Li</Name>
        <Affiliation>Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zongyuan Zhou</Name>
        <Affiliation>Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Qiang</Name>
        <Affiliation>Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Peng</Name>
        <Affiliation>Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmed A. Hussein</Name>
        <Affiliation>Chemistry Department, Cape Peninsula University of Technology, Bellville Campus, Bellville 7537, Western Cape, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Guolin Zhang</Name>
        <Affiliation>Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoxia Lu</Name>
        <Affiliation>Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Li</Name>
        <Affiliation>Department of Laboratory Medicine, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People's Hospital, Chengdu 610072, China. Electronic address: spphll@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Wang</Name>
        <Affiliation>Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China. Electronic address: wangfei@cib.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors have no conflict of interest to declare.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32822737</pubmedLink>
    <GrantList>
      <Grant>P42 ES007381</Grant>
      <Grant>R01 ES027813</Grant>
      <Grant>S10 OD023663</Grant>
      <Grant>T32 ES014562</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30330-6</DOI>
    <KeywordList>
      <Keywords>Cholesterol</Keywords>
      <Keywords>Constitutive androstane receptor</Keywords>
      <Keywords>Perfluorooctanoic acid</Keywords>
      <Keywords>Peroxisome proliferator activated receptor α</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. J. Schlezinger</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston, MA, 02118, USA. Electronic address: jschlezi@bu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>H. Puckett</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston, MA, 02118, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Oliver</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston, MA, 02118, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. Nielsen</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston, MA, 02118, USA.</Affiliation>
      </Author>
      <Author>
        <Name>W. Heiger-Bernays</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston, MA, 02118, USA.</Affiliation>
      </Author>
      <Author>
        <Name>T. F. Webster</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston, MA, 02118, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Commentary - A comprehensive safety understanding of granulocyte-colony stimulating factor biosimilars and Intended Copy Biologics in treating chemotherapy associated febrile neutropenia.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32822736</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30328-8</DOI>
    <KeywordList>
      <Keywords>Biosimilar</Keywords>
      <Keywords>Filgrastim</Keywords>
      <Keywords>Granulocyte Colony-Stimulating Factor (G-CSF)</Keywords>
      <Keywords>Intended Copy Biologic</Keywords>
      <Keywords>Pharmacovigilance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>P. G. Cornes</Name>
        <Affiliation>Comparative Outcomes Group, United Kingdom. Electronic address: paul.cornes@yahoo.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>M. Muenzberg</Name>
        <Affiliation>Comparative Outcomes Group, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cardiopulmonary function and dysregulated cardiopulmonary reflexes following acute oleoresin capsicum exposure in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32805267</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30314-8</DOI>
    <KeywordList>
      <Keywords>Biodistribution</Keywords>
      <Keywords>Cardiopulmonary</Keywords>
      <Keywords>Chemotactic</Keywords>
      <Keywords>Oleoresin Capsicum</Keywords>
      <Keywords>Riot Control</Keywords>
      <Keywords>Ultrasonography</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pompy Patowary</Name>
        <Affiliation>Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur 784 001, Assam, India; Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh 786 004, Assam, India.</Affiliation>
      </Author>
      <Author>
        <Name>Manash Pratim Pathak</Name>
        <Affiliation>Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur 784 001, Assam, India; Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh 786 004, Assam, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sumit Kishor</Name>
        <Affiliation>Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur 784 001, Assam, India.</Affiliation>
      </Author>
      <Author>
        <Name>Probin Kumar Roy</Name>
        <Affiliation>Department of Pharmaceutics, Regional Institute of Paramedical and Nursing Sciences, Aizawl, Mizoram, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sanghita Das</Name>
        <Affiliation>Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur 784 001, Assam, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pronobesh Chattopadhyay</Name>
        <Affiliation>Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur 784 001, Assam, India. Electronic address: chattopadhyay.drl@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kamaruz Zaman</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh 786 004, Assam, India.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dual targeting of EZH2 and androgen receptor as a novel therapy for castration-resistant prostate cancer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32805266</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30326-4</DOI>
    <KeywordList>
      <Keywords>Androgen receptor</Keywords>
      <Keywords>Castration resistant prostate cancer</Keywords>
      <Keywords>Dual targeting</Keywords>
      <Keywords>Enhancer of zeste homolog 2</Keywords>
      <Keywords>Polycomb repressor complex</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eswar Shankar</Name>
        <Affiliation>Department of Urology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA; The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Franco</Name>
        <Affiliation>College of Arts and Sciences, Case Western Reserve University, Cleveland, OH 44106, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Omair Iqbal</Name>
        <Affiliation>College of Arts and Sciences, Case Western Reserve University, Cleveland, OH 44106, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Moreton</Name>
        <Affiliation>Department of Urology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rajnee Kanwal</Name>
        <Affiliation>Department of Urology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA; The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sanjay Gupta</Name>
        <Affiliation>Department of Urology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA; The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA; Department of Urology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, USA; Department of Nutrition, Case Western Reserve University, Cleveland, OH 44106, USA; Division of General Medical Sciences, Case Comprehensive Cancer Center, Cleveland, OH 44106, USA. Electronic address: sanjay.gupta@case.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Histone deacetylase 3-selective inhibitor RGFP966 ameliorates impaired glucose tolerance through β-cell protection.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32800772</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30315-X</DOI>
    <KeywordList>
      <Keywords>Histone deacetylase 3-selective inhibitor</Keywords>
      <Keywords>Impaired glucose tolerance</Keywords>
      <Keywords>Insulin secretion</Keywords>
      <Keywords>Pre-diabetes</Keywords>
      <Keywords>β Cell</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lei Lei</Name>
        <Affiliation>The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guoliang Bai</Name>
        <Affiliation>The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xing Wang</Name>
        <Affiliation>The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuainan Liu</Name>
        <Affiliation>The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Xia</Name>
        <Affiliation>The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Song Wu</Name>
        <Affiliation>The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Huan</Name>
        <Affiliation>The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. Electronic address: huany@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhufang Shen</Name>
        <Affiliation>The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. Electronic address: shenzhf@imm.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there is no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Epigenetic repression of AT2 receptor is involved in β cell dysfunction and glucose intolerance of adult female offspring rats exposed to dexamethasone prenatally.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32791177</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30313-6</DOI>
    <KeywordList>
      <Keywords>Angiotensin Receptor II</Keywords>
      <Keywords>Dexamethasone</Keywords>
      <Keywords>Glucose Intolerance</Keywords>
      <Keywords>Histone Acetylation</Keywords>
      <Keywords>Pancreatic β Cell</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hao Kou</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China; Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan 40071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuxia Gui</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongguo Dai</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Guo</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China. Electronic address: guoy@whu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All authors declare they have no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Implications of miRNAs on TGF-β/TAK1/mTOR pathway in mediating the renoprotective effects of pentoxifylline against cisplatin-induced nephrotoxicity in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32777238</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30310-0</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Pentoxifylline</Keywords>
      <Keywords>TAK1</Keywords>
      <Keywords>miRNA-26b</Keywords>
      <Keywords>miRNA-34a</Keywords>
      <Keywords>miRNA-let-7b</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hekmat M. El Magdoub</Name>
        <Affiliation>Biochemistry Department, Faculty of Pharmacy, Translational Research Unit, Misr International University (MIU), Cairo, Egypt. Electronic address: Hekmat.magdoub@miuegypt.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Mona F. Schaalan</Name>
        <Affiliation>Pharmacy Practice &amp; Clinical Pharmacy Department, Faculty of Pharmacy, Translational Research Unit, Misr International University (MIU), Cairo, Egypt. Electronic address: Mona.schaalan@miuegypt.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Rania M. Rahmo</Name>
        <Affiliation>Pharmacology &amp; Toxicology Department, Faculty of Pharmacy, Translational Research Unit, Misr International University (MIU), Cairo, Egypt. Electronic address: Rania.rahmo@miuegypt.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Doaa B. Farag</Name>
        <Affiliation>Pharmaceutical Chemistry Department, Faculty of Pharmacy, Translational Research Unit, Misr International University (MIU), Cairo, Egypt. Electronic address: doaa.boshra@miuegypt.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Lobna H. Khedr</Name>
        <Affiliation>Pharmacology &amp; Toxicology Department, Faculty of Pharmacy, Translational Research Unit, Misr International University (MIU), Cairo, Egypt. Electronic address: Lobna.hatem@miuegypt.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>IL-33/ST2 signaling modulates Afghanistan particulate matter induced airway hyperresponsiveness in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32777237</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30312-4</DOI>
    <KeywordList>
      <Keywords>Airway hyperresponsiveness</Keywords>
      <Keywords>Asthma</Keywords>
      <Keywords>IL-33</Keywords>
      <Keywords>Particulate matter</Keywords>
      <Keywords>ST2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Reena Berman</Name>
        <Affiliation>Department of Medicine, Basic Science Section, National Jewish Health, Denver, CO, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Katrina W. Kopf</Name>
        <Affiliation>Biological Resource Center, National Jewish Health, Denver, CO, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Elysia Min</Name>
        <Affiliation>Department of Medicine, Medicine Office of Research, National Jewish Health, Denver, CO, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Huang</Name>
        <Affiliation>Department of Medicine, Medicine Office of Research, National Jewish Health, Denver, CO, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory P. Downey</Name>
        <Affiliation>Department of Medicine, Division of Pulmonary, Critical Care &amp; Sleep Medicine, National Jewish Health, Denver, CO, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Rafeul Alam</Name>
        <Affiliation>Department of Medicine, Division of Allergy &amp; Clinical Immunology, National Jewish Health, Denver, CO, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Wei Chu</Name>
        <Affiliation>Department of Medicine, Basic Science Section, National Jewish Health, Denver, CO, United States of America. Electronic address: ChuH@njhealth.org.</Affiliation>
      </Author>
      <Author>
        <Name>Brian J. Day</Name>
        <Affiliation>Department of Medicine, Medicine Office of Research, National Jewish Health, Denver, CO, United States of America. Electronic address: DayB@njhealth.org.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hydroxyl functionalized multi-walled carbon nanotubes modulate immune responses without increasing 2009 pandemic influenza A/H1N1 virus titers in infected mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32771490</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30293-3</DOI>
    <KeywordList>
      <Keywords>C57BL/6 mouse</Keywords>
      <Keywords>Influenza A H1N1 virus</Keywords>
      <Keywords>Innate immune responses</Keywords>
      <Keywords>Multi-walled carbon nanotubes</Keywords>
      <Keywords>Viral titers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hao Chen</Name>
        <Affiliation>Department of Environmental and Global Health, Center for Environmental and Human Toxicology, Emerging Pathogens Institute, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sara T. Humes</Name>
        <Affiliation>Department of Environmental and Global Health, Center for Environmental and Human Toxicology, Emerging Pathogens Institute, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melanie Rose</Name>
        <Affiliation>Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah E. Robinson</Name>
        <Affiliation>Department of Environmental and Global Health, Center for Environmental and Human Toxicology, Emerging Pathogens Institute, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julia C. Loeb</Name>
        <Affiliation>Department of Environmental and Global Health, Center for Environmental and Human Toxicology, Emerging Pathogens Institute, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Indu V. Sabaraya</Name>
        <Affiliation>Department of Civil, Architectural, and Environmental Engineering, University of Texas Austin, Austin, TX, 78712, USA.</Affiliation>
      </Author>
      <Author>
        <Name>L. Cody Smith</Name>
        <Affiliation>Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Navid B. Saleh</Name>
        <Affiliation>Department of Civil, Architectural, and Environmental Engineering, University of Texas Austin, Austin, TX, 78712, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William L. Castleman</Name>
        <Affiliation>Department of Infectious Diseases and Pathology, College of Veterinary Medicine, Gainesville, FL 32611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John A. Lednicky</Name>
        <Affiliation>Department of Environmental and Global Health, Center for Environmental and Human Toxicology, Emerging Pathogens Institute, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tara Sabo-Attwood</Name>
        <Affiliation>Department of Environmental and Global Health, Center for Environmental and Human Toxicology, Emerging Pathogens Institute, University of Florida, Gainesville, FL, 32611, USA. Electronic address: sabo@phhp.ufl.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Enhanced in vivo targeting of estrogen receptor alpha signaling in murine mammary adenocarcinoma by nilotinib/rosuvastatin novel combination.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32771489</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30311-2</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Estrogen receptor alpha</Keywords>
      <Keywords>Nilotinib</Keywords>
      <Keywords>Rosuvastatin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ahmed E. Goda</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt. Electronic address: AHMEDELSAYEDGODA@pharm.tanta.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Alaa E. Elsisi</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Samia S. Sokkar</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Noha M. Abdelrazik</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Formation of lamellar body-like structure may be an initiator of didecyldimethylammonium chloride-induced toxic response.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32763356</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30308-2</DOI>
    <KeywordList>
      <Keywords>Didecyldimethylammonium chloride</Keywords>
      <Keywords>Disinfectants</Keywords>
      <Keywords>Idiopathic pulmonary fibrosis</Keywords>
      <Keywords>Lamella body</Keywords>
      <Keywords>Matrix metalloproteinase-1</Keywords>
      <Keywords>Quaternary ammonium compounds</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eun Jung Park</Name>
        <Affiliation>East-West Medical Science Research Institute, Kyung Hee University, Seoul 02447, Republic of Korea. Electronic address: pejtoxic@khu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Eunsol Seong</Name>
        <Affiliation>East-West Medical Science Research Institute, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Min Sung Kang</Name>
        <Affiliation>In vivo Hazard Evaluation &amp; Research Division, General Toxicology &amp; Research Group, Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeongeup-si, Jeollabuk-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gwang Hee Lee</Name>
        <Affiliation>School of Civil, Environmental, Architectural Engineering, Korea University, Seoul 136-713, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Wan Kim</Name>
        <Affiliation>School of Civil, Environmental, Architectural Engineering, Korea University, Seoul 136-713, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Seok Han</Name>
        <Affiliation>Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Ji Lim</Name>
        <Affiliation>East-West Medical Science Research Institute, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyeun Lee</Name>
        <Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, School of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyoung Yun Han</Name>
        <Affiliation>Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hesperetin protects against palmitate-induced cellular toxicity via induction of GRP78 in hepatocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32763355</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30309-4</DOI>
    <KeywordList>
      <Keywords>GRP78</Keywords>
      <Keywords>Hepatocyte</Keywords>
      <Keywords>Hesperetin</Keywords>
      <Keywords>Lipotoxicity</Keywords>
      <Keywords>Non-alcoholic fatty liver disease</Keywords>
      <Keywords>Unfolded protein response</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yana Geng</Name>
        <Affiliation>Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: y.geng@umcg.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Zongmei Wu</Name>
        <Affiliation>Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: z.wu@umcg.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Manon Buist-Homan</Name>
        <Affiliation>Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: m.buist-homan@umcg.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Blokzijl</Name>
        <Affiliation>Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: h.blokzijl@umcg.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Han Moshage</Name>
        <Affiliation>Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: a.j.moshage@umcg.nl.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors acknowledge no conflicts of interest with this study.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Intermittent fasting ameliorates PM</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32758488</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30307-0</DOI>
    <KeywordList>
      <Keywords>Diabetes</Keywords>
      <Keywords>Intermittent fasting</Keywords>
      <Keywords>PM(2.5)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Wei</Name>
        <Affiliation>Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Department of Bile Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Tang</Name>
        <Affiliation>Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Department of Bile Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Minjie Chen</Name>
        <Affiliation>Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sufang Chen</Name>
        <Affiliation>Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Department of Endocrinology, the People's Hospital of Zhengzhou University (Henan Provincial People's Hospital), Zhengzhou, Henan 450003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huifen Zhou</Name>
        <Affiliation>Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Department of Pathology, Hubei University of Science and Technology, Xianning, Hubei 437100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhekang Ying</Name>
        <Affiliation>Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Electronic address: zying@som.umaryland.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest Non-applicable.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to 'P-Glycoprotein activation by 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5) in rat distal ileum: Ex vivo and in vivo studies' [Toxicology and Applied Pharmacology 386 (2020) 114832].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32750377</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30294-5</DOI>
    <AuthorList>
      <Author>
        <Name>Carolina Rocha-Pereira</Name>
        <Affiliation>UCIBIO/REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.. Electronic address: mcamorim@ff.up.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina Inés Ghanem</Name>
        <Affiliation>Instituto de Investigaciones Farmacológicas (ININFA) Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, CONICET, Buenos Aires, Argentina. Electronic address: cghanem@ffyb.uba.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Renata Silva</Name>
        <Affiliation>UCIBIO/REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.. Electronic address: rsilva@ff.up.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Alfredo G. Casanova</Name>
        <Affiliation>Unidad de Toxicología, Departamento de Fisiología y Farmacología, Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007 Salamanca, Spain. Electronic address: alfredogcp@usal.es.</Affiliation>
      </Author>
      <Author>
        <Name>Margarida Duarte-Araújo</Name>
        <Affiliation>LAQV/REQUIMTE, Departamento de Imuno-Fisiologia e Farmacologia, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: mdcma@icbas.up.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Salomé Gonçalves-Monteiro</Name>
        <Affiliation>LAQV/REQUIMTE, Laboratório de Farmacologia, Departamento de Ciências do Medicamento, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Emília Sousa</Name>
        <Affiliation>CIIMAR, Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: esousa@ff.up.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Maria de Lourdes Bastos</Name>
        <Affiliation>UCIBIO/REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.. Electronic address: mlbastos@ff.up.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Remião</Name>
        <Affiliation>UCIBIO/REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.. Electronic address: remiao@ff.up.pt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Natural alkaloid 8-oxo-epiberberine inhibited TGF-β1-triggred epithelial-mesenchymal transition by interfering Smad3.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32745479</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30305-7</DOI>
    <KeywordList>
      <Keywords>8-Oxo-epiberberine</Keywords>
      <Keywords>Epithelial-mesenchymal transition</Keywords>
      <Keywords>Metastasis</Keywords>
      <Keywords>TGF-β1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xin Liu</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiying Zhang</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guang Ju Zhou</Name>
        <Affiliation>Department of Emergency, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Hou</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Kong</Name>
        <Affiliation>Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center, Peking Union Medical College (PUMC), Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Jian Lu</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingwen Zhang</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China. Electronic address: qwzhang@um.edu.mo.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuping Chen</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China. Electronic address: xpchen@um.edu.mo.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of silver nanoparticles on T98G human glioblastoma cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32739528</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30304-5</DOI>
    <KeywordList>
      <Keywords>Human glioblastoma</Keywords>
      <Keywords>Nanotoxicology</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Silver nanoparticles</Keywords>
      <Keywords>T98G cells</Keywords>
      <Keywords>in vitro transcriptomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Encarnación Fuster</Name>
        <Affiliation>Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, 03202, Elche, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Héctor Candela</Name>
        <Affiliation>Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, 03202, Elche, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Estévez</Name>
        <Affiliation>Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, 03202, Elche, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ariel J. Arias</Name>
        <Affiliation>Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, 03202, Elche, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Eugenio Vilanova</Name>
        <Affiliation>Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, 03202, Elche, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Miguel A. Sogorb</Name>
        <Affiliation>Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, 03202, Elche, Spain. Electronic address: msogorb@umh.es.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All the authors declare no financial and personal relationships with other people or organizations that could inappropriately influence (bias) this work.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>NADPH-quinone oxidoreductase-1 mediates Benzo-[a]-pyrene-1,6-quinone-induced cytotoxicity and reactive oxygen species production in human EA.hy926 endothelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32739527</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30306-9</DOI>
    <KeywordList>
      <Keywords>Benzo-[a]-pyrene-1,6-quinone (BP-1,6-Q)</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Endothelial cells</Keywords>
      <Keywords>NAD(P)H: quinone oxidoreductase-1 (NQO1)</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Halley Shukla</Name>
        <Affiliation>Department of Biology, University of North Carolina at Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriella Gaje</Name>
        <Affiliation>Department of Biology, University of North Carolina at Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ashkon Koucheki</Name>
        <Affiliation>Department of Biology, University of North Carolina at Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ho Young Lee</Name>
        <Affiliation>Department of Biology, University of North Carolina at Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaolun Sun</Name>
        <Affiliation>Center of Excellence for Poultry Science, University of Arkansas, Fayetteville, AR 72701, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael A. Trush</Name>
        <Affiliation>Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Zhu</Name>
        <Affiliation>Campbell University School of Osteopathic Medicine, Buies Creek, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Y. Robert Li</Name>
        <Affiliation>Campbell University School of Osteopathic Medicine, Buies Creek, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenquan Jia</Name>
        <Affiliation>Department of Biology, University of North Carolina at Greensboro, NC, USA. Electronic address: z_jia@uncg.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None. Declaration of Competing Interest None declared.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Endocrine-disrupting chemicals rapidly affect intercellular signaling in Leydig cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32739526</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30303-3</DOI>
    <KeywordList>
      <Keywords>Connexins</Keywords>
      <Keywords>Endocrine-disrupting chemicals</Keywords>
      <Keywords>Gap junctional intercellular communication</Keywords>
      <Keywords>Leydig cells</Keywords>
      <Keywords>Reproductive toxicants</Keywords>
      <Keywords>Steroidogenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Affiefa Yawer</Name>
        <Affiliation>RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, building A29, 625 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Eliška Sychrová</Name>
        <Affiliation>RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, building A29, 625 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Petra Labohá</Name>
        <Affiliation>RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, building A29, 625 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Raška</Name>
        <Affiliation>RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, building A29, 625 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Tomáš Jambor</Name>
        <Affiliation>BioFood Centre, Faculty of Biotechnology and Food Sciences, Slovak University of Agriculture in Nitra, Tr. A. Hlinku 2, 949 76 Nitra, Slovac Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Pavel Babica</Name>
        <Affiliation>RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, building A29, 625 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Iva Sovadinová</Name>
        <Affiliation>RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, building A29, 625 00 Brno, Czech Republic. Electronic address: iva.sovadinova@recetox.muni.cz.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Epigenetic upregulation of galanin-like peptide mediates deoxynivalenol induced-growth inhibition in pituitary cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32738333</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30292-1</DOI>
    <KeywordList>
      <Keywords>DNA methylation</Keywords>
      <Keywords>Deoxynivalenol</Keywords>
      <Keywords>GALP</Keywords>
      <Keywords>Growth inhibition</Keywords>
      <Keywords>IGFALS</Keywords>
      <Keywords>Proinflammatory cytokines</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aimei Liu</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Siyi Hu</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qinghua Wu</Name>
        <Affiliation>College of Life Science, Yangtze University, Jingzhou 434025, China; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove 50003, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Irma Ares</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Universidad Complutense de Madrid, Madrid 28040, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Marta Martínez</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Universidad Complutense de Madrid, Madrid 28040, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>María Rosa Martínez-Larrañaga</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Universidad Complutense de Madrid, Madrid 28040, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Arturo Anadón</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Universidad Complutense de Madrid, Madrid 28040, Spain. Electronic address: aanadon@ucm.es.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Wang</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China; MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Hubei 430070, China. Electronic address: wangxu@mail.hzau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>María Aránzazu Martínez</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Universidad Complutense de Madrid, Madrid 28040, Spain.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of ablation and activation of Nrf2 on bile acid homeostasis in male mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32738332</pubmedLink>
    <GrantList>
      <Grant>F32 DK092069</Grant>
      <Grant>R01 ES009649</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30296-9</DOI>
    <KeywordList>
      <Keywords>Bile Acid</Keywords>
      <Keywords>Bile Acid Signaling</Keywords>
      <Keywords>CDDO-Im</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Youcai Zhang</Name>
        <Affiliation>School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, PR China. Electronic address: youcai.zhang@tju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Lickteig</Name>
        <Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Liu</Name>
        <Affiliation>School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Iván L. Csanaky</Name>
        <Affiliation>Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Division of Gastroenterology, Children's Mercy Hospital &amp; Clinics, Kansas City, MO 64108, USA; Department of Pediatrics, University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Curtis D. Klaassen</Name>
        <Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA. Electronic address: curtisklaassenphd@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All authors have no conflict of interest to declare.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel bile acid analog, A17, ameliorated non-alcoholic steatohepatitis in high-fat diet-fed hamsters.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32738331</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30295-7</DOI>
    <KeywordList>
      <Keywords>AMPKα</Keywords>
      <Keywords>Bile acid analog</Keywords>
      <Keywords>Cd36</Keywords>
      <Keywords>NASH</Keywords>
      <Keywords>TGR5</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ying Wang</Name>
        <Affiliation>State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yao Zhu</Name>
        <Affiliation>State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junxing Niu</Name>
        <Affiliation>State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiangqiang Deng</Name>
        <Affiliation>State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shimeng Guo</Name>
        <Affiliation>State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China; National Center for Drug Screening, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haowen Jiang</Name>
        <Affiliation>State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China; National Center for Drug Screening, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhaoliang Peng</Name>
        <Affiliation>State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaru Xue</Name>
        <Affiliation>State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huige Peng</Name>
        <Affiliation>State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lijiang Xuan</Name>
        <Affiliation>State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address: ljxuan@simm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Guoyu Pan</Name>
        <Affiliation>State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address: gypan@simm.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no competing financial interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Upregulation of ubiquitinated proteins and their degradation pathway in muscle atrophy induced by cisplatin in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32738330</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30291-X</DOI>
    <KeywordList>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Muscle atrophy</Keywords>
      <Keywords>Ubiquitin</Keywords>
      <Keywords>Ubiquitinated proteins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hiroyasu Sakai</Name>
        <Affiliation>Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 1428501, Japan. Electronic address: sakai@hoshi.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yohei Ikeno</Name>
        <Affiliation>Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 1428501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuka Tsukimura</Name>
        <Affiliation>Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 1428501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Maya Inomata</Name>
        <Affiliation>Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 1428501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuta Suzuki</Name>
        <Affiliation>Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 1428501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Risako Kon</Name>
        <Affiliation>Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 1428501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nobutomo Ikarashi</Name>
        <Affiliation>Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 1428501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshihiko Chiba</Name>
        <Affiliation>Department of Physiology and Molecular Sciences, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 1428501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeshi Yamada</Name>
        <Affiliation>Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 1138602, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Junzo Kamei</Name>
        <Affiliation>Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 1428501, Japan.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors have no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Natriuretic peptides and echocardiographic parameters in Mexican children environmentally exposed to arsenic.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32738329</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30290-8</DOI>
    <KeywordList>
      <Keywords>Arsenic exposure</Keywords>
      <Keywords>B-Type natriuretic peptide</Keywords>
      <Keywords>Children</Keywords>
      <Keywords>Echocardiographic evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>José M. Torres-Arellano</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Citlalli Osorio-Yáñez</Name>
        <Affiliation>Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Luz C. Sánchez-Peña</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Julio C. Ayllon-Vergara</Name>
        <Affiliation>Servicio de Cardiología del Hospital General de México, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Arreola-Mendoza</Name>
        <Affiliation>Departamento de Biociencias e Ingenieria, Centro Interdisciplinario de Investigaciones y Estudios sobre Medio Ambiente y Desarrollo del Instituto Politécnico Nacional, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Guadalupe Aguilar-Madrid</Name>
        <Affiliation>Dirección de Investigación y de Posgrado, Claustro Universitario de Chihuahua, Chihuahua, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Luz M. Del Razo</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México, Mexico. Electronic address: Ldelrazo@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The utility of a differentiated preclinical liver model, HepaRG cells, in investigating delayed toxicity via inhibition of mitochondrial-replication induced by fialuridine.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32730777</pubmedLink>
    <GrantList>
      <Grant>G0700654</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30289-1</DOI>
    <KeywordList>
      <Keywords>Fialuridine</Keywords>
      <Keywords>HepaRG</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>mtDNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carol E. Jolly</Name>
        <Affiliation>MRC Centre for Drug Safety Science, The Department of Pharmacology and Therapeutics, The University of Liverpool, Ashton Street, Liverpool L69 3GE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Oisin Douglas</Name>
        <Affiliation>MRC Centre for Drug Safety Science, The Department of Pharmacology and Therapeutics, The University of Liverpool, Ashton Street, Liverpool L69 3GE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Laleh Kamalian</Name>
        <Affiliation>MRC Centre for Drug Safety Science, The Department of Pharmacology and Therapeutics, The University of Liverpool, Ashton Street, Liverpool L69 3GE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Rosalind E. Jenkins</Name>
        <Affiliation>MRC Centre for Drug Safety Science, The Department of Pharmacology and Therapeutics, The University of Liverpool, Ashton Street, Liverpool L69 3GE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alison J. Beckett</Name>
        <Affiliation>Cellular and Molecular Physiology, The University of Liverpool, Crown Street, Liverpool L69 3BX, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sophie L. Penman</Name>
        <Affiliation>MRC Centre for Drug Safety Science, The Department of Pharmacology and Therapeutics, The University of Liverpool, Ashton Street, Liverpool L69 3GE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Dominic P. Williams</Name>
        <Affiliation>Innovative Medicines and Early Development, Drug Safety and Metabolism, Translational Safety, AstraZeneca, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mario Monshouwer</Name>
        <Affiliation>Pharmacokinetics Dynamics and Metabolism, Janssen Research and Development, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Damir Simic</Name>
        <Affiliation>Mechanistic and Investigative Toxicology, Janssen Research and Development, Spring House, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Snoeys</Name>
        <Affiliation>Pharmacokinetics Dynamics and Metabolism, Janssen Research and Development, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>B. Kevin Park</Name>
        <Affiliation>MRC Centre for Drug Safety Science, The Department of Pharmacology and Therapeutics, The University of Liverpool, Ashton Street, Liverpool L69 3GE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Amy E. Chadwick</Name>
        <Affiliation>MRC Centre for Drug Safety Science, The Department of Pharmacology and Therapeutics, The University of Liverpool, Ashton Street, Liverpool L69 3GE, UK. Electronic address: Amy.Chadwick@liverpool.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Kisspeptin-52 partially rescues the activity of the hypothalamus-pituitary-gonadal axis in underweight male rats dosed with an anti-obesity compound.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32726590</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30278-7</DOI>
    <KeywordList>
      <Keywords>GLP1/glucagon receptor co-agonist</Keywords>
      <Keywords>Kisspeptin</Keywords>
      <Keywords>Leptin</Keywords>
      <Keywords>Reproduction</Keywords>
      <Keywords>Weight loss</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Florian Bolze</Name>
        <Affiliation>Novo Nordisk A/S, Måløv, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Hannah Williams</Name>
        <Affiliation>Covance, Huntingdon, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Ridhirama Bhuwania</Name>
        <Affiliation>Novo Nordisk A/S, Måløv, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Emil Egecioglu</Name>
        <Affiliation>Novo Nordisk A/S, Måløv, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Esther Bloem</Name>
        <Affiliation>Novo Nordisk A/S, Måløv, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Johan F. Paulsson</Name>
        <Affiliation>Novo Nordisk A/S, Måløv, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Ø. Pedersen</Name>
        <Affiliation>Novo Nordisk A/S, Måløv, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Broadmeadow</Name>
        <Affiliation>Covance, Eye, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Clare J. Chesher</Name>
        <Affiliation>Covance, Huntingdon, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Emma L. Moore</Name>
        <Affiliation>Covance, Huntingdon, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Mikala Skydsgaard</Name>
        <Affiliation>Novo Nordisk A/S, Måløv, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Pia Søndergaard Galle</Name>
        <Affiliation>Novo Nordisk A/S, Måløv, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Majken Dalgaard</Name>
        <Affiliation>Novo Nordisk A/S, Måløv, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Birgitte S. Wulff</Name>
        <Affiliation>Novo Nordisk A/S, Måløv, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Manuel Tena-Sempere</Name>
        <Affiliation>Department of Cell Biology, Physiology &amp; Immunology, University of Córdoba, 14004 Córdoba, Spain; Maimónides Institute of Biomedical Research of Córdoba/Reina Sofia University Hospital, 14004 Córdoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 14004 Córdoba, Spain; FiDiPro Program, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Lærke W. Andersen</Name>
        <Affiliation>Novo Nordisk A/S, Måløv, Denmark. Electronic address: LRWA@novonordisk.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest Florian Bolze was and Ridhirama Bhuwania, NEE, Esther Bloem, Johan F. Paulsson, Marie Ø. Pedersen, Mikala Skydsgaard, Pia Søndergaard Galle, Majken Dalgaard, Birgitte S. Wulff and Lærke W. Andersen are full time employees of Novo Nordisk, and most hold a minor share portions as part of their employment.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Implications for prenatal cadmium exposure and adverse health outcomes in adulthood.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32721433</pubmedLink>
    <GrantList>
      <Grant>T32 ES011564</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30287-8</DOI>
    <KeywordList>
      <Keywords>Birth Outcomes</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Developmental Origins of Health and Disease (DOHaD) Hypothesis</Keywords>
      <Keywords>Environmental Contaminant</Keywords>
      <Keywords>Fetal Development</Keywords>
      <Keywords>Prenatal Exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jamie L. Young</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA. Electronic address: jamie.young.1@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Cai</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA; Departments of Pediatrics and Radiation Oncology, Pediatric Research Institute, University of Louisville School of Medicine, Louisville, KY 40202, USA. Electronic address: lu.cai@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None. Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Berberine attenuates severity of chronic pancreatitis and fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling and M2 polarization.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32721432</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30288-X</DOI>
    <KeywordList>
      <Keywords>AMP-activated protein kinase</Keywords>
      <Keywords>Berberine</Keywords>
      <Keywords>Chronic pancreatitis</Keywords>
      <Keywords>M2 macrophages polarization</Keywords>
      <Keywords>TGF-β1/Smad</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sapana Bansod</Name>
        <Affiliation>Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.</Affiliation>
      </Author>
      <Author>
        <Name>Nandkumar Doijad</Name>
        <Affiliation>Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.</Affiliation>
      </Author>
      <Author>
        <Name>Chandraiah Godugu</Name>
        <Affiliation>Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India. Electronic address: chandra.niperhyd@gov.in.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors have no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dihydroartemisinin exposure impairs porcine ovarian granulosa cells by activating PERK-eIF2α-ATF4 through endoplasmic reticulum stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32721431</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30285-4</DOI>
    <KeywordList>
      <Keywords>Calcium</Keywords>
      <Keywords>Dihydroartemisinin</Keywords>
      <Keywords>Endoplasmic reticulum stress</Keywords>
      <Keywords>Ovarian Granulosa Cells</Keywords>
      <Keywords>Unfolded protein response</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Luo</Name>
        <Affiliation>State Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Guo</Name>
        <Affiliation>State Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Luyao Zhang</Name>
        <Affiliation>State Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingrui Zhuan</Name>
        <Affiliation>Key Laboratory of Animal Genetics, Breeding and Reproduction, Ministry of Agriculture and National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, Beijing 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Meng</Name>
        <Affiliation>State Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangwei Fu</Name>
        <Affiliation>Key Laboratory of Animal Genetics, Breeding and Reproduction, Ministry of Agriculture and National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, Beijing 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunpeng Hou</Name>
        <Affiliation>State Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China. Electronic address: hou@cau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Empagliflozin dilates the rabbit aorta by activating PKG and voltage-dependent K</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32717242</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30279-9</DOI>
    <KeywordList>
      <Keywords>Aorta</Keywords>
      <Keywords>Empagliflozin</Keywords>
      <Keywords>Protein kinase G</Keywords>
      <Keywords>Voltage-dependent K(+) (Kv) channel</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mi Seon Seo</Name>
        <Affiliation>Department of Physiology, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hee Seok Jung</Name>
        <Affiliation>Department of Physiology, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Ryeol An</Name>
        <Affiliation>Department of Physiology, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Minji Kang</Name>
        <Affiliation>Department of Physiology, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ryeon Heo</Name>
        <Affiliation>Department of Physiology, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hongliang Li</Name>
        <Affiliation>Institute of Translational Medicine, Medical College, Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment for Senile Diseases, Yangzhou University, Yangzhou 225001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Taek Han</Name>
        <Affiliation>Department of Medical Environmental Biology and Tropical Medicine, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Se Ran Yang</Name>
        <Affiliation>Department of Thoracic and Cardiovascular Surgery, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Hee Cho</Name>
        <Affiliation>Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Min Bae</Name>
        <Affiliation>Department of Physiology, Konkuk University School of Medicine, Chungju 27478, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Won Sun Park</Name>
        <Affiliation>Department of Physiology, Kangwon National University School of Medicine, Chuncheon 24341, South Korea. Electronic address: parkws@kangwon.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic trioxide disturbs the LIS1/NDEL1/dynein microtubule dynamic complex by disrupting the CLIP170 zinc finger in head and neck cancer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32717241</pubmedLink>
    <GrantList>
      <Grant>R01 CA182969</Grant>
      <Grant>R01 ES029369</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30284-2</DOI>
    <KeywordList>
      <Keywords>Arsenic trioxide</Keywords>
      <Keywords>CLIP170</Keywords>
      <Keywords>Head and neck squamous cell carcinoma</Keywords>
      <Keywords>LIS1/NDEL1/dynein microtubule dynamic complex</Keywords>
      <Keywords>Metastasis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lu Gao</Name>
        <Affiliation>Laboratory of Oral and Maxillofacial Disease, Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, China; Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131, USA; Department of Oral Anatomy, School of Stomatology, Dalian Medical University, Dalian, Liaoning 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bingye Xue</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Xiang</Name>
        <Affiliation>Laboratory of Oral and Maxillofacial Disease, Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, China. Electronic address: xiangbin72@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Liu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131, USA. Electronic address: kliu@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no conflicts of interest with the contents of this article.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metabolomics analysis of plasma reveals voriconazole-induced hepatotoxicity is associated with oxidative stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32717240</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30283-0</DOI>
    <KeywordList>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Oxidative Stress</Keywords>
      <Keywords>Plasma</Keywords>
      <Keywords>Voriconazole</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shin Lun Wu</Name>
        <Affiliation>School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Ning Cheng</Name>
        <Affiliation>School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chi Chuan Wang</Name>
        <Affiliation>School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan; Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Wen Lin</Name>
        <Affiliation>School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan; Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: shuwenlin@ntu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Ching Hua Kuo</Name>
        <Affiliation>School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan; Centers of Genomic and Precision Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: kuoch@ntu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Label-free quantitative proteomic analysis identifies the oncogenic role of FOXA1 in BaP-transformed 16HBE cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32717239</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30286-6</DOI>
    <KeywordList>
      <Keywords>Benzo[a]Pyrene</Keywords>
      <Keywords>FOXA1</Keywords>
      <Keywords>Lung Cancer</Keywords>
      <Keywords>Proteomics</Keywords>
      <Keywords>THBEc1 Cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Wang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 10021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ludi Li</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingmei Hao</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Dawei Fu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Chen</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chuan Zhou</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Juanling Fu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Biyun Yao</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Chang</Name>
        <Affiliation>National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing 10050, PR China. Electronic address: bjchangbing@sohu.com.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Zhao</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University Health Science Center, Beijing 100191, PR China. Electronic address: zhaopeng@bjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>NLRC5 negatively regulates inflammatory responses in LPS-induced acute lung injury through NF-κB and p38 MAPK signal pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32710960</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30276-3</DOI>
    <KeywordList>
      <Keywords>Acute lung injury</Keywords>
      <Keywords>Alveolar macrophage</Keywords>
      <Keywords>Inflammatory cytokines</Keywords>
      <Keywords>NLRC5</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuanyuan Wang</Name>
        <Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, 81 Meishan Road, Hefei 230032, Anhui, China; Department of Pharmacology, The Second Hospital of Anhui Medical University, 678 Furong Road, Hefei 230601, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Huang</Name>
        <Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, 81 Meishan Road, Hefei 230032, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Erbao Bian</Name>
        <Affiliation>Department of Pharmacology, The Second Hospital of Anhui Medical University, 678 Furong Road, Hefei 230601, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Lei</Name>
        <Affiliation>Department of Pharmacology, The Second Hospital of Anhui Medical University, 678 Furong Road, Hefei 230601, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiongwen Lv</Name>
        <Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, 81 Meishan Road, Hefei 230032, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Li</Name>
        <Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, 81 Meishan Road, Hefei 230032, Anhui, China. Electronic address: lj@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic real-time particulate matter exposure causes rat pulmonary arteriole hyperresponsiveness and remodeling: The role of ET</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32710959</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30280-5</DOI>
    <KeywordList>
      <Keywords>ERK1/2-ET(B)R signaling</Keywords>
      <Keywords>PM(10) exposure</Keywords>
      <Keywords>Pulmonary arteriole remodeling</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xue Xiao</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tong Yao</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuaishuai Du</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Wang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pinging Yan</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yali Lei</Name>
        <Affiliation>Department of Environmental Science and Engineering, Xi'an Jiaotong University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Cao</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenxing Shen</Name>
        <Affiliation>Department of Environmental Science and Engineering, Xi'an Jiaotong University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongxiao Cao</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China. Electronic address: yxy@xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest There are no conflicts of interest for any of the authors.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The role of STAT3/p53 and PI3K-Akt-mTOR signaling pathway on DEHP-induced reproductive toxicity in pubertal male rat.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32710958</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30277-5</DOI>
    <KeywordList>
      <Keywords>Di (2-ethylhexyl) phthalate</Keywords>
      <Keywords>PI3K-Akt-mTOR</Keywords>
      <Keywords>Puberty</Keywords>
      <Keywords>Reproductive toxicology</Keywords>
      <Keywords>STAT3/p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guoqing Fu</Name>
        <Affiliation>School of Resource and Environmental Engineer, Wuhan University of Science and Technology, PR China; School of Public Health, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Dai</Name>
        <Affiliation>Wuhan Center For Disease Control &amp; Prevention, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Li</Name>
        <Affiliation>School of Public Health, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Chen</Name>
        <Affiliation>Chest Hospital of Jingzhou City, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lemei Liu</Name>
        <Affiliation>School of Public Health, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingna Yi</Name>
        <Affiliation>School of Public Health, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zengguang Teng</Name>
        <Affiliation>School of Public Health, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Quan</Name>
        <Affiliation>School of Public Health, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Zhang</Name>
        <Affiliation>School of Public Health, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Zhou</Name>
        <Affiliation>School of Public Health, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Donkersley</Name>
        <Affiliation>Lancaster Environment Centre, Lancaster University, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Shizhen Song</Name>
        <Affiliation>School of Resource and Environmental Engineer, Wuhan University of Science and Technology, PR China; School of Public Health, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, PR China. Electronic address: songshizhen@wust.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yuqin Shi</Name>
        <Affiliation>School of Resource and Environmental Engineer, Wuhan University of Science and Technology, PR China; School of Public Health, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, PR China. Electronic address: shiyuqin@wust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antimony and its compounds: Health impacts related to pulmonary toxicity, cancer, and genotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32710957</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30282-9</DOI>
    <KeywordList>
      <Keywords>Antimony</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Mechanism</Keywords>
      <Keywords>Pulmonary Toxicity</Keywords>
      <Keywords>Review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Craig J. Boreiko</Name>
        <Affiliation>CJB Risk Analysis LLC, Durham, NC 27705, USA. Electronic address: cboreiko@cjbra.com.</Affiliation>
      </Author>
      <Author>
        <Name>Toby G. Rossman</Name>
        <Affiliation>Environmental Medicine, NYU Grossman School of Medicine, New York, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest There are no conflicts of interest to declare.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposures to uranium and arsenic alter intraepithelial and innate immune cells in the small intestine of male and female mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32710956</pubmedLink>
    <GrantList>
      <Grant>P30 CA118100</Grant>
      <Grant>P42 ES025589</Grant>
      <Grant>R01 ES029369</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30281-7</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Arsenite (As(3+))</Keywords>
      <Keywords>Gut associated lymphoid tissues</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Innate immune cells</Keywords>
      <Keywords>Intraepithelial lymphocytes</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Small intestine</Keywords>
      <Keywords>Uranium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sebastian Medina</Name>
        <Affiliation>Department of Pharmaceutical Sciences, The University of New Mexico College of Pharmacy, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fredine T. Lauer</Name>
        <Affiliation>Department of Pharmaceutical Sciences, The University of New Mexico College of Pharmacy, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eliseo F. Castillo</Name>
        <Affiliation>Department of Internal Medicine, Division of Gastroenterology and Hepatology, The University of New Mexico School of Medicine, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alicia M. Bolt</Name>
        <Affiliation>Department of Pharmaceutical Sciences, The University of New Mexico College of Pharmacy, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Abdul Mehdi S. Ali</Name>
        <Affiliation>Department of Department of Earth and Planetary Sciences, The University of New Mexico, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Liu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, The University of New Mexico College of Pharmacy, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott W. Burchiel</Name>
        <Affiliation>Department of Pharmaceutical Sciences, The University of New Mexico College of Pharmacy, Albuquerque, NM, USA. Electronic address: sburchiel@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Polychlorinated biphenyl exposures differentially regulate hepatic metabolism and pancreatic function: Implications for nonalcoholic steatohepatitis and diabetes" [Toxicology &amp; Applied Pharmacology, 363 (2018) 22-33].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32702359</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30275-1</DOI>
    <AuthorList>
      <Author>
        <Name>Hongxue Shi</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Jin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Josiah E. Hardesty</Name>
        <Affiliation>Department of Biochemistry and Molecular Genetics, School of Medicine, University of Louisville, Louisville, KY 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>K. Cameron Falkner</Name>
        <Affiliation>Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, School of Medicine, University of Louisville, Louisville, KY 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Russell A. Prough</Name>
        <Affiliation>Department of Biochemistry and Molecular Genetics, School of Medicine, University of Louisville, Louisville, KY 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Appakalai N. Balamurugan</Name>
        <Affiliation>Department of Surgery, School of Medicine, University of Louisville, Louisville, KY 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sri Prakash Mokshagundam</Name>
        <Affiliation>Department of Medicine, Division of Endocrinology, Metabolism &amp; Diabetes, School of Medicine, University of Louisville, Louisville, KY 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Suresh T. Chari</Name>
        <Affiliation>Department of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55902, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew C. Cave</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40202, United States; Department of Biochemistry and Molecular Genetics, School of Medicine, University of Louisville, Louisville, KY 40202, United States; Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, School of Medicine, University of Louisville, Louisville, KY 40202, United States. Electronic address: matt.cave@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Elevated whole blood arsenic level is associated with type 2 diabetes in coal-burning areas in Guizhou.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32692994</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30261-1</DOI>
    <KeywordList>
      <Keywords>Case-Control</Keywords>
      <Keywords>Coal-burning arsenic exposure</Keywords>
      <Keywords>Smoking</Keywords>
      <Keywords>Type 2 Diabetes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lulu Dai</Name>
        <Affiliation>Laboratory of Microbiology and Immunology, School of Basic Medical Sciences, Zunyi Medical University, No.6 Xuefu Xilu, Zunyi 563006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyong Lv</Name>
        <Affiliation>The People's Hospital of Anlong County, Welcome Avenue, Anlong County, Qianxinan Bouyei and Miao Autonomous Prefecture, Guizhou Province 552400, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongbao Chen</Name>
        <Affiliation>Department of Hygiene Toxicology, School of Public Health, Zunyi Medical University, No.6 Xuefu Xilu, Zunyi 563006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiqin Huang</Name>
        <Affiliation>The People's Hospital of Anlong County, Welcome Avenue, Anlong County, Qianxinan Bouyei and Miao Autonomous Prefecture, Guizhou Province 552400, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Li</Name>
        <Affiliation>The People's Hospital of Anlong County, Welcome Avenue, Anlong County, Qianxinan Bouyei and Miao Autonomous Prefecture, Guizhou Province 552400, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Xie</Name>
        <Affiliation>The People's Hospital of Anlong County, Welcome Avenue, Anlong County, Qianxinan Bouyei and Miao Autonomous Prefecture, Guizhou Province 552400, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>YuFen Duan</Name>
        <Affiliation>The People's Hospital of Anlong County, Welcome Avenue, Anlong County, Qianxinan Bouyei and Miao Autonomous Prefecture, Guizhou Province 552400, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Zhao</Name>
        <Affiliation>The People's Hospital of Anlong County, Welcome Avenue, Anlong County, Qianxinan Bouyei and Miao Autonomous Prefecture, Guizhou Province 552400, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongfeng Wang</Name>
        <Affiliation>Department of Hygiene Toxicology, School of Public Health, Zunyi Medical University, No.6 Xuefu Xilu, Zunyi 563006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Yu</Name>
        <Affiliation>Department of Hygiene Toxicology, School of Public Health, Zunyi Medical University, No.6 Xuefu Xilu, Zunyi 563006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaobo Li</Name>
        <Affiliation>The People's Hospital of Anlong County, Welcome Avenue, Anlong County, Qianxinan Bouyei and Miao Autonomous Prefecture, Guizhou Province 552400, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanzhong Zhou</Name>
        <Affiliation>Department of Hygiene Toxicology, School of Public Health, Zunyi Medical University, No.6 Xuefu Xilu, Zunyi 563006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>XuBo Shen</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health, Zunyi Medical University, No.6 Xuefu Xilu, Zunyi 563006, PR China. Electronic address: shenxubo@zmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Baicalin down-regulating hepatitis B virus transcription depends on the liver-specific HNF4α-HNF1α axis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32687838</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30257-X</DOI>
    <KeywordList>
      <Keywords>Baicalin</Keywords>
      <Keywords>HBV</Keywords>
      <Keywords>HNF1α</Keywords>
      <Keywords>HNF4α</Keywords>
      <Keywords>transactivation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chengjie Xia</Name>
        <Affiliation>Department of Biological Medicines &amp; Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201203, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenyi Tang</Name>
        <Affiliation>Department of Biological Medicines &amp; Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201203, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Geng</Name>
        <Affiliation>Department of Biological Medicines &amp; Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201203, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyan Zhu</Name>
        <Affiliation>Department of Biological Medicines &amp; Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201203, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhou</Name>
        <Affiliation>Department of Chemistry, Fudan University, 220 Han Dan Road, Shanghai 200433, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hai Huang</Name>
        <Affiliation>Department of Biological Medicines &amp; Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201203, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pei Zhou</Name>
        <Affiliation>Department of Biological Medicines &amp; Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201203, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xunlong Shi</Name>
        <Affiliation>Department of Biological Medicines &amp; Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201203, PR China. Electronic address: xunlongshi@fudan.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32687837</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30265-9</DOI>
    <KeywordList>
      <Keywords>Anticancer therapy</Keywords>
      <Keywords>Chronic lymphocytic leukemia</Keywords>
      <Keywords>Dendrimers</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Poly(propylene imine)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ida Franiak-Pietryga</Name>
        <Affiliation>Department of Clinical and Laboratory Genetics, Medical University of Lodz, Pomorska Str. 251, 92-213 Lodz, Poland; GeneaMed LTD, 16/18 Kopcinskiego Str, 90-232 Lodz, Poland; University of California San Diego, Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093, United States of America. Electronic address: idafp@health.ucsd.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Ziemba</Name>
        <Affiliation>Department of Clinical and Laboratory Genetics, Medical University of Lodz, Pomorska Str. 251, 92-213 Lodz, Poland; GeneaMed LTD, 16/18 Kopcinskiego Str, 90-232 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Hanna Sikorska</Name>
        <Affiliation>Bio-Assistance, 705-801 Rue de la Commune Est, Montreal, Quebec H2L 0A3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Magdalena Jander</Name>
        <Affiliation>GeneaMed LTD, 16/18 Kopcinskiego Str, 90-232 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Wojciech Kuncman</Name>
        <Affiliation>Department of Pathomorphology, Medical University of Lodz, 251 Pomorska Str, 92-213 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Marian Danilewicz</Name>
        <Affiliation>Department of Pathomorphology, Medical University of Lodz, 251 Pomorska Str, 92-213 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Dietmar Appelhans</Name>
        <Affiliation>Leibniz Institute of Polymer Research Dresden, Hohe Str. 6, D-01069 Dresden, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Przemyslaw Lewkowicz</Name>
        <Affiliation>Department of Neurology, Laboratory of Neuroimmunology, Medical University of Lodz, 251 Pomorska Str, 92-213 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Kinga Ostrowska</Name>
        <Affiliation>Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, 62Pabianicka Str, 93-513 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Bryszewska</Name>
        <Affiliation>Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska Str, 90-236 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Maciej Borowiec</Name>
        <Affiliation>Department of Clinical and Laboratory Genetics, Medical University of Lodz, Pomorska Str. 251, 92-213 Lodz, Poland.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All authors have no relevant conflicts of interest to disclose.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic arsenic exposure enhances metastatic potential via NRF2-mediated upregulation of SOX9.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32682831</pubmedLink>
    <GrantList>
      <Grant>P30 ES006694</Grant>
      <Grant>P42 ES004940</Grant>
      <Grant>R35 ES031575</Grant>
      <Grant>T32 ES007091</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30264-7</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Metastasis</Keywords>
      <Keywords>NRF2</Keywords>
      <Keywords>NSCLC</Keywords>
      <Keywords>SOX9</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cody J. Schmidlin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Zeng</Name>
        <Affiliation>Institutue of Toxicology, School of Public Health, Shandong University, Jinan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengfei Liu</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yongyi Wei</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Dodson</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eli Chapman</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donna D. Zhang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA; University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA. Electronic address: dzhang@pharmacy.arizona.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Female-specific activation of pregnane X receptor mediates sex difference in fetal hepatotoxicity by prenatal monocrotaline exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32682830</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30263-5</DOI>
    <KeywordList>
      <Keywords>Cytochrome P450 3A</Keywords>
      <Keywords>Monocrotaline</Keywords>
      <Keywords>Pregnane X receptor</Keywords>
      <Keywords>Pyrrolizidine alkaloid</Keywords>
      <Keywords>Sex difference</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>E. Xiang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Guo</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Guo Dai</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Xiang Sun</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Liu</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Peng Fan</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Qing Wang</Name>
        <Affiliation>Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuai Kai Qiu</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Guo</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China. Electronic address: guoy@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All authors declare that they have no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluating amino acids as protectants against β-N-methylamino-l-alanine-induced developmental neurotoxicity in a rat model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32682829</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30266-0</DOI>
    <KeywordList>
      <Keywords>ALS/PDC</Keywords>
      <Keywords>BMAA</Keywords>
      <Keywords>Neurodegenerative disease</Keywords>
      <Keywords>Protection</Keywords>
      <Keywords>l-Alanine</Keywords>
      <Keywords>l-Phenylalanine</Keywords>
      <Keywords>l-Serine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rianita van Onselen</Name>
        <Affiliation>Department of Biochemistry and Microbiology, Nelson Mandela University, P.O. Box 77000, Port Elizabeth, 6031, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Louise Scott</Name>
        <Affiliation>Department of Biochemistry and Microbiology, Nelson Mandela University, P.O. Box 77000, Port Elizabeth, 6031, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Tim G. Downing</Name>
        <Affiliation>Department of Biochemistry and Microbiology, Nelson Mandela University, P.O. Box 77000, Port Elizabeth, 6031, South Africa.. Electronic address: Tim.Downing@mandela.ac.za.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of patent ductus venosus on bile acid homeostasis in aryl hydrocarbon receptor (AhR)-null mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32679164</pubmedLink>
    <GrantList>
      <Grant>F32 DK092069</Grant>
      <Grant>R01 ES009649</Grant>
      <Grant>R01 ES029280</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30262-3</DOI>
    <KeywordList>
      <Keywords>Aryl Hydrocarbon Receptor</Keywords>
      <Keywords>Bile Acids</Keywords>
      <Keywords>Biliary Excretion</Keywords>
      <Keywords>Ductus Venosus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Iván L. Csanaky</Name>
        <Affiliation>Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Division of Gastroenterology, Children's Mercy Hospital, Kansas City, Missouri 64108, USA; Department of Pediatrics, University of Kansas Medical Center, Kansas City, Kansas 66160, USA. Electronic address: ilcsanaky@cmh.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Lickteig</Name>
        <Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Youcai Zhang</Name>
        <Affiliation>School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China.</Affiliation>
      </Author>
      <Author>
        <Name>Curtis D. Klaassen</Name>
        <Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, USA. Electronic address: curtisklaassenphd@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pyridoxal isonicotinoyl hydrazone inhibition of FXR is involved in the pathogenesis of isoniazid-induced liver injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32673658</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30260-X</DOI>
    <KeywordList>
      <Keywords>Farnesoid X Receptor</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Isoniazid</Keywords>
      <Keywords>Pyridoxal Isonicotinoyl Hydrazine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guoqiang Zhang</Name>
        <Affiliation>Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Chen</Name>
        <Affiliation>Department of Infectious Disease, the First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanjie Wen</Name>
        <Affiliation>Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou 730000, China,; College of Pharmaceutical Science, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Rao</Name>
        <Affiliation>Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuhui Wei</Name>
        <Affiliation>Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin'an Wu</Name>
        <Affiliation>Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou 730000, China,. Electronic address: xinanwu6511@163.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declared no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gut microbiome in neuroendocrine and neuroimmune interactions: The case of genistein.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32673657</pubmedLink>
    <GrantList>
      <Grant>R21 ES024487</Grant>
      <Grant>R41 AT009523</Grant>
      <Grant>R41 DK121553</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30256-8</DOI>
    <KeywordList>
      <Keywords>Genistein</Keywords>
      <Keywords>Gut-brain axis</Keywords>
      <Keywords>Human/animal microbiome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tai L. Guo</Name>
        <Affiliation>Department of Veterinary Biosciences and Diagnostic Imaging, College of Veterinary Medicine, University of Georgia, Athens, GA, USA. Electronic address: tlguo1@uga.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Yingjia Chen</Name>
        <Affiliation>Department of Veterinary Biosciences and Diagnostic Imaging, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hannah Shibo Xu</Name>
        <Affiliation>Department of Veterinary Biosciences and Diagnostic Imaging, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Callie M. McDonough</Name>
        <Affiliation>Department of Veterinary Biosciences and Diagnostic Imaging, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Guannan Huang</Name>
        <Affiliation>HGG Research LLC, Athens, GA, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The protoapigenone analog WYC0209 targets CD133+ cells: A potential adjuvant agent against cancer stem cells in urothelial cancer therapy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32673656</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30255-6</DOI>
    <KeywordList>
      <Keywords>CD133</Keywords>
      <Keywords>Cancer stemness cells</Keywords>
      <Keywords>Chemoresistance</Keywords>
      <Keywords>Urothelial carcinoma</Keywords>
      <Keywords>WYC0209</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bi Wen Yeh</Name>
        <Affiliation>Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Liang En Yu</Name>
        <Affiliation>Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ching Chia Li</Name>
        <Affiliation>Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Cohort Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Cheng Yang</Name>
        <Affiliation>Graduate institute of natural products, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Ming Li</Name>
        <Affiliation>Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Cohort Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, Ministry of Health and Welfare Pingtung Hospital, Pingtung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Chang Wu</Name>
        <Affiliation>Graduate institute of natural products, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Ching Wei</Name>
        <Affiliation>Department of Pathology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hsueh Te Lee</Name>
        <Affiliation>Institute of Anatomy and Cell Biology, National Yang-Ming University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Lang Kung</Name>
        <Affiliation>Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. Electronic address: kungmeilang@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Jeng Wu</Name>
        <Affiliation>Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Cohort Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan. Electronic address: wejewu@kmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The selective lipoprotein-associated phospholipase A2 inhibitor darapladib triggers irreversible actions on glioma cell apoptosis and mitochondrial dysfunction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32668280</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30259-3</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Darapladib</Keywords>
      <Keywords>Glioma</Keywords>
      <Keywords>Mitochondria</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yun Ju Wang</Name>
        <Affiliation>Department of Life Sciences, College of Biological Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Song Bin Chang</Name>
        <Affiliation>Department of Life Sciences, College of Biological Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Yen Wang</Name>
        <Affiliation>Department of Life Sciences, College of Biological Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Ting Huang</Name>
        <Affiliation>Department of Life Sciences, College of Biological Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shun Fen Tzeng</Name>
        <Affiliation>Department of Life Sciences, College of Biological Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan. Electronic address: stzeng@mail.ncku.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there is no conflict of interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Long-term atorvastatin or the combination of atorvastatin and nicotinamide ameliorate insulin resistance and left ventricular diastolic dysfunction in a murine model of obesity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32659285</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30258-1</DOI>
    <KeywordList>
      <Keywords>Atorvastatin</Keywords>
      <Keywords>Diastolic function</Keywords>
      <Keywords>Insulin resistance</Keywords>
      <Keywords>Nicotinamide</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Osteopontin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xinquan Yang</Name>
        <Affiliation>Department of Cardiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Xiong</Name>
        <Affiliation>Department of Cardiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Ning</Name>
        <Affiliation>Department of Cardiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ti Wang</Name>
        <Affiliation>Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongyan Zhong</Name>
        <Affiliation>Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shan Tang</Name>
        <Affiliation>Department of Cardiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongqing Mao</Name>
        <Affiliation>Department of Cardiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guoqiang Zhu</Name>
        <Affiliation>Yangzhou University College of Veterinary Medicine, Yangzhou, China. Electronic address: daxinw2002@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Daxin Wang</Name>
        <Affiliation>Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China. Electronic address: yzgqzhu@yzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>LncRNA Mical2/miR-203a-3p sponge participates in epithelial-mesenchymal transition by targeting p66Shc in liver fibrosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32659284</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30251-9</DOI>
    <KeywordList>
      <Keywords>Epithelial-mesenchymal transition</Keywords>
      <Keywords>Liver fibrosis</Keywords>
      <Keywords>lncRNA Mical2</Keywords>
      <Keywords>p66Shc</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Zhao</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhecheng Wang</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junjun Zhou</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongcheng Feng</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Li</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Hu</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Zhang</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhao Chen</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangzhi Wang</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodong Ma</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofeng Tian</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China. Electronic address: txfdl@dmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jihong Yao</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China. Electronic address: yaojihong65@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of TRPV1/TRPV3 channels in olanzapine-induced metabolic alteration: Possible involvement in hypothalamic energy-sensing, appetite regulation, inflammation and mesolimbic pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32652086</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30250-7</DOI>
    <KeywordList>
      <Keywords>Antipsychotics</Keywords>
      <Keywords>Appetite dysregulation</Keywords>
      <Keywords>Energy sensing</Keywords>
      <Keywords>Food reward anticipation</Keywords>
      <Keywords>TRPV1 and TRPV3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Raghunath Singh</Name>
        <Affiliation>Pharmacology Research Lab, University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh 160014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Yashika Bansal</Name>
        <Affiliation>Pharmacology Research Lab, University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh 160014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rupinder Kaur Sodhi</Name>
        <Affiliation>Pharmacology Research Lab, University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh 160014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pragyanshu Khare</Name>
        <Affiliation>Food and Nutritional Biotechnology Division, National Agri-Food Biotechnology Institute (NABI), SAS Nagar, Punjab 140306, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mahendra Bishnoi</Name>
        <Affiliation>Food and Nutritional Biotechnology Division, National Agri-Food Biotechnology Institute (NABI), SAS Nagar, Punjab 140306, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kanthi Kiran Kondepudi</Name>
        <Affiliation>Food and Nutritional Biotechnology Division, National Agri-Food Biotechnology Institute (NABI), SAS Nagar, Punjab 140306, India.</Affiliation>
      </Author>
      <Author>
        <Name>Bikash Medhi</Name>
        <Affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anurag Kuhad</Name>
        <Affiliation>Pharmacology Research Lab, University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh 160014, India. Electronic address: anurag_pu@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest Authors have none to declare.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Single-and repeat-dose toxicity of HM10760A, a long-acting erythropoietin, in rats and monkeys.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32645313</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30252-0</DOI>
    <KeywordList>
      <Keywords>Chronic kidney disease</Keywords>
      <Keywords>HM10760A</Keywords>
      <Keywords>Long-acting erythropoietin</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyung Kyu Lim</Name>
        <Affiliation>Biotherapeutics and Glycomics Laboratory, College of Pharmacy, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Republic of Korea; Hanmi Research Center, Hanmi Pharm. Co. Ltd., 550 Dongtangiheung-Ro, Hwaseong-Si, Gyeonggi-Do 18469, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jaehyuk Choi</Name>
        <Affiliation>Biotherapeutics and Glycomics Laboratory, College of Pharmacy, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Republic of Korea; Hanmi Research Center, Hanmi Pharm. Co. Ltd., 550 Dongtangiheung-Ro, Hwaseong-Si, Gyeonggi-Do 18469, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Daejin Kim</Name>
        <Affiliation>Department of Environmental &amp; Health Chemistry, College of Pharmacy, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Republic of Korea; Hanmi Research Center, Hanmi Pharm. Co. Ltd., 550 Dongtangiheung-Ro, Hwaseong-Si, Gyeonggi-Do 18469, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Min Bae</Name>
        <Affiliation>Hanmi Research Center, Hanmi Pharm. Co. Ltd., 550 Dongtangiheung-Ro, Hwaseong-Si, Gyeonggi-Do 18469, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dae Kyong Kim</Name>
        <Affiliation>Department of Environmental &amp; Health Chemistry, College of Pharmacy, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Republic of Korea. Electronic address: kimdk@cau.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>In Young Choi</Name>
        <Affiliation>Hanmi Research Center, Hanmi Pharm. Co. Ltd., 550 Dongtangiheung-Ro, Hwaseong-Si, Gyeonggi-Do 18469, Republic of Korea. Electronic address: iychoi@hanmi.co.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Ha Hyung Kim</Name>
        <Affiliation>Biotherapeutics and Glycomics Laboratory, College of Pharmacy, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Republic of Korea. Electronic address: hahyung@cau.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Protective effect of EX-527 against high-fat diet-induced diabetic nephropathy in Zucker rats" [Toxicology and Applied Pharmacology 390 (2020) 114899].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32640284</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30254-4</DOI>
    <AuthorList>
      <Author>
        <Name>Amit Kundu</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sachan Richa</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Prasanta Dey</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyeong Seok Kim</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Yeon Son</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hae Ri Kim</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seok Yong Lee</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Hoon Lee</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kwang Youl Lee</Name>
        <Affiliation>College of Pharmacy &amp; Research Institute of Drug Development, Chonnam National University, Gwangju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sam Kacew</Name>
        <Affiliation>McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Mu Lee</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Sik Kim</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea. Electronic address: hkims@skku.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ovarian mitochondrial and oxidative stress proteins are altered by glyphosate exposure in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32634520</pubmedLink>
    <GrantList>
      <Grant>R21 ES026282</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30242-8</DOI>
    <KeywordList>
      <Keywords>Glyphosate</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Ovary</Keywords>
      <Keywords>Proteome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shanthi Ganesan</Name>
        <Affiliation>Department of Animal Science, Iowa State University, Ames, IA 50011, USA. Electronic address: shanthig@iastate.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Aileen F. Keating</Name>
        <Affiliation>Department of Animal Science, Iowa State University, Ames, IA 50011, USA. Electronic address: akeating@iastate.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative proteomic analysis of SLC13A5 knockdown reveals elevated ketogenesis and enhanced cellular toxic response to chemotherapeutic agents in HepG2 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32634519</pubmedLink>
    <GrantList>
      <Grant>R01 GM121550</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30243-X</DOI>
    <KeywordList>
      <Keywords>Ketone body</Keywords>
      <Keywords>Lipid accumulation</Keywords>
      <Keywords>Proteomics</Keywords>
      <Keywords>SLC13A5</Keywords>
      <Keywords>Stress response</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tao Hu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Weiliang Huang</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihui Li</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Maureen A. Kane</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Zhang</Name>
        <Affiliation>Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration (FDA), Silver Spring, MD 20993, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Shiew Mei Huang</Name>
        <Affiliation>Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration (FDA), Silver Spring, MD 20993, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Hongbing Wang</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, United States of America. Electronic address: hongbing.wang@rx.umaryland.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Physalin A attenuates inflammation through down-regulating c-Jun NH2 kinase phosphorylation/Activator Protein 1 activation and up-regulating the antioxidant activity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32634518</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30241-6</DOI>
    <KeywordList>
      <Keywords>Anti-inflammatory effect</Keywords>
      <Keywords>Anti-oxidative activity</Keywords>
      <Keywords>IκB/NF-κB</Keywords>
      <Keywords>JNK/AP-1</Keywords>
      <Keywords>Physalin A</Keywords>
      <Keywords>Physalis angulata</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Hsien Lin</Name>
        <Affiliation>Department of Pharmacology, China Medical University, Taichung 40402, Taiwan, ROC; School of Pharmacy, College of Pharmacy, China Medical University, No. 91, Hsueh-Shih Road, Taichung 40402, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Hsin Hsiao</Name>
        <Affiliation>Department of Pharmacology, China Medical University, Taichung 40402, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Ka Lok Ng</Name>
        <Affiliation>Department of Bioinformatics and Medical Engineering, Asia University, Taichung 41354, Taiwan, ROC; Department of Medical Research, China Medical University Hospital, China Medical University, 40402, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Yueh Hsiung Kuo</Name>
        <Affiliation>Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 40402, Taiwan, ROC; Department of Biotechnology, Asia University, Taichung 40402, Taiwan, ROC; Chinese Medicine Research Center, China Medical University, Taichung 40402, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Ping Lim</Name>
        <Affiliation>School of Pharmacy, College of Pharmacy, China Medical University, No. 91, Hsueh-Shih Road, Taichung 40402, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Tsong Hsieh</Name>
        <Affiliation>Department of Pharmacology, China Medical University, Taichung 40402, Taiwan, ROC; Chinese Medicine Research Center, China Medical University, Taichung 40402, Taiwan, ROC; Drug Development Center, China Medical University, Taichung 40402, Taiwan, ROC. Electronic address: wthsieh@mail.cmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and chronic vascular effects of inhaled crotonaldehyde in mice: Role of TRPA1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32634517</pubmedLink>
    <GrantList>
      <Grant>T32 ES011564</Grant>
      <Grant>P30 GM127607</Grant>
      <Grant>R01 ES019217</Grant>
      <Grant>R01 HL122676</Grant>
      <Grant>U54 HL120163</Grant>
      <Grant>R01 HL149351</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30246-5</DOI>
    <KeywordList>
      <Keywords>Aldehydes</Keywords>
      <Keywords>Blood pressure</Keywords>
      <Keywords>Cigarettes</Keywords>
      <Keywords>Endothelial dysfunction</Keywords>
      <Keywords>Tobacco products</Keywords>
      <Keywords>Transient receptor potential ankyrin-1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jordan Lynch</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, United States of America; Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Diabetes &amp; Obesity Center, University of Louisville, United States of America; Superfund Research Center, University of Louisville, United States of America. Electronic address: jordan.finch@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Lexiao Jin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, United States of America; Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Diabetes &amp; Obesity Center, University of Louisville, United States of America. Electronic address: lexiao.jin@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Andre Richardson</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, United States of America; Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Diabetes &amp; Obesity Center, University of Louisville, United States of America. Electronic address: andre.richardson@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ganapathy Jagatheesan</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Diabetes &amp; Obesity Center, University of Louisville, United States of America. Electronic address: ganapathy.jagatheesan@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Pawel Lorkiewicz</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Diabetes &amp; Obesity Center, University of Louisville, United States of America; Superfund Research Center, University of Louisville, United States of America; Department of Chemistry, University of Louisville, United States of America. Electronic address: pawel.lorkiewicz@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengzhi Xie</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Diabetes &amp; Obesity Center, University of Louisville, United States of America; Superfund Research Center, University of Louisville, United States of America. Electronic address: zhengzhi.xie@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Whitney S. Theis</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Diabetes &amp; Obesity Center, University of Louisville, United States of America. Electronic address: whitney.theis@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Gregg Shirk</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Diabetes &amp; Obesity Center, University of Louisville, United States of America. Electronic address: Gregg.shirk@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Marina V. Malovichko</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Diabetes &amp; Obesity Center, University of Louisville, United States of America; Superfund Research Center, University of Louisville, United States of America; Division of Environmental Medicine, Department of Medicine, University of Louisville, Louisville, KY 40202, United States of America. Electronic address: marina.malovichko@lousville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Aruni Bhatnagar</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, United States of America; Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Diabetes &amp; Obesity Center, University of Louisville, United States of America; Superfund Research Center, University of Louisville, United States of America; Division of Environmental Medicine, Department of Medicine, University of Louisville, Louisville, KY 40202, United States of America. Electronic address: aruni@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Sanjay Srivastava</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Diabetes &amp; Obesity Center, University of Louisville, United States of America; Superfund Research Center, University of Louisville, United States of America; Division of Environmental Medicine, Department of Medicine, University of Louisville, Louisville, KY 40202, United States of America. Electronic address: sanjay.srivastava@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel J. Conklin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, United States of America; Christina Lee Brown Envirome Institute, University of Louisville, United States of America; Diabetes &amp; Obesity Center, University of Louisville, United States of America; Superfund Research Center, University of Louisville, United States of America; Division of Environmental Medicine, Department of Medicine, University of Louisville, Louisville, KY 40202, United States of America. Electronic address: dj.conklin@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All authors declare no conflicts of interest in this paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration or the American Heart Association.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Multi and transgenerational epigenetic effects of di-(2-ethylhexyl) phthalate (DEHP) in liver.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32628958</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30249-0</DOI>
    <KeywordList>
      <Keywords>DEHP</Keywords>
      <Keywords>DNA methylation</Keywords>
      <Keywords>Dnmt</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Tet</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Transgenerational</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yi Wen</Name>
        <Affiliation>Department of Bioengineering. University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA; Biomedical Research Center in Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL 61801, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Saniya Rattan</Name>
        <Affiliation>Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jodi A. Flaws</Name>
        <Affiliation>Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph Irudayaraj</Name>
        <Affiliation>Department of Bioengineering. University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA; Biomedical Research Center in Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL 61801, USA; Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA; Micro and Nanotechnology Laboratory. University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. Electronic address: jirudaya@illinois.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The modulatory effects of cinnamaldehyde on uric acid level and IL-6/JAK1/STAT3 signaling as a promising therapeutic strategy against benign prostatic hyperplasia.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32628957</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30248-9</DOI>
    <KeywordList>
      <Keywords>Benign prostatic hyperplasia</Keywords>
      <Keywords>Cinnamaldehyde</Keywords>
      <Keywords>Cyclin D1</Keywords>
      <Keywords>IL-6/JAK1/STAT3 signaling</Keywords>
      <Keywords>Uric acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hassan Afify</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian-Russian University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Amira M. Abo-Youssef</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Hanaa M. Abdel-Rahman</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian-Russian University, Cairo, Egypt; Department of Forensic Medicine and Toxicology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Shady Allam</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Amany A. Azouz</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. Electronic address: amany.azoz@pharm.bsu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Systematic review of artemisinin embryotoxicity in animals: Implications for malaria control in human pregnancy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32622917</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30253-2</DOI>
    <KeywordList>
      <Keywords>Artemisinins</Keywords>
      <Keywords>Embryotoxicity</Keywords>
      <Keywords>Malaria</Keywords>
      <Keywords>Pre-clinical</Keywords>
      <Keywords>Pregnancy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Raquel González</Name>
        <Affiliation>ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain. Electronic address: raquel.gonzalez@isglobal.org.</Affiliation>
      </Author>
      <Author>
        <Name>Clara Pons-Duran</Name>
        <Affiliation>ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Azucena Bardají</Name>
        <Affiliation>ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain; Manhiça Health Research Center (CISM), Manhiça, Mozambique.</Affiliation>
      </Author>
      <Author>
        <Name>Rose G. F. Leke</Name>
        <Affiliation>Department of Microbiology, Immunology and Haematology, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Yaounde, Cameroon.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Clark</Name>
        <Affiliation>Artemis Pharmaceutical Research, Jacksonville, Florida, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Clara Menendez</Name>
        <Affiliation>ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain; Manhiça Health Research Center (CISM), Manhiça, Mozambique.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest Declaration of interests of authors of manuscript entitled “Systematic review of artemisinin embryotoxicity in animals: implications for malaria control in human pregnancy” submitted by Raquel Gonzalez. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>H-Ras induces Nrf2-Pin1 interaction: Implications for breast cancer progression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32621833</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30247-7</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>H-Ras</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Pin1</Keywords>
      <Keywords>Protein-protein interaction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Soma Saeidi</Name>
        <Affiliation>Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, South Korea; Department of Molecular Medicine, Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Su Jung Kim</Name>
        <Affiliation>Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyeong Jun Han</Name>
        <Affiliation>Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seong Hoon Kim</Name>
        <Affiliation>Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Zheng</Name>
        <Affiliation>Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Han Byoel Lee</Name>
        <Affiliation>Cancer Research Institute, Seoul National University, Seoul, South Korea; Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wonshik Han</Name>
        <Affiliation>Cancer Research Institute, Seoul National University, Seoul, South Korea; Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Young Noh</Name>
        <Affiliation>Cancer Research Institute, Seoul National University, Seoul, South Korea; Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hye Kyung Na</Name>
        <Affiliation>Department of Food Science and Biotechnology, College of Knowledge-Based Services Engineering, Sungshin Women's University, Seoul, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Joon Surh</Name>
        <Affiliation>Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, South Korea; Department of Molecular Medicine, Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea; Cancer Research Institute, Seoul National University, Seoul, South Korea. Electronic address: surh@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no potential conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dexamethasone inhibits pancreatic tumor growth in preclinical models: Involvement of activating glucocorticoid receptor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32619553</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30244-1</DOI>
    <KeywordList>
      <Keywords>Anti-cancer effect</Keywords>
      <Keywords>Dexamethasone</Keywords>
      <Keywords>Glucocorticoid receptor</Keywords>
      <Keywords>Nuclear factor κB</Keywords>
      <Keywords>Pancreatic cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ye Yao</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Yu Yao</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Sheng Xue</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiu Yun Tian</Name>
        <Affiliation>Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital &amp; Institute, Beijing 100142, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Ming An</Name>
        <Affiliation>Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital &amp; Institute, Beijing 100142, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Xuan Cui</Name>
        <Affiliation>Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital &amp; Institute, Beijing 100142, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Xu</Name>
        <Affiliation>Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital &amp; Institute, Beijing 100142, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Su</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Yang</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yao Yao Feng</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Yi Hao</Name>
        <Affiliation>Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital &amp; Institute, Beijing 100142, China. Electronic address: haochunyi@bjmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Tian Yan Zhou</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Electronic address: tianyanzhou@bjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Muscle proteolysis via ubiquitin-proteasome system (UPS) is activated by BthTx-I Lys49 PLA</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32619552</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30245-3</DOI>
    <KeywordList>
      <Keywords>E3-ligases</Keywords>
      <Keywords>GDF-8/Myostatin</Keywords>
      <Keywords>Myogenic regulatory factors</Keywords>
      <Keywords>Myonecrosis</Keywords>
      <Keywords>Myotoxin</Keywords>
      <Keywords>Viperidae snake</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bruno Kenzo-Kagawa</Name>
        <Affiliation>Department of Biochemistry and Tissue Biology, Institute of Biology, State University of Campinas - UNICAMP, Campinas, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Willians Fernando Vieira</Name>
        <Affiliation>Department of Biochemistry and Tissue Biology, Institute of Biology, State University of Campinas - UNICAMP, Campinas, SP, Brazil; Department of Structural and Functional Biology, Institute of Biology, State University of Campinas - UNICAMP, Campinas, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>José Carlos Cogo</Name>
        <Affiliation>Faculty of Biomedical Engineering, Brazil University, Itaquera, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Alice da Cruz-Höfling</Name>
        <Affiliation>Department of Biochemistry and Tissue Biology, Institute of Biology, State University of Campinas - UNICAMP, Campinas, SP, Brazil. Electronic address: hofling@unicamp.br.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest Authors declare no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Crotonaldehyde-induced vascular relaxation and toxicity: Role of endothelium and Transient receptor potential ankyrin-1 (TRPA1)" [Toxicol Appl Pharmacol. 398 (2020) 115012].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32598891</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30240-4</DOI>
    <AuthorList>
      <Author>
        <Name>L. Jin</Name>
        <Affiliation>Department of Anesthesiology, Critical Care and Pain Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY, USA; Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation Center, University of Louisville, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. Jagatheesan</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation Center, University of Louisville, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Lynch</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY, USA; Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation Center, University of Louisville, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>L. Guo</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation Center, University of Louisville, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. J. Conklin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY, USA; Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation Center, University of Louisville, Louisville, KY, USA. Electronic address: dj.conklin@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cytochrome P4501B1 in bone marrow is co-expressed with key markers of mesenchymal stem cells. BMS2 cell line models PAH disruption of bone marrow niche development functions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32553695</pubmedLink>
    <GrantList>
      <Grant>R01 DK072749</Grant>
      <Grant>R01 DK090249</Grant>
      <Grant>T32 ES007015</Grant>
      <Grant>T32 HD041921</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30235-0</DOI>
    <KeywordList>
      <Keywords>BMS2 cells</Keywords>
      <Keywords>Bone marrow vascular niche</Keywords>
      <Keywords>CYP1B1</Keywords>
      <Keywords>Hematopoietic stem and progenitor cells</Keywords>
      <Keywords>Lepr+MSC</Keywords>
      <Keywords>Mesenchymal stem cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michele Campaigne Larsen</Name>
        <Affiliation>Department of Cell and Regenerative Biology, University of Wisconsin, Madison, WI 53705, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmed Almeldin</Name>
        <Affiliation>Department of Cell and Regenerative Biology, University of Wisconsin, Madison, WI 53705, United States of America; Physiology Department, Faculty of Medicine, Tanta University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Tiegang Tong</Name>
        <Affiliation>Department of Cell and Regenerative Biology, University of Wisconsin, Madison, WI 53705, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine M. Rondelli</Name>
        <Affiliation>Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, WI 53705, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Meghan Maguire</Name>
        <Affiliation>Endocrinology and Reproductive Physiology Program, University of Wisconsin, Madison, WI 53705, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Renata Jaskula-Sztul</Name>
        <Affiliation>Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, WI 53705, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Colin R. Jefcoate</Name>
        <Affiliation>Department of Cell and Regenerative Biology, University of Wisconsin, Madison, WI 53705, United States of America; Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, WI 53705, United States of America; Endocrinology and Reproductive Physiology Program, University of Wisconsin, Madison, WI 53705, United States of America. Electronic address: jefcoate@wisc.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors acknowledge no conflicts of interest with these studies.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/β-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophages.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32544403</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30233-7</DOI>
    <KeywordList>
      <Keywords>Bladder Cancer</Keywords>
      <Keywords>Extracellular Vesicle</Keywords>
      <Keywords>M2 Tumor-Associated Macrophage</Keywords>
      <Keywords>Ovatodiolide</Keywords>
      <Keywords>mTOR/CDK6/β-Catenin Signaling, Therapeutic Development</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alexander T. H. Wu</Name>
        <Affiliation>The PhD Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan; Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 114, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Prateeti Srivastava</Name>
        <Affiliation>The PhD Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan; The Program for Translational Medicine, Graduate Institute of Biomedical Informatics, Taipei Medical University, Taipei 11031, Taiwan; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Vijesh Kumar Yadav</Name>
        <Affiliation>The Program for Translational Medicine, Graduate Institute of Biomedical Informatics, Taipei Medical University, Taipei 11031, Taiwan; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>David T. W. Tzeng</Name>
        <Affiliation>School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sitthichai Iamsaard</Name>
        <Affiliation>Department of Anatomy, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; Mekong Health Science Research Institute, Khon Kaen University, Khon Kaen, Thailand; Research Institute for Human High Performance and Health Promotion (HHP&amp;HP), Khon Kaen University, Khon Kaen, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Emily Chia Yu Su</Name>
        <Affiliation>Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Hsiao</Name>
        <Affiliation>Genomics Research Center, Academia Sinica, Taipei 11529, Taiwan; Department of Biochemistry, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Che Liu</Name>
        <Affiliation>Department of Urology, Taipei Medical University Hospital, Taipei 11031, Taiwan; Clinical Research Center, Taipei Medical University Hospital, Taipei 11031, Taiwan; Graduate Institute of Clinical Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan; School of Dental Technology, College of Oral Medicine, Taipei Medical University, Taipei 11031, Taiwan. Electronic address: d204097002@tmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All contributing authors have no known conflicts of interest associated with this publication.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Targeting lung cancer stem cells using combination of Tel and Docetaxel liposomes in 3D cultures and tumor xenografts.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32540278</pubmedLink>
    <GrantList>
      <Grant>U54 MD007582</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30236-2</DOI>
    <KeywordList>
      <Keywords>Cancer Stem Cells (CSC)</Keywords>
      <Keywords>Docetaxel (DTX)</Keywords>
      <Keywords>Docetaxel Loaded PEGylated Liposomes (DTXPL)</Keywords>
      <Keywords>Non-small Cell Lung Cancer (NSCLC)</Keywords>
      <Keywords>Resistance</Keywords>
      <Keywords>Telmisartan (Tel)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peggy Arthur</Name>
        <Affiliation>College of Pharmacy and Pharmaceutical Sciences, Florida Agricultural and Mechanical University, Tallahassee, FL 32307, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nilkumar Patel</Name>
        <Affiliation>College of Pharmacy and Pharmaceutical Sciences, Florida Agricultural and Mechanical University, Tallahassee, FL 32307, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sunil Kumar Surapaneni</Name>
        <Affiliation>College of Pharmacy and Pharmaceutical Sciences, Florida Agricultural and Mechanical University, Tallahassee, FL 32307, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Arindam Mondal</Name>
        <Affiliation>Rutgers University, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Aragaw Gebeyehu</Name>
        <Affiliation>College of Pharmacy and Pharmaceutical Sciences, Florida Agricultural and Mechanical University, Tallahassee, FL 32307, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Arvind Bagde</Name>
        <Affiliation>College of Pharmacy and Pharmaceutical Sciences, Florida Agricultural and Mechanical University, Tallahassee, FL 32307, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shallu Kutlehria</Name>
        <Affiliation>College of Pharmacy and Pharmaceutical Sciences, Florida Agricultural and Mechanical University, Tallahassee, FL 32307, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ebony Nottingham</Name>
        <Affiliation>College of Pharmacy and Pharmaceutical Sciences, Florida Agricultural and Mechanical University, Tallahassee, FL 32307, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mandip Singh</Name>
        <Affiliation>College of Pharmacy and Pharmaceutical Sciences, Florida Agricultural and Mechanical University, Tallahassee, FL 32307, USA. Electronic address: mandip.sachdeva@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All authors declare no conflicts of interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32533954</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30234-9</DOI>
    <KeywordList>
      <Keywords>Epithelial-to-mesenchymal transition</Keywords>
      <Keywords>Ferroptosis</Keywords>
      <Keywords>Gambogenic acid</Keywords>
      <Keywords>Melanoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Meng Wang</Name>
        <Affiliation>Key Laboratory of Xin'an Medicine, Ministry of Education, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shanshan Li</Name>
        <Affiliation>Key Laboratory of Xin'an Medicine, Ministry of Education, China.</Affiliation>
      </Author>
      <Author>
        <Name>Youlin Wang</Name>
        <Affiliation>Key Laboratory of Xin'an Medicine, Ministry of Education, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Cheng</Name>
        <Affiliation>Key Laboratory of Xin'an Medicine, Ministry of Education, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingjing Su</Name>
        <Affiliation>Key Laboratory of Xin'an Medicine, Ministry of Education, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qinglin Li</Name>
        <Affiliation>Key Laboratory of Xin'an Medicine, Ministry of Education, China; Key Laboratory of Chinese Medicial Formula of Anhui Province, Anhui University of Chinese Medicine, Hefei 230038, China. Electronic address: liqinglin@ahtcm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nitrofuran drugs beyond redox cycling: Evidence of Nitroreduction-independent cytotoxicity mechanism.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32531296</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30228-3</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Hydrazone</Keywords>
      <Keywords>Nitrofurans</Keywords>
      <Keywords>Nitroreduction</Keywords>
      <Keywords>Reactive Oxygen Species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. Gallardo-Garrido</Name>
        <Affiliation>Laboratorio de Farmacología y Toxicología Molecular, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Chile; Departamento de Química Orgánica y Fisicoquímica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Y. Cho</Name>
        <Affiliation>Laboratorio de Farmacología y Toxicología Molecular, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>J. Cortés-Rios</Name>
        <Affiliation>Laboratorio de Farmacología y Toxicología Molecular, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>D. Vasquez</Name>
        <Affiliation>Laboratorio de Síntesis y Desarrollo de Fármacos, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>C. D. Pessoa-Mahana</Name>
        <Affiliation>Laboratorio de Farmacología y Toxicología Molecular, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>R. Araya-Maturana</Name>
        <Affiliation>Instituto de Química y Recursos Naturales, Universidad de Talca, Talca, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>H. Pessoa-Mahana</Name>
        <Affiliation>Departamento de Química Orgánica y Fisicoquímica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Chile. Electronic address: hpessoa@ciq.uchile.cl.</Affiliation>
      </Author>
      <Author>
        <Name>M. Faundez</Name>
        <Affiliation>Laboratorio de Farmacología y Toxicología Molecular, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Chile. Electronic address: mfaundeza@uc.cl.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Angiogenesis signaling in breast cancer models is induced by hexachlorobenzene and chlorpyrifos, pesticide ligands of the aryl hydrocarbon receptor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32526215</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30217-9</DOI>
    <KeywordList>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>Aryl Hydrocarbon Receptor</Keywords>
      <Keywords>Breast Cancer</Keywords>
      <Keywords>Chlorpyrifos</Keywords>
      <Keywords>Hexachlorobenzene</Keywords>
      <Keywords>Nitric Oxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lorena V. Zárate</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Bioquímica Humana, Laboratorio de Efectos Biológicos de Contaminantes Ambientales, Paraguay 2155, 5to piso, (CP1121), Buenos Aires, Argentina. Electronic address: lzarate@fmed.uba.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina A. Pontillo</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Bioquímica Humana, Laboratorio de Efectos Biológicos de Contaminantes Ambientales, Paraguay 2155, 5to piso, (CP1121), Buenos Aires, Argentina. Electronic address: cpontillo@fmed.uba.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandro Español</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Centro de Estudios Farmacológicos y Botánicos (CEFYBO), Paraguay 2155, 16 piso, (CP1121), Buenos Aires, Argentina. Electronic address: aespanol@fmed.uba.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Noelia V. Miret</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Bioquímica Humana, Laboratorio de Efectos Biológicos de Contaminantes Ambientales, Paraguay 2155, 5to piso, (CP1121), Buenos Aires, Argentina. Electronic address: nmiret@fmed.uba.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Florencia Chiappini</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Bioquímica Humana, Laboratorio de Efectos Biológicos de Contaminantes Ambientales, Paraguay 2155, 5to piso, (CP1121), Buenos Aires, Argentina. Electronic address: fchiappini@fmed.uba.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Cocca</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Laboratorio de Radioisótopos, Junín 954, subsuelo, (CP1113), Buenos Aires, Argentina. Electronic address: cmcocca@ffyb.uba.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Álvarez</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Bioquímica Humana, Laboratorio de Efectos Biológicos de Contaminantes Ambientales, Paraguay 2155, 5to piso, (CP1121), Buenos Aires, Argentina. Electronic address: lalvarez@fmed.uba.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Diana Kleiman de Pisarev</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Bioquímica Humana, Laboratorio de Efectos Biológicos de Contaminantes Ambientales, Paraguay 2155, 5to piso, (CP1121), Buenos Aires, Argentina. Electronic address: dkleiman@fmed.uba.ar.</Affiliation>
      </Author>
      <Author>
        <Name>María E. Sales</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Centro de Estudios Farmacológicos y Botánicos (CEFYBO), Paraguay 2155, 16 piso, (CP1121), Buenos Aires, Argentina. Electronic address: msales@fmed.uba.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea S. Randi</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Bioquímica Humana, Laboratorio de Efectos Biológicos de Contaminantes Ambientales, Paraguay 2155, 5to piso, (CP1121), Buenos Aires, Argentina. Electronic address: arandi@fmed.uba.ar.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The triphenyltin carboxylate derivative triphenylstannyl 2-(benzylcarbamoyl)benzoate impedes prostate cancer progression via modulation of Akt/FOXO3a signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32525019</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30215-5</DOI>
    <KeywordList>
      <Keywords>PI3K/Akt/FOXO3a</Keywords>
      <Keywords>PTEN Null Transgenic Model</Keywords>
      <Keywords>Prostate Cancer</Keywords>
      <Keywords>Triphenyltin (IV) Carboxylate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Durdana Waseem</Name>
        <Affiliation>Department of Dermatology, University of Wisconsin-, Madison, USA; Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Gul Majid Khan</Name>
        <Affiliation>Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Ihsan Ul Haq</Name>
        <Affiliation>Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Umer Rashid</Name>
        <Affiliation>Department of Chemistry, COMSATS, Abbottabad, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Deeba N. Syed</Name>
        <Affiliation>Department of Dermatology, University of Wisconsin-, Madison, USA. Electronic address: dsyed@dermatology.wisc.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest Authors declare no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical toxicology profile of squalene epoxidase inhibitors.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32522582</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30227-1</DOI>
    <KeywordList>
      <Keywords>SCLC</Keywords>
      <Keywords>SQLE</Keywords>
      <Keywords>Small Cell Lung Cancer</Keywords>
      <Keywords>Squalene Epoxidase Inhibitor</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Tumor Metabolism</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Raj Nagaraja</Name>
        <Affiliation>Agios Pharmaceuticals, Inc., 88 Sidney St, Cambridge, MA 02139, USA. Electronic address: Raj.Nagaraja@agios.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Olaharski</Name>
        <Affiliation>Agios Pharmaceuticals, Inc., 88 Sidney St, Cambridge, MA 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rohini Narayanaswamy</Name>
        <Affiliation>Agios Pharmaceuticals, Inc., 88 Sidney St, Cambridge, MA 02139, USA. Electronic address: Rohini.Narayanaswamy@agios.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Mahoney</Name>
        <Affiliation>Agios Pharmaceuticals, Inc., 88 Sidney St, Cambridge, MA 02139, USA. Electronic address: cmahoney@momatx.com.</Affiliation>
      </Author>
      <Author>
        <Name>David Pirman</Name>
        <Affiliation>Agios Pharmaceuticals, Inc., 88 Sidney St, Cambridge, MA 02139, USA. Electronic address: David.Pirman@agios.com.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Gross</Name>
        <Affiliation>Agios Pharmaceuticals, Inc., 88 Sidney St, Cambridge, MA 02139, USA. Electronic address: Stefan.Gross@agios.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas P. Roddy</Name>
        <Affiliation>Agios Pharmaceuticals, Inc., 88 Sidney St, Cambridge, MA 02139, USA. Electronic address: Thomas.Roddy@agios.com.</Affiliation>
      </Author>
      <Author>
        <Name>Janeta Popovici-Muller</Name>
        <Affiliation>Agios Pharmaceuticals, Inc., 88 Sidney St, Cambridge, MA 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gromoslaw A. Smolen</Name>
        <Affiliation>Agios Pharmaceuticals, Inc., 88 Sidney St, Cambridge, MA 02139, USA. Electronic address: gsmolen@celsiustx.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lee Silverman</Name>
        <Affiliation>Agios Pharmaceuticals, Inc., 88 Sidney St, Cambridge, MA 02139, USA. Electronic address: Lee.Silverman@agios.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest RaN, RoN, David Pirman, Stefan Gross, Thomas P. Roddy, and Lee Silverman are employees of and stockholders in Agios Pharmaceuticals, Inc. Andrew Olaharski and Christopher Mahoney were employees of Agios Pharmaceuticals, Inc. at the time of the study, and currently hold stock in Agios Pharmaceuticals, Inc. Janeta Popovici-Muller and Gromoslaw A. Smolen were employees of and stockholders in Agios Pharmaceuticals, Inc. at the time of the study.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32512072</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30225-8</DOI>
    <KeywordList>
      <Keywords>Diosmin</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>High-Fat Diet</Keywords>
      <Keywords>Insulin Resistance</Keywords>
      <Keywords>Non-alcoholic Steatohepatitis</Keywords>
      <Keywords>Streptozotocin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Samar H. Gerges</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Organization of African Unity Street, Abbasia, Cairo 11566, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Sara A. Wahdan</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Organization of African Unity Street, Abbasia, Cairo 11566, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Doaa A. Elsherbiny</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Organization of African Unity Street, Abbasia, Cairo 11566, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Ebtehal El-Demerdash</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Organization of African Unity Street, Abbasia, Cairo 11566, Egypt. Electronic address: ebtehal_dm@pharma.asu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest There is no conflict of interest to declare.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Activation of the Erk/MAPK signaling pathway is a driver for cadmium induced prostate cancer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32512071</pubmedLink>
    <GrantList>
      <Grant>IK6 BX004473</Grant>
      <Grant>I01 BX001123</Grant>
      <Grant>IP1 BX001604</Grant>
      <Grant>R01 CA196848</Grant>
      <Grant>U01 CA184966</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30226-X</DOI>
    <KeywordList>
      <Keywords>Cadmium Toxicity</Keywords>
      <Keywords>Erk/MAPK Pathway</Keywords>
      <Keywords>Prostate Cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pritha Dasgupta</Name>
        <Affiliation>Department of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Priyanka Kulkarni</Name>
        <Affiliation>Department of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nadeem S. Bhat</Name>
        <Affiliation>Department of Surgery, Miller School of Medicine, University of Miami, 4150 Clement Street, Miami, FL 94121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shahana Majid</Name>
        <Affiliation>Department of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marisa Shiina</Name>
        <Affiliation>Department of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Varahram Shahryari</Name>
        <Affiliation>Department of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Soichiro Yamamura</Name>
        <Affiliation>Department of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuichiro Tanaka</Name>
        <Affiliation>Department of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ravi Kumar Gupta</Name>
        <Affiliation>Department of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rajvir Dahiya</Name>
        <Affiliation>Department of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA. Electronic address: rdahiya@ucsf.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Yutaka Hashimoto</Name>
        <Affiliation>Department of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA. Electronic address: Yutaka.Hashimoto@ucsf.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no potential conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integrated transcriptomic and metabolomic analyses to characterize the anti-cancer effects of (-)-epigallocatechin-3-gallate in human colon cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32512070</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30224-6</DOI>
    <KeywordList>
      <Keywords>Colorectal cancer</Keywords>
      <Keywords>EGCG</Keywords>
      <Keywords>Glutathione metabolism</Keywords>
      <Keywords>Glycerophospholipid metabolism</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Transcriptomic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zheyu Zhang</Name>
        <Affiliation>Department of Integrated Traditional Chinese &amp;Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Department of Gastroenterology, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sifang Zhang</Name>
        <Affiliation>Department of Integrated Traditional Chinese &amp;Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingjing Yang</Name>
        <Affiliation>Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengji Yi</Name>
        <Affiliation>Department of Integrated Traditional Chinese &amp;Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Panpan Xu</Name>
        <Affiliation>Department of Integrated Traditional Chinese &amp;Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Yi</Name>
        <Affiliation>Department of Integrated Traditional Chinese &amp;Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China. Electronic address: yimin66@csu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Weijun Peng</Name>
        <Affiliation>Department of Integrated Traditional Chinese &amp;Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China. Electronic address: pengweijun87@csu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cu(II) disrupts autophagy-mediated lysosomal degradation of oligomeric Aβ in microglia via mTOR-TFEB pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32512069</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30214-3</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Copper</Keywords>
      <Keywords>Microglia</Keywords>
      <Keywords>β-Amyloid clearance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaofang Tan</Name>
        <Affiliation>Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, 280 South Chongqing Road, Shanghai 200025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huifeng Guan</Name>
        <Affiliation>Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, 280 South Chongqing Road, Shanghai 200025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yang</Name>
        <Affiliation>Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, 280 South Chongqing Road, Shanghai 200025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shenying Luo</Name>
        <Affiliation>Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, 280 South Chongqing Road, Shanghai 200025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lina Hou</Name>
        <Affiliation>Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, 280 South Chongqing Road, Shanghai 200025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongzhuan Chen</Name>
        <Affiliation>Institute of Interdisciplinary Integrative Biomedical Research, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201210, China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Li</Name>
        <Affiliation>Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, 280 South Chongqing Road, Shanghai 200025, China. Electronic address: lijuanpharm@163.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>IL-8 and MCP-1/CCL2 regulate proteolytic activity in triple negative inflammatory breast cancer a mechanism that might be modulated by Src and Erk1/2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32512068</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30216-7</DOI>
    <KeywordList>
      <Keywords>Cathepsin B</Keywords>
      <Keywords>Dasatinib</Keywords>
      <Keywords>IL-8</Keywords>
      <Keywords>Inflammatory Breast Cancer</Keywords>
      <Keywords>MCP-1/CCL2</Keywords>
      <Keywords>U0126</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hossam Taha Mohamed</Name>
        <Affiliation>Department of Zoology, Faculty of Science, Cairo University, Giza 12613, Egypt; Faculty of Biotechnology, October University for Modern Sciences and Arts, Giza 12451, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Eslam A. El-Ghonaimy</Name>
        <Affiliation>Department of Zoology, Faculty of Science, Cairo University, Giza 12613, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed El-Shinawi</Name>
        <Affiliation>Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed Hosney</Name>
        <Affiliation>Department of Zoology, Faculty of Science, Cairo University, Giza 12613, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Götte</Name>
        <Affiliation>Department of Gynecology and Obstetrics, Münster University Hospital, Münster 48149, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Wendy A. Woodward</Name>
        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tahani El-Mamlouk</Name>
        <Affiliation>Department of Zoology, Faculty of Science, Cairo University, Giza 12613, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mona Mostafa Mohamed</Name>
        <Affiliation>Department of Zoology, Faculty of Science, Cairo University, Giza 12613, Egypt. Electronic address: mmostafa@sci.cu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>6-Dithio-2'-deoxyguanosine analogs induce reactive oxygen species-mediated tumor cell apoptosis via bi-targeting thioredoxin 1 and telomerase.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32497534</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30203-9</DOI>
    <KeywordList>
      <Keywords>6-Dithio-2′-Deoxyguanosine Analogs</Keywords>
      <Keywords>Antitumor Activity</Keywords>
      <Keywords>Double Target Collaboration</Keywords>
      <Keywords>Telomerase</Keywords>
      <Keywords>Thioredoxin 1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yang Zhang</Name>
        <Affiliation>Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiabei Zhou</Name>
        <Affiliation>Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Ye</Name>
        <Affiliation>Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kui Zeng</Name>
        <Affiliation>Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Pan</Name>
        <Affiliation>Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Chen</Name>
        <Affiliation>Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingying Wang</Name>
        <Affiliation>Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Yang</Name>
        <Affiliation>Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiaojun He</Name>
        <Affiliation>Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianqing Gao</Name>
        <Affiliation>Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Su Zeng</Name>
        <Affiliation>Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lushan Yu</Name>
        <Affiliation>Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China. Electronic address: yuls@zju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32497533</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30204-0</DOI>
    <KeywordList>
      <Keywords>ABCB1</Keywords>
      <Keywords>ATP</Keywords>
      <Keywords>BIRC5</Keywords>
      <Keywords>LCL161</Keywords>
      <Keywords>Multidrug Resistance</Keywords>
      <Keywords>SMAC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yung Chieh Chang</Name>
        <Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Sree Karani Kondapuram</Name>
        <Affiliation>Centre for Bioinformatics, School of Life Sciences, Pondicherry University, Kalapet, Puducherry 605014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Tsung Han Yang</Name>
        <Affiliation>Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Safiulla Basha Syed</Name>
        <Affiliation>Centre for Bioinformatics, School of Life Sciences, Pondicherry University, Kalapet, Puducherry 605014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Siao Muk Cheng</Name>
        <Affiliation>National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Tzu Yu Lin</Name>
        <Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Chen Lin</Name>
        <Affiliation>Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Mohane Selvaraj Coumar</Name>
        <Affiliation>Centre for Bioinformatics, School of Life Sciences, Pondicherry University, Kalapet, Puducherry 605014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Jang Yang Chang</Name>
        <Affiliation>National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; Center of Infectious Disease and Signaling Research, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Euphemia Leung</Name>
        <Affiliation>Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Hei Antonio Cheung</Name>
        <Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Electronic address: acheung@mail.ncku.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A type IV collagenase inhibitor, N-hydroxy-3-phenyl-2-(4-phenylbenzenesulfonamido) propanamide (BiPS), suppresses skin injury induced by sulfur mustard.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32479919</pubmedLink>
    <GrantList>
      <Grant>P30 ES005022</Grant>
      <Grant>T32 ES007148</Grant>
      <Grant>U54 AR055073</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30202-7</DOI>
    <KeywordList>
      <Keywords>Basement Membrane</Keywords>
      <Keywords>MMP-9</Keywords>
      <Keywords>Matrix Metalloproteinase Inhibitor</Keywords>
      <Keywords>Sulfur Mustard</Keywords>
      <Keywords>Type IV Collagen</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yoke Chen Chang</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States of America. Electronic address: chang@eohsi.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Rita A. Hahn</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Marion K. Gordon</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey D. Laskin</Name>
        <Affiliation>Department of Environmental &amp; Occupational Health, School of Public Health, Rutgers University, Piscataway, NJ, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Donald R. Gerecke</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States of America.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Vitamin D supplementation rescues simvastatin induced myopathy in mice via improving mitochondrial cristae shape.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32479918</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30200-3</DOI>
    <KeywordList>
      <Keywords>Cristae</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Statin Induced Myopathy</Keywords>
      <Keywords>Vitamin D Supplementation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lulu Ren</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingling Xuan</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feifei Han</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Zhang</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lili Gong</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yali Lv</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Zhang</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.</Affiliation>
      </Author>
      <Author>
        <Name>Song Yang</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.</Affiliation>
      </Author>
      <Author>
        <Name>Benshan Xu</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Yan</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lifang Guo</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China; School of Life Sciences, Tsinghua University, Beijing 100084, China.</Affiliation>
      </Author>
      <Author>
        <Name>He Liu</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zirui Wan</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China. Electronic address: wanzirui@ccmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Lihong Liu</Name>
        <Affiliation>Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China. Electronic address: liulihong@bjcyh.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In utero and lactational exposure to triclocarban: Age-associated changes in reproductive parameters of male rat offspring.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32479917</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30201-5</DOI>
    <KeywordList>
      <Keywords>Endocrine disruptor</Keywords>
      <Keywords>Hypothalamic sexual differentiation</Keywords>
      <Keywords>Personal care product</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nathália Orlandini Costa</Name>
        <Affiliation>Department of Physiological Sciences, State University of Londrina, 86051-980, Londrina, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Simone Forcato</Name>
        <Affiliation>Department of Physiological Sciences, State University of Londrina, 86051-980, Londrina, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Andreza Manzato Cavichioli</Name>
        <Affiliation>Department of Physiological Sciences, State University of Londrina, 86051-980, Londrina, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marina Rangel Ferro Pereira</Name>
        <Affiliation>Department of Physiological Sciences, State University of Londrina, 86051-980, Londrina, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela Cristina Ceccatto Gerardin</Name>
        <Affiliation>Department of Physiological Sciences, State University of Londrina, 86051-980, Londrina, Paraná, Brazil. Electronic address: dcgerardin@uel.br.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human organic anion transporting polypeptide (OATP) 1B3 and mouse OATP1A/1B affect liver accumulation of Ochratoxin A in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32470353</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30196-4</DOI>
    <KeywordList>
      <Keywords>Liver accumulation</Keywords>
      <Keywords>Ochratoxin A</Keywords>
      <Keywords>hOATP1B3</Keywords>
      <Keywords>mABCB1</Keywords>
      <Keywords>mABCG2</Keywords>
      <Keywords>mOATP1A/1B</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Wang</Name>
        <Affiliation>The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Changpei Gan</Name>
        <Affiliation>The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaozhe Qi</Name>
        <Affiliation>Standards and Quality Center of National Food and Strategic Reserves Administration, Beijing 100037, China; College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Maria C. Lebre</Name>
        <Affiliation>The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Alfred H. Schinkel</Name>
        <Affiliation>The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. Electronic address: a.schinkel@nki.nl.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The research group of Alfred H. Schinkel receives revenue from commercial distribution of some of the mouse strains used in this study.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Celastrol augments sensitivity of NLRP3 to CP-456773 by modulating HSP-90 and inducing autophagy in dextran sodium sulphate-induced colitis in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32470352</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30199-X</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>CP-456773/MCC950</Keywords>
      <Keywords>Celastrol</Keywords>
      <Keywords>Colitis</Keywords>
      <Keywords>HSP-90</Keywords>
      <Keywords>NLRP3 Inflammasome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sameh Saber</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt. Electronic address: sameh.mohamed@deltauniv.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Eman M. Abd El-Kader</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Hossam Sharaf</Name>
        <Affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Rewan El-Shamy</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Baraah El-Saeed</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Asmaa Mostafa</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Dalia Ezzat</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmed Shata</Name>
        <Affiliation>Department of Clinical pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt; Department of Clinical Pharmacy, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no competing interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>OroxylinA reverses lipopolysaccharide-induced adhesion molecule expression and endothelial barrier disruption in the rat aorta.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32464219</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30194-0</DOI>
    <KeywordList>
      <Keywords>Adhesion molecule</Keywords>
      <Keywords>Endothelial barrier disruption</Keywords>
      <Keywords>LPS</Keywords>
      <Keywords>OroxylinA (OroA)</Keywords>
      <Keywords>Vascular inflammation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tzu Ling Tseng</Name>
        <Affiliation>Department of Medical Research, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan; CardioVascular Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan,; Tzu Chi University of Science and Technology, Hualien, Taiwan. Electronic address: 93351110@gms.tcu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Fang Chen</Name>
        <Affiliation>Department of Medical Research, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan; CardioVascular Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan,; Tzu Chi University of Science and Technology, Hualien, Taiwan. Electronic address: mfchen@mail.tcu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Yung Hsiang Hsu</Name>
        <Affiliation>Department of Pathology, College of Medicine, Tzu Chi University, Hualien, Taiwan. Electronic address: yhhsu@gms.tcu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Tony J. F. Lee</Name>
        <Affiliation>Department of Medical Research, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan; CardioVascular Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan,; Department of Life Sciences, Tzu Chi University, Hualien, Taiwan; Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None declared.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In silico, in vitro and in vivo evaluation of natural Bignoniaceous naphthoquinones in comparison with atovaquone targeting the selection of potential antimalarial candidates.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32464218</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30198-8</DOI>
    <KeywordList>
      <Keywords>ADMET</Keywords>
      <Keywords>Acute oral toxicity</Keywords>
      <Keywords>Atovaquone</Keywords>
      <Keywords>In silico and in vitro toxicology</Keywords>
      <Keywords>Lapachol</Keywords>
      <Keywords>Malaria</Keywords>
      <Keywords>α- and β-lapachone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maria Fernanda Alves do Nascimento</Name>
        <Affiliation>Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Avenida Antônio Carlos 6627, Belo Horizonte, MG 31.270-901, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Tatiane Freitas Borgati</Name>
        <Affiliation>Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Avenida Antônio Carlos 6627, Belo Horizonte, MG 31.270-901, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Larissa Camila Ribeiro de Souza</Name>
        <Affiliation>Departamento de Inovação Tecnológica, Instituto de Ciências Biológicas, Universidade Federal de Minas, Gerais, Avenida Antônio Carlos 6627, Belo Horizonte, MG 31.270-901, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos Alberto Tagliati</Name>
        <Affiliation>Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas, Gerais, Avenida Antônio Carlos 6627, Belo Horizonte, MG 31.270-901, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alaíde Braga de Oliveira</Name>
        <Affiliation>Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Avenida Antônio Carlos 6627, Belo Horizonte, MG 31.270-901, Brazil. Electronic address: bragalaide@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All the authors declare to have no conflict of interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of lithium on cytokine neuro-inflammatory mediators, Wnt/β-catenin signaling and microglial activation in the hippocampus of chronic mild stress-exposed rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32454056</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30197-6</DOI>
    <KeywordList>
      <Keywords>Beta catenin</Keywords>
      <Keywords>Chronic mild stress</Keywords>
      <Keywords>Depression</Keywords>
      <Keywords>Lithium</Keywords>
      <Keywords>Microglia</Keywords>
      <Keywords>Wnt signaling pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohamed Z. Habib</Name>
        <Affiliation>Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address: Mohamed.habib@med.asu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Mai A. Ebeid</Name>
        <Affiliation>Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Yasser El Faramawy</Name>
        <Affiliation>Department of Geriatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Sherin S. T. Saad</Name>
        <Affiliation>Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Hekmat M. El Magdoub</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Misr International University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Azza A. Attia</Name>
        <Affiliation>Department of Histology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Sawsan Aboul-Fotouh</Name>
        <Affiliation>Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmed M. Abdel-Tawab</Name>
        <Affiliation>Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Eprinomectin, a novel semi-synthetic macrocylic lactone is cytotoxic to PC3 metastatic prostate cancer cells via inducing apoptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32454055</pubmedLink>
    <GrantList>
      <Grant>R03 CA212890</Grant>
      <Grant>R03 CA227218</Grant>
      <Grant>R03 CA230829</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30195-2</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Eprinomectin</Keywords>
      <Keywords>Prostate cancer</Keywords>
      <Keywords>Stem cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Angela Lincy Prem Antony Samy</Name>
        <Affiliation>Department of Biomedical Sciences, University of Illinois, Rockford, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Velavan Bakthavachalam</Name>
        <Affiliation>Department of Biomedical Sciences, University of Illinois, Rockford, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Mona Vudutha</Name>
        <Affiliation>Department of Biomedical Sciences, University of Illinois, Rockford, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Smita Vinjamuri</Name>
        <Affiliation>Department of Biomedical Sciences, University of Illinois, Rockford, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Somaiah Chinnapaka</Name>
        <Affiliation>Department of Biomedical Sciences, University of Illinois, Rockford, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Gnanasekar Munirathinam</Name>
        <Affiliation>Department of Biomedical Sciences, University of Illinois, Rockford, IL, United States of America. Electronic address: mgnanas@uic.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest Authors declare that they do not have conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of long non-coding RNAs and MYC interaction in cancer metastasis: A possible target for therapeutic intervention.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32445756</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30180-0</DOI>
    <KeywordList>
      <Keywords>Cancer metastasis</Keywords>
      <Keywords>Interaction</Keywords>
      <Keywords>Therapeutic intervention</Keywords>
      <Keywords>c-MYC</Keywords>
      <Keywords>lncRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Homa Fatma</Name>
        <Affiliation>Molecular Cancer Genetics &amp; Translational Research Lab, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh 202002, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Hifzur R. Siddique</Name>
        <Affiliation>Molecular Cancer Genetics &amp; Translational Research Lab, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh 202002, Uttar Pradesh, India. Electronic address: hifzur.zo@amu.ac.in.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PBPK modeling of impact of nonalcoholic fatty liver disease on toxicokinetics of perchloroethylene in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32445755</pubmedLink>
    <GrantList>
      <Grant>F32 ES026005</Grant>
      <Grant>P30 ES029067</Grant>
      <Grant>P42 ES027704</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30193-9</DOI>
    <KeywordList>
      <Keywords>Bayesian analysis</Keywords>
      <Keywords>Nonalcoholic Fatty Liver Disease (NAFLD)</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>Perchloroethylene</Keywords>
      <Keywords>Population variation</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chimeddulam Dalaijamts</Name>
        <Affiliation>Interdisciplinary Faculty of Toxicology, Texas A&amp;M University, College Station, TX, USA; Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph A. Cichocki</Name>
        <Affiliation>Interdisciplinary Faculty of Toxicology, Texas A&amp;M University, College Station, TX, USA; Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Syuan Luo</Name>
        <Affiliation>Interdisciplinary Faculty of Toxicology, Texas A&amp;M University, College Station, TX, USA; Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ivan Rusyn</Name>
        <Affiliation>Interdisciplinary Faculty of Toxicology, Texas A&amp;M University, College Station, TX, USA; Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Weihsueh A. Chiu</Name>
        <Affiliation>Interdisciplinary Faculty of Toxicology, Texas A&amp;M University, College Station, TX, USA; Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA. Electronic address: WChiu@cvm.tamu.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Adipose tissue-liver crosstalk during pathologic changes caused by vinyl chloride metabolites in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32445754</pubmedLink>
    <GrantList>
      <Grant>R03 DK107912</Grant>
      <Grant>P20 GM113226</Grant>
      <Grant>K01 DK096042</Grant>
      <Grant>R21 ES031531</Grant>
      <Grant>R01 AA021978</Grant>
      <Grant>R01 AA028436</Grant>
      <Grant>P30 DK120531</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30192-7</DOI>
    <KeywordList>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Metabolic syndrome</Keywords>
      <Keywords>PVC</Keywords>
      <Keywords>Plastic</Keywords>
      <Keywords>Saturated fat</Keywords>
      <Keywords>TASH</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brenna R. Kaelin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, United States of America; Hepatobiology and Toxicology Program, University of Louisville, Louisville, KY 40292, United States of America. Electronic address: brka222@uky.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Collin M. McKenzie</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, United States of America; Hepatobiology and Toxicology Program, University of Louisville, Louisville, KY 40292, United States of America. Electronic address: cmmckenz@wakehealth.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Karl W. Hempel</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, United States of America; Hepatobiology and Toxicology Program, University of Louisville, Louisville, KY 40292, United States of America. Electronic address: kwhemp01@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Anna L. Lang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, United States of America; Hepatobiology and Toxicology Program, University of Louisville, Louisville, KY 40292, United States of America. Electronic address: all159@med.miami.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Gavin E. Arteel</Name>
        <Affiliation>Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, PA 15213, United States of America; Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA 15213, United States of America. Electronic address: gearteel@pitt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Juliane I. Beier</Name>
        <Affiliation>Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, PA 15213, United States of America; Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA 15213, United States of America. Electronic address: jibeier@pitt.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Sesamin suppresses NSCLC cell proliferation through cyclin D1 inhibition-dependent cell cycle arrest via Akt/p53 pathway" [Toxicology and applied pharmacology, 387 (2020) 114848].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32428595</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30172-1</DOI>
    <AuthorList>
      <Author>
        <Name>Yueming Chen</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huachao Li</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weinan Zhang</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanchen Qi</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changpeng Lu</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huiliang Huang</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhicheng Yang</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Liu</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangdong Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou 510006, China. Electronic address: liubing520@gdpu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Luyong Zhang</Name>
        <Affiliation>Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China; The Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou 510006, China. Electronic address: lyonzhang@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Overexpression of the constitutive androstane receptor and shaken 3D-culturing increase biotransformation and oxidative phosphorylation and sensitivity to mitochondrial amiodarone toxicity of HepaRG cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32428594</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30179-4</DOI>
    <KeywordList>
      <Keywords>Amiodarone</Keywords>
      <Keywords>Energy metabolism</Keywords>
      <Keywords>Hepatocyte</Keywords>
      <Keywords>Mitochondria</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vincent A. van der Mark</Name>
        <Affiliation>Amsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&amp;M, Meibergdreef 69-71, 1105 BK, Amsterdam, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aziza A. A. Adam</Name>
        <Affiliation>Amsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&amp;M, Meibergdreef 69-71, 1105 BK, Amsterdam, the Netherlands. Electronic address: a.abdelrahmanabubakradam@amc.uva.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Chin Chang</Name>
        <Affiliation>Amsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&amp;M, Meibergdreef 69-71, 1105 BK, Amsterdam, the Netherlands. Electronic address: j.chang@amc.uva.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald P. Oude Elferink</Name>
        <Affiliation>Amsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&amp;M, Meibergdreef 69-71, 1105 BK, Amsterdam, the Netherlands. Electronic address: r.p.oude-elferink@amc.uva.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Robert A. F. M. Chamuleau</Name>
        <Affiliation>Amsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&amp;M, Meibergdreef 69-71, 1105 BK, Amsterdam, the Netherlands. Electronic address: r.a.chamuleau@amc.uva.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Ruurdtje Hoekstra</Name>
        <Affiliation>Amsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&amp;M, Meibergdreef 69-71, 1105 BK, Amsterdam, the Netherlands. Electronic address: r.hoekstra@amc.uva.nl.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>World Trade Center Dust induces airway inflammation while promoting aortic endothelial dysfunction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32428593</pubmedLink>
    <GrantList>
      <Grant>T32 ES007324</Grant>
      <Grant>S10 OD019966</Grant>
      <Grant>P30 ES000260</Grant>
      <Grant>R01 OH010921</Grant>
      <Grant>F31 ES025591</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30165-4</DOI>
    <KeywordList>
      <Keywords>Endothelial cell dysfunction</Keywords>
      <Keywords>Inhalation toxicology</Keywords>
      <Keywords>Intranasal instillation</Keywords>
      <Keywords>Particulate matter exposure</Keywords>
      <Keywords>Pulmonary inflammation</Keywords>
      <Keywords>World trade center dust</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michelle Hernandez</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Harrington</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yanqin Ma</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karen Galdanes</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Beth Halzack</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mianhua Zhong</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua Vaughan</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ethan Sebasco</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Terry Gordon</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Morton Lippmann</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lung Chi Chen</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA. Electronic address: lcc4@nyu.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cholecystokinin-1 receptor agonist induced pathological findings in the exocrine pancreas of non-human primates.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32422327</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30159-9</DOI>
    <KeywordList>
      <Keywords>CCK-1 receptor</Keywords>
      <Keywords>CCK-1R</Keywords>
      <Keywords>Non-human primate</Keywords>
      <Keywords>Pancreas hyperplasia</Keywords>
      <Keywords>Pancreatitis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Niels Chresten Berg Nyborg</Name>
        <Affiliation>Department of NCD Project Management, Global Drug Discovery, Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Maaloev, Denmark. Electronic address: NCBN@novonordisk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rikke Kaae Kirk</Name>
        <Affiliation>Department of Pathology and Imaging, Global Drug Discovery, Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Maaloev, Denmark. Electronic address: RKKI@novonordisk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Sietske de Boer</Name>
        <Affiliation>Department of Safety Pharmacology &amp; Early toxicology, Global Drug Discovery, Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Maaloev, Denmark. Electronic address: ASB@novonordisk.com.</Affiliation>
      </Author>
      <Author>
        <Name>David Wederkinck Andersen</Name>
        <Affiliation>Department of LCMS Bioanalysis, Global Drug Discovery, Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Maaloev, Denmark. Electronic address: DWEA@novonordisk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Bugge</Name>
        <Affiliation>Liver Disease Research, Global Drug Discovery, Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Maaloev, Denmark. Electronic address: AZBU@novonordisk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Birgitte Schjellerup Wulff</Name>
        <Affiliation>Obesity Research, Global Drug Discovery, Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Maaloev, Denmark. Electronic address: BSW@novonordisk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Inger Thorup</Name>
        <Affiliation>Department of Pathology and Imaging, Global Drug Discovery, Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Maaloev, Denmark. Electronic address: inger.thorup@get2net.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Trine Ryberg Clausen</Name>
        <Affiliation>Department of Obesity Biology, Global Drug Discovery, Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Maaloev, Denmark. Electronic address: TRRS@novonordisk.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All authors are, or were, employees at Novo Nordisk A/S when the work was done, and most are minor shareholders in Novo Nordisk A/S and/or other pharma companies.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MiR-122-5p increases radiosensitivity and aggravates radiation-induced rectal injury through CCAR1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32422326</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30178-2</DOI>
    <KeywordList>
      <Keywords>CCAR1</Keywords>
      <Keywords>Radiosensitivity</Keywords>
      <Keywords>Rectal injury</Keywords>
      <Keywords>miR-122-5p</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yulong Ge</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenzhi Tu</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junjun Li</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuming Chen</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Chen</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Xu</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiqing Xu</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaming Wang</Name>
        <Affiliation>Department of General Surgery, HanDan Central Hospital, Handan 056001, China. Electronic address: wymdz2008@outlook.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Liu</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China. Electronic address: yong.liu2@shgh.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest No conflicts of interest exist.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The circadian clock protects against acute radiation-induced dermatitis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32422325</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30164-2</DOI>
    <KeywordList>
      <Keywords>BMAL1</Keywords>
      <Keywords>Circadian Rhythm</Keywords>
      <Keywords>DNA Damage</Keywords>
      <Keywords>Radiodermatitis</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Panshak P. Dakup</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth I. Porter</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Shobhan Gaddameedhi</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, United States of America; Sleep and Performance Research Center, Washington State University, Spokane, WA, United States of America. Electronic address: shobhan.gaddameedhi@wsu.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A QSAR study that compares the ability of bisdioxopiperazine analogs of the doxorubicin cardioprotective agent dexrazoxane (ICRF-187) to protect myocytes with DNA topoisomerase II inhibition.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32417440</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30162-9</DOI>
    <KeywordList>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Dexrazoxane</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Mitindomide</Keywords>
      <Keywords>Myocyte</Keywords>
      <Keywords>Topoisomerase II</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brian B. Hasinoff</Name>
        <Affiliation>College of Pharmacy, Apotex Centre, University of Manitoba, Winnipeg, Manitoba R3E 0T5, Canada. Electronic address: B_Hasinoff@UManitoba.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Daywin Patel</Name>
        <Affiliation>College of Pharmacy, Apotex Centre, University of Manitoba, Winnipeg, Manitoba R3E 0T5, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Xing Wu</Name>
        <Affiliation>College of Pharmacy, Apotex Centre, University of Manitoba, Winnipeg, Manitoba R3E 0T5, Canada.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors report no declarations of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>ATPR induces acute promyelocytic leukemia cells differentiation and growth arrest by blockade of SHP2/Rho/ROCK1 pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32417439</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30177-0</DOI>
    <KeywordList>
      <Keywords>ATPR</Keywords>
      <Keywords>Acute promyelocytic leukemia (APL)</Keywords>
      <Keywords>Differentiation and growth arrest</Keywords>
      <Keywords>ROCK1</Keywords>
      <Keywords>Rho</Keywords>
      <Keywords>SHP2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lanlan Li</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoling Xu</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Du</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meiju Zhang</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yubin Feng</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuewen Qian</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shufang Li</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tianxi Du</Name>
        <Affiliation>Laboratory Animal Center, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqing Peng</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feihu Chen</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China. Electronic address: chenfeihu@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they do not have any competing financial interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An implanted port-catheter system for repeated hepatic arterial infusion of low-density lipoprotein-docosahexaenoic acid nanoparticles in normal rats: A safety study.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32417438</pubmedLink>
    <GrantList>
      <Grant>P30 CA142543</Grant>
      <Grant>R01 CA215702</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30161-7</DOI>
    <KeywordList>
      <Keywords>Docosahexaenoic acid</Keywords>
      <Keywords>Lipid oxidation</Keywords>
      <Keywords>Low-density lipoprotein</Keywords>
      <Keywords>Nanoparticle</Keywords>
      <Keywords>Nanoparticle safety</Keywords>
      <Keywords>Port-catheter systems</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuzhu Wang</Name>
        <Affiliation>Department of Hepatobiliary and pancreatic surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, Henan 450003, China; Advanced Imaging Research Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Junjie Li</Name>
        <Affiliation>Advanced Imaging Research Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Indhumathy Subramaniyan</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Department of Pharmacy Practice within the Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, TX 75235, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Goncalo Dias do Vale</Name>
        <Affiliation>Department of Molecular Genetics, Dallas, TX 75390, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jaideep Chaudhary</Name>
        <Affiliation>Advanced Imaging Research Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Arnida Anwar</Name>
        <Affiliation>Advanced Imaging Research Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Wight-Carter</Name>
        <Affiliation>Animal Resource Center, Dallas, TX 75390, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey G. McDonald</Name>
        <Affiliation>Department of Molecular Genetics, Dallas, TX 75390, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William C. Putnam</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Department of Pharmacy Practice within the Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, TX 75235, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Qin</Name>
        <Affiliation>Department of Hepatobiliary and pancreatic surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, Henan 450003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongwei Zhang</Name>
        <Affiliation>Department of Hepatobiliary and pancreatic surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, Henan 450003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ian R. Corbin</Name>
        <Affiliation>Advanced Imaging Research Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA; Internal Medicine Division of Liver and Digestive Diseases, Dallas, TX 75390, USA; RadiologyUniversity of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA. Electronic address: ian.corbin@utsouthwestern.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Elucidation of OATP1B1 and 1B3 transporter function using transgenic rodent models and commonly known single nucleotide polymorphisms.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32407928</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30163-0</DOI>
    <KeywordList>
      <Keywords>Bile acid</Keywords>
      <Keywords>Microcystin-LR</Keywords>
      <Keywords>OATP1B1</Keywords>
      <Keywords>OATP1B3</Keywords>
      <Keywords>Phalloidin</Keywords>
      <Keywords>Statin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Supratim Choudhuri</Name>
        <Affiliation>Office of Food Additive Safety, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD, United States of America. Electronic address: supratim.choudhuri@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Curtis D. Klaassen</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, School of Medicine, University of Kansas, Kansas City, KS, United States of America.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Luteolin prevents liver from tunicamycin-induced endoplasmic reticulum stress via nuclear factor erythroid 2-related factor 2-dependent sestrin 2 induction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32407927</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30160-5</DOI>
    <KeywordList>
      <Keywords>Endoplasmic reticulum (ER) stress</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Luteolin</Keywords>
      <Keywords>Nuclear factor erythroid 2-related factor 2 (Nrf2)</Keywords>
      <Keywords>Sestrin 2 (SESN2)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kyung Hwan Jegal</Name>
        <Affiliation>College of Korean Medicine, Daegu Haany University, Gyeongsan, Gyeongsangbuk-do 38610, Republic of Korea; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Ok Kim</Name>
        <Affiliation>College of Korean Medicine, Daegu Haany University, Gyeongsan, Gyeongsangbuk-do 38610, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Kwang Kim</Name>
        <Affiliation>College of Korean Medicine, Daegu Haany University, Gyeongsan, Gyeongsangbuk-do 38610, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Mi Park</Name>
        <Affiliation>College of Korean Medicine, Daegu Haany University, Gyeongsan, Gyeongsangbuk-do 38610, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dae Hwa Jung</Name>
        <Affiliation>Hani Bio Co., Ltd, 142 Yulam-ro, Daegu 41059, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gum Hwa Lee</Name>
        <Affiliation>College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Hwan Ki</Name>
        <Affiliation>College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Hui Byun</Name>
        <Affiliation>College of Korean Medicine, Daegu Haany University, Gyeongsan, Gyeongsangbuk-do 38610, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sae Kwang Ku</Name>
        <Affiliation>College of Korean Medicine, Daegu Haany University, Gyeongsan, Gyeongsangbuk-do 38610, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Il Je Cho</Name>
        <Affiliation>College of Korean Medicine, Daegu Haany University, Gyeongsan, Gyeongsangbuk-do 38610, Republic of Korea. Electronic address: skek023@dhu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Chan Kim</Name>
        <Affiliation>College of Korean Medicine, Daegu Haany University, Gyeongsan, Gyeongsangbuk-do 38610, Republic of Korea. Electronic address: sckim@dhu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Long-term mildronate treatment increased Proteobacteria level in gut microbiome, and caused behavioral deviations and transcriptome change in liver, heart and brain of healthy mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32389661</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30155-1</DOI>
    <AuthorList>
      <Author>
        <Name>Artem P. Gureev</Name>
        <Affiliation>Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russia. Electronic address: gureev@bio.vsu.ru.</Affiliation>
      </Author>
      <Author>
        <Name>Ekaterina A. Shaforostova</Name>
        <Affiliation>Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Inna Yu Vitkalova</Name>
        <Affiliation>Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russia; Voronezh State University of Engineering Technologies, Voronezh, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Irina S. Sadovnikova</Name>
        <Affiliation>Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Yulia I. Kalinina</Name>
        <Affiliation>Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Vadim R. Cherednichenko</Name>
        <Affiliation>Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Karina A. Reznikova</Name>
        <Affiliation>Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Valeria V. Valuyskikh</Name>
        <Affiliation>Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Vasily N. Popov</Name>
        <Affiliation>Department of Genetics, Cytology and Bioengineering, Voronezh State University, Voronezh, Russia; Voronezh State University of Engineering Technologies, Voronezh, Russia.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bisphenolic compounds alter gene expression in MCF-7 cells through interaction with estrogen receptor α.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32387340</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30154-X</DOI>
    <KeywordList>
      <Keywords>Bisphenol</Keywords>
      <Keywords>Estrogen receptor</Keywords>
      <Keywords>Microplastic</Keywords>
      <Keywords>Next generation sequencing</Keywords>
      <Keywords>Tetramethyl bisphenol A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Madeleine Böckers</Name>
        <Affiliation>Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Norbert W. Paul</Name>
        <Affiliation>Institute for History, Theory and Ethics of Medicine, Johannes Gutenberg University Medical Center, Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Efferth</Name>
        <Affiliation>Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany. Electronic address: efferth@uni-mainz.de.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no actual or potential competing financial interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Anti-epileptic activity, toxicity and teratogenicity in CD1 mice of a novel valproic acid arylamide derivative, N-(2-hydroxyphenyl)-2-propylpentanamide.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32387339</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30157-5</DOI>
    <KeywordList>
      <Keywords>Epilepsy</Keywords>
      <Keywords>HO-AAVPA</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Teratogenicity</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Valproic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>José Melesio Cristóbal-Luna</Name>
        <Affiliation>Laboratorio de Toxicología Preclínica, Departamento de Farmacia, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Av. Wilfrido Massieu, Col. Zacatenco, Del. Gustavo A. Madero, Ciudad de México 07738, Mexico. Electronic address: josmcl@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>José Correa-Basurto</Name>
        <Affiliation>Laboratorio de Diseño y Desarrollo de Nuevos Farmacos e Innovación Biotecnológica, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Col. Casco de Santo Tomás, Del. Miguel Hidalgo, Ciudad de México 11340, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Humberto L. Mendoza-Figueroa</Name>
        <Affiliation>Laboratorio de Diseño y Desarrollo de Nuevos Farmacos e Innovación Biotecnológica, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Col. Casco de Santo Tomás, Del. Miguel Hidalgo, Ciudad de México 11340, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Germán Chamorro-Cevallos</Name>
        <Affiliation>Laboratorio de Toxicología Preclínica, Departamento de Farmacia, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Av. Wilfrido Massieu, Col. Zacatenco, Del. Gustavo A. Madero, Ciudad de México 07738, Mexico.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters hepatic polyunsaturated fatty acid metabolism and eicosanoid biosynthesis in female Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32387183</pubmedLink>
    <GrantList>
      <Grant>P42 ES004911</Grant>
      <Grant>T32 ES007255</Grant>
      <Grant>T32 GM092715</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30158-7</DOI>
    <KeywordList>
      <Keywords>2,3,7,8-Tetracholorodibenzo-p-dioxin</Keywords>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Eicosanoids</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Leukotrienes</Keywords>
      <Keywords>Polyunsaturated fatty acids</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Claire M. Doskey</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kelly A. Fader</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rance Nault</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Todd Lydic</Name>
        <Affiliation>Department of Physiology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Matthews</Name>
        <Affiliation>Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo 0316, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Dave Potter</Name>
        <Affiliation>Wellington Laboratories Inc., Guelph, Ontario NIG 3M5, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Bonnie Sharratt</Name>
        <Affiliation>Wellington Laboratories Inc., Guelph, Ontario NIG 3M5, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Kurt Williams</Name>
        <Affiliation>Department of Pathobiology and Diagnostic Investigation, Michigan State, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tim Zacharewski</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States. Electronic address: tzachare@msu.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32387182</pubmedLink>
    <GrantList>
      <Grant>R01 CA246209</Grant>
      <Grant>R01 GM070737</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30156-3</DOI>
    <KeywordList>
      <Keywords>Efflux transporters</Keywords>
      <Keywords>Enzymes</Keywords>
      <Keywords>Irinotecan</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Uridine diphosphate glucuronosyltransferase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rongjin Sun</Name>
        <Affiliation>Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong, China; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, 4901 Calhoun Street, Houston, TX 77204, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lijun Zhu</Name>
        <Affiliation>Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Li</Name>
        <Affiliation>Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, 4901 Calhoun Street, Houston, TX 77204, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjie Song</Name>
        <Affiliation>Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xia Gong</Name>
        <Affiliation>Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoxiao Qi</Name>
        <Affiliation>Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Wang</Name>
        <Affiliation>Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Romi Ghose</Name>
        <Affiliation>Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, 4901 Calhoun Street, Houston, TX 77204, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Song Gao</Name>
        <Affiliation>Department of Pharmaceutical and Environmental Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, TX 77004, United States. Electronic address: song.gao@tsu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Hu</Name>
        <Affiliation>Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, 4901 Calhoun Street, Houston, TX 77204, United States. Electronic address: mhu4@central.uh.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongqiu Liu</Name>
        <Affiliation>Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong, China. Electronic address: liuzq@gzucm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Resveratrol protects against PM2.5-induced heart defects in zebrafish embryos as an antioxidant rather than as an AHR antagonist.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32376357</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30153-8</DOI>
    <KeywordList>
      <Keywords>AHR</Keywords>
      <Keywords>Cardiac development</Keywords>
      <Keywords>PM2.5</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>Resveratrol</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fei Ren</Name>
        <Affiliation>Medical College of Soochow University, Suzhou, China; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Soochow University, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yujie Huang</Name>
        <Affiliation>Medical College of Soochow University, Suzhou, China; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Soochow University, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yizhou Tao</Name>
        <Affiliation>Medical College of Soochow University, Suzhou, China; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Soochow University, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Ji</Name>
        <Affiliation>Medical College of Soochow University, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Stanley Aniagu</Name>
        <Affiliation>Toxicology, Risk Assessment and Research Division, Texas Commission on Environmental Quality, 12015 Park 35 Cir, Austin, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Jiang</Name>
        <Affiliation>Medical College of Soochow University, Suzhou, China. Electronic address: yjiang@suda.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Chen</Name>
        <Affiliation>Medical College of Soochow University, Suzhou, China; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Soochow University, Suzhou, China. Electronic address: tchen@suda.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Maternal-fetal disposition of domoic acid following repeated oral dosing during pregnancy in nonhuman primate.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32360744</pubmedLink>
    <GrantList>
      <Grant>P50 HD103524</Grant>
      <Grant>P51 OD010425</Grant>
      <Grant>R01 ES023043</Grant>
      <Grant>U54 HD083091</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30151-4</DOI>
    <AuthorList>
      <Author>
        <Name>Sara Shum</Name>
        <Affiliation>Department of Pharmaceutics, University of Washington, Seattle, Washington, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Jing</Name>
        <Affiliation>Department of Pharmaceutics, University of Washington, Seattle, Washington, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rebekah Petroff</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brenda Crouthamel</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kimberly S. Grant</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, USA; Infant Primate Research Laboratory, Washington National Primate Research Center, Seattle, Washington, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas M. Burbacher</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, USA; Center on Human Development and Disability, University of Washington, Seattle, Washington, USA; Infant Primate Research Laboratory, Washington National Primate Research Center, Seattle, Washington, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nina Isoherranen</Name>
        <Affiliation>Department of Pharmaceutics, University of Washington, Seattle, Washington, USA; Center on Human Development and Disability, University of Washington, Seattle, Washington, USA. Electronic address: ni2@uw.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cognitive enhancing effect of diapocynin in D-galactose-ovariectomy-induced Alzheimer's-like disease in rats: Role of ERK, GSK-3β, and JNK signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32360636</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30152-6</DOI>
    <KeywordList>
      <Keywords>Alzheimer's disease</Keywords>
      <Keywords>Diapocynin</Keywords>
      <Keywords>Morris water maze</Keywords>
      <Keywords>NADPH oxidase</Keywords>
      <Keywords>Novel object recognition</Keywords>
      <Keywords>Ovariectomy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Weam W. Ibrahim</Name>
        <Affiliation>Pharmacology &amp; Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Hesham M. Ismail</Name>
        <Affiliation>Pharmaceutical Biochemistry Department, School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Mahmoud M. Khattab</Name>
        <Affiliation>Pharmacology &amp; Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Noha F. Abdelkader</Name>
        <Affiliation>Pharmacology &amp; Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: noha.fawzy@pharma.cu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigating DNA adduct formation by flavor chemicals and tobacco byproducts in electronic nicotine delivery system (ENDS) using in silico approaches.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32353386</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30150-2</DOI>
    <KeywordList>
      <Keywords>Aldehydes</Keywords>
      <Keywords>Alkenylbenzenes</Keywords>
      <Keywords>DNA adducts</Keywords>
      <Keywords>E-cigarettes</Keywords>
      <Keywords>Flavors</Keywords>
      <Keywords>In silico toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jueichuan Connie Kang</Name>
        <Affiliation>United States Food and Drug Administration, Center for Tobacco Products, Office of Science, Division of Nonclinical Science, 11785 Beltsville Drive, Calverton, MD 20705, USA; US Public Health Service Commissioned Corps, Rockville, MD, USA. Electronic address: Jueichuan.Kang@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Luis G. Valerio</Name>
        <Affiliation>United States Food and Drug Administration, Center for Tobacco Products, Office of Science, Division of Nonclinical Science, 11785 Beltsville Drive, Calverton, MD 20705, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metabolomic-based assessment reveals dysregulation of lipid profiles in human liver cells exposed to environmental obesogens.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32353385</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30133-2</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>HepaRG cell line</Keywords>
      <Keywords>Lipidomics</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Obesogens</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marco E. Franco</Name>
        <Affiliation>Department of Environmental Science, Baylor University, Waco, TX 76798, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Maria T. Fernandez-Luna</Name>
        <Affiliation>Department of Biology, Baylor University, Waco, TX 76798, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandro J. Ramirez</Name>
        <Affiliation>Mass Spectrometry Center, Baylor University, Waco, TX 76798, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Ramon Lavado</Name>
        <Affiliation>Department of Environmental Science, Baylor University, Waco, TX 76798, United States of America. Electronic address: Ramon_Lavado@baylor.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>KRAS-retroviral fusion transcripts and gene amplification in arsenic-transformed, human prostate CAsE-PE cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32344290</pubmedLink>
    <GrantList>
      <Grant>Z99 ES999999</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30141-1</DOI>
    <KeywordList>
      <Keywords>Amplification</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>KRAS</Keywords>
      <Keywords>Prostate</Keywords>
      <Keywords>Retrovirus</Keywords>
      <Keywords>Transformation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>B. Alex Merrick</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States. Electronic address: merrick@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Dhiral P. Phadke</Name>
        <Affiliation>Sciome, LLC, Research Triangle Park, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Meredith A. Bostrom</Name>
        <Affiliation>David H. Murdock Research Institute, Kannapolis, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ruchir R. Shah</Name>
        <Affiliation>Sciome, LLC, Research Triangle Park, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Garron M. Wright</Name>
        <Affiliation>David H. Murdock Research Institute, Kannapolis, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Xinguo Wang</Name>
        <Affiliation>David H. Murdock Research Institute, Kannapolis, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Oksana Gordon</Name>
        <Affiliation>David H. Murdock Research Institute, Kannapolis, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Katherine E. Pelch</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Scott S. Auerbach</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Richard S. Paules</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. DeVito</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael P. Waalkes</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Erik J. Tokar</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors have no other conflicts to declare.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PCC0208023, a potent SHP2 allosteric inhibitor, imparts an antitumor effect against KRAS mutant colorectal cancer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32335126</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30143-5</DOI>
    <KeywordList>
      <Keywords>Allosteric inhibitor</Keywords>
      <Keywords>Colorectal cancer</Keywords>
      <Keywords>KRAS</Keywords>
      <Keywords>PCC0208023</Keywords>
      <Keywords>SHP2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiao Chen</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fangxia Zou</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengping Hu</Name>
        <Affiliation>School of Public Health and Management &amp; Institute of Toxicology, Binzhou Medical University, Yantai 264003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangying Du</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengfei Yu</Name>
        <Affiliation>School of Public Health and Management &amp; Institute of Toxicology, Binzhou Medical University, Yantai 264003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenyan Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongbo Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Ye</Name>
        <Affiliation>School of Public Health and Management &amp; Institute of Toxicology, Binzhou Medical University, Yantai 264003, China. Electronic address: project0088@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwei Tian</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China. Electronic address: ytupharmlab@163.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The selective c-Met inhibitor capmatinib offsets cisplatin-nephrotoxicity and doxorubicin-cardiotoxicity and improves their anticancer efficacies.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32333917</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30142-3</DOI>
    <KeywordList>
      <Keywords>C-Met</Keywords>
      <Keywords>Capmatinib</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Doxorubicin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohamed E. Shaker</Name>
        <Affiliation>Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia.; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.. Electronic address: mshaker2222@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmed A. Shaaban</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Aqaba University of Technology, Aqaba 77110, Jordan.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed M. El-Shafey</Name>
        <Affiliation>Department of Anatomy, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt; Department of Physiological Sciences, Fakeeh College for Medical Sciences, Jeddah 2537, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed E. El-Mesery</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no competing interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A drug potency signature links progression of chronic lymphocytic leukemia to mitochondria-related stress responses and metabolic reprogramming under hypoxia.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32325063</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30140-X</DOI>
    <KeywordList>
      <Keywords>Chronic lymphocytic leukemia</Keywords>
      <Keywords>Drug interactions</Keywords>
      <Keywords>Hypoxia</Keywords>
      <Keywords>Metabolic reprogramming</Keywords>
      <Keywords>Regulated cell death</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laura I. Kornblihtt</Name>
        <Affiliation>Department of Hematology, Clinics Hospital, Jose de San Martin, University of Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>María C. Cabral Lorenzo</Name>
        <Affiliation>Department of Pathology, Clinics Hospital, Jose de San Martin, University of Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Martin L. Gil Folgar</Name>
        <Affiliation>Laboratory of Immunotoxicology (LaITo), IDEHU-CONICET, Clinics Hospital, Jose de San Martin, University of Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Clelia J. Minissale</Name>
        <Affiliation>Department of Hematology, Clinics Hospital, Jose de San Martin, University of Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Cecilia Malusardi</Name>
        <Affiliation>Department of Hematology, Clinics Hospital, Jose de San Martin, University of Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Francisca Rojas</Name>
        <Affiliation>Department of Hematology, Clinics Hospital, Jose de San Martin, University of Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Tomás Lombardo</Name>
        <Affiliation>Laboratory of Immunotoxicology (LaITo), IDEHU-CONICET, Clinics Hospital, Jose de San Martin, University of Buenos Aires (UBA), Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Guillermo A. Blanco</Name>
        <Affiliation>Laboratory of Immunotoxicology (LaITo), IDEHU-CONICET, Clinics Hospital, Jose de San Martin, University of Buenos Aires (UBA), Buenos Aires, Argentina. Electronic address: gblanco@ffyb.uba.ar.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hyperthermia exacerbates the acute effects of psychoactive substances on neuronal activity measured using microelectrode arrays (MEAs) in rat primary cortical cultures in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32320794</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30139-3</DOI>
    <KeywordList>
      <Keywords>Designer drugs</Keywords>
      <Keywords>Hazard characterization</Keywords>
      <Keywords>Hyperthermia</Keywords>
      <Keywords>In vitro neuronal function</Keywords>
      <Keywords>Neuronal activity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anne Zwartsen</Name>
        <Affiliation>Neurotoxicology Research Group, Division Toxicology, Institute for Risk Assessment Sciences (IRAS), Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands; Dutch Poisons Information Center (DPIC), University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Hondebrink</Name>
        <Affiliation>Dutch Poisons Information Center (DPIC), University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Dylan W. de Lange</Name>
        <Affiliation>Dutch Poisons Information Center (DPIC), University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Remco H. S. Westerink</Name>
        <Affiliation>Neurotoxicology Research Group, Division Toxicology, Institute for Risk Assessment Sciences (IRAS), Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands. Electronic address: r.westerink@uu.nl.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Crotonaldehyde-induced vascular relaxation and toxicity: Role of endothelium and transient receptor potential ankyrin-1 (TRPA1).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32320793</pubmedLink>
    <GrantList>
      <Grant>T32 ES011564</Grant>
      <Grant>P30 GM127607</Grant>
      <Grant>R01 HL122676</Grant>
      <Grant>U54 HL120163</Grant>
      <Grant>R01 HL149351</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30136-8</DOI>
    <KeywordList>
      <Keywords>Aldehydes</Keywords>
      <Keywords>Crotonaldehyde (CR)</Keywords>
      <Keywords>EDRF</Keywords>
      <Keywords>Mesenteric artery</Keywords>
      <Keywords>Nitric oxide (NO)</Keywords>
      <Keywords>Transient receptor potential ankyrin-1 (TRPA1)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>L. Jin</Name>
        <Affiliation>Department of Anesthesiology, Critical Care and Pain Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY, USA; Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation Center, University of Louisville, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. Jagatheesan</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation Center, University of Louisville, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Lynch</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY, USA; Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation Center, University of Louisville, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>L. Guo</Name>
        <Affiliation>Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation Center, University of Louisville, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. J. Conklin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY, USA; Christina Lee Brown Envirome Institute, University of Louisville, Louisville, KY, USA; Diabetes and Obesity Center, University of Louisville, Louisville, KY, USA; American Heart Association-Tobacco Regulation Center, University of Louisville, Louisville, KY, USA. Electronic address: dj.conklin@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no conflicts of interest with the contents of this article.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rosmarinic acid exerts a neuroprotective effect on spinal cord injury by suppressing oxidative stress and inflammation via modulating the Nrf2/HO-1 and TLR4/NF-κB pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32320792</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30138-1</DOI>
    <KeywordList>
      <Keywords>Inflammation</Keywords>
      <Keywords>Nrf2/HO-1 Pathway</Keywords>
      <Keywords>Oxidative Stress</Keywords>
      <Keywords>Rosmarinic Acid</Keywords>
      <Keywords>Spinal Cord Injury</Keywords>
      <Keywords>TLR4/NF-κB Pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhanjun Ma</Name>
        <Affiliation>The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730030, China; Department of Orthopedics, Lanzhou University Second Hospital, Lanzhou, Gansu 730030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yubao Lu</Name>
        <Affiliation>The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengguang Yang</Name>
        <Affiliation>The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaoping Li</Name>
        <Affiliation>The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuegang He</Name>
        <Affiliation>The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yicheng Gao</Name>
        <Affiliation>The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangzhi Zhang</Name>
        <Affiliation>The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Enhui Ren</Name>
        <Affiliation>The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonggang Wang</Name>
        <Affiliation>The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730030, China; Department of Orthopedics, Lanzhou University Second Hospital, Lanzhou, Gansu 730030, China; The International Cooperation Base of Gansu Province for the Pain Research in Spinal Disorders, Gansu 730000, China. Electronic address: wangyg18@lzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xuewen Kang</Name>
        <Affiliation>The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730030, China; Department of Orthopedics, Lanzhou University Second Hospital, Lanzhou, Gansu 730030, China; The International Cooperation Base of Gansu Province for the Pain Research in Spinal Disorders, Gansu 730000, China. Electronic address: ery_kangxw@lzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic trioxide-induced p38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32305283</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30137-X</DOI>
    <KeywordList>
      <Keywords>Akt-controlled MCL1 degradation</Keywords>
      <Keywords>Arsenic trioxide</Keywords>
      <Keywords>Leukemia</Keywords>
      <Keywords>p38 MAPK-modulated MCL1 transcription</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chia Hui Huang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Chin Lee</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Ting Chiou</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Jun Shi</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Jun Wang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Long Sen Chang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan; Department of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan. Electronic address: lschang@mail.nsysu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Challenge-comet assay, a functional and genomic biomarker for precision risk assessment and disease prevention among exposed workers.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32305282</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30135-6</DOI>
    <KeywordList>
      <Keywords>Challenge assay</Keywords>
      <Keywords>Comet/hComet assay</Keywords>
      <Keywords>DNA damage and repair response</Keywords>
      <Keywords>Disease prevention</Keywords>
      <Keywords>Occupational exposure</Keywords>
      <Keywords>Personalized risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jianzhen Xu</Name>
        <Affiliation>Shantou University Medical College, Shantou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Radim J. Sram</Name>
        <Affiliation>Institute of Experimental Medicine AS, CR, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Antonina Cebulska-Wasilewska</Name>
        <Affiliation>Niewodniczański Institute of Nuclear Physics, Krakow, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Mirjana V. Miloradov</Name>
        <Affiliation>Faculty of Technical Sciences, University of Novi Sad, Novi Sad, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Semra Sardas</Name>
        <Affiliation>Istinye University, Zeytinburnu, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>William W. Au</Name>
        <Affiliation>University of Medicine, Pharmacy, Sciences and Technology, Targu Mures, Romania; University of Texas Medical Branch, Galveston, TX, USA. Electronic address: wau@stu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mechanism underlying hooked resurgent-like tail currents induced by an insecticide in human cardiac Nav1.5.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32302602</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30134-4</DOI>
    <KeywordList>
      <Keywords>Deltamethrin</Keywords>
      <Keywords>Human Nav1.5</Keywords>
      <Keywords>Pyrethroid</Keywords>
      <Keywords>Resurgent current</Keywords>
      <Keywords>Sodium channel gating states</Keywords>
      <Keywords>Voltage-gated sodium channel</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sarah Thull</Name>
        <Affiliation>Institute of Physiology, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Cristian Neacsu</Name>
        <Affiliation>Institut für Physiologie und Pathophysiologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstr. 17, 91054 Erlangen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andrias O. O'Reilly</Name>
        <Affiliation>School of Natural Sciences and Psychology, Liverpool John Moores University, Liverpool, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Stefanie Bothe</Name>
        <Affiliation>Institute of Physiology, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany; Research Training Group 2416 MultiSenses-MultiScales, RWTH Aachen University, Aachen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ralf Hausmann</Name>
        <Affiliation>Institute of Clinical Pharmacology, RWTH Aachen University, Wendlingweg 2, 52074 Aachen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tobias Huth</Name>
        <Affiliation>Institut für Physiologie und Pathophysiologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstr. 17, 91054 Erlangen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jannis Meents</Name>
        <Affiliation>Institute of Physiology, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany. Electronic address: jmeents@multichannelsystems.com.</Affiliation>
      </Author>
      <Author>
        <Name>Angelika Lampert</Name>
        <Affiliation>Institute of Physiology, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany; Research Training Group 2416 MultiSenses-MultiScales, RWTH Aachen University, Aachen, Germany; Research Training Group 2415 ME3T, RWTH Aachen University, Aachen, Germany. Electronic address: alampert@ukaachen.de.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Phenylephrine alleviates </ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32278511</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30123-X</DOI>
    <KeywordList>
      <Keywords>(131)I</Keywords>
      <Keywords>Lissencephaly-1</Keywords>
      <Keywords>Phenylephrine</Keywords>
      <Keywords>Sca-1/SOX2</Keywords>
      <Keywords>Stem cell marker</Keywords>
      <Keywords>Submandibular gland</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xin Yue Wang</Name>
        <Affiliation>Laboratory of Oral and Maxillofacial Disease, Second Hospital of Dalian Medical University, Dalian, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Yu</Name>
        <Affiliation>Department of Nuclear Medicine, Second Hospital of Dalian Medical University, Dalian, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhang</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Peking University School of Basic Medical Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fu Yin Zhang</Name>
        <Affiliation>Department of Oral and Maxillofacial Surgery, Second Hospital of Dalian Medical University, Dalian, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Liu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Xiang</Name>
        <Affiliation>Laboratory of Oral and Maxillofacial Disease, Second Hospital of Dalian Medical University, Dalian, Liaoning, China. Electronic address: xiangbin72@163.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective effect of bleomycin on 5-azacitidine induced cytotoxicity and apoptosis in mice hematopoietic stem cells via Bcl-2/Bax and HMGB1 signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32278510</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30120-4</DOI>
    <KeywordList>
      <Keywords>5-Azacitidine</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Bleomycin</Keywords>
      <Keywords>HMGB1</Keywords>
      <Keywords>Hematopoietic stem cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hoda Gol Fakhrabadi</Name>
        <Affiliation>Department of Biochemistry, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Azra Rabbani-Chadegani</Name>
        <Affiliation>Department of Biochemistry, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran. Electronic address: arabbani@ut.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Parinaz Ghadam</Name>
        <Affiliation>Department of Biotechnology, Faculty of Biological Science, University of Alzahra, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Somayeh Amiri</Name>
        <Affiliation>Department of Biochemistry, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there is no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32277947</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30125-3</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Chemoresistance</Keywords>
      <Keywords>Drug repurposing</Keywords>
      <Keywords>Mebendazole</Keywords>
      <Keywords>Notch1</Keywords>
      <Keywords>T cell acute lymphoblastic leukemia</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaolei Wang</Name>
        <Affiliation>East China University of Science and Technology, State Key Laboratory of Bioreactor Engineering, Shanghai 200237, China; East China University of Science and Technology, School of Pharmacy, Department of Pharmaceutical Sciences, Shanghai 200237, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kaiyan Lou</Name>
        <Affiliation>East China University of Science and Technology, State Key Laboratory of Bioreactor Engineering, Shanghai 200237, China; East China University of Science and Technology, School of Pharmacy, Department of Pharmaceutical Sciences, Shanghai 200237, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodong Song</Name>
        <Affiliation>Medical laboratory Department, Hua Shan Hospital North, Fudan University, Shanghai 201907, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huijuan Ma</Name>
        <Affiliation>East China University of Science and Technology, State Key Laboratory of Bioreactor Engineering, Shanghai 200237, China; East China University of Science and Technology, School of Pharmacy, Department of Pharmaceutical Sciences, Shanghai 200237, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinyi Zhou</Name>
        <Affiliation>East China University of Science and Technology, State Key Laboratory of Bioreactor Engineering, Shanghai 200237, China; East China University of Science and Technology, School of Pharmacy, Department of Pharmaceutical Sciences, Shanghai 200237, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huan Xu</Name>
        <Affiliation>East China University of Science and Technology, State Key Laboratory of Bioreactor Engineering, Shanghai 200237, China; East China University of Science and Technology, School of Pharmacy, Department of Pharmaceutical Sciences, Shanghai 200237, China. Electronic address: xuhuan@ecust.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Wang</Name>
        <Affiliation>East China University of Science and Technology, State Key Laboratory of Bioreactor Engineering, Shanghai 200237, China; East China University of Science and Technology, School of Pharmacy, Department of Pharmaceutical Sciences, Shanghai 200237, China; Department of Pharmacology and Toxicology and BIO5 Institute, University of Arizona, Tucson, AZ 85721-0207, USA. Electronic address: wwang@pharmacy.arizona.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors have filed a patent application on the repurposing of mebendazole to T cell acute lymphoblastic leukemia (application No. 2019107596441, publication No. CN110585199A).</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure to low doses of inorganic arsenic induces transgenerational changes on behavioral and epigenetic markers in zebrafish (Danio rerio).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32277946</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30126-5</DOI>
    <KeywordList>
      <Keywords>Behavioral toxicology</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Neurodevelopment genes</Keywords>
      <Keywords>Transgenerational</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Selma Valles</Name>
        <Affiliation>Facultad de Ciencias, Universidad Autónoma de Baja California (UABC), Carretera Tijuana-Ensenada 3917, Playitas, 22860 Ensenada, B.C., Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Hernández-Sánchez</Name>
        <Affiliation>Facultad de Ciencias, Universidad Autónoma de Baja California (UABC), Carretera Tijuana-Ensenada 3917, Playitas, 22860 Ensenada, B.C., Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Víctor René Dipp</Name>
        <Affiliation>Facultad de Ciencias, Universidad Autónoma de Baja California (UABC), Carretera Tijuana-Ensenada 3917, Playitas, 22860 Ensenada, B.C., Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Darién Huerta-González</Name>
        <Affiliation>Facultad de Ciencias, Universidad Autónoma de Baja California (UABC), Carretera Tijuana-Ensenada 3917, Playitas, 22860 Ensenada, B.C., Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Tatiana N. Olivares-Bañuelos</Name>
        <Affiliation>Instituto de Investigaciones Oceanológicas, Universidad Autónoma de Baja California, Ensenada, Baja California, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Jose González-Fraga</Name>
        <Affiliation>Facultad de Ciencias, Universidad Autónoma de Baja California (UABC), Carretera Tijuana-Ensenada 3917, Playitas, 22860 Ensenada, B.C., Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Ulises Bardullas</Name>
        <Affiliation>Facultad de Ciencias, Universidad Autónoma de Baja California (UABC), Carretera Tijuana-Ensenada 3917, Playitas, 22860 Ensenada, B.C., Mexico. Electronic address: bardullas@uabc.edu.mx.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of CYP3A4*22 and CYP3A4*1B but not CYP3A5*3 polymorphisms on tacrolimus pharmacokinetic model in Tunisian kidney transplant.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32275916</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30124-1</DOI>
    <KeywordList>
      <Keywords>CYP3A4</Keywords>
      <Keywords>CYP3A5</Keywords>
      <Keywords>Pharmacokinetic Model</Keywords>
      <Keywords>Tacrolimus</Keywords>
      <Keywords>Tunisian Population</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ibtissem Hannachi</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia; Faculty of Sciences of Bizerte, Carthage University, Tunisia. Electronic address: hannachi_ibtissem@yahoo.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Nadia Ben Fredj</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Zohra Chadli</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Najah Ben Fadhel</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Haifa Ben Romdhane</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Yvan Touitou</Name>
        <Affiliation>Medical Chronobiology Unit, Fondation Rothschild, 75019 Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Naceur A. Boughattas</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Amel Chaabane</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Karim Aouam</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Medicine, University of Monastir, Tunisia.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32268151</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30122-8</DOI>
    <KeywordList>
      <Keywords>Casticin</Keywords>
      <Keywords>DNA Methyltransferase 1</Keywords>
      <Keywords>Hepatocellular carcinoma</Keywords>
      <Keywords>Stemness</Keywords>
      <Keywords>miR-148a-3p</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiang Li</Name>
        <Affiliation>Department of Preclinical Medicine, Medical College, Hunan Normal University, Changsha 410013, China. Electronic address: lx58616@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lianghou Wang</Name>
        <Affiliation>Department of Preclinical Medicine, Medical College, Hunan Normal University, Changsha 410013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaocheng Cao</Name>
        <Affiliation>Department of Pharmaceutical Science, Medical College, Hunan Normal University, Changsha 410013, China; Key Laboratory of Study and Discover of Small Targeted Molecules of Hunan Province, Medical College, Hunan Normal University, Changsha 410013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingli Zhou</Name>
        <Affiliation>Department of Preclinical Medicine, Medical College, Hunan Normal University, Changsha 410013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Xu</Name>
        <Affiliation>Department of Pharmaceutical Science, Medical College, Hunan Normal University, Changsha 410013, China; Key Laboratory of Study and Discover of Small Targeted Molecules of Hunan Province, Medical College, Hunan Normal University, Changsha 410013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yinghong Cui</Name>
        <Affiliation>Department of Preclinical Medicine, Medical College, Hunan Normal University, Changsha 410013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yebei Qiu</Name>
        <Affiliation>Department of Pharmaceutical Science, Medical College, Hunan Normal University, Changsha 410013, China; Key Laboratory of Study and Discover of Small Targeted Molecules of Hunan Province, Medical College, Hunan Normal University, Changsha 410013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Cao</Name>
        <Affiliation>Department of Pharmaceutical Science, Medical College, Hunan Normal University, Changsha 410013, China; Key Laboratory of Study and Discover of Small Targeted Molecules of Hunan Province, Medical College, Hunan Normal University, Changsha 410013, China. Electronic address: caojianguo2005@126.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no competing interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of dapagliflozin and statins attenuate renal injury and liver steatosis in high-fat/high-fructose diet-induced insulin resistant rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32259528</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30121-6</DOI>
    <KeywordList>
      <Keywords>Dapagliflozin</Keywords>
      <Keywords>Insulin Resistance</Keywords>
      <Keywords>Liver Steatosis</Keywords>
      <Keywords>Renal Lipotoxicity</Keywords>
      <Keywords>Statins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laongdao Thongnak</Name>
        <Affiliation>Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Varanuj Chatsudthipong</Name>
        <Affiliation>Research Center of Transport Protein for Medical Innovation, Faculty of Science, Mahidol University, Bangkok, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Aphisek Kongkaew</Name>
        <Affiliation>Research Administration Section, Faculty of Medicine, Chiang Mai University, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Anusorn Lungkaphin</Name>
        <Affiliation>Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Functional Food Research Center for Well-being, Chiang Mai University, Chiang Mai, Thailand. Electronic address: anusorn.lungka@cmu.ac.th.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative physiology and efficacy of atropine and scopolamine in sarin nerve agent poisoning.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32251685</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30118-6</DOI>
    <KeywordList>
      <Keywords>Atropine</Keywords>
      <Keywords>ECG</Keywords>
      <Keywords>EEG</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Sarin</Keywords>
      <Keywords>Scopolamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alex S. Cornelissen</Name>
        <Affiliation>TNO Defense, Security and Safety, CBRN Protection, Lange Kleiweg 137, 2288, GJ, Rijswijk, the Netherlands. Electronic address: Alex.cornelissen@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Steven D. Klaassen</Name>
        <Affiliation>TNO Defense, Security and Safety, CBRN Protection, Lange Kleiweg 137, 2288, GJ, Rijswijk, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Tomas van Groningen</Name>
        <Affiliation>TNO Defense, Security and Safety, CBRN Protection, Lange Kleiweg 137, 2288, GJ, Rijswijk, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Sara Bohnert</Name>
        <Affiliation>Defence Research and Development Canada-Suffield Research Centre, Department of National Defence, Suffield, Alberta, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Marloes J. A. Joosen</Name>
        <Affiliation>TNO Defense, Security and Safety, CBRN Protection, Lange Kleiweg 137, 2288, GJ, Rijswijk, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Indeno[1,2,3-cd]pyrene and picene mediate actions via estrogen receptor α signaling pathway in in vitro cell systems, altering gene expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32251684</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30119-8</DOI>
    <KeywordList>
      <Keywords>Estrogen receptor</Keywords>
      <Keywords>Indeno[1,2,3-cd]pyrene</Keywords>
      <Keywords>Microplastic</Keywords>
      <Keywords>PAH</Keywords>
      <Keywords>Picene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Madeleine Böckers</Name>
        <Affiliation>Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Norbert W. Paul</Name>
        <Affiliation>Institute for History, Theory and Ethics of Medicine, Johannes Gutenberg University Medical Center, Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Efferth</Name>
        <Affiliation>Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany. Electronic address: ferth@uni-mainz.de.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there is no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm" [Toxicology and Applied Pharmacology volume 394C (2020) 114961].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32247767</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30107-1</DOI>
    <AuthorList>
      <Author>
        <Name>Bradley J. Ridder</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Derek J. Leishman</Name>
        <Affiliation>Department of Toxicology and Pathology, Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Bridgland-Taylor</Name>
        <Affiliation>Clinical Pharmacology &amp; Safety Sciences, Biopharmaceuticals R&amp;D, AstraZeneca, Cambridge, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammadreza Samieegohar</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaomei Han</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wendy W. Wu</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Aaron Randolph</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Phu Tran</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jiansong Sheng</Name>
        <Affiliation>CiPA LAB, 900 Clopper Rd, Suite 130, Gaithersburg, MD 20878, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timm Danker</Name>
        <Affiliation>NMI-TT GmbH, Markwiesenstr. 55, 72770 Reutlingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Anders Lindqvist</Name>
        <Affiliation>Sophion Bioscience A/S, Baltorpvej 154, 2750 Ballerup, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Konrad</Name>
        <Affiliation>B'SYS GmbH, The Ion Channel Company, Benkenstrasse 254, CH-4108 Witterswil, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Hebeisen</Name>
        <Affiliation>B'SYS GmbH, The Ion Channel Company, Benkenstrasse 254, CH-4108 Witterswil, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Liudmila Polonchuk</Name>
        <Affiliation>F. Hoffmann-La Roche AG, F. Hoffmann-La Roche Ltd., Bldg. 73 / R. 103b Grenzacherstrasse, 124, CH-4070, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Evgenia Gissinger</Name>
        <Affiliation>F. Hoffmann-La Roche AG, F. Hoffmann-La Roche Ltd., Bldg. 73 / R. 103b Grenzacherstrasse, 124, CH-4070, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Muthukrishnan Renganathan</Name>
        <Affiliation>Eurofins Scientific, Eurofins Discovery, 6 Research Park Drive, St. Charles, MO 63304, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan Koci</Name>
        <Affiliation>Eurofins Scientific, Eurofins Discovery, 6 Research Park Drive, St. Charles, MO 63304, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyang Wei</Name>
        <Affiliation>Eurofins Scientific, Eurofins Discovery, 6 Research Park Drive, St. Charles, MO 63304, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jingsong Fan</Name>
        <Affiliation>Bristol-Myers Squibb Company, Discovery Toxicology, Bristol-Myers Squibb, 3551 Lawrenceville, Princeton Rd, Lawrence Township, NJ 08648, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Levesque</Name>
        <Affiliation>Bristol-Myers Squibb Company, Discovery Toxicology, Bristol-Myers Squibb, 3551 Lawrenceville, Princeton Rd, Lawrence Township, NJ 08648, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Kwagh</Name>
        <Affiliation>Bristol-Myers Squibb Company, Discovery Toxicology, Bristol-Myers Squibb, 3551 Lawrenceville, Princeton Rd, Lawrence Township, NJ 08648, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Imredy</Name>
        <Affiliation>Merck &amp; Co., Inc., Kenilworth, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Zhai</Name>
        <Affiliation>Merck &amp; Co., Inc., Kenilworth, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marc Rogers</Name>
        <Affiliation>Metrion Biosciences Limited, Riverside 3, Suite 1, Granta Park, Great Abington, Cambridge CB21 6AD, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Edward Humphries</Name>
        <Affiliation>Metrion Biosciences Limited, Riverside 3, Suite 1, Granta Park, Great Abington, Cambridge CB21 6AD, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Kirby</Name>
        <Affiliation>Metrion Biosciences Limited, Riverside 3, Suite 1, Granta Park, Great Abington, Cambridge CB21 6AD, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Sonja Stoelzle-Feix</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Nina Brinkwirth</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Giustina Rotordam</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Nadine Becker</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Søren Friis</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Markus Rapedius</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tom A. Goetze</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tim Strassmaier</Name>
        <Affiliation>Nanion Technologies USA, 1 Naylon Place, Suite C, Livingston, NJ 07039, USA.</Affiliation>
      </Author>
      <Author>
        <Name>George Okeyo</Name>
        <Affiliation>Nanion Technologies USA, 1 Naylon Place, Suite C, Livingston, NJ 07039, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Kramer</Name>
        <Affiliation>Charles River Laboratories, 14656 Neo Parkway, Cleveland, OH 44128, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuri Kuryshev</Name>
        <Affiliation>Charles River Laboratories, 14656 Neo Parkway, Cleveland, OH 44128, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Caiyun Wu</Name>
        <Affiliation>Charles River Laboratories, 14656 Neo Parkway, Cleveland, OH 44128, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Herbert Himmel</Name>
        <Affiliation>Bayer AG, RD-TS-TOX-SP-SPL1, Aprather Weg 18a, 42096 Wuppertal, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gary R. Mirams</Name>
        <Affiliation>Centre for Mathematical Medicine &amp; Biology, School of Mathematical Sciences, University of Nottingham, Nottingham, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>David G. Strauss</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Remi Bardenet</Name>
        <Affiliation>Université de Lille, CNRS, Centrale Lille, UMR 9189 - CRIStAL, Villeneuve d'Ascq, France.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihua Li</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA. Electronic address: Zhihua.li@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Aldehyde dehydrogenase-2 activation decreases acetaminophen hepatotoxicity by prevention of mitochondrial depolarization.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32240663</pubmedLink>
    <GrantList>
      <Grant>F31 DK108570</Grant>
      <Grant>S10 OD018113</Grant>
      <Grant>P30 DK123704</Grant>
      <Grant>R01 AA021191</Grant>
      <Grant>P30 CA138313</Grant>
      <Grant>T32 DK083262</Grant>
      <Grant>R01 DK073336</Grant>
      <Grant>R01 AA025379</Grant>
      <Grant>R01 DK102142</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30106-X</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Alda-1</Keywords>
      <Keywords>Aldehyde dehydrogenase-2</Keywords>
      <Keywords>Aldehydes</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Mitochondrial depolarization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hereward J. Wimborne</Name>
        <Affiliation>Center for Cell Death, Injury &amp; Regeneration, Medical University of South Carolina, Charleston, SC, United States of America; Department of Drug Discovery &amp; Biomedical Sciences, Medical University of South Carolina, Charleston, SC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jiangting Hu</Name>
        <Affiliation>Center for Cell Death, Injury &amp; Regeneration, Medical University of South Carolina, Charleston, SC, United States of America; Department of Drug Discovery &amp; Biomedical Sciences, Medical University of South Carolina, Charleston, SC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Kenji Takemoto</Name>
        <Affiliation>Center for Cell Death, Injury &amp; Regeneration, Medical University of South Carolina, Charleston, SC, United States of America; Department of Drug Discovery &amp; Biomedical Sciences, Medical University of South Carolina, Charleston, SC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Nga T. Nguyen</Name>
        <Affiliation>Department of Pharmacology, Toxicology, &amp; Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Hartmut Jaeschke</Name>
        <Affiliation>Department of Pharmacology, Toxicology, &amp; Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>John J. Lemasters</Name>
        <Affiliation>Center for Cell Death, Injury &amp; Regeneration, Medical University of South Carolina, Charleston, SC, United States of America; Department of Drug Discovery &amp; Biomedical Sciences, Medical University of South Carolina, Charleston, SC, United States of America; Department of Biochemistry &amp; Molecular Biology, Medical University of South Carolina, Charleston, SC, United States of America; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States of America. Electronic address: JJLemasters@musc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Zhong</Name>
        <Affiliation>Center for Cell Death, Injury &amp; Regeneration, Medical University of South Carolina, Charleston, SC, United States of America; Department of Drug Discovery &amp; Biomedical Sciences, Medical University of South Carolina, Charleston, SC, United States of America. Electronic address: zhong@musc.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure to diisononyl phthalate promotes atopic march by activating of NF-κB and p38 MAPK.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32240662</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30105-8</DOI>
    <KeywordList>
      <Keywords>Asthma</Keywords>
      <Keywords>Atopic dermatitis</Keywords>
      <Keywords>Atopic march</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>Phthalate</Keywords>
      <Keywords>p38 MAPK</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Qin</Name>
        <Affiliation>Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiufei Duan</Name>
        <Affiliation>Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoman Xie</Name>
        <Affiliation>Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Kang</Name>
        <Affiliation>Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Deng</Name>
        <Affiliation>Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingqing Chen</Name>
        <Affiliation>Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, Hubei, China. Electronic address: chenmq@mail.ccnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare they have no actual or potential competing financial interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>miR-148a/LDLR mediates hypercholesterolemia induced by prenatal dexamethasone exposure in male offspring rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32234517</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30103-4</DOI>
    <KeywordList>
      <Keywords>Dexamethasone</Keywords>
      <Keywords>Glucocorticoid receptor</Keywords>
      <Keywords>Hypercholesterolemia</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Low-density lipoprotein receptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Li Li</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Hu</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kexin Liu</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dingmei Zhang</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Liu</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xufeng Li</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Minocycline prevents neuronal hyperexcitability and neuroinflammation in medial prefrontal cortex, as well as memory impairment caused by repeated toluene inhalation in adolescent rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32234516</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30104-6</DOI>
    <KeywordList>
      <Keywords>Hyperexcitability</Keywords>
      <Keywords>IL-1β</Keywords>
      <Keywords>Inhalants</Keywords>
      <Keywords>NLRP3 inflammasome</Keywords>
      <Keywords>Neuroinflammation</Keywords>
      <Keywords>mPFC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Silvia L. Cruz</Name>
        <Affiliation>Departamento de Farmacobiología. Cinvestav, Sede Sur, Ciudad de México, Mexico. Electronic address: slcruzm@cinvestav.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Monserrat Armenta-Reséndiz</Name>
        <Affiliation>Departamento de Farmacobiología. Cinvestav, Sede Sur, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>César J. Carranza-Aguilar</Name>
        <Affiliation>Departamento de Farmacobiología. Cinvestav, Sede Sur, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Emilio J. Galván</Name>
        <Affiliation>Departamento de Farmacobiología. Cinvestav, Sede Sur, Ciudad de México, Mexico.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest Funding was provided by grant 239192 (Silvia L. Cruz); CB 2016-281617 (Emilio J. Galván) and scholarships 261795 (Monserrat Armenta-Reséndiz) and 338376 (César J. Carranza-Aguilar) from Conacyt (National Council of Science and Technology) Mexico.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Enantioselectivity on the absorption of methylone and pentedrone using Caco-2 cell line: Development and validation of an UHPLC method for cathinones quantification.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32234388</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30094-6</DOI>
    <KeywordList>
      <Keywords>Caco-2 cells</Keywords>
      <Keywords>Enantioselectivity</Keywords>
      <Keywords>Intestinal absorption</Keywords>
      <Keywords>Methylone</Keywords>
      <Keywords>Pentedrone</Keywords>
      <Keywords>UHPLC-UV</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bárbara Silva</Name>
        <Affiliation>UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira,228, 4050-313 Porto, Portugal. Electronic address: barbarapolerisilva@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Renata Silva</Name>
        <Affiliation>UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Carla Fernandes</Name>
        <Affiliation>Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira,228, 4050-313 Porto, Portugal; Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR), Universidade do Porto, Avenida General Norton de Matos, 4450-208 Matosinhos, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Paula Guedes de Pinho</Name>
        <Affiliation>UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Remião</Name>
        <Affiliation>UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: remiao@ff.up.pt.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Group II muscarinic acetylcholine receptors attenuate hepatic injury via Nrf2/ARE pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32234387</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30102-2</DOI>
    <KeywordList>
      <Keywords>CCL4</Keywords>
      <Keywords>Hepatocytes injury</Keywords>
      <Keywords>Muscarinic acetylcholine receptors</Keywords>
      <Keywords>Nrf2/ARE signaling pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lin Luo</Name>
        <Affiliation>School of Pharmacy, Nantong University, PR China.. Electronic address: luolin207@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gaoshan Zhang</Name>
        <Affiliation>School of Pharmacy, Nantong University, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liuliu Mao</Name>
        <Affiliation>School of Pharmacy, Nantong University, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengbo Wang</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenghao Xi</Name>
        <Affiliation>School of Pharmacy, Nantong University, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Gaoyong Shi</Name>
        <Affiliation>School of Pharmacy, Nantong University, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianmei W. Leavenworth</Name>
        <Affiliation>Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.. Electronic address: jleavenworth@uabmc.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Organophosphate ester tri-o-cresyl phosphate interacts with estrogen receptor α in MCF-7 breast cancer cells promoting cancer growth.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32234386</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30101-0</DOI>
    <KeywordList>
      <Keywords>Endocrine disrupting chemical</Keywords>
      <Keywords>Estrogen receptor</Keywords>
      <Keywords>NGS</Keywords>
      <Keywords>Organophosphate ester</Keywords>
      <Keywords>TOCP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Madeleine Böckers</Name>
        <Affiliation>Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Norbert W. Paul</Name>
        <Affiliation>Institute for History, Theory and Ethics of Medicine, Johannes Gutenberg University Medical Center, Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Efferth</Name>
        <Affiliation>Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany. Electronic address: efferth@uni-mainz.de.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no actual or potential competing financial interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Towards a comprehensive safety understanding of granulocyte-colony stimulating factor biosimilars in treating chemotherapy associated febrile neutropenia: Trends from decades of data.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32222375</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30100-9</DOI>
    <KeywordList>
      <Keywords>Biosimilars</Keywords>
      <Keywords>Febrile neutropenia</Keywords>
      <Keywords>Filgrastim</Keywords>
      <Keywords>Granulocyte-Colony Stimulating Factor (G-CSF)</Keywords>
      <Keywords>Pharmacovigilance</Keywords>
      <Keywords>Public health</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shruti Rastogi</Name>
        <Affiliation>Indian Pharmacopoeia Commission, Ministry of Health &amp; Family Welfare, Government of India, Sector-23, Raj Nagar, Ghaziabad 201002, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Shatrunajay Shukla</Name>
        <Affiliation>Indian Pharmacopoeia Commission, Ministry of Health &amp; Family Welfare, Government of India, Sector-23, Raj Nagar, Ghaziabad 201002, Uttar Pradesh, India. Electronic address: shatrunjay.iitr@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Arvind Kumar Sharma</Name>
        <Affiliation>Indian Pharmacopoeia Commission, Ministry of Health &amp; Family Welfare, Government of India, Sector-23, Raj Nagar, Ghaziabad 201002, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Maryam Sarwat</Name>
        <Affiliation>Amity Institute of Pharmacy, Amity University, Noida 201313, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pranay Srivastava</Name>
        <Affiliation>UConn Health, University of Connecticut, Farmington, CT 06032, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tridiv Katiyar</Name>
        <Affiliation>System Toxicology &amp; Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Lucknow, Uttar Pradesh 226001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vivekanandan Kalaiselvan</Name>
        <Affiliation>Indian Pharmacopoeia Commission, Ministry of Health &amp; Family Welfare, Government of India, Sector-23, Raj Nagar, Ghaziabad 201002, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Gyanendra Nath Singh</Name>
        <Affiliation>Indian Pharmacopoeia Commission, Ministry of Health &amp; Family Welfare, Government of India, Sector-23, Raj Nagar, Ghaziabad 201002, Uttar Pradesh, India.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All authors state that no competing conflicts of interest exist regarding research, authorship and publication of article.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MS-275 combined with cisplatin exerts synergistic antitumor effects in human esophageal squamous cell carcinoma cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32217144</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30095-8</DOI>
    <KeywordList>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Esophageal Squamous Cell Carcinoma</Keywords>
      <Keywords>MS-275</Keywords>
      <Keywords>Synergistic Antitumor Effects</Keywords>
      <Keywords>Wnt/β-Catenin Signaling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tengfei Liu</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fangxia Guan</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China; Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaping Wang</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenkun Zhang</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Li</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanbo Cui</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Li</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongtao Liu</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanting Zhang</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuming Wang</Name>
        <Affiliation>Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shanshan Ma</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China. Electronic address: mss@zzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest We declare that there is no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Efficacy of retigabine in ameliorating the brain insult following sarin exposure in the rat.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32209366</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30087-9</DOI>
    <KeywordList>
      <Keywords>Atropine</Keywords>
      <Keywords>Brain damage</Keywords>
      <Keywords>Convulsions</Keywords>
      <Keywords>Organophosphates</Keywords>
      <Keywords>Retigabine</Keywords>
      <Keywords>Sarin</Keywords>
      <Keywords>TA</Keywords>
      <Keywords>TMB-4</Keywords>
      <Keywords>TSPO</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ariel Gore</Name>
        <Affiliation>Department. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel. Electronic address: arielg@iibr.gov.il.</Affiliation>
      </Author>
      <Author>
        <Name>Adi Neufeld-Cohen</Name>
        <Affiliation>Department. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Inbal Egoz</Name>
        <Affiliation>Department. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Shlomi Baranes</Name>
        <Affiliation>Department. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Rellie Gez</Name>
        <Affiliation>Department. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Ettie Grauer</Name>
        <Affiliation>Department. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Shira Chapman</Name>
        <Affiliation>Department. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Shlomi Lazar</Name>
        <Affiliation>Department. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel. Electronic address: shlomil@iibr.gov.il.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32209365</pubmedLink>
    <GrantList />
    <Year>2020</Year>
    <DOI>S0041-008X(20)30085-5</DOI>
    <AuthorList>
      <Author>
        <Name>Bradley J. Ridder</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Derek J. Leishman</Name>
        <Affiliation>Department of Toxicology and Pathology, Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Bridgland-Taylor</Name>
        <Affiliation>Clinical Pharmacology &amp; Safety Sciences, R&amp;D, AstraZeneca, Cambridge, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammadreza Samieegohar</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaomei Han</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wendy W. Wu</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Aaron Randolph</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Phu Tran</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jiansong Sheng</Name>
        <Affiliation>CiPA LAB, 900 Clopper Rd, Suite 130, Gaithersburg, MD 20878, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timm Danker</Name>
        <Affiliation>NMI-TT GmbH, Markwiesenstr. 55, 72770 Reutlingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Anders Lindqvist</Name>
        <Affiliation>Sophion Bioscience A/S, Baltorpvej 154, 2750 Ballerup, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Konrad</Name>
        <Affiliation>B'SYS GmbH, The Ion Channel Company, Benkenstrasse 254, CH-4108, Witterswil, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Hebeisen</Name>
        <Affiliation>B'SYS GmbH, The Ion Channel Company, Benkenstrasse 254, CH-4108, Witterswil, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Liudmila Polonchuk</Name>
        <Affiliation>F. Hoffmann-La Roche AG, F. Hoffmann-La Roche Ltd Bldg. 73/R. 103b Grenzacherstrasse, 124, CH-4070 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Evgenia Gissinger</Name>
        <Affiliation>F. Hoffmann-La Roche AG, F. Hoffmann-La Roche Ltd Bldg. 73/R. 103b Grenzacherstrasse, 124, CH-4070 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Muthukrishnan Renganathan</Name>
        <Affiliation>Eurofins Scientific, Eurofins Discovery, 6 Research Park Drive, St. Charles, MO 63304, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan Koci</Name>
        <Affiliation>Eurofins Scientific, Eurofins Discovery, 6 Research Park Drive, St. Charles, MO 63304, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyang Wei</Name>
        <Affiliation>Eurofins Scientific, Eurofins Discovery, 6 Research Park Drive, St. Charles, MO 63304, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jingsong Fan</Name>
        <Affiliation>Bristol-Myers Squibb Company, Discovery Toxicology, Bristol-Myers Squibb, 3551 Lawrenceville, Princeton Rd, Lawrence Township, NJ 08648, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Levesque</Name>
        <Affiliation>Bristol-Myers Squibb Company, Discovery Toxicology, Bristol-Myers Squibb, 3551 Lawrenceville, Princeton Rd, Lawrence Township, NJ 08648, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Kwagh</Name>
        <Affiliation>Bristol-Myers Squibb Company, Discovery Toxicology, Bristol-Myers Squibb, 3551 Lawrenceville, Princeton Rd, Lawrence Township, NJ 08648, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Imredy</Name>
        <Affiliation>Merck &amp; Co., Inc, Kenilworth, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Zhai</Name>
        <Affiliation>Merck &amp; Co., Inc, Kenilworth, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marc Rogers</Name>
        <Affiliation>Metrion Biosciences Limited, Riverside 3, Suite 1, Granta Park, Great Abington, Cambridge CB21, 6AD, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Edward Humphries</Name>
        <Affiliation>Metrion Biosciences Limited, Riverside 3, Suite 1, Granta Park, Great Abington, Cambridge CB21, 6AD, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Kirby</Name>
        <Affiliation>Metrion Biosciences Limited, Riverside 3, Suite 1, Granta Park, Great Abington, Cambridge CB21, 6AD, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Sonja Stoelzle-Feix</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Nina Brinkwirth</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Giustina Rotordam</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Nadine Becker</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Søren Friis</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Markus Rapedius</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tom A. Goetze</Name>
        <Affiliation>Nanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tim Strassmaier</Name>
        <Affiliation>Nanion Technologies, USA, 1 Naylon Place, Suite C, Livingston, NJ 07039, USA.</Affiliation>
      </Author>
      <Author>
        <Name>George Okeyo</Name>
        <Affiliation>Nanion Technologies, USA, 1 Naylon Place, Suite C, Livingston, NJ 07039, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Kramer</Name>
        <Affiliation>Charles River Laboratories, 14656 Neo Parkway, Cleveland, OH 44128, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuri Kuryshev</Name>
        <Affiliation>Charles River Laboratories, 14656 Neo Parkway, Cleveland, OH 44128, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Caiyun Wu</Name>
        <Affiliation>Charles River Laboratories, 14656 Neo Parkway, Cleveland, OH 44128, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Herbert Himmel</Name>
        <Affiliation>Bayer AG, RD-TS-TOX-SP-SPL1, Aprather Weg 18a, 42096 Wuppertal, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gary R. Mirams</Name>
        <Affiliation>Centre for Mathematical Medicine &amp; Biology, School of Mathematical Sciences, University of Nottingham, Nottingham, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>David G. Strauss</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rémi Bardenet</Name>
        <Affiliation>Université de Lille, CNRS, Centrale Lille, UMR 9189 - CRIStAL, Villeneuve d'Ascq, France.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihua Li</Name>
        <Affiliation>Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA. Electronic address: Zhihua.li@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declared no conflict of interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative toxicokinetics of Trans-resveratrol and its major metabolites in Harlan Sprague Dawley rats and B6C3F1/N mice following oral and intravenous administration.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32205187</pubmedLink>
    <GrantList>
      <Grant>HHSN273201000016C</Grant>
      <Grant>ZIA ES103316</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30086-7</DOI>
    <KeywordList>
      <Keywords>Plasma</Keywords>
      <Keywords>Resveratrol</Keywords>
      <Keywords>Resveratrol-3-glucorinide</Keywords>
      <Keywords>Resveratrol-3-sulfate</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Esra Mutlu</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America. Electronic address: esra.mutlu@nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Seth T. Gibbs</Name>
        <Affiliation>Battelle, Columbus, OH, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Natalie South</Name>
        <Affiliation>Battelle, Columbus, OH, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica Pierfelice</Name>
        <Affiliation>Battelle, Columbus, OH, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Burback</Name>
        <Affiliation>Battelle, Columbus, OH, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Dori Germolec</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Suramya Waidyanatha</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors report no declarations of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Di-(2-ethylhexyl) phthalate inhibits expression and internalization of transthyretin in human placental trophoblastic cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32201330</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30084-3</DOI>
    <KeywordList>
      <Keywords>Di-(2-ethylhexyl) phthalate</Keywords>
      <Keywords>HTR-8/SVneo cells</Keywords>
      <Keywords>JEG-3 cells</Keywords>
      <Keywords>Thyroid hormone transport</Keywords>
      <Keywords>Transthyretin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhi Ping Du</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China; Key Laboratory of Environmental Toxicology of Anhui Higher Education Institutes/Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shun Feng</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China; Key Laboratory of Environmental Toxicology of Anhui Higher Education Institutes/Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Ling Li</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China; Key Laboratory of Environmental Toxicology of Anhui Higher Education Institutes/Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Li</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China; Key Laboratory of Environmental Toxicology of Anhui Higher Education Institutes/Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Lv</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China; Key Laboratory of Environmental Toxicology of Anhui Higher Education Institutes/Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Qiang Ren</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China; Key Laboratory of Environmental Toxicology of Anhui Higher Education Institutes/Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Wei Feng</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China; Key Laboratory of Environmental Toxicology of Anhui Higher Education Institutes/Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Liu</Name>
        <Affiliation>Department of Anatomy, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, Dunedin, New Zealand. Electronic address: ping.liu@otago.ac.nz.</Affiliation>
      </Author>
      <Author>
        <Name>Qu Nan Wang</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China; Key Laboratory of Environmental Toxicology of Anhui Higher Education Institutes/Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, No 81 Meishan Road, Hefei 230032, China. Electronic address: wqn@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there is no professional or other personal interest of any nature or kind in any product, service and/or company.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic represses airway epithelial mucin expression by affecting retinoic acid signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32201329</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30083-1</DOI>
    <KeywordList>
      <Keywords>Airway epithelial</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Mucin</Keywords>
      <Keywords>Retinoic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuchen Liu</Name>
        <Affiliation>School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu, China; Department of Pharmacology and Toxicology, School of Pharmacy, University of Arizona, Tucson, AZ 85724, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Fangwei Liu</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, University of Arizona, Tucson, AZ 85724, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Weifeng Liang</Name>
        <Affiliation>School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu, China; Department of Pharmacology and Toxicology, School of Pharmacy, University of Arizona, Tucson, AZ 85724, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Lingxiang Zhu</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, University of Arizona, Tucson, AZ 85724, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>R. Clark Lantz</Name>
        <Affiliation>Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ 85724, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jiapeng Zhu</Name>
        <Affiliation>School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu, China; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu, China. Electronic address: zhujiapeng@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yin Chen</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, University of Arizona, Tucson, AZ 85724, United States of America; Asthma &amp; Airway Disease Research Center, University of Arizona, Tucson, AZ 85724, United States of America. Electronic address: ychen@pharmacy.arizona.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modernization of chemical risk assessment to make use of novel toxicological data.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32199875</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30075-2</DOI>
    <AuthorList />
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32198022</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30082-X</DOI>
    <KeywordList>
      <Keywords>Animal Testing Alternative</Keywords>
      <Keywords>Artificial Neural Network Analysis</Keywords>
      <Keywords>Cholestasis</Keywords>
      <Keywords>Drug-Induced Liver Injury</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Mitochondria</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Moemi Kawaguchi</Name>
        <Affiliation>Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8675, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takumi Nukaga</Name>
        <Affiliation>SHISEIDO Global Innovation Center, 1-2-11 Takashima, Nishi-ku, Yokohama city, Kanagawa 220-0011, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shuichi Sekine</Name>
        <Affiliation>Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8675, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akinori Takemura</Name>
        <Affiliation>Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8675, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeshi Susukida</Name>
        <Affiliation>Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8675, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shiho Oeda</Name>
        <Affiliation>SHISEIDO Global Innovation Center, 1-2-11 Takashima, Nishi-ku, Yokohama city, Kanagawa 220-0011, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Atsushi Kodama</Name>
        <Affiliation>SHISEIDO Global Innovation Center, 1-2-11 Takashima, Nishi-ku, Yokohama city, Kanagawa 220-0011, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Morihiko Hirota</Name>
        <Affiliation>SHISEIDO Global Innovation Center, 1-2-11 Takashima, Nishi-ku, Yokohama city, Kanagawa 220-0011, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hirokazu Kouzuki</Name>
        <Affiliation>SHISEIDO Global Innovation Center, 1-2-11 Takashima, Nishi-ku, Yokohama city, Kanagawa 220-0011, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kousei Ito</Name>
        <Affiliation>Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8675, Japan. Electronic address: itokousei@chiba-u.jp.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest There is no conflict of interest</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Thyroid disruption and developmental toxicity caused by triphenyltin (TPT) in zebrafish embryos/larvae.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32173372</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30081-8</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Hypothalamic-pituitary-thyroid axis</Keywords>
      <Keywords>TPT</Keywords>
      <Keywords>Thyroid disruption</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fan Yao</Name>
        <Affiliation>College of Fisheries, Huazhong Agricultural University, Wuhan 430070, China; Fishery Resources and Environmental Science Experimental Station of The Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunfeng Li</Name>
        <Affiliation>Fishery Resources and Environmental Science Experimental Station of The Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huijun Ru</Name>
        <Affiliation>Fishery Resources and Environmental Science Experimental Station of The Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China.</Affiliation>
      </Author>
      <Author>
        <Name>Luyin Wu</Name>
        <Affiliation>Fishery Resources and Environmental Science Experimental Station of The Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhangang Xiao</Name>
        <Affiliation>Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhaohui Ni</Name>
        <Affiliation>Fishery Resources and Environmental Science Experimental Station of The Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China.</Affiliation>
      </Author>
      <Author>
        <Name>Daqing Chen</Name>
        <Affiliation>Fishery Resources and Environmental Science Experimental Station of The Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China. Electronic address: chdq@yfi.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Liqiao Zhong</Name>
        <Affiliation>Fishery Resources and Environmental Science Experimental Station of The Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China. Electronic address: zhonglq@yfi.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The paradox of dipeptidyl peptidase IV inhibition in enterocytic differentiation and epithelial-mesenchymal transition in rat cholestatic sepsis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32171571</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30080-6</DOI>
    <KeywordList>
      <Keywords>DPP-IV</Keywords>
      <Keywords>E-cadherin</Keywords>
      <Keywords>EMT</Keywords>
      <Keywords>PI3K/Akt (PKB) axis</Keywords>
      <Keywords>Vimentin</Keywords>
      <Keywords>β-catenin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Doaa A. Zaky</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini street, Cairo, P.O. Box 11562, Egypt. Electronic address: doaa.zaky@pharma.cu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Dalia M. Abouelfadl</Name>
        <Affiliation>Medical Division, National Research Center, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Noha N. Nassar</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini street, Cairo, P.O. Box 11562, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Dalaal M. Abdallah</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini street, Cairo, P.O. Box 11562, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Muhammad Y. Al-Shorbagy</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini street, Cairo, P.O. Box 11562, Egypt; School of Pharmacy, NewGiza University, Giza, Egypt.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Aliskiren and captopril improve cognitive deficits in poorly controlled STZ-induced diabetic rats via amelioration of the hippocampal P-ERK, GSK3β, P-GSK3β pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32171570</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30078-8</DOI>
    <KeywordList>
      <Keywords>Aliskiren</Keywords>
      <Keywords>Captopril</Keywords>
      <Keywords>Cognition</Keywords>
      <Keywords>Hippocampus</Keywords>
      <Keywords>Renin</Keywords>
      <Keywords>Type 1 Diabetes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Madonna M. Youssef</Name>
        <Affiliation>Department of Pharmacology, National organization for drug control and research (NODCAR), Giza, Egypt. Electronic address: madonna.magdy@std.pharma.cu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>H. A. Abd El-Latif</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini St, Cairo 11562, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>M. F. El-Yamany</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini St, Cairo 11562, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Gehan S. Georgy</Name>
        <Affiliation>Department of Pharmacology, National organization for drug control and research (NODCAR), Giza, Egypt.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Demyelination associated with chronic arsenic exposure in Wistar rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32171569</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30079-X</DOI>
    <KeywordList>
      <Keywords>Amyloid</Keywords>
      <Keywords>Anisotropy</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Axonal damage</Keywords>
      <Keywords>DTI</Keywords>
      <Keywords>Demyelination</Keywords>
      <Keywords>Development</Keywords>
      <Keywords>MRI</Keywords>
      <Keywords>Microstructure</Keywords>
      <Keywords>Mitochondria</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sandra A. Niño</Name>
        <Affiliation>Laboratorio de Neurotoxicología, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Manuel Nava 6, C.P 78210 San Luis Potosí, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Erika Chi-Ahumada</Name>
        <Affiliation>Departamento de Bioquímica, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, Av. Venustiano Carranza 2405, C.P 78210 San Luis Potosí, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Ortíz</Name>
        <Affiliation>Instituto de Neurobiología, Universidad Nacional Autónoma de México, Boulevard Juriquilla 3001, Querétaro, Querétaro C.P 76230, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Sergio Zarazua</Name>
        <Affiliation>Laboratorio de Neurotoxicología, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Manuel Nava 6, C.P 78210 San Luis Potosí, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Luis Concha</Name>
        <Affiliation>Instituto de Neurobiología, Universidad Nacional Autónoma de México, Boulevard Juriquilla 3001, Querétaro, Querétaro C.P 76230, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Maria E. Jiménez-Capdeville</Name>
        <Affiliation>Departamento de Bioquímica, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, Av. Venustiano Carranza 2405, C.P 78210 San Luis Potosí, Mexico. Electronic address: mejimenez@uaslp.mx.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Irisin lowers blood pressure by activating the Nrf2 signaling pathway in the hypothalamic paraventricular nucleus of spontaneously hypertensive rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32165127</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30077-6</DOI>
    <KeywordList>
      <Keywords>Hypertension</Keywords>
      <Keywords>Irisin</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Paraventricular nucleus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chan Juan Huo</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Jing Yu</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yao Jun Sun</Name>
        <Affiliation>Key Laboratory of Cellular Physiology at Shanxi Medical University, Ministry of Education, Department of Physiology, Shanxi Medical University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Bao Li</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Su</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Bai</Name>
        <Affiliation>Department of Anesthesiology, Center for Brian Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Li</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Li Liu</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Qi</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shao Wen Zhou</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ning Jia</Name>
        <Affiliation>Department of Anatomy, Histology and Embryology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Qing Zhu</Name>
        <Affiliation>Key Laboratory of Cardiovascular Disease and Molecular Intervention, Department of Physiology, Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Jun Liu</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China. Electronic address: jupet@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Ming Kang</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China. Electronic address: ykang@mail.xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no competing financial interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure to di(2-ethylhexyl) phthalate and diisononyl phthalate during adulthood disrupts hormones and ovarian folliculogenesis throughout the prime reproductive life of the mouse.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32165126</pubmedLink>
    <GrantList>
      <Grant>T32 ES007326</Grant>
      <Grant>P50 HD028934</Grant>
      <Grant>R56 ES025147</Grant>
      <Grant>T35 OD011145</Grant>
      <Grant>R01 ES028661</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30076-4</DOI>
    <KeywordList>
      <Keywords>DEHP</Keywords>
      <Keywords>DiNP</Keywords>
      <Keywords>Endocrine disruptors</Keywords>
      <Keywords>Female reproduction</Keywords>
      <Keywords>Follicles</Keywords>
      <Keywords>Ovary</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Catheryne Chiang</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Lily R. Lewis</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Borkowski</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jodi A. Flaws</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America. Electronic address: jflaws@illinois.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors have no conflicts of interest to declare.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic acrylamide exposure induced glia cell activation, NLRP3 infl-ammasome upregulation and cognitive impairment.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32147541</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30073-9</DOI>
    <KeywordList>
      <Keywords>Acrylamide</Keywords>
      <Keywords>Cognitive impairment</Keywords>
      <Keywords>Microglia</Keywords>
      <Keywords>NLRP3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ying Liu</Name>
        <Affiliation>Department of Health Toxicology, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong-Road, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xing Zhang</Name>
        <Affiliation>Department of Health Toxicology, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong-Road, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Dandan Yan</Name>
        <Affiliation>Department of Health Toxicology, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong-Road, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiqi Wang</Name>
        <Affiliation>Department of Health Toxicology, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong-Road, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Wang</Name>
        <Affiliation>Department of Health Toxicology, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong-Road, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufan Liu</Name>
        <Affiliation>China Medical University-The Queen's University of Belfast Joint College, China Medical University, Shenyang North New Area, Shenyang 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Aijun Tan</Name>
        <Affiliation>Zhuhai Center for Disease Control and Prevention, Zhuhai 519000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyi Chen</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Guangzhou Medical University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Yan</Name>
        <Affiliation>Department of Health Toxicology, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong-Road, Wuhan 430030, PR China. Electronic address: yanhong@mails.tjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Calcitriol ameliorated autonomic dysfunction and hypertension by down-regulating inflammation and oxidative stress in the paraventricular nucleus of SHR.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32147540</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30074-0</DOI>
    <KeywordList>
      <Keywords>Autonomic dysfunction</Keywords>
      <Keywords>Calcitriol</Keywords>
      <Keywords>Hypertension</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Paraventricular nucleus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Meng Lu Xu</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China; Department of Nephrology, the First Affiliated Hospital of Xi'an Medical University, Xi'an 710003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Jing Yu</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Qiang Zhao</Name>
        <Affiliation>Department of Nephrology, the First Affiliated Hospital of Xi'an Medical University, Xi'an 710003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Du</Name>
        <Affiliation>Department of Nephrology, the First Affiliated Hospital of Xi'an Medical University, Xi'an 710003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Jie Xia</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Su</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Meng Du</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Yang</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Qi</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Li</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shao Wen Zhou</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Qing Zhu</Name>
        <Affiliation>Key Laboratory of Cardiovascular Disease and Molecular Intervention, Department of Physiology, Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Bao Li</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China. Electronic address: hongbaoli1985@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Ming Kang</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an 710061, China. Electronic address: ykang@mail.xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All authors confirm that they are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low dose lead exposure at the onset of puberty disrupts spermatogenesis-related gene expression and causes abnormal spermatogenesis in mouse.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32142724</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30066-1</DOI>
    <KeywordList>
      <Keywords>Lead</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Sperm deformity</Keywords>
      <Keywords>Spermatogenesis</Keywords>
      <Keywords>Spermatogenesis-related gene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jie Xie</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan 430071, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Yu</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan 430071, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongsheng Fan</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan 430071, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Zhao</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan 430071, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianmei Su</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan 430071, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Meng</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan 430071, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Wu</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan 430071, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Burhan Uddin</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chunhong Wang</Name>
        <Affiliation>Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan 430071, PR China. Electronic address: wchunhong027@whu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhishan Wang</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY 40536, USA. Electronic address: zhishan.wang@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32126212</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30065-X</DOI>
    <KeywordList>
      <Keywords>Benzyl Isothiocyanate (BITC)</Keywords>
      <Keywords>Cholesterol Crystals</Keywords>
      <Keywords>Kupffer Cells</Keywords>
      <Keywords>NLRP3 Inflammasome</Keywords>
      <Keywords>Nonalcoholic Steatohepatitis (NASH)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haw Wen Chen</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan. Electronic address: chenhw@mail.cmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Ching Yen</Name>
        <Affiliation>Department of Respiratory Therapy, China Medical University, Taichung, Taiwan; Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Li Li Kuo</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Wen Lo</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chin Shiu Huang</Name>
        <Affiliation>Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Chieh Chen</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chong Kuei Lii</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan; Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan. Electronic address: cklii@mail.cmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors have declared no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Melatonin's efficacy in stroke patients; a matter of dose? A systematic review.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32112789</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30057-0</DOI>
    <KeywordList>
      <Keywords>Melatonin</Keywords>
      <Keywords>Stroke</Keywords>
      <Keywords>Systematic review</Keywords>
      <Keywords>Translational doses</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eva Ramos</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain. Electronic address: eva.ramos@ucm.es.</Affiliation>
      </Author>
      <Author>
        <Name>Víctor Farré-Alins</Name>
        <Affiliation>Health Research Institute, Clinical Pharmacology Service, University Hospital La Princesa, Autonomous University of Madrid, C/ Diego de León 62, 28006 Madrid, Spain; Institute Teófilo Hernando for Drug I+D, School of Medicine, Autonomous University of Madrid, 28029 Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Javier Egea</Name>
        <Affiliation>Health Research Institute, Clinical Pharmacology Service, University Hospital La Princesa, Autonomous University of Madrid, C/ Diego de León 62, 28006 Madrid, Spain; Institute Teófilo Hernando for Drug I+D, School of Medicine, Autonomous University of Madrid, 28029 Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Francisco López-Muñoz</Name>
        <Affiliation>Faculty of Health Sciences, University Camilo José Cela, C/ Castillo de Alarcón 49, 28692 Villanueva de la Cañada, Madrid, Spain; Neuropsychopharmacology Unit, Hospital 12 de Octubre Research Institute (i+12), Avda, Córdoba, s/n, 28041 Madrid, Spain; Portucalense Institute of Neuropsychology and Cognitive and Behavioural Neurosciences (INPP), Portucalense University, R. Dr. António Bernardino de Almeida 541, 4200-072 Porto, Portugal; Thematic Network for Cooperative Health Research (RETICS), Addictive Disorders Network, Health Institute Carlos III, MICINN and FEDER, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Russel J. Reiter</Name>
        <Affiliation>Department of Cellular and Structural Biology, UT Health Science Center, San Antonio 78229, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandro Romero</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain. Electronic address: manarome@ucm.es.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Suppression of iron mobilization from lysosomes to mitochondria attenuates liver injury after acetaminophen overdose in vivo in mice: Protection by minocycline.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32109512</pubmedLink>
    <GrantList>
      <Grant>S10 OD018113</Grant>
      <Grant>P30 DK123704</Grant>
      <Grant>R01 AA021191</Grant>
      <Grant>T32 DK083262</Grant>
      <Grant>R56 DK037034</Grant>
      <Grant>C06 RR015455</Grant>
      <Grant>R01 AA025379</Grant>
      <Grant>R01 DK102142</Grant>
      <Grant>R37 DK037034</Grant>
      <Grant>P30 CA138313</Grant>
      <Grant>P20 GM103542</Grant>
      <Grant>R01 DK037034</Grant>
      <Grant>R01 DK073336</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30054-5</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Calcium uniporter</Keywords>
      <Keywords>Iron</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Minocycline</Keywords>
      <Keywords>Mitochondria</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiangting Hu</Name>
        <Affiliation>Center for Cell Death, Injury &amp; Regeneration, Medical University of South Carolina, Charleston, SC 29425, United States of America; Department of Drug Discovery &amp; Biomedical Sciences, Medical University of South Carolina, Charleston, SC 29425, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>John J. Lemasters</Name>
        <Affiliation>Center for Cell Death, Injury &amp; Regeneration, Medical University of South Carolina, Charleston, SC 29425, United States of America; Department of Drug Discovery &amp; Biomedical Sciences, Medical University of South Carolina, Charleston, SC 29425, United States of America; Department of Biochemistry &amp; Molecular Biology, Medical University of South Carolina, Charleston, SC 29425, United States of America. Electronic address: JJLemasters@musc.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Montelukast ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting TNF-α/JNK signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32109511</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30055-7</DOI>
    <KeywordList>
      <Keywords>Bax/caspase3</Keywords>
      <Keywords>Beclin1/LC3</Keywords>
      <Keywords>CD4+</Keywords>
      <Keywords>Concanavalin A</Keywords>
      <Keywords>Montelukast</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dalia H. El-Kashef</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, 35516 Mansoura, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Rehab S. Abdelrahman</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al-Madina Al-Munawwarah, 30001, Saudi Arabia. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, 35516, Mansoura, Egypt. Electronic address: rsabri77@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reducing the antigen-independent toxicity of antibody-drug conjugates by minimizing their non-specific clearance through PEGylation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32109510</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30056-9</DOI>
    <KeywordList>
      <Keywords>Antibody-drug conjugates</Keywords>
      <Keywords>Biodistribution</Keywords>
      <Keywords>PEGylation</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jessica K. Simmons</Name>
        <Affiliation>Seattle Genetics, Inc., 21823 30(th) Dr SE, Bothell, WA, USA. Electronic address: jsimmons@seagen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick J. Burke</Name>
        <Affiliation>Seattle Genetics, Inc., 21823 30(th) Dr SE, Bothell, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julia H. Cochran</Name>
        <Affiliation>Seattle Genetics, Inc., 21823 30(th) Dr SE, Bothell, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul G. Pittman</Name>
        <Affiliation>Seattle Genetics, Inc., 21823 30(th) Dr SE, Bothell, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert P. Lyon</Name>
        <Affiliation>Seattle Genetics, Inc., 21823 30(th) Dr SE, Bothell, WA, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All authors are employees of Seattle Genetics, Inc.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MicroRNA biomarkers for chemical hazard screening identified by RNA deep sequencing analysis in mouse embryonic stem cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32105654</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30053-3</DOI>
    <KeywordList>
      <Keywords>Chemical toxicity</Keywords>
      <Keywords>Deep sequencing analysis</Keywords>
      <Keywords>Non-coding RNAs</Keywords>
      <Keywords>RNA biomarkers</Keywords>
      <Keywords>RNA-seq</Keywords>
      <Keywords>microRNAs (miRNAs)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hiroshi Aoki</Name>
        <Affiliation>Environmental Management Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan. Electronic address: aoki-h@aist.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hidenori Tani</Name>
        <Affiliation>Environmental Management Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kaoru Nakamura</Name>
        <Affiliation>Environmental Management Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroaki Sato</Name>
        <Affiliation>Research Institute of Sustainable Chemistry, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8565, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masaki Torimura</Name>
        <Affiliation>Environmental Management Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tetsuya Nakazato</Name>
        <Affiliation>Environmental Management Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ovariectomy provokes inflammatory and cardiovascular effects of endotoxemia in rats: Dissimilar benefits of hormonal supplements.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32092384</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30052-1</DOI>
    <KeywordList>
      <Keywords>Cardiovascular</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Endotoxemia</Keywords>
      <Keywords>Estrogen receptors</Keywords>
      <Keywords>Hormone replacement</Keywords>
      <Keywords>Ovariectomy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohammed A. El-Lakany</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed A. Fouda</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Hanan M. El-Gowelli</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mahmoud M. El-Mas</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt. Electronic address: mahmoud.elmas@alexu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developmental arsenic exposure is associated with sex differences in the epigenetic regulation of stress genes in the adult mouse frontal cortex.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32061746</pubmedLink>
    <GrantList>
      <Grant>R01 ES019583</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30044-2</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Frontal cortex</Keywords>
      <Keywords>Sex differences</Keywords>
      <Keywords>Stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elizabeth R. Solomon</Name>
        <Affiliation>Department of Neurosciences, School of Medicine, University of New Mexico HSC, MSC08 4740, 1 University of New Mexico, Albuquerque, NM 87131-0001, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin K. Caldwell</Name>
        <Affiliation>Department of Neurosciences, School of Medicine, University of New Mexico HSC, MSC08 4740, 1 University of New Mexico, Albuquerque, NM 87131-0001, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea M. Allan</Name>
        <Affiliation>Department of Neurosciences, School of Medicine, University of New Mexico HSC, MSC08 4740, 1 University of New Mexico, Albuquerque, NM 87131-0001, United States. Electronic address: aallan@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare the research was conducted in the absence of any conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Leucovorin ameliorated methotrexate induced intestinal toxicity via modulation of the gut microbiota.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32061593</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30024-7</DOI>
    <KeywordList>
      <Keywords>Bifidobacteria</Keywords>
      <Keywords>Gut microbiota</Keywords>
      <Keywords>Intestinal toxicity</Keywords>
      <Keywords>Leucovorin</Keywords>
      <Keywords>Methotrexate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xinyi Huang</Name>
        <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, PR China; Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha Duxact Biotech Co., Ltd., Changsha 411000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Fang</Name>
        <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, PR China; Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha Duxact Biotech Co., Ltd., Changsha 411000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Tai Rao</Name>
        <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, PR China; Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha Duxact Biotech Co., Ltd., Changsha 411000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Luping Zhou</Name>
        <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, PR China; Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha Duxact Biotech Co., Ltd., Changsha 411000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangchang Zeng</Name>
        <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, PR China; Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha Duxact Biotech Co., Ltd., Changsha 411000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhirong Tan</Name>
        <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, PR China; Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha Duxact Biotech Co., Ltd., Changsha 411000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lulu Chen</Name>
        <Affiliation>Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha Duxact Biotech Co., Ltd., Changsha 411000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongsheng Ouyang</Name>
        <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, PR China; Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha Duxact Biotech Co., Ltd., Changsha 411000, PR China. Electronic address: 801940@csu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>H</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32061592</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30045-4</DOI>
    <KeywordList>
      <Keywords>Endothelial cells</Keywords>
      <Keywords>H(1)R</Keywords>
      <Keywords>Histaminergic angioedema</Keywords>
      <Keywords>Local anesthetic</Keywords>
      <Keywords>Vascular permeability</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiao Cao</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongjing Zhang</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Delu Che</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Liu</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liu Yang</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Zhang</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Langchong He</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China. Electronic address: helc@mail.xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no competing interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Orlistat delays hepatocarcinogenesis in mice with hepatic co-activation of AKT and c-Met.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32045588</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30042-9</DOI>
    <KeywordList>
      <Keywords>Fatty acid synthase</Keywords>
      <Keywords>Hepatocarcinogenesis</Keywords>
      <Keywords>Lipogenesis</Keywords>
      <Keywords>Orlistat</Keywords>
      <Keywords>Proliferation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cong Zhang</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Sheng</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Yuan</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Junjie Hu</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Meng</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Wu</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Chen</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Huifan Yu</Name>
        <Affiliation>Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, Shiyan 442000, People's Republic of China; Institute of Biomedicine, Hubei University of Medicine, Shiyan 442000, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Shan Li</Name>
        <Affiliation>Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, Shiyan 442000, People's Republic of China; Department of Biochemistry, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, People's Republic of China. Electronic address: lishanhbmu@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guohua Zheng</Name>
        <Affiliation>Key Laboratory for Chinese Medicine Resource and Compound Prescription of Ministry of Education, Hubei University of Chinese Medicine, Wuhan 430065, People's Republic of China. Electronic address: zgh1227@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenpeng Qiu</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, People's Republic of China; Hubei Key Laboratory of Resources and Chemistry of Chinese Medicine, Hubei University of Chinese Medicine, Wuhan 430065, People's Republic of China. Electronic address: whuqq@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest There are no conflicts of interest to declare.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gliclazide attenuates acetic acid-induced colitis via the modulation of PPARγ, NF-κB and MAPK signaling pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32045587</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30043-0</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Colitis</Keywords>
      <Keywords>Gliclazide</Keywords>
      <Keywords>MAPKs</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>PPARγ</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>El Shaimaa A. Arafa</Name>
        <Affiliation>Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman 346, United Arab Emirates; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt. Electronic address: e.arafa@ajman.ac.ae.</Affiliation>
      </Author>
      <Author>
        <Name>Wafaa R. Mohamed</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Dana M. Zaher</Name>
        <Affiliation>College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates.</Affiliation>
      </Author>
      <Author>
        <Name>Hany A. Omar</Name>
        <Affiliation>College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt. Electronic address: hanyomar@sharjah.ac.ae.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there is no conflict of interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cyanidin prevents the hyperproliferative potential of fibroblast-like synoviocytes and disease progression via targeting IL-17A cytokine signalling in rheumatoid arthritis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32044269</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30041-7</DOI>
    <KeywordList>
      <Keywords>Cyanidin</Keywords>
      <Keywords>Fibroblast-like synoviocytes</Keywords>
      <Keywords>Hyperplastic synovium</Keywords>
      <Keywords>Interleukin-17A</Keywords>
      <Keywords>Rheumatoid arthritis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Snigdha Samarpita</Name>
        <Affiliation>Immunopathology Lab, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632 014, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ramamoorthi Ganesan</Name>
        <Affiliation>Immunology Program, Department of Clinical Science, H. Lee Moffitt Cancer Center, Tampa, Florida 33612, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mahaboobkhan Rasool</Name>
        <Affiliation>Immunopathology Lab, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632 014, Tamil Nadu, India. Electronic address: mkr474@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>SILAC-based proteomic profiling of the suppression of TGF-β1-induced lung fibroblast-to-myofibroblast differentiation by trehalose.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32035996</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30040-5</DOI>
    <KeywordList>
      <Keywords>Fibroblast Differentiation</Keywords>
      <Keywords>Pulmonary Fibrosis</Keywords>
      <Keywords>Quantitative Proteomics</Keywords>
      <Keywords>Trehalose</Keywords>
      <Keywords>β-Catenin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fanqing Lu</Name>
        <Affiliation>College of Pharmaceutical Sciences, Soochow University, 199 Renai Road, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xionghua Sun</Name>
        <Affiliation>College of Pharmaceutical Sciences, Soochow University, 199 Renai Road, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiafang Xu</Name>
        <Affiliation>College of Pharmaceutical Sciences, Soochow University, 199 Renai Road, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaogang Jiang</Name>
        <Affiliation>College of Pharmaceutical Sciences, Soochow University, 199 Renai Road, Suzhou 215123, China. Electronic address: jiangxiaogang@suda.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest There are no conflicts of interest to declare.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32035082</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30039-9</DOI>
    <KeywordList>
      <Keywords>Drug-induced liver injury</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>LPS</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>TNF</Keywords>
      <Keywords>Trovafloxacin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Giulio Giustarini</Name>
        <Affiliation>Immunotoxicology, Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands. Electronic address: g.giustarini@uu.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Suzanna Huppelschoten</Name>
        <Affiliation>Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Barra</Name>
        <Affiliation>Immunotoxicology, Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands; University of Pisa, Department of Pharmacy, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Angela Oppelt</Name>
        <Affiliation>Division Systems Biology of Signal Transduction, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Wagenaar</Name>
        <Affiliation>Immunotoxicology, Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Richard J. Weaver</Name>
        <Affiliation>Biopharmacy, Institut de Recherches Internationales Servier (I.R.I.S.), Suresnes 92284, France.</Affiliation>
      </Author>
      <Author>
        <Name>Marianne Bol-Schoenmakers</Name>
        <Affiliation>Immunotoxicology, Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Joost J. Smit</Name>
        <Affiliation>Immunotoxicology, Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Bob van de Water</Name>
        <Affiliation>Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula Klingmüller</Name>
        <Affiliation>Division Systems Biology of Signal Transduction, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond H. H. Pieters</Name>
        <Affiliation>Immunotoxicology, Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands. Electronic address: r.h.h.pieters@uu.nl.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32032644</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30037-5</DOI>
    <KeywordList>
      <Keywords>Bleomycin</Keywords>
      <Keywords>Honokiol</Keywords>
      <Keywords>IL-6/CD44/STAT3 axis</Keywords>
      <Keywords>Pulmonary fibrosis</Keywords>
      <Keywords>TGF-beta</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gauthami Pulivendala</Name>
        <Affiliation>Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana 500037, India.</Affiliation>
      </Author>
      <Author>
        <Name>Swarna Bale</Name>
        <Affiliation>Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana 500037, India.</Affiliation>
      </Author>
      <Author>
        <Name>Chandraiah Godugu</Name>
        <Affiliation>Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana 500037, India. Electronic address: chandra.niperhyd@gov.in.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Perinatal exposure to octabromodiphenyl ether mixture, DE-79, alters the vasopressinergic system in adult rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32032643</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30038-7</DOI>
    <KeywordList>
      <Keywords>DE-79</Keywords>
      <Keywords>Neuroendocrine disruptors</Keywords>
      <Keywords>Nitric oxide</Keywords>
      <Keywords>Osmoregulation</Keywords>
      <Keywords>PBDEs</Keywords>
      <Keywords>Vasopressin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mhar Y. Alvarez-Gonzalez</Name>
        <Affiliation>Departamento de Neuromorfología Funcional, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México Xochimilco No. 101, Col. San Lorenzo Huipulco, Ciudad de México, C.P. 14370, Mexico. Electronic address: mhar_ag@imp.edu.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo Sánchez-Islas</Name>
        <Affiliation>Departamento de Neuromorfología Funcional, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México Xochimilco No. 101, Col. San Lorenzo Huipulco, Ciudad de México, C.P. 14370, Mexico. Electronic address: edaxy@imp.edu.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel Mucio-Ramirez</Name>
        <Affiliation>Departamento de Neuromorfología Funcional, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México Xochimilco No. 101, Col. San Lorenzo Huipulco, Ciudad de México, C.P. 14370, Mexico. Electronic address: mucios@imp.edu.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia de Gortari</Name>
        <Affiliation>Laboratorio de Neurofisiología Molecular, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México Xochimilco No. 101, Col. San Lorenzo Huipulco, Ciudad de México, C.P. 14370, Mexico. Electronic address: gortari@imp.edu.mx.</Affiliation>
      </Author>
      <Author>
        <Name>María I. Amaya</Name>
        <Affiliation>Laboratorio de Neurofisiología Molecular, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México Xochimilco No. 101, Col. San Lorenzo Huipulco, Ciudad de México, C.P. 14370, Mexico. Electronic address: amayag@imp.edu.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Prasada Rao S. Kodavanti</Name>
        <Affiliation>Neurotoxicology Branch, Toxicity Assessment Division, NHEERL/ORD, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: kodavanti.prasada@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Martha León-Olea</Name>
        <Affiliation>Departamento de Neuromorfología Funcional, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México Xochimilco No. 101, Col. San Lorenzo Huipulco, Ciudad de México, C.P. 14370, Mexico. Electronic address: marthalo@imp.edu.mx.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic induces platelet shape change through altering focal adhesion kinase-mediated actin dynamics, contributing to increased platelet reactivity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32014540</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30036-3</DOI>
    <KeywordList>
      <Keywords>Actin dynamics</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Focal adhesion kinase</Keywords>
      <Keywords>Platelet</Keywords>
      <Keywords>Platelet shape change</Keywords>
      <Keywords>Thrombosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Keunyoung Kim</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea; College of Pharmacy, Kangwon National University, Chuncheon 24341, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Kyung Shin</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Ho Chung</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea. Electronic address: jhc302@snu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Min Lim</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea. Electronic address: kmlim@ewha.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Leukocyte apoptosis, TNF-α concentration and oxidative damage in lead-exposed workers.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32004562</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30025-9</DOI>
    <KeywordList>
      <Keywords>Eryptosis</Keywords>
      <Keywords>Immune dysfunction</Keywords>
      <Keywords>Infections</Keywords>
      <Keywords>Lipid peroxidation</Keywords>
      <Keywords>Lipopolysaccharide</Keywords>
      <Keywords>Pro-inflammatory</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nadia Cristina López-Vanegas</Name>
        <Affiliation>Biochemistry Department, Centro de Investigación y Estudios Avanzados-IPN, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Gerardo Hernández</Name>
        <Affiliation>Section Methodology of Science, Centro de Investigación y Estudios Avanzados-IPN, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>María Maldonado-Vega</Name>
        <Affiliation>Planning, Teaching and Research Department, Hospital Regional de Alta Especialidad del Bajío, Blvd. Milenio 130, San Carlos La Roncha, León, Guanajuato, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>José Víctor Calderón-Salinas</Name>
        <Affiliation>Biochemistry Department, Centro de Investigación y Estudios Avanzados-IPN, Ciudad de México, Mexico. Electronic address: jcalder@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective effect of EX-527 against high-fat diet-induced diabetic nephropathy in Zucker rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31981641</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30023-5</DOI>
    <KeywordList>
      <Keywords>Diabetic nephropathy</Keywords>
      <Keywords>EX-527</Keywords>
      <Keywords>High-fat diet</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>SIRT</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amit Kundu</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sachan Richa</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Prasanta Dey</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyeong Seok Kim</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Yeon Son</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hae Ri Kim</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seok Yong Lee</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Hoon Lee</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kwang Youl Lee</Name>
        <Affiliation>College of Pharmacy &amp; Research Institute of Drug Development, Chonnam National University, Gwangju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sam Kacew</Name>
        <Affiliation>McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Mu Lee</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Sik Kim</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 440-746, Republic of Korea. Electronic address: hkims@skku.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Combining an in silico proarrhythmic risk assay with a tPKPD model to predict QTc interval prolongation in the anesthetized guinea pig assay.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31981640</pubmedLink>
    <GrantList>
      <Grant>NC/P001076/1</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30007-7</DOI>
    <KeywordList>
      <Keywords>Anesthetized Cardiovascular Guinea Pig</Keywords>
      <Keywords>In Silico modeling</Keywords>
      <Keywords>QT corrected interval</Keywords>
      <Keywords>Safety pharmacology</Keywords>
      <Keywords>Torsade de Pointes</Keywords>
      <Keywords>Translational PKPD modeling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pierre Morissette</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources (SALAR), Merck &amp; Co., Inc., West Point, PA, USA. Electronic address: pierre_morissette@merck.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastian Polak</Name>
        <Affiliation>Certara UK Limited, Simcyp Division, Sheffield, UK; Jagiellonian University Medical College, Faculty of Pharmacy, Krakow, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Chain</Name>
        <Affiliation>Pharmacokinetics, Pharmacodynamics and Drug Metabolism (PPDM), Merck &amp; Co., Inc., Rahway, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Zhai</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources (SALAR), Merck &amp; Co., Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John P. Imredy</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources (SALAR), Merck &amp; Co., Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Jo Wildey</Name>
        <Affiliation>Pharmacology, Screening and Informatics, Merck &amp; Co., Kenilworth, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Travis</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources (SALAR), Merck &amp; Co., Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Fitzgerald</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources (SALAR), Merck &amp; Co., Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Fanelli</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources (SALAR), Merck &amp; Co., Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elisa Passini</Name>
        <Affiliation>Computational Cardiovascular Science Group, Department of Computer Science, BHF Centre of Research Excellence, University of Oxford, Oxford, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Blanca Rodriguez</Name>
        <Affiliation>Computational Cardiovascular Science Group, Department of Computer Science, BHF Centre of Research Excellence, University of Oxford, Oxford, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Frederick Sannajust</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources (SALAR), Merck &amp; Co., Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Regan</Name>
        <Affiliation>Safety Assessment &amp; Laboratory Animal Resources (SALAR), Merck &amp; Co., Inc., West Point, PA, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative analysis of lung and blood transcriptomes in mice exposed to multi-walled carbon nanotubes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31978390</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30022-3</DOI>
    <KeywordList>
      <Keywords>IPA Analysis</Keywords>
      <Keywords>Lung Transcriptome</Keywords>
      <Keywords>MWCNT</Keywords>
      <Keywords>Whole Blood Transcriptome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Timur O. Khaliullin</Name>
        <Affiliation>Department of Physiology and Pharmacology, West Virginia University, Morgantown, WV, USA; Health Effects Laboratory Division, NIOSH, CDC, Morgantown, WV, USA. Electronic address: ved2@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Naveena Yanamala</Name>
        <Affiliation>Health Effects Laboratory Division, NIOSH, CDC, Morgantown, WV, USA. Electronic address: wqu1@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Mackenzie S. Newman</Name>
        <Affiliation>Department of Physiology and Pharmacology, West Virginia University, Morgantown, WV, USA. Electronic address: msnewman@mix.wvu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Elena R. Kisin</Name>
        <Affiliation>Health Effects Laboratory Division, NIOSH, CDC, Morgantown, WV, USA. Electronic address: edk8@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Liliya M. Fatkhutdinova</Name>
        <Affiliation>Department of Hygiene and Occupational Medicine, Kazan State Medical University, Kazan, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Anna A. Shvedova</Name>
        <Affiliation>Department of Physiology and Pharmacology, West Virginia University, Morgantown, WV, USA; Health Effects Laboratory Division, NIOSH, CDC, Morgantown, WV, USA. Electronic address: ats1@cdc.gov.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no competing interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Amorphous silica nanoparticle-induced pulmonary inflammatory response depends on particle size and is sex-specific in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31972177</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30014-4</DOI>
    <KeywordList>
      <Keywords>Amorphous silica nanoparticles</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Matrix metalloproteinase</Keywords>
      <Keywords>Sex</Keywords>
      <Keywords>Size</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyoung Yun Han</Name>
        <Affiliation>Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea; College of Veterinary Medicine &amp; Institute of Veterinary Science, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Woo Cho</Name>
        <Affiliation>Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eunsol Seong</Name>
        <Affiliation>Graduate School of East-West Medical Science, Kyung Hee University, Yongin 17104, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Jun Park</Name>
        <Affiliation>Graduate School of East-West Medical Science, Kyung Hee University, Yongin 17104, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gwang Hee Lee</Name>
        <Affiliation>School of Civil, Environmental, and Architectural Engineering, Korea University, Seoul 136-713, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Wan Kim</Name>
        <Affiliation>School of Civil, Environmental, and Architectural Engineering, Korea University, Seoul 136-713, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Su Yang</Name>
        <Affiliation>Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Hwa Oh</Name>
        <Affiliation>Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seokjoo Yoon</Name>
        <Affiliation>Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Geol Lee</Name>
        <Affiliation>Korea Research Institute of Standards and Science, 267 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Won Kim</Name>
        <Affiliation>College of Veterinary Medicine &amp; Institute of Veterinary Science, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Jung Park</Name>
        <Affiliation>Graduate School of East-West Medical Science, Kyung Hee University, Yongin 17104, Republic of Korea. Electronic address: pejtoxic@khu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dexmedetomidine attenuates ethanol-induced inhibition of hippocampal neurogenesis in neonatal mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31954762</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30005-3</DOI>
    <KeywordList>
      <Keywords>Dexmedetomidine</Keywords>
      <Keywords>Ethanol</Keywords>
      <Keywords>Hippocampus neurogenesis</Keywords>
      <Keywords>Radial glial cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Keyi Lv</Name>
        <Affiliation>Department of Developmental Neuropsychology, School of Psychology, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Congwen Yang</Name>
        <Affiliation>Department of Anesthesiology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Xiao</Name>
        <Affiliation>Department of Developmental Neuropsychology, School of Psychology, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Yang</Name>
        <Affiliation>Department of Developmental Neuropsychology, School of Psychology, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tianyao Liu</Name>
        <Affiliation>Department of Developmental Neuropsychology, School of Psychology, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruiyu Zhang</Name>
        <Affiliation>Department of Developmental Neuropsychology, School of Psychology, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaotang Fan</Name>
        <Affiliation>Department of Developmental Neuropsychology, School of Psychology, Third Military Medical University, Chongqing 400038, China. Electronic address: fanxiaotang2005@163.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no competing interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31953203</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30006-5</DOI>
    <KeywordList>
      <Keywords>Bleomycin</Keywords>
      <Keywords>Fibrotic process</Keywords>
      <Keywords>Nagilactone D</Keywords>
      <Keywords>Pulmonary fibrosis</Keywords>
      <Keywords>TGF-β1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ao Li</Name>
        <Affiliation>College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Xiao</Name>
        <Affiliation>College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Ling Feng</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuping Chen</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Juan Liu</Name>
        <Affiliation>College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Gen Lin</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China. Electronic address: ligenl@um.edu.mo.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Jian Lu</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China. Electronic address: jinjianlu@um.edu.mo.</Affiliation>
      </Author>
      <Author>
        <Name>Le Le Zhang</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China; School of Medicine, Chengdu University, Chengdu, China. Electronic address: lele443119328@126.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no competing financial interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A single-injection targeted metabolomics profiling method for determination of biomarkers to reflect tripterygium glycosides efficacy and toxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31945383</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30004-1</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Efficacy</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Single-Injection</Keywords>
      <Keywords>Tripterygium Glycosides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ting Hu</Name>
        <Affiliation>Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Shi</Name>
        <Affiliation>Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lihong Liu</Name>
        <Affiliation>Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengfei Li</Name>
        <Affiliation>Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Sun</Name>
        <Affiliation>Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuoling An</Name>
        <Affiliation>Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, PR China. Electronic address: anzhuoling@163.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The antidotes atropine and pralidoxime distinctively recover cardiorespiratory components impaired by acute poisoning with chlorpyrifos in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31931016</pubmedLink>
    <GrantList>
      <Grant>MR/M026442/1</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30003-X</DOI>
    <KeywordList>
      <Keywords>Atropine</Keywords>
      <Keywords>Cardiorespiratory</Keywords>
      <Keywords>Chlorpyrifos</Keywords>
      <Keywords>Organophosphate</Keywords>
      <Keywords>Pralidoxime</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Igor Simões Assunção Felippe</Name>
        <Affiliation>Postgraduate Program in Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil; Department of Physiology, Faculty of Health &amp; Medical Sciences, University of Auckland, Grafton Campus, Auckland 1023, New Zealand.</Affiliation>
      </Author>
      <Author>
        <Name>Cláudia Janaína Torres Müller</Name>
        <Affiliation>Postgraduate Program in Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alciene Almeida Siqueira</Name>
        <Affiliation>Postgraduate Program in Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Leonardo Dos Santos</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alana Cavadino</Name>
        <Affiliation>Department of Epidemiology and Biostatistics, Faculty of Health &amp; Medical Sciences, University of Auckland, Tamaki Campus, Auckland 1072, New Zealand.</Affiliation>
      </Author>
      <Author>
        <Name>Julian Francis Richmond Paton</Name>
        <Affiliation>Department of Physiology, Faculty of Health &amp; Medical Sciences, University of Auckland, Grafton Campus, Auckland 1023, New Zealand; Department of Physiology, Pharmacology &amp; Neuroscience, Biomedical Sciences, University of Bristol, Bristol, BS8 ITD, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Vanessa Beijamini</Name>
        <Affiliation>Postgraduate Program in Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Karla Nívea Sampaio</Name>
        <Affiliation>Postgraduate Program in Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil. Electronic address: kniveas@yahoo.co.uk.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterizing biopersistence potential of the metabolite 5:3 fluorotelomer carboxylic acid after repeated oral exposure to the 6:2 fluorotelomer alcohol.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31923437</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30002-8</DOI>
    <KeywordList>
      <Keywords>5:3 acid</Keywords>
      <Keywords>6:2 fluorotelomer alcohol</Keywords>
      <Keywords>Biopersistence</Keywords>
      <Keywords>Elimination half-life</Keywords>
      <Keywords>Elimination rate constant</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Time to steady state</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shruti V. Kabadi</Name>
        <Affiliation>FDA/CFSAN/OFAS/DFCS, 5001 Campus Drive, HFS 275, College Park, MD 20740, United States of America. Electronic address: Shruti.Kabadi@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey W. Fisher</Name>
        <Affiliation>FDA/NCTR/DBT, 3900 NCTR Road, Jefferson, AR 72079, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel R. Doerge</Name>
        <Affiliation>FDA/NCTR/DBT, 3900 NCTR Road, Jefferson, AR 72079, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Darshan Mehta</Name>
        <Affiliation>FDA/NCTR/DBT, 3900 NCTR Road, Jefferson, AR 72079, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Aungst</Name>
        <Affiliation>FDA/CFSAN/OFAS/DFCS, 5001 Campus Drive, HFS 275, College Park, MD 20740, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Penelope Rice</Name>
        <Affiliation>FDA/CFSAN/OFAS/DFCS, 5001 Campus Drive, HFS 275, College Park, MD 20740, United States of America.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors disclose that they have no competing financial and other interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Resveratrol modulates the blood plasma levels of Cu and Zn, the antioxidant status and the vascular response of thoracic arteries in copper deficient Wistar rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31917326</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(20)30001-6</DOI>
    <KeywordList>
      <Keywords>Antioxidant status</Keywords>
      <Keywords>Copper deficiency</Keywords>
      <Keywords>Pinacidil</Keywords>
      <Keywords>Resveratrol</Keywords>
      <Keywords>Superoxide dismutase</Keywords>
      <Keywords>Thoracic aorta</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michał Majewski</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Medicine, UWM, Olsztyn, Poland. Electronic address: michal.majewski@uwm.edu.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Katarzyna Ognik</Name>
        <Affiliation>Department of Biochemistry and Toxicology, Faculty of Biology, Animal Sciences and Bioeconomy, University of Life Sciences, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Thoene</Name>
        <Affiliation>Department of Medical Biology, Faculty of Health Sciences, UWM, Olsztyn, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Aleksandra Rawicka</Name>
        <Affiliation>Policlinico Veterinario Roma Sud, Ophthalmology, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Jerzy Juśkiewicz</Name>
        <Affiliation>Division of Food Science, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there is no conflict of interest regarding the publication of this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bioactivity screening of environmental chemicals using imaging-based high-throughput phenotypic profiling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31899216</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30484-3</DOI>
    <KeywordList>
      <Keywords>Cell painting</Keywords>
      <Keywords>High content imaging</Keywords>
      <Keywords>High-throughput profiling</Keywords>
      <Keywords>ToxCast</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Johanna Nyffeler</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development, US Environmental Protection Agency, Durham, NC 27711, United States of America; Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN 37831, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Clinton Willis</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development, US Environmental Protection Agency, Durham, NC 27711, United States of America; Oak Ridge Associated Universities (ORAU) National Student Services Contractor, Oak Ridge, TN 37831, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Ryan Lougee</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development, US Environmental Protection Agency, Durham, NC 27711, United States of America; Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN 37831, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Ann Richard</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development, US Environmental Protection Agency, Durham, NC 27711, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Katie Paul-Friedman</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development, US Environmental Protection Agency, Durham, NC 27711, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua A. Harrill</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development, US Environmental Protection Agency, Durham, NC 27711, United States of America. Electronic address: harrill.joshua@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effects of a phthalate metabolite mixture on antral follicle growth and sex steroid synthesis in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31884101</pubmedLink>
    <GrantList>
      <Grant>R01 ES028661</Grant>
      <Grant>R56 ES025147</Grant>
      <Grant>T32 ES007326</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30483-1</DOI>
    <KeywordList>
      <Keywords>Antral follicle</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cell cycle</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Phthalate mixture</Keywords>
      <Keywords>Steroidogenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daryl D. Meling</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois at Urbana-Champaign, 2001 S. Lincoln Ave., Urbana, IL 61802, USA. Electronic address: dmeling@illinois.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Genoa R. Warner</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois at Urbana-Champaign, 2001 S. Lincoln Ave., Urbana, IL 61802, USA. Electronic address: genoa@illinois.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jason R. Szumski</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois at Urbana-Champaign, 2001 S. Lincoln Ave., Urbana, IL 61802, USA. Electronic address: szumski2@illinois.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Liying Gao</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois at Urbana-Champaign, 2001 S. Lincoln Ave., Urbana, IL 61802, USA. Electronic address: lgao@illinois.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Andressa V. Gonsioroski</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois at Urbana-Champaign, 2001 S. Lincoln Ave., Urbana, IL 61802, USA. Electronic address: avg5@illinois.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Saniya Rattan</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois at Urbana-Champaign, 2001 S. Lincoln Ave., Urbana, IL 61802, USA. Electronic address: rattan2@illinois.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jodi A. Flaws</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois at Urbana-Champaign, 2001 S. Lincoln Ave., Urbana, IL 61802, USA; Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, 1206 W. Gregory Dr., Urbana, IL 61801, USA. Electronic address: jflaws@illinois.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>p38 MAPK-DRP1 signaling is involved in mitochondrial dysfunction and cell death in mutant A53T α-synuclein model of Parkinson's disease.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31881179</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30482-X</DOI>
    <KeywordList>
      <Keywords>DRP1</Keywords>
      <Keywords>Mitochondrial homeostasis</Keywords>
      <Keywords>p38MAPK</Keywords>
      <Keywords>α-Synuclein A53T</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chen Gui</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yixian Ren</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jialong Chen</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xian Wu</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kanmin Mao</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huihui Li</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Honglin Yu</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Zou</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjun Li</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China. Electronic address: cjlwj@smu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None of the authors have competing interests. Every author has seen and contributed to the final draft, and also agree the manuscript is ready to submit.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Transcriptomic modifications of the thyroid gland upon exposure to phytosanitary-grade fipronil: Evidence for the activation of compensatory pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31881178</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30481-8</DOI>
    <KeywordList>
      <Keywords>Endocrine disruptor</Keywords>
      <Keywords>Fipronil</Keywords>
      <Keywords>Thyroid</Keywords>
      <Keywords>Toxicokinetic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pascal G. P. Martin</Name>
        <Affiliation>ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, 180 chemin de Tournefeuille, BP93173, F-31027 Toulouse Cedex 03, France.</Affiliation>
      </Author>
      <Author>
        <Name>Véronique Dupouy</Name>
        <Affiliation>ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, 180 chemin de Tournefeuille, BP93173, F-31027 Toulouse Cedex 03, France; IntheRes, INRAE, ENVT, 23 chemin des Capelles, BP87614, F-31076 Toulouse Cedex 03, France.</Affiliation>
      </Author>
      <Author>
        <Name>Julien Leghait</Name>
        <Affiliation>ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, 180 chemin de Tournefeuille, BP93173, F-31027 Toulouse Cedex 03, France.</Affiliation>
      </Author>
      <Author>
        <Name>Thierry Pineau</Name>
        <Affiliation>ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, 180 chemin de Tournefeuille, BP93173, F-31027 Toulouse Cedex 03, France.</Affiliation>
      </Author>
      <Author>
        <Name>Arnaud Polizzi</Name>
        <Affiliation>ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, 180 chemin de Tournefeuille, BP93173, F-31027 Toulouse Cedex 03, France.</Affiliation>
      </Author>
      <Author>
        <Name>Frédéric Lasserre</Name>
        <Affiliation>ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, 180 chemin de Tournefeuille, BP93173, F-31027 Toulouse Cedex 03, France.</Affiliation>
      </Author>
      <Author>
        <Name>Béatrice B. Roques</Name>
        <Affiliation>ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, 180 chemin de Tournefeuille, BP93173, F-31027 Toulouse Cedex 03, France; IntheRes, INRAE, ENVT, 23 chemin des Capelles, BP87614, F-31076 Toulouse Cedex 03, France.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Viguié</Name>
        <Affiliation>ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, 180 chemin de Tournefeuille, BP93173, F-31027 Toulouse Cedex 03, France. Electronic address: catherine.viguie@inra.fr.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective effect of resveratrol on obesity-related osteoarthritis via alleviating JAK2/STAT3 signaling pathway is independent of SOCS3.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31881177</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30479-X</DOI>
    <KeywordList>
      <Keywords>Leptin</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Osteoarthritis</Keywords>
      <Keywords>Resveratrol</Keywords>
      <Keywords>SOCS3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mengqi Jiang</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianyi He</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hailun Gu</Name>
        <Affiliation>Department of Orthopedics, Shengjing Hospital, China Medical University, No. 36 Sanhao Street, Heping District, Shenyang 110004, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingchun Yang</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Huang</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaolei Xu</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Liu</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, Liaoning, China. Electronic address: lliu@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A toxicogenomic approach for the risk assessment of the food contaminant acetamide.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31881176</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30480-6</DOI>
    <KeywordList>
      <Keywords>Acetamide</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxicogenomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rance Nault</Name>
        <Affiliation>Institute for Integrative Toxicology, Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan Bals</Name>
        <Affiliation>Michigan Biotechnology Institute, Lansing, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Farzaneh Teymouri</Name>
        <Affiliation>Michigan Biotechnology Institute, Lansing, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael B. Black</Name>
        <Affiliation>ScitoVation, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>ScitoVation, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick D. McMullen</Name>
        <Affiliation>ScitoVation, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Seetha Krishnan</Name>
        <Affiliation>Syngene International, Bengaluru, India.</Affiliation>
      </Author>
      <Author>
        <Name>Nagesh Kuravadi</Name>
        <Affiliation>Syngene International, Bengaluru, India.</Affiliation>
      </Author>
      <Author>
        <Name>Neetha Paul</Name>
        <Affiliation>Syngene International, Bengaluru, India.</Affiliation>
      </Author>
      <Author>
        <Name>Santhosh Kumar</Name>
        <Affiliation>Eurofins Advinus, Bengaluru, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kamala Kannan</Name>
        <Affiliation>Eurofins Advinus, Bengaluru, India.</Affiliation>
      </Author>
      <Author>
        <Name>K. C. Jayachandra</Name>
        <Affiliation>Eurofins Advinus, Bengaluru, India.</Affiliation>
      </Author>
      <Author>
        <Name>Lakshmanan Alagappan</Name>
        <Affiliation>Eurofins Advinus, Bengaluru, India.</Affiliation>
      </Author>
      <Author>
        <Name>Bhavesh Dhirajlal Patel</Name>
        <Affiliation>Eurofins Advinus, Bengaluru, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth T. Bogen</Name>
        <Affiliation>ktbogen.com, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bhaskar B. Gollapudi</Name>
        <Affiliation>Exponent, Alexandria, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Klaunig</Name>
        <Affiliation>Indiana University Bloomington, Bloomington, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tim R. Zacharewski</Name>
        <Affiliation>Institute for Integrative Toxicology, Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Venkataraman Bringi</Name>
        <Affiliation>Chemical Engineering &amp; Materials Science, Michigan State University, East Lansing, MI, USA. Electronic address: bringi@msu.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Triptonide effectively suppresses gastric tumor growth and metastasis through inhibition of the oncogenic Notch1 and NF-κB signaling pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31866380</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30478-8</DOI>
    <KeywordList>
      <Keywords>Cancer therapy</Keywords>
      <Keywords>Gastric cancer</Keywords>
      <Keywords>Metastasis</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>Notch1</Keywords>
      <Keywords>Triptonide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shufen Xiang</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Zhao</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Tong Zhang</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Zhang</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Meng</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhifei Cao</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Quansheng Zhou</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, 2011 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu 215123, PR China. Electronic address: zhouqs@suda.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that there are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>miR-187-5p/apaf-1 axis was involved in oxidative stress-mediated apoptosis caused by ammonia via mitochondrial pathway in chicken livers.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31863799</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30477-6</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Chicken</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Mitochondrial pathway</Keywords>
      <Keywords>NH(3)</Keywords>
      <Keywords>miR-187-5p</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yanmin Xu</Name>
        <Affiliation>College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuo Li</Name>
        <Affiliation>College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuai Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongfu Zhang</Name>
        <Affiliation>State Key Laboratory of Animal Nutrition, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, People's Republic of China. Electronic address: zhanghongfu@caas.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohua Teng</Name>
        <Affiliation>College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, People's Republic of China. Electronic address: tengxiaohua@neau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest All authors read and approved the final manuscript. The authors declare that there are no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis "Toxicol Appl Pharmacol. 2016;305:194-202".</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31843362</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30466-1</DOI>
    <AuthorList>
      <Author>
        <Name>Chao Feng Lin</Name>
        <Affiliation>Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taiwan; Department of Medicine, MacKay Medical College, New Taipei City, Taiwan; Division of Cardiology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan; Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Han Li Huang</Name>
        <Affiliation>Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chieh Yu Peng</Name>
        <Affiliation>Chinese Medicine Research and Development Center, China Medical University Hospital, Taichung 404, Taiwan; School of Pharmacy, College of Pharmacy, China Medical University, Taichung 404, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Ching Lee</Name>
        <Affiliation>The Center of Translational Medicine, Taipei Medical University, Taipei, Taiwan; Program for Biotechnology in Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Po Wang</Name>
        <Affiliation>College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Che Ming Teng</Name>
        <Affiliation>College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan; Pharmacological Institute, College of Medicine, National Taiwan University, Taipei 100, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shiow Lin Pan</Name>
        <Affiliation>Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taiwan; Department of Pharmacology, College of Medicine, Taipei Medical University, Taipei 10031, Taiwan. Electronic address: slpan@tmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31837377</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30465-X</DOI>
    <KeywordList>
      <Keywords>Chronic myeloid leukemia</Keywords>
      <Keywords>HuR</Keywords>
      <Keywords>MCL1</Keywords>
      <Keywords>Survivin</Keywords>
      <Keywords>YM155</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Ting Chiou</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Chin Lee</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Hui Huang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Jun Shi</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Jun Wang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Long Sen Chang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan; Department of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan. Electronic address: lschang@mail.nsysu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of cytochrome P450 reactivity on the characterization of chemical compounds and its association with repeated-dose toxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31836524</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30462-4</DOI>
    <KeywordList>
      <Keywords>Chemical descriptors</Keywords>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Enzyme inhibition</Keywords>
      <Keywords>Repeated-dose toxicity</Keywords>
      <Keywords>Toxicity prediction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michiko Watanabe</Name>
        <Affiliation>Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takamitsu Sasaki</Name>
        <Affiliation>Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Ichi Takeshita</Name>
        <Affiliation>Research Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Madoka Kushida</Name>
        <Affiliation>Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuki Shimizu</Name>
        <Affiliation>Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hitomi Oki</Name>
        <Affiliation>Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoko Kitsunai</Name>
        <Affiliation>Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Haruka Nakayama</Name>
        <Affiliation>Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hitomi Saruhashi</Name>
        <Affiliation>Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Ogura</Name>
        <Affiliation>Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ryota Shizu</Name>
        <Affiliation>Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takuomi Hosaka</Name>
        <Affiliation>Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kouichi Yoshinari</Name>
        <Affiliation>Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan. Electronic address: yoshinari@u-shizuoka-ken.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the exposure, dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to TiO</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31836523</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30464-8</DOI>
    <KeywordList>
      <Keywords>Amosite</Keywords>
      <Keywords>Brake dust</Keywords>
      <Keywords>Chrysotile</Keywords>
      <Keywords>Crocidolite</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>D. M. Bernstein</Name>
        <Affiliation>Consultant in Toxicology, Geneva, Switzerland. Electronic address: davidb@itox.ch.</Affiliation>
      </Author>
      <Author>
        <Name>B. Toth</Name>
        <Affiliation>Citoxlab Hungary, Veszprém, Szabadságpuszta, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>R. A. Rogers</Name>
        <Affiliation>Rogers Imaging, Natick, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. E. Kling</Name>
        <Affiliation>Rogers Imaging, Natick, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. Kunzendorf</Name>
        <Affiliation>GSA Gesellschaft für Schadstoffanalytik mbH, Ratingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>J. I. Phillips</Name>
        <Affiliation>National Institute for Occupational Health, National Health Laboratory Service, Johannesburg South Africa and Department of Biomedical Technology, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>H. Ernst</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The article was funded by Honeywell International Inc. All protocol, design of the experimental procedures and the choice of laboratories was performed by D. M. Bernstein in conjunction with the scientific advisory board (see acknowledgements, below). The laboratory work to Citoxlab, Fraunhofer Institute, GSA and Rogers Imaging was sub-contracted by D. M. Bernstein. The affiliations of the authors are as shown on the cover page and include research laboratories, government institute, corporate affiliations, as well as independent toxicology consultant. This publication is the professional work product of the authors and may not necessarily represent the views of the corporate sponsor. One of the authors, David Bernstein, has appeared as an expert witness in litigation concerned with alleged health effects of exposure to chrysotile. Honeywell is a defendant in asbestos-product litigation and its predecessor manufactured the automotive brakes used in this study. There have been periodic communications between Honeywell and the authors concerning the status of this study. The work performed by Prof J. I. Phillips is based on research supported by the National Research Foundation.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low doses of BPA induced abnormal mitochondrial fission and hypertrophy in human embryonic stem cell-derived cardiomyocytes via the calcineurin-DRP1 signaling pathway: A comparison between XX and XY cardiomyocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31830493</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30458-2</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Calcineurin</Keywords>
      <Keywords>Cardiomyocytes</Keywords>
      <Keywords>Human embryonic stem cells</Keywords>
      <Keywords>Mitochondrial fission</Keywords>
      <Keywords>Sex-specific effect</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Cheng</Name>
        <Affiliation>School of Public Health, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shoufei Yang</Name>
        <Affiliation>School of Public Health, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaolan Li</Name>
        <Affiliation>School of Public Health, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Liang</Name>
        <Affiliation>School of Public Health, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ren Zhou</Name>
        <Affiliation>The Ninth People's Hospital of Shanghai Jiao Tong University, School of Medicine, Shanghai 200011, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Feng</Name>
        <Affiliation>School of Public Health, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Wang</Name>
        <Affiliation>School of Public Health, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, PR China; The Ninth People's Hospital of Shanghai Jiao Tong University, School of Medicine, Shanghai 200011, PR China; Shanghai Collaborative Innovation Center for Translational Medicine, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, PR China. Electronic address: wangyan@shsmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to TiO</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31830492</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30455-7</DOI>
    <AuthorList>
      <Author>
        <Name>D. M. Bernstein</Name>
        <Affiliation>Consultant in Toxicology, Geneva, Switzerland. Electronic address: davidb@itox.ch.</Affiliation>
      </Author>
      <Author>
        <Name>B. Toth</Name>
        <Affiliation>Citoxlab Hungary, Veszprém, Szabadságpuszta, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>R. A. Rogers</Name>
        <Affiliation>Rogers Imaging, Natick, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. E. Kling</Name>
        <Affiliation>Rogers Imaging, Natick, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. Kunzendorf</Name>
        <Affiliation>GSA Gesellschaft für Schadstoffanalytik mbH, Ratingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>J. I. Phillips</Name>
        <Affiliation>National Institute for Occupational Health, National Health Laboratory Service, Johannesburg South Africa and Department of Biomedical Technology, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>H. Ernst</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest This study was funded by Honeywell International Inc. All protocol, design of the experimental procedures and the choice of laboratories was performed by D. M. Bernstein inconjunction with the scientific advisory board (see acknowledgements, below). The laboratory work to Citoxlab, Fraunhofer Institute, GSA and Rogers Imaging was sub-contracted by D. M. Bernstein. The affiliations of the authors are as shown on the cover page and include research laboratories, government institute, corporate affiliations, as well as independent toxicology consultant. This publication is the professional work product of the authors and may not necessarily represent the views of the corporate sponsor. One of the authors, David Bernstein, has appeared as an expert witness in litigation concerned with alleged health effects of exposure to chrysotile. Honeywell is a defendant in asbestos-product litigation and its predecessor manufactured the automotive brakes used in this study. There have been periodic communications between Honeywell and the authors concerning the status of this study. The contribution of Prof J. I. Phillips is based on research supported by the National Research Foundation.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Vanillin derivative VND3207 activates DNA-PKcs conferring protection against radiation-induced intestinal epithelial cells injury in vitro and in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31830491</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30463-6</DOI>
    <KeywordList>
      <Keywords>DNA damage</Keywords>
      <Keywords>DNA-PKcs</Keywords>
      <Keywords>Mitotic catastrophe</Keywords>
      <Keywords>Radiation-induced intestinal injuries</Keywords>
      <Keywords>VND3207</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ming Li</Name>
        <Affiliation>State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Lang</Name>
        <Affiliation>State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Meng Gu</Name>
        <Affiliation>State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China; Department of Laboratory Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou 215002, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianming Shi</Name>
        <Affiliation>Suzhou Digestive Diseases and Nutrition Research Center, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou 215008, China.</Affiliation>
      </Author>
      <Author>
        <Name>Benjamin P. C. Chen</Name>
        <Affiliation>Department of Radiation Oncology, University of Texas Southwestern Medical Center, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Yu</Name>
        <Affiliation>Suzhou Digestive Diseases and Nutrition Research Center, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou 215008, China. Electronic address: Yulan_229@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Kun Zhou</Name>
        <Affiliation>State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, China. Electronic address: zhoupk@bmi.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zeng Fu Shang</Name>
        <Affiliation>State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China. Electronic address: zengfu.shang@suda.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest There are no conflicts of interest to declare.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gant61 ameliorates CCl</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31816328</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30461-2</DOI>
    <KeywordList>
      <Keywords>4,6-diamidino-2-phenylindole</Keywords>
      <Keywords>DAPI</Keywords>
      <Keywords>Dhh</Keywords>
      <Keywords>ECM</Keywords>
      <Keywords>G protein-coupled receptor Smoothened</Keywords>
      <Keywords>GAPDH</Keywords>
      <Keywords>Gant61</Keywords>
      <Keywords>Glis</Keywords>
      <Keywords>H&amp;E</Keywords>
      <Keywords>HSCs</Keywords>
      <Keywords>Hedgehog</Keywords>
      <Keywords>Hedgehog signaling</Keywords>
      <Keywords>Hepatic stellate cells</Keywords>
      <Keywords>Hh</Keywords>
      <Keywords>Hh receptor Patched</Keywords>
      <Keywords>Ihh</Keywords>
      <Keywords>Indian Hh</Keywords>
      <Keywords>Liver fibrosis</Keywords>
      <Keywords>MMP2</Keywords>
      <Keywords>Ptch</Keywords>
      <Keywords>Quantitative real-time polymerase chain reaction</Keywords>
      <Keywords>Shh</Keywords>
      <Keywords>Smo</Keywords>
      <Keywords>TGF-β</Keywords>
      <Keywords>WB</Keywords>
      <Keywords>Western blot</Keywords>
      <Keywords>col1α1</Keywords>
      <Keywords>collagen-α1</Keywords>
      <Keywords>cycD1/2</Keywords>
      <Keywords>cyclin D1/2</Keywords>
      <Keywords>desert Hh</Keywords>
      <Keywords>extracellular matrix</Keywords>
      <Keywords>glyceraldehyde-3-phosphate-dehydrogenase</Keywords>
      <Keywords>hematoxylin-eosin</Keywords>
      <Keywords>hepatic stellate cells</Keywords>
      <Keywords>matrix metalloproteinases 2</Keywords>
      <Keywords>qRT-PCR</Keywords>
      <Keywords>sonic Hh</Keywords>
      <Keywords>transforming growth factor β</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shen Jiayuan</Name>
        <Affiliation>College of Life Science, Shaoxing University, Shaoxing, Zhejiang, China; Department of pathology, Affliliated hospital of Shaoxing University, Shaoxing, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Junyan</Name>
        <Affiliation>College of Life Science, Shaoxing University, Shaoxing, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Xiangzhen</Name>
        <Affiliation>Xi'an Jiaotong-liverpool University, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liu Zuping</Name>
        <Affiliation>College of Life Science, Shaoxing University, Shaoxing, Zhejiang, China; Department of pathology, Affliliated hospital of Shaoxing University, Shaoxing, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ni Jian</Name>
        <Affiliation>College of Life Science, Shaoxing University, Shaoxing, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hu Baowei</Name>
        <Affiliation>College of Life Science, Shaoxing University, Shaoxing, Zhejiang, China. Electronic address: hbw@usx.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Lifang</Name>
        <Affiliation>College of Life Science, Shaoxing University, Shaoxing, Zhejiang, China. Electronic address: lifangj@sohu.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Thymoquinone promotes mouse mesenchymal stem cells migration in vitro and induces their immunogenicity in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31812774</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30459-4</DOI>
    <KeywordList>
      <Keywords>Gene expression</Keywords>
      <Keywords>In vitro wound healing assay</Keywords>
      <Keywords>In vivo immunomodulation</Keywords>
      <Keywords>Mesenchymal stem cell</Keywords>
      <Keywords>Migration</Keywords>
      <Keywords>Thymoquinone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Niloufar Rezaei</Name>
        <Affiliation>Department of Biology, Faculty of Science, Razi University, Kermanshah, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Tayebeh Sardarzadeh</Name>
        <Affiliation>Department of Biology, Faculty of Science, Razi University, Kermanshah, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Sajjad Sisakhtnezhad</Name>
        <Affiliation>Department of Biology, Faculty of Science, Razi University, Kermanshah, Iran. Electronic address: s.sisakhtnezhad@razi.ac.ir.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest We confirm that there are no known conflicts of interest with this publication.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Verteporfin inhibits lipopolysaccharide-induced inflammation by multiple functions in RAW 264.7 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31812773</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30460-0</DOI>
    <KeywordList>
      <Keywords>Inflammation</Keywords>
      <Keywords>LPS</Keywords>
      <Keywords>RAW 264.7</Keywords>
      <Keywords>Verteporfin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuting Wang</Name>
        <Affiliation>Department of Pulmonology, the Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Zhejiang 310052, People's Republic of China; Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Wang</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James T. F. Wise</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA; Department of Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xianglin Shi</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA. Electronic address: xianglin.shi@uky.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Zhimin Chen</Name>
        <Affiliation>Department of Pulmonology, the Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Zhejiang 310052, People's Republic of China. Electronic address: zmchen@zju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mice deficient in pyruvate dehydrogenase kinase 4 are protected against acetaminophen-induced hepatotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31809757</pubmedLink>
    <GrantList>
      <Grant>P30 GM118247</Grant>
      <Grant>F31 DK120194</Grant>
      <Grant>P20 GM103549</Grant>
      <Grant>R01 DK102142</Grant>
      <Grant>R01 DK119131</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30457-0</DOI>
    <KeywordList>
      <Keywords>Acetaminophen, drug-induced liver injury</Keywords>
      <Keywords>Bioenergetics</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Oxidant stress</Keywords>
      <Keywords>UCP2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Luqi Duan</Name>
        <Affiliation>Department of Pharmacology, Toxicology &amp; Therapeutics and Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anup Ramachandran</Name>
        <Affiliation>Department of Pharmacology, Toxicology &amp; Therapeutics and Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jephte Y. Akakpo</Name>
        <Affiliation>Department of Pharmacology, Toxicology &amp; Therapeutics and Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Benjamin L. Woolbright</Name>
        <Affiliation>Department of Pharmacology, Toxicology &amp; Therapeutics and Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuxia Zhang</Name>
        <Affiliation>Department of Pharmacology, Toxicology &amp; Therapeutics and Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hartmut Jaeschke</Name>
        <Affiliation>Department of Pharmacology, Toxicology &amp; Therapeutics and Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA. Electronic address: hjaeschke@kumc.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sesamin suppresses NSCLC cell proliferation and induces apoptosis via Akt/p53 pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31809756</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30456-9</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cell cycle arrest</Keywords>
      <Keywords>Cyclin D1</Keywords>
      <Keywords>NSCLC</Keywords>
      <Keywords>Sesamin</Keywords>
      <Keywords>p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yueming Chen</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huachao Li</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weinan Zhang</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanchen Qi</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changpeng Lu</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huiliang Huang</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhicheng Yang</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Liu</Name>
        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangdong Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou 510006, China. Electronic address: liubing520@gdpu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Luyong Zhang</Name>
        <Affiliation>Guangzhou key laboratory of construction and application of new drug screening model systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou 510006, China; The Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou 510006, China. Electronic address: lyzhang@cpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Anti-inflammatory effects of Aureusidin in LPS-stimulated RAW264.7 macrophages via suppressing NF-κB and activating ROS- and MAPKs-dependent Nrf2/HO-1 signaling pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31790703</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30454-5</DOI>
    <KeywordList>
      <Keywords>Aureusidin</Keywords>
      <Keywords>HO-1</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>MAPKs</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jie Ren</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China. Electronic address: renjie@cczu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Su</Name>
        <Affiliation>Changzhou No.2 People's Hospital, Changzhou, Jiangsu 213164, People's Republic of China. Electronic address: bjj4461@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lixia Li</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Heng Cai</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Meiju Zhang</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingchen Zhai</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Minyue Li</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinyue Wu</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Kun Hu</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest We declare that we do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicokinetics of bisphenol S in rats for predicting human bisphenol S clearance from allometric scaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31786412</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30453-3</DOI>
    <KeywordList>
      <Keywords>Allometric scaling</Keywords>
      <Keywords>Bisphenol S</Keywords>
      <Keywords>Clearance</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Véronique Gayrard</Name>
        <Affiliation>ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, France. Electronic address: v.gayrard@envt.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Marlène Z. Lacroix</Name>
        <Affiliation>INTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France. Electronic address: m.lacroix@envt.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Clémence A. Gély</Name>
        <Affiliation>ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, France; INTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France. Electronic address: clemence.gely@inra.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Flore C. Grandin</Name>
        <Affiliation>ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Roger Léandri</Name>
        <Affiliation>EA 3694 Human Fertility Research Group, Toulouse University Hospital, 330 Avenue de Grande Bretagne, 31059 Toulouse, France. Electronic address: leandri.r@chu-toulouse.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Michèle Bouchard</Name>
        <Affiliation>Département de santé environnementale et santé au travail, Centre de recherche en santé publique de l'Université de Montréal (CReSP), Université de Montréal, Montréal, Canada. Electronic address: michele.bouchard@umontreal.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Béatrice Roques</Name>
        <Affiliation>INTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France. Electronic address: b.roques@envt.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Pierre Louis Toutain</Name>
        <Affiliation>INTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France; The Royal Veterinary College, University of London, London, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Picard-Hagen</Name>
        <Affiliation>ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, France. Electronic address: n.hagen-picard@envt.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low molecular polypeptide from oyster hydrolysate recovers photoaging in SKH-1 hairless mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31785243</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30452-1</DOI>
    <KeywordList>
      <Keywords>Hairless mice</Keywords>
      <Keywords>Oyster</Keywords>
      <Keywords>Photoaging</Keywords>
      <Keywords>Type I collagen</Keywords>
      <Keywords>UVB radiation</Keywords>
      <Keywords>Wrinkle formation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joon Sok Bang</Name>
        <Affiliation>Department of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Jung Jin</Name>
        <Affiliation>Department of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Se Young Choung</Name>
        <Affiliation>Department of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea; Department of Preventive Pharmacy and Toxicology, College of Pharmacy, Kyung Hee University, 26, Hyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea. Electronic address: sychoung@khu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31783037</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30382-5</DOI>
    <KeywordList>
      <Keywords>Estrogen active compounds</Keywords>
      <Keywords>Fit-for-purpose in vitro assays</Keywords>
      <Keywords>IVIVE</Keywords>
      <Keywords>In vitro assays sufficient for risk assessment</Keywords>
      <Keywords>Uterine tissue responses</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tyler Beames</Name>
        <Affiliation>ScitoVation, 100 Capitola Drive, Suite 106, Durham, NC 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marjory Moreau</Name>
        <Affiliation>ScitoVation, 100 Capitola Drive, Suite 106, Durham, NC 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>L. Avery Roberts</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kamel Mansouri</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Saad Haider</Name>
        <Affiliation>ScitoVation, 100 Capitola Drive, Suite 106, Durham, NC 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marci Smeltz</Name>
        <Affiliation>ScitoVation, 100 Capitola Drive, Suite 106, Durham, NC 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chantel I. Nicolas</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Doheny</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Martin B. Phillips</Name>
        <Affiliation>ScitoVation, 100 Capitola Drive, Suite 106, Durham, NC 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Miyoung Yoon</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Becker</Name>
        <Affiliation>American Chemistry Council (ACC), Washington, DC 20002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick D. McMullen</Name>
        <Affiliation>ScitoVation, 100 Capitola Drive, Suite 106, Durham, NC 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>ScitoVation, 100 Capitola Drive, Suite 106, Durham, NC 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca A. Clewell</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica K. Hartman</Name>
        <Affiliation>ScitoVation, 100 Capitola Drive, Suite 106, Durham, NC 27713, USA. Electronic address: correspondingauthor@scitovation.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest None.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Applicability of the OECD 455 in-vitro assay for determination of hERa agonistic activity of isoflavonoids.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31756431</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30439-9</DOI>
    <KeywordList>
      <Keywords>Endocrine activity</Keywords>
      <Keywords>Estrogenic effect</Keywords>
      <Keywords>Flavonoid</Keywords>
      <Keywords>OECD TG 455</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Darja Gramec Skledar</Name>
        <Affiliation>Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia.</Affiliation>
      </Author>
      <Author>
        <Name>Václav Tvrdý</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Maša Kenda</Name>
        <Affiliation>Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia.</Affiliation>
      </Author>
      <Author>
        <Name>Anamarija Zega</Name>
        <Affiliation>Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia.</Affiliation>
      </Author>
      <Author>
        <Name>Milan Pour</Name>
        <Affiliation>Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Pavel Horký</Name>
        <Affiliation>Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Přemysl Mladěnka</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Marija Sollner Dolenc</Name>
        <Affiliation>Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia.</Affiliation>
      </Author>
      <Author>
        <Name>Lucija Peterlin Mašič</Name>
        <Affiliation>Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia. Electronic address: lucija.peterlin@ffa.uni-lj.si.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>P-glycoprotein activation by 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5) in rat distal ileum: ex vivo and in vivo studies.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31756430</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30440-5</DOI>
    <KeywordList>
      <Keywords>Activators</Keywords>
      <Keywords>Ex Vivo</Keywords>
      <Keywords>In Vivo</Keywords>
      <Keywords>Inducers</Keywords>
      <Keywords>P-Glycoprotein</Keywords>
      <Keywords>Thioxanthones</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carolina Rocha-Pereira</Name>
        <Affiliation>UCIBIO/REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: mcamorim@ff.up.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina I. Ghanem</Name>
        <Affiliation>Instituto de Investigaciones Farmacológicas (ININFA), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, CONICET, Buenos Aires, Argentina. Electronic address: cghanem@ffyb.uba.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Renata Silva</Name>
        <Affiliation>UCIBIO/REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: rsilva@ff.up.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Alfredo G. Casanova</Name>
        <Affiliation>Unidad de Toxicología, Departamento de Fisiología y Farmacología, Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007 Salamanca, Spain. Electronic address: alfredogcp@usal.es.</Affiliation>
      </Author>
      <Author>
        <Name>Margarida Duarte-Araújo</Name>
        <Affiliation>LAQV/REQUIMTE, Departamento de Imuno-Fisiologia e Farmacologia, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: mdcma@icbas.up.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Salomé Gonçalves-Monteiro</Name>
        <Affiliation>LAQV/REQUIMTE, Laboratório de Farmacologia, Departamento de Ciências do Medicamento, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: salomegmonteiro@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Emília Sousa</Name>
        <Affiliation>CIIMAR, Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: esousa@ff.up.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Maria de Lourdes Bastos</Name>
        <Affiliation>UCIBIO/REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: mlbastos@ff.up.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Remião</Name>
        <Affiliation>UCIBIO/REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: remiao@ff.up.pt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro toxicity screening of polyglycerol esters of fatty acids as excipients for pulmonary formulations.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31756429</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30441-7</DOI>
    <KeywordList>
      <Keywords>Alveolar epithelial cells</Keywords>
      <Keywords>Alveolar macrophage</Keywords>
      <Keywords>Lipid-based excipients</Keywords>
      <Keywords>Polyglycerol esters of fatty acids</Keywords>
      <Keywords>in vitro Lung Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eleonore Fröhlich</Name>
        <Affiliation>Research Center Pharmaceutical Engineering GmbH, Graz, Austria; Center for Medical Research, Medical University of Graz, Graz, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Öhlinger</Name>
        <Affiliation>Center for Medical Research, Medical University of Graz, Graz, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Meindl</Name>
        <Affiliation>Center for Medical Research, Medical University of Graz, Graz, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina Corzo</Name>
        <Affiliation>Research Center Pharmaceutical Engineering GmbH, Graz, Austria; Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology, University of Graz, Graz, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Dirk Lochmann</Name>
        <Affiliation>IOI OLEO GmbH, Witten, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastian Reyer</Name>
        <Affiliation>IOI OLEO GmbH, Witten, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sharareh Salar-Behzadi</Name>
        <Affiliation>Research Center Pharmaceutical Engineering GmbH, Graz, Austria; Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology, University of Graz, Graz, Austria. Electronic address: sharareh.salar@rcpe.at.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of physicochemical properties of TiO</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31734322</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30438-7</DOI>
    <KeywordList>
      <Keywords>Acute phase response</Keywords>
      <Keywords>Crystal phase</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Pulmonary alveolar proteinosis</Keywords>
      <Keywords>Titanium dioxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pernille Høgh Danielsen</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen Ø, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Kristina Bram Knudsen</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen Ø, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Janez Štrancar</Name>
        <Affiliation>Jožef Stefan Institute, Ljubljana, Slovenia.</Affiliation>
      </Author>
      <Author>
        <Name>Polona Umek</Name>
        <Affiliation>Jožef Stefan Institute, Ljubljana, Slovenia.</Affiliation>
      </Author>
      <Author>
        <Name>Tilen Koklič</Name>
        <Affiliation>Jožef Stefan Institute, Ljubljana, Slovenia.</Affiliation>
      </Author>
      <Author>
        <Name>Maja Garvas</Name>
        <Affiliation>Jožef Stefan Institute, Ljubljana, Slovenia.</Affiliation>
      </Author>
      <Author>
        <Name>Esa Vanhala</Name>
        <Affiliation>Finnish Institute of Occupational Health, Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Sauli Savukoski</Name>
        <Affiliation>Finnish Institute of Occupational Health, Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Yaobo Ding</Name>
        <Affiliation>Institute of Lung Biology and Disease, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Mette Madsen</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen Ø, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Nicklas Raun Jacobsen</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen Ø, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Ingrid Konow Weydahl</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen Ø, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Trine Berthing</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen Ø, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Søs Poulsen</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen Ø, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Otmar Schmid</Name>
        <Affiliation>Institute of Lung Biology and Disease, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Henrik Wolff</Name>
        <Affiliation>Finnish Institute of Occupational Health, Helsinki, Finland; Helsinki University, Department of Pathology, Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Ulla Vogel</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen Ø, Denmark; DTU Health Tech, Technical University of Denmark, Kgs. Lyngby, Denmark. Electronic address: ubv@nrcwe.dk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31734321</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30436-3</DOI>
    <KeywordList>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>CXCL14</Keywords>
      <Keywords>Human keratinocytes</Keywords>
      <Keywords>OECD TG429</Keywords>
      <Keywords>Sensitizers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eunyoung Lee</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sungjin Ahn</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Hee Jin</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Moonyoung Lee</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Joo Pyo</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeayoung C. Shin</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seungchan An</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jaehyoun Ha</Name>
        <Affiliation>Toxicology Division, IEC Korea Inc., Suwon 17074, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Minsoo Noh</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea. Electronic address: minsoonoh@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>miR-181b-5p inhibits endothelial-mesenchymal transition in monocrotaline-induced pulmonary arterial hypertension by targeting endocan and TGFBR1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31734320</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30435-1</DOI>
    <KeywordList>
      <Keywords>Endocan</Keywords>
      <Keywords>Endothelial-mesenchymal transition</Keywords>
      <Keywords>Pulmonary arterial hypertension</Keywords>
      <Keywords>TGFBR1</Keywords>
      <Keywords>miR-181b-5p</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haiyan Zhao</Name>
        <Affiliation>Department of Immunology and Rheumatology, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Wang</Name>
        <Affiliation>Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang 110032, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoli Zhang</Name>
        <Affiliation>Department of Immunology and Rheumatology, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingying Guo</Name>
        <Affiliation>Department of Immunology and Rheumatology, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofei Wang</Name>
        <Affiliation>Department of Immunology and Rheumatology, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China. Electronic address: xiaofei.wang@cstar.org.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ginsenoside compound K alleviates sodium valproate-induced hepatotoxicity in rats via antioxidant effect, regulation of peroxisome pathway and iron homeostasis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31734319</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30437-5</DOI>
    <KeywordList>
      <Keywords>Ginsenoside compound K</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Hepcidin</Keywords>
      <Keywords>Iron</Keywords>
      <Keywords>Sodium valproate</Keywords>
      <Keywords>Soluble epoxide hydrolase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Luping Zhou</Name>
        <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, P.R. China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, P.R. China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, P.R. China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Lulu Chen</Name>
        <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, P.R. China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, P.R. China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, P.R. China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, P.R. China; Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha, Hunan 410000, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangchang Zeng</Name>
        <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, P.R. China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, P.R. China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, P.R. China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianwei Liao</Name>
        <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, P.R. China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, P.R. China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, P.R. China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongsheng Ouyang</Name>
        <Affiliation>Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, P.R. China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, P.R. China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, P.R. China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, P.R. China; Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha, Hunan 410000, P.R. China. Electronic address: 801940@csu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of a physiologically-based pharmacokinetic model to explore the potential disparity in nicotine disposition between adult and adolescent nonhuman primates.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31730783</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30434-X</DOI>
    <KeywordList>
      <Keywords>Adolescents</Keywords>
      <Keywords>Cotinine</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Nonhuman primates</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>Squirrel monkey</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaoxia Yang</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: xiaoxia.yang@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Naylor</Name>
        <Affiliation>Division of Neurotoxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katelin Matazel</Name>
        <Affiliation>Division of Neurotoxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amy Goodwin</Name>
        <Affiliation>Division of Neurotoxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cristina C. Jacob</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Bryant</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lucie Loukotková</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gonçalo Gamboa da Costa</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Chemerynski</Name>
        <Affiliation>Division of Nonclinical Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Deng-Bryant</Name>
        <Affiliation>Division of Nonclinical Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chad Reissig</Name>
        <Affiliation>Division of Individual Health Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kia Jackson</Name>
        <Affiliation>Division of Individual Health Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Fisher</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and Wnt/β-catenin signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31715269</pubmedLink>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30421-1</DOI>
    <KeywordList>
      <Keywords>Colorectal cancer</Keywords>
      <Keywords>Murine models</Keywords>
      <Keywords>Pristimerin</Keywords>
      <Keywords>Wnt/β-catenin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qun Zhao</Name>
        <Affiliation>Laboratory of Inflammation and Molecular Pharmacology, School of Basic Medical Sciences &amp; Biomedical Research Institute, Hubei University of Medicine, Shiyan 442000, China; Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan 442000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Bi</Name>
        <Affiliation>Laboratory of Inflammation and Molecular Pharmacology, School of Basic Medical Sciences &amp; Biomedical Research Institute, Hubei University of Medicine, Shiyan 442000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Zhong</Name>
        <Affiliation>Laboratory of Inflammation and Molecular Pharmacology, School of Basic Medical Sciences &amp; Biomedical Research Institute, Hubei University of Medicine, Shiyan 442000, China; Hubei Key Laboratory of Natural Products Research and Development, China Three Gorges University, Yichang 443002, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ziting Ren</Name>
        <Affiliation>Laboratory of Inflammation and Molecular Pharmacology, School of Basic Medical Sciences &amp; Biomedical Research Institute, Hubei University of Medicine, Shiyan 442000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingxiang Liu</Name>
        <Affiliation>Laboratory of Inflammation and Molecular Pharmacology, School of Basic Medical Sciences &amp; Biomedical Research Institute, Hubei University of Medicine, Shiyan 442000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junjun Jia</Name>
        <Affiliation>Laboratory of Inflammation and Molecular Pharmacology, School of Basic Medical Sciences &amp; Biomedical Research Institute, Hubei University of Medicine, Shiyan 442000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengting Yu</Name>
        <Affiliation>Laboratory of Inflammation and Molecular Pharmacology, School of Basic Medical Sciences &amp; Biomedical Research Institute, Hubei University of Medicine, Shiyan 442000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Tan</Name>
        <Affiliation>Laboratory of Inflammation and Molecular Pharmacology, School of Basic Medical Sciences &amp; Biomedical Research Institute, Hubei University of Medicine, Shiyan 442000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiufang Zhang</Name>
        <Affiliation>Laboratory of Inflammation and Molecular Pharmacology, School of Basic Medical Sciences &amp; Biomedical Research Institute, Hubei University of Medicine, Shiyan 442000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xianjun Yu</Name>
        <Affiliation>Laboratory of Inflammation and Molecular Pharmacology, School of Basic Medical Sciences &amp; Biomedical Research Institute, Hubei University of Medicine, Shiyan 442000, China; Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan 442000, China. Electronic address: xjyu@hbmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of transcriptome expression alterations by chronic exposure to low-dose bisphenol A in different subtypes of breast cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31715268</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30422-3</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Breast cancer cells</Keywords>
      <Keywords>Informatics</Keywords>
      <Keywords>RNA-sequencing</Keywords>
      <Keywords>Transcriptome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyelim Kim</Name>
        <Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hoe Suk Kim</Name>
        <Affiliation>Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Woo Kyung Moon</Name>
        <Affiliation>Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea; Department of Radiology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea. Electronic address: moonwk@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemerin-induced angiogenesis and adipogenesis in 3 T3-L1 preadipocytes is mediated by lncRNA Meg3 through regulating Dickkopf-3 by sponging miR-217.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31715267</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30423-5</DOI>
    <KeywordList>
      <Keywords>3 T3-L1 Preadipocytes</Keywords>
      <Keywords>Adipogenesis</Keywords>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>Long non-coding RNA Meg3</Keywords>
      <Keywords>microRNA-217</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xianwei Huang</Name>
        <Affiliation>Department of Cardiology, The Second Hospital of Shandong University, Jinan, Shandong 250033, China; Department of Emergency, the First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Caihua Fu</Name>
        <Affiliation>Department of Cardiology, Jinan central hospital affiliated Shandong University, Jinan, Shandong 250012, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenhui Liu</Name>
        <Affiliation>Department of Cardiology, The Second Hospital of Shandong University, Jinan, Shandong 250033, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yansheng Liang</Name>
        <Affiliation>Department of Cardiology, The Second Hospital of Shandong University, Jinan, Shandong 250033, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peilun Li</Name>
        <Affiliation>Department of Cardiology, Linyi People's Hospital, Linyi, Shandong 276003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiquan Liu</Name>
        <Affiliation>Department of Cardiology, The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, Anhui 230001,China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiping Sheng</Name>
        <Affiliation>Department of Cardiology, The Second Hospital of Shandong University, Jinan, Shandong 250033, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Liu</Name>
        <Affiliation>Department of Cardiology, The Second Hospital of Shandong University, Jinan, Shandong 250033, China. Electronic address: lping@sdu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fibrin gels entrapment of a doxorubicin-containing targeted polycyclodextrin: Evaluation of in vivo antitumor activity in orthotopic models of human neuroblastoma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31705944</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30419-3</DOI>
    <KeywordList>
      <Keywords>Activity in vivo</Keywords>
      <Keywords>Cyclodextrin polymer</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Fibrin gel</Keywords>
      <Keywords>Neuroblastoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maurizio Viale</Name>
        <Affiliation>UOC Bioterapie, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi 10, 16132 Genova, Italy. Electronic address: maurizio.viale@hsanmartino.it.</Affiliation>
      </Author>
      <Author>
        <Name>Graziella Vecchio</Name>
        <Affiliation>Dipartimento di Scienze Chimiche, Università di Catania, Viale A. Doria, 6, 95125 Catania, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Irena Maric</Name>
        <Affiliation>UOC Bioterapie, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi 10, 16132 Genova, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Michele Cilli</Name>
        <Affiliation>UOS Animal Facility, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi 10, 16132 Genova, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Aprile</Name>
        <Affiliation>UOS Biopolimeri e Proteomica, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi 10, 16132 Genova, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Mirco Ponzoni</Name>
        <Affiliation>Laboratorio di Terapie Sperimentali in Oncologia, Istituto G. Gaslini, Via G. Gaslini 5, 16147 Genova, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Vincenzo Fontana</Name>
        <Affiliation>UOC Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi 10, 16132 Genova, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Erica C. Priori</Name>
        <Affiliation>Lab. di Biologia Cellulare e Neurobiologia, Dipartimento di Biologia e Biotecnologie, Università di Pavia "L. Spallanzani", Via Ferrata 9, 27100 Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Vittorio Bertone</Name>
        <Affiliation>Lab. di Anatomia Comparata e Citologia, Dipartimento di Biologia e Biotecnologie, Università di Pavia "L. Spallanzani", Via Ferrata 9, 27100 Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Mattia Rocco</Name>
        <Affiliation>UOS Biopolimeri e Proteomica, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi 10, 16132 Genova, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Schisandrin B attenuates renal fibrosis via miR-30e-mediated inhibition of EMT.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31697999</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30377-1</DOI>
    <KeywordList>
      <Keywords>EMT</Keywords>
      <Keywords>Schisandrin B</Keywords>
      <Keywords>Tubulointerstitial fibrosis</Keywords>
      <Keywords>miR-30e</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guangxu Cao</Name>
        <Affiliation>Department of Pathology, School of Medicine, Jinan University, Guangzhou 510632, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuang Li</Name>
        <Affiliation>Henan Provincial People's Hospital, Zhengzhou 450003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hezhan Shi</Name>
        <Affiliation>Department of Pathology, School of Medicine, Jinan University, Guangzhou 510632, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peidi Yin</Name>
        <Affiliation>Department of Pathology, School of Medicine, Jinan University, Guangzhou 510632, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jialing Chen</Name>
        <Affiliation>Department of Pathology, School of Medicine, Jinan University, Guangzhou 510632, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huifeng Li</Name>
        <Affiliation>Department of Pathology, School of Medicine, Jinan University, Guangzhou 510632, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Zhong</Name>
        <Affiliation>Department of Pathology, School of Medicine, Jinan University, Guangzhou 510632, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Ting Diao</Name>
        <Affiliation>Biotherapy Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China. Electronic address: diaolt@mail2.sysu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Du</Name>
        <Affiliation>Department of Pathology, School of Medicine, Jinan University, Guangzhou 510632, China. Electronic address: tdubin@jnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Amlexanox ameliorates acetaminophen-induced acute liver injury by reducing oxidative stress in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31697998</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30375-8</DOI>
    <KeywordList>
      <Keywords>AMPK</Keywords>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Amlexanox</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative Stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Qi</Name>
        <Affiliation>Biosafety Research Institute and Laboratory of Pathology (BK21 Plus Program), College of Veterinary Medicine, Jeonbuk National University, Iksan 54596, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Zixiong Zhou</Name>
        <Affiliation>Biosafety Research Institute and Laboratory of Pathology (BK21 Plus Program), College of Veterinary Medicine, Jeonbuk National University, Iksan 54596, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Chae Woong Lim</Name>
        <Affiliation>Biosafety Research Institute and Laboratory of Pathology (BK21 Plus Program), College of Veterinary Medicine, Jeonbuk National University, Iksan 54596, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Won Kim</Name>
        <Affiliation>Biosafety Research Institute and Laboratory of Pathology (BK21 Plus Program), College of Veterinary Medicine, Jeonbuk National University, Iksan 54596, Republic of Korea. Electronic address: kjw@jbnu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Bumseok Kim</Name>
        <Affiliation>Biosafety Research Institute and Laboratory of Pathology (BK21 Plus Program), College of Veterinary Medicine, Jeonbuk National University, Iksan 54596, Republic of Korea. Electronic address: bskims@jbnu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Fullerene (C60) particle size implications in neurotoxicity following infusion into the hippocampi of Wistar rats" [Toxicology and Applied Toxicology 338 (2018) 197-203].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31697997</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30372-2</DOI>
    <AuthorList>
      <Author>
        <Name>Ândrea Barbosa Kraemer</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gustavo Morrone Parfitt</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daiane da Silva Acosta</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gisele Eva Bruch</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marcos Freitas Cordeiro</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luis Fernando Marins</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juliane Ventura-Lima</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>José María Monserrat</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela Martí Barros</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil. Electronic address: barrosdm@yahoo.com.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Two novel peptides from ark shell protein stimulate osteoblast differentiation and rescue ovariectomy-induced bone loss.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31697996</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30387-4</DOI>
    <KeywordList>
      <Keywords>BMP</Keywords>
      <Keywords>Bone formation</Keywords>
      <Keywords>OVX</Keywords>
      <Keywords>Osteogenic peptides</Keywords>
      <Keywords>Osteoporosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yunok Oh</Name>
        <Affiliation>Department of Marine-Bio Convergence Science, Pukyong National University, Busan 48547, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Bum Ahn</Name>
        <Affiliation>Division of Food and Nutrition, Chonnam National University, Gwangju 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Ho Hyung</Name>
        <Affiliation>Department of Marine-Bio Convergence Science, Pukyong National University, Busan 48547, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Young Je</Name>
        <Affiliation>Department of Marine-Bio Convergence Science, Pukyong National University, Busan 48547, Republic of Korea. Electronic address: jjy1915@pknu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacological and toxicological aspects of carbon nanotubes (CNTs) to vascular system: A review.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31678607</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30409-0</DOI>
    <KeywordList>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>Blood pressure</Keywords>
      <Keywords>Carbon nanotubes (CNTs)</Keywords>
      <Keywords>Nanocarriers</Keywords>
      <Keywords>Plaque progression</Keywords>
      <Keywords>Vasomotor dysfunction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yi Cao</Name>
        <Affiliation>Key Laboratory of Environment-Friendly Chemistry and Application of Ministry of Education, Lab of Biochemistry, College of Chemistry, Xiangtan University, Xiangtan 411105, PR China. Electronic address: caoyi39@xtu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yingmei Luo</Name>
        <Affiliation>Key Laboratory of Environment-Friendly Chemistry and Application of Ministry of Education, Lab of Biochemistry, College of Chemistry, Xiangtan University, Xiangtan 411105, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dipeptidyl peptidase-4 inhibitor sitagliptin induces vasorelaxation via the activation of Kv channels and PKA.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31678606</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30407-7</DOI>
    <KeywordList>
      <Keywords>Aorta</Keywords>
      <Keywords>Protein kinase A</Keywords>
      <Keywords>Sitagliptin</Keywords>
      <Keywords>Voltage-dependent K(+) channels</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hongliang Li</Name>
        <Affiliation>Institute of Translational Medicine, Medical College, Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment for Senile Diseases, Yangzhou University, Yangzhou 225001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Seon Seo</Name>
        <Affiliation>Institute of Medical Sciences, Department of Physiology, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Ryeol An</Name>
        <Affiliation>Institute of Medical Sciences, Department of Physiology, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hee Seok Jung</Name>
        <Affiliation>Institute of Medical Sciences, Department of Physiology, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kwon Soo Ha</Name>
        <Affiliation>Department of Molecular and Cellular Biochemistry, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Taek Han</Name>
        <Affiliation>Department of Medical Environmental Biology and Tropical Medicine, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seok Ho Hong</Name>
        <Affiliation>Institute of Medical Sciences, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon 24341, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Min Bae</Name>
        <Affiliation>Department of Physiology, Konkuk University School of Medicine, Chungju 27478, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Hun Na</Name>
        <Affiliation>Department of Obstetrics and Gynecology, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon 24341, South Korea. Electronic address: lahun@kangwon.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Won Sun Park</Name>
        <Affiliation>Institute of Medical Sciences, Department of Physiology, Kangwon National University School of Medicine, Chuncheon 24341, South Korea. Electronic address: parkws@kangwon.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Polymer-coated nanoparticles and their effects on mitochondrial function in brain endothelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31678605</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30408-9</DOI>
    <KeywordList>
      <Keywords>Laser tissue soldering</Keywords>
      <Keywords>Mitochondrial respiration</Keywords>
      <Keywords>Nanomedicine</Keywords>
      <Keywords>rBCEC4 Cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aniela Bittner</Name>
        <Affiliation>Division of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Bern, Länggassstrasse 124, 3012 Bern, Switzerland. Electronic address: aniela.bittner@vetsuisse.unibe.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Angélique Dominique Ducray</Name>
        <Affiliation>Division of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Bern, Länggassstrasse 124, 3012 Bern, Switzerland. Electronic address: angelique.ducray@vetsuisse.unibe.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Hubert Stoffel</Name>
        <Affiliation>Division of Veterinary Anatomy, Vetsuisse Faculty, University of Bern, Länggassstrasse 120, 3012 Bern, Switzerland. Electronic address: michael.stoffel@vetsuisse.unibe.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Felser</Name>
        <Affiliation>Institute of Clinical Chemistry, University Hospital Bern, Freiburgstrasse 4, 3010 Bern, Switzerland. Electronic address: andreadebora.felser@insel.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Meike Mevissen</Name>
        <Affiliation>Division of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Bern, Länggassstrasse 124, 3012 Bern, Switzerland. Electronic address: meike.mevissen@vetsuisse.unibe.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Suppression of macrophages- Induced inflammation via targeting RAS and PAR-4 signaling in breast cancer cell lines.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31678245</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30381-3</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>NSAID</Keywords>
      <Keywords>PAR-4</Keywords>
      <Keywords>RAS</Keywords>
      <Keywords>TAMs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nadia A. Thabet</Name>
        <Affiliation>Department of Cancer biology, Pharmacology Unit, National Cancer Institute, Cairo University, Cairo 11796, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Nadia El-Guendy</Name>
        <Affiliation>Department of Cancer biology, Biochemistry Unit, National Cancer Institute, Cairo University, Cairo 11796, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mona M. Mohamed</Name>
        <Affiliation>Department of Zoology, Faculty of Science, Cairo University, Giza 12613, Egypt. Electronic address: mmostafa@sci.cu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Samia A. Shouman</Name>
        <Affiliation>Department of Cancer biology, Pharmacology Unit, National Cancer Institute, Cairo University, Cairo 11796, Egypt. Electronic address: samia.shouman@nci.cu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lung injury, oxidative stress and fibrosis in mice following exposure to nitrogen mustard.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31678244</pubmedLink>
    <GrantList>
      <Grant>P30 ES005022</Grant>
      <Grant>R01 ES004738</Grant>
      <Grant>R01 HL086621</Grant>
      <Grant>U54 AR055073</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0041-008X(19)30406-5</DOI>
    <KeywordList>
      <Keywords>Fibrosis</Keywords>
      <Keywords>Lung injury</Keywords>
      <Keywords>Macrophages</Keywords>
      <Keywords>Mustard vesicants</Keywords>
      <Keywords>Pulmonary function</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vasanthi R. Sunil</Name>
        <Affiliation>Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States of America. Electronic address: sunilva@pharmacy.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Kinal N. Vayas</Name>
        <Affiliation>Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States of America. Electronic address: kinalv5@pharmacy.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Elena V. Abramova</Name>
        <Affiliation>Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States of America. Electronic address: eabramov@pharmacy.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond Rancourt</Name>
        <Affiliation>Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States of America. Electronic address: rcr13@pharmacy.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica A. Cervelli</Name>
        <Affiliation>Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States of America. Electronic address: cervelli@pharmacy.rutgers.eduu.</Affiliation>
      </Author>
      <Author>
        <Name>Rama Malaviya</Name>
        <Affiliation>Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States of America. Electronic address: malaviya@pharmacy.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Goedken</Name>
        <Affiliation>Research Pathology Services, Rutgers University, Piscataway, NJ 08854;, United States of America. Electronic address: Michael.goedken@rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Venosa</Name>
        <Affiliation>Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Gow</Name>
        <Affiliation>Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States of America. Electronic address: gow@pharmacy.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey D. Laskin</Name>
        <Affiliation>School of Public Health, Rutgers University, Piscataway, NJ 08854, United States of America. Electronic address: jlaskin@eohsi.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Debra L. Laskin</Name>
        <Affiliation>Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States of America. Electronic address: laskin@eohsi.rutgers.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective role of mesenchymal stem cells and mesenchymal stem cell-derived exosomes in cigarette smoke-induced mitochondrial dysfunction in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31678243</pubmedLink>
    <GrantList>
      <Grant>R01 HL135613</Grant>
      <Grant>R01 HL085613</Grant>
      <Grant>R01 ES029177</Grant>
      <Grant>R01 HL133404</Grant>
      <Grant>R21 ES028006</Grant>
      <Grant>R56 ES027012</Grant>
      <Grant>R01 HL137738</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30396-5</DOI>
    <KeywordList>
      <Keywords>COPD</Keywords>
      <Keywords>Cellular Senescence</Keywords>
      <Keywords>Exosomes</Keywords>
      <Keywords>Mesenchymal stem cells</Keywords>
      <Keywords>Mitochondria</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Krishna Prahlad Maremanda</Name>
        <Affiliation>Department of Environmental Medicine, University of Rochester Medical Center, Box 850, 601 Elmwood Avenue, Rochester, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Isaac Kirubakaran Sundar</Name>
        <Affiliation>Department of Environmental Medicine, University of Rochester Medical Center, Box 850, 601 Elmwood Avenue, Rochester, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Irfan Rahman</Name>
        <Affiliation>Department of Environmental Medicine, University of Rochester Medical Center, Box 850, 601 Elmwood Avenue, Rochester, NY, USA. Electronic address: irfan_rahman@urmc.rochester.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of organoid-based drug metabolism model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31678242</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30398-9</DOI>
    <KeywordList>
      <Keywords>CYP</Keywords>
      <Keywords>Drug metabolism</Keywords>
      <Keywords>Organoid</Keywords>
      <Keywords>Toxicological model</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Enoch Park</Name>
        <Affiliation>Department of Microbiology and CHA Organoid Research Center, School of Medicine, CHA University, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Han Kyung Kim</Name>
        <Affiliation>Department of Microbiology and CHA Organoid Research Center, School of Medicine, CHA University, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>JooHyun Jee</Name>
        <Affiliation>Department of Microbiology and CHA Organoid Research Center, School of Medicine, CHA University, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soojung Hahn</Name>
        <Affiliation>Department of Microbiology and CHA Organoid Research Center, School of Medicine, CHA University, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sukin Jeong</Name>
        <Affiliation>Department of Microbiology and CHA Organoid Research Center, School of Medicine, CHA University, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jongman Yoo</Name>
        <Affiliation>Department of Microbiology and CHA Organoid Research Center, School of Medicine, CHA University, South Korea. Electronic address: jongmanyoo@cha.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Alpinetin improves intestinal barrier homeostasis via regulating AhR/suv39h1/TSC2/mTORC1/autophagy pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31676321</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30380-1</DOI>
    <KeywordList>
      <Keywords>Alpinetin</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Colitis</Keywords>
      <Keywords>Intestinal epithelial barrier</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yumeng Miao</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Lv</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Simiao Qiao</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Yang</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Tao</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenxin Yan</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengfei Wang</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Cao</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Dai</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China. Electronic address: yuedaicpu@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhifeng Wei</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China. Electronic address: 1020132346@cpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Increasing ERK phosphorylation by inhibition of p38 activity protects against cadmium-induced apoptotic cell death through ERK/Drp1/p38 signaling axis in spermatocyte-derived GC-2spd cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31676320</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30405-3</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>MAPK Pathway</Keywords>
      <Keywords>Mitochondrial Damage</Keywords>
      <Keywords>Spermatocyte</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jung Bae Seong</Name>
        <Affiliation>School of Life Sciences, BK21 Plus KNU Creative BioResearch Group, Kyungpook National University, Daegu, Republic of Korea; School of Life Sciences &amp; Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Chul Bae</Name>
        <Affiliation>Department of Anatomy and Neurobiology, School of Dentistry, Kyungpook National University, Daegu, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Shik Lee</Name>
        <Affiliation>School of Life Sciences, BK21 Plus KNU Creative BioResearch Group, Kyungpook National University, Daegu, Republic of Korea; School of Life Sciences &amp; Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Won Huh</Name>
        <Affiliation>National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Rae Lee</Name>
        <Affiliation>National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Jun Lee</Name>
        <Affiliation>College of Medicine, Chungbuk National University, Chungbuk, Republic of Korea; Department of Radiology, Chungbuk National University Hospital, Chungbuk, Republic of Korea; Research Institute, e-biogen Inc., Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Seok Lee</Name>
        <Affiliation>School of Life Sciences, BK21 Plus KNU Creative BioResearch Group, Kyungpook National University, Daegu, Republic of Korea; School of Life Sciences &amp; Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu, Republic of Korea. Electronic address: lee1@knu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An increase in circulating B cells and B cell activation markers in peripheral blood is associated with cigarette smoking in a male cohort in Bangladesh.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31669812</pubmedLink>
    <GrantList>
      <Grant>P30 CA118100</Grant>
      <Grant>S10 OD016384</Grant>
      <Grant>P42 ES010349</Grant>
      <Grant>P30 CA013696</Grant>
      <Grant>P30 ES027792</Grant>
      <Grant>R01 ES019968</Grant>
      <Grant>P30 DK092949</Grant>
      <Grant>P30 ES009089</Grant>
      <Grant>R01 ES023888</Grant>
      <Grant>R24 ES028532</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30391-6</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>B Cells</Keywords>
      <Keywords>Cigarette Smoke</Keywords>
      <Keywords>Flow Cytometry</Keywords>
      <Keywords>Human Immunotoxicity</Keywords>
      <Keywords>PAHs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Scott W. Burchiel</Name>
        <Affiliation>The University of New Mexico College of Pharmacy, Department of Pharmaceutical Sciences, Albuquerque, NM 87131, United States of America. Electronic address: sburchiel@salud.unm.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Fredine T. Lauer</Name>
        <Affiliation>The University of New Mexico College of Pharmacy, Department of Pharmaceutical Sciences, Albuquerque, NM 87131, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Pam Factor-Litvak</Name>
        <Affiliation>Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Xinhua Liu</Name>
        <Affiliation>Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY 10032, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Regina M. Santella</Name>
        <Affiliation>Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Tariqul Islam</Name>
        <Affiliation>University of Chicago Field Research Office, Dhaka 1230, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Mahbubul Eunus</Name>
        <Affiliation>University of Chicago Field Research Office, Dhaka 1230, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Nur Alam</Name>
        <Affiliation>University of Chicago Field Research Office, Dhaka 1230, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Tariqul Islam</Name>
        <Affiliation>University of Chicago Field Research Office, Dhaka 1230, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Mizanour Rahman</Name>
        <Affiliation>University of Chicago Field Research Office, Dhaka 1230, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Alauddin Ahmed</Name>
        <Affiliation>University of Chicago Field Research Office, Dhaka 1230, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Habibul Ahsan</Name>
        <Affiliation>Department of Health Studies, University of Chicago, Chicago, IL 60637, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph Graziano</Name>
        <Affiliation>Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Faruque Parvez</Name>
        <Affiliation>Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>N-arylpiperazine-containing compound (C2): An enhancer of sunitinib in the treatment of pancreatic cancer, involving D1DR activation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31669811</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30397-7</DOI>
    <KeywordList>
      <Keywords>Cancer Stem-like Cells</Keywords>
      <Keywords>Dopamine Receptor D1</Keywords>
      <Keywords>N-Arylpiperazine Derivative C2</Keywords>
      <Keywords>Pancreatic Cancer</Keywords>
      <Keywords>Sunitinib</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hong Su</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zixi Xue</Name>
        <Affiliation>School of Chemistry and Chemical Engineering, Guangzhou University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaoyao Feng</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Xie</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Deng</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ye Yao</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuyun Tian</Name>
        <Affiliation>Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital &amp; Institute, Beijing 100142, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiming An</Name>
        <Affiliation>School of Chemistry and Chemical Engineering, Guangzhou University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Yang</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingyu Yao</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junsheng Xue</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guoshu Chen</Name>
        <Affiliation>School of Chemistry and Chemical Engineering, Guangzhou University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunyi Hao</Name>
        <Affiliation>Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital &amp; Institute, Beijing 100142, China. Electronic address: haochunyi@bjmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Tianyan Zhou</Name>
        <Affiliation>Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Electronic address: tianyanzhou@bjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Involvement of PML-I in reformation of PML nuclear bodies in acute promyelocytic leukemia cells by leptomycin B.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31669778</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30383-7</DOI>
    <KeywordList>
      <Keywords>Acute promyelocytic leukemia</Keywords>
      <Keywords>Arsenic trioxide</Keywords>
      <Keywords>Chromosome region maintenance 1</Keywords>
      <Keywords>Leptomycin B</Keywords>
      <Keywords>PML-NBs</Keywords>
      <Keywords>Promyelocytic leukemia protein</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chao Wang</Name>
        <Affiliation>Department of Toxicology, School of Medicine and Public Health, Zhejiang University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li De Su</Name>
        <Affiliation>Inner Mongolia Medical University, Hohhot, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Ming Shao</Name>
        <Affiliation>Inner Mongolia Medical University, Hohhot, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhong Chen</Name>
        <Affiliation>Department of Pharmacology, School of medicine, Zhejiang University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Bu</Name>
        <Affiliation>Women's Hospital, School of Medicine, Zhejiang University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Hao</Name>
        <Affiliation>Inner Mongolia Medical University, Hohhot, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Ya Ma</Name>
        <Affiliation>Department of Hematology, First Affiliated Hospital, Zhejiang University, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liaqat Hussain</Name>
        <Affiliation>Department of Pharmacology, School of medicine, Zhejiang University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Yang Lu</Name>
        <Affiliation>Department of Pharmacy, First Affiliated Hospital, Zhejiang University, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Qian Wang</Name>
        <Affiliation>Department of Toxicology, School of Medicine and Public Health, Zhejiang University, China; College of Pharmaceutical Sciences, Zhejiang University, China. Electronic address: wangqian_cc@zju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Naranmandura</Name>
        <Affiliation>Department of Toxicology, School of Medicine and Public Health, Zhejiang University, China; Inner Mongolia Medical University, Hohhot, China; Department of Pharmacology, School of medicine, Zhejiang University, China; Women's Hospital, School of Medicine, Zhejiang University, China; College of Pharmaceutical Sciences, Zhejiang University, China. Electronic address: narenman@zju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Endocytosis mechanism in physiologically-based pharmacokinetic modeling of nanoparticles.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31669777</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30373-4</DOI>
    <KeywordList>
      <Keywords>Endocytosis</Keywords>
      <Keywords>Gold-nanoparticles</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>Particle size</Keywords>
      <Keywords>Phagocytes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Linjing Deng</Name>
        <Affiliation>School of Energy Science and Engineering, Central South University, Changsha 410083, Hunan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Liu</Name>
        <Affiliation>School of Energy Science and Engineering, Central South University, Changsha 410083, Hunan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongsheng Ma</Name>
        <Affiliation>XiangYa School of Public Health, Central South University, Changsha 410008, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufeng Miao</Name>
        <Affiliation>School of Energy Science and Engineering, Central South University, Changsha 410083, Hunan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoli Fu</Name>
        <Affiliation>School of Public Health, Zhengzhou University, Zhengzhou 450001, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qihong Deng</Name>
        <Affiliation>School of Energy Science and Engineering, Central South University, Changsha 410083, Hunan, China; XiangYa School of Public Health, Central South University, Changsha 410008, China; School of Public Health, Zhengzhou University, Zhengzhou 450001, Henan, China; School of Architecture and Art, Central South University, Changsha 410083, Hunan, China. Electronic address: qhdeng@csu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effect of the inhalation of and topical exposure to zinc oxide nanoparticles on airway inflammation in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31669718</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30395-3</DOI>
    <KeywordList>
      <Keywords>Asthma</Keywords>
      <Keywords>Atopic Dermatitis</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Zinc Oxide Nanoparticles (ZnONPs)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kuo Liang Huang</Name>
        <Affiliation>Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan; School of Medicine, Tzu-Chi University, Hualien, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hung Lun Chang</Name>
        <Affiliation>Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Fu Ming Tsai</Name>
        <Affiliation>Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Hsin Lee</Name>
        <Affiliation>Department of Pathology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Hua Wang</Name>
        <Affiliation>School of Medicine, Tzu-Chi University, Hualien, Taiwan; Department of Dermatology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Tsun Jen Cheng</Name>
        <Affiliation>Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, National Taiwan University, Taipei, Taiwan. Electronic address: tcheng@ntu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Converting bleomycin into a prodrug that undergoes spontaneous reactivation under physiological conditions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31655077</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30390-4</DOI>
    <KeywordList>
      <Keywords>Bleomycin</Keywords>
      <Keywords>Conjugate</Keywords>
      <Keywords>Pharmacokinetic</Keywords>
      <Keywords>Prodrug</Keywords>
      <Keywords>Simulation</Keywords>
      <Keywords>Therapeutic Window</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Itzik Cooper</Name>
        <Affiliation>The Joseph Sagol Neuroscience Center, Sheba Medical Center Tel Hashomer, Ramat Gan 52621, Israel. Electronic address: Itzik.cooper@sheba.health.gov.il.</Affiliation>
      </Author>
      <Author>
        <Name>Dana Atrakchi</Name>
        <Affiliation>The Joseph Sagol Neuroscience Center, Sheba Medical Center Tel Hashomer, Ramat Gan 52621, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Michael D. Walker</Name>
        <Affiliation>Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot 76100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Amnon Horovitz</Name>
        <Affiliation>Department of Structural Biology, The Weizmann Institute of Science, Rehovot 76100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Mati Fridkin</Name>
        <Affiliation>Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Yoram Shechter</Name>
        <Affiliation>Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot 76100, Israel.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Peptidome profiles in melamine diet-induced bladder stones in C57BL/6 mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31655076</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30394-1</DOI>
    <KeywordList>
      <Keywords>Basigin</Keywords>
      <Keywords>Bladder Stone</Keywords>
      <Keywords>Melamine</Keywords>
      <Keywords>Ndufα8</Keywords>
      <Keywords>Serum Biomarkers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liying Liu</Name>
        <Affiliation>The Center Laboratory for Biomedical Research, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mai Luo</Name>
        <Affiliation>Core Research Laboratory, The Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofan Xiong</Name>
        <Affiliation>Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Shaanxi, Shaanxi Province, Xi'an 710061, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingyu Zhao</Name>
        <Affiliation>Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Shaanxi, Shaanxi Province, Xi'an 710061, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofei Wang</Name>
        <Affiliation>The Center Laboratory for Biomedical Research, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Ni</Name>
        <Affiliation>Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Shaanxi, Shaanxi Province, Xi'an 710061, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Yang</Name>
        <Affiliation>The Center Laboratory for Biomedical Research, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi Province, PR China; Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Shaanxi, Shaanxi Province, Xi'an 710061, PR China. Electronic address: yangjuan0112@xjtu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Huang</Name>
        <Affiliation>The Center Laboratory for Biomedical Research, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi Province, PR China; Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Shaanxi, Shaanxi Province, Xi'an 710061, PR China. Electronic address: hchen@mail.xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The compartmentalised nature of the mechanisms governing superoxide formation and scavenging in cells exposed to arsenite.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31647942</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30374-6</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Arsenite</Keywords>
      <Keywords>Ascorbate</Keywords>
      <Keywords>Ca(2+)</Keywords>
      <Keywords>Mitochondrial respiratory chain</Keywords>
      <Keywords>NADPH oxidase</Keywords>
      <Keywords>Superoxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrea Guidarelli</Name>
        <Affiliation>Department of Biomolecular Sciences, University of Urbino Carlo Bo, via Saffi 2, 61029 Urbino, PU, Italy. Electronic address: andrea.guidarelli@uniurb.it.</Affiliation>
      </Author>
      <Author>
        <Name>Mara Fiorani</Name>
        <Affiliation>Department of Biomolecular Sciences, University of Urbino Carlo Bo, via Saffi 2, 61029 Urbino, PU, Italy. Electronic address: mara.fiorani@uniurb.it.</Affiliation>
      </Author>
      <Author>
        <Name>Liana Cerioni</Name>
        <Affiliation>Department of Biomolecular Sciences, University of Urbino Carlo Bo, via Saffi 2, 61029 Urbino, PU, Italy. Electronic address: liana.cerioni@uniurb.it.</Affiliation>
      </Author>
      <Author>
        <Name>Orazio Cantoni</Name>
        <Affiliation>Department of Biomolecular Sciences, University of Urbino Carlo Bo, via Saffi 2, 61029 Urbino, PU, Italy. Electronic address: orazio.cantoni@uniurb.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>ROS-dependent DNA damage contributes to crizotinib-induced hepatotoxicity via the apoptotic pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31639374</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30376-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Crizotinib</Keywords>
      <Keywords>DNA damage</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Mitochondrial membrane potential</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hao Yan</Name>
        <Affiliation>Institute of Pharmacology &amp; Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiangxia Du</Name>
        <Affiliation>Institute of Pharmacology &amp; Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xueqin Chen</Name>
        <Affiliation>Department of Oncology, Hangzhou First People's Hospital, Zhejiang University, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Yang</Name>
        <Affiliation>Institute of Pharmacology &amp; Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiaojun He</Name>
        <Affiliation>Institute of Pharmacology &amp; Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaochun Yang</Name>
        <Affiliation>Institute of Pharmacology &amp; Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.. Electronic address: yangxiaochun@zju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Peihua Luo</Name>
        <Affiliation>Institute of Pharmacology &amp; Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.. Electronic address: peihualuo@zju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacological and toxicological in vitro and in vivo effect of higher doses of oxime reactivators.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31629733</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30384-9</DOI>
    <KeywordList>
      <Keywords>Cholinergic receptor</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Maximal tolerated dose</Keywords>
      <Keywords>NMDA receptor</Keywords>
      <Keywords>Reactivator</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vendula Hepnarova</Name>
        <Affiliation>University of Defence, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic; University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Lubica Muckova</Name>
        <Affiliation>University of Defence, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic; University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Avi Ring</Name>
        <Affiliation>Norwegian Defence Research Establishment, Kjeller, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Jaroslav Pejchal</Name>
        <Affiliation>University of Defence, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>David Herman</Name>
        <Affiliation>University of Defence, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic; University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Misik</Name>
        <Affiliation>University of Defence, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic; University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Hrabinova</Name>
        <Affiliation>University of Defence, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic; University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Jun</Name>
        <Affiliation>University of Defence, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic; University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Ondrej Soukup</Name>
        <Affiliation>University of Defence, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic; University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. Electronic address: ondrej.soukup@fnhk.cz.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integrated metabolomics and network toxicology to reveal molecular mechanism of celastrol induced cardiotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31629732</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30393-X</DOI>
    <KeywordList>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Celastrol</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Molecular mechanism</Keywords>
      <Keywords>Network toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chuanxin Liu</Name>
        <Affiliation>School of Chinese Materia Medica, Beijing University of Chinese Medicine, Liangxiang Town, Fangshan District, Beijing 102488, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenning Zhang</Name>
        <Affiliation>School of Chinese Materia Medica, Beijing University of Chinese Medicine, Liangxiang Town, Fangshan District, Beijing 102488, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenxin Wang</Name>
        <Affiliation>School of Chinese Materia Medica, Beijing University of Chinese Medicine, Liangxiang Town, Fangshan District, Beijing 102488, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fuli Yuan</Name>
        <Affiliation>School of Chinese Materia Medica, Beijing University of Chinese Medicine, Liangxiang Town, Fangshan District, Beijing 102488, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tao He</Name>
        <Affiliation>School of Chinese Materia Medica, Beijing University of Chinese Medicine, Liangxiang Town, Fangshan District, Beijing 102488, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yahong Chen</Name>
        <Affiliation>School of Chinese Materia Medica, Beijing University of Chinese Medicine, Liangxiang Town, Fangshan District, Beijing 102488, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Wang</Name>
        <Affiliation>School of Chinese Materia Medica, Beijing University of Chinese Medicine, Liangxiang Town, Fangshan District, Beijing 102488, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianmei Huang</Name>
        <Affiliation>School of Chinese Materia Medica, Beijing University of Chinese Medicine, Liangxiang Town, Fangshan District, Beijing 102488, China.. Electronic address: huangjm@bucm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Urban air pollution induces redox imbalance and epithelium hyperplasia in mice cornea.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31628919</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30378-3</DOI>
    <KeywordList>
      <Keywords>Air Pollution</Keywords>
      <Keywords>Cornea</Keywords>
      <Keywords>Hyperplasia</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Oxidative Stress</Keywords>
      <Keywords>Redox Imbalance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Romina M. Lasagni Vitar</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Química Analítica y Fisicoquímica, Cátedra de Química General e Inorgánica, Buenos Aires, Argentina; CONICET- Universidad de Buenos Aires, Instituto de Bioquímica y Medicina Molecular (IBIMOL), Buenos Aires, Argentina. Electronic address: rlasagni@ffyb.uba.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Ailen G. Hvozda Arana</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Química Analítica y Fisicoquímica, Cátedra de Química General e Inorgánica, Buenos Aires, Argentina; CONICET- Universidad de Buenos Aires, Instituto de Bioquímica y Medicina Molecular (IBIMOL), Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Natasha S. Janezic</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Química Analítica y Fisicoquímica, Cátedra de Química General e Inorgánica, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Timoteo Marchini</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Química Analítica y Fisicoquímica, Cátedra de Química General e Inorgánica, Buenos Aires, Argentina; CONICET- Universidad de Buenos Aires, Instituto de Bioquímica y Medicina Molecular (IBIMOL), Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Julia Tau</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Patología, Laboratorio Translacional de Inmunopatología y Oftalmología, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Manuela Martinefski</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Tecnología Farmacéutica, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Agustina I. Tesone</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Patología, Laboratorio Translacional de Inmunopatología y Oftalmología, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Lourdes Racca</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Patología, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia G. Reides</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Química Analítica y Fisicoquímica, Cátedra de Química General e Inorgánica, Buenos Aires, Argentina; CONICET- Universidad de Buenos Aires, Instituto de Bioquímica y Medicina Molecular (IBIMOL), Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Valeria Tripodi</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Tecnología Farmacéutica, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Pablo A. Evelson</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Química Analítica y Fisicoquímica, Cátedra de Química General e Inorgánica, Buenos Aires, Argentina; CONICET- Universidad de Buenos Aires, Instituto de Bioquímica y Medicina Molecular (IBIMOL), Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandro Berra</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Patología, Laboratorio Translacional de Inmunopatología y Oftalmología, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Susana F. Llesuy</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Química Analítica y Fisicoquímica, Cátedra de Química General e Inorgánica, Buenos Aires, Argentina; CONICET- Universidad de Buenos Aires, Instituto de Bioquímica y Medicina Molecular (IBIMOL), Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra M. Ferreira</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Química Analítica y Fisicoquímica, Cátedra de Química General e Inorgánica, Buenos Aires, Argentina; CONICET- Universidad de Buenos Aires, Instituto de Bioquímica y Medicina Molecular (IBIMOL), Buenos Aires, Argentina.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cytotoxicity and oxidative stress induced by nickel and titanium ions from dental alloys on cells of gastrointestinal tract.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31628918</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30392-8</DOI>
    <KeywordList>
      <Keywords>Corrosion</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Nickel-titanium alloy</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Rincic Mlinaric</Name>
        <Affiliation>University of Zagreb, School of Dental Medicine, Croatia. Electronic address: rincic_marijana@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>K. Durgo</Name>
        <Affiliation>University of Zagreb, Faculty of Food Technology and Biotechnology, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>V. Katic</Name>
        <Affiliation>University of Rijeka, Faculty of Dental Medicine, Department of Orthodontics, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>S. Spalj</Name>
        <Affiliation>University of Rijeka, Faculty of Dental Medicine, Department of Orthodontics, Croatia; J. J. Strossmayer University of Osijek, Faculty of Dental Medicine and Health, Department of Dental Medicine, Croatia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Small molecule PIKfyve inhibitors as cancer therapeutics: Translational promises and limitations.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31628917</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30379-5</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Cell Death</Keywords>
      <Keywords>PIKfyve Inhibitors</Keywords>
      <Keywords>Vacuolation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ognian C. Ikonomov</Name>
        <Affiliation>Department of Physiology, Wayne State University School of Medicine, Detroit, MI 48201, USA. Electronic address: oikonomo@med.wayne.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Diego Sbrissa</Name>
        <Affiliation>Department of Urology, Wayne State University School of Medicine, Detroit, MI 48201, USA. Electronic address: dsbrissa@med.wayne.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Assia Shisheva</Name>
        <Affiliation>Department of Physiology, Wayne State University School of Medicine, Detroit, MI 48201, USA. Electronic address: ashishev@med.wayne.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Growth and neurite stimulating effects of the neonicotinoid pesticide clothianidin on human neuroblastoma SH-SY5Y cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31626844</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30385-0</DOI>
    <KeywordList>
      <Keywords>Clothianidin</Keywords>
      <Keywords>Intracellular signaling</Keywords>
      <Keywords>Neonicotinoid</Keywords>
      <Keywords>Neuroblastoma cell</Keywords>
      <Keywords>Nicotinic acetylcholine receptor</Keywords>
      <Keywords>Pesticide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tetsushi Hirano</Name>
        <Affiliation>Life Science Research Center, University of Toyama, Toyama, Japan. Electronic address: thirano@cts.u-toyama.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Satsuki Minagawa</Name>
        <Affiliation>Life Science Research Center, University of Toyama, Toyama, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yukihiro Furusawa</Name>
        <Affiliation>Department of Liberal Arts and Sciences, Toyama Prefectural University, Toyama, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tatsuya Yunoki</Name>
        <Affiliation>Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshinori Ikenaka</Name>
        <Affiliation>Laboratory of Toxicology, Department of Environmental Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan; Water Research Group, Unit for Environmental Sciences and Management, North-West University, Potchefstroom, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Toshifumi Yokoyama</Name>
        <Affiliation>Department of Animal Science, Graduate School of Agricultural Science, Kobe University, Kobe, Hyogo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nobuhiko Hoshi</Name>
        <Affiliation>Department of Animal Science, Graduate School of Agricultural Science, Kobe University, Kobe, Hyogo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshiaki Tabuchi</Name>
        <Affiliation>Life Science Research Center, University of Toyama, Toyama, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Coenzyme Q10 mitigates ionizing radiation-induced testicular damage in rats through inhibition of oxidative stress and mitochondria-mediated apoptotic cell death.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31618661</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30388-6</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Coenzyme Q10</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Spermatogenesis impairment</Keywords>
      <Keywords>ϒ-radiation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Riham S. Said</Name>
        <Affiliation>Drug Radiation Research Department, National Center for Radiation Research &amp; Technology, Atomic Energy Authority, Cairo, Egypt. Electronic address: riham.said@eaea.org.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Heba A. Mohamed</Name>
        <Affiliation>Drug Radiation Research Department, National Center for Radiation Research &amp; Technology, Atomic Energy Authority, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed M. Kamal</Name>
        <Affiliation>Pharmacology and Biochemistry Department, Faculty of Pharmacy, The British University in Egypt (BUE), Cairo, Egypt; Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tiotropium bromide, a long acting muscarinic receptor antagonist triggers intracellular calcium signalling in the heart.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31618660</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30386-2</DOI>
    <KeywordList>
      <Keywords>Ca(2+)/Calmodulin Kinase II (CaMKII)</Keywords>
      <Keywords>Calcium</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Long acting muscarinic receptor antagonist</Keywords>
      <Keywords>Tiotropium bromide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shabana Cassambai</Name>
        <Affiliation>Centre for Sports, Exercise and Life Sciences, Coventry University, Coventry CV1 5FB, United Kingdom; Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Leicester, United Kingdom. Electronic address: sc720@le.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher J. Mee</Name>
        <Affiliation>Centre for Sports, Exercise and Life Sciences, Coventry University, Coventry CV1 5FB, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Derek Renshaw</Name>
        <Affiliation>Centre for Sports, Exercise and Life Sciences, Coventry University, Coventry CV1 5FB, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Afthab Hussain</Name>
        <Affiliation>Centre for Sports, Exercise and Life Sciences, Coventry University, Coventry CV1 5FB, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel ALK inhibitor ZYY inhibits Karpas299 cell growth in vitro and in a mouse xenograft model and induces protective autophagy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31618659</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30389-8</DOI>
    <KeywordList>
      <Keywords>Anaplastic large cell lymphoma</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>G1 arrest</Keywords>
      <Keywords>Karpas299 cells</Keywords>
      <Keywords>ZYY</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiwei Shen</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junfang Wang</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianan Du</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lijing Wang</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuejiao Zhou</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xing Chang</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zengqiang Li</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Zhai</Name>
        <Affiliation>Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China. Electronic address: zhaixin_syphu@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Daiying Zuo</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China. Electronic address: zuodaiying@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yingliang Wu</Name>
        <Affiliation>Department of Pharmacology, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, China. Electronic address: yingliang_1016@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31533062</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30369-2</DOI>
    <KeywordList>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>High-content analysis</Keywords>
      <Keywords>Induced pluripotent stem cell-derived cardiomyocytes</Keywords>
      <Keywords>Sarcomere disruption</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Toshikatsu Matsui</Name>
        <Affiliation>Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazumasa Miyamoto</Name>
        <Affiliation>Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazunori Yamanaka</Name>
        <Affiliation>Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshiko Okai</Name>
        <Affiliation>Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Emily Pfeiffer Kaushik</Name>
        <Affiliation>Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 35 Landsdowne St, Cambridge, MA 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kousuke Harada</Name>
        <Affiliation>Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Wagoner</Name>
        <Affiliation>Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 35 Landsdowne St, Cambridge, MA 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tadahiro Shinozawa</Name>
        <Affiliation>Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan. Electronic address: tadahiro.shinozawa@takeda.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>WZ3146 inhibits mast cell Lyn and Fyn to reduce IgE-mediated allergic responses in vitro and in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31526816</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30371-0</DOI>
    <KeywordList>
      <Keywords>Allergy</Keywords>
      <Keywords>Drug Repositioning</Keywords>
      <Keywords>Mast Cells</Keywords>
      <Keywords>Src-Family Kinase</Keywords>
      <Keywords>WZ3146</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Young Hwan Park</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Do Kyun Kim</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyuk Soon Kim</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dajeong Lee</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Min Bum Lee</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Keun Young Min</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Min Geun Jo</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Eon Lee</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Mi Kim</Name>
        <Affiliation>College of Pharmacy, Duksung Women's University, Seoul 01369, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wahn Soo Choi</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea. Electronic address: wahnchoi@kku.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein" [Toxicology and Applied Pharmacology 271 (2013) 144-145].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31526815</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30370-9</DOI>
    <AuthorList>
      <Author>
        <Name>Xiuming Song</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210,009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Yao</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210,009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Wang</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210,009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Zhou</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210,009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuxin Zhou</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210,009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Hu Wang</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210,009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Libin Wei</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210,009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Zhao</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210,009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiyu Li</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210,009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Lu</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210,009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qinglong Guo</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210,009, People's Republic of China. Electronic address: anticancaer_drug@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemotherapeutic doses of arsenic trioxide delays hepatic regeneration by oxidative stress and hepatocyte apoptosis in partial hepatectomy rat.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31525389</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30368-0</DOI>
    <KeywordList>
      <Keywords>Hepatic re-sectioning</Keywords>
      <Keywords>Hepatic regeneration</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Transplantation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Subramaniyam Nithyananthan</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Pondicherry University, Puducherry 605 014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Chinnasamy Thirunavukkarasu</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Pondicherry University, Puducherry 605 014, India. Electronic address: tarasu.bbm@pondiuni.edu.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Food ingredient safety evaluation: Utility and relevance of toxicokinetic methods.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31521730</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30367-9</DOI>
    <KeywordList>
      <Keywords>BPA</Keywords>
      <Keywords>Compartment TK</Keywords>
      <Keywords>Food ingredients</Keywords>
      <Keywords>Noncompartment TK</Keywords>
      <Keywords>PBTK modeling</Keywords>
      <Keywords>Styrene</Keywords>
      <Keywords>TK</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shruti V. Kabadi</Name>
        <Affiliation>FDA/CFSAN/OFAS, 5001 Campus Drive, HFS-275, College Park, MD 20740, United States of America. Electronic address: Shruti.Kabadi@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Zang</Name>
        <Affiliation>FDA/CFSAN/OFAS, 5001 Campus Drive, HFS-275, College Park, MD 20740, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey W. Fisher</Name>
        <Affiliation>FDA/NCTR, 3900 NCTR Road, Jefferson, AR 72079, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Nikki Smith</Name>
        <Affiliation>FDA/CFSAN/OFAS, 5001 Campus Drive, HFS-275, College Park, MD 20740, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Whiteside</Name>
        <Affiliation>FDA/CFSAN/OFAS, 5001 Campus Drive, HFS-275, College Park, MD 20740, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Aungst</Name>
        <Affiliation>FDA/CFSAN/OFAS, 5001 Campus Drive, HFS-275, College Park, MD 20740, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lipidomes of brain from rats acutely intoxicated with diisopropylfluorophosphate identifies potential therapeutic targets.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31521729</pubmedLink>
    <GrantList>
      <Grant>P42 ES004699</Grant>
      <Grant>R01 ES002710</Grant>
      <Grant>U54 NS079202</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30357-6</DOI>
    <KeywordList>
      <Keywords>COX</Keywords>
      <Keywords>DFP</Keywords>
      <Keywords>Lipidomics</Keywords>
      <Keywords>Regulatory lipid mediators</Keywords>
      <Keywords>sEH</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Yang</Name>
        <Affiliation>Department of Entomology and Nematology, and UCD Comprehensive Cancer Center, University of California, Davis, Davis, CA 95616, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donald A. Bruun</Name>
        <Affiliation>Department of Molecular Biosciences, University of California, Davis, CA 95616, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Wang</Name>
        <Affiliation>Department of Entomology and Nematology, and UCD Comprehensive Cancer Center, University of California, Davis, Davis, CA 95616, USA; School of Radiation Medicine and Protection, Medical College of Soochow University, School for Radiological and Interdisciplinary Sciences (RAD-X), Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection, Suzhou 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Debin Wan</Name>
        <Affiliation>Department of Entomology and Nematology, and UCD Comprehensive Cancer Center, University of California, Davis, Davis, CA 95616, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cindy B. McReynolds</Name>
        <Affiliation>Department of Entomology and Nematology, and UCD Comprehensive Cancer Center, University of California, Davis, Davis, CA 95616, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kenny Phu</Name>
        <Affiliation>Department of Entomology and Nematology, and UCD Comprehensive Cancer Center, University of California, Davis, Davis, CA 95616, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bora Inceoglu</Name>
        <Affiliation>Department of Entomology and Nematology, and UCD Comprehensive Cancer Center, University of California, Davis, Davis, CA 95616, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pamela J. Lein</Name>
        <Affiliation>Department of Molecular Biosciences, University of California, Davis, CA 95616, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce D. Hammock</Name>
        <Affiliation>Department of Entomology and Nematology, and UCD Comprehensive Cancer Center, University of California, Davis, Davis, CA 95616, USA. Electronic address: bdhammock@ucdavis.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PEGylated gold nanorods are not cytotoxic to human endothelial cells but affect kruppel-like factor signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31521728</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30366-7</DOI>
    <KeywordList>
      <Keywords>Au Nanorods (NRs)</Keywords>
      <Keywords>Endothelial Nitric Oxide Synthase (eNOS)</Keywords>
      <Keywords>Human Umbilical Vein Endothelial Cells (HUVECs)</Keywords>
      <Keywords>Kruppel-Like Factor (KLF)</Keywords>
      <Keywords>Monocyte Chemotactic Protein 1 (MCP-1)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xianqiang Li</Name>
        <Affiliation>College of Animal Science, Key Laboratory of Tarim Animal Husbandry Science and Technology of Xinjiang Production and Construction Corps, Tarim University, Xinjiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanfang Tang</Name>
        <Affiliation>Key Laboratory of Environment-Friendly Chemistry and Application of Ministry of Education, Laboratory of Biochemistry, College of Chemistry, Xiangtan University, Xiangtan 411105, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunying Chen</Name>
        <Affiliation>CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dexin Qiu</Name>
        <Affiliation>State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Shizishan Street 1, Hongshan District, Wuhan 430070, People's Republic of China. Electronic address: dxqiucn@mail.hzau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Cao</Name>
        <Affiliation>Key Laboratory of Environment-Friendly Chemistry and Application of Ministry of Education, Laboratory of Biochemistry, College of Chemistry, Xiangtan University, Xiangtan 411105, China. Electronic address: caoyi39@xtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification of differentially expressed genes and networks related to hepatic lipid dysfunction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31520653</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30365-5</DOI>
    <AuthorList>
      <Author>
        <Name>Jaleh A. Abedini</Name>
        <Affiliation>Integrated Laboratory Systems, Inc., United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Sakshi Handa</Name>
        <Affiliation>Integrated Laboratory Systems, Inc., United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Edwards</Name>
        <Affiliation>Integrated Systems Toxicology Division, National Health and Environmental Effects Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States of America; Research Computing Division, RTI International, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Chorley</Name>
        <Affiliation>Integrated Systems Toxicology Division, National Health and Environmental Effects Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Hisham El-Masri</Name>
        <Affiliation>Integrated Systems Toxicology Division, National Health and Environmental Effects Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States of America. Electronic address: el-masri.hisham@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carvedilol protects against hepatic ischemia/reperfusion injury in high-fructose/high-fat diet-fed mice: Role of G protein-coupled receptor kinase 2 and 5.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31518596</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30358-8</DOI>
    <KeywordList>
      <Keywords>Carvedilol</Keywords>
      <Keywords>GRK2</Keywords>
      <Keywords>GRK5</Keywords>
      <Keywords>Hepatic ischemia/reperfusion</Keywords>
      <Keywords>β-arrestin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Samar G. Mohammed</Name>
        <Affiliation>Department of Toxic and Narcotic Drugs, Forensic Medicine, Cairo Laboratory, Medicolegal Organization, Ministry of Justice, Cairo, Egypt; Department of Toxic and Narcotic Drugs, Forensic Medicine, Cairo Laboratory, Medicolegal Organization, Ministry of Justice, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Islam A. A. E. H. Ibrahim</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mona F. Mahmoud</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Amr A. A. Mahmoud</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt. Electronic address: aamahmoud@pharmacy.zu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rapamycin attenuates liver injury caused by vinyl chloride metabolite chloroethanol and lipopolysaccharide in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31499194</pubmedLink>
    <GrantList>
      <Grant>R03 DK107912</Grant>
      <Grant>P20 GM113226</Grant>
      <Grant>K01 DK096042</Grant>
      <Grant>P50 AA024337</Grant>
      <Grant>P01 AA017103</Grant>
      <Grant>P30 DK120531</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30353-9</DOI>
    <KeywordList>
      <Keywords>Hepatotoxicant</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>TASH</Keywords>
      <Keywords>Vinyl chloride</Keywords>
      <Keywords>mTOR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anna L. Lang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, United States of America; Hepatobiology and Toxicology Program, University of Louisville, Louisville, KY 40292, United States of America. Electronic address: all159@med.miami.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Austin M. Krueger</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, United States of America. Electronic address: Austin.krueger@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Regina D. Schnegelberger</Name>
        <Affiliation>Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15213, United States of America; Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA 15213, United States of America. Electronic address: rds88@pitt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Brenna R. Kaelin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, United States of America. Electronic address: brka222@uky.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Maxwell J. Rakutt</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, United States of America. Electronic address: Maxrakutt@uky.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Liya Chen</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, United States of America; Hepatobiology and Toxicology Program, University of Louisville, Louisville, KY 40292, United States of America. Electronic address: l0chen26@foxmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gavin E. Arteel</Name>
        <Affiliation>Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA 15213, United States of America; Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, PA 15213, United States of America. Electronic address: gearteel@pitt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Juliane I. Beier</Name>
        <Affiliation>Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA 15213, United States of America; Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, PA 15213, United States of America. Electronic address: jibeier@pitt.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Iron chelation by deferasirox confers protection against concanavalin A-induced liver fibrosis: A mechanistic approach.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31499193</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30356-4</DOI>
    <KeywordList>
      <Keywords>Concanavalin A</Keywords>
      <Keywords>Deferasirox</Keywords>
      <Keywords>Hepcidin</Keywords>
      <Keywords>Iron overload</Keywords>
      <Keywords>Liver fibrosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nada Adel</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Eman M. Mantawy</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Doaa A. El-Sherbiny</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Ebtehal El-Demerdash</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. Electronic address: ebtehal_dm@pharma.asu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of polypyrimidine tract-binding protein 1/yin yang 2 signaling in regulating vascular smooth muscle cell proliferation and neointima hyperplasia.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31499192</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30355-2</DOI>
    <KeywordList>
      <Keywords>Neointima hyperplasia</Keywords>
      <Keywords>PTBP1</Keywords>
      <Keywords>VSMC proliferation</Keywords>
      <Keywords>YY2</Keywords>
      <Keywords>vascular restenosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhen Wang</Name>
        <Affiliation>Department of Cardiology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China; Department of Cardiology, The General Hospital of Western Theater Command (Chengdu Military General Hospital), Chengdu, Sichuan 610083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xueqing Gan</Name>
        <Affiliation>Department of Cardiology, The General Hospital of Western Theater Command (Chengdu Military General Hospital), Chengdu, Sichuan 610083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenming Qiu</Name>
        <Affiliation>Department of Cardiology, The General Hospital of Western Theater Command (Chengdu Military General Hospital), Chengdu, Sichuan 610083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dachun Yang</Name>
        <Affiliation>Department of Cardiology, The General Hospital of Western Theater Command (Chengdu Military General Hospital), Chengdu, Sichuan 610083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiongshan Sun</Name>
        <Affiliation>Department of Cardiology, The General Hospital of Western Theater Command (Chengdu Military General Hospital), Chengdu, Sichuan 610083, China.. Electronic address: shan19910927@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Zeng</Name>
        <Affiliation>Department of Cardiology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China. Electronic address: zengzhi2013@qq.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>High- and low- selenium diets affect endocrine energy balance during early programming.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31494150</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30352-7</DOI>
    <KeywordList>
      <Keywords>Early programming</Keywords>
      <Keywords>Energy balance</Keywords>
      <Keywords>Gastrointestinal peptides</Keywords>
      <Keywords>Leptin</Keywords>
      <Keywords>Selenium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>María Luisa Ojeda</Name>
        <Affiliation>Department of Physiology, Faculty of Pharmacy, Seville University, 41012 Seville, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Olimpia Carreras</Name>
        <Affiliation>Department of Physiology, Faculty of Pharmacy, Seville University, 41012 Seville, Spain. Electronic address: olimpia@us.es.</Affiliation>
      </Author>
      <Author>
        <Name>Javier Díaz-Castro</Name>
        <Affiliation>Department of Physiology, Institute of Nutrition and Food Technology "José Mataix", University of Granada, 18071 Granada, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>María Luisa Murillo</Name>
        <Affiliation>Department of Physiology, Faculty of Pharmacy, Seville University, 41012 Seville, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Fátima Nogales</Name>
        <Affiliation>Department of Physiology, Faculty of Pharmacy, Seville University, 41012 Seville, Spain.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure to silver nanoparticles primes mast cells for enhanced activation through the high-affinity IgE receptor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31494149</pubmedLink>
    <GrantList>
      <Grant>R01 ES019311</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30354-0</DOI>
    <KeywordList>
      <Keywords>Allergy</Keywords>
      <Keywords>Degranulation</Keywords>
      <Keywords>Engineered nanomaterials</Keywords>
      <Keywords>Late-phase activation</Keywords>
      <Keywords>Mast cell</Keywords>
      <Keywords>Sensitization</Keywords>
      <Keywords>Silver nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nasser B. Alsaleh</Name>
        <Affiliation>Colorado Center for Nanomedicine and Nanosafety, Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, The University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ryan P. Mendoza</Name>
        <Affiliation>Colorado Center for Nanomedicine and Nanosafety, Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, The University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jared M. Brown</Name>
        <Affiliation>Colorado Center for Nanomedicine and Nanosafety, Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, The University of Colorado Anschutz Medical Campus, Aurora, CO, United States. Electronic address: jared.brown@cuanschutz.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dexmedetomidine attenuates the induction and reverses the progress of 6-hydroxydopamine- induced parkinsonism; involvement of K</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31476326</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30351-5</DOI>
    <KeywordList>
      <Keywords>6-OHDA</Keywords>
      <Keywords>Dexmedetomidine</Keywords>
      <Keywords>IL-6</Keywords>
      <Keywords>K(ATP) Channels</Keywords>
      <Keywords>TNF-α</Keywords>
      <Keywords>α(2)-Adrenoceptors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Azita Minaei</Name>
        <Affiliation>Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Hashem Haghdoost-Yazdi</Name>
        <Affiliation>Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran. Electronic address: hhaghdoost@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cortisol disruption and transgenerational alteration in the expression of stress-related genes in zebrafish larvae following fluoxetine exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31476325</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30350-3</DOI>
    <KeywordList>
      <Keywords>Cortisol</Keywords>
      <Keywords>Epigenetic</Keywords>
      <Keywords>Fluoxetine</Keywords>
      <Keywords>Gene Expression</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marilyn N. Vera-Chang</Name>
        <Affiliation>Department of Biology, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada. Electronic address: mvera69@uottawa.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas W. Moon</Name>
        <Affiliation>Department of Biology, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada. Electronic address: tmoon@uottawa.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Vance L. Trudeau</Name>
        <Affiliation>Department of Biology, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada. Electronic address: trudeauv@uottawa.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The comparative effects of high dose atorvastatin and proprotein convertase subtilisin/kexin type 9 inhibitor on the mitochondria of oxidative muscle fibers in obese-insulin resistant female rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31473249</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30349-7</DOI>
    <KeywordList>
      <Keywords>Lipid lowering drug</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Oxidative muscle fiber</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chanisa Thonusin</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Nattayaporn Apaijai</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Thidarat Jaiwongkam</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Sasiwan Kerdphoo</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Busarin Arunsak</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Patchareeya Amput</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Siripong Palee</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Wasana Pratchayasakul</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Nipon Chattipakorn</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Siriporn C. Chattipakorn</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand; Department of Oral Biology and Diagnostic Sciences, Faculty of Dentistry, Chiang Mai University, Chiang Mai, Thailand. Electronic address: siriporn.c@cmu.ac.th.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gefitinib and curcumin-loaded nanoparticles enhance cell apoptosis in human oral cancer SAS cells in vitro and inhibit SAS cell xenografted tumor in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31470033</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30342-4</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Curcumin</Keywords>
      <Keywords>Gefitinib</Keywords>
      <Keywords>SAS human oral cancer cells</Keywords>
      <Keywords>γ-PGA-Cur/Gef nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kuang Chi Lai</Name>
        <Affiliation>Department of Medical Laboratory Science and Biotechnology, College of Medical Technology, Chung Hwa University of Medical Technology, Tainan, Taiwan; Department of Surgery, China Medical University Beigang Hospital, Beigang, Yunlin, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Fu Shin Chueh</Name>
        <Affiliation>Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yung Ting Hsiao</Name>
        <Affiliation>Department of Biological Science and Technology, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Yu Cheng</Name>
        <Affiliation>Department of Biological Science and Technology, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Cherng Lien</Name>
        <Affiliation>Department of School of Pharmacy, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Kuo Ching Liu</Name>
        <Affiliation>Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Fen Peng</Name>
        <Affiliation>Department of Biological Science and Technology, China Medical University, Taichung, Taiwan; Department of Medical Research, China Medical University Hospital, Taichung, Taiwan. Electronic address: t20811@mail.cmuh.org.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Gung Chung</Name>
        <Affiliation>Department of Biological Science and Technology, China Medical University, Taichung, Taiwan; Department of Biotechnology, Asia University, Taichung, Taiwan. Electronic address: jgchung@mail.cmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Thromboxane A</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31470032</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30341-2</DOI>
    <KeywordList>
      <Keywords>Endothelial Cells</Keywords>
      <Keywords>Liver Injury</Keywords>
      <Keywords>Monocrotaline</Keywords>
      <Keywords>Platelets</Keywords>
      <Keywords>SOS</Keywords>
      <Keywords>Thromboxane</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fumisato Otaka</Name>
        <Affiliation>Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan; Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan; Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshiya Ito</Name>
        <Affiliation>Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan; Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoyoshi Inoue</Name>
        <Affiliation>Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan; Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan; Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hirotoki Ohkubo</Name>
        <Affiliation>Department of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nobuyuki Nishizawa</Name>
        <Affiliation>Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan; Department of Surgery, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ken Kojo</Name>
        <Affiliation>Department of Surgery, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomohiro Betto</Name>
        <Affiliation>Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan; Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan; Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Sakiko Yamane</Name>
        <Affiliation>Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan; Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan; Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shuh Narumiya</Name>
        <Affiliation>Laboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Wasaburo Koizumi</Name>
        <Affiliation>Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masataka Majima</Name>
        <Affiliation>Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan; Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan. Electronic address: mmajima@med.kitasto-u.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>IMM-H007, a novel small molecule inhibitor for atherosclerosis, represses endothelium inflammation by regulating the activity of NF-κB and JNK/AP1 signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31454633</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30340-0</DOI>
    <KeywordList>
      <Keywords>Endothelium Inflammation</Keywords>
      <Keywords>H007</Keywords>
      <Keywords>JNK/c-Jun Signaling</Keywords>
      <Keywords>NF-κB Signaling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jinjin Yu</Name>
        <Affiliation>School of psychology, Xinxiang Medical University, Xinxiang 453003, Henan, China. Electronic address: 181016@xxmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Ming</Name>
        <Affiliation>Synthetic Biology Engineering Lab of Henan Province, College of Life Sciences and Technology, Xinxiang Medical University, Xinxiang, 453003, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Henry You Li</Name>
        <Affiliation>Biomolecular Interaction Centre, University of Canterbury, Christchurch 8140, New Zealand.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Yu</Name>
        <Affiliation>LC-Bio Technologies (Hangzhou) CO., LTD, Hangzhou 310000, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Maoping Chu</Name>
        <Affiliation>Children's Heart Center, the Second Affiliated Hospital and Yuying Children's Hospital, Institute of Cardiovascular Development and Translational Medicine, Wenzhou Medical University, Wenzhou 325000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haibo Zhu</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medical, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing 10050, China. Electronic address: zhuhaibo@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xinxing Zhu</Name>
        <Affiliation>Henan Joint International Research Laboratory of Stem Cell Medicine, College of Biomedical Engineering, Xinxiang Medical University, Xinxiang 453003, Henan, China. Electronic address: zhuxinxing0202@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Constitutive androstane receptor mediates PCB-induced disruption of retinoid homeostasis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31449830</pubmedLink>
    <GrantList>
      <Grant>P30 ES009089</Grant>
      <Grant>R01 DK068437</Grant>
      <Grant>R01 DK101251</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30339-4</DOI>
    <KeywordList>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Environmental Pollutant</Keywords>
      <Keywords>Metabolic Disruption</Keywords>
      <Keywords>Transcriptional Regulation</Keywords>
      <Keywords>Vitamin A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Igor O. Shmarakov</Name>
        <Affiliation>Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA. Electronic address: is2553@cumc.columbia.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Jee Lee</Name>
        <Affiliation>Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hongfeng Jiang</Name>
        <Affiliation>Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William S. Blaner</Name>
        <Affiliation>Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of endoplasmic reticulum stress and oxidative stress in vinyl chloride-induced hepatic steatosis in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31445928</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30338-2</DOI>
    <KeywordList>
      <Keywords>Endoplasmic reticulum stress</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Toxicant associated steatohepatitis</Keywords>
      <Keywords>Vinyl chloride</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qian Wang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Shanxi Medical University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Zhang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Shanxi Medical University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shi Qi Chen</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Shanxi Medical University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Yan Ma</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Shanxi Medical University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Lin Guo</Name>
        <Affiliation>Department of Pathology, School of Basic Medical, Shanxi Medical University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Gao</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Shanxi Medical University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Jie Tian</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Shanxi Medical University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Lan Qiu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Shanxi Medical University, Taiyuan, China. Electronic address: ylqiu@sxmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PI3K/AKT inhibitors aggravate death receptor-mediated hepatocyte apoptosis and liver injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31445927</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30337-0</DOI>
    <KeywordList>
      <Keywords>AKT inhibition</Keywords>
      <Keywords>Death receptor</Keywords>
      <Keywords>Hepatocytic apoptosis</Keywords>
      <Keywords>Liver injury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Liu</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Tang Jing</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Rong Xue</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Xiang Wu</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wan Nan Chen</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Jian Lin</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Lin</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China. Electronic address: linxu@mail.fjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Perfluorooctanoic acid-induced toxicities in chicken embryo primary cardiomyocytes: Roles of PPAR alpha and Wnt5a/Frizzled2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31445018</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30324-2</DOI>
    <KeywordList>
      <Keywords>Perfluorooctanoic acid</Keywords>
      <Keywords>Wnt5a/Frizzled2</Keywords>
      <Keywords>in ovo gene silencing</Keywords>
      <Keywords>intracellular calcium</Keywords>
      <Keywords>primary cardiomyocyte</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Na Lv</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Qingdao University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junhua Yuan</Name>
        <Affiliation>Department of Special Medicine, School of Basic Medicine, Qingdao University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Andong Ji</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Qingdao University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Limei Shi</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Qingdao University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengyu Gao</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Qingdao University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lianhua Cui</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Qingdao University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qixiao Jiang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Qingdao University, China. Electronic address: jiangq@qdu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cannabidiol differentially regulates basal and LPS-induced inflammatory responses in macrophages, lung epithelial cells, and fibroblasts.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31437494</pubmedLink>
    <GrantList>
      <Grant>R01 HL135613</Grant>
      <Grant>U54 CA228110</Grant>
      <Grant>P30 ES001247</Grant>
      <Grant>R01 HL085613</Grant>
      <Grant>R01 ES029177</Grant>
      <Grant>R01 HL133404</Grant>
      <Grant>R21 ES028006</Grant>
      <Grant>T32 ES007026</Grant>
      <Grant>R56 ES027012</Grant>
      <Grant>R01 HL137738</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30321-7</DOI>
    <KeywordList>
      <Keywords>CBD</Keywords>
      <Keywords>E-cigarette</Keywords>
      <Keywords>E-liquid</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Marijuana</Keywords>
      <Keywords>Vaping</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thivanka Muthumalage</Name>
        <Affiliation>Department of Environmental Medicine, School of Medicine &amp; Dentistry, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Irfan Rahman</Name>
        <Affiliation>Department of Environmental Medicine, School of Medicine &amp; Dentistry, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: irfan_rahman@urmc.rochester.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Structure-activity relationship study: Mechanism of cyto-genotoxicity of Nitropyrazole-derived high energy density materials family.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31437493</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30320-5</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>HEDMs</Keywords>
      <Keywords>Nitropyrazole-derived</Keywords>
      <Keywords>RNAseq</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laetitia Guyot</Name>
        <Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, France; UMR INSERM U1052/CNRS 5286, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, France.</Affiliation>
      </Author>
      <Author>
        <Name>Florian Simon</Name>
        <Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica Garcia</Name>
        <Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, France.</Affiliation>
      </Author>
      <Author>
        <Name>Floriane Vanhalle</Name>
        <Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, France.</Affiliation>
      </Author>
      <Author>
        <Name>Gaelle Vilchez</Name>
        <Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, France.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Bardel</Name>
        <Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, France.</Affiliation>
      </Author>
      <Author>
        <Name>Brigitte Manship</Name>
        <Affiliation>UMR INSERM U1052/CNRS 5286, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, France.</Affiliation>
      </Author>
      <Author>
        <Name>Alain Puisieux</Name>
        <Affiliation>UMR INSERM U1052/CNRS 5286, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, France; Université Lyon 1, ISPBL, Faculté de pharmacie, Laboratoire de Toxicologie, France.</Affiliation>
      </Author>
      <Author>
        <Name>Christelle Machon</Name>
        <Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, France.</Affiliation>
      </Author>
      <Author>
        <Name>Guy Jacob</Name>
        <Affiliation>Université Lyon 1, Faculté des sciences et technologies, UMR CNRS 5278 Hydrazines et Composés Energetiques Polyazotés, France; ArianeGroup Centre de Recherche du Bouchet, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jérôme Guitton</Name>
        <Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, France; Université Lyon 1, ISPBL, Faculté de pharmacie, Laboratoire de Toxicologie, France. Electronic address: jerome.guitton@univ-lyon1.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Léa Payen</Name>
        <Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, France; UMR INSERM U1052/CNRS 5286, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, France; Université Lyon 1, ISPBL, Faculté de pharmacie, Laboratoire de Toxicologie, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Doxorubicin obliterates mouse ovarian reserve through both primordial follicle atresia and overactivation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31437492</pubmedLink>
    <GrantList>
      <Grant>K01 ES030014</Grant>
      <Grant>P01 ES028942</Grant>
      <Grant>P20 GM103641</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30322-9</DOI>
    <KeywordList>
      <Keywords>Chemotherapy</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Fertility</Keywords>
      <Keywords>Ovarian reserve</Keywords>
      <Keywords>Primordial follicle</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yingzheng Wang</Name>
        <Affiliation>Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mingjun Liu</Name>
        <Affiliation>Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah B. Johnson</Name>
        <Affiliation>Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gehui Yuan</Name>
        <Affiliation>Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA; Department of Hygienic Analysis and Detection, School of Public Health, Nanjing Medical University, Nanjing 21009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Alana K. Arriba</Name>
        <Affiliation>Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maria E. Zubizarreta</Name>
        <Affiliation>Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Saurabh Chatterjee</Name>
        <Affiliation>Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mitzi Nagarkatti</Name>
        <Affiliation>Department of Microbiology and Immunology, School of Medicine, University of South Carolina, SC 29208, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Prakash Nagarkatti</Name>
        <Affiliation>Department of Microbiology and Immunology, School of Medicine, University of South Carolina, SC 29208, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shuo Xiao</Name>
        <Affiliation>Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA. Electronic address: sxiao@mailbox.sc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure to perfluorooctane sulfonate based on circadian rhythm changes the fecundity and expression of certain genes on the hypothalamic-pituitary-gonadal-liver axis of female zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31437491</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30323-0</DOI>
    <KeywordList>
      <Keywords>Circadian rhythm</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Hypothalamic-pituitary-gonadal-liver (HPGL) axis</Keywords>
      <Keywords>Perfluorooctane sulfonate (PFOS)</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mian Bao</Name>
        <Affiliation>Department of Preventive Medicine, Shantou University Medical College, Shantou 515041, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenlong Huang</Name>
        <Affiliation>Department of Preventive Medicine, Shantou University Medical College, Shantou 515041, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>William W. Au</Name>
        <Affiliation>University of Medicine, Pharmacy, Sciences and Technology, Targu Mures, Romania and Shantou University Medical College, Shantou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shukai Zheng</Name>
        <Affiliation>Department of Preventive Medicine, Shantou University Medical College, Shantou 515041, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Caixia Liu</Name>
        <Affiliation>Department of Preventive Medicine, Shantou University Medical College, Shantou 515041, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanni Huang</Name>
        <Affiliation>Department of Preventive Medicine, Shantou University Medical College, Shantou 515041, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kusheng Wu</Name>
        <Affiliation>Department of Preventive Medicine, Shantou University Medical College, Shantou 515041, Guangdong, China. Electronic address: kswu@stu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Population-based toxicity screening in human induced pluripotent stem cell-derived cardiomyocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31425687</pubmedLink>
    <GrantList>
      <Grant>P30 ES029067</Grant>
      <Grant>P42 ES027704</Grant>
      <Grant>R835802</Grant>
      <Grant>T32 ES026568</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30319-9</DOI>
    <KeywordList>
      <Keywords>Alternative methods</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Environmental chemicals</Keywords>
      <Keywords>High-content screening</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>iPSC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sarah D. Burnett</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX 77843-4458, USA. Electronic address: sburnett@cvm.tamu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander D. Blanchette</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX 77843-4458, USA. Electronic address: ablanchette@cvm.tamu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Fabian A. Grimm</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX 77843-4458, USA. Electronic address: fgrimm@cvm.tamu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>John S. House</Name>
        <Affiliation>Bioinformatics Research Center, North Carolina State University, Raleigh, NC 27695, USA. Electronic address: jshouse@ncsu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>David M. Reif</Name>
        <Affiliation>Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695, USA; Department of Statistics, North Carolina State University, Raleigh, NC 27695, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fred A. Wright</Name>
        <Affiliation>Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695, USA; Department of Statistics, North Carolina State University, Raleigh, NC 27695, USA. Electronic address: fred_wright@ncsu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Weihsueh A. Chiu</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX 77843-4458, USA. Electronic address: wchiu@cvm.tamu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ivan Rusyn</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX 77843-4458, USA. Electronic address: irusyn@cvm.tamu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mercury induces nuclear estrogen receptors to act as vasoconstrictors promoting endothelial denudation via the PI3K/Akt signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31415774</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30318-7</DOI>
    <KeywordList>
      <Keywords>Aorta</Keywords>
      <Keywords>Endothelial Denudation</Keywords>
      <Keywords>Estrogen Receptors</Keywords>
      <Keywords>Mercury</Keywords>
      <Keywords>Vascular Reactivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Evellyn Rodrigues Cordeiro</Name>
        <Affiliation>Dept. of Physiological Sciences, Universidade Federal do Espírito Santo, Vitória, ES CEP 29043-900, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Filipe Martinuzo Filetti</Name>
        <Affiliation>Dept. of Physiological Sciences, Universidade Federal do Espírito Santo, Vitória, ES CEP 29043-900, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maylla Ronacher Simões</Name>
        <Affiliation>Dept. of Physiological Sciences, Universidade Federal do Espírito Santo, Vitória, ES CEP 29043-900, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Dalton Valentim Vassallo</Name>
        <Affiliation>Dept. of Physiological Sciences, Universidade Federal do Espírito Santo, Vitória, ES CEP 29043-900, Brazil; Health Science Center of Vitória-EMESCAM, Vitória, ES CEP 29045-402, Brazil. Electronic address: daltonv2@outlook.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Differential activity of BPA, BPAF and BPC on zebrafish estrogen receptors in vitro and in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31415773</pubmedLink>
    <GrantList>
      <Grant>R21 ES020036</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30317-5</DOI>
    <KeywordList>
      <Keywords>Bisphenol</Keywords>
      <Keywords>Estrogen receptor</Keywords>
      <Keywords>Reporter cell lines</Keywords>
      <Keywords>Transgenic fish</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Caroline Pinto</Name>
        <Affiliation>Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ruixin Hao</Name>
        <Affiliation>Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marina Grimaldi</Name>
        <Affiliation>Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Institut régional du Cancer de Montpellier, Université de Montpellier, 34298 Montpellier, Cedex 5, France.</Affiliation>
      </Author>
      <Author>
        <Name>Savini Thrikawala</Name>
        <Affiliation>Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Abdelhay Boulahtouf</Name>
        <Affiliation>Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Institut régional du Cancer de Montpellier, Université de Montpellier, 34298 Montpellier, Cedex 5, France.</Affiliation>
      </Author>
      <Author>
        <Name>Selim Aït-Aïssa</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des risques (INERIS), Unité Ecotoxicologie in vitro et in vivo, UMR-I 02 SEBIO, 60550 Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>François Brion</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des risques (INERIS), Unité Ecotoxicologie in vitro et in vivo, UMR-I 02 SEBIO, 60550 Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Åke Gustafsson</Name>
        <Affiliation>Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA; Department of Biosciences and Nutrition, Karolinska Institutet, 14183 Huddinge, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Balaguer</Name>
        <Affiliation>Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Institut régional du Cancer de Montpellier, Université de Montpellier, 34298 Montpellier, Cedex 5, France. Electronic address: patrick.balaguer@inserm.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Bondesson</Name>
        <Affiliation>Department of Intelligent Systems Engineering, Indiana University, Bloomington, IN 47408, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Progress in data interoperability to support computational toxicology and chemical safety evaluation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31404555</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30315-1</DOI>
    <KeywordList>
      <Keywords>Applications</Keywords>
      <Keywords>Bioinformatics</Keywords>
      <Keywords>Computational Toxicology</Keywords>
      <Keywords>Data Interoperability</Keywords>
      <Keywords>Databases</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sean Watford</Name>
        <Affiliation>Booz Allen Hamilton, Rockville, MD 20852, USA; National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Edwards</Name>
        <Affiliation>Research Triangle Institute International, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Angrish</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard S. Judson</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katie Paul Friedman</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: paul-friedman.katie@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway". [Toxicology and Applied Pharmacology 292 (2016) 19-29].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31401032</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30316-3</DOI>
    <AuthorList>
      <Author>
        <Name>Lina Gu</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xufeng Tao</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Youwei Xu</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Han</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Qi</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lina Xu</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lianhong Yin</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinyong Peng</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China. Electronic address: jinyongpeng2008@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The critical role for TAK1 in trichloroethylene-induced contact hypersensitivity in vivo and in CD4</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31400415</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30313-8</DOI>
    <KeywordList>
      <Keywords>CD4(+) T cells</Keywords>
      <Keywords>Contact hypersensitivity</Keywords>
      <Keywords>Oxidative metabolites</Keywords>
      <Keywords>Transforming growth factor-β activated kinase-1</Keywords>
      <Keywords>Trichloroethylene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yao Pan</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China; Department of Cosmetics, School of Science, Beijing Technology and Business University, Beijing 100048, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohong Hou</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qinghe Meng</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohua Yang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lanqin Shang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuetao Wei</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weidong Hao</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China. Electronic address: whao@bjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The use of evidence from high-throughput screening and transcriptomic data in human health risk assessments.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31400414</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30314-X</DOI>
    <KeywordList>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Carcinogen</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>HTS</Keywords>
      <Keywords>High throughput screening</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>ToxCast™</Keywords>
      <Keywords>Toxicogenomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Roman Mezencev</Name>
        <Affiliation>Integrated Risk Information System (IRIS), National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Washington DC, United States of America. Electronic address: Mezencev.Roman@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Ravi Subramaniam</Name>
        <Affiliation>Integrated Risk Information System (IRIS), National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Washington DC, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Porous Se@SiO2 nanospheres attenuate cisplatin-induced acute kidney injury via activation of Sirt1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31400413</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30312-6</DOI>
    <KeywordList>
      <Keywords>Acute kidney injury</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Nanospheres</Keywords>
      <Keywords>Sirt1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xi Li</Name>
        <Affiliation>Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Wang</Name>
        <Affiliation>Trauma Center, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, No. 650 Xin Songjiang Road, Shanghai 201620, PR China; Trauma Center, Shanghai General Hospital of Nanjing Medical University, Shanghai 200080, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guoying Deng</Name>
        <Affiliation>Trauma Center, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, No. 650 Xin Songjiang Road, Shanghai 201620, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yinping Liu</Name>
        <Affiliation>Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Boxuan Wei</Name>
        <Affiliation>Trauma Center, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, No. 650 Xin Songjiang Road, Shanghai 201620, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xijian Liu</Name>
        <Affiliation>College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai 201620, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Bao</Name>
        <Affiliation>Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China. Electronic address: forever_chipper@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Qiugen Wang</Name>
        <Affiliation>Trauma Center, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, No. 650 Xin Songjiang Road, Shanghai 201620, PR China. Electronic address: wangqiugen@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sufang Wu</Name>
        <Affiliation>Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China. Electronic address: fangsw@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Efficacy and safety of Ramucirumab and methotrexate co-therapy in rheumatoid arthritis experimental model: Involvement of angiogenic and immunomodulatory signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31398424</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30310-2</DOI>
    <KeywordList>
      <Keywords>Adjuvant Induced Arthritis</Keywords>
      <Keywords>Immune Response</Keywords>
      <Keywords>Ramucirumab</Keywords>
      <Keywords>Rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amany E. Abdel-Maged</Name>
        <Affiliation>National Organization for Research and Control of Biologicals (NORCB), Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Amany M. Gad</Name>
        <Affiliation>Department of Pharmacology, National Organization for Drug Control and Research (NODCAR), Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Sara A. Wahdan</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Samar S. Azab</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. Electronic address: samar_saad_azab@pharma.asu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic impairs GLUT1 trafficking through the inhibition of the calpain system in lymphocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31398423</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30308-4</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Calpain</Keywords>
      <Keywords>GLUT1</Keywords>
      <Keywords>Glucose uptake</Keywords>
      <Keywords>Lymphocytes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pablo Pánico</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Adriana Juárez-Nájera</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Emilio Iturriaga-Goyon</Name>
        <Affiliation>MD/PhD (PECEM) Program, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Ostrosky-Wegman</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Ana María Salazar</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico. Electronic address: anamsm@biomedicas.unam.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Plasma endoxifen and 4-hydroxytamoxifen levels in CYP2D6(C100T) carrying breast cancer patients and association with serum cholesterol" [Toxicology and Applied Pharmacology, 378 (2019) 114619].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31398422</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30309-6</DOI>
    <AuthorList>
      <Author>
        <Name>Ta Chung Chao</Name>
        <Affiliation>Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Chi Pan</Name>
        <Affiliation>Institute of Environmental and Occupational Health Sciences, School of Medicine, National Yang-Ming University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Fang Tsai</Name>
        <Affiliation>Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yueh Ching Chou</Name>
        <Affiliation>Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan; Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Rong Liu</Name>
        <Affiliation>National Research Institute of Chinese Medicine, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Sheng Fan Wang</Name>
        <Affiliation>Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Jen Chen</Name>
        <Affiliation>Division of General Internal Medicine and Geriatrics, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan City, Taiwan; Chang Gung University College of Medicine, Taoyuan City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Pavel Souček</Name>
        <Affiliation>Department of Toxicogenomics, National Institute of Public Health, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Yune Fang Ueng</Name>
        <Affiliation>National Research Institute of Chinese Medicine, Taipei, Taiwan; Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Institute of Biopharmaceutical Sciences, School of Pharmacy, National Yang-Ming University, Taipei, Taiwan; Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan. Electronic address: ueng@nricm.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective effect of peptide DR8 on bleomycin-induced pulmonary fibrosis by regulating the TGF-β/MAPK signaling pathway and oxidative stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31398421</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30311-4</DOI>
    <KeywordList>
      <Keywords>Bleomycin</Keywords>
      <Keywords>DR8</Keywords>
      <Keywords>MAPK</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Pulmonary fibrosis</Keywords>
      <Keywords>TGF-β1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dan Wang</Name>
        <Affiliation>School of Life Sciences, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhibin Yan</Name>
        <Affiliation>School of Life Sciences, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lili Bu</Name>
        <Affiliation>School of Life Sciences, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei An</Name>
        <Affiliation>Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Institute of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bochuan Deng</Name>
        <Affiliation>School of Life Sciences, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianfeng Zhang</Name>
        <Affiliation>School of Life Sciences, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Rao</Name>
        <Affiliation>Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Institute of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Cheng</Name>
        <Affiliation>School of Life Sciences, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingying Zhang</Name>
        <Affiliation>Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Institute of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bangzhi Zhang</Name>
        <Affiliation>Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Institute of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China. Electronic address: zhangbz@lzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Junqiu Xie</Name>
        <Affiliation>Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Institute of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China. Electronic address: xiejq@lzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Maternal-to-zygotic transition as a potential target for niclosamide during early embryogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31398420</pubmedLink>
    <GrantList>
      <Grant>R01 ES027576</Grant>
      <Grant>T32 ES018827</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30307-2</DOI>
    <KeywordList>
      <Keywords>Embryonic development</Keywords>
      <Keywords>Maternal-to-zygotic transition</Keywords>
      <Keywords>Niclosamide</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sara M. F. Vliet</Name>
        <Affiliation>Environmental Toxicology Graduate Program, University of California, Riverside, CA, USA; Department of Environmental Sciences, University of California, Riverside, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Subham Dasgupta</Name>
        <Affiliation>Department of Environmental Sciences, University of California, Riverside, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole R. L. Sparks</Name>
        <Affiliation>Department of Molecular, Cell, and Systems Biology, University of California, Riverside, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jay S. Kirkwood</Name>
        <Affiliation>Metabolomics Core Facility, Institute for Integrative Genome Biology, University of California, Riverside, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alyssa Vollaro</Name>
        <Affiliation>Metabolomics Core Facility, Institute for Integrative Genome Biology, University of California, Riverside, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Manhoi Hur</Name>
        <Affiliation>Metabolomics Core Facility, Institute for Integrative Genome Biology, University of California, Riverside, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole I. Zur Nieden</Name>
        <Affiliation>Department of Molecular, Cell, and Systems Biology, University of California, Riverside, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David C. Volz</Name>
        <Affiliation>Department of Environmental Sciences, University of California, Riverside, CA, USA. Electronic address: david.volz@ucr.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing children's exposure to manganese in drinking water using a PBPK model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31394159</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30303-5</DOI>
    <KeywordList>
      <Keywords>Bioavailability</Keywords>
      <Keywords>Children</Keywords>
      <Keywords>Drinking water exposure</Keywords>
      <Keywords>Infant</Keywords>
      <Keywords>Manganese</Keywords>
      <Keywords>PBPK</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Yoon</Name>
        <Affiliation>ToxStrategies, Inc., RTP, NC, USA. Electronic address: yoon.m.work@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>C. Ring</Name>
        <Affiliation>ToxStrategies, Inc., Austin, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>C. B. Van Landingham</Name>
        <Affiliation>Ramboll, Monroe, LA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Suh</Name>
        <Affiliation>ToxStrategies, Inc., Orange County, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. Song</Name>
        <Affiliation>ToxStrategies, Inc., Orange County, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>T. Antonijevic</Name>
        <Affiliation>ToxStrategies, Inc., Katy, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. R. Gentry</Name>
        <Affiliation>Ramboll, Monroe, LA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. D. Taylor</Name>
        <Affiliation>NiPERA, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Keene</Name>
        <Affiliation>Afton Chemical Corporation, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. E. Andersen</Name>
        <Affiliation>Andersen ToxConsulting LLC, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>H. J. Clewell</Name>
        <Affiliation>Ramboll, RTP, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31394158</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30305-9</DOI>
    <KeywordList>
      <Keywords>Bile duct ligation (BDL)</Keywords>
      <Keywords>Cholestasis</Keywords>
      <Keywords>Glioma-associated oncogene homolog 1 (Gli1)</Keywords>
      <Keywords>Hedgehog (Hh)</Keywords>
      <Keywords>Smoothened (Smo)</Keywords>
      <Keywords>Vitamin D</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Noha Abdel-Rahman</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt; School of Pharmacy, Newgiza University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Maha H. Sharawy</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. Electronic address: maha_hesham@mans.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Nirmeen Megahed</Name>
        <Affiliation>Department of Pathology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammed S. El-Awady</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pulmonary fibroblasts-secreted CXCL10 polarizes alveolar macrophages under pro-inflammatory stimuli.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31394157</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30306-0</DOI>
    <KeywordList>
      <Keywords>Alveolar Macrophage</Keywords>
      <Keywords>CXCL10</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Polarization</Keywords>
      <Keywords>Pulmonary Fibroblast</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cheng Fang Tsai</Name>
        <Affiliation>Department of Biotechnology, Asia University, No.500 Lioufeng Road, Taichung 41354, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Hong Chen</Name>
        <Affiliation>Department of General Surgery, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 42743, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Lan Yeh</Name>
        <Affiliation>Institute of New Drug Development, China Medical University, No.91 Hsueh-Shih Road, Taichung 40402, Taiwan. Electronic address: wlyeh@mail.cmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The involvement of lipid raft pathway in suppression of TGFβ-mediated metastasis by tolfenamic acid in hepatocellular carcinoma cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31381904</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30304-7</DOI>
    <KeywordList>
      <Keywords>Hepatocellular Carcinoma</Keywords>
      <Keywords>Lipid Raft</Keywords>
      <Keywords>Metastasis</Keywords>
      <Keywords>TGFβ</Keywords>
      <Keywords>Tolfenamic Acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jingfang Sun</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ran Tao</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Tianxiao Mao</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Feng</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qinglong Guo</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaobo Zhang</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, People's Republic of China. Electronic address: zxb@cpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacological and physicochemical profile of arylacetamides as tools against human cancers.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31356931</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30300-X</DOI>
    <KeywordList>
      <Keywords>Anxiolytic-like Effects</Keywords>
      <Keywords>Behavioral Animal</Keywords>
      <Keywords>Colon Carcinoma</Keywords>
      <Keywords>Physiological Parameters</Keywords>
      <Keywords>Xenograft Model</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paulo Michel Pinheiro Ferreira</Name>
        <Affiliation>Department of Biophysics and Physiology, Laboratory of Experimental Cancerology, Federal University of Piauí, Teresina 64049-550, Brazil; Postgraduate Programs in Pharmaceutical Sciences and Biotechnology, Federal University of Piauí, Teresina 64.049-550, Brazil. Electronic address: pmpf@ufpi.edu.br.</Affiliation>
      </Author>
      <Author>
        <Name>Kátia da Conceição Machado</Name>
        <Affiliation>Department of Biophysics and Physiology, Laboratory of Experimental Cancerology, Federal University of Piauí, Teresina 64049-550, Brazil; Postgraduate Programs in Pharmaceutical Sciences and Biotechnology, Federal University of Piauí, Teresina 64.049-550, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Stefânia Neiva Lavorato</Name>
        <Affiliation>Department of Pharmaceutical Products, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil; Center of Biological Sciences and Health, Federal University of Western Bahia, Barreiras 47808-021, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Fátima de Cássia Evangelista de Oliveira</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Fortaleza 60430-270, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jurandy do Nascimento Silva</Name>
        <Affiliation>Department of Biophysics and Physiology, Laboratory of Experimental Cancerology, Federal University of Piauí, Teresina 64049-550, Brazil; Postgraduate Programs in Pharmaceutical Sciences and Biotechnology, Federal University of Piauí, Teresina 64.049-550, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Antonia Amanda Cardoso de Almeida</Name>
        <Affiliation>Department of Biophysics and Physiology, Laboratory of Experimental Cancerology, Federal University of Piauí, Teresina 64049-550, Brazil; Postgraduate Programs in Pharmaceutical Sciences and Biotechnology, Federal University of Piauí, Teresina 64.049-550, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luciano de Souza Santos</Name>
        <Affiliation>Oswaldo Cruz Foundation, Salvador 40296-710, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Valdenizia Rodrigues Silva</Name>
        <Affiliation>Oswaldo Cruz Foundation, Salvador 40296-710, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Pereira Bezerra</Name>
        <Affiliation>Oswaldo Cruz Foundation, Salvador 40296-710, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Milena Botelho Pereira Soares</Name>
        <Affiliation>Oswaldo Cruz Foundation, Salvador 40296-710, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cláudia Pessoa</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Fortaleza 60430-270, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Manoel Odorico de Moraes Filho</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Fortaleza 60430-270, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>José Roberto de Oliveira Ferreira</Name>
        <Affiliation>School of Medical Sciences, State University of Alagoas, Maceió 57010-382, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>João Marcelo de Castro E. Sousa</Name>
        <Affiliation>Postgraduate Programs in Pharmaceutical Sciences and Biotechnology, Federal University of Piauí, Teresina 64.049-550, Brazil; Department of Biology, Federal University of Piauí, Picos, Piauí 64067-670, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Vinícius Gonçalves Maltarollo</Name>
        <Affiliation>Department of Pharmaceutical Products, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ricardo José Alves</Name>
        <Affiliation>Department of Pharmaceutical Products, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low concentrations of lead decrease the sperm fertilization ability by altering the acrosome reaction in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31356930</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30302-3</DOI>
    <KeywordList>
      <Keywords>Acrosome reaction</Keywords>
      <Keywords>Actin polymerization</Keywords>
      <Keywords>Capacitation</Keywords>
      <Keywords>Fertilization</Keywords>
      <Keywords>Lead</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yazmín Godínez-Solís</Name>
        <Affiliation>Toxicology Department, Cinvestav, Mexico City, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>María de Jesúa Solís-Heredia</Name>
        <Affiliation>Toxicology Department, Cinvestav, Mexico City, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Roa-Espitia</Name>
        <Affiliation>Cell Biology Department, Cinvestav, Mexico City, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Lyda Yuliana Parra-Forero</Name>
        <Affiliation>Toxicology Department, Cinvestav, Mexico City, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Enrique O. Hernández-González</Name>
        <Affiliation>Cell Biology Department, Cinvestav, Mexico City, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Isabel Hernández-Ochoa</Name>
        <Affiliation>Toxicology Department, Cinvestav, Mexico City, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Betzabet Quintanilla-Vega</Name>
        <Affiliation>Toxicology Department, Cinvestav, Mexico City, Mexico. Electronic address: mquintan@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cypermethrin exposure reduces the ovarian reserve by causing mitochondrial dysfunction in granulosa cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31351989</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30301-1</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cypermethrin</Keywords>
      <Keywords>Granulosa cell</Keywords>
      <Keywords>Mitochondrial dysfunction</Keywords>
      <Keywords>Ovarian reserve</Keywords>
      <Keywords>Ovotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Huiyuan Wang</Name>
        <Affiliation>State Key Laboratory of Reproductive Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Jiangsu Women and Children Health Hospital, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuheng He</Name>
        <Affiliation>State Key Laboratory of Reproductive Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Jiangsu Women and Children Health Hospital, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Donger Cheng</Name>
        <Affiliation>State Key Laboratory of Reproductive Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Jiangsu Women and Children Health Hospital, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Danhua Pu</Name>
        <Affiliation>State Key Laboratory of Reproductive Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Jiangsu Women and Children Health Hospital, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rongrong Tan</Name>
        <Affiliation>State Key Laboratory of Reproductive Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Jiangsu Women and Children Health Hospital, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Gao</Name>
        <Affiliation>State Key Laboratory of Reproductive Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Jiangsu Women and Children Health Hospital, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yugui Cui</Name>
        <Affiliation>State Key Laboratory of Reproductive Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Jiangsu Women and Children Health Hospital, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Wu</Name>
        <Affiliation>State Key Laboratory of Reproductive Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Jiangsu Women and Children Health Hospital, Nanjing, China. Electronic address: wujiemd@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Akt and Notch pathways mediate polyhexamethylene guanidine phosphate-induced epithelial-mesenchymal transition via ZEB2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31348943</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30299-6</DOI>
    <KeywordList>
      <Keywords>Akt</Keywords>
      <Keywords>Epithelial-mesenchymal transition</Keywords>
      <Keywords>Notch</Keywords>
      <Keywords>PHMG-p</Keywords>
      <Keywords>ZEB2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mi Ho Jeong</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do 16419, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ha Ryong Kim</Name>
        <Affiliation>College of Pharmacy, Daegu Catholic University, Gyeongsan, Gyeongsangbuk-do 38430, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Joo Park</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do 16419, Republic of Korea. Electronic address: pyj084@skku.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Kyu Hyuck Chung</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do 16419, Republic of Korea. Electronic address: khchung@skku.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Edaravone presents antidepressant-like activity in corticosterone model of depression in mice with possible role of Fkbp5, Comt, Adora1 and Slc6a15 genes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31344373</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30297-2</DOI>
    <KeywordList>
      <Keywords>Antioxidants</Keywords>
      <Keywords>Chronic stress</Keywords>
      <Keywords>Depression</Keywords>
      <Keywords>Edaravone</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mariola Herbet</Name>
        <Affiliation>Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland. Electronic address: mariola.herbet@umlub.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Dorota Natorska-Chomicka</Name>
        <Affiliation>Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Marta Ostrowska</Name>
        <Affiliation>Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Monika Gawrońska-Grzywacz</Name>
        <Affiliation>Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Magdalena Izdebska</Name>
        <Affiliation>Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Iwona Piątkowska-Chmiel</Name>
        <Affiliation>Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Agnieszka Korga</Name>
        <Affiliation>Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Andrzej Wróbel</Name>
        <Affiliation>Second Department of Gynecology, Medical University of Lublin, Jaczewskiego 8 Street, 20-090 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Jarosław Dudka</Name>
        <Affiliation>Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicokinetics and bioavailability of sulfolane, a ground water contaminant, following oral and intravenous administration in rodents: A dose, species, and sex comparison.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31344372</pubmedLink>
    <GrantList>
      <Grant>HHSN273201400004C</Grant>
      <Grant>HHSN273201400022C</Grant>
      <Grant>ZIA ES103316</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30298-4</DOI>
    <KeywordList>
      <Keywords>Bioavailability</Keywords>
      <Keywords>Rodents</Keywords>
      <Keywords>Sulfolane</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suramya Waidyanatha</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America. Electronic address: waidyanathas@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Sherry R. Black</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy R. Fennell</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Scott L. Watson</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Purvi R. Patel</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen D. Cooper</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>James Blake</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Veronica Godfrey Robinson</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Reshan A. Fernando</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Chad R. Blystone</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Andrographolide triggers autophagy-mediated inflammation inhibition and attenuates chronic unpredictable mild stress (CUMS)-induced depressive-like behavior in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31340160</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30296-0</DOI>
    <KeywordList>
      <Keywords>Andrographolide</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Depression</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>NLRP3 inflammasome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ji Geng</Name>
        <Affiliation>Department of Pharmacology and Laboratory of Aging and Nervous Diseases, Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases, School of Pharmaceutical Sciences, Soochow University, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Liu</Name>
        <Affiliation>Department of Clinical Pharmacy, Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Yuan</Name>
        <Affiliation>Pathology Department, The first affiliated hospital of Soochow university, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Liu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, 210093 Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjie Guo</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, 210093 Nanjing, China. Electronic address: guowj@nju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Influence of AS3MT polymorphisms on arsenic metabolism and liver injury in APL patients treated with arsenic trioxide.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31330140</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30295-9</DOI>
    <KeywordList>
      <Keywords>AS3MT polymorphism</Keywords>
      <Keywords>Acute promyelocytic leukemia</Keywords>
      <Keywords>Arsenic metabolism</Keywords>
      <Keywords>Arsenic trioxide</Keywords>
      <Keywords>Liver injury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Lu</Name>
        <Affiliation>Department of Pharmacy, the First Affiliated Hospital, Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kaijiang Yu</Name>
        <Affiliation>Department of Critical Care Medicine, the First Affiliated Hospital, Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengjin Fan</Name>
        <Affiliation>Department of Hematology, the First Affiliated Hospital, Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wensheng Liu</Name>
        <Affiliation>Department of Pharmacy, the First Affiliated Hospital, Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zengxiang Dong</Name>
        <Affiliation>Department of Pharmacy, the First Affiliated Hospital, Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Li</Name>
        <Affiliation>Department of Pharmacy, the First Affiliated Hospital, Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinyu Wang</Name>
        <Affiliation>Department of Pharmacy, the First Affiliated Hospital, Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Hai</Name>
        <Affiliation>Department of Pharmacy, the First Affiliated Hospital, Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, China. Electronic address: hai_xin@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Zhou</Name>
        <Affiliation>Department of Hematology, the First Affiliated Hospital, Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, China. Electronic address: zj_hmu@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Daily ascending dosing in cynomolgus monkeys to mitigate cytokine release syndrome induced by ERY22, surrogate for T-cell redirecting bispecific antibody ERY974 for cancer immunotherapy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31326447</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30265-0</DOI>
    <KeywordList>
      <Keywords>Bispecific Antibody</Keywords>
      <Keywords>CD3</Keywords>
      <Keywords>Cynomolgus Monkey</Keywords>
      <Keywords>Cytokine Release Syndrome (CRS)</Keywords>
      <Keywords>GPC3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yoshika Iwata</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masanori Sasaki</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Asako Harada</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Junko Taketo</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshiko Hara</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Sho Akai</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takahiro Ishiguro</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Atsushi Narita</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akihisa Kaneko</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masayuki Mishima</Name>
        <Affiliation>Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan. Electronic address: mishimamsy@chugai-pharm.co.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicogenomic analyses of the effects of BDE-47/209, TBBPA/S and TCBPA on early neural development with a human embryonic stem cell in vitro differentiation system.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31326446</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30293-5</DOI>
    <KeywordList>
      <Keywords>BDE-47/209</Keywords>
      <Keywords>Developmental neural toxicity</Keywords>
      <Keywords>Human embryonic stem cells</Keywords>
      <Keywords>TBBPA/S</Keywords>
      <Keywords>TCBPA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shengxian Liang</Name>
        <Affiliation>State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China; College of Resources and Environment, University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaojun Liang</Name>
        <Affiliation>State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China; College of Resources and Environment, University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Nuoya Yin</Name>
        <Affiliation>State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China; College of Resources and Environment, University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bowen Hu</Name>
        <Affiliation>State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China; College of Resources and Environment, University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Francesco Faiola</Name>
        <Affiliation>State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China; College of Resources and Environment, University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address: faiola@rcees.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification of potential endocrine disrupting chemicals using gene expression biomarkers.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31325560</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30291-1</DOI>
    <KeywordList>
      <Keywords>Androgen receptor</Keywords>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Endocrine disrupting chemicals</Keywords>
      <Keywords>Estrogen receptor</Keywords>
      <Keywords>Nuclear receptors</Keywords>
      <Keywords>Toxicogenomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Christopher Corton</Name>
        <Affiliation>Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, 109 T.W. Alexander Dr, MD-B105-03, NC 27711, United States. Electronic address: corton.chris@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole C. Kleinstreuer</Name>
        <Affiliation>National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States. Electronic address: nicole.kleinstreuer@nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Richard S. Judson</Name>
        <Affiliation>National Center for Computational Toxicology, US Environmental Protection Agency, Research Triangle Park, NC, United States. Electronic address: Judson.richard@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evidence that melatonin downregulates Nedd4-1 E3 ligase and its role in cellular survival.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31325559</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30294-7</DOI>
    <KeywordList>
      <Keywords>Melatonin</Keywords>
      <Keywords>Nedd4-1</Keywords>
      <Keywords>Proteasome</Keywords>
      <Keywords>Proteomic</Keywords>
      <Keywords>Ubiquitin</Keywords>
      <Keywords>Ubiquitin proteosome system</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Esra Yalcin</Name>
        <Affiliation>Istanbul Medipol University, School of Medicine, Dept. of Physiology, Istanbul, Turkey; Istanbul Medipol University, Regenerative and Restorative Medical Research Center, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Mustafa C. Beker</Name>
        <Affiliation>Istanbul Medipol University, School of Medicine, Dept. of Physiology, Istanbul, Turkey; Istanbul Medipol University, Regenerative and Restorative Medical Research Center, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Seyma Turkseven</Name>
        <Affiliation>Istanbul Medipol University, Regenerative and Restorative Medical Research Center, Istanbul, Turkey; Imperial College London, Division of Computational and Systems Medicine, Dept. of Surgery and Cancer, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Berrak Caglayan</Name>
        <Affiliation>Istanbul Medipol University, Regenerative and Restorative Medical Research Center, Istanbul, Turkey; Istanbul Medipol University, International School of Medicine, Dept. of Medical Biology, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Busra Gurel</Name>
        <Affiliation>Acibadem Mehmet Ali Aydinlar University, School of Medicine, Dept. of Medical Biochemistry, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ulkan Kilic</Name>
        <Affiliation>University of Health Sciences, School of Medicine, Dept. of Medical Biology, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmet B. Caglayan</Name>
        <Affiliation>Istanbul Medipol University, Regenerative and Restorative Medical Research Center, Istanbul, Turkey; Istanbul Medipol University, International School of Medicine, Dept. of Physiology, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Rabia Kalkan</Name>
        <Affiliation>University of Health Sciences, School of Medicine, Dept. of Medical Biology, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmet T. Baykal</Name>
        <Affiliation>Acibadem Mehmet Ali Aydinlar University, School of Medicine, Dept. of Medical Biochemistry, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Taha Kelestemur</Name>
        <Affiliation>Istanbul Medipol University, School of Medicine, Dept. of Physiology, Istanbul, Turkey; Istanbul Medipol University, Regenerative and Restorative Medical Research Center, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ertugrul Kilic</Name>
        <Affiliation>Istanbul Medipol University, School of Medicine, Dept. of Physiology, Istanbul, Turkey; Istanbul Medipol University, Regenerative and Restorative Medical Research Center, Istanbul, Turkey. Electronic address: ekilic@medipol.edu.tr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reproductive toxicity of acute Cd exposure in mouse: Resulting in oocyte defects and decreased female fertility.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31325558</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30292-3</DOI>
    <KeywordList>
      <Keywords>Epigenetic modification</Keywords>
      <Keywords>Heavy metal pollution</Keywords>
      <Keywords>Oocyte quality</Keywords>
      <Keywords>Oxidation stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuyao Cheng</Name>
        <Affiliation>College of Veterinary Medicine, Northwest A&amp;F University, Yangling, Shaanxi Province 712100, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Zhang</Name>
        <Affiliation>Academy of Animal Science and Veterinary Medicine, Qinghai University, Xining, Qinghai Province 810003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Teng Wu</Name>
        <Affiliation>College of Veterinary Medicine, Northwest A&amp;F University, Yangling, Shaanxi Province 712100, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xianlei Jiang</Name>
        <Affiliation>College of Veterinary Medicine, Northwest A&amp;F University, Yangling, Shaanxi Province 712100, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Huiqun Jia</Name>
        <Affiliation>College of Veterinary Medicine, Northwest A&amp;F University, Yangling, Shaanxi Province 712100, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Suzhu Qing</Name>
        <Affiliation>College of Veterinary Medicine, Northwest A&amp;F University, Yangling, Shaanxi Province 712100, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Quanli An</Name>
        <Affiliation>College of Veterinary Medicine, Northwest A&amp;F University, Yangling, Shaanxi Province 712100, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Zhang</Name>
        <Affiliation>College of Veterinary Medicine, Northwest A&amp;F University, Yangling, Shaanxi Province 712100, PR China. Electronic address: zhangyong1956@nwsuaf.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jianmin Su</Name>
        <Affiliation>College of Veterinary Medicine, Northwest A&amp;F University, Yangling, Shaanxi Province 712100, PR China. Electronic address: sujm@nwafu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Determination of chemical-disease risk values to prioritize connections between environmental factors, genetic variants, and human diseases.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31323264</pubmedLink>
    <GrantList>
      <Grant>T32 ES007046</Grant>
      <Grant>P30 ES025128</Grant>
      <Grant>R01 CA161608</Grant>
      <Grant>R835802</Grant>
      <Grant>R56 ES030007</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30282-0</DOI>
    <KeywordList>
      <Keywords>Data integration</Keywords>
      <Keywords>Gene-environment interactions</Keywords>
      <Keywords>New approach methodologies</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marissa B. Kosnik</Name>
        <Affiliation>Toxicology Program, North Carolina State University, Raleigh, NC 27695-7617, United States of America; Bioinformatics Research Center, North Carolina State University, Raleigh, NC 27695-7617, United States of America; Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695-7617, United States of America. Electronic address: mbkosnik@ncsu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>David M. Reif</Name>
        <Affiliation>Toxicology Program, North Carolina State University, Raleigh, NC 27695-7617, United States of America; Bioinformatics Research Center, North Carolina State University, Raleigh, NC 27695-7617, United States of America; Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695-7617, United States of America; Center for Human Health and the Environment, North Carolina State University, Raleigh, NC 27695-7617, United States of America. Electronic address: dmreif@ncsu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tadalafil restores long-term memory and synaptic plasticity in mice with hepatic encephalopathy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31323263</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30281-9</DOI>
    <KeywordList>
      <Keywords>Hepatic encephalopathy</Keywords>
      <Keywords>Learning and memory</Keywords>
      <Keywords>Neuroinflammation</Keywords>
      <Keywords>PDE5 inhibitor</Keywords>
      <Keywords>Synaptic plasticity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maria Eduarda Rocha França</Name>
        <Affiliation>Laboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Recife, Pernambuco, Brazil; Postgraduate Program in Biological Sciences (PPGCB), Federal University of Pernambuco Recife, Pernambuco, Brazil. Electronic address: mariaeduarda.rfranca@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Renata Kelly Luna Gomes Ramos</Name>
        <Affiliation>Laboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Wilma Helena Oliveira</Name>
        <Affiliation>Laboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Recife, Pernambuco, Brazil; Postgraduate Program in Biological Sciences (PPGCB), Federal University of Pernambuco Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo Duarte-Silva</Name>
        <Affiliation>Laboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Recife, Pernambuco, Brazil; Postgraduate Program in Biosciences and Biotechnology for Health (PPGBBS), Oswaldo Cruz Foundation (FIOCRUZ-PE)/ Aggeu Magalhães Institute (IAM), Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Shyrlene Meyre Rocha Araújo</Name>
        <Affiliation>Laboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Recife, Pernambuco, Brazil; Postgraduate Program in Biological Sciences (PPGCB), Federal University of Pernambuco Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Deniele Bezerra Lós</Name>
        <Affiliation>Laboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Recife, Pernambuco, Brazil; Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Christina Alves Peixoto</Name>
        <Affiliation>Laboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Recife, Pernambuco, Brazil; Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Electronic address: cpeixoto@cpqam.fiocruz.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Untargeted liquid chromatography-mass spectrometry metabolomics to assess drug-induced cholestatic features in HepaRG® cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31323262</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30274-1</DOI>
    <KeywordList>
      <Keywords>Bosentan</Keywords>
      <Keywords>Drug-induced cholestasis</Keywords>
      <Keywords>HepaRG</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Liquid chromatography-mass spectrometry</Keywords>
      <Keywords>Metabolomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Matthias Cuykx</Name>
        <Affiliation>Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium; Research group In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Jette, Belgium. Electronic address: Matthias.Cuykx@uantwerpen.be.</Affiliation>
      </Author>
      <Author>
        <Name>Charlie Beirnaert</Name>
        <Affiliation>Department of Mathematics &amp; Computer Science, University of Antwerp, Middelheimlaan 1, 2020 Antwerp, Belgium; Biomedical Informatics Network Antwerpen (Biomina), University of Antwerp, Middelheimlaan 1, 2020 Antwerp, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Robim M. Rodrigues</Name>
        <Affiliation>Research group In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Jette, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Kris Laukens</Name>
        <Affiliation>Department of Mathematics &amp; Computer Science, University of Antwerp, Middelheimlaan 1, 2020 Antwerp, Belgium; Biomedical Informatics Network Antwerpen (Biomina), University of Antwerp, Middelheimlaan 1, 2020 Antwerp, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Tamara Vanhaecke</Name>
        <Affiliation>Research group In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Jette, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Adrian Covaci</Name>
        <Affiliation>Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium. Electronic address: Adrian.Covaci@uantwerpen.be.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective effect of sestrin2 against iron overload and ferroptosis-induced liver injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31323261</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30273-X</DOI>
    <KeywordList>
      <Keywords>Ferroptosis</Keywords>
      <Keywords>Hepatocytes</Keywords>
      <Keywords>Liver injury</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Sestrin2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Su Jung Park</Name>
        <Affiliation>College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea; National Development Institute of Korean Medicine, Jangheung, Jeollanam-do 59338, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sam Seok Cho</Name>
        <Affiliation>College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyu Min Kim</Name>
        <Affiliation>College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Hye Yang</Name>
        <Affiliation>College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea; College of Korean Medicine, Dongshin University, Naju, Jeollanam-do 58245, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Hoon Kim</Name>
        <Affiliation>College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Hee Jeong</Name>
        <Affiliation>College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Won Yang</Name>
        <Affiliation>College of Pharmacy, Woosuk University, Wanju, Jeonbuk 55338, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Yeob Han</Name>
        <Affiliation>Department of Pharmacology, School of Medicine, Wonkwang University, Iksan, Jeonbuk 54538, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sae Kwang Ku</Name>
        <Affiliation>HCLD-RC, College of Korean Medicine, Daegu Haany University, Gyeongsan, Gyeongsangbuk-do 38610, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Il Je Cho</Name>
        <Affiliation>HCLD-RC, College of Korean Medicine, Daegu Haany University, Gyeongsan, Gyeongsangbuk-do 38610, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Hwan Ki</Name>
        <Affiliation>College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea. Electronic address: shki@chosun.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Altered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31306673</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30272-8</DOI>
    <KeywordList>
      <Keywords>Bile acid</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>NASH</Keywords>
      <Keywords>Transporter</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Takahiro Suga</Name>
        <Affiliation>Graduate School of Pharmaceutical Sciences, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroaki Yamaguchi</Name>
        <Affiliation>Graduate School of Pharmaceutical Sciences, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan; Department of Pharmaceutical Sciences, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan; Faculty of Pharmaceutical Sciences, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan. Electronic address: hiroaki.yamaguchi@med.id.yamagata-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Jiro Ogura</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Saori Shoji</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masamitsu Maekawa</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nariyasu Mano</Name>
        <Affiliation>Graduate School of Pharmaceutical Sciences, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan; Department of Pharmaceutical Sciences, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan; Faculty of Pharmaceutical Sciences, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan. Electronic address: mano@hosp.tohoku.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31301315</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30270-4</DOI>
    <KeywordList>
      <Keywords>Bufalin</Keywords>
      <Keywords>EGFR</Keywords>
      <Keywords>Ku70</Keywords>
      <Keywords>MCL-1</Keywords>
      <Keywords>Non-small cell lung cancer (NSCLC)</Keywords>
      <Keywords>Osimertinib</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fei Cao</Name>
        <Affiliation>Department of Oncology, the First Affiliated Hospital of Xinxiang Medical University, 88 JianKang Road, Xinxiang 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Bin Gong</Name>
        <Affiliation>Department of Oncology, Yueyang Hospital, Shanghai University of Traditional Chinese Medicine, No.110 Ganhe Road, Shanghai 200437, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Hong Kang</Name>
        <Affiliation>Department of Oncology, the First Affiliated Hospital of Xinxiang Medical University, 88 JianKang Road, Xinxiang 453003, China. Electronic address: kxhhgd@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Hong Lu</Name>
        <Affiliation>Department of Oncology, the First Affiliated Hospital of Xinxiang Medical University, 88 JianKang Road, Xinxiang 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Wang</Name>
        <Affiliation>Department of Oncology, the First Affiliated Hospital of Xinxiang Medical University, 88 JianKang Road, Xinxiang 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Lei Zhao</Name>
        <Affiliation>Department of Oncology, the First Affiliated Hospital of Xinxiang Medical University, 88 JianKang Road, Xinxiang 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhan Hui Miao</Name>
        <Affiliation>Department of Oncology, the First Affiliated Hospital of Xinxiang Medical University, 88 JianKang Road, Xinxiang 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Juan Liao</Name>
        <Affiliation>Department of Traditionl Chinese Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No.639 Zhizaoju Road, Shanghai 200011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Ye Xu</Name>
        <Affiliation>Department of Oncology, Longhua Hospital Affiliated to Shanghai University of TCM, No.725 Wanping South Road, Shanghai 200032, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>IFN-α-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31299271</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30258-3</DOI>
    <KeywordList>
      <Keywords>Hypertriglyceridemia</Keywords>
      <Keywords>Lipid metabolism</Keywords>
      <Keywords>Lipids</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Metabolic syndrome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ariel D. Quiroga</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE), Facultad de Ciencias Bioquímicas y Farmacéuticas, CONICET, UNR, Rosario, Argentina; Área Morfología, Facultad de Ciencias Bioquímicas y Farmacéuticas, UNR, Rosario, Argentina; CAECIHS, Universidad Abierta Interamericana, Rosario, Argentina. Electronic address: quiroga@ifise-conicet.gov.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Carla G. Comanzo</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE), Facultad de Ciencias Bioquímicas y Farmacéuticas, CONICET, UNR, Rosario, Argentina. Electronic address: comanzo@ifise-conicet.gov.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Francisco J. Heit Barbini</Name>
        <Affiliation>CAECIHS, Universidad Abierta Interamericana, Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Alvaro Lucci</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE), Facultad de Ciencias Bioquímicas y Farmacéuticas, CONICET, UNR, Rosario, Argentina; Área Morfología, Facultad de Ciencias Bioquímicas y Farmacéuticas, UNR, Rosario, Argentina. Electronic address: lucci@ifise-conicet.gov.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Marina C. Vera</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE), Facultad de Ciencias Bioquímicas y Farmacéuticas, CONICET, UNR, Rosario, Argentina. Electronic address: vera@ifise-conicet.gov.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Florencia Lorenzetti</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE), Facultad de Ciencias Bioquímicas y Farmacéuticas, CONICET, UNR, Rosario, Argentina. Electronic address: lorenzetti@ifise-conicet.gov.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Anabela C. Ferretti</Name>
        <Affiliation>Área Morfología, Facultad de Ciencias Bioquímicas y Farmacéuticas, UNR, Rosario, Argentina. Electronic address: ferretti@ifise-conicet.gov.ar.</Affiliation>
      </Author>
      <Author>
        <Name>María P. Ceballos</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE), Facultad de Ciencias Bioquímicas y Farmacéuticas, CONICET, UNR, Rosario, Argentina. Electronic address: ceballos@ifise-conicet.gov.ar.</Affiliation>
      </Author>
      <Author>
        <Name>María De L. Alvarez</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE), Facultad de Ciencias Bioquímicas y Farmacéuticas, CONICET, UNR, Rosario, Argentina; Área Morfología, Facultad de Ciencias Bioquímicas y Farmacéuticas, UNR, Rosario, Argentina; CAECIHS, Universidad Abierta Interamericana, Rosario, Argentina. Electronic address: alvarez@ifise-conicet.gov.ar.</Affiliation>
      </Author>
      <Author>
        <Name>María C. Carrillo</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE), Facultad de Ciencias Bioquímicas y Farmacéuticas, CONICET, UNR, Rosario, Argentina; Área Morfología, Facultad de Ciencias Bioquímicas y Farmacéuticas, UNR, Rosario, Argentina. Electronic address: carrillo@ifise-conicet.gov.ar.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Interaction of swine organic anion transporting polypeptide 1a2 with tetracycline, macrolide and β-lactam antibiotics.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31287969</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30257-1</DOI>
    <KeywordList>
      <Keywords>Macrolides</Keywords>
      <Keywords>Organic anion transporting polypeptides</Keywords>
      <Keywords>Pig</Keywords>
      <Keywords>Tetracyclines</Keywords>
      <Keywords>β-Lactams</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xunkai Lin</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhaojian Xiang</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Wang</Name>
        <Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Chen</Name>
        <Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tong Zhou</Name>
        <Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Hong</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China; Guangdong Provincial Key Laboratory of Protein Function and Regulation in Agricultural Organisms, South China Agricultural University, Guangzhou, China. Electronic address: mh2788@scau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>ROS -mediated p53 activation by juglone enhances apoptosis and autophagy in vivo and in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31283929</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30255-8</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>HepG2 cells</Keywords>
      <Keywords>Juglone</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peng Wang</Name>
        <Affiliation>Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Dong Zhang</Name>
        <Affiliation>Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiao Jiao</Name>
        <Affiliation>Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Wang</Name>
        <Affiliation>Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Yu</Name>
        <Affiliation>Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Lian Zhao</Name>
        <Affiliation>Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Tao Wang</Name>
        <Affiliation>College of Forestry, Beijing Forestry University, Beijing 100083, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Meng</Name>
        <Affiliation>Beijing Advanced Innovation Center for Tree Breeding by Molecular Design, Beijing Forestry University, Beijing 100083, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Jie Fu</Name>
        <Affiliation>Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, PR China; College of Forestry, Beijing Forestry University, Beijing 100083, PR China; Beijing Advanced Innovation Center for Tree Breeding by Molecular Design, Beijing Forestry University, Beijing 100083, PR China. Electronic address: yujie_fu@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Imatinib mesylate effects on zebrafish reproductive success: Gonadal development, gamete quality, fertility, embryo-larvae viability and development, and related genes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31278918</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30253-4</DOI>
    <KeywordList>
      <Keywords>Imatinib</Keywords>
      <Keywords>Reproduction</Keywords>
      <Keywords>Vegfaa</Keywords>
      <Keywords>Zebrafish</Keywords>
      <Keywords>igf2a</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nader Ahmadi</Name>
        <Affiliation>Aquatic Lab, Department of Food Hygiene and Quality Control, Faculty of Veterinary Medicine, Urmia University, Urmia 165, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Seyed Mohammadreza Samaee</Name>
        <Affiliation>Aquatic Lab, Department of Food Hygiene and Quality Control, Faculty of Veterinary Medicine, Urmia University, Urmia 165, Iran. Electronic address: seyedmohammadreza.samaee@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert A. Yokel</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Aliasghar Tehrani</Name>
        <Affiliation>Department of Pathobiology, Faculty of Veterinary Medicine, Urmia University, Urmia 165, Iran.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TET1 regulates DNA repair in human glial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31278917</pubmedLink>
    <GrantList>
      <Grant>T32 ES007141</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30254-6</DOI>
    <KeywordList>
      <Keywords>DNA-PK</Keywords>
      <Keywords>Human glioma</Keywords>
      <Keywords>Ionizing radiation</Keywords>
      <Keywords>Non homologous DNA repair</Keywords>
      <Keywords>TET1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katherine J. Kuhns</Name>
        <Affiliation>Environmental Health Sciences, The Johns Hopkins University Bloomberg School of Public Health, Johns Hopkins School of Medicine, 600 N. Wolfe Street, Baltimore, MD 21287, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hernando Lopez-Bertoni</Name>
        <Affiliation>Department of Neurology, Hugo W. Moser Research Institute at Kennedy Krieger, 707 N. Broadway, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins School of Medicine, 600 N. Wolfe Street, Baltimore, MD 21287, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan B. Coulter</Name>
        <Affiliation>Department of Neurology, Hugo W. Moser Research Institute at Kennedy Krieger, 707 N. Broadway, Baltimore, MD 21205, USA; Environmental Health Sciences, The Johns Hopkins University Bloomberg School of Public Health, Johns Hopkins School of Medicine, 600 N. Wolfe Street, Baltimore, MD 21287, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph P. Bressler</Name>
        <Affiliation>Department of Neurology, Hugo W. Moser Research Institute at Kennedy Krieger, 707 N. Broadway, Baltimore, MD 21205, USA; Environmental Health Sciences, The Johns Hopkins University Bloomberg School of Public Health, Johns Hopkins School of Medicine, 600 N. Wolfe Street, Baltimore, MD 21287, USA. Electronic address: bressler@kennedykrieger.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative mechanisms of PAH toxicity by benzo[a]pyrene and dibenzo[def,p]chrysene in primary human bronchial epithelial cells cultured at air-liquid interface.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31255691</pubmedLink>
    <GrantList>
      <Grant>P42 ES016465</Grant>
      <Grant>T32 ES007060</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30252-2</DOI>
    <KeywordList>
      <Keywords>Benzo[a]pyrene</Keywords>
      <Keywords>Bronchial epithelial cells</Keywords>
      <Keywords>Mixtures</Keywords>
      <Keywords>Organotypic culture</Keywords>
      <Keywords>Polycyclic aromatic hydrocarbons</Keywords>
      <Keywords>Toxicogenomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yvonne Chang</Name>
        <Affiliation>Environmental and Molecular Toxicology Department, Oregon State University, Corvallis, OR, USA; Superfund Research Program, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisbeth K. Siddens</Name>
        <Affiliation>Environmental and Molecular Toxicology Department, Oregon State University, Corvallis, OR, USA; Superfund Research Program, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lauren K. Heine</Name>
        <Affiliation>Environmental and Molecular Toxicology Department, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David A. Sampson</Name>
        <Affiliation>Environmental and Molecular Toxicology Department, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Yu</Name>
        <Affiliation>Environmental and Molecular Toxicology Department, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kay A. Fischer</Name>
        <Affiliation>College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christiane V. Löhr</Name>
        <Affiliation>College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susan C. Tilton</Name>
        <Affiliation>Environmental and Molecular Toxicology Department, Oregon State University, Corvallis, OR, USA; Superfund Research Program, Oregon State University, Corvallis, OR, USA. Electronic address: susan.tilton@oregonstate.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Adoptive transfer of DMSO-induced regulatory T cells exhibits a similar preventive effect compared to an in vivo DMSO treatment for chemical-induced experimental encapsulating peritoneal sclerosis in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31254568</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30249-2</DOI>
    <KeywordList>
      <Keywords>Cell therapy</Keywords>
      <Keywords>Dimethyl sulfoxide (DMSO)</Keywords>
      <Keywords>Encapsulating peritoneal sclerosis (EPS)</Keywords>
      <Keywords>Peritoneal dialysis (PD)</Keywords>
      <Keywords>Th17 cells</Keywords>
      <Keywords>Treg cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gu Jiun Lin</Name>
        <Affiliation>Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Hsiung Wu</Name>
        <Affiliation>Department of General Surgery, En Chu Kong Hospital, New Taipei, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Chiao Chi Yu</Name>
        <Affiliation>Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan, Republic of China; Department of General Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jeng Rong Lin</Name>
        <Affiliation>Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Dong Liu</Name>
        <Affiliation>Department of General Surgery, En Chu Kong Hospital, New Taipei, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Wu Chen</Name>
        <Affiliation>School of Dentistry, National Defense Medical Center, Taipei, Taiwan, Republic of China; Department of Oral and Maxillofacial Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Ming Chang</Name>
        <Affiliation>Department of General Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Jie Hong</Name>
        <Affiliation>Department of General Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Pi Cheng</Name>
        <Affiliation>Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Huey Kang Sytwu</Name>
        <Affiliation>National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Miaoli County, Taiwan, Republic of China; Department of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Shing Hwa Huang</Name>
        <Affiliation>Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan, Republic of China; Department of General Surgery, En Chu Kong Hospital, New Taipei, Taiwan, Republic of China; Department of General Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China. Electronic address: h610129@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>ATPR-induced differentiation and G0/G1 phase arrest in acute promyelocytic leukemia by repressing EBP50/NCF1 complex to promote the production of ROS.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31254567</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30246-7</DOI>
    <KeywordList>
      <Keywords>4-amino-2-trifluoromethyl-phenyl retinate (ATPR)</Keywords>
      <Keywords>Acute promyelocytic leukemia (APL)</Keywords>
      <Keywords>Differentiation</Keywords>
      <Keywords>EBP50</Keywords>
      <Keywords>G0/G1 cell cycle arrest</Keywords>
      <Keywords>NCF1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yubin Feng</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruowen Niu</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Cheng</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Wang</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Du</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqing Peng</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feihu Chen</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei, Anhui, China. Electronic address: cfhchina@sohu.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Amino-terminal region of human organic anion transporting polypeptide 1B1 dictates transporter stability and substrate interaction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31254566</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30250-9</DOI>
    <KeywordList>
      <Keywords>Amino-terminus</Keywords>
      <Keywords>Organic anion transporting polypeptides</Keywords>
      <Keywords>Protein stability</Keywords>
      <Keywords>Transmembrane domains</Keywords>
      <Keywords>Uptake function</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xuyang Wang</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Chen</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaopeng Xu</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China; Guangdong Provincial Key Laboratory of Protein Function and Regulation in Agricultural Organisms, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunxu Ni</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zihui Fang</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Hong</Name>
        <Affiliation>College of Life Sciences, South China Agricultural University, Guangzhou, China; Guangdong Provincial Key Laboratory of Protein Function and Regulation in Agricultural Organisms, South China Agricultural University, Guangzhou, China. Electronic address: mh2788@scau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modeling of antipsychotic-induced metabolic alterations in mice: An experimental approach precluding psychosis as a predisposing factor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31254565</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30251-0</DOI>
    <KeywordList>
      <Keywords>Animal model</Keywords>
      <Keywords>Antipsychotics</Keywords>
      <Keywords>Metabolic syndrome</Keywords>
      <Keywords>Olanzapine</Keywords>
      <Keywords>Risperidone</Keywords>
      <Keywords>Weight gain</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Raghunath Singh</Name>
        <Affiliation>Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Study (UGC-CAS), Panjab University, Chandigarh 160014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Yashika Bansal</Name>
        <Affiliation>Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Study (UGC-CAS), Panjab University, Chandigarh 160014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rupinder Kaur Sodhi</Name>
        <Affiliation>Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Study (UGC-CAS), Panjab University, Chandigarh 160014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Priyanka Saroj</Name>
        <Affiliation>Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Study (UGC-CAS), Panjab University, Chandigarh 160014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Bikash Medhi</Name>
        <Affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anurag Kuhad</Name>
        <Affiliation>Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Study (UGC-CAS), Panjab University, Chandigarh 160014, India. Electronic address: anurag_pu@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Icariin protects rotenone-induced neurotoxicity through induction of SIRT3.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31251943</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30247-9</DOI>
    <KeywordList>
      <Keywords>Icariin</Keywords>
      <Keywords>Mitochondrial dysfunction</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>PGC-1α</Keywords>
      <Keywords>SIRT3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ru Zeng</Name>
        <Affiliation>Joint International Research Laboratory of Ethnomedicine, Zunyi Medical University, Zunyi, Guizhou, China; Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xueting Wang</Name>
        <Affiliation>Joint International Research Laboratory of Ethnomedicine, Zunyi Medical University, Zunyi, Guizhou, China; Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Zhou</Name>
        <Affiliation>Joint International Research Laboratory of Ethnomedicine, Zunyi Medical University, Zunyi, Guizhou, China; Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaolong Fu</Name>
        <Affiliation>Joint International Research Laboratory of Ethnomedicine, Zunyi Medical University, Zunyi, Guizhou, China; Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Wu</Name>
        <Affiliation>Joint International Research Laboratory of Ethnomedicine, Zunyi Medical University, Zunyi, Guizhou, China; Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanfu Lu</Name>
        <Affiliation>Joint International Research Laboratory of Ethnomedicine, Zunyi Medical University, Zunyi, Guizhou, China; Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingshan Shi</Name>
        <Affiliation>Joint International Research Laboratory of Ethnomedicine, Zunyi Medical University, Zunyi, Guizhou, China; Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Klaunig</Name>
        <Affiliation>Department of Environmental Health, Indiana University, Bloomington, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shaoyu Zhou</Name>
        <Affiliation>Joint International Research Laboratory of Ethnomedicine, Zunyi Medical University, Zunyi, Guizhou, China; Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China; Department of Environmental Health, Indiana University, Bloomington, IN, USA. Electronic address: szhou@zmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prediction of maternal and foetal exposures to perfluoroalkyl compounds in a Spanish birth cohort using toxicokinetic modelling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31251942</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30248-0</DOI>
    <KeywordList>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>In utero</Keywords>
      <Keywords>PBPK model</Keywords>
      <Keywords>PFAS</Keywords>
      <Keywords>Pregnancy</Keywords>
      <Keywords>Reverse dosimetry</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Céline Brochot</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), Unité Modèles pour l'Ecotoxicologie et la Toxicologie (METO), Parc ALATA BP2, 60550 Verneuil en Halatte, France. Electronic address: celine.brochot@ineris.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Maribel Casas</Name>
        <Affiliation>ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública (CIBERESP), Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Cyntia Manzano-Salgado</Name>
        <Affiliation>ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública (CIBERESP), Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Florence A. Zeman</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), Unité Modèles pour l'Ecotoxicologie et la Toxicologie (METO), Parc ALATA BP2, 60550 Verneuil en Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Schettgen</Name>
        <Affiliation>Institute for Occupational Medicine, RWTH Aachen University, Aachen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martine Vrijheid</Name>
        <Affiliation>ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública (CIBERESP), Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Frédéric Y. Bois</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), Unité Modèles pour l'Ecotoxicologie et la Toxicologie (METO), Parc ALATA BP2, 60550 Verneuil en Halatte, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bakuchiol suppresses oestrogen/testosterone-induced Benign Prostatic Hyperplasia development through up-regulation of epithelial estrogen receptor β and down-regulation of stromal aromatase.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31238046</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30245-5</DOI>
    <KeywordList>
      <Keywords>Aromatase</Keywords>
      <Keywords>Bakuchiol (Ba)</Keywords>
      <Keywords>Benign Prostatic Hyperplasia (BPH)</Keywords>
      <Keywords>Estrogen Receptor β (ERβ)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lin Miao</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; Laboratory of Pharmacology of TCM Formulae Co-Constructed by the Province-Ministry, Tianjin University of TCM, Tianjin 300193, China. Electronic address: mmmlin@tjutcm.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Chanyuan Jiao</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Shao</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; Laboratory of Pharmacology of TCM Formulae Co-Constructed by the Province-Ministry, Tianjin University of TCM, Tianjin 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaxin Qi</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; Laboratory of Pharmacology of TCM Formulae Co-Constructed by the Province-Ministry, Tianjin University of TCM, Tianjin 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guanwei Fan</Name>
        <Affiliation>Laboratory of Pharmacology of TCM Formulae Co-Constructed by the Province-Ministry, Tianjin University of TCM, Tianjin 300193, China; First teaching hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojiang Li</Name>
        <Affiliation>First teaching hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuefei Wang</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhu</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; Laboratory of Pharmacology of TCM Formulae Co-Constructed by the Province-Ministry, Tianjin University of TCM, Tianjin 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ju Zhang</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, College of Life Sciences, and Bioactive Materials Key Lab of Ministry of Education (J.Z.), Nankai University, Tianjin 300071, China. Electronic address: zhangju@nankai.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiumei Gao</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; Laboratory of Pharmacology of TCM Formulae Co-Constructed by the Province-Ministry, Tianjin University of TCM, Tianjin 300193, China. Electronic address: gaoxiumei@tjutcm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developing novel in vitro methods for the risk assessment of developmental and placental toxicants in the environment.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31233757</pubmedLink>
    <GrantList>
      <Grant>P30 ES010126</Grant>
      <Grant>P42 ES005948</Grant>
      <Grant>T32 ES007126</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30243-1</DOI>
    <KeywordList>
      <Keywords>Alternative methods</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Environmental chemicals</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Placenta</Keywords>
      <Keywords>Pregnancy</Keywords>
      <Keywords>Prenatal exposure</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rebecca C. Fry</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; The Institute for Environmental Health Solutions, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Curriculum in Toxicology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jacqueline Bangma</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Szilagyi</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julia E. Rager</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; The Institute for Environmental Health Solutions, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Curriculum in Toxicology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: jrager@unc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dietary administration of black raspberries modulates arsenic biotransformation and reduces urinary 8-oxo-2'-deoxyguanosine in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31229487</pubmedLink>
    <GrantList>
      <Grant>R01 ES024950</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30241-8</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Biotransformation</Keywords>
      <Keywords>Black raspberry</Keywords>
      <Keywords>Diet</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pengcheng Tu</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jingchuan Xue</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoming Bian</Name>
        <Affiliation>Department of Environmental Health Sciences, University of Georgia, Athens, GA 30602, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Chi</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Bei Gao</Name>
        <Affiliation>Department of Environmental Health Sciences, University of Georgia, Athens, GA 30602, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jiapeng Leng</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Hongyu Ru</Name>
        <Affiliation>Department of Population Health and Pathobiology, North Carolina State University, Raleigh, NC 27607, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas J. Knobloch</Name>
        <Affiliation>Division of Environmental Health Sciences, College of Public Health, Ohio State University, Columbus, OH 43210, United States of America; Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher M. Weghorst</Name>
        <Affiliation>Division of Environmental Health Sciences, College of Public Health, Ohio State University, Columbus, OH 43210, United States of America; Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, United States of America. Electronic address: weghorst.2@osu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Kun Lu</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States of America. Electronic address: kunlu@unc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Potent antitumor activity of Laccaic acid and Phenethyl isothiocyanate combination in colorectal cancer via dual inhibition of DNA methyltransferase-1 and Histone deacetylase-1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31228495</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30239-X</DOI>
    <KeywordList>
      <Keywords>Colorectal cancer</Keywords>
      <Keywords>DNA methyltransferase inhibitor 1</Keywords>
      <Keywords>Epigenetic therapy</Keywords>
      <Keywords>Histone methyltransferase inhibitor 1</Keywords>
      <Keywords>Laccaic acid</Keywords>
      <Keywords>Phenethyl isothiocyanate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Riya Gupta</Name>
        <Affiliation>Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai, India.</Affiliation>
      </Author>
      <Author>
        <Name>Lokesh Kumar Bhatt</Name>
        <Affiliation>Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai, India. Electronic address: lokesh.bhatt@bncp.ac.in.</Affiliation>
      </Author>
      <Author>
        <Name>Munira Momin</Name>
        <Affiliation>Department of Pharmaceutics, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Molecular and epigenetic mechanisms of Cr(VI)-induced carcinogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31228494</pubmedLink>
    <GrantList>
      <Grant>P30 ES000260</Grant>
      <Grant>R01 ES022935</Grant>
      <Grant>R01 ES023174</Grant>
      <Grant>R01 ES026138</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30244-3</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Cr(VI)</Keywords>
      <Keywords>Epigenetic</Keywords>
      <Keywords>Mechanism</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qiao Yi Chen</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, 341 East 25 Street, New York, NY 10016, United States of America. Electronic address: qyc203@nyu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony Murphy</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, 341 East 25 Street, New York, NY 10016, United States of America. Electronic address: ajm911@nyu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Sun</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, 341 East 25 Street, New York, NY 10016, United States of America. Electronic address: hong.sun@nyumc.org.</Affiliation>
      </Author>
      <Author>
        <Name>Max Costa</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, 341 East 25 Street, New York, NY 10016, United States of America. Electronic address: Max.Costa@nyumc.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Transcriptomic points-of-departure from short-term exposure studies are protective of chronic effects for fish exposed to estrogenic chemicals.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31226361</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30242-X</DOI>
    <KeywordList>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Ecological risk assessment</Keywords>
      <Keywords>Endocrine disruptors</Keywords>
      <Keywords>Genomic dose-response study</Keywords>
      <Keywords>Transcriptomic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Florence Pagé-Larivière</Name>
        <Affiliation>National Wildlife Research Center, Environment and Climate Change Canada, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Doug Crump</Name>
        <Affiliation>National Wildlife Research Center, Environment and Climate Change Canada, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jason M. O'Brien</Name>
        <Affiliation>National Wildlife Research Center, Environment and Climate Change Canada, Ontario, Canada. Electronic address: jason.obrien@canada.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Contact allergen (PPD and DNCB)-induced keratinocyte sensitization is partly mediated through a low molecular weight hyaluronan (LMWHA)/TLR4/NF-κB signaling axis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31226360</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30240-6</DOI>
    <KeywordList>
      <Keywords>Allergic Contact Dermatitis</Keywords>
      <Keywords>Hyaluronan</Keywords>
      <Keywords>Hyaluronan Synthases</Keywords>
      <Keywords>Keratinocyte Sensitization</Keywords>
      <Keywords>Signal Transduction</Keywords>
      <Keywords>Toll-Like Receptor 4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rafaela Maria Kavasi</Name>
        <Affiliation>Laboratory of Anatomy-Histology-Embryology, School of Medicine, University of Crete, Heraklion, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Aikaterini Berdiaki</Name>
        <Affiliation>Laboratory of Anatomy-Histology-Embryology, School of Medicine, University of Crete, Heraklion, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Ioanna Spyridaki</Name>
        <Affiliation>Laboratory of Anatomy-Histology-Embryology, School of Medicine, University of Crete, Heraklion, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Antonis Papoutsidakis</Name>
        <Affiliation>Laboratory of Anatomy-Histology-Embryology, School of Medicine, University of Crete, Heraklion, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Emanuela Corsini</Name>
        <Affiliation>Laboratory of Toxicology, ESP, Università degli Studi di Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Aristidis Tsatsakis</Name>
        <Affiliation>Department of Forensic Sciences and Toxicology, University of Crete, Heraklion, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>George N. Tzanakakis</Name>
        <Affiliation>Laboratory of Anatomy-Histology-Embryology, School of Medicine, University of Crete, Heraklion, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Dragana Nikitovic</Name>
        <Affiliation>Laboratory of Anatomy-Histology-Embryology, School of Medicine, University of Crete, Heraklion, Greece. Electronic address: nikitovic@uoc.gr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Predicting estrogen receptor binding of chemicals using a suite of in silico methods - Complementary approaches of (Q)SAR, molecular docking and molecular dynamics.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31220507</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30238-8</DOI>
    <KeywordList>
      <Keywords>Estrogen receptor</Keywords>
      <Keywords>In Silico</Keywords>
      <Keywords>Low-mode molecular dynamics simulation</Keywords>
      <Keywords>Molecular docking</Keywords>
      <Keywords>QSAR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. V. Cotterill</Name>
        <Affiliation>Fera Science Limited, Sand Hutton, York YO41 1LZ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>L. Palazzolo</Name>
        <Affiliation>Università degli Studi di Milano, Dipartimento di Scienze Farmacologiche e Biomolecolari, Via Balzaretti 9, 20133 Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>C. Ridgway</Name>
        <Affiliation>Fera Science Limited, Sand Hutton, York YO41 1LZ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>N. Price</Name>
        <Affiliation>Fera Science Limited, Sand Hutton, York YO41 1LZ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>E. Rorije</Name>
        <Affiliation>Centre for Safety of Substances and Products, National Institute for Public Health and Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>A. Moretto</Name>
        <Affiliation>Università degli Studi di Milano, Dipartimento di Scienze Biomediche e Cliniche, Ospedale L. Sacco, Padiglione 17, Via G.B. Grassi 74, 20157 Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>A. Peijnenburg</Name>
        <Affiliation>Wageningen University &amp; Research, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>I. Eberini</Name>
        <Affiliation>Università degli Studi di Milano, Dipartimento di Scienze Farmacologiche e Biomolecolari &amp; DSRC, Via Balzaretti 9, 20133 Milano, Italy. Electronic address: ivano.eberini@unimi.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prenatal and ancestral exposure to di(2-ethylhexyl) phthalate alters gene expression and DNA methylation in mouse ovaries.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31211961</pubmedLink>
    <GrantList>
      <Grant>F31 ES030467</Grant>
      <Grant>P01 ES022848</Grant>
      <Grant>T32 ES007326</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30237-6</DOI>
    <KeywordList>
      <Keywords>DEHP</Keywords>
      <Keywords>Endocrine disruptor</Keywords>
      <Keywords>Methylation</Keywords>
      <Keywords>Ovary</Keywords>
      <Keywords>Transgenerational</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Saniya Rattan</Name>
        <Affiliation>Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Hannah K. Beers</Name>
        <Affiliation>Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Athilakshmi Kannan</Name>
        <Affiliation>Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Anujaianthi Ramakrishnan</Name>
        <Affiliation>Department of Bioengineering, College of Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Emily Brehm</Name>
        <Affiliation>Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Indrani Bagchi</Name>
        <Affiliation>Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph M. K. Irudayaraj</Name>
        <Affiliation>Department of Bioengineering, College of Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jodi A. Flaws</Name>
        <Affiliation>Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America. Electronic address: jflaws@illinois.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Alpha-linolenic acid based nano-suspension protect against lipopolysaccharides induced mastitis by inhibiting NFκBp65, HIF-1α, and mitochondria-mediated apoptotic pathway in albino Wistar rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31207257</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30236-4</DOI>
    <KeywordList>
      <Keywords>Alpha-linolenic acid</Keywords>
      <Keywords>Hypoxia</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Lipopolysaccharides</Keywords>
      <Keywords>Mastitis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rajnish Kumar Yadav</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University, (A Central University), Vidya vihar, Raebareli road, Lucknow 226 025, UP, India.</Affiliation>
      </Author>
      <Author>
        <Name>Chandra Bhusan Tripathi</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University, (A Central University), Vidya vihar, Raebareli road, Lucknow 226 025, UP, India.</Affiliation>
      </Author>
      <Author>
        <Name>Shubhini A. Saraf</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University, (A Central University), Vidya vihar, Raebareli road, Lucknow 226 025, UP, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mohd Nazam Ansari</Name>
        <Affiliation>Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Abdulaziz S. Saeedan</Name>
        <Affiliation>Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Sara Aldosary</Name>
        <Affiliation>Department of Pharmaceutical Sciences, King Faisal University, Al-Ahsa, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Paruvathanahalli S. Rajinikanth</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University, (A Central University), Vidya vihar, Raebareli road, Lucknow 226 025, UP, India.</Affiliation>
      </Author>
      <Author>
        <Name>Gaurav Kaithwas</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University, (A Central University), Vidya vihar, Raebareli road, Lucknow 226 025, UP, India. Electronic address: gauravk@bbau.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Realgar and cinnabar are essential components contributing to neuroprotection of Angong Niuhuang Wan with no hepatorenal toxicity in transient ischemic brain injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31207256</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30215-7</DOI>
    <KeywordList>
      <Keywords>Angong Niuhuang Wan</Keywords>
      <Keywords>Cerebral ischemia-reperfusion injury</Keywords>
      <Keywords>Cinnabar</Keywords>
      <Keywords>Heavy metal toxicity</Keywords>
      <Keywords>Realgar</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bun Tsoi</Name>
        <Affiliation>School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Songlin Wang</Name>
        <Affiliation>School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chong Gao</Name>
        <Affiliation>School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunhao Luo</Name>
        <Affiliation>School of Biomedical Science, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenting Li</Name>
        <Affiliation>School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Yang</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, The University of Hong Kong, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Depo Yang</Name>
        <Affiliation>School of Pharmaceutical Science, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiangang Shen</Name>
        <Affiliation>School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China. Electronic address: shenjg@hkucc.hku.hk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neurostatin and other O-acetylated gangliosides show anti-neuroinflammatory activity involving the NFκB pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31202640</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30235-2</DOI>
    <KeywordList>
      <Keywords>Anti-inflammatory</Keywords>
      <Keywords>Gangliosides</Keywords>
      <Keywords>Lipopolysaccharide</Keywords>
      <Keywords>Microglia</Keywords>
      <Keywords>Neuroinflammation</Keywords>
      <Keywords>Neurostatin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Natalia Yanguas-Casás</Name>
        <Affiliation>Departamento de Neurobiología Funcional y de Sistemas, Instituto Cajal, Madrid, Spain; Unidad de Investigación, Hospital Nacional de Parapléjicos, SESCAM, Toledo, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Cristina Ojalvo-Sanz</Name>
        <Affiliation>Departamento de Neurobiología Funcional y de Sistemas, Instituto Cajal, Madrid, Spain; Facultad de Ciencias Ambientales, Universidad de Castilla-La Mancha, Toledo, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Aroa Martínez-Vázquez</Name>
        <Affiliation>Departamento de Neurobiología Funcional y de Sistemas, Instituto Cajal, Madrid, Spain; Facultad de Biología, Universidad de Alcalá, Alcalá de Henares, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Marie France Goneau</Name>
        <Affiliation>Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Michel Gilbert</Name>
        <Affiliation>Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Manuel Nieto-Sampedro</Name>
        <Affiliation>Departamento de Neurobiología Funcional y de Sistemas, Instituto Cajal, Madrid, Spain; Unidad de Investigación, Hospital Nacional de Parapléjicos, SESCAM, Toledo, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Lorenzo Romero-Ramírez</Name>
        <Affiliation>Unidad de Investigación, Hospital Nacional de Parapléjicos, SESCAM, Toledo, Spain. Electronic address: lromeroramirez@sescam.jccm.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel oleanolic acid derivative HA-19 ameliorates muscle atrophy via promoting protein synthesis and preventing protein degradation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31201822</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30233-9</DOI>
    <KeywordList>
      <Keywords>HA-19</Keywords>
      <Keywords>Muscle atrophy</Keywords>
      <Keywords>Muscle regeneration</Keywords>
      <Keywords>Protein degradation</Keywords>
      <Keywords>Protein synthesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Cui</Name>
        <Affiliation>State Key Laboratory of Analytical Chemistry for Life Science, Collaborative Innovation Center of Chemistry for Life Sciences, Jiangsu Key Laboratory of Advanced Organic Materials, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Xi Liu</Name>
        <Affiliation>State Key Laboratory of Analytical Chemistry for Life Science, Collaborative Innovation Center of Chemistry for Life Sciences, Jiangsu Key Laboratory of Advanced Organic Materials, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Chao Zhang</Name>
        <Affiliation>State Key Laboratory of Analytical Chemistry for Life Science, Collaborative Innovation Center of Chemistry for Life Sciences, Jiangsu Key Laboratory of Advanced Organic Materials, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Shen</Name>
        <Affiliation>State Key Laboratory of Analytical Chemistry for Life Science, Collaborative Innovation Center of Chemistry for Life Sciences, Jiangsu Key Laboratory of Advanced Organic Materials, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Hua Feng</Name>
        <Affiliation>The Center of Diagnosis and Treatment for Joint Disease, Drum Tower Hospital Affiliated to Medical School of Nanjing University, Nanjing 210008, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Wang</Name>
        <Affiliation>State Key Laboratory of Analytical Chemistry for Life Science, Collaborative Innovation Center of Chemistry for Life Sciences, Jiangsu Key Laboratory of Advanced Organic Materials, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sheng Feng Lu</Name>
        <Affiliation>Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Wu</Name>
        <Affiliation>State Key Laboratory of Analytical Chemistry for Life Science, Collaborative Innovation Center of Chemistry for Life Sciences, Jiangsu Key Laboratory of Advanced Organic Materials, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China. Electronic address: wujnju@nju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Xin Li</Name>
        <Affiliation>State Key Laboratory of Analytical Chemistry for Life Science, Collaborative Innovation Center of Chemistry for Life Sciences, Jiangsu Key Laboratory of Advanced Organic Materials, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China. Electronic address: lijxnju@nju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Microcystin-LR promotes necroptosis in primary mouse hepatocytes by overproducing reactive oxygen species.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31201821</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30234-0</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cyanbacteria</Keywords>
      <Keywords>Eutrophication</Keywords>
      <Keywords>Liver injury</Keywords>
      <Keywords>Microcystins</Keywords>
      <Keywords>Necroptosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yun Li Wu</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yun He</Name>
        <Affiliation>Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Jian Shi</Name>
        <Affiliation>Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tian Xiu Zheng</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Jian Lin</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Lin</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China. Electronic address: linxu@mail.fjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of intestinal microbiota-mediated genipin dialdehyde intermediate formation in geniposide-induced hepatotoxicity in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31199932</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30232-7</DOI>
    <KeywordList>
      <Keywords>Covalent Binding</Keywords>
      <Keywords>Dialdehyde Intermediate</Keywords>
      <Keywords>Genipin</Keywords>
      <Keywords>Geniposide</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Protein Adducts</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yi Li</Name>
        <Affiliation>Department of Pharmacology, Key Laboratory of Basic Pharmacology of Ministry of Education &amp; Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Pan</Name>
        <Affiliation>Department of clinical pharmacy, Zunyi Medical University, Zunyi 563003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaobing Li</Name>
        <Affiliation>Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang 110004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Neng Jiang</Name>
        <Affiliation>Department of Pharmacy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Linyan Huang</Name>
        <Affiliation>Department of clinical pharmacy, Zunyi Medical University, Zunyi 563003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanfu Lu</Name>
        <Affiliation>Department of Pharmacology, Key Laboratory of Basic Pharmacology of Ministry of Education &amp; Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563003, China. Electronic address: luyuanfu2000@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fuguo Shi</Name>
        <Affiliation>Department of Pharmacology, Key Laboratory of Basic Pharmacology of Ministry of Education &amp; Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563003, China. Electronic address: fuguoshi@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Receptor-binding affinities of bisphenol A and its next-generation analogs for human nuclear receptors.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31195007</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30212-1</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Endocrine-disruption effects</Keywords>
      <Keywords>NextGen bisphenols</Keywords>
      <Keywords>Nuclear receptors</Keywords>
      <Keywords>Receptor-binding assay</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaohui Liu</Name>
        <Affiliation>Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Science, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan; Risk Science Research Center, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan. Electronic address: xiaohuiscc@kyudai.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroki Sakai</Name>
        <Affiliation>Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Science, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mitsuhiro Nishigori</Name>
        <Affiliation>Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Science, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Keitaro Suyama</Name>
        <Affiliation>Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Science, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tasuku Nawaji</Name>
        <Affiliation>Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Science, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shin Ikeda</Name>
        <Affiliation>Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Science, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Nishigouchi</Name>
        <Affiliation>Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Science, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroyuki Okada</Name>
        <Affiliation>Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Science, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ayami Matsushima</Name>
        <Affiliation>Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Science, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan; Risk Science Research Center, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeru Nose</Name>
        <Affiliation>Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Science, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan; Risk Science Research Center, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Miki Shimohigashi</Name>
        <Affiliation>Division of Biology, Department of Earth System of Science, Faculty of Science, Fukuoka University, Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan; Risk Science Research Institute, Ikimatsudai 3-7-5, Nishi-ku, Fukuoka 819-0044, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuyuki Shimohigashi</Name>
        <Affiliation>Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Science, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan; Risk Science Research Center, Kyushu University, Motooka 744, Nishi-ku, Fukuoka 819-0395, Japan; Risk Science Research Institute, Ikimatsudai 3-7-5, Nishi-ku, Fukuoka 819-0044, Japan. Electronic address: shimo@kyudai.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative proteomics reveals concordant and discordant biochemical effects of caffeine versus epigallocatechin-3-gallate in human endothelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31195006</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30229-7</DOI>
    <KeywordList>
      <Keywords>Cellular response</Keywords>
      <Keywords>Coffee</Keywords>
      <Keywords>Epigallocatechin-3-gallate</Keywords>
      <Keywords>Polyphenol</Keywords>
      <Keywords>Proteome</Keywords>
      <Keywords>Tea</Keywords>
      <Keywords>Vascular biology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chanettee Chanthick</Name>
        <Affiliation>Medical Proteomics Unit, Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Visith Thongboonkerd</Name>
        <Affiliation>Medical Proteomics Unit, Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Electronic address: thongboonkerd@dr.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Targeted metabolome analysis of the dog brain exposed to PCBs suggests inhibition of oxidative phosphorylation by hydroxylated PCBs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31195005</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30228-5</DOI>
    <KeywordList>
      <Keywords>Brain</Keywords>
      <Keywords>Dog</Keywords>
      <Keywords>Hydroxylated PCBs</Keywords>
      <Keywords>Metabolome</Keywords>
      <Keywords>OXPHOS</Keywords>
      <Keywords>Urea cycle</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kei Nomiyama</Name>
        <Affiliation>Center for Marine Environmental Studies (CMES), Ehime University, Bunkyo-cho 2-5, Matsuyama, Ehime 790-8577, Japan. Electronic address: keinomi@agr.ehime-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Akifumi Eguchi</Name>
        <Affiliation>Chiba University, Center for Preventive Medical Sciences, Inage-ku Yayoi-cho 1, -33 Chiba-city, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kohki Takaguchi</Name>
        <Affiliation>Center for Marine Environmental Studies (CMES), Ehime University, Bunkyo-cho 2-5, Matsuyama, Ehime 790-8577, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Yoo</Name>
        <Affiliation>Environmental Health Research Department, National Institute of Environmental Research, Incheon 404-708, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hazuki Mizukawa</Name>
        <Affiliation>Laboratory of Environmental Analytical Chemistry, Department of Science and Technology for Biological Resources and Environment, Graduate School of Agriculture, Ehime University, Tarumi 3-5-7, Matsuyama, Ehime 790-8566, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoko Oshihoi</Name>
        <Affiliation>Center for Marine Environmental Studies (CMES), Ehime University, Bunkyo-cho 2-5, Matsuyama, Ehime 790-8577, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shinsuke Tanabe</Name>
        <Affiliation>Center for Marine Environmental Studies (CMES), Ehime University, Bunkyo-cho 2-5, Matsuyama, Ehime 790-8577, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hisato Iwata</Name>
        <Affiliation>Center for Marine Environmental Studies (CMES), Ehime University, Bunkyo-cho 2-5, Matsuyama, Ehime 790-8577, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developmental exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) selectively decreases brain dopamine levels in Northern leopard frogs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31195004</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30231-5</DOI>
    <KeywordList>
      <Keywords>Dopamine</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Per- and polyfluoroalkyl substances</Keywords>
      <Keywords>Perfluorooctane sulfonate</Keywords>
      <Keywords>Perfluorooctanoic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rachel M. Foguth</Name>
        <Affiliation>School of Health Sciences, Purdue University, West Lafayette, IN 47907, United States of America; Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN 47907, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>R. Wesley Flynn</Name>
        <Affiliation>Department of Forestry and Natural Resources, Purdue University, West Lafayette, IN 47907, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Chloe de Perre</Name>
        <Affiliation>Department of Agronomy, Purdue University, West Lafayette, IN 47907, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Iacchetta</Name>
        <Affiliation>Department of Forestry and Natural Resources, Purdue University, West Lafayette, IN 47907, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Linda S. Lee</Name>
        <Affiliation>Department of Agronomy, Purdue University, West Lafayette, IN 47907, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Maria S. Sepúlveda</Name>
        <Affiliation>Department of Forestry and Natural Resources, Purdue University, West Lafayette, IN 47907, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jason R. Cannon</Name>
        <Affiliation>School of Health Sciences, Purdue University, West Lafayette, IN 47907, United States of America; Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN 47907, United States of America. Electronic address: cannonjr@purdue.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Polycyclic aromatic hydrocarbons exposure and hematotoxicity in occupational population: A two-year follow-up study.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31195003</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30230-3</DOI>
    <KeywordList>
      <Keywords>8-Hydroxy-2′-deoxyguanosine</Keywords>
      <Keywords>Benzene</Keywords>
      <Keywords>Hematotoxicity</Keywords>
      <Keywords>Polycyclic aromatic hydrocarbons</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yanhua Wang</Name>
        <Affiliation>Key Laboratory of Chemical Safety and Health, National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongwei Zhao</Name>
        <Affiliation>Laigang Hospital Affiliated to Taishan Medical University, Laiwu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Wang</Name>
        <Affiliation>Key Laboratory of Chemical Safety and Health, National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuling Liu</Name>
        <Affiliation>Laigang Hospital Affiliated to Taishan Medical University, Laiwu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qianpeng Ji</Name>
        <Affiliation>Key Laboratory of Chemical Safety and Health, National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojun Zhu</Name>
        <Affiliation>Key Laboratory of Chemical Safety and Health, National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinfang Sun</Name>
        <Affiliation>Office for Epidemiology, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiqi Wang</Name>
        <Affiliation>Office for Epidemiology, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongyan Yao</Name>
        <Affiliation>Office for Epidemiology, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Niu</Name>
        <Affiliation>Key Laboratory of Chemical Safety and Health, National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Jia</Name>
        <Affiliation>Shandong Academy of Medical Sciences, Shandong Academy of Occupational Health and Occupational Medicine, Jinan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenge Su</Name>
        <Affiliation>Laigang Hospital Affiliated to Taishan Medical University, Laiwu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Chen</Name>
        <Affiliation>Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufei Dai</Name>
        <Affiliation>Key Laboratory of Chemical Safety and Health, National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Zhi</Name>
        <Affiliation>Inner Mongolia Center for Disease Control and Prevention, Hohhot, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenrui Wang</Name>
        <Affiliation>Inner Mongolia Center for Disease Control and Prevention, Hohhot, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanbo Li</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Capital Medical University, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ai Gao</Name>
        <Affiliation>Department of Occupational Health and Environmental Health, School of Public Health, Capital Medical University, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huawei Duan</Name>
        <Affiliation>Key Laboratory of Chemical Safety and Health, National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China. Electronic address: duanhw@niohp.chinacdc.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Plasma endoxifen and 4-hydroxytamoxifen levels in CYP2D6(C100T) carrying breast cancer patients and association with serum cholesterol.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31195002</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30221-2</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>CYP2D6(C100T)</Keywords>
      <Keywords>Cholesterol</Keywords>
      <Keywords>Endoxifen</Keywords>
      <Keywords>Metastasis</Keywords>
      <Keywords>Tamoxifen</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ta Chung Chao</Name>
        <Affiliation>Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Chi Pan</Name>
        <Affiliation>Institute of Environmental and Occupational Health Sciences, School of Medicine, National Yang-Ming University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Fang Tsai</Name>
        <Affiliation>Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yueh Ching Chou</Name>
        <Affiliation>Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan; Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Rong Liu</Name>
        <Affiliation>National Research Institute of Chinese Medicine, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Sheng Fan Wang</Name>
        <Affiliation>Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Jen Chen</Name>
        <Affiliation>Division of General Internal Medicine and Geriatrics, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan City, Taiwan; Chang Gung University College of Medicine, Taoyuan City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Pavel Souček</Name>
        <Affiliation>Department of Toxicogenomics, National Institute of Public Health, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Yune Fang Ueng</Name>
        <Affiliation>National Research Institute of Chinese Medicine, Taipei, Taiwan; Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Institute of Biopharmaceutical Sciences, School of Pharmacy, National Yang-Ming University, Taipei, Taiwan; Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan. Electronic address: ueng@nricm.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>NF-κB-regulation of miR-155, via SOCS1/STAT3, is involved in the PM</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31185220</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30218-2</DOI>
    <KeywordList>
      <Keywords>Cell Cycle</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>PM(2.5)</Keywords>
      <Keywords>Proliferation</Keywords>
      <Keywords>miRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tian Xiao</Name>
        <Affiliation>Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, PR China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Ling</Name>
        <Affiliation>Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Xu</Name>
        <Affiliation>Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, PR China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Luo</Name>
        <Affiliation>Faculty of Public Health, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Junchao Xue</Name>
        <Affiliation>Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, PR China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Chen</Name>
        <Affiliation>Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, PR China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Bai</Name>
        <Affiliation>School of Public Health, Southwest Medical University, Luzhou 646000, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingbi Zhang</Name>
        <Affiliation>School of Public Health, Southwest Medical University, Luzhou 646000, Sichuan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Wang</Name>
        <Affiliation>Faculty of Public Health, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Bian</Name>
        <Affiliation>Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu 210009, China. Electronic address: bianqian@jscdc.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Qizhan Liu</Name>
        <Affiliation>Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, PR China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, PR China. Electronic address: drqzliu@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Phenanthrene, but not its isomer anthracene, effectively activates both human and mouse nuclear receptor constitutive androstane receptor (CAR) and induces hepatotoxicity in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31181217</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30220-0</DOI>
    <KeywordList>
      <Keywords>Constitutive Androstane Receptor (CAR)</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Phenanthrene</Keywords>
      <Keywords>Polycyclic Aromatic Hydrocarbons (PAHs)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Han Yang</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Shi</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Xiao Wang</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Cheng</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Lu</Name>
        <Affiliation>Department of Anorectal Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiayin Zhu</Name>
        <Affiliation>Laboratory of Animal Center, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenhai Deng</Name>
        <Affiliation>Zhejiang Provincial Key Laboratory for Technology and Application of Model Organisms, Key Laboratory of Laboratory Medicine, Ministry of Education of China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuyao Zeng</Name>
        <Affiliation>Wenzhou Institute of Industry and Science, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Yang Zhao</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Yun Zhang</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. Electronic address: shuyunzh@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Overexpression of hsa-miR-186 induces chromosomal instability in arsenic-exposed human keratinocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31176655</pubmedLink>
    <GrantList>
      <Grant>R01 ES027778</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30216-9</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Chromosomal Instability</Keywords>
      <Keywords>Keratinocytes</Keywords>
      <Keywords>Skin Cancer</Keywords>
      <Keywords>miR-186</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiguo Wu</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, USA; Department of Environmental Health Science, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ana P. Ferragut Cardoso</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vanessa A. R. States</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laila Al-Eryani</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Doll</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra S. Wise</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shesh N. Rai</Name>
        <Affiliation>Biostatisitcs and Bioinformatics Shared Facility, JGB Cancer Center and Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Christopher States</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, USA. Electronic address: jcstates@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31176654</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30213-3</DOI>
    <KeywordList>
      <Keywords>Cyp2e1 Activity</Keywords>
      <Keywords>Hepatocellular Carcinoma</Keywords>
      <Keywords>Liver Fibrosis</Keywords>
      <Keywords>Proliferation</Keywords>
      <Keywords>Reactive Oxygen Species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sergio Fuentes-Hernández</Name>
        <Affiliation>Laboratorio de Enfermedades Hepáticas, Instituto Nacional de Medicina Genómica, CDMX, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Brisa Rodope Alarcón-Sánchez</Name>
        <Affiliation>Laboratorio de Enfermedades Hepáticas, Instituto Nacional de Medicina Genómica, CDMX, Mexico; Departamento de Biología Celular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, CDMX, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Dafne Guerrero-Escalera</Name>
        <Affiliation>Laboratorio de Enfermedades Hepáticas, Instituto Nacional de Medicina Genómica, CDMX, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Alexia Viridiana Montes-Aparicio</Name>
        <Affiliation>Laboratorio de Enfermedades Hepáticas, Instituto Nacional de Medicina Genómica, CDMX, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>María Paulette Castro-Gil</Name>
        <Affiliation>Laboratorio de Enfermedades Hepáticas, Instituto Nacional de Medicina Genómica, CDMX, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Osiris Germán Idelfonso-García</Name>
        <Affiliation>Laboratorio de Enfermedades Hepáticas, Instituto Nacional de Medicina Genómica, CDMX, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra Rosas-Madrigal</Name>
        <Affiliation>Laboratorio de Enfermedades Cardiovasculares, Instituto Nacional de Medicina Genómica, CDMX, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Diana Ivette Aparicio-Bautista</Name>
        <Affiliation>Unidad de Proteómica, Instituto Nacional de Medicina Genómica, CDMX, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>José Luis Pérez-Hernández</Name>
        <Affiliation>Servicios de Gastroenterología, Hospital General de México "Dr. Eduardo Liceaga", CDMX, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Karina Reyes-Gordillo</Name>
        <Affiliation>Lipid Research Laboratory, VA Medical Center, and Department of Biochemistry and Molecular Medicine, The George Washington University Medical Center, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Raj Lakshman</Name>
        <Affiliation>Lipid Research Laboratory, VA Medical Center, and Department of Biochemistry and Molecular Medicine, The George Washington University Medical Center, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Verónica Rocío Vásquez-Garzón</Name>
        <Affiliation>Consejo Nacional de Ciencia y Tecnología, CDMX, Mexico; Facultad de Medicina, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca de Juárez, Oax, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Rafael Baltiérrez-Hoyos</Name>
        <Affiliation>Consejo Nacional de Ciencia y Tecnología, CDMX, Mexico; Facultad de Medicina, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca de Juárez, Oax, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Ma de Lourdes López-González</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, CDMX, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Adolfo Sierra-Santoyo</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, CDMX, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Saúl Villa-Treviño</Name>
        <Affiliation>Departamento de Biología Celular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, CDMX, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Julio Isael Pérez-Carreón</Name>
        <Affiliation>Laboratorio de Enfermedades Hepáticas, Instituto Nacional de Medicina Genómica, CDMX, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Jaime Arellanes-Robledo</Name>
        <Affiliation>Laboratorio de Enfermedades Hepáticas, Instituto Nacional de Medicina Genómica, CDMX, Mexico; Consejo Nacional de Ciencia y Tecnología, CDMX, Mexico. Electronic address: jarellanes@inmegen.gob.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson's disease model by activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31176653</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30219-4</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>C. elegans</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Parkinson's disease</Keywords>
      <Keywords>Tricetin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jie Ren</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China. Electronic address: renjie@cczu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Yuan</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenbin Wang</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Meiju Zhang</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qun Wang</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Simin Li</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Zhang</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Kun Hu</Name>
        <Affiliation>School of Pharmaceutical Engineering &amp; Life Science, Changzhou University, Changzhou, Jiangsu 213164, People's Republic of China. Electronic address: hukun@cczu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>HgS and Zuotai differ from HgCl</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31175882</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30217-0</DOI>
    <KeywordList>
      <Keywords>Gut microbiome</Keywords>
      <Keywords>Gut transporter</Keywords>
      <Keywords>HgCl(2)</Keywords>
      <Keywords>HgS</Keywords>
      <Keywords>MeHg</Keywords>
      <Keywords>Zuotai</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bin Bin Zhang</Name>
        <Affiliation>Key Lab for Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine, Zunyi Medical College, Zunyi 563000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Mei Liu</Name>
        <Affiliation>Department of Infectious Diseases, Hospital Affiliated to Guizhou Medical University, No. 4 Beijing Road, Guiyang, Guizhou 550004, China.</Affiliation>
      </Author>
      <Author>
        <Name>An Ling Hu</Name>
        <Affiliation>Key Lab for Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine, Zunyi Medical College, Zunyi 563000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shang Fu Xu</Name>
        <Affiliation>Key Lab for Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine, Zunyi Medical College, Zunyi 563000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Da Fan</Name>
        <Affiliation>Department of Infectious Diseases, Hospital Affiliated to Guizhou Medical University, No. 4 Beijing Road, Guiyang, Guizhou 550004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Liang Cheng</Name>
        <Affiliation>Department of Infectious Diseases, Hospital Affiliated to Guizhou Medical University, No. 4 Beijing Road, Guiyang, Guizhou 550004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cen Li</Name>
        <Affiliation>Qinghai Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining 810008, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Xin Wei</Name>
        <Affiliation>Qinghai Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining 810008, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Liu</Name>
        <Affiliation>Key Lab for Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine, Zunyi Medical College, Zunyi 563000, China. Electronic address: jieliu@zmc.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Icariin protects mouse Leydig cell testosterone synthesis from the adverse effects of di(2-ethylhexyl) phthalate.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31175881</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30214-5</DOI>
    <KeywordList>
      <Keywords>Icariin</Keywords>
      <Keywords>Leydig cells</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Testes</Keywords>
      <Keywords>di(2-Ethylhexyl) Phthalate (DEHP)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiandong Sun</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fuzhou 350122, PR China; Undergraduate Class, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongdi Wang</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fuzhou 350122, PR China; Undergraduate Class, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianmin Lin</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fuzhou 350122, PR China; Undergraduate Class, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Liu</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fuzhou 350122, PR China; Department of Human Anatomy, Histology and Embryology, Fujian Medical University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lixuan Xu</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruimin Lv</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Kaien Mo</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuli Lian</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fuzhou 350122, PR China; Department of Human Anatomy, Histology and Embryology, Fujian Medical University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Meirong Xie</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fuzhou 350122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Songhua Xu</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fuzhou 350122, PR China. Electronic address: schsonghua@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shie Wang</Name>
        <Affiliation>Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fuzhou 350122, PR China; Department of Human Anatomy, Histology and Embryology, Fujian Medical University, Fuzhou 350122, PR China. Electronic address: shiewang@fjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of long-term fluoride exposure on cognitive ability and the underlying mechanisms: Role of autophagy and its association with apoptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31173788</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30210-8</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Fluoride</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>mTOR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guoyu Zhou</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Sha Tang</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Yang</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Niu</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwen Chen</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Xia</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Sumei Wang</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengwei Wang</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Zhao</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Liu</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Pei Li</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Lixin Dong</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Kedi Yang</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Shun Zhang</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China. Electronic address: shunzhang@hust.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Aiguo Wang</Name>
        <Affiliation>Department of Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, People's Republic of China. Electronic address: wangaiguo@mails.tjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhalation toxicity of benzalkonium chloride and triethylene glycol mixture in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31173787</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30211-X</DOI>
    <KeywordList>
      <Keywords>Aerosol particle size</Keywords>
      <Keywords>Benzalkonium chloride</Keywords>
      <Keywords>Bronchoalveolar lavage fluid</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Inhalation toxicity</Keywords>
      <Keywords>Triethylene glycol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Doyoung Kwon</Name>
        <Affiliation>Risk Assessment Division, Environmental Health Research Department, National Institute of Environmental Research, Hwangyong-ro 42, Seogu. Incheon 22689, Republic of Korea. Electronic address: kwondoy@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Taek Kwon</Name>
        <Affiliation>Risk Assessment Division, Environmental Health Research Department, National Institute of Environmental Research, Hwangyong-ro 42, Seogu. Incheon 22689, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yeon Mi Lim</Name>
        <Affiliation>Risk Assessment Division, Environmental Health Research Department, National Institute of Environmental Research, Hwangyong-ro 42, Seogu. Incheon 22689, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ilseob Shim</Name>
        <Affiliation>Risk Assessment Division, Environmental Health Research Department, National Institute of Environmental Research, Hwangyong-ro 42, Seogu. Incheon 22689, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eunji Kim</Name>
        <Affiliation>Risk Assessment Division, Environmental Health Research Department, National Institute of Environmental Research, Hwangyong-ro 42, Seogu. Incheon 22689, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Doo Hee Lee</Name>
        <Affiliation>Environmental Measurement &amp; Analysis Center, National Institute of Environmental Research, Hwangyong-ro 42, Seogu. Incheon 22689, Republic of Korea; Mass Spectrometer Lab, National Instrumentation Center for Environmental Management, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Il Yoon</Name>
        <Affiliation>College of Veterinary Medicine, Kangwon National University, Gangwondaehak-gil 1, Chuncheon-si, Gangwon-do 24341, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Pilje Kim</Name>
        <Affiliation>Risk Assessment Division, Environmental Health Research Department, National Institute of Environmental Research, Hwangyong-ro 42, Seogu. Incheon 22689, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Mi Kim</Name>
        <Affiliation>Risk Assessment Division, Environmental Health Research Department, National Institute of Environmental Research, Hwangyong-ro 42, Seogu. Incheon 22689, Republic of Korea.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31170416</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30209-1</DOI>
    <KeywordList>
      <Keywords>Detoxification</Keywords>
      <Keywords>Drug screening</Keywords>
      <Keywords>Gene therapy</Keywords>
      <Keywords>Glycine N-methyltransferase</Keywords>
      <Keywords>Hepatocellular carcinoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marcelo Chen</Name>
        <Affiliation>Department of Urology, Mackay Memorial Hospital, Taipei, Taiwan; Department of Cosmetic Applications and Management, Mackay Junior College of Medicine, Nursing and Management, Taipei, Taiwan; School of Medicine, Mackay Medical College, New Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Hui Yang</Name>
        <Affiliation>National Mosquito-Borne Diseases Control Research Center, National Health Research Institutes, Miaoli, Taiwan; Master Program of Clinical Pharmacogenomics and Pharmacoproteomics, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Min Chang</Name>
        <Affiliation>Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Chang Tyan</Name>
        <Affiliation>Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Ming Arthur Chen</Name>
        <Affiliation>Master Program of Clinical Pharmacogenomics and Pharmacoproteomics, College of Pharmacy, Taipei Medical University, Taipei, Taiwan. Electronic address: mchen4270@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic-induced metabolic shift triggered by the loss of miR-199a-5p through Sp1-dependent DNA methylation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31170415</pubmedLink>
    <GrantList>
      <Grant>R00 CA215316</Grant>
      <Grant>R01 ES027901</Grant>
      <Grant>P30 ES005605</Grant>
      <Grant>P30 CA086862</Grant>
      <Grant>R01 CA193511</Grant>
      <Grant>R01 ES020868</Grant>
      <Grant>R01 CA232587</Grant>
      <Grant>K02 ES029119</Grant>
      <Grant>K99 CA215316</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30208-X</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>DNA methylation</Keywords>
      <Keywords>Glycolysis</Keywords>
      <Keywords>PKM2</Keywords>
      <Keywords>Sp1</Keywords>
      <Keywords>miR-199a-5p</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun He</Name>
        <Affiliation>Department of Pathology, Anatomy &amp; Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, United States of America. Electronic address: Jun.he@jefferson.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Weitao Liu</Name>
        <Affiliation>Department of Pathology, Nanjing Medical University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Ge</Name>
        <Affiliation>Department of Pathology, Nanjing Medical University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gao Chan Wang</Name>
        <Affiliation>Department of Pathology, Anatomy &amp; Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Vilas Desai</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Shaomin Wang</Name>
        <Affiliation>Department of Pathology, Anatomy &amp; Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Mu</Name>
        <Affiliation>School of Public Health, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Vikas Bhardwaj</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Erin Seifert</Name>
        <Affiliation>Department of Pathology, Anatomy &amp; Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Zhi Liu</Name>
        <Affiliation>Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IW 52242, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Alok Bhushan</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen C. Peiper</Name>
        <Affiliation>Department of Pathology, Anatomy &amp; Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Hua Jiang</Name>
        <Affiliation>Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IW 52242, United States of America. Electronic address: bing-hua-jiang@uiowa.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-monotonic dose-response effects of arsenic on glucose metabolism.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31170414</pubmedLink>
    <GrantList>
      <Grant>R21 CA215591</Grant>
      <Grant>P30 CA125123</Grant>
      <Grant>P30 DK056338</Grant>
      <Grant>P50 CA126752</Grant>
      <Grant>U54 HD083092</Grant>
      <Grant>R01 DK114356</Grant>
      <Grant>UM1 HG006348</Grant>
      <Grant>R01 ES027544</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30207-8</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Dose Effect</Keywords>
      <Keywords>Glucose Metabolism</Keywords>
      <Keywords>Insulin Sensitivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yingyun Gong</Name>
        <Affiliation>Department of Endocrinology and Metabolism, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Medicine-Endocrinology, Baylor College of Medicine, Houston, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jidong Liu</Name>
        <Affiliation>Department of Medicine-Endocrinology, Baylor College of Medicine, Houston, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Yanfeng Xue</Name>
        <Affiliation>Department of Medicine-Endocrinology, Baylor College of Medicine, Houston, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Zhong Zhuang</Name>
        <Affiliation>Department of Medicine-Endocrinology, Baylor College of Medicine, Houston, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Sichong Qian</Name>
        <Affiliation>Department of Medicine-Endocrinology, Baylor College of Medicine, Houston, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjun Zhou</Name>
        <Affiliation>Department of Medicine-Endocrinology, Baylor College of Medicine, Houston, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Li</Name>
        <Affiliation>Department of Medicine-Endocrinology, Baylor College of Medicine, Houston, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Justin Qian</Name>
        <Affiliation>Department of Medicine-Endocrinology, Baylor College of Medicine, Houston, TX, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Guolian Ding</Name>
        <Affiliation>Department of Medicine-Endocrinology, Baylor College of Medicine, Houston, TX, United States of America; The International Peace Maternity and Child Health Hospital, Institute of Embryo-Fetal Original Adult Disease, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: dingguolian@shsmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Sun</Name>
        <Affiliation>Department of Medicine-Endocrinology, Baylor College of Medicine, Houston, TX, United States of America; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States of America. Electronic address: zheng.sun@bcm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of brain SERT with 4-[</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31153898</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30206-6</DOI>
    <KeywordList>
      <Keywords>4-[(18)F]-ADAM</Keywords>
      <Keywords>Dextromethorphan</Keywords>
      <Keywords>Micro-PET</Keywords>
      <Keywords>Noise-Induced Hearing Loss</Keywords>
      <Keywords>SERT</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cheng Tsung Liu</Name>
        <Affiliation>Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan; Department of Pharmacy Practice, Tri-Service General Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuahn Sieh Huang</Name>
        <Affiliation>Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hsin Chien Chen</Name>
        <Affiliation>Department of Otorhinolaryngology-Head and Neck Surgery, Tri-Service General Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Kuo Hsing Ma</Name>
        <Affiliation>Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Hung Wang</Name>
        <Affiliation>Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan; Department of Otorhinolaryngology, Taichung Armed Forces General Hospital, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chuang Hsin Chiu</Name>
        <Affiliation>Department of Nuclear Medicine, Tri-Service General Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Jui Hu Shih</Name>
        <Affiliation>Department of Pharmacy Practice, Tri-Service General Hospital, Taipei, Taiwan; School of Pharmacy, National Defense Medical Center, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hsiao Hsien Kang</Name>
        <Affiliation>Universal Eye Center, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chyng Yann Shiue</Name>
        <Affiliation>Department of Nuclear Medicine, Tri-Service General Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>I. Hsun Li</Name>
        <Affiliation>Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan; Department of Pharmacy Practice, Tri-Service General Hospital, Taipei, Taiwan; School of Pharmacy, National Defense Medical Center, Taipei, Taiwan. Electronic address: lhs01077@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Peroxynitrite contributes to arsenic-induced PARP-1 inhibition through ROS/RNS generation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31152818</pubmedLink>
    <GrantList>
      <Grant>P42 ES025589</Grant>
      <Grant>R01 CA182969</Grant>
      <Grant>R01 ES021100</Grant>
      <Grant>R01 ES029369</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30204-2</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>PARP-1</Keywords>
      <Keywords>Peroxynitrite</Keywords>
      <Keywords>Reactive nitrogen species</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xixi Zhou</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA. Electronic address: xzhou@salud.unm.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofeng Ding</Name>
        <Affiliation>College of Life Science, Hunan Normal University, Changsha, Hunan 410081, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiangang Shen</Name>
        <Affiliation>School of Chinese Medicine, The University of Hong Kong, Pokfulam Road, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Yang</Name>
        <Affiliation>Morningside Laboratory for Chemical Biology and Department of Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Laurie G. Hudson</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Liu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Zinc accumulation in mitochondria promotes ischemia-induced BBB disruption through Drp1-dependent mitochondria fission.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31152817</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30203-0</DOI>
    <KeywordList>
      <Keywords>Blood–Brain Barrier (BBB)</Keywords>
      <Keywords>Fission</Keywords>
      <Keywords>Ischemia/reperfusion</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Reactive Oxygen Species (ROS)</Keywords>
      <Keywords>Zinc</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhifeng Qi</Name>
        <Affiliation>Department of Neurology, Cerebrovascular Diseases Research Institute, Xuanwu hospital of Capital Medical University, 45 Changchun Street, Beijing 100053, China. Electronic address: email_qzf@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjuan Shi</Name>
        <Affiliation>Department of Neurology, Cerebrovascular Diseases Research Institute, Xuanwu hospital of Capital Medical University, 45 Changchun Street, Beijing 100053, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongmei Zhao</Name>
        <Affiliation>Department of Neurology, Cerebrovascular Diseases Research Institute, Xuanwu hospital of Capital Medical University, 45 Changchun Street, Beijing 100053, China. Electronic address: yongmeizhao@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xunming Ji</Name>
        <Affiliation>Department of Neurology, Cerebrovascular Diseases Research Institute, Xuanwu hospital of Capital Medical University, 45 Changchun Street, Beijing 100053, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Liu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of New Mexico, Albuquerque, NM 87131-0001, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Suppression of miR-143 contributes to overexpression of IL-6, HIF-1α and NF-κB p65 in Cr(VI)-induced human exposure and tumor growth.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31152816</pubmedLink>
    <GrantList>
      <Grant>R01 ES027901</Grant>
      <Grant>P30 ES005605</Grant>
      <Grant>P30 CA086862</Grant>
      <Grant>R01 CA193511</Grant>
      <Grant>R01 ES020868</Grant>
      <Grant>R01 CA232587</Grant>
      <Grant>K02 ES029119</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30205-4</DOI>
    <KeywordList>
      <Keywords>Cr (VI)</Keywords>
      <Keywords>IL-6</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Tumor growth</Keywords>
      <Keywords>miR-143</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lin Wang</Name>
        <Affiliation>The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Ge Qiu</Name>
        <Affiliation>The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun He</Name>
        <Affiliation>Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Jing Liu</Name>
        <Affiliation>Department of Oncology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Ge</Name>
        <Affiliation>Department of Pathology, Nanjing Medical University, Nanjing 210000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Mei Zhou</Name>
        <Affiliation>The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Xue Huang</Name>
        <Affiliation>The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Hua Jiang</Name>
        <Affiliation>The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, Henan, China; Department of Pathology, Carver College of Medicine, the University of Iowa, IA 52242, USA. Electronic address: binghjiang@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Zhi Liu</Name>
        <Affiliation>Department of Pathology, Carver College of Medicine, the University of Iowa, IA 52242, USA. Electronic address: Ling-Zhi-Liu@uiowa.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Study on the absorption of corosolic acid in the gastrointestinal tract and its metabolites in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31150656</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30202-9</DOI>
    <KeywordList>
      <Keywords>Corosolic acid</Keywords>
      <Keywords>in situ gastric absorption</Keywords>
      <Keywords>in situ single-pass perfusion</Keywords>
      <Keywords>metabolite identification</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Biying Zhang</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China. Electronic address: 1631020089@stu.cpu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yawen Lu</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China. Electronic address: 1731020066@stu.cpu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Li</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodong Wen</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China. Electronic address: xiaodongwen@cpu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Yang</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China. Electronic address: 1020092098@cpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of isocorynoxeine, from Uncaria, on lower urinary tract dysfunction caused by benign prostatic hyperplasia via antagonism of α</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31145917</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30201-7</DOI>
    <KeywordList>
      <Keywords>Benign prostatic hyperplasia</Keywords>
      <Keywords>Isocorynoxeine</Keywords>
      <Keywords>Lower urinary tract symptoms</Keywords>
      <Keywords>α(1A)-Adrenoceptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ting Li</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University Health Science Center, Xi'an 710061, PR China; Shaanxi Engineering Research Center of Cardiovascular Drugs Screening &amp;Analysis, Xi'an 710061, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Xu</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University Health Science Center, Xi'an 710061, PR China; Shaanxi Engineering Research Center of Cardiovascular Drugs Screening &amp;Analysis, Xi'an 710061, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianyu He</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University Health Science Center, Xi'an 710061, PR China; Shaanxi Engineering Research Center of Cardiovascular Drugs Screening &amp;Analysis, Xi'an 710061, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Nabila Jahan</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University Health Science Center, Xi'an 710061, PR China; Shaanxi Engineering Research Center of Cardiovascular Drugs Screening &amp;Analysis, Xi'an 710061, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Song</Name>
        <Affiliation>Xi'an Jiaotong University, Xi'an 710061, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Sicen Wang</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University Health Science Center, Xi'an 710061, PR China; Shaanxi Engineering Research Center of Cardiovascular Drugs Screening &amp;Analysis, Xi'an 710061, PR China. Electronic address: wangsc@mail.xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The antineoplastic agent anacardic 6-pentadecyl salicylic acid produces immunomodulation in vivo via the activation of MAPKs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31129177</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30194-2</DOI>
    <KeywordList>
      <Keywords>6-Pentadecyl salicylic acid</Keywords>
      <Keywords>Amphipterygium adstringens</Keywords>
      <Keywords>Immune modulation</Keywords>
      <Keywords>MAP kinases</Keywords>
      <Keywords>Macrophages</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. N. Rashida Gnanaprakasam</Name>
        <Affiliation>Department of Toxicology, Centre for Research and Advanced Studies of the National Polytechnic Institute, Av. IPN, 2508, San Pedro Zacatenco, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabet Estrada-Muñiz</Name>
        <Affiliation>Department of Toxicology, Centre for Research and Advanced Studies of the National Polytechnic Institute, Av. IPN, 2508, San Pedro Zacatenco, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Libia Vega</Name>
        <Affiliation>Department of Toxicology, Centre for Research and Advanced Studies of the National Polytechnic Institute, Av. IPN, 2508, San Pedro Zacatenco, Mexico City 07360, Mexico. Electronic address: lvega@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Structure-activity study of acute neurobehavioral effects of cyclohexane, benzene, m-xylene, and toluene in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31128119</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30193-0</DOI>
    <KeywordList>
      <Keywords>Aromatic solvents</Keywords>
      <Keywords>Behavioral effects</Keywords>
      <Keywords>Benzene ring</Keywords>
      <Keywords>Cyclohexane</Keywords>
      <Keywords>Inhalants</Keywords>
      <Keywords>Toluene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Monserrat Armenta-Reséndiz</Name>
        <Affiliation>Departamento de Farmacobiología, Cinvestav, Sede Sur, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Elvira Ríos-Leal</Name>
        <Affiliation>Central Analítica, Departamento de Biotecnología y Bioingeniería, Cinvestav Zacatenco, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>María Teresa Rivera-García</Name>
        <Affiliation>Departamento de Farmacobiología, Cinvestav, Sede Sur, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina López-Rubalcava</Name>
        <Affiliation>Departamento de Farmacobiología, Cinvestav, Sede Sur, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Lorenia Cruz</Name>
        <Affiliation>Departamento de Farmacobiología, Cinvestav, Sede Sur, Ciudad de México, Mexico. Electronic address: slcruzm@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>M10 peptide attenuates silica-induced pulmonary fibrosis by inhibiting Smad2 phosphorylation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31125577</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30192-9</DOI>
    <KeywordList>
      <Keywords>M10 peptide</Keywords>
      <Keywords>Phosphorylation of Smad2</Keywords>
      <Keywords>Pulmonary fibrosis</Keywords>
      <Keywords>Therapy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Li</Name>
        <Affiliation>Centre for Global Health, Department of Occupational Medicine and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, 2111166, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoming Ji</Name>
        <Affiliation>Centre for Global Health, Department of Occupational Medicine and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, 2111166, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenxi Yao</Name>
        <Affiliation>Centre for Global Health, Department of Occupational Medicine and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, 2111166, China; Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Honghong Pan</Name>
        <Affiliation>Centre for Global Health, Department of Occupational Medicine and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, 2111166, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Li</Name>
        <Affiliation>Centre for Global Health, Department of Occupational Medicine and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, 2111166, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Liu</Name>
        <Affiliation>Centre for Global Health, Department of Occupational Medicine and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, 2111166, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiali Yuan</Name>
        <Affiliation>Centre for Global Health, Department of Occupational Medicine and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, 2111166, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Xu</Name>
        <Affiliation>Centre for Global Health, Department of Occupational Medicine and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, 2111166, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunhui Ni</Name>
        <Affiliation>Centre for Global Health, Department of Occupational Medicine and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, 2111166, China. Electronic address: chni@njmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tanshinone prevents alveolar bone loss in ovariectomized osteoporosis rats by up-regulating phosphoglycerate dehydrogenase.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31108107</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30185-1</DOI>
    <KeywordList>
      <Keywords>Aging</Keywords>
      <Keywords>Alveolar bone loss</Keywords>
      <Keywords>Osteoporosis</Keywords>
      <Keywords>Phosphoglycerate dehydrogenase (PHGDH)</Keywords>
      <Keywords>Tanshinone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Luyao Wang</Name>
        <Affiliation>The Center of Stomatology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liangxing Cheng</Name>
        <Affiliation>Editorial Department of Journal of Basic and Clinical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Baixia Zhang</Name>
        <Affiliation>The Center of Stomatology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Nan Wang</Name>
        <Affiliation>Department of Emergency Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China. Electronic address: alpha19820607@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Wang</Name>
        <Affiliation>Department of Orthopaedic Surgery, Shanghai Sixth People's Hospital East Affiliated to Shanghai University of Medicine &amp; Health Sciences, Shanghai 201306, China. Electronic address: fengwang4@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comparison of particulate hexavalent chromium cytotoxicity and genotoxicity in human and leatherback sea turtle lung cells from a one environmental health perspective.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31108106</pubmedLink>
    <GrantList>
      <Grant>R01 ES016893</Grant>
      <Grant>T32 ES011564</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30184-X</DOI>
    <KeywordList>
      <Keywords>Chromate</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Hexavalent chromium</Keywords>
      <Keywords>Leatherback sea turtle</Keywords>
      <Keywords>Marine pollution</Keywords>
      <Keywords>One health</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rachel M. Speer</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra S. Wise</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Tayler J. Croom-Perez</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY 40202, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>AbouEl Makarim Aboueissa</Name>
        <Affiliation>University of Southern Maine, 96 Falmouth St, Portland, ME 04103, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Martin-Bras</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY 40202, United States of America; Vieques Conservation and Historical Trust, 138 Calle Flamboyan, Vieques 00765, Puerto Rico.</Affiliation>
      </Author>
      <Author>
        <Name>Mike Barandiaran</Name>
        <Affiliation>U.S. Fish and Wildlife Service, State Rd 997 km 3.2, Vieques 00765, Puerto Rico.</Affiliation>
      </Author>
      <Author>
        <Name>Erick Bermúdez</Name>
        <Affiliation>U.S. Fish and Wildlife Service, State Rd 997 km 3.2, Vieques 00765, Puerto Rico.</Affiliation>
      </Author>
      <Author>
        <Name>John Pierce Wise</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY 40202, United States of America. Electronic address: john.wise@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Early life exposure of a biocide, CMIT/MIT causes metabolic toxicity via the O-GlcNAc transferase pathway in the nematode C. elegans.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31100289</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30183-8</DOI>
    <KeywordList>
      <Keywords>CMIT/MIT</Keywords>
      <Keywords>Early-life exposure</Keywords>
      <Keywords>Humidifier disinfectant</Keywords>
      <Keywords>Metabolic toxicity</Keywords>
      <Keywords>O-GlcNAc transferase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Youngho Kim</Name>
        <Affiliation>School of Environmental Engineering, University of Seoul, 163 Siripdaero, Dongdaemun-gu, Seoul 02504, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jinhee Choi</Name>
        <Affiliation>School of Environmental Engineering, University of Seoul, 163 Siripdaero, Dongdaemun-gu, Seoul 02504, Republic of Korea. Electronic address: jinhchoi@uos.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative disposition of dimethylaminoethanol and choline in rats and mice following oral or intravenous administration.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31100288</pubmedLink>
    <GrantList>
      <Grant>N01ES75562</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30182-6</DOI>
    <KeywordList>
      <Keywords>Choline</Keywords>
      <Keywords>Dimethylaminoethanol</Keywords>
      <Keywords>Disposition</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>N-N-dimethylnitrosamine</Keywords>
      <Keywords>Tissue distribution</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>K. A. Shipkowski</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>J. M. Sanders</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>J. D. McDonald</Name>
        <Affiliation>Lovelace Biomedical and Environmental Research Institute, Albuquerque, NM, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>C. E. Garner</Name>
        <Affiliation>Lovelace Biomedical and Environmental Research Institute, Albuquerque, NM, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>M. Doyle-Eisele</Name>
        <Affiliation>Lovelace Biomedical and Environmental Research Institute, Albuquerque, NM, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>C. J. Wegerski</Name>
        <Affiliation>Lovelace Biomedical and Environmental Research Institute, Albuquerque, NM, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>S. Waidyanatha</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America. Electronic address: waidyanathas@niehs.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Letter-to-the-editor of toxicology and applied pharmacology about: Chatfield (2018) measurement of elongate mineral particles: What we should measure and how do we do it? Toxicology and applied pharmacology 361, 36-46.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31095965</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30181-4</DOI>
    <AuthorList>
      <Author>
        <Name>R. P. Nolan</Name>
        <Affiliation>Graduate School and University Center, The City University of New York, 365 Fifth Avenue, New York, NY 10016, United States of America. Electronic address: rnolan@gc.cuny.edu.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Langer</Name>
        <Affiliation>Graduate School and University Center, The City University of New York, 365 Fifth Avenue, New York, NY 10016, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>BPDE and B[a]P induce mitochondrial compromise by ROS-mediated suppression of the SIRT1/TERT/PGC-1α pathway in spermatogenic cells both in vitro and in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31085209</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30167-X</DOI>
    <KeywordList>
      <Keywords>Benzo[a]pyrene</Keywords>
      <Keywords>Benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide</Keywords>
      <Keywords>Male reproductive toxicity</Keywords>
      <Keywords>Mitochondrial damage</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wang Yang</Name>
        <Affiliation>Key Lab for the Medical Protection of Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guowei Zhang</Name>
        <Affiliation>Department of Environmental Health, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Jiang</Name>
        <Affiliation>Key Lab for the Medical Protection of Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingfei Zeng</Name>
        <Affiliation>Key Lab for the Medical Protection of Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Zou</Name>
        <Affiliation>Key Lab for the Medical Protection of Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huihui An</Name>
        <Affiliation>Key Lab for the Medical Protection of Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Chen</Name>
        <Affiliation>Key Lab for the Medical Protection of Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xi Ling</Name>
        <Affiliation>Key Lab for the Medical Protection of Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Han</Name>
        <Affiliation>Key Lab for the Medical Protection of Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenbin Liu</Name>
        <Affiliation>Key Lab for the Medical Protection of Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huan Yang</Name>
        <Affiliation>Key Lab for the Medical Protection of Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinyi Liu</Name>
        <Affiliation>Key Lab for the Medical Protection of Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Cao</Name>
        <Affiliation>Key Lab for the Medical Protection of Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Ao</Name>
        <Affiliation>Key Lab for the Medical Protection of Electromagnetic Radiation, Ministry of Education of China, Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China. Electronic address: aolin@tmmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gadolinium-based contrast agents: Stimulators of myeloid-induced renal fibrosis and major metabolic disruptors.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31082427</pubmedLink>
    <GrantList>
      <Grant>I01 BX001958</Grant>
      <Grant>R01 DK102085</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30180-2</DOI>
    <KeywordList>
      <Keywords>Antigens, CD45</Keywords>
      <Keywords>Bone marrow</Keywords>
      <Keywords>CCR2</Keywords>
      <Keywords>Chemokines</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>Gadolinium</Keywords>
      <Keywords>Nephrogenic fibrosing dermopathy</Keywords>
      <Keywords>Renal insufficiency</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Catherine Do</Name>
        <Affiliation>Kidney Institute of New Mexico and the University of New Mexico Department of Medicine, United States of America; New Mexico Veterans Administration Health Care System, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Bridget Ford</Name>
        <Affiliation>University of Texas Health Science Center at San Antonio, United States of America; University of the Incarnate Word, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Doug Yoon Lee</Name>
        <Affiliation>University of Texas Health Science Center at San Antonio, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Chunyan Tan</Name>
        <Affiliation>University of Texas Health Science Center at San Antonio, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Escobar</Name>
        <Affiliation>Kidney Institute of New Mexico and the University of New Mexico Department of Medicine, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Brent Wagner</Name>
        <Affiliation>Kidney Institute of New Mexico and the University of New Mexico Department of Medicine, United States of America; New Mexico Veterans Administration Health Care System, United States of America. Electronic address: BrWagner@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Profiling of differentially expressed genes in cadmium-induced prostate carcinogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31082426</pubmedLink>
    <GrantList>
      <Grant>R01 ES028102</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30177-2</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Differential gene expression</Keywords>
      <Keywords>Enrichment</Keywords>
      <Keywords>KEGG</Keywords>
      <Keywords>Prostate cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Venkatesh Kolluru</Name>
        <Affiliation>Department of Urology, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ashish Tyagi</Name>
        <Affiliation>Department of Urology, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Balaji Chandrasekaran</Name>
        <Affiliation>Department of Urology, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chendil Damodaran</Name>
        <Affiliation>Department of Urology, Louisville, KY, USA. Electronic address: chendil.damodaran@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A whale of a tale: A One Environmental Health approach to study metal pollution in the Sea of Cortez.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31078588</pubmedLink>
    <GrantList>
      <Grant>R01 ES010838</Grant>
      <Grant>R01 ES016893</Grant>
      <Grant>T32 ES011564</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30174-7</DOI>
    <KeywordList>
      <Keywords>Gulf of California</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>One Environmental Health</Keywords>
      <Keywords>Sea of Cortez</Keywords>
      <Keywords>Whales</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John Pierce Wise</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tayler J. Croom-Perez</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Idoia Meaza</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>AbouEl Makarim Aboueissa</Name>
        <Affiliation>Univeristy of Southern Maine, Portland, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos A. López Montalvo</Name>
        <Affiliation>Departamento de Ciencias Marinas y Costeras, Universidad Autónoma de Baja California Sur. La Paz, BCS, México.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Martin-Bras</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel M. Speer</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Bonilla-Garzón</Name>
        <Affiliation>Departamento de Ciencias Marinas y Costeras, Universidad Autónoma de Baja California Sur. La Paz, BCS, México.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Urbán R</Name>
        <Affiliation>Departamento de Ciencias Marinas y Costeras, Universidad Autónoma de Baja California Sur. La Paz, BCS, México.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Perkins</Name>
        <Affiliation>Center for Environmental Sciences and Engineering, University of Connecticut, Storrs, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Pierce Wise</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm 1422, Louisville, KY, USA. Electronic address: John.Wise.Sr@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization and determination of cadmium resistance of CD133</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31078587</pubmedLink>
    <GrantList>
      <Grant>P20 GM103442</Grant>
      <Grant>P20 GM113123</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30176-0</DOI>
    <KeywordList>
      <Keywords>CD133</Keywords>
      <Keywords>CD24</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Kidney</Keywords>
      <Keywords>Regeneration</Keywords>
      <Keywords>Stem cell</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Swojani Shrestha</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States of America. Electronic address: swojani.shrestha@und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Scott H. Garrett</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States of America. Electronic address: scott.garrett@med.und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Donald A. Sens</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States of America. Electronic address: donald.sens@med.und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Dong Zhou</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States of America. Electronic address: xudong.zhou@med.und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel Guyer</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States of America. Electronic address: rachel.guyer@und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Seema Somji</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States of America. Electronic address: seema.somji@med.und.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Review of arsenic toxicity, speciation and polyadenylation of canonical histones.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31077704</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30175-9</DOI>
    <KeywordList>
      <Keywords>Arsenic methylation</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Polyadenylation of canonical histones</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Max Costa</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, 341 East 25th Street, New York, NY 10100, United States of America. Electronic address: max.costa@nyumc.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Glucocorticoid programming mechanism for hypercholesterolemia in prenatal ethanol-exposed adult offspring rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31075344</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30165-6</DOI>
    <KeywordList>
      <Keywords>Glucocorticoid</Keywords>
      <Keywords>Hepatic cholesterol metabolism</Keywords>
      <Keywords>Histone acetylation</Keywords>
      <Keywords>Hypercholesterolemia</Keywords>
      <Keywords>Insulin-like growth factor 1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shuwei Hu</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Qin</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Zhou</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jacques Magdalou</Name>
        <Affiliation>UMR 7561, CNRS-Université de Lorraine, Faculté de Médicine, Vandoeuvre-lès-Nancy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Liaobin Chen</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Xu</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China. Electronic address: xuyidan70188@whu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nectandra grandiflora essential oil and its isolated sesquiterpenoids minimize anxiety-related behaviors in mice through GABAergic mechanisms.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31075342</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30166-8</DOI>
    <KeywordList>
      <Keywords>(+)-dehydrofukinone</Keywords>
      <Keywords>Calcium influx</Keywords>
      <Keywords>Eremophil-11-en-10-ol</Keywords>
      <Keywords>Membrane potential</Keywords>
      <Keywords>Selin-11-en-4-α-ol</Keywords>
      <Keywords>Synaptosome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Quelen Iane Garlet</Name>
        <Affiliation>Post-Graduation Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Patrícia Rodrigues</Name>
        <Affiliation>Post-Graduation Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luísa Barichello Barbosa</Name>
        <Affiliation>Pharmacy Graduation Course, Federal University of Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>André Luís Londero</Name>
        <Affiliation>Medicine Graduation Course, Federal University of Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos Fernando Mello</Name>
        <Affiliation>Post-Graduation Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil; Medicine Graduation Course, Federal University of Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Berta Maria Heinzmann</Name>
        <Affiliation>Post-Graduation Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil; Pharmacy Graduation Course, Federal University of Santa Maria, Santa Maria, RS, Brazil. Electronic address: berta.heinzmann@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The interaction of Hemin and Sestrin2 modulates oxidative stress and colon tumor growth.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31054940</pubmedLink>
    <GrantList>
      <Grant>K01 DK114390</Grant>
      <Grant>K12 GM088021</Grant>
      <Grant>P30 CA118100</Grant>
      <Grant>P42 ES025589</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30163-2</DOI>
    <KeywordList>
      <Keywords>Colorectal cancer</Keywords>
      <Keywords>Hemin</Keywords>
      <Keywords>Nuclear factor (erythroid-derived 2)-like 2</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Sestrin2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyeoncheol Kim</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM 87131, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Kunlun Yin</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM 87131, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel M. Falcon</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM 87131, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Xiang Xue</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM 87131, United States of America. Electronic address: xxue@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Alpha ketoglutarate exerts a pro-osteogenic effect in osteoblast cell lines through activation of JNK and mTOR/S6K1/S6 signaling pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31051157</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30162-0</DOI>
    <KeywordList>
      <Keywords>Alpha ketoglutarate</Keywords>
      <Keywords>C-Jun N-terminal protein kinase</Keywords>
      <Keywords>Differentiation</Keywords>
      <Keywords>G-protein-coupled receptor 99</Keywords>
      <Keywords>Mammalian target of rapamycin</Keywords>
      <Keywords>Osteoblasts</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aleksandra Żurek</Name>
        <Affiliation>Department of Virology and Immunology, Maria Curie-Sklodowska University, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Magdalena Mizerska-Kowalska</Name>
        <Affiliation>Department of Virology and Immunology, Maria Curie-Sklodowska University, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Adrianna Sławińska-Brych</Name>
        <Affiliation>Department of Cell Biology, Maria Curie-Sklodowska University, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Katarzyna Kaławaj</Name>
        <Affiliation>Department of Virology and Immunology, Maria Curie-Sklodowska University, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Agnieszka Bojarska-Junak</Name>
        <Affiliation>Chair and Department of Clinical Immunology, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Martyna Kandefer-Szerszeń</Name>
        <Affiliation>Department of Virology and Immunology, Maria Curie-Sklodowska University, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Zdzisińska</Name>
        <Affiliation>Department of Virology and Immunology, Maria Curie-Sklodowska University, Lublin, Poland. Electronic address: basiaz@poczta.umcs.lublin.pl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Multi-walled carbon nanotubes promoted lipid accumulation in human aortic smooth muscle cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31047983</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30160-7</DOI>
    <KeywordList>
      <Keywords>Endoplasmic reticulum (ER) Stress</Keywords>
      <Keywords>Human aortic smooth muscle cells (HASMCs)</Keywords>
      <Keywords>Kruppel-like factor (KLF)</Keywords>
      <Keywords>Lipid accumulation</Keywords>
      <Keywords>Multi-walled carbon nanotubes (MWCNTs)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haiyin Yang</Name>
        <Affiliation>Key Laboratory of Environment-Friendly Chemistry and Application of Ministry of Education, Laboratory of Biochemistry, College of Chemistry, Xiangtan University, Xiangtan 411105, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Li</Name>
        <Affiliation>Key Laboratory of Environment-Friendly Chemistry and Application of Ministry of Education, Laboratory of Biochemistry, College of Chemistry, Xiangtan University, Xiangtan 411105, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunguang Yang</Name>
        <Affiliation>Key Laboratory of Environment-Friendly Chemistry and Application of Ministry of Education, Laboratory of Biochemistry, College of Chemistry, Xiangtan University, Xiangtan 411105, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongwen Liu</Name>
        <Affiliation>Key Laboratory of Environment-Friendly Chemistry and Application of Ministry of Education, Laboratory of Biochemistry, College of Chemistry, Xiangtan University, Xiangtan 411105, China. Electronic address: liuhongwen@xtu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Cao</Name>
        <Affiliation>Key Laboratory of Environment-Friendly Chemistry and Application of Ministry of Education, Laboratory of Biochemistry, College of Chemistry, Xiangtan University, Xiangtan 411105, China. Electronic address: caoyi39@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nicotine-induced oxidative stress contributes to EMT and stemness during neoplastic transformation through epigenetic modifications in human kidney epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31047982</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30161-9</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Kidney cancer</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Oxidative tress</Keywords>
      <Keywords>Stem cell</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Wei Chang</Name>
        <Affiliation>Department of Environmental Toxicology, The Institute of Environmental and Human Health (TIEHH), Texas Tech University, Lubbock, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kamaleshwar P. Singh</Name>
        <Affiliation>Department of Environmental Toxicology, The Institute of Environmental and Human Health (TIEHH), Texas Tech University, Lubbock, TX, USA. Electronic address: Kamaleshwar.singh@ttu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Enrichment of genes associated with squamous differentiation in cancer initiating cells isolated from urothelial cells transformed by the environmental toxicant arsenite.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31047981</pubmedLink>
    <GrantList>
      <Grant>P20 GM103442</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30159-0</DOI>
    <KeywordList>
      <Keywords>Arsenite</Keywords>
      <Keywords>Squamous differentiation</Keywords>
      <Keywords>Stem cells</Keywords>
      <Keywords>UROtsa</Keywords>
      <Keywords>Urothelial cell carcinoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zachary E. Hoggarth</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: zachary.hoggarth@und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Danyelle B. Osowski</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: danyelle.osowski@und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Slusser-Nore</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: andrea.slusser@und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Swojani Shrestha</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: swojani.shrestha@und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Prakash Pathak</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: prakash.pathak@und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Theoren Solseng</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: theoren.solseng@und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Scott H. Garrett</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: scott.garrett@med.und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Divyen H. Patel</Name>
        <Affiliation>Genome Explorations, 1910 Nonconnah Avenue, Suite 120, Memphis, TN 38132, United States. Electronic address: dpatel@genome-explorations.com.</Affiliation>
      </Author>
      <Author>
        <Name>Evan Savage</Name>
        <Affiliation>Genome Explorations, 1910 Nonconnah Avenue, Suite 120, Memphis, TN 38132, United States. Electronic address: esavage@genome-explorations.com.</Affiliation>
      </Author>
      <Author>
        <Name>Donald A. Sens</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: donald.sens@med.und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Seema Somji</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: seema.somji@med.und.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Heme oxygenase-1 attenuates low-dose of deoxynivalenol-induced liver inflammation potentially associating with microbiota.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31034930</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30158-9</DOI>
    <KeywordList>
      <Keywords>Deoxynivalenol</Keywords>
      <Keywords>Gut microbiota</Keywords>
      <Keywords>Heme oxygenase-1</Keywords>
      <Keywords>Liver damage</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhao Peng</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Technology, Hangkong Road 13, 430030 Wuhan, China; Department of Nutrition and Food Hygiene, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road 13, 430030 Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuxiao Liao</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Technology, Hangkong Road 13, 430030 Wuhan, China; Department of Nutrition and Food Hygiene, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road 13, 430030 Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liangkai Chen</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Technology, Hangkong Road 13, 430030 Wuhan, China; Department of Nutrition and Food Hygiene, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road 13, 430030 Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuang Liu</Name>
        <Affiliation>Hubei Center for Disease Control and Prevention, 6 North Zhuodaoquan Road, Wuhan 430079, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhilei Shan</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Technology, Hangkong Road 13, 430030 Wuhan, China; Department of Nutrition and Food Hygiene, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road 13, 430030 Wuhan, China; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas K. Nüssler</Name>
        <Affiliation>Department of Traumatology, BG Trauma Center, University of Tübingen, Schnarrenbergstr. 95, 72076 Tübingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Yao</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Technology, Hangkong Road 13, 430030 Wuhan, China; Department of Nutrition and Food Hygiene, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road 13, 430030 Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Yan</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Technology, Hangkong Road 13, 430030 Wuhan, China; Department of Nutrition and Food Hygiene, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road 13, 430030 Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liegang Liu</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Technology, Hangkong Road 13, 430030 Wuhan, China; Department of Nutrition and Food Hygiene, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road 13, 430030 Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Yang</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Technology, Hangkong Road 13, 430030 Wuhan, China; Department of Nutrition and Food Hygiene, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road 13, 430030 Wuhan, China. Electronic address: yw8278@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical evaluation of the maximum tolerated dose and toxicokinetics of enteric-coated lantibiotic OG253 capsules.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31034929</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30157-7</DOI>
    <KeywordList>
      <Keywords>Bacteriocin</Keywords>
      <Keywords>CDAD</Keywords>
      <Keywords>Lanthipeptide</Keywords>
      <Keywords>Lantibiotic</Keywords>
      <Keywords>Mutacin</Keywords>
      <Keywords>Nisin and Toxicokinetics</Keywords>
      <Keywords>OG253</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>N. V. Rajeshkumar</Name>
        <Affiliation>Intrexon Corporation, Human Therapeutics Division, 20358 Seneca Meadows Pkwy, Germantown, MD 20876, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Johan A. Kers</Name>
        <Affiliation>Intrexon Corporation, Industrial Products Division, 29 Oyster Point Blvd., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Moncrief</Name>
        <Affiliation>Intrexon Corporation, Human Therapeutics Division, 20358 Seneca Meadows Pkwy, Germantown, MD 20876, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony W. Defusco</Name>
        <Affiliation>Oragenics, Inc., 13700 Progress Blvd., Alachua, FL 32608, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jae H. Park</Name>
        <Affiliation>Oragenics, Inc., 13700 Progress Blvd., Alachua, FL 32608, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Handfield</Name>
        <Affiliation>Oragenics, Inc., 13700 Progress Blvd., Alachua, FL 32608, USA. Electronic address: mhandfield@oragenics.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of Nrf2 in the antioxidation and oxidative stress induced developmental toxicity of honokiol in zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31022495</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30148-6</DOI>
    <KeywordList>
      <Keywords>Antioxidation</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Honokiol microemulsion</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hui Li</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing 100050, China; New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qianqian Zhang</Name>
        <Affiliation>National Research Center for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanfang Li</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China; Beijing Union-Genious Pharmaceutical Technology Ltd., Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongying Li</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing 100050, China; New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Bao</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China; Beijing Union-Genious Pharmaceutical Technology Ltd., Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cuiping Yang</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China; Beijing Union-Genious Pharmaceutical Technology Ltd., Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Aiping Wang</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China; Beijing Union-Genious Pharmaceutical Technology Ltd., Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinfeng Wei</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China; Beijing Union-Genious Pharmaceutical Technology Ltd., Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shizhong Chen</Name>
        <Affiliation>School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongtao Jin</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China; Beijing Union-Genious Pharmaceutical Technology Ltd., Beijing 100176, China. Electronic address: jinhongtao@imm.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Synthetic secoisolariciresinol diglucoside (LGM2605) inhibits Libby amphibole fiber-induced acute inflammation in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31022494</pubmedLink>
    <GrantList>
      <Grant>R21 CA178654</Grant>
      <Grant>P30 ES013508</Grant>
      <Grant>P42 ES023720</Grant>
      <Grant>R03 CA180548</Grant>
      <Grant>R01 CA133470</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30150-4</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>Autoimmunity</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>LGM2605</Keywords>
      <Keywords>Libby amphibole</Keywords>
      <Keywords>Secoisolariciresinol diglucoside</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melpo Christofidou-Solomidou</Name>
        <Affiliation>Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania Perelman School of Medicine, 3450 Hamilton Walk, Stemmler Hall, Office Suite 227, Philadelphia, PA 19104, United States of America. Electronic address: melpo@pennmedicine.upenn.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ralph A. Pietrofesa</Name>
        <Affiliation>Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania Perelman School of Medicine, 3450 Hamilton Walk, Stemmler Hall, Office Suite 227, Philadelphia, PA 19104, United States of America. Electronic address: ralphp@pennmedicine.upenn.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Kyewon Park</Name>
        <Affiliation>Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania Perelman School of Medicine, 3450 Hamilton Walk, Stemmler Hall, Office Suite 227, Philadelphia, PA 19104, United States of America. Electronic address: kyewpark@pennmedicine.upenn.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Steven M. Albelda</Name>
        <Affiliation>Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania Perelman School of Medicine, 3450 Hamilton Walk, Stemmler Hall, Office Suite 227, Philadelphia, PA 19104, United States of America. Electronic address: albelda@pennmedicine.upenn.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Kinta M. Serve</Name>
        <Affiliation>Department of Biological Sciences, Life Sciences 207, Idaho State University, Pocatello, ID 83209, United States of America. Electronic address: servkint@isu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Deborah E. Keil</Name>
        <Affiliation>Department of Microbiology and Immunology, Montana State University, Health Sciences Building Rm 133, PO Box 173610, Bozeman, MT 59717, United States of America. Electronic address: deborah.keil@montana.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jean C. Pfau</Name>
        <Affiliation>Department of Microbiology and Immunology, Montana State University, Health Sciences Building Rm 133, PO Box 173610, Bozeman, MT 59717, United States of America. Electronic address: jean.pfau@montana.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicokinetics and bioavailability of bisphenol AF following oral administration in rodents: A dose, species, and sex comparison.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31022493</pubmedLink>
    <GrantList>
      <Grant>HHSN273201400004C</Grant>
      <Grant>HHSN273201400020C</Grant>
      <Grant>HHSN273201400022C</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30147-4</DOI>
    <KeywordList>
      <Keywords>Bioavailability</Keywords>
      <Keywords>Bisphenol AF</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suramya Waidyanatha</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America. Electronic address: waidyanathas@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Sherry R. Black</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Aillon</Name>
        <Affiliation>MRIGlobal, Kansas City, MO, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Brad Collins</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Purvi R. Patel</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Felicia Riordan</Name>
        <Affiliation>MRIGlobal, Kansas City, MO, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Vicki Sutherland</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Veronica Godfrey Robinson</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Reshan Fernando</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy R. Fennell</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>HHQ-4, a quinoline derivate, preferentially inhibits proliferation of glucose-deprived breast cancer cells as a GRP78 down-regulator.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31022492</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30149-8</DOI>
    <KeywordList>
      <Keywords>Breast cancer cells</Keywords>
      <Keywords>Glucose deprivation</Keywords>
      <Keywords>Glucose-regulated protein 78</Keywords>
      <Keywords>HHQ-4</Keywords>
      <Keywords>Unfolded protein response</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiao Xiao</Name>
        <Affiliation>College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuo Li</Name>
        <Affiliation>School of Chemistry and Chemical Engineering, Chongqing University of Technology, Chongqing 400054, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoxun Zhang</Name>
        <Affiliation>College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinjian Lu</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiguang Wang</Name>
        <Affiliation>Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming, Yunnan 650031, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shijia Zhou</Name>
        <Affiliation>College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingyao Zhang</Name>
        <Affiliation>College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Wang</Name>
        <Affiliation>College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China. Electronic address: wangrui1974@cqut.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Ao Li</Name>
        <Affiliation>Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China. Electronic address: ao_li@cqut.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Untargeted LC-MS-based metabonomics revealed that aristolochic acid I induces testicular toxicity by inhibiting amino acids metabolism, glucose metabolism, β-oxidation of fatty acids and the TCA cycle in male mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31009690</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30146-2</DOI>
    <KeywordList>
      <Keywords>ATP</Keywords>
      <Keywords>Aristolochic acid I</Keywords>
      <Keywords>Metabonomics</Keywords>
      <Keywords>TCA cycle</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuan Cui</Name>
        <Affiliation>Chinese Academy of Inspection and Quarantine, Institute of Chemicals Safety, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiayin Han</Name>
        <Affiliation>Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Ren</Name>
        <Affiliation>The Rocket Army General Hospital of the PLA, Pneumology Department, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huiming Chen</Name>
        <Affiliation>Chinese Academy of Inspection and Quarantine, Institute of Chemicals Safety, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Baoliang Xu</Name>
        <Affiliation>Chinese Academy of Inspection and Quarantine, Institute of Chemicals Safety, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Naining Song</Name>
        <Affiliation>Chinese Academy of Inspection and Quarantine, Institute of Chemicals Safety, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haishan Li</Name>
        <Affiliation>Chinese Academy of Inspection and Quarantine, Institute of Chemicals Safety, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Aihua Liang</Name>
        <Affiliation>Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: ahliang@icmm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Guolin Shen</Name>
        <Affiliation>Chinese Academy of Inspection and Quarantine, Institute of Chemicals Safety, Beijing, China. Electronic address: shengl@aqsiqch.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sirtuin 6 inhibits MWCNTs-induced epithelial-mesenchymal transition in human bronchial epithelial cells via inactivating TGF-β1/Smad2 signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31005557</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30145-0</DOI>
    <KeywordList>
      <Keywords>BEAS-2B cells</Keywords>
      <Keywords>Epithelial-mesenchymal transition</Keywords>
      <Keywords>MWCNTs</Keywords>
      <Keywords>Pulmonary fibrosis</Keywords>
      <Keywords>SIRT6</Keywords>
      <Keywords>TGF-β1/Smad</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Panpan Chen</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Kunming Tian</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Tu</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Zhang</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lianyong Han</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Zhou</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China. Electronic address: xue.zhou@hust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Induction of endoplasmic reticulum stress might be responsible for defective autophagy in cadmium-induced prostate carcinogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31002860</pubmedLink>
    <GrantList>
      <Grant>R01 ES028102</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30138-3</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>ER stress</Keywords>
      <Keywords>Prostate cancer</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>Transformation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Venkatesh Kolluru</Name>
        <Affiliation>Department of Urology, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ashish Tyagi</Name>
        <Affiliation>Department of Urology, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Balaji Chandrasekaran</Name>
        <Affiliation>Department of Urology, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Murali Ankem</Name>
        <Affiliation>Department of Urology, Louisville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chendil Damodaran</Name>
        <Affiliation>Department of Urology, Louisville, KY, USA. Electronic address: chendil.damodaran@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to Stage-specific metabolic features of differentiating neurons: Implications for toxicant sensitivity Toxicol Appl Pharmacol, 354 (2018) 64-80.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31002859</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30136-X</DOI>
    <AuthorList>
      <Author>
        <Name>Johannes Delp</Name>
        <Affiliation>In Vitro Toxicology and Biomedicine, Dept Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, 78457 Konstanz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Gutbier</Name>
        <Affiliation>In Vitro Toxicology and Biomedicine, Dept Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, 78457 Konstanz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Cerff</Name>
        <Affiliation>Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich 52425, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christin Zasada</Name>
        <Affiliation>Max-Delbrück-Center of Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastian Niedenführ</Name>
        <Affiliation>Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich 52425, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Zhao</Name>
        <Affiliation>Johns Hopkins University, Bloomberg School of Public Health, Center for Alternatives to Animal Testing (CAAT), Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lena Smirnova</Name>
        <Affiliation>Johns Hopkins University, Bloomberg School of Public Health, Center for Alternatives to Animal Testing (CAAT), Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Hartung</Name>
        <Affiliation>Johns Hopkins University, Bloomberg School of Public Health, Center for Alternatives to Animal Testing (CAAT), Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hanna Borlinghaus</Name>
        <Affiliation>Department of Computer and Information Science, University of Konstanz, Konstanz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Falk Schreiber</Name>
        <Affiliation>Department of Computer and Information Science, University of Konstanz, Konstanz, Germany; Faculty of Information Technology, Monash University, Melbourne, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Jörg Bergemann</Name>
        <Affiliation>Department of Life Sciences, Albstadt-Sigmaringen University of Applied Sciences, Sigmaringen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jochem Gätgens</Name>
        <Affiliation>Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich 52425, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Beyss</Name>
        <Affiliation>Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich 52425, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Salah Azzouzi</Name>
        <Affiliation>Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich 52425, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tanja Waldmann</Name>
        <Affiliation>In Vitro Toxicology and Biomedicine, Dept Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, 78457 Konstanz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Kempa</Name>
        <Affiliation>Max-Delbrück-Center of Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Katharina Nöh</Name>
        <Affiliation>Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich 52425, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Marcel Leist</Name>
        <Affiliation>In Vitro Toxicology and Biomedicine, Dept Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, 78457 Konstanz, Germany; CAAT-Europe, University of Konstanz, Konstanz 78457, Germany. Electronic address: marcel.leist@uni-konstanz.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cadmium exposure upregulates SNAIL through miR-30 repression in human lung epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30998937</pubmedLink>
    <GrantList>
      <Grant>P30 CA016087</Grant>
      <Grant>P30 ES000260</Grant>
      <Grant>R01 ES023174</Grant>
      <Grant>R01 ES024727</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30137-1</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>EMT</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Lung epithelial cells</Keywords>
      <Keywords>SNAIL</Keywords>
      <Keywords>miR-30</Keywords>
      <Keywords>miRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vinay Singh Tanwar</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoru Zhang</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lakshmanan Jagannathan</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cynthia C. Jose</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suresh Cuddapah</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, New York, NY 10010, USA. Electronic address: suresh.cuddapah@nyulangone.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metagenomic analysis of gut microbiota alteration in a mouse model exposed to mycotoxin deoxynivalenol.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30981666</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30135-8</DOI>
    <KeywordList>
      <Keywords>Deoxynivalenol</Keywords>
      <Keywords>Gut microbiome</Keywords>
      <Keywords>Metagenome</Keywords>
      <Keywords>Mouse</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Jie Wang</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China; Key Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Qian Zhang</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China; Key Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiu Yue Zhai</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China; Key Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Cai Liu</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China; Key Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Li</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China; Key Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Xiang Liu</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China; Key Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Li</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China; Key Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Shen</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China; Key Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, Qingdao 266109, China. Electronic address: wshen@qau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30978400</pubmedLink>
    <GrantList>
      <Grant>U01 NS058046</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30133-4</DOI>
    <KeywordList>
      <Keywords>2PAM</Keywords>
      <Keywords>Acetylcholinesterase reactivation</Keywords>
      <Keywords>Antidotes to nerve agents</Keywords>
      <Keywords>Bioscavengers</Keywords>
      <Keywords>Organophosphates</Keywords>
      <Keywords>Phosphoramidates</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zrinka Kovarik</Name>
        <Affiliation>Institute for Medical Research and Occupational Health, Zagreb, Croatia. Electronic address: zkovarik@imi.hr.</Affiliation>
      </Author>
      <Author>
        <Name>Nikolina Maček Hrvat</Name>
        <Affiliation>Institute for Medical Research and Occupational Health, Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Jarosław Kalisiak</Name>
        <Affiliation>Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maja Katalinić</Name>
        <Affiliation>Institute for Medical Research and Occupational Health, Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Rakesh K. Sit</Name>
        <Affiliation>Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tamara Zorbaz</Name>
        <Affiliation>Institute for Medical Research and Occupational Health, Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Zoran Radić</Name>
        <Affiliation>Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, La Jolla, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Valery V. Fokin</Name>
        <Affiliation>Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Barry Sharpless</Name>
        <Affiliation>Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Palmer Taylor</Name>
        <Affiliation>Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, La Jolla, USA. Electronic address: pwtaylor@ucsd.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Minimal uranium immunotoxicity following a 60-day drinking water exposure to uranyl acetate in male and female C57BL/6J mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30978399</pubmedLink>
    <GrantList>
      <Grant>P42 ES025589</Grant>
      <Grant>UL1 TR001449</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30129-2</DOI>
    <KeywordList>
      <Keywords>Drinking water exposure</Keywords>
      <Keywords>Humoral immunity</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Innate immunity</Keywords>
      <Keywords>Uranium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alicia M. Bolt</Name>
        <Affiliation>The University of New Mexico College of Pharmacy, Department of Pharmaceutical Sciences, Albuquerque, NM 87131, United States of America. Electronic address: ambolt@salud.unm.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastian Medina</Name>
        <Affiliation>The University of New Mexico College of Pharmacy, Department of Pharmaceutical Sciences, Albuquerque, NM 87131, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Fredine T. Lauer</Name>
        <Affiliation>The University of New Mexico College of Pharmacy, Department of Pharmaceutical Sciences, Albuquerque, NM 87131, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Liu</Name>
        <Affiliation>The University of New Mexico College of Pharmacy, Department of Pharmaceutical Sciences, Albuquerque, NM 87131, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Scott W. Burchiel</Name>
        <Affiliation>The University of New Mexico College of Pharmacy, Department of Pharmaceutical Sciences, Albuquerque, NM 87131, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Parental exposure to 2,2',4,4'5 - pentain polybrominated diphenyl ethers (BDE-99) causes thyroid disruption and developmental toxicity in zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30978398</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30134-6</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Hypothalamic-pituitary-thyroid-liver (HPTL) axis</Keywords>
      <Keywords>PBDEs</Keywords>
      <Keywords>Thyroid disruption</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Luyin Wu</Name>
        <Affiliation>National Demonstration Center for Experimental Fisheries Science Education, Shanghai Ocean University, Shanghai 200120, China; Observation Station for Fishery Resource and Environment in Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Key Laboratory of Freshwater Biodiversity Conservation (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunfeng Li</Name>
        <Affiliation>Observation Station for Fishery Resource and Environment in Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Key Laboratory of Freshwater Biodiversity Conservation (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huijun Ru</Name>
        <Affiliation>Observation Station for Fishery Resource and Environment in Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Key Laboratory of Freshwater Biodiversity Conservation (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huaxiao Xie</Name>
        <Affiliation>National Demonstration Center for Experimental Fisheries Science Education, Shanghai Ocean University, Shanghai 200120, China; Observation Station for Fishery Resource and Environment in Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Key Laboratory of Freshwater Biodiversity Conservation (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Yao</Name>
        <Affiliation>Observation Station for Fishery Resource and Environment in Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Key Laboratory of Freshwater Biodiversity Conservation (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China; College of Fisheries, Huazhong Agricultural University, Wuhan 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhaohui Ni</Name>
        <Affiliation>Observation Station for Fishery Resource and Environment in Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Key Laboratory of Freshwater Biodiversity Conservation (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China. Electronic address: nizhaoh@yfi.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Liqiao Zhong</Name>
        <Affiliation>Observation Station for Fishery Resource and Environment in Upper-Middle Reaches of Yangtze River (Ministry of Agriculture), Key Laboratory of Freshwater Biodiversity Conservation (Ministry of Agriculture), Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan 430223, China. Electronic address: zhonglq@yfi.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Updating physiologically based pharmacokinetic models for manganese by incorporating rapid association/dissociation processes in tissues.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30978397</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30132-2</DOI>
    <KeywordList>
      <Keywords>Dose-dependent kinetics</Keywords>
      <Keywords>Essential metal</Keywords>
      <Keywords>Essential metal homeostasis</Keywords>
      <Keywords>Manganese</Keywords>
      <Keywords>Metal transporters</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Miyoung Yoon</Name>
        <Affiliation>ScitoVation, LLC, RTP, Cary, NC, USA; Toxstrategies, Inc., Cary, NC, USA. Electronic address: yoon.m.work@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alina Efremenko</Name>
        <Affiliation>ScitoVation, LLC, RTP, Cary, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cynthia Van Landingham</Name>
        <Affiliation>Ramboll, RTP, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. Robinan Gentry</Name>
        <Affiliation>Ramboll, RTP, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Athena M. Keene</Name>
        <Affiliation>Afton Chemical, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael D. Taylor</Name>
        <Affiliation>NiPERA, RTP, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>ScitoVation, LLC, RTP, Cary, NC, USA; Ramboll, RTP, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>ScitoVation, LLC, RTP, Cary, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30974157</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30131-0</DOI>
    <KeywordList>
      <Keywords>Akt</Keywords>
      <Keywords>Doxorubicin resistance</Keywords>
      <Keywords>Osteosarcoma</Keywords>
      <Keywords>Polydatin</Keywords>
      <Keywords>TUG1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tongzhou Hu</Name>
        <Affiliation>Department of Orthopedics, Ningbo Fourth Hospital, Ningbo, Zhejiang 315700, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenghua Fei</Name>
        <Affiliation>Department of Radiotherapy and Chemotherapy, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang 325000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Huafang Su</Name>
        <Affiliation>Department of Radiotherapy and Chemotherapy, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang 325000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Raoying Xie</Name>
        <Affiliation>Department of Radiotherapy and Chemotherapy, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang 325000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liting Chen</Name>
        <Affiliation>Department of Oncology, Zhejiang Hospital, Hangzhou, Zhejiang 310013, PR China. Electronic address: alka304@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mechanistic identification of biofluid metabolite changes as markers of acetaminophen-induced liver toxicity in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30974156</pubmedLink>
    <GrantList>
      <Grant>P30 DK058404</Grant>
      <Grant>G20 RR030956</Grant>
      <Grant>P30 EY008126</Grant>
      <Grant>P30 CA068485</Grant>
      <Grant>UL1 RR024975</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30127-9</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Blood and urine metabolites</Keywords>
      <Keywords>Genome-scale model</Keywords>
      <Keywords>Glutathione</Keywords>
      <Keywords>Glycine limitation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Venkat R. Pannala</Name>
        <Affiliation>The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA; Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Materiel Command, Fort Detrick, MD 21702, USA. Electronic address: vpannala@bhsai.org.</Affiliation>
      </Author>
      <Author>
        <Name>Kalyan C. Vinnakota</Name>
        <Affiliation>The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA; Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Materiel Command, Fort Detrick, MD 21702, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kristopher D. Rawls</Name>
        <Affiliation>Department of Biomedical Engineering, University of Virginia, Box 800759, Health System, Charlottesville, Virginia 22908, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shanea K. Estes</Name>
        <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tracy P. O'Brien</Name>
        <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard L. Printz</Name>
        <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jason A. Papin</Name>
        <Affiliation>Department of Biomedical Engineering, University of Virginia, Box 800759, Health System, Charlottesville, Virginia 22908, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jaques Reifman</Name>
        <Affiliation>Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Materiel Command, Fort Detrick, MD 21702, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Masakazu Shiota</Name>
        <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jamey D. Young</Name>
        <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Department of Chemical and Biomolecular Engineering, Vanderbilt University School of Engineering, Nashville, TN 37232, USA. Electronic address: j.d.young@vanderbilt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Anders Wallqvist</Name>
        <Affiliation>Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Materiel Command, Fort Detrick, MD 21702, USA. Electronic address: sven.a.wallqvist.civ@mail.mil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biotransformation and oxidative stress responses in rat hepatic cell-line (H4IIE) exposed to organophosphate esters (OPEs).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30974155</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30130-9</DOI>
    <KeywordList>
      <Keywords>Brotransformation</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>H4IIE</Keywords>
      <Keywords>Organophosphate esters</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Screening</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elvira Mennillo</Name>
        <Affiliation>Department of Veterinary Sciences, University of Pisa, San Piero a Grado (PI) 56122, Italy; Department of Biology, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Francesca Cappelli</Name>
        <Affiliation>Department of Biology, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Augustine Arukwe</Name>
        <Affiliation>Department of Biology, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. Electronic address: augustine.arukwe@ntnu.no.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The 10th conference on metal toxicity and carcinogenesis: Overview and recent advances.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30965048</pubmedLink>
    <GrantList>
      <Grant>P30 CA118100</Grant>
      <Grant>R01 ES021100</Grant>
      <Grant>R01 ES029369</Grant>
      <Grant>R13 ES029807</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30128-0</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xixi Zhou</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jesse Denson Hesch</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Liu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA. Electronic address: kliu@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gambogic acid attenuates liver fibrosis by inhibiting the PI3K/AKT and MAPK signaling pathways via inhibiting HSP90.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30953615</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30118-8</DOI>
    <KeywordList>
      <Keywords>Gambogic acid</Keywords>
      <Keywords>Heat shock protein 90</Keywords>
      <Keywords>Hepatic stellate cell</Keywords>
      <Keywords>Liver fibrosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhenlong Yu</Name>
        <Affiliation>College of Pharmacy, Academy of Integrative Medicine, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanan Jv</Name>
        <Affiliation>College of Pharmacy, Academy of Integrative Medicine, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Cai</Name>
        <Affiliation>College of Pharmacy, Academy of Integrative Medicine, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangge Tian</Name>
        <Affiliation>College of Pharmacy, Academy of Integrative Medicine, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaokui Huo</Name>
        <Affiliation>College of Pharmacy, Academy of Integrative Medicine, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Wang</Name>
        <Affiliation>College of Pharmacy, Academy of Integrative Medicine, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Baojing Zhang</Name>
        <Affiliation>College of Pharmacy, Academy of Integrative Medicine, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>ChengPeng Sun</Name>
        <Affiliation>College of Pharmacy, Academy of Integrative Medicine, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Ning</Name>
        <Affiliation>College of Pharmacy, Academy of Integrative Medicine, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Feng</Name>
        <Affiliation>College of Pharmacy, Academy of Integrative Medicine, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Houli Zhang</Name>
        <Affiliation>College of Pharmacy, Academy of Integrative Medicine, Dalian Medical University, Dalian 116044, China. Electronic address: zhanghouli@dmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaochi Ma</Name>
        <Affiliation>College of Pharmacy, Academy of Integrative Medicine, Dalian Medical University, Dalian 116044, China. Electronic address: maxc1978@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits bladder cancer cell growth via the mitochondrial apoptosis and JNK pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30946863</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30117-6</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Bladder cancer</Keywords>
      <Keywords>Erianin</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>JNK pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qiyu Zhu</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; University of Chinese Academy of Sciences, Beijing 100000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuwen Sheng</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; University of Chinese Academy of Sciences, Beijing 100000, China. Electronic address: shengyuwen0326@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wenhua Li</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; University of Chinese Academy of Sciences, Beijing 100000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Wang</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; University of Chinese Academy of Sciences, Beijing 100000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yulin Ma</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; University of Chinese Academy of Sciences, Beijing 100000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Baowen Du</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; University of Chinese Academy of Sciences, Beijing 100000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaxiong Tang</Name>
        <Affiliation>Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; University of Chinese Academy of Sciences, Beijing 100000, China. Electronic address: tangyx@cib.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30946862</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30113-9</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>Elongate mineral particles</Keywords>
      <Keywords>Risk asessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Murray Martin Finkelstein</Name>
        <Affiliation>Department of Family and Community Medicine, University of Toronto, 336 Spadina Road, Suite 902, Toronto, Ontario M5R 2V8, Canada; Department of Family Medicine, McMaster University, 336 Spadina Road, Suite 902, Toronto, Ontario M5R 2V8, Canada. Electronic address: murray.finkelstein@utoronto.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Anti-inflammatory effect of trans-4-methoxycinnamaldehyde from Etlingera pavieana in LPS-stimulated macrophages mediated through inactivation of NF-κB and JNK/c-Jun signaling pathways and in rat models of acute inflammation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30943385</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30116-4</DOI>
    <KeywordList>
      <Keywords>COX-2</Keywords>
      <Keywords>Carrageenan</Keywords>
      <Keywords>Nitric oxide</Keywords>
      <Keywords>PGE(2)</Keywords>
      <Keywords>Trans-4-methoxycinnamaldehyde</Keywords>
      <Keywords>iNOS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Klaokwan Srisook</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science, Burapha University, Chonburi 20131, Thailand; Center of Excellence for Innovation in Chemistry, Burapha University, 20131, Thailand. Electronic address: klaokwan@buu.ac.th.</Affiliation>
      </Author>
      <Author>
        <Name>Sakulrat Mankhong</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science, Burapha University, Chonburi 20131, Thailand; Center of Excellence for Innovation in Chemistry, Burapha University, 20131, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Natthakarn Chiranthanut</Name>
        <Affiliation>Department of Pharmacology, Center of Excellence for Innovation in Chemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Kittiya Kongsamak</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science, Burapha University, Chonburi 20131, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Na Thanit Kitwiwat</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science, Burapha University, Chonburi 20131, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Patsara Tongjurai</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science, Burapha University, Chonburi 20131, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Pornpun Aramsangtienchai</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science, Burapha University, Chonburi 20131, Thailand.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Participation of phospholipase-A</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30928402</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30115-2</DOI>
    <KeywordList>
      <Keywords>Erythrocytes</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>Intracellular calcium</Keywords>
      <Keywords>Lead Intoxication</Keywords>
      <Keywords>Oxidative damage</Keywords>
      <Keywords>Phosphatidylserine externalization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gerardo Hernández</Name>
        <Affiliation>Section Methodology of Science, Centro de Investigación y Estudios Avanzados-IPN (Cinvestav), Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Carla Angélica Villanueva-Ibarra</Name>
        <Affiliation>Biochemistry Department, Centro de Investigación y Estudios Avanzados-IPN (Cinvestav), Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>María Maldonado-Vega</Name>
        <Affiliation>Planning, Teaching and Research Department, Hospital Regional de Alta Especialidad del Bajío. León, Guanajuato, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Nadia Cristina López-Vanegas</Name>
        <Affiliation>Biochemistry Department, Centro de Investigación y Estudios Avanzados-IPN (Cinvestav), Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Estefania Ruiz-Cascante</Name>
        <Affiliation>Programa de Maestría y Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Salud en el Trabajo, UNAM, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>José Víctor Calderón-Salinas</Name>
        <Affiliation>Biochemistry Department, Centro de Investigación y Estudios Avanzados-IPN (Cinvestav), Ciudad de México, Mexico. Electronic address: jcalder@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Validation of a multiplexed LC-MS/MS clinical assay to quantify insulin-like growth factor-binding proteins in human serum and its application in a clinical study.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30926377</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30114-0</DOI>
    <KeywordList>
      <Keywords>Alkylation reagent</Keywords>
      <Keywords>Insulin-like growth factor-binding proteins</Keywords>
      <Keywords>LC–MS/MS</Keywords>
      <Keywords>Matrix effect</Keywords>
      <Keywords>Protein quantitation</Keywords>
      <Keywords>Spinal and bulbar muscular atrophy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nanjun Liu</Name>
        <Affiliation>Nextcea Inc., 500 West Cummings Park #4550, Woburn, MA 01801, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth Tengstrand</Name>
        <Affiliation>Nextcea Inc., 500 West Cummings Park #4550, Woburn, MA 01801, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Olaf Boernsen</Name>
        <Affiliation>Advanced Osteotomy Tools AG, Wallstrasse 6, CH-4051 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Stephan Bek</Name>
        <Affiliation>F.Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Hsieh</Name>
        <Affiliation>Nextcea Inc., 500 West Cummings Park #4550, Woburn, MA 01801, USA. Electronic address: frank.hsieh@nextcea.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Overexpression of cerebral cytochrome P450s in prenatally exposed offspring modify the toxicity of lindane in rechallenged offspring.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30926376</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30112-7</DOI>
    <KeywordList>
      <Keywords>Brain</Keywords>
      <Keywords>CYPs</Keywords>
      <Keywords>Epigenetic</Keywords>
      <Keywords>Lindane</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Rechallenge</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anita Agrahari</Name>
        <Affiliation>Developmental Toxicology Laboratory, System Toxicology &amp; Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (IITR), Vishvigyan Bhavan, 31, M.G. Marg, Lucknow 226 001, UP, India; Department of Biochemistry, College of Dental Sciences, Babu Banarasi Das University, Lucknow 226028, UP, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anshuman Singh</Name>
        <Affiliation>Developmental Toxicology Laboratory, System Toxicology &amp; Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (IITR), Vishvigyan Bhavan, 31, M.G. Marg, Lucknow 226 001, UP, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ankita Srivastava</Name>
        <Affiliation>Developmental Toxicology Laboratory, System Toxicology &amp; Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (IITR), Vishvigyan Bhavan, 31, M.G. Marg, Lucknow 226 001, UP, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, UP, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rakesh R. Jha</Name>
        <Affiliation>Regulatory Toxicology Group, CSIR-IITR, Lucknow 226 001, UP, India.</Affiliation>
      </Author>
      <Author>
        <Name>Devendra K. Patel</Name>
        <Affiliation>Regulatory Toxicology Group, CSIR-IITR, Lucknow 226 001, UP, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sanjay Yadav</Name>
        <Affiliation>Developmental Toxicology Laboratory, System Toxicology &amp; Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (IITR), Vishvigyan Bhavan, 31, M.G. Marg, Lucknow 226 001, UP, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vikas Srivastava</Name>
        <Affiliation>Developmental Toxicology Laboratory, System Toxicology &amp; Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (IITR), Vishvigyan Bhavan, 31, M.G. Marg, Lucknow 226 001, UP, India. Electronic address: 76.vikas@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Devendra Parmar</Name>
        <Affiliation>Developmental Toxicology Laboratory, System Toxicology &amp; Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (IITR), Vishvigyan Bhavan, 31, M.G. Marg, Lucknow 226 001, UP, India. Electronic address: dparmar@iitr.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigating the interaction between melamine and cyanuric acid using a Physiologically-Based Toxicokinetic model in rainbow trout.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30922832</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30111-5</DOI>
    <KeywordList>
      <Keywords>Interaction</Keywords>
      <Keywords>Melamine</Keywords>
      <Keywords>Mixture</Keywords>
      <Keywords>Physiologically-Based Toxicokinetic (PBTK) model</Keywords>
      <Keywords>Rainbow Trout</Keywords>
      <Keywords>Toxicodynamics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cleo Tebby</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), Models for Ecotoxicology and Toxicology Unit, Parc ALATA, BP2, 60550 Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Céline Brochot</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), Models for Ecotoxicology and Toxicology Unit, Parc ALATA, BP2, 60550 Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Lou Dorne</Name>
        <Affiliation>European Food Safety Authority (EFSA), Scientific Committee and Emerging Risks Unit, Via Carlo Magno 1A, 43126 Parma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Rémy Beaudouin</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), Models for Ecotoxicology and Toxicology Unit, Parc ALATA, BP2, 60550 Verneuil-en-Halatte, France; Institut National de l'Environnement Industriel et des Risques (INERIS), UMR-I 02 SEBIO, Parc ALATA, BP2, 60550 Verneuil-en-Halatte, France. Electronic address: remy.beaudouin@ineris.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Emerging role of proprotein convertase subtilisin/kexin type-9 (PCSK-9) in inflammation and diseases.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30914377</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30108-5</DOI>
    <KeywordList>
      <Keywords>Autoimmune Diseases</Keywords>
      <Keywords>Chemokines</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>PCSK9</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Madalyn Brown</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Salahuddin Ahmed</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA, USA; Division of Rheumatology, University of Washington School of Medicine, Seattle, WA, USA. Electronic address: salah.ahmed@wsu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30914376</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30110-3</DOI>
    <KeywordList>
      <Keywords>BLT-humanized mouse</Keywords>
      <Keywords>CD34-humanized mouse</Keywords>
      <Keywords>Cytokine release syndrome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hangyi Yan</Name>
        <Affiliation>Division of Applied Regulatory Sciences, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bhagyashree Bhagwat</Name>
        <Affiliation>MRL, Merck &amp; Co., Inc., Palo Alto, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Sanden</Name>
        <Affiliation>MRL, Merck &amp; Co., Inc., Palo Alto, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Aarron Willingham</Name>
        <Affiliation>MRL, Merck &amp; Co., Inc., Palo Alto, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alick Tan</Name>
        <Affiliation>Division of Applied Regulatory Sciences, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan D. Knapton</Name>
        <Affiliation>Division of Applied Regulatory Sciences, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James L. Weaver</Name>
        <Affiliation>Division of Applied Regulatory Sciences, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kristina E. Howard</Name>
        <Affiliation>Division of Applied Regulatory Sciences, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA. Electronic address: Kristina.Howard@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MiR-142a-3p and miR-155-5p reduce methamphetamine-induced inflammation: Role of the target protein Peli1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30914375</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30109-7</DOI>
    <KeywordList>
      <Keywords>Methamphetamine</Keywords>
      <Keywords>Neuroinflammation</Keywords>
      <Keywords>Peli1</Keywords>
      <Keywords>miR-142a-3p</Keywords>
      <Keywords>miR-155-5p</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guoqin Yu</Name>
        <Affiliation>Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Song</Name>
        <Affiliation>Department of Emergency, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cuiwei Xie</Name>
        <Affiliation>Key Laboratory of Modern Toxicology (NJMU), Ministry of Education, Department of Toxicology, School of Public Health, Nanjing Medical University, 818 Tianyuan East Road, Nanjing, Jiangsu 211166, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liyuan Tao</Name>
        <Affiliation>Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fen Wan</Name>
        <Affiliation>Department of Emergency, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Jiang</Name>
        <Affiliation>Department of Emergency, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Wang</Name>
        <Affiliation>Key Laboratory of Modern Toxicology (NJMU), Ministry of Education, Department of Toxicology, School of Public Health, Nanjing Medical University, 818 Tianyuan East Road, Nanjing, Jiangsu 211166, China. Electronic address: wangjun@njmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jinrong Tang</Name>
        <Affiliation>Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu 210029, China. Electronic address: zdgaoyang@outlook.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>HDAC6 inhibition blocks inflammatory signaling and caspase-1 activation in LPS-induced acute lung injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30910594</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30107-3</DOI>
    <KeywordList>
      <Keywords>Epithelial barrier</Keywords>
      <Keywords>HDAC6</Keywords>
      <Keywords>Inflammasome</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Lung injury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Li Liu</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, First Hospital of China Medical University, Shenyang, Liaoning, PR China; Center for Research on Environmental Disease, University of Kentucky, Lexington, KY, USA; Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoming Zhou</Name>
        <Affiliation>Department of Respiratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, PR China; Center for Research on Environmental Disease, University of Kentucky, Lexington, KY, USA; Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sreerama Shetty</Name>
        <Affiliation>Department of Medicine, University of Texas Health Science Center at Tyler, Tyler, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gang Hou</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, First Hospital of China Medical University, Shenyang, Liaoning, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiuyue Wang</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, First Hospital of China Medical University, Shenyang, Liaoning, PR China. Electronic address: qywangcmu@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Fu</Name>
        <Affiliation>Center for Research on Environmental Disease, University of Kentucky, Lexington, KY, USA; Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacology, toxicology and clinical safety of glycopyrrolate.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30905688</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30106-1</DOI>
    <KeywordList>
      <Keywords>Glycopyrrolate</Keywords>
      <Keywords>Glycopyrronium</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Pharmacology</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Monika Chabicovsky</Name>
        <Affiliation>MC Toxicology Consulting GmbH, Vienna, Austria. Electronic address: mc@toxicology.cc.</Affiliation>
      </Author>
      <Author>
        <Name>Swantje Winkler</Name>
        <Affiliation>MC Toxicology Consulting GmbH, Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Soeberdt</Name>
        <Affiliation>Dr. August Wolff GmbH &amp; Co. KG Arzneimittel, Bielefeld, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Kilic</Name>
        <Affiliation>Dr. August Wolff GmbH &amp; Co. KG Arzneimittel, Bielefeld, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Clarissa Masur</Name>
        <Affiliation>Dr. August Wolff GmbH &amp; Co. KG Arzneimittel, Bielefeld, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christoph Abels</Name>
        <Affiliation>Dr. August Wolff GmbH &amp; Co. KG Arzneimittel, Bielefeld, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Methamphetamine produces cardiac damage and apoptosis by decreasing melusin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30904475</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30105-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Melusin</Keywords>
      <Keywords>Methamphetamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaoyu Sun</Name>
        <Affiliation>Department of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Wang</Name>
        <Affiliation>Department of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Xia</Name>
        <Affiliation>Department of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhu Li</Name>
        <Affiliation>Department of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jialin Dai</Name>
        <Affiliation>Department of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pingming Qiu</Name>
        <Affiliation>School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ande Ma</Name>
        <Affiliation>Department of Hygiene Inspection &amp; Quarantine Science, Guangdong Province Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhoumeng Lin</Name>
        <Affiliation>Institute of Computational Comparative Medicine and Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jiang Huang</Name>
        <Affiliation>Department of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiawen Wang</Name>
        <Affiliation>Department of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Bing Xie</Name>
        <Affiliation>School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China. Electronic address: xieweib@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Wang</Name>
        <Affiliation>Department of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China. Electronic address: gywangj123@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Virtual screening-guided discovery of thioredoxin reductase inhibitors.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30898620</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30104-8</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Inhibitor</Keywords>
      <Keywords>Small molecules</Keywords>
      <Keywords>Thioredoxin reductase</Keywords>
      <Keywords>Virtual screening</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ruijuan Liu</Name>
        <Affiliation>State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou 730000, China; School of Pharmacy, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Danfeng Shi</Name>
        <Affiliation>College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junmin Zhang</Name>
        <Affiliation>School of Pharmacy, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinming Li</Name>
        <Affiliation>State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou 730000, China; College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Han</Name>
        <Affiliation>State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou 730000, China; College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojun Yao</Name>
        <Affiliation>College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China. Electronic address: xjyao@lzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Fang</Name>
        <Affiliation>State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou 730000, China; College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China. Electronic address: fangjg@lzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Stimulation of eryptosis by broad-spectrum insect repellent N,N-Diethyl-3-methylbenzamide (DEET).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30880218</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30093-6</DOI>
    <KeywordList>
      <Keywords>Eryptosis</Keywords>
      <Keywords>N,N-Diethyl-3-Methylbenzamide (DEET)</Keywords>
      <Keywords>Phosphatidylserine</Keywords>
      <Keywords>Red blood cells (Erythrocytes)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohammad A. Alfhili</Name>
        <Affiliation>Division of Hematology/Oncology, Department of Medicine, Brody School of Medicine, East Carolina University, Greenville, NC 27834, United States; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Mabusa B. Nkany</Name>
        <Affiliation>Department of Psychology, Thomas Harriot College of Arts and Sciences, East Carolina University, Greenville, NC 27834, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas A. Weidner</Name>
        <Affiliation>Department of Microbiology &amp; Immunology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Myon Hee Lee</Name>
        <Affiliation>Division of Hematology/Oncology, Department of Medicine, Brody School of Medicine, East Carolina University, Greenville, NC 27834, United States; Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, United States. Electronic address: leemy@ecu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Coordinated cytochrome P450 expression in mouse liver and intestine under different dietary conditions during liver regeneration after partial hepatectomy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30880217</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30092-4</DOI>
    <KeywordList>
      <Keywords>Bile acid</Keywords>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Intestine</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Purified diet</Keywords>
      <Keywords>Regeneration</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chieri Fujino</Name>
        <Affiliation>Graduate School of Biomedical and Health Sciences, Hiroshima University, 734-8553, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Seigo Sanoh</Name>
        <Affiliation>Graduate School of Biomedical and Health Sciences, Hiroshima University, 734-8553, Japan. Electronic address: sanoh@hiroshima-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Chise Tateno</Name>
        <Affiliation>R&amp;D Dept., PhoenixBio, Co., Ltd., 739-0046, Japan; Research Center for Hepatology and Gastroenterology, Hiroshima University, 739-8511, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shigeru Ohta</Name>
        <Affiliation>Graduate School of Biomedical and Health Sciences, Hiroshima University, 734-8553, Japan; Wakayama Medical University, 641-8509, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yaichiro Kotake</Name>
        <Affiliation>Graduate School of Biomedical and Health Sciences, Hiroshima University, 734-8553, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gender- and dose-related metabolome alterations in rat offspring after in utero and lactational exposure to PCB 180.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30880216</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30101-2</DOI>
    <KeywordList>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Polychlorinated biphenyls</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Antti Pikkarainen</Name>
        <Affiliation>Department of Environmental, Department of Biological Sciences, University of Eastern Finland, Kuopio, Finland. Electronic address: antpi@uef.fi.</Affiliation>
      </Author>
      <Author>
        <Name>Marko Lehtonen</Name>
        <Affiliation>School of Pharmacy, University of Eastern Finland, Kuopio, Finland; LC-MS Metabolomics Center, Biocenter Kuopio, Kuopio, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Helen Håkansson</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Seppo Auriola</Name>
        <Affiliation>School of Pharmacy, University of Eastern Finland, Kuopio, Finland; LC-MS Metabolomics Center, Biocenter Kuopio, Kuopio, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Matti Viluksela</Name>
        <Affiliation>Department of Environmental, Department of Biological Sciences, University of Eastern Finland, Kuopio, Finland; School of Pharmacy, University of Eastern Finland, Kuopio, Finland; Environmental Health Unit, National Institute for Health and Welfare, Kuopio, Finland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel MyD88 inhibitor LM9 prevents atherosclerosis by regulating inflammatory responses and oxidative stress in macrophages.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30880215</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30094-8</DOI>
    <KeywordList>
      <Keywords>Atherosclerosis</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Macrophage</Keywords>
      <Keywords>MyD88</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Taiwei Chen</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Department of Cardiology, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wu Luo</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gaojun Wu</Name>
        <Affiliation>Department of Cardiology, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lanlan Wu</Name>
        <Affiliation>Department of Pharmacy, Traditional Chinese Medicine Hospital of Yiwu, Yiwu, Zhejiang 322000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shushi Huang</Name>
        <Affiliation>Department of Cardiology, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jieli Li</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingying Wang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiang Hu</Name>
        <Affiliation>Department of Endocrinology, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weijian Huang</Name>
        <Affiliation>Department of Cardiology, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. Electronic address: weijianhuang69@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guang Liang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. Electronic address: wzmcliangguang@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Resveratrol inhibits cancer cell proliferation by impairing oxidative phosphorylation and inducing oxidative stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30878505</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30090-0</DOI>
    <KeywordList>
      <Keywords>Antioxidant response</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Mitophagy</Keywords>
      <Keywords>Oxidative phosphorylation</Keywords>
      <Keywords>ROS production</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sara Rodríguez-Enríquez</Name>
        <Affiliation>Departamento de Bioquímica, Instituto Nacional de Cardiología, Mexico. Electronic address: sara.rodriguez@cardiologia.org.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Cecilia Pacheco-Velázquez</Name>
        <Affiliation>Departamento de Bioquímica, Instituto Nacional de Cardiología, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Álvaro Marín-Hernández</Name>
        <Affiliation>Departamento de Bioquímica, Instituto Nacional de Cardiología, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Carlos Gallardo-Pérez</Name>
        <Affiliation>Departamento de Bioquímica, Instituto Nacional de Cardiología, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Diana Xochiquetzal Robledo-Cadena</Name>
        <Affiliation>Departamento de Bioquímica, Instituto Nacional de Cardiología, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Ileana Hernández-Reséndiz</Name>
        <Affiliation>Departamento de Bioquímica, Instituto Nacional de Cardiología, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Donato García-García</Name>
        <Affiliation>Departamento de Bioquímica, Instituto Nacional de Cardiología, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Javier Belmont-Díaz</Name>
        <Affiliation>Departamento de Bioquímica, Instituto Nacional de Cardiología, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Rebeca López-Marure</Name>
        <Affiliation>Departamento de Fisiología, Instituto Nacional de Cardiología, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Luz Hernández-Esquivel</Name>
        <Affiliation>Departamento de Bioquímica, Instituto Nacional de Cardiología, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Rosina Sánchez-Thomas</Name>
        <Affiliation>Departamento de Bioquímica, Instituto Nacional de Cardiología, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Rafael Moreno-Sánchez</Name>
        <Affiliation>Departamento de Bioquímica, Instituto Nacional de Cardiología, Mexico. Electronic address: rafael.moreno@cardiologia.org.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The protective role of spermine against male reproductive aberrations induced by exposure to electromagnetic field - An experimental investigation in the rat.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30878504</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30091-2</DOI>
    <KeywordList>
      <Keywords>Electromagnetic field</Keywords>
      <Keywords>Sperm profile</Keywords>
      <Keywords>Spermine</Keywords>
      <Keywords>Steroid sex hormone</Keywords>
      <Keywords>Testis</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nancy N. Shahin</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: nancy.shahin@cu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Nagla A. El-Nabarawy</Name>
        <Affiliation>National Egyptian Center of Environmental and Toxicological Research (NECTER), Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmed S. Gouda</Name>
        <Affiliation>National Egyptian Center of Environmental and Toxicological Research (NECTER), Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Mégarbane</Name>
        <Affiliation>INSERM UMRS-1144, Paris-Diderot University, Paris, France; Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30876865</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30089-4</DOI>
    <KeywordList>
      <Keywords>4-O-Methylhonokiol</Keywords>
      <Keywords>AMPK</Keywords>
      <Keywords>Diabetic Nephropathy</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tianjiao Ma</Name>
        <Affiliation>Department of Rheumatology and Immunology, China-Japan Union Hospital of Jilin University, Changchun 130033, China; Pediatric Research Institute, Department of Pediatrics, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zongyu Zheng</Name>
        <Affiliation>Pediatric Research Institute, Department of Pediatrics, University of Louisville, Louisville, KY 40202, USA; Department of Urology, the First Hospital of Jilin University, Changchun 130021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Guo</Name>
        <Affiliation>Pediatric Research Institute, Department of Pediatrics, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Lian</Name>
        <Affiliation>Pediatric Research Institute, Department of Pediatrics, University of Louisville, Louisville, KY 40202, USA; Department of Urology, the First Hospital of Jilin University, Changchun 130021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Madhavi J. Rane</Name>
        <Affiliation>Division of Nephropathy, Department of Medicine, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Cai</Name>
        <Affiliation>Pediatric Research Institute, Department of Pediatrics, University of Louisville, Louisville, KY 40202, USA; Departments of Radiation Oncology, Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ki Soo Kim</Name>
        <Affiliation>SK Bioland Haimen Co. LTD, Haimen, 226133, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kyoung Tae Kim</Name>
        <Affiliation>SK Bioland Haimen Co. LTD, Haimen, 226133, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiguo Zhang</Name>
        <Affiliation>Department of Cardiology at the First Hospital of Jilin University, Changchun 130021, China. Electronic address: zg529@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Liqi Bi</Name>
        <Affiliation>Department of Rheumatology and Immunology, China-Japan Union Hospital of Jilin University, Changchun 130033, China. Electronic address: biliqi66@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developmental exposure to mercury chloride impairs social behavior in male offspring dependent on genetic background and maternal autoimmune environment.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30862457</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30088-2</DOI>
    <KeywordList>
      <Keywords>Anti-brain antibody</Keywords>
      <Keywords>Autoimmune</Keywords>
      <Keywords>IFNγ</Keywords>
      <Keywords>Macrophage</Keywords>
      <Keywords>Mercury chloride</Keywords>
      <Keywords>Social behavior</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhengli Yang</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health Safety, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yifan Zhao</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health Safety, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Li</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health Safety, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiming Shao</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health Safety, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinchun Yu</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health Safety, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Cong</Name>
        <Affiliation>Institutes of Brain Science, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodong Jia</Name>
        <Affiliation>Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weidong Qu</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health Safety, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Longzhen Cheng</Name>
        <Affiliation>Department of Biology, Southern University of Science and Technology, Shenzhen 518055, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Xue</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health Safety, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhijun Zhou</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health Safety, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Miao He</Name>
        <Affiliation>Institutes of Brain Science, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yubin Zhang</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health Safety, MOE, Fudan University, Shanghai 200032, China. Electronic address: yz001@fudan.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Blockage of ROS and MAPKs-mediated inflammation via restoring SIRT1 by a new compound LF10 prevents type 1 diabetic cardiomyopathy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30857947</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30087-0</DOI>
    <KeywordList>
      <Keywords>Diabetic cardiomyopathy</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>MAPK</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Sirt1</Keywords>
      <Keywords>Thiazolones</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wu Luo</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Zhejiang, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiyi Jin</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Zhejiang, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gaojun Wu</Name>
        <Affiliation>Department of Cardiology, The First Affiliated Hospital, Wenzhou Medical University, Zhejiang, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiwei Zhu</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Zhejiang, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyuan Qian</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Zhejiang, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yali Zhang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Zhejiang, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jieli Li</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Zhejiang, Wenzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Aisong Zhu</Name>
        <Affiliation>School of Basic Medicine, Liaoning University of Traditional Chinese Medicine, Liaoning, Shenyang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guang Liang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Zhejiang, Wenzhou, China. Electronic address: wzmcliangguang@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Potential Problems with Determining Elongate Mineral Particle (EMP) Potency (Comments on article entitled, "A Comparison of Asbestos Fiber Potency and Elongate Mineral Particle (EMP) Potency for Mesothelioma in Humans").</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30851279</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30084-5</DOI>
    <AuthorList>
      <Author>
        <Name>Jeffrey H. Mandel</Name>
        <Affiliation>University of Minnesota School of Public Health, Division of Environmental Health Sciences, Minneapolis, MN, United States of America. Electronic address: mand0125@umn.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Nnaemeka U. Odo</Name>
        <Affiliation>Exponent, Inc., Oakland, CA, United States of America. Electronic address: nodo@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce H. Alexander</Name>
        <Affiliation>University of Minnesota School of Public Health, Division of Environmental Health Sciences, Minneapolis, MN, United States of America. Electronic address: balex@umn.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Transplacental transport of paracetamol and its phase II metabolites using the ex vivo placenta perfusion model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30849458</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30086-9</DOI>
    <KeywordList>
      <Keywords>Ex vivo</Keywords>
      <Keywords>Human placenta perfusion model</Keywords>
      <Keywords>Paracetamol</Keywords>
      <Keywords>Paracetamol glucuronide</Keywords>
      <Keywords>Paracetamol sulphate</Keywords>
      <Keywords>Placental transfer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sigrid Conings</Name>
        <Affiliation>Organ Systems, KU Leuven, Department of Development and Regeneration, Leuven, Belgium. Electronic address: sigrid.conings@kuleuven.be.</Affiliation>
      </Author>
      <Author>
        <Name>Fotini Tseke</Name>
        <Affiliation>Organ Systems, KU Leuven, Department of Development and Regeneration, Leuven, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Annick Van den Broeck</Name>
        <Affiliation>Cluster Oncology, Department of Gynaecological Oncology, Biomedical Sciences, KU Leuven, Leuven, Belgium. Electronic address: Annick.vandenbroeck@kuleuven.be.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Qi</Name>
        <Affiliation>Drug Delivery and Disposition, KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium. Electronic address: bing.qi@kuleuven.be.</Affiliation>
      </Author>
      <Author>
        <Name>Jasmin Paulus</Name>
        <Affiliation>Organ Systems, KU Leuven, Department of Development and Regeneration, Leuven, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Frédéric Amant</Name>
        <Affiliation>Gynaecological Oncology, KU eLeuven Department of Oncology, Leuven (Belgium) and Center for Gynecologic Oncology Amsterdam (CGOA), Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: frederic.amant@uzleuven.be.</Affiliation>
      </Author>
      <Author>
        <Name>Pieter Annaert</Name>
        <Affiliation>Drug Delivery and Disposition, KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium. Electronic address: pieter.annaert@kuleuven.be.</Affiliation>
      </Author>
      <Author>
        <Name>Kristel Van Calsteren</Name>
        <Affiliation>Organ Systems, KU Leuven, Department of Development and Regeneration, Leuven, Belgium. Electronic address: kristel.vancalsteren@uzleuven.be.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of the neurotoxicity associated with cobalt nanoparticles and cobalt chloride in Wistar rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30849457</pubmedLink>
    <GrantList>
      <Grant>R01 ES020852</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30085-7</DOI>
    <KeywordList>
      <Keywords>CoCl(2)</Keywords>
      <Keywords>CoNPs</Keywords>
      <Keywords>NRF2</Keywords>
      <Keywords>Neurotoxic effects</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fuli Zheng</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou 350122, China; Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou 350122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhousong Luo</Name>
        <Affiliation>Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou 350122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunyan Zheng</Name>
        <Affiliation>Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou 350122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Li</Name>
        <Affiliation>Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou 350122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwen Zeng</Name>
        <Affiliation>Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou 350122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongyu Yang</Name>
        <Affiliation>Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou 350122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinfa Chen</Name>
        <Affiliation>Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou 350122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanqiao Jin</Name>
        <Affiliation>College of Materials Science and Engineering, Fuzhou University, Fuzhou 350116, China.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Aschner</Name>
        <Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer 209, 1300 Morris Park Avenue, Bronx, NY 10461, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Siying Wu</Name>
        <Affiliation>Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou 350122, China; Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou 350122, China. Electronic address: fmuwsy@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Qunwei Zhang</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Louisville, 485 E. Gray Street, Louisville, KY 40202, USA. Electronic address: qunwei.zhang@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Huangyuan Li</Name>
        <Affiliation>Department of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou 350122, China; Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou 350122, China. Electronic address: fmulhy@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MitoQ ameliorates testis injury from oxidative attack by repairing mitochondria and promoting the Keap1-Nrf2 pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30836114</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30075-4</DOI>
    <KeywordList>
      <Keywords>Blood-Testis Barrier</Keywords>
      <Keywords>MitoQ</Keywords>
      <Keywords>Mitochondrial Targeting</Keywords>
      <Keywords>Nrf2/Keap1</Keywords>
      <Keywords>Oxidative Stress</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jie Zhang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowen Bao</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingya Zhang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiming Zhu</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lvqi Zhou</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiaohui Chen</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Zhang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, PR China. Electronic address: nancyzhang03@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Ma</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, PR China. Electronic address: mabo201012@njtech.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30831132</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30073-0</DOI>
    <KeywordList>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Drp1</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>PGC-1α</Keywords>
      <Keywords>miR-23a</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jingjing Du</Name>
        <Affiliation>Institute of Clinical Pharmacology, the Second Affiliated Hospital of Harbin Medical University (The University Key Laboratory of Drug Research, Heilongjiang Province), Harbin 150086, PR China; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengzhou Hang</Name>
        <Affiliation>Institute of Clinical Pharmacology, the Second Affiliated Hospital of Harbin Medical University (The University Key Laboratory of Drug Research, Heilongjiang Province), Harbin 150086, PR China; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Pan</Name>
        <Affiliation>Institute of Clinical Pharmacology, the Second Affiliated Hospital of Harbin Medical University (The University Key Laboratory of Drug Research, Heilongjiang Province), Harbin 150086, PR China; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Burong Feng</Name>
        <Affiliation>Institute of Clinical Pharmacology, the Second Affiliated Hospital of Harbin Medical University (The University Key Laboratory of Drug Research, Heilongjiang Province), Harbin 150086, PR China; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuyang Zheng</Name>
        <Affiliation>Institute of Clinical Pharmacology, the Second Affiliated Hospital of Harbin Medical University (The University Key Laboratory of Drug Research, Heilongjiang Province), Harbin 150086, PR China; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Tingting Chen</Name>
        <Affiliation>Institute of Clinical Pharmacology, the Second Affiliated Hospital of Harbin Medical University (The University Key Laboratory of Drug Research, Heilongjiang Province), Harbin 150086, PR China; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lihui Zhao</Name>
        <Affiliation>Institute of Clinical Pharmacology, the Second Affiliated Hospital of Harbin Medical University (The University Key Laboratory of Drug Research, Heilongjiang Province), Harbin 150086, PR China; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhimin Du</Name>
        <Affiliation>Institute of Clinical Pharmacology, the Second Affiliated Hospital of Harbin Medical University (The University Key Laboratory of Drug Research, Heilongjiang Province), Harbin 150086, PR China; State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, PR China; Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, PR China. Electronic address: dzm1956@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30831131</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30074-2</DOI>
    <KeywordList>
      <Keywords>HIF-1α</Keywords>
      <Keywords>Hypoxic pulmonary hypertension</Keywords>
      <Keywords>Rho-kinase</Keywords>
      <Keywords>RhoA</Keywords>
      <Keywords>TRPC channels</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xue Ying Wang</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Mo</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Tian</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Xiao Liu</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Guang Zhou</Name>
        <Affiliation>Department of Physiology, School of Basic Medical Sciences, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Sun</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Da Feng</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiong Xiao</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Wei Hao</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Nan Zhang</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Li</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Cao</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China; School of Chemistry &amp; Pharmacy, Northwest A&amp;F University, Yangling, China. Electronic address: caowei@nwafu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Qiang Li</Name>
        <Affiliation>Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China. Electronic address: xxqqli@fmmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ac-SDKP increases α-TAT 1 and promotes the apoptosis in lung fibroblasts and epithelial cells double-stimulated with TGF-β1 and silica.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30826375</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30072-9</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>DNA double strand breaks</Keywords>
      <Keywords>N-acetyl-seryl-aspartyl-lysyl-proline</Keywords>
      <Keywords>Silicosis</Keywords>
      <Keywords>α-Tubulin acetyltransferase 1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Li Shifeng</Name>
        <Affiliation>Basic Medical College, Hebei Medical University, Shijiazhuang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Hong</Name>
        <Affiliation>Medical Research Center, Hebei Key Laboratory for Organ Fibrosis Research, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Xue</Name>
        <Affiliation>Key Laboratory of Functional and Clinical Translational Medicine, Fujian Province University, Department of Basic Medicine, Xiamen Medical College, Xiamen, China.</Affiliation>
      </Author>
      <Author>
        <Name>Niu Siyu</Name>
        <Affiliation>Medical Research Center, Hebei Key Laboratory for Organ Fibrosis Research, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhang Qiaodan</Name>
        <Affiliation>Medical Research Center, Hebei Key Laboratory for Organ Fibrosis Research, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Dingjie</Name>
        <Affiliation>College of Traditional Chinese Medicine, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhang Lijuan</Name>
        <Affiliation>Medical Research Center, Hebei Key Laboratory for Organ Fibrosis Research, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhongqiu</Name>
        <Affiliation>Basic Medicine College, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gao Xuemin</Name>
        <Affiliation>Basic Medical College, Hebei Medical University, Shijiazhuang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cai Wenchen</Name>
        <Affiliation>School of Public Health, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhang Guizhen</Name>
        <Affiliation>Medical Research Center, Hebei Key Laboratory for Organ Fibrosis Research, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Dan</Name>
        <Affiliation>Medical Research Center, Hebei Key Laboratory for Organ Fibrosis Research, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wang Ruimin</Name>
        <Affiliation>Medical Research Center, Hebei Key Laboratory for Organ Fibrosis Research, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Fang</Name>
        <Affiliation>Basic Medical College, Hebei Medical University, Shijiazhuang, China. Electronic address: fangyang@ncst.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical safety evaluation of the adrenomedullin-binding antibody Adrecizumab in rodents, dogs and non-human primates.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30822437</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30071-7</DOI>
    <KeywordList>
      <Keywords>Adrecizumab</Keywords>
      <Keywords>Adrenomedullin</Keywords>
      <Keywords>Antibody</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Sepsis</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christopher Geven</Name>
        <Affiliation>Department of Intensive Care Medicine, Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Matthijs Kox</Name>
        <Affiliation>Department of Intensive Care Medicine, Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Alice Blet</Name>
        <Affiliation>UMR 942 Inserm, University Paris Diderot, INI-CRCT, APHP, Department of Anesthesia, Burn and Critical Care, Hôpitaux Universitaire Saint Louis Lariboisière, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandre Mebazaa</Name>
        <Affiliation>UMR 942 Inserm, University Paris Diderot, INI-CRCT, APHP, Department of Anesthesia, Burn and Critical Care, Hôpitaux Universitaire Saint Louis Lariboisière, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Mathias Schroedter</Name>
        <Affiliation>Adrenomed AG, Hennigsdorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Joachim Struck</Name>
        <Affiliation>Adrenomed AG, Hennigsdorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Bergmann</Name>
        <Affiliation>Adrenomed AG, Hennigsdorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Pickkers</Name>
        <Affiliation>Department of Intensive Care Medicine, Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: peter.pickkers@radboudumc.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30807757</pubmedLink>
    <GrantList>
      <Grant>R01 DA007908</Grant>
      <Grant>R01 DA047180</Grant>
      <Grant>T32 ES007255</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30070-5</DOI>
    <KeywordList>
      <Keywords>Cannabinoids</Keywords>
      <Keywords>Interferon α</Keywords>
      <Keywords>Plasmacytoid dendritic cells</Keywords>
      <Keywords>Toll-like receptors</Keywords>
      <Keywords>Tumor necrosis factor α</Keywords>
      <Keywords>Δ9-Tetrahydrocannabinol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joseph E. Henriquez</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert B. Crawford</Name>
        <Affiliation>Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Norbert E. Kaminski</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, USA. Electronic address: kamins11@msu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cadmium-induced apoptosis through reactive oxygen species-mediated mitochondrial oxidative stress and the JNK signaling pathway in TM3 cells, a model of mouse Leydig cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30796935</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30069-9</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>JNK</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>TM3 cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susu Wang</Name>
        <Affiliation>Department of Nutrition, School of Public Health, Xuzhou Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangmei Ren</Name>
        <Affiliation>Department of Nutrition, School of Public Health, Xuzhou Medical University, China. Electronic address: rxm@xzhmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xindi Hu</Name>
        <Affiliation>Department of Nutrition, School of Public Health, Xuzhou Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Zhou</Name>
        <Affiliation>Department of Nutrition, School of Public Health, Xuzhou Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chaoqin Zhang</Name>
        <Affiliation>Department of Nutrition, School of Public Health, Xuzhou Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meirong Zhang</Name>
        <Affiliation>Department of Hygiene, School of Public Health, Xuzhou Medical University, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30796934</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30066-3</DOI>
    <KeywordList>
      <Keywords>Cannabidiol</Keywords>
      <Keywords>DHM-Cannabidiol</Keywords>
      <Keywords>Macrophages</Keywords>
      <Keywords>NF-kB</Keywords>
      <Keywords>TNF</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rangel L. Silva</Name>
        <Affiliation>Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriela T. Silveira</Name>
        <Affiliation>Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos W. Wanderlei</Name>
        <Affiliation>Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil; Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Nerry T. Cecilio</Name>
        <Affiliation>Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandre G. M. Maganin</Name>
        <Affiliation>Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marcelo Franchin</Name>
        <Affiliation>Piracicaba Dental School, University of Campinas, Piracicaba 13414-903, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lucas M. M. Marques</Name>
        <Affiliation>Department of Physical Chemistry, Faculty of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Norberto P. Lopes</Name>
        <Affiliation>Department of Physical Chemistry, Faculty of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>José A. Crippa</Name>
        <Affiliation>Department of Neurosciences and Behavior, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Francisco S. Guimarães</Name>
        <Affiliation>Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>José C. F. Alves-Filho</Name>
        <Affiliation>Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Q. Cunha</Name>
        <Affiliation>Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Thiago M. Cunha</Name>
        <Affiliation>Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil. Electronic address: thicunha@usp.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Folate receptor-beta expression as a diagnostic target in human &amp; rodent nonalcoholic steatohepatitis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30794826</pubmedLink>
    <GrantList>
      <Grant>R01 HD062489</Grant>
      <Grant>T32 ES007091</Grant>
      <Grant>P30 ES006694</Grant>
      <Grant>F31 AT002842</Grant>
      <Grant>HHSN267200700004G</Grant>
      <Grant>R01 DK068039</Grant>
      <Grant>R01 ES028668</Grant>
      <Grant>HHSN267200700004C</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30058-4</DOI>
    <KeywordList>
      <Keywords>Folate receptor-beta</Keywords>
      <Keywords>Imaging</Keywords>
      <Keywords>Macrophages</Keywords>
      <Keywords>NAFLD</Keywords>
      <Keywords>NASH models</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>April D. Lake</Name>
        <Affiliation>University of Arizona, Department of Pharmacology and Toxicology, Tucson, AZ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rhiannon N. Hardwick</Name>
        <Affiliation>University of Arizona, Department of Pharmacology and Toxicology, Tucson, AZ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher P. Leamon</Name>
        <Affiliation>Endocyte, Inc., West Lafayette, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Philip S. Low</Name>
        <Affiliation>Purdue University, Department of Chemistry, West Lafayette, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nathan J. Cherrington</Name>
        <Affiliation>University of Arizona, Department of Pharmacology and Toxicology, Tucson, AZ, USA. Electronic address: cherrington@pharmacy.arizona.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure-activity relationships.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30790579</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30059-6</DOI>
    <KeywordList>
      <Keywords>Flavonoids</Keywords>
      <Keywords>Inhibition</Keywords>
      <Keywords>P-glycoprotein</Keywords>
      <Keywords>Structure–activity relationships</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jie Bai</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China. Electronic address: baijie@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shengyu Zhao</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China. Electronic address: zhaoshengyu@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqing Fan</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China. Electronic address: fanxiaoqing@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yonghui Chen</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China. Electronic address: chenyonghui@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowen Zou</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China. Electronic address: zouxiaowen@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Minwan Hu</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China. Electronic address: huminwan@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Baolian Wang</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China. Electronic address: wangbaolian@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Jin</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China. Electronic address: rebeccagold@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojian Wang</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China. Electronic address: wangxiaojian@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jinping Hu</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China. Electronic address: hujp@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Zhang</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China. Electronic address: danzhang@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Li</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China. Electronic address: yanli@imm.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Combined use of vitamin E and nimodipine ameliorates dibutyl phthalate-induced memory deficit and apoptosis in mice by inhibiting the ERK 1/2 pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30776390</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30057-2</DOI>
    <KeywordList>
      <Keywords>Dibutyl phthalate</Keywords>
      <Keywords>ERK 1/2 pathway</Keywords>
      <Keywords>Hippocampal neurons</Keywords>
      <Keywords>Learning disabilities</Keywords>
      <Keywords>Nimodipine</Keywords>
      <Keywords>Vitamin E</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Biao Yan</Name>
        <Affiliation>Laboratory of Environment-Immunological and Neurological Diseases, School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning 437100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanling Sun</Name>
        <Affiliation>Laboratory of Environment-Immunological and Neurological Diseases, School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning 437100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Zeng</Name>
        <Affiliation>Laboratory of Environment-Immunological and Neurological Diseases, School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning 437100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingying Chen</Name>
        <Affiliation>Laboratory of Environment-Immunological and Neurological Diseases, School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning 437100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chongyao Li</Name>
        <Affiliation>Laboratory of Environment-Immunological and Neurological Diseases, School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning 437100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Song</Name>
        <Affiliation>Laboratory of Environment-Immunological and Neurological Diseases, School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning 437100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Zhang</Name>
        <Affiliation>Laboratory of Environment-Immunological and Neurological Diseases, School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning 437100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Yang</Name>
        <Affiliation>Laboratory of Environment-Immunological and Neurological Diseases, School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning 437100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Wu</Name>
        <Affiliation>Laboratory of Environment-Immunological and Neurological Diseases, School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning 437100, China. Electronic address: wuyang@hbstu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Ma</Name>
        <Affiliation>Laboratory of Environment-Immunological and Neurological Diseases, School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning 437100, China. Electronic address: maping@hbstu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PFKFB3 promotes endotoxemia-induced myocardial dysfunction through inflammatory signaling and apoptotic induction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30776389</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30056-0</DOI>
    <KeywordList>
      <Keywords>3-(3pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO)</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cardiac dysfunction</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>PFKFB3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wen Tian</Name>
        <Affiliation>Department of Pharmacology and Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Sheng Guo</Name>
        <Affiliation>Department of Pharmacology and Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chong Yao Li</Name>
        <Affiliation>School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Cao</Name>
        <Affiliation>Shaanxi Key Laboratory of Natural Products &amp; Chemical Biology, School of Chemistry &amp; Pharmacy, Northwest A&amp;F University, Yangling, China. Electronic address: caowei@nwafu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Ying Wang</Name>
        <Affiliation>Department of Pharmacology and Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Mo</Name>
        <Affiliation>Department of Pharmacology and Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Wei Hao</Name>
        <Affiliation>Department of Pharmacology and Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Da Feng</Name>
        <Affiliation>Department of Pharmacology and Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Sun</Name>
        <Affiliation>Department of Pharmacology and Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Lei</Name>
        <Affiliation>School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Nan Zhang</Name>
        <Affiliation>Department of Pharmacology and Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Gao Zhao</Name>
        <Affiliation>Department of Pharmacology and Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Qiang Li</Name>
        <Affiliation>Department of Pharmacology and Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, School of Pharmacy, Fourth Military Medical University, Xi'an, China. Electronic address: xxqqli@fmmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of a human in vitro skin test for predicting drug hypersensitivity reactions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30768973</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30054-7</DOI>
    <KeywordList>
      <Keywords>Drug allergy</Keywords>
      <Keywords>Drug hypersensitivity</Keywords>
      <Keywords>Drug induced T cell responses</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>Low molecular weight drugs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. S. Ahmed</Name>
        <Affiliation>Alcyomics Ltd, Bulman House, Regent Centre, Gosforth, Newcastle-upon-Tyne NE3 3LS, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>J. Whritenour</Name>
        <Affiliation>Pfizer Inc., Drug Safety Research and Development, Eastern Point Rd, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. M. Ahmed</Name>
        <Affiliation>Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne NE2 4HH, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>L. Bibby</Name>
        <Affiliation>Alcyomics Ltd, Bulman House, Regent Centre, Gosforth, Newcastle-upon-Tyne NE3 3LS, United Kingdom; Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne NE2 4HH, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>L. Darby</Name>
        <Affiliation>Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne NE2 4HH, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>X. N. Wang</Name>
        <Affiliation>Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne NE2 4HH, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>J. Watson</Name>
        <Affiliation>Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne NE2 4HH, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Dickinson</Name>
        <Affiliation>Alcyomics Ltd, Bulman House, Regent Centre, Gosforth, Newcastle-upon-Tyne NE3 3LS, United Kingdom; Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne NE2 4HH, United Kingdom. Electronic address: anne.dickinson@ncl.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PCB 126 induces monocyte/macrophage polarization and inflammation through AhR and NF-κB pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30768972</pubmedLink>
    <GrantList>
      <Grant>K99 ES028734</Grant>
      <Grant>P42 ES007380</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30055-9</DOI>
    <KeywordList>
      <Keywords>Atherosclerosis</Keywords>
      <Keywords>Cardiovascular disease</Keywords>
      <Keywords>Dioxins</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Monocyte macrophage polarization</Keywords>
      <Keywords>PCB 126</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chunyan Wang</Name>
        <Affiliation>University of Kentucky Superfund Research Center, University of Kentucky, Lexington, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael C. Petriello</Name>
        <Affiliation>University of Kentucky Superfund Research Center, University of Kentucky, Lexington, KY, USA; Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Beibei Zhu</Name>
        <Affiliation>Department of Internal Medicine, Division of Endocrinology, Barnstable Brown Diabetes and Obesity Center, University of Kentucky, Lexington, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bernhard Hennig</Name>
        <Affiliation>University of Kentucky Superfund Research Center, University of Kentucky, Lexington, KY, USA; Department of Animal and Food Sciences, University of Kentucky, Lexington, KY, USA. Electronic address: bhennig@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evidence for the involvement of opioid and cannabinoid systems in the peripheral antinociception mediated by resveratrol.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30763598</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30053-5</DOI>
    <AuthorList>
      <Author>
        <Name>Cristina da Costa Oliveira</Name>
        <Affiliation>Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marina Gomes Miranda E. Castor</Name>
        <Affiliation>Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Camila Gomes Miranda E. Castor</Name>
        <Affiliation>Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ághata de França Costa</Name>
        <Affiliation>Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Renata Cristina Mendes Ferreira</Name>
        <Affiliation>Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Josiane Fernandes da Silva</Name>
        <Affiliation>Department of Physiology, Institute of Biological Sciences, UFMG, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juliana Maria Navia Pelaez</Name>
        <Affiliation>Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luciano Dos Santos Aggum Capettini</Name>
        <Affiliation>Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Virginia Soares Lemos</Name>
        <Affiliation>Department of Physiology, Institute of Biological Sciences, UFMG, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Igor Dimitri Gama Duarte</Name>
        <Affiliation>Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea de Castro Perez</Name>
        <Affiliation>Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sérgio Henrique Sousa Santos</Name>
        <Affiliation>Department of Physiology, Institute of Biological Sciences, UFMG, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Thiago Roberto Lima Romero</Name>
        <Affiliation>Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil. Electronic address: thiromero@ufmg.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30742845</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30052-3</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>NFATc1</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Osteoporosis</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>p38</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhiyuan Liu</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongyong Hou</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Li</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yang</Name>
        <Affiliation>Department of Rehabilitation, The First Affiliated Hospital of China Medical University, No. 155 Nanjing North Road, Heping Area, Shenyang 110001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingkun Jia</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhixuan Hong</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tingfeng Li</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyuan Xu</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingqi Fu</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongxin Sun</Name>
        <Affiliation>Department of Rehabilitation, The First Affiliated Hospital of China Medical University, No. 155 Nanjing North Road, Heping Area, Shenyang 110001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Masayuki Yamamoto</Name>
        <Affiliation>Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Huihui Wang</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China. Electronic address: hhwang@cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China. Electronic address: jbpi@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low concentrations of perfluorooctane sulfonate repress osteogenic and enhance adipogenic differentiation of human mesenchymal stem cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30738844</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30042-0</DOI>
    <KeywordList>
      <Keywords>Bone health</Keywords>
      <Keywords>Microarray analysis</Keywords>
      <Keywords>Multipotent differentiation</Keywords>
      <Keywords>Perfluoroalkyl compounds</Keywords>
      <Keywords>Stem cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Liu</Name>
        <Affiliation>Key Laboratory of Industrial Ecology and Environmental Engineering (MOE), School of Environmental Science and Technology, Dalian University of Technology, Dalian, China. Electronic address: liu_wei@dlut.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Qin</Name>
        <Affiliation>Key Laboratory of Industrial Ecology and Environmental Engineering (MOE), School of Environmental Science and Technology, Dalian University of Technology, Dalian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yifan Pan</Name>
        <Affiliation>Key Laboratory of Industrial Ecology and Environmental Engineering (MOE), School of Environmental Science and Technology, Dalian University of Technology, Dalian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Luo</Name>
        <Affiliation>Key Laboratory of Industrial Ecology and Environmental Engineering (MOE), School of Environmental Science and Technology, Dalian University of Technology, Dalian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhou Zhang</Name>
        <Affiliation>Key Laboratory of Industrial Ecology and Environmental Engineering (MOE), School of Environmental Science and Technology, Dalian University of Technology, Dalian, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The inhibitory effect of antiretroviral drugs on the L-carnitine uptake in human placenta.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30735677</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30043-2</DOI>
    <KeywordList>
      <Keywords>Antiretrovirals</Keywords>
      <Keywords>Carnitine</Keywords>
      <Keywords>Carnitine deficiency</Keywords>
      <Keywords>Membrane transport</Keywords>
      <Keywords>Placenta</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rona Karahoda</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Ceckova</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Czech Republic. Electronic address: martina.ceckova@faf.cuni.cz.</Affiliation>
      </Author>
      <Author>
        <Name>Frantisek Staud</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Czech Republic.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>New insights into nuclear factor erythroid 2-related factors in toxicology and pharmacology.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30731095</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30023-7</DOI>
    <AuthorList>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>School of Public Health, China Medical University, PR China. Electronic address: jbpi@cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>John D. Hayes</Name>
        <Affiliation>Jacqui Wood Cancer Centre, Division of Cellular Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK. Electronic address: j.d.hayes@dundee.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Masayuki Yamamoto</Name>
        <Affiliation>Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan. Electronic address: masiyamamoto@med.tohoku.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Maternal titanium dioxide nanomaterial inhalation exposure compromises placental hemodynamics.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30711534</pubmedLink>
    <GrantList>
      <Grant>R01 ES015022</Grant>
      <Grant>U54 GM104942</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30040-7</DOI>
    <KeywordList>
      <Keywords>Engineered nanomaterials</Keywords>
      <Keywords>Microcirculation</Keywords>
      <Keywords>Placenta</Keywords>
      <Keywords>Titanium dioxide nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alaeddin B. Abukabda</Name>
        <Affiliation>Department of Physiology and Pharmacology, West Virginia University School of Medicine, Morgantown, WV, USA; Toxicology Working Group, West Virginia University School of Medicine, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth C. Bowdridge</Name>
        <Affiliation>Department of Physiology and Pharmacology, West Virginia University School of Medicine, Morgantown, WV, USA; Toxicology Working Group, West Virginia University School of Medicine, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carroll R. McBride</Name>
        <Affiliation>Department of Physiology and Pharmacology, West Virginia University School of Medicine, Morgantown, WV, USA; Toxicology Working Group, West Virginia University School of Medicine, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas P. Batchelor</Name>
        <Affiliation>Department of Physiology and Pharmacology, West Virginia University School of Medicine, Morgantown, WV, USA; Toxicology Working Group, West Virginia University School of Medicine, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William T. Goldsmith</Name>
        <Affiliation>Department of Physiology and Pharmacology, West Virginia University School of Medicine, Morgantown, WV, USA; Toxicology Working Group, West Virginia University School of Medicine, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Krista L. Garner</Name>
        <Affiliation>Department of Physiology and Pharmacology, West Virginia University School of Medicine, Morgantown, WV, USA; Toxicology Working Group, West Virginia University School of Medicine, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sherri Friend</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy R. Nurkiewicz</Name>
        <Affiliation>Department of Physiology and Pharmacology, West Virginia University School of Medicine, Morgantown, WV, USA; Toxicology Working Group, West Virginia University School of Medicine, Morgantown, WV, USA; National Institute for Occupational Safety and Health, Morgantown, WV, USA. Electronic address: tnurkiewicz@hsc.wvu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antibacterial activity of resveratrol structural analogues: A mechanistic evaluation of the structure-activity relationship.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30711533</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30041-9</DOI>
    <KeywordList>
      <Keywords>Antibacterial</Keywords>
      <Keywords>DNA cleavage</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Resveratrol analogues</Keywords>
      <Keywords>Stilbenes</Keywords>
      <Keywords>Structure-activity relation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Deepti Singh</Name>
        <Affiliation>Bio-Organic Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400 085, India; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400 094, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca Mendonsa</Name>
        <Affiliation>Bio-Organic Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400 085, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mrunesh Koli</Name>
        <Affiliation>Bio-Organic Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400 085, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mahesh Subramanian</Name>
        <Affiliation>Bio-Organic Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400 085, India; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400 094, India. Electronic address: maheshs@barc.gov.in.</Affiliation>
      </Author>
      <Author>
        <Name>Sandip Kumar Nayak</Name>
        <Affiliation>Bio-Organic Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400 085, India; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400 094, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxic and immunotoxic effects of the organophosphate metabolite diethyldithiophosphate (DEDTP) in Vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30703381</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30039-0</DOI>
    <KeywordList>
      <Keywords>Antigen challenge</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>DEDTP</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Immunomodulation</Keywords>
      <Keywords>Murine model</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>D. Medina-Buelvas</Name>
        <Affiliation>Toxicology Department, Centre for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV-IPN), Av. IPN 2508, San Pedro Zacatenco, GA. Madero, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>E. Estrada-Muñiz</Name>
        <Affiliation>Toxicology Department, Centre for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV-IPN), Av. IPN 2508, San Pedro Zacatenco, GA. Madero, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>M. Flores-Valadez</Name>
        <Affiliation>Toxicology Department, Centre for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV-IPN), Av. IPN 2508, San Pedro Zacatenco, GA. Madero, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>L. Vega</Name>
        <Affiliation>Toxicology Department, Centre for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV-IPN), Av. IPN 2508, San Pedro Zacatenco, GA. Madero, Mexico City 07360, Mexico. Electronic address: lvega@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>M1 macrophage mediated increased reactive oxygen species (ROS) influence wound healing via the MAPK signaling in vitro and in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30690042</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30038-9</DOI>
    <KeywordList>
      <Keywords>Benign prostatic hyperplasia</Keywords>
      <Keywords>M1 macrophage</Keywords>
      <Keywords>MAPK</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>Wound healing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zheng Deng</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Shi</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Zhou</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital Affiliated to Nanjing Medical University, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Sun</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; Institute of Urology, Shanghai Jiao Tong University, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Hao Sun</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; Institute of Urology, Shanghai Jiao Tong University, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Sun</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital Affiliated to Nanjing Medical University, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Chen</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Deng Li</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Yi Jiang</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Zhe Zhao</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Di Cui</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; Institute of Urology, Shanghai Jiao Tong University, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xing Jie Wang</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; Institute of Urology, Shanghai Jiao Tong University, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Feng Jing</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; Institute of Urology, Shanghai Jiao Tong University, Shanghai 200080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Jie Xia</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; Institute of Urology, Shanghai Jiao Tong University, Shanghai 200080, China. Electronic address: xsjurologist@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bang Min Han</Name>
        <Affiliation>Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; Institute of Urology, Shanghai Jiao Tong University, Shanghai 200080, China. Electronic address: hanbm@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of hepatic cytochrome b</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30685480</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30034-1</DOI>
    <KeywordList>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Cytochrome b(5)</Keywords>
      <Keywords>DNA Adducts</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Mouse models</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lindsay Reed</Name>
        <Affiliation>Department of Analytical, Environmental and Forensic Sciences, MRC-PHE Centre for Environment and Health, King's College London, London, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Radek Indra</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Iveta Mrizova</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Michaela Moserova</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Heinz H. Schmeiser</Name>
        <Affiliation>Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>C. Roland Wolf</Name>
        <Affiliation>Division of Cancer Research, Jacqui Wood Cancer Centre, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Colin J. Henderson</Name>
        <Affiliation>Division of Cancer Research, Jacqui Wood Cancer Centre, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Stiborova</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>David H. Phillips</Name>
        <Affiliation>Department of Analytical, Environmental and Forensic Sciences, MRC-PHE Centre for Environment and Health, King's College London, London, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Volker M. Arlt</Name>
        <Affiliation>Department of Analytical, Environmental and Forensic Sciences, MRC-PHE Centre for Environment and Health, King's College London, London, United Kingdom. Electronic address: volker.arlt@kcl.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30684532</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30021-3</DOI>
    <KeywordList>
      <Keywords>Bisphenol S</Keywords>
      <Keywords>Breast cancer cells</Keywords>
      <Keywords>Cell cycle</Keywords>
      <Keywords>Cell proliferation</Keywords>
      <Keywords>Cyclin D</Keywords>
      <Keywords>Retinoblastoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhenxian Lin</Name>
        <Affiliation>Marine Life Science College, Ocean University of China, 5 Yushan Road, Qingdao 266003, Shandong province, PR China; School of Biology and Brewing Engineering, Taishan University, 525 Dongyue Street, Tai'an 271000, Shandong province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaona Zhang</Name>
        <Affiliation>Marine Life Science College, Ocean University of China, 5 Yushan Road, Qingdao 266003, Shandong province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Zhao</Name>
        <Affiliation>School of Environmental and Municipal Engineering, Qingdao University of Technology, 11 Fushun Road, Qingdao 266033, Shandong province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaoguo Ru</Name>
        <Affiliation>Marine Life Science College, Ocean University of China, 5 Yushan Road, Qingdao 266003, Shandong province, PR China. Electronic address: rusg@ouc.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dehydroandrographolide inhibits IgE-mediated anaphylactic reactions via calcium signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30684531</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30033-X</DOI>
    <KeywordList>
      <Keywords>Degranulation</Keywords>
      <Keywords>Dehydroandrographolide</Keywords>
      <Keywords>IgE-mediated anaphylactic reactions</Keywords>
      <Keywords>Mast cells</Keywords>
      <Keywords>P-PLCγ inhibitor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Delu Che</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yajing Hou</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingnan Zeng</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chaomei Li</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongjing Zhang</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Di Wei</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shiling Hu</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Liu</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongli An</Name>
        <Affiliation>Center for Translational Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yajun Wang</Name>
        <Affiliation>Department of Physical Examination, First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an 710061, China. Electronic address: 13709199383@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Zhang</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China. Electronic address: taozhang@mail.xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estrogen down regulates COMT transcription via promoter DNA methylation in human breast cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30684530</pubmedLink>
    <GrantList>
      <Grant>R00 ES016817</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30025-0</DOI>
    <KeywordList>
      <Keywords>COMT</Keywords>
      <Keywords>DNA Methylation</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Estradiol</Keywords>
      <Keywords>Genistein</Keywords>
      <Keywords>Sulforaphane</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qian Wu</Name>
        <Affiliation>Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Department of Hygienic Analysis and Detection and Ministry of Education Key Lab for Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shelly Odwin-Dacosta</Name>
        <Affiliation>Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Shuyuan Cao</Name>
        <Affiliation>Department of Hygienic Analysis and Detection and Ministry of Education Key Lab for Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>James D. Yager</Name>
        <Affiliation>Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Wan Yee Tang</Name>
        <Affiliation>Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. Electronic address: wtang10@jhu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hinokitiol suppresses growth of B16 melanoma by activating ERK/MKP3/proteosome pathway to downregulate survivin expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30684529</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30024-9</DOI>
    <KeywordList>
      <Keywords>B16 melanoma</Keywords>
      <Keywords>ERK</Keywords>
      <Keywords>Hinokitiol</Keywords>
      <Keywords>MAPK phosphatase-3</Keywords>
      <Keywords>Proteosome</Keywords>
      <Keywords>Survivin</Keywords>
      <Keywords>Ubiquitin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kai Che Wei</Name>
        <Affiliation>Department of Dermatology, Kaohsiung Veterans General Hospital, Kaoshiung 802, Taiwan; Faculty of Yuhing Junior College of Health Care and Management, Kaohsiung 802, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Fang Chen</Name>
        <Affiliation>Master and PhD Programs in Pharmacology and Toxicology, School of Medicine, Tzu Chi University, Hualien 970, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Fu Chen</Name>
        <Affiliation>Master and PhD Programs in Pharmacology and Toxicology, School of Medicine, Tzu Chi University, Hualien 970, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Ho Lin</Name>
        <Affiliation>Master and PhD Programs in Pharmacology and Toxicology, School of Medicine, Tzu Chi University, Hualien 970, Taiwan; Department of Pharmacology, School of Medicine, Tzu Chi University, Hualien 970, Taiwan. Electronic address: chlin97@mail.tcu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel target for the promotion of dermal wound healing: Ryanodine receptors.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30684528</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30035-3</DOI>
    <KeywordList>
      <Keywords>Calcium channel</Keywords>
      <Keywords>Ryanodine receptor</Keywords>
      <Keywords>Skin fold chamber</Keywords>
      <Keywords>Wound healing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Döníz Degovics</Name>
        <Affiliation>Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary. Electronic address: degovics.doniz@med.u-szeged.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Petra Hartmann</Name>
        <Affiliation>Institute of Surgical Research, University of Szeged, Szeged, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>István Balázs Németh</Name>
        <Affiliation>Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Noémi Árva-Nagy</Name>
        <Affiliation>Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Enikő Kaszonyi</Name>
        <Affiliation>Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Edit Szél</Name>
        <Affiliation>Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Gerda Strifler</Name>
        <Affiliation>Institute of Surgical Research, University of Szeged, Szeged, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Balázs Bende</Name>
        <Affiliation>Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>László Krenács</Name>
        <Affiliation>Laboratory of Tumour Pathology and Molecular Diagnostics, Szeged, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Lajos Kemény</Name>
        <Affiliation>Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary; MTA-SZTE Dermatological Research Group, Szeged, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Gábor Erős</Name>
        <Affiliation>Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quantum dots and mouse strain influence house dust mite-induced allergic airway disease.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30682383</pubmedLink>
    <GrantList>
      <Grant>R01 HL089215</Grant>
      <Grant>K24 AI130263</Grant>
      <Grant>P30 DK089507</Grant>
      <Grant>T32 ES015459</Grant>
      <Grant>P30 ES007033</Grant>
      <Grant>U19 ES019545</Grant>
      <Grant>U19 AI125378</Grant>
      <Grant>F32 HL134217</Grant>
      <Grant>R01 HL122895</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30026-2</DOI>
    <AuthorList>
      <Author>
        <Name>David K. Scoville</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James D. Nolin</Name>
        <Affiliation>Department of Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>H. Luke Ogden</Name>
        <Affiliation>Department of Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dowon An</Name>
        <Affiliation>Department of Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zahra Afsharinejad</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brian W. Johnson</Name>
        <Affiliation>Department of Comparative Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Theo K. Bammler</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohu Gao</Name>
        <Affiliation>Department of Bioengineering, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Charles W. Frevert</Name>
        <Affiliation>Department of Comparative Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William A. Altemeier</Name>
        <Affiliation>Department of Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Teal S. Hallstrand</Name>
        <Affiliation>Department of Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Terrance J. Kavanagh</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA. Electronic address: tjkav@uw.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective effects of polydatin against sulfur mustard-induced hepatic injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30677423</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30022-5</DOI>
    <KeywordList>
      <Keywords>Hepatic injury</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Polydatin</Keywords>
      <Keywords>Sirt1</Keywords>
      <Keywords>Sulfur mustard</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hao Zhang</Name>
        <Affiliation>College of Science, Dalian Ocean University, Dalian 116023, China; Lab of Toxicology &amp; Pharmacology, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongchun Chen</Name>
        <Affiliation>Lab of Toxicology &amp; Pharmacology, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhipeng Pei</Name>
        <Affiliation>Lab of Toxicology &amp; Pharmacology, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huanhuan Gao</Name>
        <Affiliation>Lab of Toxicology &amp; Pharmacology, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenwen Shi</Name>
        <Affiliation>Lab of Toxicology &amp; Pharmacology, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingxue Sun</Name>
        <Affiliation>Lab of Toxicology &amp; Pharmacology, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingqiang Xu</Name>
        <Affiliation>Lab of Toxicology &amp; Pharmacology, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Zhao</Name>
        <Affiliation>Lab of Toxicology &amp; Pharmacology, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenqi Meng</Name>
        <Affiliation>Lab of Toxicology &amp; Pharmacology, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, China. Electronic address: mengwenqi_xy@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Xiao</Name>
        <Affiliation>Lab of Toxicology &amp; Pharmacology, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, China. Electronic address: kaixiaocn@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of a spiroketal compound Peniciketal A and its molecular mechanisms on growth inhibition in human leukemia.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30660475</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30543-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Leukemia</Keywords>
      <Keywords>Peniciketal A</Keywords>
      <Keywords>Proteomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xue Gao</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuming Zhou</Name>
        <Affiliation>Affiliated Hospital of Binzhou Medical University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongliu Sun</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Desheng Liu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Zhang</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junru Zhang</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weizhong Liu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China. Electronic address: lwz1963@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohong Pan</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China. Electronic address: panxiaohong@bzmc.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A multiplexed UPLC-MS/MS assay for the simultaneous measurement of urinary safety biomarkers of drug-induced kidney injury and phospholipidosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30653977</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30020-1</DOI>
    <KeywordList>
      <Keywords>Bis(monoacylglycerol)phosphate</Keywords>
      <Keywords>Drug-induced kidney injury</Keywords>
      <Keywords>Drug-induced phospholipidosis</Keywords>
      <Keywords>Kidney injury molecule-1 (KIM-1)</Keywords>
      <Keywords>Nephrotoxicity</Keywords>
      <Keywords>Urinary safety biomarkers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elizabeth Tengstrand</Name>
        <Affiliation>Nextcea Inc., 500 West Cummings Park #4550, Woburn, MA 01801, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hannah Zhang</Name>
        <Affiliation>Nextcea Inc., 500 West Cummings Park #4550, Woburn, MA 01801, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nanjun Liu</Name>
        <Affiliation>Nextcea Inc., 500 West Cummings Park #4550, Woburn, MA 01801, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kelly Dunn</Name>
        <Affiliation>Nextcea Inc., 500 West Cummings Park #4550, Woburn, MA 01801, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Hsieh</Name>
        <Affiliation>Nextcea Inc., 500 West Cummings Park #4550, Woburn, MA 01801, USA. Electronic address: frank.hsieh@nextcea.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Macrophage-secreted TSLP and MMP9 promote bleomycin-induced pulmonary fibrosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30653976</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30018-3</DOI>
    <KeywordList>
      <Keywords>Epithelial-mesenchymal transition</Keywords>
      <Keywords>Fibroblast migration</Keywords>
      <Keywords>MMP9</Keywords>
      <Keywords>Macrophage</Keywords>
      <Keywords>Pulmonary fibrosis</Keywords>
      <Keywords>TSLP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guanqun Li</Name>
        <Affiliation>Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology &amp; Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fuquan Jin</Name>
        <Affiliation>Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology &amp; Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiangxia Du</Name>
        <Affiliation>Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology &amp; Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiaojun He</Name>
        <Affiliation>Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology &amp; Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Yang</Name>
        <Affiliation>Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology &amp; Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peihua Luo</Name>
        <Affiliation>Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology &amp; Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Electronic address: peihualuo@zju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Time-course effects of antioxidants and phase II enzymes on diesel exhaust particles-induced oxidative damage in the mouse lung.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30641076</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30017-1</DOI>
    <KeywordList>
      <Keywords>Antioxidant enzymes</Keywords>
      <Keywords>Diesel exhaust particles</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Phase II enzymes</Keywords>
      <Keywords>Time point</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaomei Zheng</Name>
        <Affiliation>National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Xicheng District, 29 Nanwei Road, Beijing 100050, China. Electronic address: zhengxm90@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guanglei Wang</Name>
        <Affiliation>National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Xicheng District, 29 Nanwei Road, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Bin</Name>
        <Affiliation>National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Xicheng District, 29 Nanwei Road, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Meng</Name>
        <Affiliation>School of Medicine, Datong University, Yudong District,16 Xingyun Street, Datong 037009, Shanxi Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Niu</Name>
        <Affiliation>National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Xicheng District, 29 Nanwei Road, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mo Yang</Name>
        <Affiliation>Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou 510080, Guangdong Province, China. Electronic address: yangm93@mail2.sysu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Liping Zhang</Name>
        <Affiliation>Faculty of Public Health, Weifang Medical University, 7166 Baotong West Street, Weifang 261053, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huawei Duan</Name>
        <Affiliation>National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Xicheng District, 29 Nanwei Road, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Yu</Name>
        <Affiliation>National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Xicheng District, 29 Nanwei Road, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufei Dai</Name>
        <Affiliation>National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Xicheng District, 29 Nanwei Road, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuxin Zheng</Name>
        <Affiliation>School of Public Health, Qingdao University, Dengzhou Road 38, Qingdao 266021, Shandong Province, China; National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Xicheng District, 29 Nanwei Road, Beijing 100050, China. Electronic address: yxzheng@qdu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>High copper levels in follicular fluid affect follicle development in polycystic ovary syndrome patients: Population-based and in vitro studies.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30641075</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30016-X</DOI>
    <KeywordList>
      <Keywords>Copper</Keywords>
      <Keywords>Follicle development</Keywords>
      <Keywords>Follicular fluid</Keywords>
      <Keywords>ICP-MS</Keywords>
      <Keywords>Polycystic ovary syndrome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Sun</Name>
        <Affiliation>Reproductive Medicine Center, Fujian Provincial Maternity and Children's Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China; Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenxiang Wang</Name>
        <Affiliation>Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China; Department of Health Inspection and Quarantine, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China. Electronic address: wangwenxiang@fjmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yiwei Guo</Name>
        <Affiliation>Department of Health Inspection and Quarantine, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Beihong Zheng</Name>
        <Affiliation>Reproductive Medicine Center, Fujian Provincial Maternity and Children's Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Li</Name>
        <Affiliation>Department of Pharmaceuticals, Fujian Health College, Fuzhou, Fujian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinfa Chen</Name>
        <Affiliation>Department of Health Inspection and Quarantine, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenchang Zhang</Name>
        <Affiliation>Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China; Fujian Province Key Laboratory of Environment and Cancer, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Early life inhalation exposure to mine tailings dust affects lung development.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30641074</pubmedLink>
    <GrantList>
      <Grant>P30 ES006694</Grant>
      <Grant>P42 ES004940</Grant>
      <Grant>R01 ES027013</Grant>
      <Grant>R21 ES028889</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30019-5</DOI>
    <KeywordList>
      <Keywords>Lung development</Keywords>
      <Keywords>Lung disease</Keywords>
      <Keywords>Mine tailings dust</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark L. Witten</Name>
        <Affiliation>Phoenix Biometrics, Inc., Tucson, AZ 85710, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Binh Chau</Name>
        <Affiliation>Department of Cellular &amp; Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85724, United States. Electronic address: bchau@email.arizona.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo Sáez</Name>
        <Affiliation>Department of Chemical and Environmental Engineering, University of Arizona, United States. Electronic address: esaez@email.arizona.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Boitano</Name>
        <Affiliation>Department of Physiology, The Asthma and Airway Disease Research Center, University of Arizona Health Sciences Center, Tucson, AZ 85724, United States. Electronic address: sboitano@email.arizona.edu.</Affiliation>
      </Author>
      <Author>
        <Name>R. Clark Lantz</Name>
        <Affiliation>Department of Cellular &amp; Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85724, United States. Electronic address: lantz@email.arizona.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In utero exposure to simvastatin reduces postnatal survival and permanently alters reproductive tract development in the Crl:CD(SD) male rat.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30639414</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30001-8</DOI>
    <KeywordList>
      <Keywords>Male rat sex differentiation</Keywords>
      <Keywords>Postnatal survival</Keywords>
      <Keywords>Simvastatin (SMV)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brandiese E. J. Beverly</Name>
        <Affiliation>Reproductive Toxicology Branch, Toxicity Assessment Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, US Environmental Protection Agency, B105-04, 109 TW Alexander Dr., Research Triangle Park, NC 27709, United States; Oak Ridge Institute for Science and Education, Oak Ridge, TN 37831, United States. Electronic address: beverly.brandy@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Johnathan R. Furr</Name>
        <Affiliation>Reproductive Toxicology Branch, Toxicity Assessment Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, US Environmental Protection Agency, B105-04, 109 TW Alexander Dr., Research Triangle Park, NC 27709, United States. Electronic address: jfurr@southernresearch.org.</Affiliation>
      </Author>
      <Author>
        <Name>Christy S. Lambright</Name>
        <Affiliation>Reproductive Toxicology Branch, Toxicity Assessment Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, US Environmental Protection Agency, B105-04, 109 TW Alexander Dr., Research Triangle Park, NC 27709, United States. Electronic address: lambright.christy@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Vickie S. Wilson</Name>
        <Affiliation>Reproductive Toxicology Branch, Toxicity Assessment Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, US Environmental Protection Agency, B105-04, 109 TW Alexander Dr., Research Triangle Park, NC 27709, United States. Electronic address: wilson.vickie@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Barry S. McIntyre</Name>
        <Affiliation>National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, United States. Electronic address: mcintyrebs@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Paul M. D. Foster</Name>
        <Affiliation>National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, United States. Electronic address: foster2@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Greg Travlos</Name>
        <Affiliation>National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, United States. Electronic address: travlos@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>L. Earl Gray</Name>
        <Affiliation>Reproductive Toxicology Branch, Toxicity Assessment Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, US Environmental Protection Agency, B105-04, 109 TW Alexander Dr., Research Triangle Park, NC 27709, United States. Electronic address: gray.earl@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pulmonary exposure to silver nanoparticles impairs cardiovascular homeostasis: Effects of coating, dose and time.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30639276</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30006-7</DOI>
    <KeywordList>
      <Keywords>DNA oxidative damage</Keywords>
      <Keywords>Silver nanoparticles</Keywords>
      <Keywords>apoptosis</Keywords>
      <Keywords>coating, thrombosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zannatul Ferdous</Name>
        <Affiliation>Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, United Arab Emirates.</Affiliation>
      </Author>
      <Author>
        <Name>Suhail Al-Salam</Name>
        <Affiliation>Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, P.O Box 17666, Al Ain, United Arab Emirates.</Affiliation>
      </Author>
      <Author>
        <Name>Yaser E. Greish</Name>
        <Affiliation>Department of Chemistry, College of Science, United Arab Emirates University, P.O. Box 17551, United Arab Emirates.</Affiliation>
      </Author>
      <Author>
        <Name>Badreldin H. Ali</Name>
        <Affiliation>Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, P.O. Box 35, Muscat 123, Al-Khod, Oman.</Affiliation>
      </Author>
      <Author>
        <Name>Abderrahim Nemmar</Name>
        <Affiliation>Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, United Arab Emirates. Electronic address: anemmar@uaeu.ac.ae.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of the modes of action and dose-response relationship for thiocyanate on the thyroid hormone levels in rats using a computational approach.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30639275</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30013-4</DOI>
    <AuthorList>
      <Author>
        <Name>Marie Emilie Willemin</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: mwille15@its.jnj.com.</Affiliation>
      </Author>
      <Author>
        <Name>Annie Lumen</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: Annie.Lumen@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30633885</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30005-5</DOI>
    <KeywordList>
      <Keywords>Acetyl-macrocalin B</Keywords>
      <Keywords>Chk1/Chk2</Keywords>
      <Keywords>Esophageal squamous cell carcinoma</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>p38 MAPK</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Nan Wang</Name>
        <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Che</Name>
        <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zu Yang Yuan</Name>
        <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Liang Lu</Name>
        <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Li</Name>
        <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Rong Zhang</Name>
        <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ning Li</Name>
        <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ren Da Li</Name>
        <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Wan</Name>
        <Affiliation>State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, Yunnan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Han Dong Sun</Name>
        <Affiliation>State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, Yunnan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Nan Sun</Name>
        <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: sunnan@vip.126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pema Tenzin Puno</Name>
        <Affiliation>State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, Yunnan, China. Electronic address: punopematenzin@mail.kib.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jie He</Name>
        <Affiliation>Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: prof.jiehe@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30625338</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30004-3</DOI>
    <KeywordList>
      <Keywords>Fatty acid synthase</Keywords>
      <Keywords>Hepatocarcinogenesis</Keywords>
      <Keywords>Hexokinase 2</Keywords>
      <Keywords>Metformin</Keywords>
      <Keywords>Pyruvate kinase M2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cong Zhang</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Junjie Hu</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Sheng</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Yuan</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Wu</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Chen</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Guohua Zheng</Name>
        <Affiliation>Key Laboratory of Chinese Medicine Resource and Compound Prescription, Ministry of Education, Hubei University of Chinese Medicine, Wuhan, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenpeng Qiu</Name>
        <Affiliation>College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, People's Republic of China. Electronic address: whuqq@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30611723</pubmedLink>
    <GrantList>
      <Grant>P30 ES020957</Grant>
      <Grant>R01 HL050710</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30003-1</DOI>
    <KeywordList>
      <Keywords>Farnesol</Keywords>
      <Keywords>HepaRG cells</Keywords>
      <Keywords>Lipid metabolism</Keywords>
      <Keywords>Peroxisome proliferator-activated receptor</Keywords>
      <Keywords>Steatosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Asmita Pant</Name>
        <Affiliation>Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA. Electronic address: pantasmi@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth A. Rondini</Name>
        <Affiliation>Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA. Electronic address: rondinie@wayne.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas A. Kocarek</Name>
        <Affiliation>Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA. Electronic address: t.kocarek@wayne.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Vanillin protects the blood-milk barrier and inhibits the inflammatory response in LPS-induced mastitis in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30610879</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30581-7</DOI>
    <KeywordList>
      <Keywords>Blood–Milk Barrier</Keywords>
      <Keywords>MAPK</Keywords>
      <Keywords>Mastitis</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>Vanillin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wenjin Guo</Name>
        <Affiliation>College of Veterinary Medicine, Jilin University, Changchun 130062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bingrun Liu</Name>
        <Affiliation>Laboratory of Biomolecular Research, Division of Biology and Chemistry, Paul Scherrer Institute, Villigen CH-5232, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Guiqiu Hu</Name>
        <Affiliation>College of Veterinary Medicine, Jilin University, Changchun 130062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xingchi Kan</Name>
        <Affiliation>College of Veterinary Medicine, Jilin University, Changchun 130062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanwei Li</Name>
        <Affiliation>College of Veterinary Medicine, Jilin University, Changchun 130062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Gong</Name>
        <Affiliation>College of Veterinary Medicine, Jilin University, Changchun 130062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dianwen Xu</Name>
        <Affiliation>College of Veterinary Medicine, Jilin University, Changchun 130062, China.</Affiliation>
      </Author>
      <Author>
        <Name>He Ma</Name>
        <Affiliation>College of Veterinary Medicine, Jilin University, Changchun 130062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Cao</Name>
        <Affiliation>College of Veterinary Medicine, Jilin University, Changchun 130062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bingxu Huang</Name>
        <Affiliation>College of Veterinary Medicine, Jilin University, Changchun 130062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shoupeng Fu</Name>
        <Affiliation>College of Veterinary Medicine, Jilin University, Changchun 130062, China. Electronic address: fushoupeng@jlu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Juxiong Liu</Name>
        <Affiliation>College of Veterinary Medicine, Jilin University, Changchun 130062, China. Electronic address: juxiong@jlu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Triptonide inhibits lung cancer cell tumorigenicity by selectively attenuating the Shh-Gli1 signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30610878</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(19)30002-X</DOI>
    <KeywordList>
      <Keywords>Cancer therapy</Keywords>
      <Keywords>Gli1</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Shh</Keywords>
      <Keywords>Signaling pathway</Keywords>
      <Keywords>Triptonide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mengli Zhang</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, 2011 Collaborative Innovation Center of Hematology, Soochow University; Suzhou, Jiangsu 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shijie Tan</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, 2011 Collaborative Innovation Center of Hematology, Soochow University; Suzhou, Jiangsu 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Di Yu</Name>
        <Affiliation>Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu 214122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Zhao</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, 2011 Collaborative Innovation Center of Hematology, Soochow University; Suzhou, Jiangsu 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Zhang</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, 2011 Collaborative Innovation Center of Hematology, Soochow University; Suzhou, Jiangsu 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pan Zhang</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, 2011 Collaborative Innovation Center of Hematology, Soochow University; Suzhou, Jiangsu 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunping Lv</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, 2011 Collaborative Innovation Center of Hematology, Soochow University; Suzhou, Jiangsu 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Quansheng Zhou</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, 2011 Collaborative Innovation Center of Hematology, Soochow University; Suzhou, Jiangsu 215123, PR China. Electronic address: zhouqs@suda.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhifei Cao</Name>
        <Affiliation>Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, 2011 Collaborative Innovation Center of Hematology, Soochow University; Suzhou, Jiangsu 215123, PR China. Electronic address: zhfcao@suda.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30597158</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30576-3</DOI>
    <KeywordList>
      <Keywords>Dexmedetomidine</Keywords>
      <Keywords>GSK-3β</Keywords>
      <Keywords>Lipopolysaccharide</Keywords>
      <Keywords>Liver damage</Keywords>
      <Keywords>α2 adrenergic receptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jichen Sha</Name>
        <Affiliation>Heilongjiang Key Laboratory for Laboratory Animals and Comparative Medicine, College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huayun Zhang</Name>
        <Affiliation>Heilongjiang Key Laboratory for Laboratory Animals and Comparative Medicine, College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Zhao</Name>
        <Affiliation>Heilongjiang Key Laboratory for Laboratory Animals and Comparative Medicine, College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiujing Feng</Name>
        <Affiliation>Heilongjiang Key Laboratory for Laboratory Animals and Comparative Medicine, College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xueyuan Hu</Name>
        <Affiliation>Heilongjiang Key Laboratory for Laboratory Animals and Comparative Medicine, College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chaoran Wang</Name>
        <Affiliation>Heilongjiang Key Laboratory for Laboratory Animals and Comparative Medicine, College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Manyu Song</Name>
        <Affiliation>Heilongjiang Key Laboratory for Laboratory Animals and Comparative Medicine, College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Honggang Fan</Name>
        <Affiliation>Heilongjiang Key Laboratory for Laboratory Animals and Comparative Medicine, College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China. Electronic address: fanhonggang2002@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Multigenerational consequences of early-life cannabinoid exposure in zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30594692</pubmedLink>
    <GrantList>
      <Grant>P20 GM104932</Grant>
      <Grant>R21 DA044473</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30580-5</DOI>
    <KeywordList>
      <Keywords>Behavior</Keywords>
      <Keywords>Cannabidiol</Keywords>
      <Keywords>Development</Keywords>
      <Keywords>Multigenerational</Keywords>
      <Keywords>Tetrahydrocannabinol</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dennis R. Carty</Name>
        <Affiliation>Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA; Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zachary S. Miller</Name>
        <Affiliation>Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cammi Thornton</Name>
        <Affiliation>Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zacharias Pandelides</Name>
        <Affiliation>Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marisa L. Kutchma</Name>
        <Affiliation>Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kristine L. Willett</Name>
        <Affiliation>Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA. Electronic address: kwillett@olemiss.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30594691</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30578-7</DOI>
    <KeywordList>
      <Keywords>Myricetin</Keywords>
      <Keywords>NLRP3 inflammasome</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Ubiquitination</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hanwen Chen</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Zhejiang University, Zhejiang, Hangzhou 310058, China; Department of Gastroenterology, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou 310009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Lin</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Zhejiang University, Zhejiang, Hangzhou 310058, China; Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shujun Xie</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Zhejiang University, Zhejiang, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Huang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Zhejiang University, Zhejiang, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufeng Qian</Name>
        <Affiliation>Department of Cardiology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kelie Chen</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Zhejiang University, Zhejiang, Hangzhou 310058, China; Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuequn Niu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Zhejiang University, Zhejiang, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Han Ming Shen</Name>
        <Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 119077, Singapore.</Affiliation>
      </Author>
      <Author>
        <Name>Jianting Cai</Name>
        <Affiliation>Department of Gastroenterology, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou 310009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peiwei Li</Name>
        <Affiliation>Department of Gastroenterology, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou 310009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianhang Leng</Name>
        <Affiliation>Central Laboratory, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Yang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Zhejiang University, Zhejiang, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dajing Xia</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou 310058, China. Electronic address: dxia@zju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yihua Wu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Zhejiang University, Zhejiang, Hangzhou 310058, China. Electronic address: georgewu@zju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30594690</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30579-9</DOI>
    <KeywordList>
      <Keywords>Bax:BCL-2</Keywords>
      <Keywords>NFκB</Keywords>
      <Keywords>Nrf2, HO-1</Keywords>
      <Keywords>Olmesartan</Keywords>
      <Keywords>Ulcerative Colitis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sameh Saber</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa City, Mansoura, Dakahlia, Egypt. Electronic address: sameh.mohamed@deltauniv.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Rania M. Khalil</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa City, Mansoura, Dakahlia, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Walied S. Abdo</Name>
        <Affiliation>Department of Pathology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Doaa Nassif</Name>
        <Affiliation>Department of Pharmacy Practice, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa City, Mansoura, Dakahlia, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Eman El-Ahwany</Name>
        <Affiliation>Department of Immunology, Theodor Bilharz Research Institute, Giza, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The interaction of zinc and the blood-brain barrier under physiological and ischemic conditions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30594689</pubmedLink>
    <GrantList>
      <Grant>P30 GM103400</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30577-5</DOI>
    <KeywordList>
      <Keywords>Blood-brain barrier</Keywords>
      <Keywords>Endothelial cells</Keywords>
      <Keywords>Ischemia</Keywords>
      <Keywords>Zinc</Keywords>
      <Keywords>Zinc transporter</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhifeng Qi</Name>
        <Affiliation>Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Liu</Name>
        <Affiliation>Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University, Beijing, China; Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM, USA. Electronic address: kliu@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>L-Carnosine protects against Oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: A perspective on targeting Nrf-2 and NF-κB pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30592963</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30562-3</DOI>
    <KeywordList>
      <Keywords>Caspase-3</Keywords>
      <Keywords>L-carnosine</Keywords>
      <Keywords>MDA</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>Nrf-2</Keywords>
      <Keywords>Oxaliplatin</Keywords>
      <Keywords>TNF-α</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rana Yehia</Name>
        <Affiliation>Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Misr International University, Cairo, Egypt. Electronic address: rana.magdy@miuegypt.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Samira Saleh</Name>
        <Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University in Egypt (FUE), Cairo, Egypt.; Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Hanan El Abhar</Name>
        <Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Amr S. Saad</Name>
        <Affiliation>Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mona Schaalan</Name>
        <Affiliation>Biochemistry and Clinical Pharmacy Department, Faculty of Pharmacy, Misr International University, Cairo, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Micromolar concentrations of citalopram or escitalopram inhibit glycoprotein VI-mediated and integrin αIIbβ3-mediated signaling in human platelets.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30592962</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30575-1</DOI>
    <KeywordList>
      <Keywords>Citalopram</Keywords>
      <Keywords>Escitalopram</Keywords>
      <Keywords>Platelet function</Keywords>
      <Keywords>Selective serotonin reuptake inhibitor</Keywords>
      <Keywords>Syk</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Lun Tseng</Name>
        <Affiliation>Department of Psychiatry, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan; School of Medicine, Tzu Chi University, Hualien, Taiwan. Electronic address: tsengyulun@tzuchi.com.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Attila Braun</Name>
        <Affiliation>Institute of Experimental Biomedicine, University Hospital of Würzburg, Würzburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Pei Chen Chang</Name>
        <Affiliation>Department of Psychiatry, University Hospital and School of Medicine, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Ling Chiang</Name>
        <Affiliation>Department of Oral Pathology and Oral Diagnosis, Department of Pediatric Dentistry, Chang Gung Memorial Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chi Yu Tseng</Name>
        <Affiliation>Department of Neurology, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan; School of Medicine, Tzu Chi University, Hualien, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wenchun Chen</Name>
        <Affiliation>Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicokinetics of benzo[a]pyrene in humans: Extensive metabolism as determined by UPLC-accelerator mass spectrometry following oral micro-dosing.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30582946</pubmedLink>
    <GrantList>
      <Grant>P41 GM103483</Grant>
      <Grant>P42 ES016465</Grant>
      <Grant>R01 ES028600</Grant>
      <Grant>T32 ES007060</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30557-X</DOI>
    <KeywordList>
      <Keywords>Accelerator mass spectrometry</Keywords>
      <Keywords>Benzo[a]pyrene</Keywords>
      <Keywords>Metabolites</Keywords>
      <Keywords>Micro-dosing</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Polycyclic aromatic hydrocarbons</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Erin Madeen</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, USA; NIEHS Superfund Research Program, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisbeth K. Siddens</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, USA; NIEHS Superfund Research Program, Oregon State University, Corvallis, OR, USA; Linus Pauling Institute, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra Uesugi</Name>
        <Affiliation>Linus Pauling Institute, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tammie McQuistan</Name>
        <Affiliation>Western University of Health Sciences, Lebanon, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Corley</Name>
        <Affiliation>NIEHS Superfund Research Program, Oregon State University, Corvallis, OR, USA; Chemical Biology and Exposure Science, Pacific Northwest National Laboratory, Richland, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jordan Smith</Name>
        <Affiliation>NIEHS Superfund Research Program, Oregon State University, Corvallis, OR, USA; Chemical Biology and Exposure Science, Pacific Northwest National Laboratory, Richland, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katrina M. Waters</Name>
        <Affiliation>NIEHS Superfund Research Program, Oregon State University, Corvallis, OR, USA; Chemical Biology and Exposure Science, Pacific Northwest National Laboratory, Richland, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susan C. Tilton</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, USA; NIEHS Superfund Research Program, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kim A. Anderson</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, USA; NIEHS Superfund Research Program, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ted Ognibene</Name>
        <Affiliation>Center for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, Livermore, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth Turteltaub</Name>
        <Affiliation>Center for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, Livermore, CA, USA; Biology and Biotechnology Research Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David E. Williams</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, USA; NIEHS Superfund Research Program, Oregon State University, Corvallis, OR, USA; Linus Pauling Institute, Oregon State University, Corvallis, OR, USA. Electronic address: david.williams@oregonstate.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Venlafaxine and carvedilol ameliorate testicular impairment and disrupted spermatogenesis in rheumatoid arthritis by targeting AMPK/ERK and PI3K/AKT/mTOR pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30578887</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30561-1</DOI>
    <KeywordList>
      <Keywords>AMPK/ERK</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Carvedilol</Keywords>
      <Keywords>PI3K/AKT/mTOR</Keywords>
      <Keywords>Venlafaxine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ahmed H. Eid</Name>
        <Affiliation>Department of Pharmacology, National Organization for Drug Control and Research, NODCAR, Giza 12553, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Amany M. Gad</Name>
        <Affiliation>Department of Pharmacology, National Organization for Drug Control and Research, NODCAR, Giza 12553, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Ebtehal Mohammad Fikry</Name>
        <Affiliation>Department of Pharmacology, National Organization for Drug Control and Research, NODCAR, Giza 12553, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Hany H. Arab</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt; Biochemistry Division and GTMR Unit, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Taif University, Taif, Saudi Arabia. Electronic address: hany.arab@pharma.cu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>M2 macrophage-derived IL6 mediates resistance of breast cancer cells to hedgehog inhibition.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30578886</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30560-X</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Hedgehog inhibitor</Keywords>
      <Keywords>IL6</Keywords>
      <Keywords>Tumor-associated macrophage</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaojun Xu</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiabao Ye</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Huang</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunwen Yan</Name>
        <Affiliation>Department of Breast Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Li</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, China. Electronic address: lijun@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
</PubmedArticleSet>
